Citrus Sinensis ID: 027003

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------23
Protein Sequence
MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR
Secondary Structure (PSIPRED)
cEEEccHHHHHHHHHccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEHHHHHHHHHHHHcccccEEEEcccHcHEEccccccccHcHccccccccccccccEEEEEEccccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcHHHHHHHHcHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MKVAIGaakgltflhdaesqVIYRDFKASNILLDAEFNAklsdfglakagptgdrthvstqvmgthgyaapeyvatgrlttksdvYSFGVVLLELLSgrcavdktkvGIEQSLVdwakpylsdkrKLFRIMdtklggqypqkAAHTAATLALQClnnepklrprMSEVLAILERLeapknsaklsqsephrqtgpvtvrkspmrqqrsplnmtptasplpshrqsprvr
Flexible Loop (DISEMBL)
mkvaigaakgltflhdaeSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSgrcavdktkvgieqslvdwakpylsdkrKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEApknsaklsqsephrqtgpvtvrkspmrqqrsplnmtptasplpshrqsprvr
Low Complexity Region (SEG)
MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR
Disordered region (IsUnstruct)
****IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN**********VLAI**********************************************************
Disordered Region (DISOPRED)
MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER*******************************************************
Disordered Region (DISEMBL)
MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK*****************************PLNMTP***************
Disordered Region (DISPRO)
MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA****************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	229	2.2.26 [Sep-21-2011]
O49840	426	Protein kinase 2B, chloro	yes	no	1.0	0.537	0.757	1e-96
O49839	426	Protein kinase 2A, chloro	no	no	1.0	0.537	0.741	7e-92
Q06548	410	Protein kinase APK1A, chl	no	no	0.772	0.431	0.689	1e-68
P46573	412	Protein kinase APK1B, chl	no	no	0.965	0.536	0.577	2e-68
Q8GXZ3	410	Serine/threonine-protein	no	no	0.772	0.431	0.661	1e-63
P43293	389	Probable serine/threonine	no	no	0.873	0.514	0.584	2e-63
Q9FM85	408	Probable receptor-like pr	no	no	0.803	0.450	0.608	1e-61
Q9LFP7	493	Probable receptor-like pr	no	no	0.807	0.375	0.596	3e-59
Q9SRH7	490	Receptor-like serine/thre	no	no	0.807	0.377	0.596	3e-59
Q8H186	389	Probable receptor-like pr	no	no	0.903	0.532	0.539	4e-58

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  352 bits (904), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 178/235 (75%), Positives = 200/235 (85%), Gaps = 6/235 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGLAKAGPTGD+THVST
Sbjct: 192 MKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVST 251

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+KVG+EQSLVDWA PY
Sbjct: 252 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPY 311

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MSEVLA L++LE+ K 
Sbjct: 312 LGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTKP 371

Query: 181 SAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 229
              +    +Q +  R +    V+KSP R    R  L++TP ASPLP+H  SPRVR
Sbjct: 372 GTGVGNRQAQIDSPRGSNGSIVQKSPRRYSYDRPLLHITPGASPLPTHNHSPRVR 426

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  336 bits (862), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 172/232 (74%), Positives = 192/232 (82%), Gaps = 3/232 (1%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDFGLAKAGPTGD THVST
Sbjct: 195 MKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVST 254

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D +  G E SLVDWA PY
Sbjct: 255 KVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPY 314

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-PK 179
           L DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+MSEVL  LE+LE+  K
Sbjct: 315 LGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAK 374

Query: 180 NSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 229
              K +Q E  R      ++KSP+R    R  L+MTP ASPLPS+ QSPRVR
Sbjct: 375 PGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSYTQSPRVR 426

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  259 bits (661), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 122/177 (68%), Positives = 150/177 (84%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVA+GAAKGL FLH +E++VIYRDFK SNILLD+E+NAKLSDFGLAK GP GD++HVST
Sbjct: 179 LKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVST 238

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +VMGTHGYAAPEY+ATG LTTKSDVYSFGVVLLELLSGR AVDK +   E++LV+WAKPY
Sbjct: 239 RVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPY 298

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
           L +KRK+FR++D +L  QY  + A   ATL+L+CL  E KLRP MSEV++ LE +++
Sbjct: 299 LVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQS 355

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  258 bits (659), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 131/227 (57%), Positives = 170/227 (74%), Gaps = 6/227 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKLSDFGLAK GPTGD++HVST
Sbjct: 180 LKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 239

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           ++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR AVDK +   EQ LV+WA+P 
Sbjct: 240 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPL 299

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL----E 176
           L++KRKLFR++D +L  QY  + A   ATLAL+CL  E KLRP M+EV++ LE +    E
Sbjct: 300 LANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 359

Query: 177 APKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPS 221
           A   +  + Q    R++  V + + P     +++ + +  TA P PS
Sbjct: 360 AGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATAYPRPS 406

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  243 bits (619), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 117/177 (66%), Positives = 142/177 (80%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M +A+GAAKGL FLH+AE  VIYRDFK SNILLD+++ AKLSDFGLAKAGP GD THVST
Sbjct: 175 MMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 234

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+   EQ+LVDWA+P 
Sbjct: 235 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPK 294

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
           L+DKRKL +I+D +L  QY  +AA  A +LA  CL+  PK RP MS+V+  LE L+ 
Sbjct: 295 LNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC 351

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  241 bits (616), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 118/202 (58%), Positives = 152/202 (75%), Gaps = 2/202 (0%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLSDFGLA+ GP GD +HVST
Sbjct: 179 VRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVST 238

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+DK +   E +LVDWA+PY
Sbjct: 239 RVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPY 298

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L++KR+L R+MD +L GQY    A   A LAL C++ + K RP M+E++  +E L   K 
Sbjct: 299 LTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKE 358

Query: 181 SAKLSQSEPHRQTGPVTVRKSP 202
           ++K  Q  P      + + KSP
Sbjct: 359 ASK-EQQNPQISIDNI-INKSP 378

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  236 bits (602), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 112/184 (60%), Positives = 141/184 (76%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MK+A GAAKGL FLH+A+  VIYRDFK SNILLD ++NAKLSDFGLAK GP GD++HVST
Sbjct: 185 MKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVST 244

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           ++MGT+GYAAPEY+ TG LT  SDVYSFGVVLLELL+GR ++DK++   EQ+L+DWA P 
Sbjct: 245 RIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPL 304

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L +K+K+  I+D K+  +YP KA   AA LA  CLN  PK RP M +++  LE L+A + 
Sbjct: 305 LKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEE 364

Query: 181 SAKL 184
            A L
Sbjct: 365 EALL 368

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  228 bits (580), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 111/186 (59%), Positives = 144/186 (77%), Gaps = 1/186 (0%)

Query: 1   MKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 59
           MK+A+GAAKGL+FLH+ A   VIYRDFK SNILLDA++NAKLSDFGLAK  P   +THVS
Sbjct: 250 MKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVS 309

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           T+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GR ++DK +   E +LV+WA+P
Sbjct: 310 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 369

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
           +L DKR+ +R++D +L G +  K A     LA QCL+ +PK+RP+MS+V+  L+ L   K
Sbjct: 370 HLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLK 429

Query: 180 NSAKLS 185
           + A  S
Sbjct: 430 DMASSS 435

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  228 bits (580), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 111/186 (59%), Positives = 143/186 (76%), Gaps = 1/186 (0%)

Query: 1   MKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 59
           MK+A+GAAKGL+FLH+ A   VIYRDFK SNILLD E+NAKLSDFGLAK  P   +THVS
Sbjct: 244 MKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVS 303

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           T+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GR ++DK +   E +LV+WA+P
Sbjct: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
           +L DKR+ +R++D +L G +  K A     LA QCL+ + K+RP+MSEV+ +L+ L   K
Sbjct: 364 HLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLK 423

Query: 180 NSAKLS 185
           + A  S
Sbjct: 424 DMASAS 429

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  224 bits (570), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 116/215 (53%), Positives = 152/215 (70%), Gaps = 8/215 (3%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVA+ AAKGL FLH    +VIYRD KASNILLD++FNAKLSDFGLA+ GP G++++VST
Sbjct: 173 IKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYVST 232

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +VMGT GYAAPEYV+TG L  +SDVYSFGVVLLELL GR A+D  +   EQ+LVDWA+PY
Sbjct: 233 RVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVDWARPY 292

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE---- 176
           L+ +RK+  I+DT+L  QY  + A   A++A+QCL+ EPK RP M +V+  L +L+    
Sbjct: 293 LTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQDSVV 352

Query: 177 APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 211
            P N   L   +  +  G     K+  + QR+ LN
Sbjct: 353 KPANVDPLKVKDTKKLVG----LKTEDKYQRNGLN 383

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	229
255558180	419	Protein kinase APK1A, chloroplast precur	0.986	0.539	0.839	1e-107
225425762	420	PREDICTED: protein kinase 2B, chloroplas	0.991	0.540	0.829	1e-106
224099729	418	predicted protein [Populus trichocarpa]	0.991	0.543	0.803	1e-100
224111270	417	predicted protein [Populus trichocarpa]	0.991	0.544	0.794	1e-100
48209875	420	putative protein kinase [Solanum demissu	0.991	0.540	0.786	6e-99
113205211	401	Protein kinase APK1B, chloroplast precur	0.991	0.566	0.786	1e-98
356498210	422	PREDICTED: LOW QUALITY PROTEIN: protein	0.951	0.516	0.814	3e-97
356500447	414	PREDICTED: LOW QUALITY PROTEIN: protein	0.951	0.526	0.814	5e-97
297817892	426	hypothetical protein ARALYDRAFT_484186 [	1.0	0.537	0.761	2e-95
357486685	410	Protein kinase 2B [Medicago truncatula]	0.978	0.546	0.775	5e-95

>gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis]

 Score =  392 bits (1007), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 193/230 (83%), Positives = 209/230 (90%), Gaps = 4/230 (1%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVA+GAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAK GPTGDRTHVST
Sbjct: 193 IKVAVGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKEGPTGDRTHVST 252

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTKVGIEQ+LVDWAKPY
Sbjct: 253 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVGIEQNLVDWAKPY 312

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           LSDKRKLFRIMDTKLGGQYPQK+AH AA LALQCL+ E K RPRMSEVLA LE++E+PK 
Sbjct: 313 LSDKRKLFRIMDTKLGGQYPQKSAHMAANLALQCLSTEAKARPRMSEVLATLEQIESPKT 372

Query: 181 SAKLSQSE-PHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
           + +LS SE P  Q   + VRKSPMRQ  SPLN+TP+ASPLPSHRQSPRVR
Sbjct: 373 AGRLSHSEHPSIQ---IPVRKSPMRQHHSPLNLTPSASPLPSHRQSPRVR 419

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera]

 Score =  391 bits (1005), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 190/229 (82%), Positives = 209/229 (91%), Gaps = 2/229 (0%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++VAIGAA+GL+FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST
Sbjct: 194 IRVAIGAARGLSFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 253

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTK+G+EQ+LVDWAKPY
Sbjct: 254 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKIGVEQNLVDWAKPY 313

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKR+LFRIMDTKL GQYPQK A  AATLALQCLN E K+RPRMSEVLA LE++++PKN
Sbjct: 314 LGDKRRLFRIMDTKLEGQYPQKGAFMAATLALQCLNTEAKVRPRMSEVLATLEQIQSPKN 373

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
           +AK  QSE H  T  + V+KSP+RQQ SPLN+TP ASPLPS+RQSPRVR
Sbjct: 374 AAKHIQSEQH--TVSIPVQKSPLRQQHSPLNLTPRASPLPSYRQSPRVR 420

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa]

 Score =  371 bits (953), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 184/229 (80%), Positives = 201/229 (87%), Gaps = 2/229 (0%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST
Sbjct: 192 VKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 251

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTKVG+EQ+L DWAKPY
Sbjct: 252 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVGVEQNLADWAKPY 311

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKRKLFRIMDTKLGGQYPQK A  AA LALQCL+NE K+RPRMSEVLA LE +E+PK 
Sbjct: 312 LGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSNEAKVRPRMSEVLATLENIESPKG 371

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
           +AK S+SE  +QT    VR+SPMR   +P     +ASPLPSH QSPR+R
Sbjct: 372 AAKNSRSE--QQTVQTPVRQSPMRHHHAPGTPPASASPLPSHHQSPRLR 418

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa]

 Score =  369 bits (947), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 182/229 (79%), Positives = 199/229 (86%), Gaps = 2/229 (0%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST
Sbjct: 191 IKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 250

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLE LSGR AVDK+KVG+EQ+LVDW KPY
Sbjct: 251 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEFLSGRRAVDKSKVGVEQNLVDWVKPY 310

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKRKLFRIMDTKLGGQYPQK A  AA LALQCL+ E K+RPRMSEVLA LE++E+PK 
Sbjct: 311 LGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSTEAKVRPRMSEVLATLEQIESPKG 370

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
           + K  Q E   QT    VR+SPMR  RSP+  T +ASPLPSH QSPR+R
Sbjct: 371 AVKNIQLE--HQTVQTPVRQSPMRHHRSPVIPTASASPLPSHHQSPRLR 417

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|48209875|gb|AAT40481.1| putative protein kinase [Solanum demissum]

 Score =  365 bits (938), Expect = 6e-99,   Method: Compositional matrix adjust.
 Identities = 180/229 (78%), Positives = 198/229 (86%), Gaps = 2/229 (0%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVST
Sbjct: 194 IKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVST 253

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD TKVGIEQ+LVDWAKPY
Sbjct: 254 QVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDNTKVGIEQNLVDWAKPY 313

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+MSEVL  LE L++PK 
Sbjct: 314 LGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPKMSEVLTALEELQSPKG 373

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
            +KLS +E      PV V  SPMR  RSPL+MTP+ASP  ++++SPR R
Sbjct: 374 VSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPFQAYQKSPRGR 420

Source: Solanum demissum

Species: Solanum demissum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|113205211|gb|AAT39953.2| Protein kinase APK1B, chloroplast precursor, putative [Solanum demissum]

 Score =  364 bits (935), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 180/229 (78%), Positives = 198/229 (86%), Gaps = 2/229 (0%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVST
Sbjct: 175 IKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVST 234

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD  KVGIEQ+LVDWAKPY
Sbjct: 235 QVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDNAKVGIEQNLVDWAKPY 294

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+MSEVL  LE L++PK 
Sbjct: 295 LGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPKMSEVLTALEELQSPKG 354

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
            +KLS +E      PV V  SPMR  RSPL+MTP+ASPL ++++SPR R
Sbjct: 355 VSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPLQAYQKSPRGR 401

Source: Solanum demissum

Species: Solanum demissum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  360 bits (923), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 180/221 (81%), Positives = 196/221 (88%), Gaps = 3/221 (1%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVST
Sbjct: 186 MKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVST 245

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKT  G+EQ+LVDWAKPY
Sbjct: 246 QVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITGMEQNLVDWAKPY 305

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           LSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP M+EVLA LE++EAPK 
Sbjct: 306 LSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEVLATLEQIEAPKT 365

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 221
           + + S SE HR   P  VRKSP R  RSPLN+TPTASPLP+
Sbjct: 366 AGRNSHSEHHRVQTP--VRKSPAR-NRSPLNLTPTASPLPA 403

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  359 bits (922), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 180/221 (81%), Positives = 196/221 (88%), Gaps = 3/221 (1%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVST
Sbjct: 186 MKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVST 245

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKT  G+EQ+LVDWAKPY
Sbjct: 246 QVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITGMEQNLVDWAKPY 305

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           LSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP M+EVLA LE++EAPK 
Sbjct: 306 LSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEVLATLEQIEAPKT 365

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 221
           + + S SE HR   P  VRKSP R  RSPLN+TPTASPLP+
Sbjct: 366 AGRNSHSEHHRLQTP--VRKSPAR-NRSPLNLTPTASPLPA 403

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297817892|ref|XP_002876829.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata] gi|297322667|gb|EFH53088.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata]

 Score =  353 bits (907), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 179/235 (76%), Positives = 200/235 (85%), Gaps = 6/235 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGLAKAGPTGD+THVST
Sbjct: 192 MKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVST 251

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+KVG+EQSLVDWA PY
Sbjct: 252 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPY 311

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MSEVLA L++LE+ K 
Sbjct: 312 LGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTKP 371

Query: 181 SAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 229
              +    +Q +  R +    V+KSP R    R  L++TP ASPLPSH  SPRVR
Sbjct: 372 GTGIGNRQAQIDSPRGSNGSVVQKSPRRYSYDRPLLHITPGASPLPSHNHSPRVR 426

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula]

 Score =  352 bits (904), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 176/227 (77%), Positives = 198/227 (87%), Gaps = 3/227 (1%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           MKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVST
Sbjct: 185 MKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVST 244

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           QV+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLSGR AVDKT  G++Q+LVDWAKPY
Sbjct: 245 QVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIAGVDQNLVDWAKPY 304

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
           L DKR+LFRIMD+KL GQYPQK A  AATLALQCLN E K RP M+EVLA LE++EAPK+
Sbjct: 305 LGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTEVLATLEQIEAPKH 364

Query: 181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 227
           +++ S SE HR   P  VR+SP R  R+P  +TPTASPLPS RQSPR
Sbjct: 365 ASRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTASPLPSVRQSPR 408

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	229
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.995	0.535	0.754	2.3e-87
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	1.0	0.537	0.741	9.1e-84
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.960	0.533	0.694	9.3e-75
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.803	0.475	0.728	2.4e-69
TAIR|locus:2019180	399	AT1G74490 [Arabidopsis thalian	0.807	0.463	0.677	8.8e-63
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.965	0.522	0.577	8.8e-63
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.768	0.380	0.681	9.9e-62
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.986	0.498	0.550	1.7e-59
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.768	0.429	0.664	9.3e-59
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.868	0.511	0.591	2.5e-58

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 873 (312.4 bits), Expect = 2.3e-87, P = 2.3e-87
 Identities = 178/236 (75%), Positives = 199/236 (84%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             MKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGLAKAGPTGD+THVST
Sbjct:   192 MKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVST 251

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             QVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+KVG+EQSLVDWA PY
Sbjct:   252 QVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPY 311

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
             L DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MSEVLA L++LE+ K 
Sbjct:   312 LGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTKP 371

Query:   181 SAKLSQSE-----PHRQTGPVTVRKSPMRQQ--RSPLNMTPTASPLPSHRQSPRVR 229
                +   +     P    G + V+KSP R    R  L++TP ASPLP+H  SPRVR
Sbjct:   372 GTGVGNRQAQIDSPRGSNGSI-VQKSPRRYSYDRPLLHITPGASPLPTHNHSPRVR 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
 Identities = 172/232 (74%), Positives = 192/232 (82%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             MKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDFGLAKAGPTGD THVST
Sbjct:   195 MKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVST 254

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             +V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D +  G E SLVDWA PY
Sbjct:   255 KVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPY 314

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-PK 179
             L DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+MSEVL  LE+LE+  K
Sbjct:   315 LGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAK 374

Query:   180 NSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 229
                K +Q E  R      ++KSP+R    R  L+MTP ASPLPS+ QSPRVR
Sbjct:   375 PGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSYTQSPRVR 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
 Identities = 159/229 (69%), Positives = 176/229 (76%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             +KVAIGAA+GL FLH+A  QVIYRDFKASNILLD+EFNAKLSDFGLAK GPTGDRTHVST
Sbjct:   193 IKVAIGAARGLAFLHEA--QVIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVST 250

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             QVMGT GYAAPEYVATGR+T KSDVYSFGVVLLELLSGR  VDKTKVG+E++LVDWA PY
Sbjct:   251 QVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGVERNLVDWAIPY 310

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
             L DKRK+FRIMDTKLGGQYP K A   A  ALQCLN EPKLRP+MS+VL+ LE LE    
Sbjct:   311 LGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLSTLEELEMTLK 370

Query:   181 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
             S  +S S     +       S   +QR     TP A P+ S R+  RVR
Sbjct:   371 SGSISNSVMKLTSSS----SSFTAKQRV---RTPVADPVLSSRRCRRVR 412

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
 Identities = 137/188 (72%), Positives = 164/188 (87%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             MKVA  AA+GL+FLH+A+  VIYRDFKASNILLD +FNAKLSDFGLAKAGPTGDRTHV+T
Sbjct:   193 MKVAFSAARGLSFLHEAK--VIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDRTHVTT 250

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             QV+GT GYAAPEY+ATGRLT+KSDVYSFGVVLLELLSGR  +DK+KVG+E++LVDWA PY
Sbjct:   251 QVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGVERNLVDWAIPY 310

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
             L D+RK+FRIMDTKLGGQYP K A  AA +AL+CLN EPKLRP M++VL+ L++LE   +
Sbjct:   311 LVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVLSTLQQLET--S 368

Query:   181 SAKLSQSE 188
             S K+  ++
Sbjct:   369 SKKMGSTQ 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)]

 Score = 641 (230.7 bits), Expect = 8.8e-63, P = 8.8e-63
 Identities = 126/186 (67%), Positives = 153/186 (82%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             MKVAIGAA+GL FLH+A  QVIYRDFKA+NILLD+ FNAKLSDFGLAK GP  +R+HV+T
Sbjct:   194 MKVAIGAARGLCFLHEANDQVIYRDFKAANILLDSGFNAKLSDFGLAKEGPKDNRSHVTT 253

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             +VMGT GYAAPEY+ATG LTTK DVYSFGVVLLE+LSGR  +DK+K   E++LVDWA PY
Sbjct:   254 EVMGTEGYAAPEYLATGHLTTKCDVYSFGVVLLEILSGRRVIDKSKSREEENLVDWATPY 313

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
             L DKRK+FRIMDTKL GQYPQKAA   + LALQC+  + K+RP M EV+++LE++  P++
Sbjct:   314 LRDKRKVFRIMDTKLVGQYPQKAAFMMSFLALQCIG-DVKVRPSMLEVVSLLEKVPIPRH 372

Query:   181 SAKLSQ 186
                 S+
Sbjct:   373 RKSRSK 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 641 (230.7 bits), Expect = 8.8e-63, P = 8.8e-63
 Identities = 131/227 (57%), Positives = 170/227 (74%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             +KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKLSDFGLAK GPTGD++HVST
Sbjct:   191 LKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 250

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             ++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR AVDK +   EQ LV+WA+P 
Sbjct:   251 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPL 310

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL----E 176
             L++KRKLFR++D +L  QY  + A   ATLAL+CL  E KLRP M+EV++ LE +    E
Sbjct:   311 LANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 370

Query:   177 APKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPS 221
             A   +  + Q    R++  V + + P     +++ + +  TA P PS
Sbjct:   371 AGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATAYPRPS 417

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 9.9e-62, Sum P(2) = 9.9e-62
 Identities = 120/176 (68%), Positives = 142/176 (80%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             MK+A GAA GL FLH+AE+ VIYRDFKASNILLD+++ AKLSDFGLAK GP GD THVST
Sbjct:   193 MKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 252

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             +VMGT GYAAPEY+ TG LT +SDVYSFGVVLLELL+GR +VDK +   EQ+LVDWA+P 
Sbjct:   253 RVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNLVDWARPM 312

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
             L+D RKL RIMD +L GQY +  A  AATLA QCL++ PK RP MS V++IL  L+
Sbjct:   313 LNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILNDLK 368

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 610 (219.8 bits), Expect = 1.7e-59, P = 1.7e-59
 Identities = 131/238 (55%), Positives = 164/238 (68%)

Query:     1 MKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 59
             MK+A+GAAKGL FLH+ AE  VIYRDFK SNILLD E+NAKLSDFGLAK  P   ++HVS
Sbjct:   211 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVS 270

Query:    60 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
             T+VMGT+GYAAPEYV TG LTTKSDVYSFGVVLLE+L+GR +VDK++   EQ+LV+W +P
Sbjct:   271 TRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRP 330

Query:   120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
             +L DK++ +R++D +L G Y  K A  A  +A QCLN + K RP+MSEV+  L+ L   K
Sbjct:   331 HLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLK 390

Query:   180 NSAKLSQS----EP------HRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 227
             + A  S S    +P        Q G    R  P  +  S LN+ P ASP    RQSP+
Sbjct:   391 DFASSSSSFQTMQPVAKNGVRTQGGGFVSRNGPPMRSLSSLNL-PQASPYRYARQSPK 447

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
 Identities = 117/176 (66%), Positives = 142/176 (80%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             M +A+GAAKGL FLH+AE  VIYRDFK SNILLD+++ AKLSDFGLAKAGP GD THVST
Sbjct:   175 MMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 234

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             +VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+   EQ+LVDWA+P 
Sbjct:   235 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPK 294

Query:   121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
             L+DKRKL +I+D +L  QY  +AA  A +LA  CL+  PK RP MS+V+  LE L+
Sbjct:   295 LNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
 Identities = 120/203 (59%), Positives = 154/203 (75%)

Query:     1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             +++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLSDFGLA+ GP GD +HVST
Sbjct:   179 VRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVST 238

Query:    61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK-VGIEQSLVDWAKP 119
             +VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+DK + VG E +LVDWA+P
Sbjct:   239 RVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVG-EHNLVDWARP 297

Query:   120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
             YL++KR+L R+MD +L GQY    A   A LAL C++ + K RP M+E++  +E L   K
Sbjct:   298 YLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQK 357

Query:   180 NSAKLSQSEPHRQTGPVTVRKSP 202
              ++K  Q  P      + + KSP
Sbjct:   358 EASK-EQQNPQISIDNI-INKSP 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O49840	APK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7574	1.0	0.5375	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00037020001 SubName- Full=Chromosome chr1 scaffold_84, whole genome shotgun sequence; (420 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	229
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-25
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-24
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-10
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-09
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.003
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  103 bits (258), Expect = 1e-26
 Identities = 55/166 (33%), Positives = 80/166 (48%), Gaps = 22/166 (13%)

Query: 8   AKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            +GL +LH   S  +I+RD K  NILLD     K++DFGLAK       + ++T V GT 
Sbjct: 108 LRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTP 162

Query: 67  GYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
            Y APE +  G     K DV+S GV+L ELL+G+                  +  L   +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQ 209

Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVL 169
            + RI+   L    P+ ++ +     L  +CLN +P  RP   E+L
Sbjct: 210 LIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  102 bits (256), Expect = 2e-26
 Identities = 46/168 (27%), Positives = 68/168 (40%), Gaps = 29/168 (17%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
              L +LH     +++RD K  NILLD + + KL+DFGLA+    G++    T V GT  
Sbjct: 107 LSALEYLHSK--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPE 161

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +         D++S GV+L ELL+G+                   P      +L
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGK-------------------PPFPGDDQL 202

Query: 128 FRIMDTKLGGQYPQKAAH-----TAATLALQCLNNEPKLRPRMSEVLA 170
             +       + P           A  L  + L  +P+ R    E L 
Sbjct: 203 LELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.1 bits (248), Expect = 3e-25
 Identities = 54/182 (29%), Positives = 79/182 (43%), Gaps = 38/182 (20%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
             AI  AKG+ +L     + ++RD  A N L+  +   K+SDFGL++     D       
Sbjct: 109 SFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY----- 161

Query: 62  VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 116
              T G     + APE +  G  T+KSDV+SFGV+L E+ +          G        
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL---------G-------- 204

Query: 117 AKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAI 171
           A PY  LS++  L  +      G    K  +    L    L C   +P+ RP  SE++  
Sbjct: 205 ATPYPGLSNEEVLEYLRK----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Query: 172 LE 173
           LE
Sbjct: 261 LE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 96.2 bits (240), Expect = 1e-24
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 6/97 (6%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVS 59
           +++ +   +GL +LH   + +I+RD K  NILLD+     KL+DFGL+K   +       
Sbjct: 95  LRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--L 150

Query: 60  TQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLEL 95
             ++GT  Y APE  +  G  + KSD++S GV+L EL
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.4 bits (241), Expect = 3e-24
 Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 36/180 (20%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           ++A+  AKG+ +L       ++RD  A N L+      K+SDFGL++     D       
Sbjct: 106 QMALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----- 158

Query: 62  VMGTHGYA-----APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 116
                G       APE +  G+ T+KSDV+SFGV+L E+ +          G        
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL---------G-------- 201

Query: 117 AKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
            +PY  +S++  L  + D   G +   P+        L LQC   +P+ RP  SE++  L
Sbjct: 202 EQPYPGMSNEEVLELLED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 95.3 bits (238), Expect = 7e-24
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 39/179 (21%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A+  A+G+ +L       I+RD  A N L+      K+SDFGL++     D         
Sbjct: 108 ALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK----- 160

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              G     + APE +  G+ T+KSDV+SFGV+L E+ +          G         +
Sbjct: 161 -RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL---------G--------EQ 202

Query: 119 PY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLAIL 172
           PY  +S++  L  + +    G    +  +       L LQC   +P+ RP  SE++ IL
Sbjct: 203 PYPGMSNEEVLEYLKN----GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 95.3 bits (238), Expect = 9e-24
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 39/179 (21%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A+  A+G+ +L       I+RD  A N L+      K+SDFGL++     D   V     
Sbjct: 109 ALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK---- 162

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              G     + APE +  G+ T+KSDV+SFGV+L E+ +          G         +
Sbjct: 163 --GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL---------G--------EE 203

Query: 119 PY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLAIL 172
           PY  +S+   L  +      G    K  +       L LQC   +P+ RP  SE++ IL
Sbjct: 204 PYPGMSNAEVLEYLKK----GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 94.9 bits (237), Expect = 1e-23
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 25/165 (15%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH     +++RD K +NIL+D++   KL+DFG AK     +    +  V GT  +
Sbjct: 112 EGLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK-- 126
            APE +        +D++S G  ++E+ +G                   KP  S+     
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATG-------------------KPPWSELGNPM 210

Query: 127 --LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             L++I  +    + P+  +  A     +CL  +PK RP   E+L
Sbjct: 211 AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 4e-20
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 31/166 (18%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH  E  VI+RD KA+NIL   +   KL+DFG+  A    D +     V+GT  +
Sbjct: 110 QGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGV--ATKLNDVSKDDASVVGTPYW 165

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 126
            APE +     +T SD++S G  ++ELL+G                    PY  L+    
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN------------------PPYYDLNPMAA 207

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVL 169
           LFRI+       +P      +  L    +QC   +P LRP   ++L
Sbjct: 208 LFRIVQD----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 4e-20
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 28/156 (17%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGY 68
            L +LH     +IYRD K  NILLDA+ + KL+DFGLAK     G RT+      GT  Y
Sbjct: 105 ALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN---TFCGTPEY 159

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +         D +S GV+L E+L+G+                   P+ ++ RK  
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAEDRKEI 201

Query: 129 --RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
             +I+   L  ++P+  +  A  L    L  +P  R
Sbjct: 202 YEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.4 bits (209), Expect = 1e-19
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 19/176 (10%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-----V 62
            KG+ +L     + I+RD  A NIL+++E   K+SDFGLAK  P     +   +     +
Sbjct: 119 CKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE + T + ++ SDV+SFGV L EL +     D ++    + L         
Sbjct: 177 F----WYAPECLRTSKFSSASDVWSFGVTLYELFT-YG--DPSQSPPAEFLRMIGIA--Q 227

Query: 123 DKRKLFRIMDT-KLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 175
            +  + R+++  K G + P+  +       L   C   EP+ RP  ++++ I++RL
Sbjct: 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 83.8 bits (208), Expect = 2e-19
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQ 61
           V     KGL +LH   + +I+RD KA+NILL ++   KL DFGL+     T  R      
Sbjct: 103 VCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---- 156

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           ++GT  + APE +       K+D++S G+  +EL  G+
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 81.0 bits (201), Expect = 2e-18
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 29/166 (17%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGY 68
            L +LH    ++++RD K  NI L +    KL DFG++K    T D     T V GT  Y
Sbjct: 115 ALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVV-GTPYY 169

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            +PE         KSD++S G VL EL + +   +   +     L               
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELA-------------L 213

Query: 129 RIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAI 171
           +I+     GQYP   +  ++ L       L  +P+ RP ++++L  
Sbjct: 214 KILK----GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.9 bits (200), Expect = 3e-18
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVST 60
           K+A    KGL++LH    ++I+RD K SNILL  +   KL DFG++ +   +   T    
Sbjct: 109 KIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-- 164

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
              GT  Y APE +     +  SDV+S G+ LLE+   R
Sbjct: 165 ---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 12/183 (6%)

Query: 2   KVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           K+AIG AK L FLH      V+  +     I++D +    L    L     T  +  +S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  Y APE   T  +T KSD+Y FG++L+ELL+G+   D  + G+  S+V+WA+  
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYC 895

Query: 121 LSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
            SD   L   +D  + G     Q        LAL C   +P  RP  ++VL  LE     
Sbjct: 896 YSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954

Query: 179 KNS 181
            +S
Sbjct: 955 SSS 957

Length = 968

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 77.7 bits (192), Expect = 3e-17
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 40/181 (22%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   KGLT+LH+ + ++I+RD K SNIL+++    KL DFG            VS Q
Sbjct: 104 KIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQ 150

Query: 62  VM--------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 113
           ++        GT  Y APE +     + KSD++S G+ L+EL +GR              
Sbjct: 151 LVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP--------- 201

Query: 114 VDWAKPYLSDKRKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                P       L  I++    +L  G++              CL  +P+ RP   E+L
Sbjct: 202 --ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD----FVNLCLIKDPRERPSYKELL 255

Query: 170 A 170
            
Sbjct: 256 E 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 78.2 bits (191), Expect = 7e-17
 Identities = 57/228 (25%), Positives = 81/228 (35%), Gaps = 16/228 (7%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK----AGPTGDRTHVSTQV 62
              L +LH     +I+RD K  NILLD +    KL DFGLAK     G T     + +  
Sbjct: 111 LSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168

Query: 63  MGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           +GT GY APE +        ++ SD++S G+ L ELL+G    +  K     S       
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKII 227

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI-LERLEAP 178
                  L   +         + A+     L  + L  +PK R   S  L+  L      
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASD----LLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283

Query: 179 KNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 226
           K S      +P             +    S LN    +        S 
Sbjct: 284 KESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331

Length = 384

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.5 bits (189), Expect = 8e-17
 Identities = 47/156 (30%), Positives = 63/156 (40%), Gaps = 27/156 (17%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
             +LH     +IYRD K  N+LLD+    KL DFG AK   +G +T       GT  Y A
Sbjct: 106 FEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +S G++L ELL+GR                   P+  D      I
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR------------------PPFGEDDEDPMEI 202

Query: 131 MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLR 162
            +  L G    ++P      A  L  Q L   P+ R
Sbjct: 203 YNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 8e-17
 Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH  E  +IYRD K  N+LLD+E + K++DFG+ K G  G  T  ++   GT  Y 
Sbjct: 108 GLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYI 163

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE ++        D ++ GV+L E+L+G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 75.6 bits (186), Expect = 2e-16
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           +  I    GL  LH    ++++RD K+ N+ LDA  N K+ D G+AK     D T+ +  
Sbjct: 105 RFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANT 160

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           ++GT  Y +PE         KSDV++ GVVL E  +G+   D    G   +L+       
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI------- 210

Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
               K+ R +   +   Y Q+ A     L  QCL  + + RP   ++L
Sbjct: 211 ---LKIIRGVFPPVSQMYSQQLAQ----LIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 74.9 bits (185), Expect = 3e-16
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 30/176 (17%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
             +A    KGL +LH  +  +I+RD K SN+L++++   K++DFG++K    T D+ +  
Sbjct: 102 AYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN-- 158

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           T V GT  Y +PE +     +  +D++S G+ LLE   G+                   P
Sbjct: 159 TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF------------------P 199

Query: 120 YLSDKR-KLFRIMDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           +L   +   F +M     G  P     + +      ++  CL  +PK RP  +E+L
Sbjct: 200 FLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA-CLQKDPKKRPSAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 5e-16
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH     +++RD K SNIL++ +   KL+DFGLA+   T   +   T  + T  Y
Sbjct: 111 EGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167

Query: 69  AAPEYV--ATGRLTTKSDVYSFGVVLLELLSGR 99
             PE +  AT R   + D++S G +L EL  G+
Sbjct: 168 RPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 8e-16
 Identities = 35/99 (35%), Positives = 63/99 (63%), Gaps = 7/99 (7%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VST 60
           K+A+   +GLT+L++   ++++RD K SNIL+++    KL DFG+     +G+  + ++ 
Sbjct: 107 KIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIAD 160

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
             +GT  Y +PE +  G+ T KSDV+S G+ ++EL  G+
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.8 bits (181), Expect = 1e-15
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 31/176 (17%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           ++A+   KGLT+L     ++++RD K SN+L++     KL DFG++    T     ++  
Sbjct: 99  RIAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKT 152

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK--------VGIEQSL 113
            +GT+ Y APE ++  +    SDV+S G+  +EL  GR    + +        + + Q +
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212

Query: 114 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           VD   P L               GQ+ +K  H       QC+  +PK RP    ++
Sbjct: 213 VDEDPPVLPV-------------GQFSEKFVHFIT----QCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 2e-15
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 5/90 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH  + +++YRD K  N+LLD   N ++SD GLA     G +        GT GY 
Sbjct: 107 GLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYM 161

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +         D ++ G  L E+++GR
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-15
 Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TK+ D++S G +L E+LS R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 71.9 bits (177), Expect = 5e-15
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 29/166 (17%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH     VI+RD K+ NILL  + + KL+DFG A A  T +++  ++ V GT  +
Sbjct: 127 QGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVV-GTPYW 182

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK--RK 126
            APE +       K D++S G++ +E+  G                    PYL +   R 
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE------------------PPYLREPPLRA 224

Query: 127 LFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           LF I  T  G    + P+K +        +CL  +P+ RP   E+L
Sbjct: 225 LFLI--TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.1 bits (175), Expect = 6e-15
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH   ++ I+RD KA NILL+ E  AKL+DFG+  +G   D       V+GT  +
Sbjct: 110 KGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFW 165

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +       K+D++S G+  +E+  G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 7e-15
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 14/103 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTH 57
           +  A+   +G+ +L   E   ++RD  A N+L+  +  AK+SDFGLAK    G    +  
Sbjct: 105 LGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 99
           V         + APE +   + +TKSDV+SFG++L E+ S GR
Sbjct: 163 VK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.7 bits (176), Expect = 8e-15
 Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH  +  +IYRD K  N+LLD + + K++DFG+ K    G+    ++   GT  Y 
Sbjct: 108 GLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +   +     D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 71.0 bits (174), Expect = 9e-15
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 36/179 (20%)

Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ +L  A  + ++RD  A N +LD  F  K++DFGLA+     D+ + S     T 
Sbjct: 107 VAKGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVH-NHTG 161

Query: 67  G-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-----VDKTKVGIEQSLVDW 116
                 + A E + T + TTKSDV+SFGV+L EL++ R A     VD   + +       
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITV------- 213

Query: 117 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              YL   R+L +          P+        + L C + +P++RP  SE+++ +E++
Sbjct: 214 ---YLLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 38/171 (22%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM----- 63
            GL +LHD     ++RD K +NIL+D     KL+DFG+AK         V          
Sbjct: 113 LGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFK 162

Query: 64  GTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
           G+  + APE +A  G     +D++S G  +LE+ +G                   KP  S
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG-------------------KPPWS 203

Query: 123 DKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
                  +F+I  +K     P   +  A    L+CL  +P LRP  +E+L 
Sbjct: 204 QLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 2e-14
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 4/96 (4%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A GL FLH     +IYRD K  N++LDAE + K++DFG+ K    G +T  +    GT  
Sbjct: 111 AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPD 166

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           Y APE +A        D ++FGV+L E+L+G+   D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.0 bits (171), Expect = 2e-14
 Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 27/176 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVS 59
           ++ ++  A+G+ +L     ++++RD  A NIL+  +  AK+SDFGLA+ G  G D + + 
Sbjct: 103 LQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
            +      + APE +   + ++KSDV+S+GV+L E+ S GR    K  +   +  V+   
Sbjct: 161 VK------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE--- 211

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
                  K +R M+       P+        L   C   EPK RP   ++   LE+
Sbjct: 212 -------KGYR-MEP------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 6/92 (6%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGY 68
           GL +LH  E++++YRD K  N+LLD E   K++DFGL K G   GDRT  ST   GT  +
Sbjct: 113 GLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEF 167

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 100
            APE +     T   D +  GV++ E+L G  
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 38/185 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +  G A G+ +L  +E   ++RD  A NIL+++    K+SDFGL++      R   S 
Sbjct: 109 VGMLRGIASGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSE 160

Query: 61  QVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
               T G      + APE +A  + T+ SDV+SFG+V+ E++S G               
Sbjct: 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE-------------- 206

Query: 114 VDWAKPY--LSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               +PY  +S++  +  + D  +L    P         L L C   +   RP  S++++
Sbjct: 207 ----RPYWDMSNQDVIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVS 260

Query: 171 ILERL 175
            L+++
Sbjct: 261 TLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 70.0 bits (172), Expect = 2e-14
 Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 2/84 (2%)

Query: 16  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 75
           D  + V++RD K +NI LDA  N KL DFGLAK    G  +  +   +GT  Y +PE + 
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 76  TGRLTTKSDVYSFGVVLLELLSGR 99
                 KSD++S G ++ EL +  
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 6e-14
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 21/106 (19%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K++I   +GLT+L + + ++++RD K SNIL+++    KL DFG            VS Q
Sbjct: 103 KISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQ 149

Query: 62  VM--------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           ++        GT  Y +PE +     T +SD++S G+ L+E+  GR
Sbjct: 150 LIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.8 bits (168), Expect = 7e-14
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD    +    GT  Y 
Sbjct: 108 GLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYI 163

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +   +  T  D +SFGV+L E+L G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 1e-13
 Identities = 37/89 (41%), Positives = 50/89 (56%), Gaps = 4/89 (4%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L FLH     VIYRD K  NILLDAE + KL+DFG+ K G     T  +T   GT  Y A
Sbjct: 109 LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIA 164

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           PE +         D ++ GV++ E+++G+
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 10/96 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS------TQVM 63
            L +LH   + +I+RD K  NIL+D+  + KL+DFGL+K G    + +++       +++
Sbjct: 105 ALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 64  GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 98
           GT  Y APE V  G+  +K+ D +S G +L E L G
Sbjct: 163 GTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.9 bits (166), Expect = 1e-13
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 10/171 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG- 67
           KG+ +L     + ++RD    NIL+++E   K+ DFGL K  P  D+ +   +  G    
Sbjct: 119 KGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPI 175

Query: 68  -YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +   + +  SDV+SFGVVL EL +       +       ++   K        
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 175
           L  ++  K  G+ P      A   A+  +C NN+P  RP  SE+   +E +
Sbjct: 235 LIELL--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 35/176 (19%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ +L       ++RD  A N+LL     AK+SDFG+++A   G   + +T    T G
Sbjct: 105 AMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAG 158

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 121
                + APE +  G+ ++KSDV+S+GV L E  S G                  AKPY 
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPY- 199

Query: 122 SDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
             + K   ++     G+    P++      ++ L C    P+ RP  SE+ +   R
Sbjct: 200 -GEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.0 bits (166), Expect = 1e-13
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 5/166 (3%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHG 67
           +G+ +LH      I+RD  A N+LLD +   K+ DFGLAKA P G   + V         
Sbjct: 118 EGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           + A E +   + +  SDV+SFGV L ELL+  C   ++     + ++   +  ++  R L
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVR-L 233

Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             +++  +    P+        L   C   E K RP    ++ IL+
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 67.4 bits (165), Expect = 2e-13
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTH-VSTQVMGTH 66
           KGL +LH   +  I+RD KA NILL  + + K++DFG+ A     GDRT  V    +GT 
Sbjct: 113 KGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 67  GYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            + APE +        K+D++SFG+  +EL +G 
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---VSTQVMGT 65
           K L ++H     VI+RD K SNILL+++   KL+DFGLA++    +      V T  + T
Sbjct: 118 KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 66  HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
             Y APE  + + R T   D++S G +L E+L G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 3e-13
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 2/97 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +AI  A G+ +L  +    ++RD  A N L+      K+SDFGL++   + D   V +
Sbjct: 127 LHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + +    +  PE +  G+ TT+SD++SFGVVL E+ S
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.3 bits (164), Expect = 3e-13
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH     +IYRD K  N++LD + + K++DFG+ K    GD    ++   GT  Y 
Sbjct: 108 GLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYI 163

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +   + T   D +SFGV+L E+L G+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 66.7 bits (163), Expect = 3e-13
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 31/173 (17%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           ++ I   +GL  LH  E ++++RD K++NILL A    K+ D G++K      +    TQ
Sbjct: 107 RIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQ 161

Query: 62  VMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + GT  Y APE V  GR  + KSD++S G +L E+ +                  +    
Sbjct: 162 I-GTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFA--------------PPFEARS 205

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLA 170
           + D R  +++      G+YP      +  L       L  +PKLRP   ++LA
Sbjct: 206 MQDLR--YKVQ----RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 4e-13
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 26/178 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L  A  + ++RD  A N ++  +   K+ DFG+ +     D      
Sbjct: 122 IQMAAEIADGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TTKSDV+SFGVVL E+                +L    +PY
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA---------------TLA--EQPY 222

Query: 121 --LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
             LS++  L  ++D   GG    P+        L   C    PK+RP   E+++ L+ 
Sbjct: 223 QGLSNEEVLKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 66.2 bits (162), Expect = 5e-13
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 33/172 (19%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVM-GTH 66
           +GL +LH     +++RD K +NI LD     KL DFG A              Q + GT 
Sbjct: 110 EGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 67  GYAAPEYVATGRLTTK---SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 123
            Y APE +  G+       +D++S G V+LE+ +G+                W++    D
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--------------RPWSE---LD 210

Query: 124 KRKLFRIMDTKLG-GQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 169
               F+IM   +G G  P        +        +CL ++PK RP  SE+L
Sbjct: 211 NE--FQIM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.8 bits (163), Expect = 5e-13
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 6/94 (6%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYA 69
           L FLH  E  +IYRD K  N+LLDAE + KL+D+G+ K G   GD T   +   GT  Y 
Sbjct: 109 LNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYI 163

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           APE +         D ++ GV++ E+++GR   D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 5e-13
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 24/176 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 59
           +++++ AA G+ +L   ES+  I+RD  A N L+      K+SDFG+++    G  T   
Sbjct: 96  LQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
                   + APE +  GR T++SDV+S+G++L E  S                     P
Sbjct: 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG-----------------DTP 195

Query: 120 Y--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           Y  +S+++   RI ++      PQ        L LQC   +P+ RP  SE+   L+
Sbjct: 196 YPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 6e-13
 Identities = 49/134 (36%), Positives = 66/134 (49%), Gaps = 19/134 (14%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L  LH     +IYRD K  NILLD E + KL+DFGL+K     ++   S    GT  
Sbjct: 108 ALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 163

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA------------VDKTKVGIEQSLVD 115
           Y APE V     T  +D +SFGV++ E+L+G               + K K+G+ Q L  
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSP 223

Query: 116 WAKPYLSDKRKLFR 129
            A+  L   R LF+
Sbjct: 224 EAQSLL---RALFK 234

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.2 bits (161), Expect = 6e-13
 Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 15/154 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGY 68
            L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G   GD T   +   GT  Y
Sbjct: 108 ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNY 162

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +         D ++ GV++ E+++GR   D   VG   +      P  + +  LF
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLF 214

Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +++  K   + P+  +  AA++    LN +PK R
Sbjct: 215 QVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 65.4 bits (160), Expect = 7e-13
 Identities = 31/90 (34%), Positives = 43/90 (47%), Gaps = 5/90 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILLD + +  ++DF +A        T   T   GT GY 
Sbjct: 112 ALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYM 166

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +     +   D +S GV   E L G+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.2 bits (161), Expect = 7e-13
 Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 17/154 (11%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGY 68
            L FLH  E  +IYRD K  N+LLDA+ + KL+D+G+ K G   GD T   +   GT  Y
Sbjct: 108 ALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNY 162

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +         D ++ GV++ E+++GR   D          +    P ++ +  LF
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------IITDNPDMNTEDYLF 212

Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +++  K   + P+  +  A+ +    LN +PK R
Sbjct: 213 QVILEK-PIRIPRFLSVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.5 bits (160), Expect = 8e-13
 Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 27/175 (15%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   K L +LH ++  VI+RD K SN+L++     KL DFG+  +G   D +   T 
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVD-SVAKTI 162

Query: 62  VMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD 115
             G   Y APE +           KSDV+S G+ ++EL +GR   D  K   +Q   +V+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Query: 116 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
              P L  ++      D                    +CL    K RP   E+L 
Sbjct: 223 EPSPQLPAEKFSPEFQD-----------------FVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (160), Expect = 9e-13
 Identities = 53/179 (29%), Positives = 71/179 (39%), Gaps = 56/179 (31%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------ 62
            GL +LH  E   I+RD KA+NILL  E + KL+DFG            VS Q+      
Sbjct: 109 LGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFG------------VSGQLTSTMSK 154

Query: 63  ----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
               +GT  + APE +       K+D++S G+  +EL  G                   +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG-------------------E 195

Query: 119 PYLSDK---RKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 169
           P LSD    R LF I         P        +         CLN +PK RP   E+L
Sbjct: 196 PPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.2 bits (159), Expect = 1e-12
 Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 4/93 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH     +++RD KA N+L+DA+   K+SDFG++K          +  + G+  +
Sbjct: 119 EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 69  AAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 99
            APE + +     + K D++S G V+LE+ +GR
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.2 bits (159), Expect = 1e-12
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 21/146 (14%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGR 78
           +IYRD K  NILLD+E +  L+DFGL+K       +R +      GT  Y APE +  G 
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGS 182

Query: 79  LTTKS--DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 136
                  D +S GV+  ELL+G  A   T  G + S  + ++          RI+ +K  
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTG--ASPFTVDGEQNSQSEISR----------RILKSKP- 229

Query: 137 GQYPQKAAHTAATLALQCLNNEPKLR 162
             +P+  +  A     + L  +PK R
Sbjct: 230 -PFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 11/97 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L FLH    +VI+RD KA NILL  + + KL+DFG+ AK   T  +       +GT  
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPY 168

Query: 68  YAAPEYVATGRLTT-----KSDVYSFGVVLLELLSGR 99
           + APE VA           K+D++S G+ L+EL    
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 3/86 (3%)

Query: 14  LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           LH     ++YRD K  N+LLD + N +LSD GLA     G      TQ  GT+GY APE 
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEI 165

Query: 74  VATGRLTTKSDVYSFGVVLLELLSGR 99
           +     +   D ++ G  + E+++GR
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 3/95 (3%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QV 62
           A+  A G+ +L     + I+RD  A NILL ++   K+ DFGL +A P  +  +V    +
Sbjct: 103 AVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                + APE + T   +  SDV+ FGV L E+ +
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 33/178 (18%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQV 62
           G A G+ +L  ++   ++RD  A NIL+++    K+SDFGL++     P G  T    ++
Sbjct: 115 GIAAGMKYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 120
                + APE +A  + T+ SDV+SFG+V+ E++S G                   +PY 
Sbjct: 173 --PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE------------------RPYW 212

Query: 121 -LSDKRKLFRIMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILERL 175
            +S+   +  I D   G + P      +A   L LQC   +   RPR  +++ +L++L
Sbjct: 213 DMSNHEVMKAIND---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.5 bits (157), Expect = 2e-12
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 18/164 (10%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLA-KAGPTGDRT-HVSTQVMGT 65
           +GL++LH+  +Q+I+RD K +N+L+D+     +++DFG A +    G        Q++GT
Sbjct: 114 RGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
             + APE +   +     DV+S G V++E+ + +   +  K     +L            
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------------ 219

Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            +F+I         P+  +     + L+CL  +P+ RP   E+L
Sbjct: 220 -IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 64.7 bits (157), Expect = 2e-12
 Identities = 51/166 (30%), Positives = 71/166 (42%), Gaps = 31/166 (18%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH      I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  +
Sbjct: 112 KGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFW 167

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 126
            APE +       K+D++S G+  +EL  G                    P   L   R 
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGE------------------PPNSDLHPMRV 209

Query: 127 LFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           LF I       L GQY +            CLN +P+ RP   E+L
Sbjct: 210 LFLIPKNSPPTLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 64.5 bits (158), Expect = 2e-12
 Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 20/108 (18%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM------ 63
            L +LH     +I+RD K  NILLD + + K++DFG AK          +          
Sbjct: 114 ALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 64  ------------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
                       GT  Y +PE +        SD+++ G ++ ++L+G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 19/153 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH    +++YRD K  NILLD   + ++SD GLA   P G+   +  +V GT GY 
Sbjct: 114 GLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYM 168

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE V   R T   D +  G ++ E++ G+    + K  +++  V+             R
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER------------R 216

Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           + + +   +Y +K +  A ++  Q L  +P  R
Sbjct: 217 VKEDQ--EEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.1 bits (157), Expect = 3e-12
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  ++YRD K  N+LLD++   K++DFG AK      RT+    + GT  Y 
Sbjct: 113 ALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYL 165

Query: 70  APEYVATGRLTTKS-DVYSFGVVLLELLSG 98
           APE +   +   K+ D ++ G+++ E+L+G
Sbjct: 166 APE-IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 64.2 bits (156), Expect = 3e-12
 Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 20/169 (11%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           ++G+ +L  AE ++++RD  A N+L+      K+SDFGL++     D     ++      
Sbjct: 137 SRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + A E +     TT+SDV+SFGV+L E+++         +G          PY      +
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPYPGIAPER 237

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           LF ++ T    + P+  +     L L C   EP  RP  +++   LE++
Sbjct: 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 7/101 (6%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   K L +L + E ++I+RD K SNILLD   N KL DFG+  +G   D     T+
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSI-AKTR 166

Query: 62  VMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGR 99
             G   Y APE +          +SDV+S G+ L E+ +G+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 8/102 (7%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+ +   K L +L + +  VI+RD K SNILLDA  N KL DFG+  +G   D +   T+
Sbjct: 118 KMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGI--SGRLVD-SKAKTR 173

Query: 62  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGR 99
             G   Y APE +       +   ++DV+S G+ L+EL +G+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.8 bits (155), Expect = 5e-12
 Identities = 36/88 (40%), Positives = 49/88 (55%), Gaps = 4/88 (4%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L FLHD    +IYRD K  N+LLD E + KL+DFG+ K G    +T  ++   GT  Y A
Sbjct: 109 LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIA 164

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +         D ++ GV+L E+L G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.4 bits (154), Expect = 5e-12
 Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 16/175 (9%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + VA+  A G+ +L  +    ++RD    N L+      K++DFG+++    GD   +  
Sbjct: 141 LHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQG 198

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + A E +  G+ TT SDV++FGV L E+L   C         ++ +++ A  +
Sbjct: 199 RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM-LCKEQPYGELTDEQVIENAGEF 257

Query: 121 LSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             D+ +   LFR          P         L LQC + + + RP  S++ A L
Sbjct: 258 FRDQGRQVYLFR----------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 6e-12
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 9/101 (8%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +     + + +L    +  I+RD  A N L+  +   K+SDFGLA+     D  + S+
Sbjct: 103 LDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS 158

Query: 61  QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Q  GT     +A PE     R ++KSDV+SFGV++ E+ S 
Sbjct: 159 Q--GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 8e-12
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 10/97 (10%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
           A+G+ +L       I+RD  A NIL+      K++DFGLA+     D  + + +  G   
Sbjct: 113 AEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTARE--GAKF 166

Query: 67  --GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC 100
              + APE    GR T KSDV+SFG++L E+++ GR 
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.6 bits (152), Expect = 1e-11
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162

Query: 70  APEYVATG-RLTTKSDVYSFGVVLLELLSG 98
           APE +  G    + +D +S G +L +LL G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H     +++RD K  N+L++ E   KL+DFGLA++  +  R +  T  + T  Y
Sbjct: 109 QGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWY 164

Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  ELLS R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 19/153 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH  + +++YRD K  NILLD   + ++SD GLA   P G    +  +V GT GY 
Sbjct: 114 GLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 168

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE V   R T   D ++ G +L E+++G+    + K  I              KR+   
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--------------KREEVE 214

Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
            +  ++  +Y +K +  A +L    L  +PK R
Sbjct: 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A GL FLH     +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 111 AIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPD 166

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           Y APE +A        D ++FGV+L E+L+G+   +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 42/124 (33%), Positives = 61/124 (49%), Gaps = 15/124 (12%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH  E  ++YRD K  NILLD E + KL+DFG AK     DRT     + GT  Y A
Sbjct: 114 LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPEYLA 166

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           PE + +       D ++ G+++ E+L G     D    GI + +       L+ K +  R
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LAGKLEFPR 219

Query: 130 IMDT 133
            +D 
Sbjct: 220 HLDL 223

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 8/101 (7%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L ++H  +  VI+RD KA+NIL+    N KL DFG+A A    + +  ST V GT  + A
Sbjct: 114 LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTFV-GTPYWMA 169

Query: 71  PEYVATGRL-TTKSDVYSFGVVLLELLSGR---CAVDKTKV 107
           PE +  G+   TK+D++S G+ + E+ +G      VD  + 
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 2e-11
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 27/164 (16%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           L   H     +++RD K  NILLD      K+ DFG++K      ++   T V+GT  Y 
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           +PE         KSD+++ G VL EL S + A +   +           P L     + +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PAL-----VLK 212

Query: 130 IMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           IM      +  +Y          L L  LN +P  RP++S+++A
Sbjct: 213 IMSGTFAPISDRYSPDLRQ----LILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 24/156 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + GL FLH     +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 111 SVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPD 166

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +A        D +++GV+L E+L+G+   D                   D+ +L
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-----------------EDEDEL 209

Query: 128 FR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           F+ IM+  +   YP+  +  A ++    +   P  R
Sbjct: 210 FQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 20/120 (16%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L   H  +  ++YRD K  NILLDA  +  L DFGL+KA  T ++T  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 71  PEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           PE +   +  TK  D +S GV++ E+  G                 W+  Y  D ++++R
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQMYR 207

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 28/192 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++ A   A G+ +L  +E Q I+RD  A N+L+     +K++DFGL++    G+  +V  
Sbjct: 122 LQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK- 174

Query: 61  QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           + MG     + A E +     TTKSDV+SFGV+L E++S         +G          
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS---------LG--------GT 217

Query: 119 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LE 176
           PY      +L+  +      + P+        L  QC  + P  RP  +++   L R LE
Sbjct: 218 PYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Query: 177 APKNSAKLSQSE 188
           A K    ++  E
Sbjct: 278 ARKAYVNMALFE 289

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.1 bits (148), Expect = 3e-11
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 11/93 (11%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   E+  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   +   THG  
Sbjct: 107 GMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAK---THGKW 160

Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 32/90 (35%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L   E   I+RD  A NIL+  +   K++DFGLA+     +  ++S+     + 
Sbjct: 114 AEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYK 169

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE  + G  +TKSDV+SFG++L E+ +
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 2/97 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A+  A G+ +L  A    ++RD    N L+  +   K+ DFG+++   T D   V  
Sbjct: 125 LQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +AI  A G+ +L  +    +++D  A NIL+  + + K+SD GL++   + D   V  
Sbjct: 127 LHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    +  PE +  G+ ++ SD++SFGVVL E+ S          G++        PY
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS---------FGLQ--------PY 227

Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                +++  ++  +      +       +L  +C    P  RPR  ++
Sbjct: 228 YGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 60.5 bits (147), Expect = 4e-11
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 25/162 (15%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           ++++H A   +++RD K  NI L      KL DFG++K    G    ++  V+GT  Y +
Sbjct: 114 VSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMS 169

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE     +   KSD+++ G VL EL      + +T        +              +I
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYEL----LTLKRTFDATNPLNLVV------------KI 213

Query: 131 MDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLA 170
           +    G   P  + +++  ++L    L  +P+ RP   EVL 
Sbjct: 214 VQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 35/98 (35%), Positives = 59/98 (60%), Gaps = 5/98 (5%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   +GL +L + + Q+++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 107 KVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 161

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+EL  GR
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 60.5 bits (146), Expect = 5e-11
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 33/167 (19%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  +
Sbjct: 112 KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFW 167

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD---KR 125
            APE +      +K+D++S G+  +EL  G                   +P  SD    R
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKG-------------------EPPNSDMHPMR 208

Query: 126 KLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            LF I       L G++ +            CLN +P  RP   E+L
Sbjct: 209 VLFLIPKNNPPTLTGEFSK----PFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.5 bits (146), Expect = 5e-11
 Identities = 52/183 (28%), Positives = 77/183 (42%), Gaps = 31/183 (16%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 112 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFW 167

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 126
            APE +      +K+D++S G+  +EL  G                    P+  L   + 
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGE------------------PPHSELHPMKV 209

Query: 127 LFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 183
           LF I       L G Y +            CLN EP  RP   E+L     +   K ++ 
Sbjct: 210 LFLIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLKHKFIVRFAKKTSY 265

Query: 184 LSQ 186
           L++
Sbjct: 266 LTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.4 bits (146), Expect = 6e-11
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 19/153 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  L     +++YRD K  NILLD   + ++SD GLA   P G+   V  +V GT GY 
Sbjct: 114 GLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYM 168

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +   + T   D +  G ++ E++ G+    K K  +++  VD             R
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR------------R 216

Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           + + +   +Y +K +  A ++    L   PK R
Sbjct: 217 VKEDQ--EEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 6e-11
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 8/89 (8%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH     +I+RD K  N+L+D   + KL+DFGL++ G        + + +GT  Y 
Sbjct: 109 GVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYL 160

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +        SD +S G V+ E L G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 60.6 bits (147), Expect = 6e-11
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 24/153 (15%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y A
Sbjct: 108 LGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 163

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR- 129
           PE +         D +  GVV+ E++ GR                    Y  D  KLF  
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 206

Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           I+  ++  ++P+  +  A +L    L  +PK R
Sbjct: 207 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.4 bits (146), Expect = 6e-11
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162

Query: 70  APEYVATGR-LTTKSDVYSFGVVLLELLSG 98
           APE +  G    + +D +S G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 60.3 bits (146), Expect = 6e-11
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 33/179 (18%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVM 63
           G A G+ +L  +E   ++RD  A NIL+++    K+SDFGL++     T D T+ S+  +
Sbjct: 114 GIAAGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--L 169

Query: 64  GTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
           G      + APE +A  + T+ SDV+S+G+V+ E++S G                   +P
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE------------------RP 211

Query: 120 Y--LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           Y  +S++  +  I  D +L    P         L L C   +   RP+  ++++ L+++
Sbjct: 212 YWDMSNQDVINAIEQDYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.0 bits (145), Expect = 7e-11
 Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 19/153 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH      +YRD K  NILLD   + ++SD GLA   P G+        +GT GY 
Sbjct: 114 GLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYM 168

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +   R T   D +  G ++ E++ G+      K  +++  VD             R
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR------------R 216

Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +++T+    Y  K +  A ++    L  +PK R
Sbjct: 217 VLETE--EVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 8e-11
 Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L +LH     +IYRD K  NILLD++ +  L+DFGL K G    +T  ++   GT  
Sbjct: 106 ASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPE 161

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.4 bits (146), Expect = 8e-11
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 107 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 161

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 59.6 bits (144), Expect = 8e-11
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 25/156 (16%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGR 78
           I+RD +++NIL+      K++DFGLA+     D  + + Q  G      + APE    GR
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEAALYGR 179

Query: 79  LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGG 137
            T KSDV+SFG++L EL      V K +V           PY   + R++   ++     
Sbjct: 180 FTIKSDVWSFGILLTEL------VTKGRV-----------PYPGMNNREVLEQVERGYRM 222

Query: 138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             PQ    +   L LQC   +P+ RP    + + LE
Sbjct: 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 9e-11
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGTH 66
           GL ++H A   V++RD K  N+L++A+   K+ DFGLA+     P  +   + T+ + T 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173

Query: 67  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            Y APE + + +  TK+ DV+S G +L ELL  +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+++L   E ++++RD  A N+L+    + K++DFGLAK     ++ + +        
Sbjct: 119 AKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + A E +     T KSDV+S+GV + EL++
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 29/170 (17%)

Query: 9   KGLTFLHDAES-QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
           +G+ +L   ES Q I+RD  A N L+D +   K+SDFGL++     D  + S+  +G+  
Sbjct: 111 EGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKF 163

Query: 67  --GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 123
              ++ PE +   + ++KSDV++FGV++ E+ S G+   ++         V+     +S 
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVE----KVSQ 216

Query: 124 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             +L+R          P  A+     +   C + + + RP   ++L+ +E
Sbjct: 217 GLRLYR----------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 16/99 (16%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ F+       I+RD +A+NIL+      K++DFGLA       R     +     G
Sbjct: 112 AEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLA-------RLIEDNEYTAREG 162

Query: 68  ------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 99
                 + APE +  G  T KSDV+SFG++L E+++ GR
Sbjct: 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 126 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 181

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            APE V       K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 59.1 bits (143), Expect = 1e-10
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-----AGPTGDRTHVSTQVM 63
           KGL +LH+    +I+RD K +NIL+D +   K+SDFG++K     +  T       + + 
Sbjct: 117 KGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQ 173

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           G+  + APE V     T K+D++S G +++E+L+G+
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 30/170 (17%)

Query: 10  GLTFL-------HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           GL F+       H     +I+RD K++NILL +    KL DFG +K         V    
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
            GT  Y APE       + K+D++S GV+L ELL+ +                  +P+  
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------------------RPF-- 245

Query: 123 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           D   +  +M   L G+Y   P   +     +    L+++PK RP  S++L
Sbjct: 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 58/191 (30%), Positives = 81/191 (42%), Gaps = 63/191 (32%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ FL  A  + I+RD  A NILL      K+ DFGLA+                   
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-----------------DI 223

Query: 68  YAAPEYVATG--RL---------------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 110
           Y  P+YV  G  RL               TT+SDV+SFGV+L E+ S         +G  
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG-- 272

Query: 111 QSLVDWAKPYLSDK------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 164
                 A PY   +      R+L     T++    P+ A     ++ L C +N P+ RP 
Sbjct: 273 ------ASPYPGVQIDEEFCRRLKE--GTRMRA--PEYATPEIYSIMLDCWHNNPEDRPT 322

Query: 165 MSEVLAILERL 175
            SE++ IL  L
Sbjct: 323 FSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 23/168 (13%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTH 66
           A G+ ++       I+RD +A+NIL+      K++DFGLA+     D  + + Q      
Sbjct: 112 ADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPI 167

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-KR 125
            + APE    GR T KSDV+SFG++L EL      V K +V           PY     R
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTEL------VTKGRV-----------PYPGMVNR 210

Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           ++   ++       PQ    +   L   C   +P  RP    + + LE
Sbjct: 211 EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 7/86 (8%)

Query: 13  FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 72
           +LH     +IYRD K  N+LLD + + K++DFG AK  P  DRT     + GT  Y APE
Sbjct: 133 YLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPE 185

Query: 73  YVATGRLTTKSDVYSFGVVLLELLSG 98
            + +       D ++ GV+L E ++G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 29/90 (32%), Positives = 54/90 (60%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ +L   E ++++R+  A NILL ++   +++DFG+A      D+ +  ++      
Sbjct: 119 AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + A E +  GR T +SDV+S+GV + E++S
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 59.0 bits (143), Expect = 2e-10
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 20/174 (11%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KVA+     L   H + ++ ++RD  A N L+ ++   K+S   L+K     +   +   
Sbjct: 119 KVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 120
           ++    + APE V     +TKSDV+SFGV++ E+ +      + ++           P+ 
Sbjct: 179 LIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT------QGEL-----------PFY 220

Query: 121 -LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
            LSD+  L R+   KL    P+        L  +C    PK RP  SE+++ L 
Sbjct: 221 GLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 4/93 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 67
           +GL +LH A   VI+RD K SNIL+++  + K+ DFGLA+   P  D     T+ + T  
Sbjct: 114 RGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE + +    TK+ D++S G +  ELL+ +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH   + +++RD K +N+L+ ++   KL+DFGLA++  + +R  ++ QV+ T  Y
Sbjct: 113 RGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV-TRWY 168

Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            APE +   R      D++S G +  ELL   
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 21/153 (13%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y 
Sbjct: 107 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYL 163

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  KLF 
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFE 206

Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 207 LILME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 10/101 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGP-TGD----RTHVSTQ 61
            L   H+    +++RD K  NI++       +AK+ DFG+    P   D        +T+
Sbjct: 91  ALACAHNQ--GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 102
           V+GT  Y APE +    +T  SD+Y++G++ LE L+G+  V
Sbjct: 149 VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 2e-10
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH A   +++RD K  N+L+++    K+ DFGLA+     +  H++ +V+ T  Y
Sbjct: 114 RGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 69  AAPEYVATG--RLTTKSDVYSFGVVLLELLSGR 99
            APE +  G    T+  D++S G +  ELL  R
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 35/169 (20%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTGDRTHVSTQVM 63
           G+ +LH     +++RD K +NIL D+  N KL DFG +K      +  TG ++     V 
Sbjct: 116 GVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VT 168

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 123
           GT  + +PE ++      K+DV+S G  ++E+L+                    KP  ++
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-------------------EKPPWAE 209

Query: 124 KRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                 +F+I       Q P   +  A     +      K RP   E+L
Sbjct: 210 FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 27/177 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K A  T D   + 
Sbjct: 105 LKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
            +      + APE +   + +TKSDV+SFG++L E+ S GR  V   ++ ++  +    K
Sbjct: 163 VK------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEK 214

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            Y  D                P         +  QC + +   RP   ++   LE +
Sbjct: 215 GYKMDA---------------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 66
           GL  LH  + ++IYRD K  N+LLD + N ++SD GLA   K G +  + +      GT 
Sbjct: 109 GLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           G+ APE +         D ++ GV L E+++ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 26/177 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 122 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 222

Query: 121 --LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD   GG    P         L   C    PK+RP   E++ +L+
Sbjct: 223 QGLSNEQVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 3e-10
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 31/175 (17%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 64
           A+G+ FL  A  + I+RD  A NILL      K+ DFGLA+     P   R   +   + 
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-- 122
              + APE +     TT+SDV+SFGV+L E+ S         +G        A PY    
Sbjct: 242 ---WMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG--------ASPYPGVQ 281

Query: 123 -DKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            ++    R+ D T++  + P+ A      + L C   +PK RP  S ++ IL  L
Sbjct: 282 INEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 11/98 (11%)

Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGT 65
             +GL +LH  E++VI+RD K  NILL      KL DFG+ A+   T  R +      GT
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GT 176

Query: 66  HGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG 98
             + APE +A           +SDV+S G+  +EL  G
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.1 bits (141), Expect = 4e-10
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH  E+ +I+RD K SN+LL  +   K++DFGLA+    G      T  + T  Y
Sbjct: 119 RGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWY 174

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +      T + D+++ G +L ELL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.3 bits (141), Expect = 4e-10
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 49/184 (26%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+     D  + S  V+  + 
Sbjct: 222 AQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNA 274

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC-----AVDK-----TKVGIEQ 111
                + APE +     T +SDV+S+G++L E+ S G+       V+       K G + 
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334

Query: 112 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 171
           S  D+A P      +++ IM                      C N EP  RP  S++  +
Sbjct: 335 SRPDFAPP------EIYSIMKM--------------------CWNLEPTERPTFSQISQL 368

Query: 172 LERL 175
           ++R 
Sbjct: 369 IQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.1 bits (141), Expect = 4e-10
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 12/100 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVST 60
           G+ +LH  E+ +++RD KA+NIL+D +   K++DFGLA+          G  G  T   T
Sbjct: 127 GINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 61  QVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            ++ T  Y  PE +   R  TT  D++  G V  E+ + R
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.8 bits (139), Expect = 4e-10
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167

Query: 61  QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 210

Query: 119 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 211 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 27/170 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
           A+G+ F+   +   I+RD +A+NIL+ A    K++DFGLA+     D  + + +  G   
Sbjct: 112 AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKF 165

Query: 67  --GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 123
              + APE +  G  T KSDV+SFG++L+E+++ GR                   P +S+
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PGMSN 209

Query: 124 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             ++ R ++       P+        + ++C  N P+ RP    + ++L+
Sbjct: 210 P-EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.8 bits (139), Expect = 6e-10
 Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ N+LL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 126 QALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 181

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            APE V       K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.2 bits (138), Expect = 6e-10
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 27/175 (15%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQV 62
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     P    T    ++
Sbjct: 114 GIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 121
                + APE +A  + T+ SDV+S+G+V+ E++S G                   +PY 
Sbjct: 172 --PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE------------------RPYW 211

Query: 122 S-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
               + + + ++       P         L L C   +   RP+  ++++IL++L
Sbjct: 212 EMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 6e-10
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 22/152 (14%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y A
Sbjct: 108 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  +LF +
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFEL 206

Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+  +  A +L    L  +PK R
Sbjct: 207 ILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 47/173 (27%), Positives = 72/173 (41%), Gaps = 27/173 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ FL  A    ++RD  A N+LL      K+ DFGLA+     D  H S  V     
Sbjct: 247 ARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGST 299

Query: 68  Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
           +      APE +     TT SDV+S+G++L E+                SL     P + 
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF---------------SLGGTPYPGMI 344

Query: 123 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                +  + +      P  A      + ++C N+EP+ RP    +  I+E L
Sbjct: 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.4 bits (138), Expect = 7e-10
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 126 QALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 181

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            APE V       K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.2 bits (138), Expect = 7e-10
 Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 35/179 (19%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RTHVST 60
           ++     KGL FL + E  +I+RD K +N+L++     KL DFG+     +G+    ++ 
Sbjct: 106 RITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAK 159

Query: 61  QVMGTHGYAAPEYV----ATGRLT--TKSDVYSFGVVLLELLSGRCA----VDKTKVGIE 110
             +G   Y APE +         T   +SDV+S G+ +LE+  GR               
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219

Query: 111 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            ++VD   P L                  P   +  A     +CLN  P  RP  +++L
Sbjct: 220 SAIVDGDPPTL------------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 7e-10
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 6/92 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   V++RD K SN+LL+A  + K+ DFGLA+   T ++    T+ + T  Y
Sbjct: 119 RGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 69  AAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +      TT  DV+S G +  ELL GR
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.9 bits (137), Expect = 9e-10
 Identities = 47/144 (32%), Positives = 68/144 (47%), Gaps = 17/144 (11%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL- 79
           +IYRD K  NILLD+  +  L+DFGL+K     D    +    GT  Y AP+ V  G   
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 80  -TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 138
                D +S GV++ ELL+G  A   T  G + S  + ++          RI+  K    
Sbjct: 185 HDKAVDWWSMGVLMYELLTG--ASPFTVDGEKNSQAEISR----------RIL--KSEPP 230

Query: 139 YPQKAAHTAATLALQCLNNEPKLR 162
           YPQ+ +  A  +  + L  +PK R
Sbjct: 231 YPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.8 bits (138), Expect = 9e-10
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LHD  + +++RD K SN+LL+     K+ DFGLA+    G      TQ++ T  Y 
Sbjct: 118 GVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYR 173

Query: 70  APE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE  +     +T  D++S G +  ELL+ +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 56.7 bits (138), Expect = 9e-10
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 17/98 (17%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL + H    ++++RD K  NIL++ +   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 109 RGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWY 164

Query: 69  AAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE       Y      +T  D++S G +  E+++G+
Sbjct: 165 RAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ FL  A    I+RD  A N+LL      K+ DFGLA+     D  + S  V+  + 
Sbjct: 151 AKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNA 203

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                + APE +     T +SDV+S+G++L E+ S
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   V++RD K SNIL++   + K+ DFGLA+      +    T  + T  Y
Sbjct: 119 RGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYY 171

Query: 69  AAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 99
            APE + T  +   + D++S G +  E+L G+
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 9/98 (9%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           GA  GL  LH+  +++I+RD K +NILL  E   KL DFG++ A  T  R   +T V GT
Sbjct: 136 GALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSV-GT 191

Query: 66  HGYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSG 98
             + APE +A  +        + DV+S G+  +EL  G
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 15/95 (15%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG- 67
           +G+ +L    S VI+RD  A N L+      K+SDFG+        R  +  Q   + G 
Sbjct: 111 EGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVLDDQYTSSTGT 161

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                +++PE  +  + ++KSDV+SFGV++ E+ S
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 56.7 bits (136), Expect = 1e-09
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 6/91 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG  A+  P   +    + ++GT  
Sbjct: 127 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 181

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           + APE V       K D++S G++ +E++ G
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 9   KGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           K L+FLH   +Q VI+RD K+ +ILL ++   KLSDFG                ++GT  
Sbjct: 126 KALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPY 180

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           + APE ++     T+ D++S G++++E++ G
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 18/105 (17%)

Query: 3   VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           +A   A G+ +L   E+Q  I+RD  A N+L+      K++DFGLA       R      
Sbjct: 108 MAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLA-------RVIKEDI 157

Query: 62  VMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 99
                G      + APE     R + KSDV+SFG++L E+++ GR
Sbjct: 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 55/189 (29%), Positives = 80/189 (42%), Gaps = 40/189 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----GPTGDRTHVSTQVMG 64
           + L ++H A   V +RD K  NIL +A+   K+ DFGLA+      PT       T  + 
Sbjct: 114 RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVA 168

Query: 65  THGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-------- 114
           T  Y APE   +   + T   D++S G +  E+L+G+       V  +  L+        
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228

Query: 115 ---------DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN----EPKL 161
                    + A+ YLS  RK       K    + QK  + A  LAL+ L      +PK 
Sbjct: 229 PETISRVRNEKARRYLSSMRK-------KQPVPFSQKFPN-ADPLALRLLERLLAFDPKD 280

Query: 162 RPRMSEVLA 170
           RP   E LA
Sbjct: 281 RPTAEEALA 289

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 28/156 (17%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH    +++YRD K  N++LD + + K++DFGL K G T   T  +    GT  Y 
Sbjct: 107 ALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYL 162

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  KLF 
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFE 205

Query: 130 IM---DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++   D K    +P+  +  A +L    L  +P  R
Sbjct: 206 LILMEDIK----FPRTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 35/91 (38%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L +LH     ++YRD K  NILLD++ +  L+DFGL K G     T  +T   GT  
Sbjct: 106 ASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPE 161

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179

Query: 61  QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 222

Query: 119 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 223 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 21/154 (13%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLT 80
           ++RD +A+NIL+      K++DFGLA+     D  + + Q       + APE    GR T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 81  TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-KRKLFRIMDTKLGGQY 139
            KSDV+SFG++L EL +      K +V           PY     R++   ++       
Sbjct: 182 IKSDVWSFGILLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPC 224

Query: 140 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           P +   +   L  QC   EP+ RP    + A LE
Sbjct: 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KG+ ++H   + +++RD K +N+L+ A+   K++DFGLA+     +    S QV  T  Y
Sbjct: 110 KGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWY 166

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +   R      D+++ G +  ELL+G 
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 27/100 (27%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------ 62
           KGL +LH  E+  I+RD K +NILL  + + KL+DFG            VS Q+      
Sbjct: 112 KGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAK 157

Query: 63  ----MGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 95
               +GT  + APE  A    G    K D+++ G+  +EL
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 3/98 (3%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VS 59
           +K A+   KG+ +L     Q ++RD  A N+L+++E   K+ DFGL KA  T    + V 
Sbjct: 112 LKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             +     + APE +   +    SDV+SFGV L ELL+
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 20/178 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + + + H     +I+RD K  NIL+      KL DFG A+A      + ++  V  T  Y
Sbjct: 111 QAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWY 167

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR------CAVDKTKVGIEQSL--VDWAKP 119
            APE +       K  DV++ G ++ ELL G         +D+  + I++ L  +  +  
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQ 226

Query: 120 YLSDKRKLFRIMDT-------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
            L      F  +          L  +YP K +  A      CL  +PK R    E+L 
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 3e-09
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 31/170 (18%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG- 67
           +G+ +L    +  I+RD  A N L+ +    K+SDFG+        R  +  +   + G 
Sbjct: 111 EGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVLDDEYTSSSGA 161

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                ++ PE     + ++KSDV+SFGV++ E+ +      + K+  E+         +S
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT------EGKMPFEKKSNYEVVEMIS 215

Query: 123 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
              +L+R          P+ A+ T   +   C + +P+ RP  +E+L  +
Sbjct: 216 RGFRLYR----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 35/88 (39%), Positives = 45/88 (51%), Gaps = 4/88 (4%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L  LH  +  VIYRD K  NILLD + +  L DFGL K     D    +    GT  Y A
Sbjct: 106 LENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLA 161

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +     T   D ++ GV+L E+L+G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 45/131 (34%), Positives = 64/131 (48%), Gaps = 20/131 (15%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           +IYRD K  NILLDA+ + KL+DFGL K     G  TH      GT  Y APE +     
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRSGH 177

Query: 80  TTKSDVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAK----PYLSD------KRK 126
               D +S G ++ ++L+G     A ++ K  I++ L    K    PYL+       K+ 
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKILK--GKLNLPPYLTPEARDLLKKL 234

Query: 127 LFRIMDTKLGG 137
           L R   ++LG 
Sbjct: 235 LKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.4 bits (134), Expect = 3e-09
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTHVSTQVMGTH 66
           +GL ++H A   VI+RD K SN+L++ +   ++ DFG+A+   +   +  +  T+ + T 
Sbjct: 118 RGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 67  GYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 99
            Y APE + +    TT  D++S G +  E+L GR
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 54.9 bits (132), Expect = 4e-09
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 6/95 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRTHVSTQVMG 64
            G+ +LH+  + V++RD K +N++L      KL DFG A+     G  G  +++   + G
Sbjct: 113 DGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           T  + APE +       KSD++S G  + E+ +G+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 24/166 (14%)

Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 74
           H    +V++RD K +N+ + A    KL D GL +   +  +T  +  ++GT  Y +PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178

Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
                  KSD++S G +L E+               QS      P+  DK  LF +    
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLFSLCQKI 220

Query: 135 LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
               YP    +  +     L   C+  +P  RP +  V  I +++ 
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 30/174 (17%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ FL  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+      T+G
Sbjct: 142 ARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRKTTNG 194

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +     T +SDV+SFGV+L E+ +         +G          PY  
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LG--------GSPYPG 237

Query: 123 DK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
               +LF+++      + PQ        L   C +  P  RP   +++  L+R+
Sbjct: 238 IPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 22/165 (13%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +    
Sbjct: 129 ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKR 125
           + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY  +S+++
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPYQGMSNEQ 229

Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
            L  +M+  L  + P         L   C    PK+RP   E+++
Sbjct: 230 VLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 5e-09
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH    ++I+RD K  NI ++      + D G A+  P      +   + GT   
Sbjct: 168 EGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVET 222

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            APE +A  +  +K+D++S G+VL E+L+
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 54.8 bits (132), Expect = 5e-09
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 111 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWY 166

Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.6 bits (131), Expect = 5e-09
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 2/97 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  A    ++RD    N L+ A    K+ DFG+++   + D   V  
Sbjct: 126 LHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             M    +  PE +   + TT+SDV+SFGV+L E+ +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 5e-09
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 21/169 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K A+ AA G+ +L       I+RD  A N L+      K+SDFG+++    G  +    
Sbjct: 96  VKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
           + +    + APE +  GR +++SDV+S+G++L E  S G C          +  V+    
Sbjct: 154 KQIPIK-WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---- 208

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                 K +R+         PQK       +  +C + +P+ RP+ SE+
Sbjct: 209 ------KGYRM-------SCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 6e-09
 Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 4/95 (4%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A   A  + +LH     +IYRD K  NILLD++ +  L+DFGL K G   + T  ++   
Sbjct: 102 AAEVASAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFC 157

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           GT  Y APE +         D +  G VL E+L G
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.7 bits (131), Expect = 6e-09
 Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 20/162 (12%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ FL  +   V+++D    N+L+  + N K+SD GL +     D   +    +    
Sbjct: 134 AAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + +PE +  G+ +  SD++S+GVVL E+ S          G++        PY     + 
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQ--------PYCGYSNQD 234

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
           +  ++  +     P        TL L+C N  P  RPR  ++
Sbjct: 235 VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 54.2 bits (130), Expect = 6e-09
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 5/87 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           GL  +HD   ++++RD K+ NI L      AKL DFG+A+     D   ++   +GT  Y
Sbjct: 113 GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYY 168

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLEL 95
            +PE         K+D++S G VL EL
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 54.5 bits (131), Expect = 7e-09
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 27/163 (16%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L  +HD   ++++RD K+ NI L  +   KL DFG+A+         ++   +GT  Y 
Sbjct: 113 ALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYL 168

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           +PE         KSD+++ G VL E+ + + A +    G  ++LV           K+ R
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV----------LKIIR 215

Query: 130 IMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVL 169
                  G YP  ++H +     L  Q     P+ RP ++ +L
Sbjct: 216 -------GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 8e-09
 Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 27/173 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 64
           AKG+ FL  A  + I+RD  A NILL      K+ DFGLA+     P   R   +   + 
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 122
              + APE +     T +SDV+SFGV+L E+ S         +G        A PY  + 
Sbjct: 246 --KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVK 286

Query: 123 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 54.3 bits (131), Expect = 8e-09
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ +L       ++RD    N L+   +  K++DFG+++   + D   V  +      
Sbjct: 140 ASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR 197

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + A E V  G+ TTKSDV++FGV L E+L+
Sbjct: 198 WMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 8e-09
 Identities = 35/125 (28%), Positives = 51/125 (40%), Gaps = 35/125 (28%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVS 59
           + +A+ +   L F+H        RD K  NIL+DA+ + KL+DFGL K      DR +  
Sbjct: 110 LVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 60  TQ--------------------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 93
                                        +GT  Y APE +       + D +S GV+L 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 94  ELLSG 98
           E+L G
Sbjct: 222 EMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.9 bits (129), Expect = 8e-09
 Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 34/169 (20%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTGDRTHVSTQV 62
           +G+++LH   + +++RD K +NIL D+  N KL DFG +K         TG R+     V
Sbjct: 117 EGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-----V 169

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
            GT  + +PE ++      K+DV+S G  ++E+L+                    KP  +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-------------------EKPPWA 210

Query: 123 DKRKLFRIMDTKLGGQYPQKAAHTA--ATLALQCLNNEPKLRPRMSEVL 169
           +   +  I         PQ  +H +  A   L C+  E + RP   E+L
Sbjct: 211 EYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.9 bits (129), Expect = 9e-09
 Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ ++       I+RD +A+N+L+      K++DFGLA+     + T           
Sbjct: 113 AEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 169

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +  G  T KSDV+SFG++L E+++
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 54.1 bits (130), Expect = 9e-09
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 22/174 (12%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           +A   A G+ +L  +E + ++RD    N L+      K++DFGL++   + D    S   
Sbjct: 135 IAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 120
                +  PE +   R TT+SDV+++GVVL E+ S          G++        PY  
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGMQ--------PYYG 235

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           ++ +  ++ + D  +    P         L   C +  P  RP  + +  IL+R
Sbjct: 236 MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 32/184 (17%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           +  A   AKG  +L   E+  I+RD  A N LL  +     AK++DFG+A+         
Sbjct: 119 LFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
              + M    +  PE    G  T+K+DV+SFGV+L E+ S G                  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM---------------- 220

Query: 117 AKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             PY     +   +M+   GG     P+        +   C  + P+ RP  +    ILE
Sbjct: 221 --PYPGRTNQ--EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT---ILE 273

Query: 174 RLEA 177
           R++ 
Sbjct: 274 RIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A+  A G+ +L  A    ++RD    N L+   +  K++DFG+++   +GD   +  
Sbjct: 132 LYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + +    + A E +  G+ TT SDV++FGV L E+ +
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 24/175 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 59
           +++   AA G+ +L   ES+  I+RD  A N L+  +   K+SDFG+++    G      
Sbjct: 97  IQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
                   + APE +  GR +++SDV+SFG++L E  S         +G        A P
Sbjct: 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS---------LG--------AVP 196

Query: 120 YLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
           Y +   +  R    + G +   P+        L  +C   +P  RP  S V   L
Sbjct: 197 YANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 53.7 bits (129), Expect = 1e-08
 Identities = 39/169 (23%), Positives = 70/169 (41%), Gaps = 21/169 (12%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           +  + +L   +   I+RD  A N L+      K++DFGL++   TGD             
Sbjct: 114 SSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK 170

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE +A  + + KSDV++FGV+L E+ +   +                 PY   D  +
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQ 213

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           ++ +++     + P+        L   C    P  RP  +E+    E +
Sbjct: 214 VYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 40/167 (23%), Positives = 71/167 (42%), Gaps = 24/167 (14%)

Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 74
           H    +V++RD K +N+ + A    KL D GL +   +  +T  +  ++GT  Y +PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178

Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
                  KSD++S G +L E+ +                     P+  DK  L+ +    
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAA------------------LQSPFYGDKMNLYSLCKKI 220

Query: 135 LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
               YP       +     L   C+N +P+ RP ++ V  + +R+ A
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.7 bits (129), Expect = 1e-08
 Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 4/85 (4%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH  E ++++RD   +NI+L  +    ++DFGLAK           T V+GT  Y+ 
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181

Query: 71  PEYVATGRLTTKSDVYSFGVVLLEL 95
           PE V       K+DV++FG +L ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--G 67
           G+ +L       ++RD  A N+LL  +  AK+SDFGL+KA    D ++   +  G     
Sbjct: 107 GMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLK 163

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +   + +++SDV+S+G+ + E  S
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 24/178 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 123 LHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
             M    +  PE +   + TT+SDV+S GVVL E+ + G+                  +P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------------QP 222

Query: 120 Y--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +  LS+   +  I   ++  Q P+        L L C   EP +R  + E+ ++L+ L
Sbjct: 223 WYQLSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 26/174 (14%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
              L  +H    ++++RD K +N+ + A    KL D GL +      +T  +  ++GT  
Sbjct: 116 CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPY 171

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y +PE +       KSD++S G +L E+ + +                   P+  DK  L
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNL 213

Query: 128 FRIMDTKLGGQY-PQKAAHTAATL---ALQCLNNEPKLRPRMSEVLAILERLEA 177
           + +        Y P  A H +  L     +C+N +P+ RP +S VL + + + A
Sbjct: 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG++FL  A    I+RD  A NILL      K+ DFGLA+         V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 2/97 (2%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 125 LAIASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + M    +  PE +   + TT+SD++SFGVVL E+ +
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 13/97 (13%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ 61
           +  GA +GL +LH  E   I+RD KA NILL      KL+DFG A    P       +  
Sbjct: 120 ICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANS 170

Query: 62  VMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 95
            +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 33/98 (33%), Positives = 46/98 (46%), Gaps = 13/98 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M  A+ A   L ++H        RD K  N L+DA  + KL+DFGL+K   T      + 
Sbjct: 110 MFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YAN 156

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            V+G+  Y APE +         D +S G +L E L G
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 20/176 (11%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++  I  A G+ +L  +    I+RD  A N +L+      ++DFGL+K   +GD      
Sbjct: 116 VRFMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
                  + A E +A    TT SDV++FGV + E+++ G+        G+E S +     
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY----AGVENSEI---YN 226

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           YL    +L          + P         L  QC + EPK RP    +   LE +
Sbjct: 227 YLIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 32/182 (17%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTH 57
           +K  +  A G+ +L  +    I+RD  A N +L  +    ++DFGL+K   +GD   +  
Sbjct: 116 LKFMVDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
           ++   +    + A E +A    T+KSDV++FGV + E+ + G+        G+E      
Sbjct: 174 IAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP----GVENH---- 222

Query: 117 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL---ALQCLNNEPKLRPRMSEVLAILE 173
                        I D    G   ++       L      C   +PK RP  +++  +LE
Sbjct: 223 ------------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Query: 174 RL 175
            +
Sbjct: 271 NI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 7/102 (6%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDR 55
           + + +  AKG  +L       I+RD  A N L+     DA+   K+ DFGLA+     D 
Sbjct: 109 LDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166

Query: 56  THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                + +    + APE +  G+ TT+SDV+SFGV++ E+L+
Sbjct: 167 YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 43/171 (25%), Positives = 83/171 (48%), Gaps = 24/171 (14%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+++L +   ++++RD  A N+L+ +  + K++DFGLA+     +  + +        
Sbjct: 119 AKGMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + A E +   R T +SDV+S+GV + EL++          G        AKPY     R+
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT---------FG--------AKPYDGIPARE 219

Query: 127 LFRIMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILERL 175
           +  +++   G + PQ    T     + ++C   + + RPR  E++    R+
Sbjct: 220 IPDLLEK--GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KG+ F H  E++V++RD K  N+L++     KL+DFGLA+A      T  +  V  T  Y
Sbjct: 111 KGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWY 166

Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            AP+ +   R  +T  D++S G ++ E+++GR
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 23/153 (15%)

Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           ++++RD K++NI L      KL DFG +K         V++   GT  Y APE     R 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 139
           + K+D++S GV+L ELL+                    +P+    ++   IM   L G+Y
Sbjct: 249 SKKADMWSLGVILYELLT------------------LHRPFKGPSQR--EIMQQVLYGKY 288

Query: 140 ---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
              P   +     L    L+  P LRP   ++L
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 21/194 (10%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D    +T   
Sbjct: 140 AYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS- 122
               + APE +     T +SDV+SFGV+L E+ +         +G          PY   
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LG--------GSPYPGI 240

Query: 123 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNS 181
              +LF+++        P    H    +  +C +  P  RP   +++  L+R L      
Sbjct: 241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300

Query: 182 AKLSQSEPHRQTGP 195
             L  S P  Q  P
Sbjct: 301 EYLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ F H    +V++RD K  N+L+D +   KL+DFGLA+A   G    V T  + T  Y 
Sbjct: 113 GILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEVVTLWYR 168

Query: 70  APE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE  + + R +T  D++S G +  E+ + +
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 26/169 (15%)

Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           A  GL  LH   ++ I+RD K +NILL  E   KL DFG++ A  T  R   +T V GT 
Sbjct: 133 ALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSV-GTP 188

Query: 67  GYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
            + APE +A  +        + DV+S G+  +EL  G           +  L D     L
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DPPLAD-----L 232

Query: 122 SDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
              R LF+I  +       P+  ++       +CL  + + RP +S++L
Sbjct: 233 HPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +G+ + H    +V++RD K  N+L+D E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 110 QGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWY 165

Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            APE +   R  +T  D++S G +  E+++ R
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.0 bits (125), Expect = 4e-08
 Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 23/167 (13%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
             L +L     + ++RD  A N+L+ +    KL DFGL++          S   +    +
Sbjct: 118 TALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-W 174

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +   R T+ SDV+ FGV + E+L          +G+        KP+   K    
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILM---------LGV--------KPFQGVKNNDV 217

Query: 129 RIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
            I   + G +   P     T  +L  +C   +P  RPR +E+ A L 
Sbjct: 218 -IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 30/180 (16%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+     
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKK 198

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
            T+G     + APE +     T +SDV+SFGV+L E+ +         +G          
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------GS 241

Query: 119 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
           PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 242 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 13/94 (13%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMG 64
           GA +GL +LH     +I+RD KA NILL      KL+DFG A K+ P       +   +G
Sbjct: 129 GALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVG 179

Query: 65  THGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 95
           T  + APE +     G+   K DV+S G+  +EL
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 20/189 (10%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L     + I+RD  A N+L+  +   K++DFGLA+     D    ++       
Sbjct: 144 ARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE +     T +SDV+SFG+++ E+ +         +G          PY      +
Sbjct: 202 WMAPEALFDRVYTHQSDVWSFGILMWEIFT---------LG--------GSPYPGIPVEE 244

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ 186
           LF+++        P    H    L  +C +  P  RP   +++  L+++ A  +   L  
Sbjct: 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDL 304

Query: 187 SEPHRQTGP 195
           S P  Q  P
Sbjct: 305 SMPFEQYSP 313

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.5 bits (123), Expect = 6e-08
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 21/162 (12%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L +LH  E  +++RD K  N+ L      K+ D G+A+     ++  +++ ++GT  
Sbjct: 112 AMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y +PE  +      KSDV++ G  + E+ + + A +   +    SLV             
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLV------------- 211

Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           +RI++ KL    P+  +     L    L+  P+ RP +  +L
Sbjct: 212 YRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 51.6 bits (124), Expect = 6e-08
 Identities = 45/136 (33%), Positives = 60/136 (44%), Gaps = 26/136 (19%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTH 66
           + + F H  +   I+RD K  NIL+  +   KL DFG A+   GP  D     T  + T 
Sbjct: 111 QAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATR 164

Query: 67  GYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
            Y APE  V   +     DV++ G V  ELL+G            Q L  W  P  SD  
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG------------QPL--W--PGKSDVD 208

Query: 126 KLFRIMDTKLGGQYPQ 141
           +L+ I  T LG   P+
Sbjct: 209 QLYLIRKT-LGDLIPR 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L +LH     ++YRD K  NILLD++ +  L+DFGL K     + T  ++   GT  
Sbjct: 106 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPE 161

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 7e-08
 Identities = 30/79 (37%), Positives = 47/79 (59%), Gaps = 2/79 (2%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           ++YRD K  NILLD+E +  L+DFGL+K   + ++   +    GT  Y APE +      
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGH 184

Query: 81  TKS-DVYSFGVVLLELLSG 98
            K+ D +S G+++ ELL+G
Sbjct: 185 GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L++LH+    VI+RD K+ +ILL ++   KLSDFG                +
Sbjct: 123 VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKSL 178

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +GT  + APE ++     T+ D++S G++++E++ G
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 13/94 (13%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMG 64
           GA +GL +LH     +I+RD KA NILL      KL+DFG A  A P       +   +G
Sbjct: 133 GALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVG 183

Query: 65  THGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 95
           T  + APE +     G+   K DV+S G+  +EL
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           +G+ + H    +V++RD K  N+L+D   NA KL+DFGLA+A     RT   T  + T  
Sbjct: 113 RGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLW 168

Query: 68  YAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
           Y APE +   R  +T  D++S G +  E+++ +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 31/86 (36%), Positives = 41/86 (47%), Gaps = 2/86 (2%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NI LD   NA L DFG A        T       GT    +
Sbjct: 198 LAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELL 96
           PE +A      K+D++S G+VL E+ 
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 50/168 (29%), Positives = 73/168 (43%), Gaps = 20/168 (11%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ +L  +    I+RD  A N +L+   N  ++DFGL+K    GD             
Sbjct: 122 ASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           + A E +A    TTKSDV+SFGV + E+ + G+        G+E S +     YL    +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP----GVENSEI---YDYLRQGNR 232

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           L +  D  L G Y         +L   C    PK RP    +   LE+
Sbjct: 233 LKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 41/168 (24%), Positives = 76/168 (45%), Gaps = 30/168 (17%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFG----LAKAGPTGDRTHVSTQVM 63
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG    LA   P       +    
Sbjct: 119 EGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFT 170

Query: 64  GTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           GT  Y APE +  G       +D++S G  ++E+ +G+              ++  +P  
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK-----------PPFIELGEPQA 219

Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           +    +F++   K+  + P+  +  A    L+C   +P  R    ++L
Sbjct: 220 A----MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL + H      ++RD K SNILL+ +   KL+DFGLA+   + +    + +V+ T  Y 
Sbjct: 128 GLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYR 184

Query: 70  APE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
            PE  +   R     DV+S G +L EL + +
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 11/93 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L +LH  E+++I+RD KA NIL   + + KL+DFG+ AK   T  R       +GT  
Sbjct: 114 EALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPY 168

Query: 68  YAAPEYV--ATGR---LTTKSDVYSFGVVLLEL 95
           + APE V   T +      K+DV+S G+ L+E+
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 183

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 115 RGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWY 170

Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
             P+  + +   +T+ D++  G +  E+ SGR
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 12/94 (12%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG----LAKAGPTGDRTHVSTQVMG 64
           + L +LH     VI+RD K+ +ILL  +   KLSDFG    ++K  P          ++G
Sbjct: 128 QALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVG 179

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T  + APE ++     T+ D++S G++++E++ G
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.9 bits (120), Expect = 2e-07
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 5/87 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +G+ FLH    ++++RD K  NIL+ ++   K++DFGLA+           T V+ T  Y
Sbjct: 118 RGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWY 172

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLEL 95
            APE +      T  D++S G +  EL
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L F +     ++YRD K  N+LLD +   K++DFG AK   T  RT+    + GT  Y A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT---LCGTPEYIA 196

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        +D ++ G+ + E+L G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   +I+RD K SNI ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEM---TGYVATRWY 181

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 14/95 (14%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           KGL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+           +++ G   T
Sbjct: 129 KGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVT 178

Query: 66  HGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 99
             Y APE +      T   D++S G ++ E+L+G+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 17/114 (14%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGY 68
           G+ +LH     +++RD K SN+L+++  N K++DFG+++    T D  + S   +GT  Y
Sbjct: 180 GIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAY 234

Query: 69  AAPEYVAT----GRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
            +PE + T    G     + D++S GV +LE   GR      + G      DWA
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWA 282

Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T     + T  + T  Y 
Sbjct: 135 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYR 189

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 49.7 bits (118), Expect = 3e-07
 Identities = 35/94 (37%), Positives = 47/94 (50%), Gaps = 13/94 (13%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMG 64
           GA +GL +LH     +I+RD KA NILL      KL DFG A    P       +   +G
Sbjct: 123 GALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVG 173

Query: 65  THGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 95
           T  + APE +     G+   K DV+S G+  +EL
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHG 67
           +G+++LH   + +++RD K +NIL D+  N KL DFG +K   T   +    + V GT  
Sbjct: 117 EGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           + +PE ++      K+D++S G  ++E+L+ +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 18/133 (13%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL++ H  + ++++RD K  N+L++ +   KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 114 RGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWY 169

Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
             P+  + +   +T  D++  G +L E+ +GR     + V  E  L+             
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI------------- 216

Query: 128 FRIMDTKLGGQYP 140
           FR++ T     +P
Sbjct: 217 FRLLGTPTEETWP 229

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (116), Expect = 4e-07
 Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 3/90 (3%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHG 67
           +G+++LH   + +++RD K +NIL D+  N KL DFG +K   T   +    + V GT  
Sbjct: 117 QGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + +PE ++      K+DV+S    ++E+L+
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 5e-07
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 7/84 (8%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 81
           ++RD K  N+L+D   + KL+DFG A A  T ++   S   +GT  Y APE + T     
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 82  KS------DVYSFGVVLLELLSGR 99
           K       D +S GV+  E++ GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.8 bits (117), Expect = 5e-07
 Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 7/90 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           K L  +H   + + +RD K  NIL+  +   KL+DFG  +           T+ + T  Y
Sbjct: 111 KSLDHMH--RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWY 164

Query: 69  AAPEYVAT-GRLTTKSDVYSFGVVLLELLS 97
            APE + T G    K D+++ G V  E+LS
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ +L   E ++++RD  A N+L+ +  + K++DFGLA+     ++ + +        
Sbjct: 119 AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + A E +   + T +SDV+S+GV + EL++
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 31/83 (37%), Positives = 40/83 (48%), Gaps = 6/83 (7%)

Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPE 72
           H  E +V++RD K+ NI L      KL DFG A+    P     +  T V GT  Y  PE
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPPE 170

Query: 73  YVATGRLTTKSDVYSFGVVLLEL 95
                    KSD++S G +L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 36/169 (21%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ ++H  + ++++RD KA NI L      K+ DFG+++         ++T   GT  Y 
Sbjct: 118 GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYM 172

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-----IEQSLVDWAKPYLSDK 124
           +PE +      +KSD++S G +L E+    C +     G     +   +V+   P L + 
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM----CCLAHAFEGQNFLSVVLRIVEGPTPSLPET 228

Query: 125 --RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 171
             R+L  IM +                     LN +P LRP  +E+L  
Sbjct: 229 YSRQLNSIMQSM--------------------LNKDPSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 48.9 bits (117), Expect = 6e-07
 Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 26/179 (14%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTH 66
           +G+ F H     +I+RD K  NIL+      KL DFG A+  A P G+   V T  + T 
Sbjct: 111 RGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATR 164

Query: 67  GYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR------CAVDKTKVGIEQSLVDWAKP 119
            Y APE  V   +     D+++ G ++ E+L+G         +D+    I + L +    
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY-HIIKCLGNLIPR 223

Query: 120 Y--LSDKRKLFRIM---DTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           +  +  K  LF  M   + K    L  ++P K +     LA QCL  +P  RP  S++L
Sbjct: 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.0 bits (117), Expect = 6e-07
 Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK-AGPTGDRTHVSTQVMGTH 66
           +GL ++H A   V++RD K +N+ ++ E    K+ DFGLA+   P        ++ + T 
Sbjct: 125 RGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 67  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            Y +P  + +    TK+ D+++ G +  E+L+G+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.9 bits (116), Expect = 6e-07
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 121 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 175

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +      T  D++S G +  E+   +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 7e-07
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 15/101 (14%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-------------PTGDRTH 57
           L +LH+    +++RD K  N+L+ +  + KL+DFGL+K G                 R  
Sbjct: 114 LEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +  QV GT  Y APE +         D ++ G++L E L G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.5 bits (115), Expect = 8e-07
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 11/93 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L +LH    ++I+RD KA N+LL  + + KL+DFG+ AK   T  R       +GT  
Sbjct: 121 EALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPY 175

Query: 68  YAAPEYVATGRLTT-----KSDVYSFGVVLLEL 95
           + APE V    +       K+D++S G+ L+E+
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.5 bits (115), Expect = 9e-07
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185

Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   K L+ LH     VI+RD K+ +ILL  +   KLSDFG                +
Sbjct: 121 VCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSL 176

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +GT  + APE ++      + D++S G++++E++ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHG 67
           GL ++H   +++++RD KA+NIL+  +   KL+DFGLA+A       + +  T  + T  
Sbjct: 131 GLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 68  YAAPEYVATGR-LTTKSDVYSFGVVLLEL 95
           Y  PE +   R      D++  G ++ E+
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 115 RGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWY 170

Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
             P+  + +   +T+ D++  G +  E+ +GR
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 31/82 (37%), Positives = 41/82 (50%), Gaps = 7/82 (8%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT---- 76
           I+RD K  N+LLD   + KL+DFG   K    G      T V GT  Y +PE + +    
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 77  GRLTTKSDVYSFGVVLLELLSG 98
           G    + D +S GV L E+L G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H     +++RD K  N+L+      KL+DFGLA+A     +T+ S  V  T  Y
Sbjct: 114 RGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWY 169

Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 116
             P+  +     ++  D++  G + +E+L G+ A        EQ    W
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 29/180 (16%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M +  G A G+ +L  +E   +++   A  +L++++   K+S F   +     D++    
Sbjct: 110 MGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIY 163

Query: 61  QVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVD 115
             M       +AAPE +     ++ SDV+SFG+V+ E++S   R   D +   + +++ D
Sbjct: 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED 223

Query: 116 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                       FR+         P+   +    L L C   E   RPR S++ +IL ++
Sbjct: 224 G-----------FRL-------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 26/178 (14%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           +A   A G+ +L  +    ++RD    N L+   +  K++DFG+++   +GD   +  + 
Sbjct: 135 MATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRA 192

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 120
           +    + + E +  G+ TT SDV++FGV L E+L+  C         EQ       PY  
Sbjct: 193 VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT-LCK--------EQ-------PYSQ 236

Query: 121 LSDKR------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
           LSD++      + FR    ++    P     +   L L C     K RP   E+ A L
Sbjct: 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 147 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 205 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+    G    ++  V+ T  Y 
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV-TRYYR 184

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +         D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 28/90 (31%), Positives = 51/90 (56%), Gaps = 2/90 (2%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ +L   E ++++RD  A N+L+    + K++DFGLAK     ++ + +        
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + A E +     T +SDV+S+GV + EL++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192

Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  G   +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 11/96 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHG 67
           +GL+ LH  + +VI+RD K  N+LL      KL DFG++      DRT       +GT  
Sbjct: 122 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPY 176

Query: 68  YAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 98
           + APE +A           KSD++S G+  +E+  G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.8 bits (111), Expect = 3e-06
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 14/95 (14%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
            GL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 128 CGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 177

Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
             Y APE +       ++ D++S G ++ E+L+G+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVMGTHG 67
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+         ++ T V+ T  
Sbjct: 119 RGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLW 172

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELL 96
           Y APE +      T  D++S G +  E+ 
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ FL  A    ++RD  A N+L+      K+ DFGLA+     D    S  +     
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKGST 301

Query: 68  Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           +      APE +     TT SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.0 bits (109), Expect = 4e-06
 Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 15/110 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVS 59
           M VA+ A      LH     ++ RD   +NILLD   + +L+ F   ++   + D   V 
Sbjct: 94  MVVALDA------LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE 145

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 109
                   Y APE       T   D +S G +L ELL+G+  V+    GI
Sbjct: 146 NM------YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 5e-06
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 20/100 (20%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLA-------KAGPTGDRTHV 58
           G+ +LH   + V++RD K +NIL+  E       K+ D GLA       K     D    
Sbjct: 120 GVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP--- 174

Query: 59  STQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 97
              V+ T  Y APE +   R  TK+ D+++ G +  ELL+
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.2 bits (109), Expect = 5e-06
 Identities = 29/82 (35%), Positives = 40/82 (48%), Gaps = 5/82 (6%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---- 76
           +I+RD K  N+LLD   + KL+DFG              T V GT  Y +PE + +    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 77  GRLTTKSDVYSFGVVLLELLSG 98
           G    + D +S GV L E+L G
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 6e-06
 Identities = 27/106 (25%), Positives = 40/106 (37%), Gaps = 27/106 (25%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV---------------------- 58
           ++YRD K  NILL    +  LSDF L+K                                
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 59  -----STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
                S   +GT  Y APE ++     +  D ++ G++L E+L G 
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL + H    +V++RD K  N+L+      KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWY 169

Query: 69  AAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 99
             P+ V  G    +T  D++  G +  E+ +GR
Sbjct: 170 RPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 14/103 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M +AI +   L ++H        RD K  NIL+D   + +L+DFG +      D T  S+
Sbjct: 111 MVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSS 161

Query: 61  QVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 98
             +GT  Y +PE +       G+   + D +S GV + E+L G
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.5 bits (108), Expect = 8e-06
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL F H     V++RD K  N+L++     KL+DFGLA+A     R + S +V+ T  Y
Sbjct: 110 KGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWY 165

Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLELLSG 98
             P+ +   +L +T  D++S G +  EL + 
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 8e-06
 Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 16/104 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVS 59
           M +AI +   L ++H        RD K  N+LLD   + +L+DFG   +    G  T  S
Sbjct: 111 MVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQS 160

Query: 60  TQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 98
              +GT  Y +PE +       GR   + D +S GV + E+L G
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 30/102 (29%), Positives = 44/102 (43%), Gaps = 9/102 (8%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
            ++A   A GL +LH A+   I+ D    N  L A+ + K+ D+GLA      D      
Sbjct: 103 QRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160

Query: 61  QVMGTHGYAAPEYVA-------TGRLTTKSDVYSFGVVLLEL 95
                  + APE V            T KS+++S GV + EL
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+     D     T  + T  Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 15/104 (14%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-------AGPTGDRTHVS-- 59
            GL  LH  +   ++RD   +NI ++++   K++DFGLA+       +        +   
Sbjct: 130 NGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 60  ---TQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 99
              T  + T  Y APE +    +     D++S G +  ELL+G+
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 11/96 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHG 67
           +GL  LH    +VI+RD K  N+LL      KL DFG++      DRT       +GT  
Sbjct: 132 RGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPY 186

Query: 68  YAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 98
           + APE +A           +SD++S G+  +E+  G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 32/113 (28%), Positives = 45/113 (39%), Gaps = 36/113 (31%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGL----------------AKAGPTGDRTHVSTQ---- 61
           I+RD K  N+LLDA+ + KLSDFGL                + A P+     +S      
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 62  ----------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                            +GT  Y APE         + D +S GV++ E+L G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 28/94 (29%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL+++H  +  +++RD K  N+L+      KL+DFGLA+A      T+ S +V+ T  Y
Sbjct: 114 RGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWY 169

Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCA 101
             P+  + +   +T  D++  G + +E++ G  A
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 37/143 (25%), Positives = 54/143 (37%), Gaps = 50/143 (34%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVST-------------------- 60
           I+RD K  NIL+D + + KL+DFGL     TG R TH S                     
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 61  ------------------------QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 96
                                    ++GT  Y APE +     T   D +S GV+L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 97  SGRCA-VDKTKVGIEQSLVDWAK 118
            G+   +  T    +  +++W  
Sbjct: 239 VGQPPFLADTPAETQLKVINWET 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 6/82 (7%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-----AT 76
           ++RD K  N+LLD   + +L+DFG +      D T  S+  +GT  Y +PE +       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 77  GRLTTKSDVYSFGVVLLELLSG 98
           G+   + D +S GV + E+L G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 3e-05
 Identities = 37/129 (28%), Positives = 49/129 (37%), Gaps = 41/129 (31%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA------------- 49
           +AI A   L F+H        RD K  N+LLDA+ + KLSDFGL                
Sbjct: 112 LAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 50  --GPTGD------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 89
              P  D                  R  ++   +GT  Y APE           D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 90  VVLLELLSG 98
           V++ E+L G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 44/202 (21%), Positives = 69/202 (34%), Gaps = 53/202 (26%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF----GLAKAG---------PT 52
                L ++H      I+R  KAS+ILL  +    LS       + K G         P 
Sbjct: 109 DVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 53  GDRTHV---STQVM--GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA----VD 103
               ++   S +V+     GY             KSD+YS G+   EL +G       + 
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGY-----------NEKSDIYSVGITACELANG-HVPFKDMP 214

Query: 104 KTKVGIEQSLVDWAKPYLSDKRKLFRIMD------TKLGGQYPQKAAHTAAT-------- 149
            T++ +E+  V    P L DK       D      +       + +     T        
Sbjct: 215 ATQMLLEK--VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFH 272

Query: 150 -LALQCLNNEPKLRPRMSEVLA 170
                CL  +P+ RP  S++L 
Sbjct: 273 QFVELCLQRDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.5 bits (102), Expect = 4e-05
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           K + + H  ++ +++RD K  N+L+      KL DFG A+    G   +  T+ + T  Y
Sbjct: 111 KAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWY 167

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +PE +         D++S G +L EL  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.9 bits (101), Expect = 6e-05
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG--PTGDRTHVSTQVMGT 65
           KG+   H  +  V++RD K  N+L+D +    K++D GL +A   P    TH   +++ T
Sbjct: 121 KGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV-T 174

Query: 66  HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 98
             Y APE +      +T  D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.8 bits (101), Expect = 6e-05
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 14/100 (14%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPT-----GDRTH 57
           AI  A G+++LH     VI++D  A N ++D E   K++D  L++   P      GD  +
Sbjct: 123 AIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + M      A E +     ++ SDV+SFGV+L EL++
Sbjct: 181 RPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 9e-05
 Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 5/81 (6%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----G 77
           I+RD K  N+LLD   + KL+DFG              T V GT  Y +PE + +    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 78  RLTTKSDVYSFGVVLLELLSG 98
               + D +S GV L E+L G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + + +LH  E+++I+RD KA NI ++   +  L DFG A   P     +      GT   
Sbjct: 193 RAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIAT 249

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +A        D++S G+VL E+ +  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 33/110 (30%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------------- 56
           I+RD K  N+LLD++ + KLSDFGL        RT                         
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 57  --------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                    ++   +GT  Y APE           D +S GV++ E+L G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 40.6 bits (96), Expect = 3e-04
 Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 46/189 (24%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----THVSTQVM 63
            +GL  +H       +RD K  N+L+      K++DFGLA+      R     +VST+  
Sbjct: 109 LQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-- 162

Query: 64  GTHGYAAPEYVATGRLTTKS---DVYSFGVVLLELLS------GRCAVD---KTKVGIEQ 111
               Y APE +   R T+ S   D+++ G ++ EL +      G   +D   K    I  
Sbjct: 163 ---WYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK----ICS 213

Query: 112 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNNEPK 160
            L    K    +  KL      KLG ++PQ            A+  A  L    L  +PK
Sbjct: 214 VLGTPTKQDWPEGYKLAS----KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK 269

Query: 161 LRPRMSEVL 169
            RP  S+ L
Sbjct: 270 KRPTASQAL 278

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 40.0 bits (93), Expect = 4e-04
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           +GL +LH      ++RD K +NILL    + KL+DFG+ AK   T  +       +GT  
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPY 171

Query: 68  YAAPEYVA---TGRLTTKSDVYSFGVVLLEL 95
           + APE  A    G      D+++ G+  +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.1 bits (94), Expect = 6e-04
 Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 16/93 (17%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLA-------------KAGPTGDRTHVST---QVMG 64
           V++RD K  NILL       + D+G A                         T   +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           T  Y APE +     +  +D+Y+ GV+L ++L+
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 6e-04
 Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 46/141 (32%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGL---------AKAGPTGD------------------ 54
           I+RD K  NIL+D + + KL+DFGL         +K   +GD                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 55  ---------------RTH---VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 96
                          R H   ++  ++GT  Y APE +     T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 97  SGRCA-VDKTKVGIEQSLVDW 116
            G+   + +T +  +  +++W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.3 bits (92), Expect = 7e-04
 Identities = 36/174 (20%), Positives = 69/174 (39%), Gaps = 26/174 (14%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           +AI   KGL  L+   ++  Y++  + + L+   +  K+   GL K   +    +V+  V
Sbjct: 127 MAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV 185

Query: 63  MGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                Y + + +       T K D+YS GVVL E+ +G       K+  E          
Sbjct: 186 -----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-------KIPFEN--------- 224

Query: 121 LSDKRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
               ++++ ++  K      P         +   C +++   RP + E+L  L 
Sbjct: 225 -LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 24/74 (32%), Positives = 36/74 (48%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +I+RD K  N+L++   +  L DFG A        T     + GT    APE +A    T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 81  TKSDVYSFGVVLLE 94
              D++S G+V+ E
Sbjct: 341 PSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.7 bits (90), Expect = 0.001
 Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 8/45 (17%)

Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 47
           +AI A   L F+H        RD K  NIL+D   + KLSDFGL+
Sbjct: 112 LAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 34/123 (27%), Positives = 47/123 (38%), Gaps = 45/123 (36%)

Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKA---------------------GPT-------- 52
           I+RD K  NIL+D + + KL+DFGL                         P+        
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 53  ---GDRTHVSTQ-------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 96
              GDR     Q             ++GT  Y APE +     T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 97  SGR 99
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 38.5 bits (89), Expect = 0.002
 Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 3/87 (3%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           + ++HD   ++I+RD K  NI L+ +    L DFG A      +R       +GT    +
Sbjct: 280 VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK-EREAFDYGWVGTVATNS 336

Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLS 97
           PE +A       +D++S G++LL++LS
Sbjct: 337 PEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           +GL +LH      ++RD K +NILL    + KL+DFG+ A+   T  +       +GT  
Sbjct: 117 QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPY 171

Query: 68  YAAPEYVATGR---LTTKSDVYSFGVVLLEL 95
           + APE  A  R        D+++ G+  +EL
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.0 bits (88), Expect = 0.003
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 15/104 (14%)

Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD----FGLAKAGPTG----DRTH 57
           GA +GL +LH  ++  I+R+ KAS+IL+  +    LS     + L + G       D   
Sbjct: 109 GALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166

Query: 58  VSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 99
            ST V+    + +PE +         KSD+YS G+   EL +GR
Sbjct: 167 FSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 22/133 (16%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK-----AGPTGDRTHVST 60
           G+ +LH   + V++RD K +NIL+  E       K++D G A+       P  D      
Sbjct: 120 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----D 173

Query: 61  QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
            V+ T  Y APE +   R  TK+ D+++ G +  ELL+        +  I+ S      P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS-----NP 228

Query: 120 YLSDK-RKLFRIM 131
           Y  D+  ++F +M
Sbjct: 229 YHHDQLDRIFNVM 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	229
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.98
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.98
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.98
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.98
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.98
PTZ00267	478	NIMA-related protein kinase; Provisional	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.98
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.98
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.98
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.98
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.92
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.91
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.91
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.91
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.87
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.86
KOG1152	772	consensus Signal transduction serine/threonine kin	99.83
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.8
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.74
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.65
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.6
PRK09188	365	serine/threonine protein kinase; Provisional	99.55
PRK12274	218	serine/threonine protein kinase; Provisional	99.52
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.48
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.34
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.28
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.28
COG4248	637	Uncharacterized protein with protein kinase and he	99.11
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.06
smart00090	237	RIO RIO-like kinase.	99.06
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.92
PRK10345	210	hypothetical protein; Provisional	98.91
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.87
PRK14879	211	serine/threonine protein kinase; Provisional	98.84
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.84
KOG1243	690	consensus Protein kinase [General function predict	98.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.64
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.37
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.32
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.21
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.2
KOG3087	229	consensus Serine/threonine protein kinase [General	98.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.54
PRK09902	216	hypothetical protein; Provisional	97.44
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.38
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.22
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	96.81
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	96.75
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.42
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.41
PRK05231	319	homoserine kinase; Provisional	96.39
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.36
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.31
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.29
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.19
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.08
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.06
PRK10271	188	thiK thiamine kinase; Provisional	96.01
PF01636	239	APH: Phosphotransferase enzyme family This family	95.99
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.87
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.8
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.73
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	95.7
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.69
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.2
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	95.16
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.07
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	95.06
COG0661	517	AarF Predicted unusual protein kinase [General fun	94.95
COG2334	331	Putative homoserine kinase type II (protein kinase	94.94
PHA03111	444	Ser/Thr kinase; Provisional	94.8
PLN02236	344	choline kinase	94.77
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.63
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.54
PRK11768	325	serine/threonine protein kinase; Provisional	94.39
PRK06148	1013	hypothetical protein; Provisional	94.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.57
KOG1093	725	consensus Predicted protein kinase (contains TBC a	93.03
KOG2268	465	consensus Serine/threonine protein kinase [Signal	92.59
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	92.38
PRK09550	401	mtnK methylthioribose kinase; Reviewed	92.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	91.79
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	91.5
PRK06149	972	hypothetical protein; Provisional	91.01
PRK10593	297	hypothetical protein; Provisional	89.66
PLN02876	822	acyl-CoA dehydrogenase	89.29
PRK12396	409	5-methylribose kinase; Reviewed	89.04
KOG1235	538	consensus Predicted unusual protein kinase [Genera	87.33
PLN02756	418	S-methyl-5-thioribose kinase	84.34

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=257.89  Aligned_cols=153  Identities=29%  Similarity=0.515  Sum_probs=124.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.++++||.|||.. .+||||||||+|||++..|.|||||||.+......    ...+++||..|||||.+.+..|+.
T Consensus       182 ~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~  256 (364)
T KOG0581|consen  182 KIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSV  256 (364)
T ss_pred             HHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCc
Confidence            5899999999999952 56999999999999999999999999999876443    245689999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHH-HHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||++++|+.+|+.||.....           +. ...-.+...+........|.. ++.++.+|+..||++||.
T Consensus       257 ~sDIWSLGLsllE~a~GrfP~~~~~~-----------~~-~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~  324 (364)
T KOG0581|consen  257 KSDIWSLGLSLLELAIGRFPYPPPNP-----------PY-LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPS  324 (364)
T ss_pred             ccceecccHHHHHHhhCCCCCCCcCC-----------CC-CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcc
Confidence            99999999999999999999976411           00 111122222333334455554 899999999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +||++.++++.
T Consensus       325 ~R~s~~qLl~H  335 (364)
T KOG0581|consen  325 ERPSAKQLLQH  335 (364)
T ss_pred             cCCCHHHHhcC
Confidence            99999999974

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=257.97  Aligned_cols=161  Identities=31%  Similarity=0.512  Sum_probs=134.5

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccc--cC
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--TG   77 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~   77 (229)
                      ++|+.|||+||+|||++++ |||||||++|||++.++ ++||+|||+++......  ...+...||..|||||++.  ..
T Consensus       145 l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~  221 (362)
T KOG0192|consen  145 LRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKS  221 (362)
T ss_pred             HHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCC
Confidence            4789999999999996533 99999999999999998 99999999998754322  2233467999999999999  55


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      .|+.|+||||||+++|||+||+.||.+...                ......+.....+...+..+...+..|+.+||+.
T Consensus       222 ~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~  285 (362)
T KOG0192|consen  222 PYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLV  285 (362)
T ss_pred             cCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCC
Confidence            899999999999999999999999987542                2334445556666777777899999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCC
Q 027003          158 EPKLRPRMSEVLAILERLEAPKN  180 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~~~~~~  180 (229)
                      ||.+||++.+++..|+.+.....
T Consensus       286 dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  286 DPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCcCCCHHHHHHHHHHHHHhhc
Confidence            99999999999999988765433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-37  Score=256.76  Aligned_cols=147  Identities=30%  Similarity=0.473  Sum_probs=124.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .+++||+.||.|||++  +|||||||..|+||+++.+|||+|||+|.......  ....+++||+.|+|||++.....++
T Consensus       122 y~l~QIv~GlkYLH~~--~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsf  197 (592)
T KOG0575|consen  122 YFLRQIVEGLKYLHSL--GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSF  197 (592)
T ss_pred             HHHHHHHHHHHHHHhc--CceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCC
Confidence            4689999999999965  59999999999999999999999999998764322  2255689999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      .+||||+||++|-||+|++||+..++                ...+.++.....  ..|...+.++.+||.++|+.||.+
T Consensus       198 EvDiWSlGcvmYtLL~G~PPFetk~v----------------kety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~  259 (592)
T KOG0575|consen  198 EVDIWSLGCVMYTLLVGRPPFETKTV----------------KETYNKIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSE  259 (592)
T ss_pred             chhhhhhhhHHHhhhhCCCCcccchH----------------HHHHHHHHhcCc--ccccccCHHHHHHHHHHhcCCccc
Confidence            99999999999999999999988643                223333333332  455678899999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |||+.+|+.
T Consensus       260 Rpsl~~vL~  268 (592)
T KOG0575|consen  260 RPSLDEVLD  268 (592)
T ss_pred             CCCHHHHhc
Confidence            999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=252.24  Aligned_cols=149  Identities=26%  Similarity=0.408  Sum_probs=123.3

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc---------cee--eccccccccccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---------HVS--TQVMGTHGYAAP   71 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------~~~--~~~~gt~~y~aP   71 (229)
                      .+.+|+.||+|||+  +|||||||||+||||+.+|+++|+|||.++.+......         ...  ..++||..|.+|
T Consensus       179 YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  179 YAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             HHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCH
Confidence            46899999999995  56999999999999999999999999999876443221         112  568999999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      |++.....+..+|||+||||||.|++|++||.+.+.                .....+++.-  ...++...+..+.+|+
T Consensus       257 ElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----------------yliFqkI~~l--~y~fp~~fp~~a~dLv  318 (604)
T KOG0592|consen  257 ELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----------------YLIFQKIQAL--DYEFPEGFPEDARDLI  318 (604)
T ss_pred             HHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----------------HHHHHHHHHh--cccCCCCCCHHHHHHH
Confidence            999999999999999999999999999999988652                2223333332  2355666778999999


Q ss_pred             HHhccCCCCCCCCHHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .++|..||.+|+|+.+|.+.
T Consensus       319 ~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  319 KKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHccCccccccHHHHhhC
Confidence            99999999999999998763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-37  Score=231.85  Aligned_cols=152  Identities=24%  Similarity=0.359  Sum_probs=124.0

Q ss_pred             hhHHHHHHHHHHhhcCCCC--ceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQ--VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~--ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||..+|+.-++  |+||||||.||+|+.+|.|||+|||+++.+...  .....+.+||+.||+||++.+.+|
T Consensus       128 k~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y  205 (375)
T KOG0591|consen  128 KYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGY  205 (375)
T ss_pred             HHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCC
Confidence            5789999999999974344  999999999999999999999999999987543  333567899999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc-HHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~d  158 (229)
                      +.++||||+||++|||+.-+.||.+.+.                 ..+.+.+....-.+.| ...+..+..||..|+..|
T Consensus       206 ~~kSDiWslGCllyEMcaL~~PF~g~n~-----------------~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd  268 (375)
T KOG0591|consen  206 NFKSDIWSLGCLLYEMCALQSPFYGDNL-----------------LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVD  268 (375)
T ss_pred             CcchhHHHHHHHHHHHHhcCCCcccccH-----------------HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCC
Confidence            9999999999999999999999988632                 1122223333333445 678999999999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 027003          159 PKLRPRMSEVLAIL  172 (229)
Q Consensus       159 P~~Rpt~~~v~~~l  172 (229)
                      ++.||+...++..+
T Consensus       269 ~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  269 PEQRPDTVPYVQDI  282 (375)
T ss_pred             cccCCCcchHHHHH
Confidence            99999855554443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=244.92  Aligned_cols=157  Identities=29%  Similarity=0.479  Sum_probs=135.0

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +.++.|||+|++||+++  ++|||||-+.||||+++..+||+|||+++...+. .+.......-...|.|||.+..+.++
T Consensus       306 l~~a~qIaeGM~YLes~--~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS  382 (468)
T KOG0197|consen  306 LDFAAQIAEGMAYLESK--NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFS  382 (468)
T ss_pred             HHHHHHHHHHHHHHHhC--CccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcc
Confidence            46899999999999964  5999999999999999999999999999954433 23233333446789999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .|||||||||+||||+| |+.||.+..                 ...+.+.+..+.+.+.|..++..+.++|..||+.+|
T Consensus       383 ~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P  445 (468)
T KOG0197|consen  383 SKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDP  445 (468)
T ss_pred             cccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCc
Confidence            99999999999999998 888887753                 345667778888889999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcC
Q 027003          160 KLRPRMSEVLAILERLEA  177 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~  177 (229)
                      ++|||+..+...|+.+..
T Consensus       446 ~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  446 EDRPTFETLREVLEDFFT  463 (468)
T ss_pred             ccCCCHHHHHHHHHHhhh
Confidence            999999999998887654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=236.86  Aligned_cols=145  Identities=30%  Similarity=0.445  Sum_probs=116.5

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccC
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS   83 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~   83 (229)
                      +..|+.||.|||+  ++||||||||+|||||.+|+++|+|||+++......  ..+.+++||+.|||||++.+..++..+
T Consensus       131 laEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~v  206 (357)
T KOG0598|consen  131 LAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAV  206 (357)
T ss_pred             HHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCccc
Confidence            5689999999995  569999999999999999999999999999643332  224568999999999999999999999


Q ss_pred             ceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 027003           84 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP  163 (229)
Q Consensus        84 Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  163 (229)
                      |.||||+++|||++|.+||.+.+.                .....++...+ ....+...+....+|+.++|..||.+|.
T Consensus       207 DWWsLGillYeML~G~pPF~~~~~----------------~~~~~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  207 DWWSLGILLYEMLTGKPPFYAEDV----------------KKMYDKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             chHhHHHHHHHHhhCCCCCcCccH----------------HHHHHHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            999999999999999999988652                11222222222 2234444788899999999999999996


Q ss_pred             ----CHHHHH
Q 027003          164 ----RMSEVL  169 (229)
Q Consensus       164 ----t~~~v~  169 (229)
                          ++.++.
T Consensus       270 g~~~d~~~ik  279 (357)
T KOG0598|consen  270 GGPGDAEEIK  279 (357)
T ss_pred             CCCCChHHhh
Confidence                455544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=240.87  Aligned_cols=174  Identities=58%  Similarity=0.929  Sum_probs=143.8

Q ss_pred             ChhHHHHHHHHHHhhcCC-CCceeecCCCCCeeecCCCcEEEcccCCcccCCC-CCCcceeeccccccccccccccccCC
Q 027003            1 MKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~-~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      ++|+.++|.||+|||... ..|||||||++|||||+++.+||+|||+++.... ....  .....||.+|++||.+..+.
T Consensus       177 ~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~  254 (361)
T KOG1187|consen  177 LKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGK  254 (361)
T ss_pred             HHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce--eeecCCCCccCChhhhccCC
Confidence            589999999999999743 3699999999999999999999999999976543 2111  11117999999999999899


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC-CCCcH-HHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQ-KAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~  156 (229)
                      .+.++||||||++|+||+||+.+.+.........+..|..+...+. .+.++++..+. ..+.. .....+..+..+|++
T Consensus       255 lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~  333 (361)
T KOG1187|consen  255 LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLR  333 (361)
T ss_pred             cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcC
Confidence            9999999999999999999998888765444555888887766655 77788888876 55554 567779999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhcC
Q 027003          157 NEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      .+|.+||+|.+|++.|+.+..
T Consensus       334 ~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  334 PDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cCCCcCcCHHHHHHHHHhhcc
Confidence            999999999999999966543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-36  Score=238.00  Aligned_cols=148  Identities=29%  Similarity=0.402  Sum_probs=118.6

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++|++.|+.|||+  .||+||||||+|||++.+   -.+||+|||+|+..+.   .....+.|||+.|.|||++.++..
T Consensus       281 ~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~  355 (475)
T KOG0615|consen  281 LFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGV  355 (475)
T ss_pred             HHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCe
Confidence            58999999999995  569999999999999776   6689999999998653   334667899999999999987653


Q ss_pred             c---ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHH-hhccc--CCCCcHHHHHHHHHHHHH
Q 027003           80 T---TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKL--GGQYPQKAAHTAATLALQ  153 (229)
Q Consensus        80 ~---~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~li~~  153 (229)
                      +   .++|+|||||+||-+++|.+||.+....                ..+.+. .....  ....+...+.+..+||..
T Consensus       356 ~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----------------~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~  419 (475)
T KOG0615|consen  356 EYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----------------PSLKEQILKGRYAFGPLQWDRISEEALDLINW  419 (475)
T ss_pred             ecccchheeeeccceEEEEeccCCCcccccCC----------------ccHHHHHhcCcccccChhhhhhhHHHHHHHHH
Confidence            3   4789999999999999999999775421                111122 22222  234556789999999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~~  171 (229)
                      ||..||++|||+.|+++.
T Consensus       420 mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  420 MLVVDPENRPSADEALNH  437 (475)
T ss_pred             hhEeCcccCcCHHHHhcC
Confidence            999999999999999863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=237.49  Aligned_cols=155  Identities=29%  Similarity=0.478  Sum_probs=122.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCC-CCCcceeeccccccccccccccccC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATG-R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~   78 (229)
                      +...||++||+|||+  +||||+||||+|||++. ++.+||+|||+++.... .........+.||+.|||||++.++ .
T Consensus       121 ~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~  198 (313)
T KOG0198|consen  121 RYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV  198 (313)
T ss_pred             HHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCc
Confidence            467899999999995  46999999999999999 79999999999986553 1111223457899999999999853 3


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ...++|||||||++.||+||..||....               ........+.........+...+....+|+.+|+..|
T Consensus       199 ~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~  263 (313)
T KOG0198|consen  199 ARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRD  263 (313)
T ss_pred             CCccchhhhcCCEEEeccCCCCcchhhc---------------chHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcC
Confidence            3459999999999999999999997630               0112223333333344677788999999999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 027003          159 PKLRPRMSEVLAILE  173 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~  173 (229)
                      |++|||+.++++...
T Consensus       264 p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  264 PEKRPTAEELLEHPF  278 (313)
T ss_pred             cccCcCHHHHhhChh
Confidence            999999999998654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=241.23  Aligned_cols=150  Identities=27%  Similarity=0.406  Sum_probs=124.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .||.+++.||+|||  +++|+|||||.+|||++.+|.+||+|||++..+.....  ....++||+.|||||++....|+.
T Consensus       373 ~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~  448 (550)
T KOG0578|consen  373 AICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGP  448 (550)
T ss_pred             HHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCc
Confidence            37899999999999  45699999999999999999999999999987644432  345689999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||++++||+.|++||-..+.                .+.+..+... ......+...+..+.+|+.+||+.|++
T Consensus       449 KVDIWSLGIMaIEMveGEPPYlnE~P----------------lrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~  512 (550)
T KOG0578|consen  449 KVDIWSLGIMAIEMVEGEPPYLNENP----------------LRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVE  512 (550)
T ss_pred             cccchhhhhHHHHHhcCCCCccCCCh----------------HHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchh
Confidence            99999999999999999999965321                1112222222 223456678899999999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|+++.|+|+.
T Consensus       513 ~RasA~eLL~H  523 (550)
T KOG0578|consen  513 QRASAKELLEH  523 (550)
T ss_pred             cCCCHHHHhcC
Confidence            99999999973

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-35  Score=240.17  Aligned_cols=157  Identities=29%  Similarity=0.418  Sum_probs=121.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       178 ~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  255 (338)
T cd05102         178 CYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT  255 (338)
T ss_pred             HHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCc
Confidence            468899999999995  569999999999999999999999999998653332222223344678899999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+.....                .....+........+...+..+.+|+.+||+.||+
T Consensus       256 ~sDiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         256 QSDVWSFGVLLWEIFSLGASPYPGVQINE----------------EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999997 999997643210                11111111112223345567889999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+++.
T Consensus       320 ~RPs~~el~~~l~~~~  335 (338)
T cd05102         320 ERPTFSALVEILGDLL  335 (338)
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-35  Score=224.77  Aligned_cols=164  Identities=25%  Similarity=0.333  Sum_probs=122.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      +++.|++.|+.|+|++  ++|||||||+||||+.+|.+||||||+|+....  ....-+..+.|.+|.|||.+.| .+|.
T Consensus       105 ~~l~Q~l~ai~~cHk~--n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG  180 (396)
T KOG0593|consen  105 KYLYQLLKAIHFCHKN--NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYG  180 (396)
T ss_pred             HHHHHHHHHhhhhhhc--CeecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCC
Confidence            5789999999999965  499999999999999999999999999998653  2333567889999999999988 6899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHH-HhhhhhhcchhhHHHHh-------hcc------cCCCCcHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIM-------DTK------LGGQYPQKAAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-------~~~------~~~~~~~~~~~~  146 (229)
                      ..+||||+||++.||++|++.|.+...-+.-..+ .-..+.......++..-       ...      +...+ +..+..
T Consensus       181 ~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~  259 (396)
T KOG0593|consen  181 KPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNV  259 (396)
T ss_pred             CcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhc-ccchHH
Confidence            9999999999999999999999887543222211 11112211111111100       000      00111 245668


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+..||+.||++|++.++++.
T Consensus       260 ~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  260 LLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHHHHhcCCccccccHHHHhc
Confidence            899999999999999999999884

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=242.66  Aligned_cols=151  Identities=30%  Similarity=0.483  Sum_probs=127.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .|.++||.|+.|||.++  |||||||.-||||+.+..|||+|||-++.....   .....+.||..|||||+++..+.+.
T Consensus       216 ~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsE  290 (904)
T KOG4721|consen  216 DWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSE  290 (904)
T ss_pred             HHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCccc
Confidence            57899999999999875  999999999999999999999999999865332   2355789999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      |+|||||||+|||||||..||..-+.                ...++-+-.+.+....|..+++.+.-|+++||+..|..
T Consensus       291 KVDIwSfGVVLWEmLT~EiPYkdVds----------------sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN  354 (904)
T KOG4721|consen  291 KVDIWSFGVVLWEMLTGEIPYKDVDS----------------SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN  354 (904)
T ss_pred             ccceehhHHHHHHHHhcCCCccccch----------------heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence            99999999999999999999976431                11111122234455678888999999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 027003          162 RPRMSEVLAILE  173 (229)
Q Consensus       162 Rpt~~~v~~~l~  173 (229)
                      ||++++++..|+
T Consensus       355 RPSFrqil~Hld  366 (904)
T KOG4721|consen  355 RPSFRQILLHLD  366 (904)
T ss_pred             CccHHHHHHHHh
Confidence            999999998764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=241.15  Aligned_cols=163  Identities=28%  Similarity=0.444  Sum_probs=121.8

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC---
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---   77 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---   77 (229)
                      ++|+.||++|+.|||.  ++|||||||..||||.++++|||+|||++..-.......-.....|...|||||+++.+   
T Consensus       491 idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n  568 (678)
T KOG0193|consen  491 IDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN  568 (678)
T ss_pred             HHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC
Confidence            3689999999999995  56999999999999999999999999998653222111112345688899999999753   


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +|++.+|||||||++|||+||..||.....  ++.+....+.+..           ........++.+++.+|+..||..
T Consensus       569 PfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmVGrG~l~-----------pd~s~~~s~~pk~mk~Ll~~C~~~  635 (678)
T KOG0193|consen  569 PFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMVGRGYLM-----------PDLSKIRSNCPKAMKRLLSDCWKF  635 (678)
T ss_pred             CCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEecccccC-----------ccchhhhccCHHHHHHHHHHHHhc
Confidence            689999999999999999999999984321  1110000000000           000112245678999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcCC
Q 027003          158 EPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      ++++||.+.+|+..|+.+...
T Consensus       636 ~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  636 DREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             CcccCccHHHHHHHHHHhhhc
Confidence            999999999999988877653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=228.93  Aligned_cols=165  Identities=25%  Similarity=0.326  Sum_probs=124.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .|+.||++||+|+|.  +|+.||||||+|||+..+..+||+|||+|+...+...+   +..+.|.+|+|||++.. +-|+
T Consensus       114 nim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys  188 (538)
T KOG0661|consen  114 NIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYS  188 (538)
T ss_pred             HHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHhhhccccC
Confidence            589999999999995  56999999999999999999999999999987665554   46788999999998754 5789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHH-hhhhhhcch---hhHHHHhhcccCCC-------CcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDK---RKLFRIMDTKLGGQ-------YPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~-~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~  148 (229)
                      .+.|+||+|||++|+.+-++.|.|.++-+.-. +.+ ...|.....   ..+.+.+.-.+...       .-...+.++.
T Consensus       189 ~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~  268 (538)
T KOG0661|consen  189 SPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAA  268 (538)
T ss_pred             CchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHH
Confidence            99999999999999999999999876532221 111 111221111   22222222222111       1123778899


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +||.+||..||++|||+.++++.
T Consensus       269 ~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  269 SLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhcCCCccCccHHHHhcC
Confidence            99999999999999999999974

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=235.01  Aligned_cols=147  Identities=31%  Similarity=0.454  Sum_probs=119.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-L   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~   79 (229)
                      +++.|++.|++|||++  ||+||||||+|||++.+ +.+||+|||++....  .........+||+.|+|||++.+.. |
T Consensus       124 ~~F~Qlisav~y~H~~--gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y  199 (370)
T KOG0583|consen  124 KYFRQLISAVAYCHSR--GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTY  199 (370)
T ss_pred             HHHHHHHHHHHHHHhC--CEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCc
Confidence            4789999999999964  59999999999999999 999999999998763  1222345679999999999999877 7


Q ss_pred             c-ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHH-HHHHHHHHHHhccC
Q 027003           80 T-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA-AHTAATLALQCLNN  157 (229)
Q Consensus        80 ~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~  157 (229)
                      + .++||||+|++||.|++|..||+..+..                ....++...  ...++... +..+..|+.+||..
T Consensus       200 ~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----------------~l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~  261 (370)
T KOG0583|consen  200 SGKAADVWSLGVILYVLLCGRLPFDDSNVP----------------NLYRKIRKG--EFKIPSYLLSPEARSLIEKMLVP  261 (370)
T ss_pred             CCchhhhhhhHHHHHHHHhCCCCCCCccHH----------------HHHHHHhcC--CccCCCCcCCHHHHHHHHHHcCC
Confidence            6 6899999999999999999999874321                111112222  22445555 88999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+|+++.++++
T Consensus       262 ~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  262 DPSTRITLLEILE  274 (370)
T ss_pred             CcccCCCHHHHhh
Confidence            9999999999994

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=244.54  Aligned_cols=159  Identities=23%  Similarity=0.310  Sum_probs=129.7

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCccee-------eccccccccccccc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-------TQVMGTHGYAAPEY   73 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~   73 (229)
                      |+|+.|+++|+.+||....+|||||||.+||||+.+|..||||||.+...-........       -...-|+.|+|||+
T Consensus       147 LkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEM  226 (738)
T KOG1989|consen  147 LKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEM  226 (738)
T ss_pred             HHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHH
Confidence            58999999999999998888999999999999999999999999998743222211000       01235899999997


Q ss_pred             c---ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           74 V---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        74 ~---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                      +   ++...+.|+|||+|||+||-|+....||++..                    ...|+......+..+.++..+.+|
T Consensus       227 IDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------------~laIlng~Y~~P~~p~ys~~l~~L  286 (738)
T KOG1989|consen  227 IDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------------KLAILNGNYSFPPFPNYSDRLKDL  286 (738)
T ss_pred             HhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------------ceeEEeccccCCCCccHHHHHHHH
Confidence            7   56788999999999999999999999998752                    123445555555556889999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHhhcCCC
Q 027003          151 ALQCLNNEPKLRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~l~~~~~~~  179 (229)
                      |+.||+.||++||++-+|++.+.++....
T Consensus       287 I~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  287 IRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             HHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            99999999999999999999988876443

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.1e-34  Score=225.71  Aligned_cols=154  Identities=28%  Similarity=0.481  Sum_probs=123.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus       128 ~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  205 (283)
T cd05048         128 HIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT  205 (283)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch
Confidence            578999999999995  569999999999999999999999999987654333222233445688899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+...                 ......+........+..++..+.+|+.+||+.||.
T Consensus       206 ~sDv~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~  268 (283)
T cd05048         206 ESDIWSFGVVLWEIFSYGLQPYYGFSN-----------------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPA  268 (283)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChh
Confidence            9999999999999998 9999876431                 111222222233344556778999999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|+.
T Consensus       269 ~Rp~~~~i~~~l~~  282 (283)
T cd05048         269 RRPRFKDIHTRLRS  282 (283)
T ss_pred             hCcCHHHHHHHHhc
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-34  Score=216.52  Aligned_cols=148  Identities=30%  Similarity=0.439  Sum_probs=122.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      +|+.|+.+|++|||.  +.||||||||+|||++++.++||+|||+++....+..   ....+||++|+|||.+.-     
T Consensus       127 ~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~  201 (411)
T KOG0599|consen  127 RIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYEN  201 (411)
T ss_pred             HHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccC
Confidence            589999999999995  4599999999999999999999999999998766544   346799999999998853     


Q ss_pred             -CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHH
Q 027003           77 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQ  153 (229)
Q Consensus        77 -~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  153 (229)
                       ..|+..+|+|++|+|+|.|+.|.+||....                ..--+..++..+.  ..+.+.+.+.+..+||.+
T Consensus       202 ~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----------------QmlMLR~ImeGkyqF~speWadis~~~KdLIsr  265 (411)
T KOG0599|consen  202 HPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----------------QMLMLRMIMEGKYQFRSPEWADISATVKDLISR  265 (411)
T ss_pred             CCCccchhhHHHHHHHHHHHHcCCCchhHHH----------------HHHHHHHHHhcccccCCcchhhccccHHHHHHH
Confidence             357889999999999999999999996542                1112223334433  334456788999999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||+.||.+|.|+.|++.
T Consensus       266 lLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  266 LLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHeeCchhcccHHHHhc
Confidence            99999999999999986

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=221.69  Aligned_cols=167  Identities=28%  Similarity=0.318  Sum_probs=122.3

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCcc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTT   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~   81 (229)
                      +++||+.||.|+|+.  +|+||||||.|+|++.+..+||+|||+|+...........+..+-|.+|.|||++.. ..|+.
T Consensus       130 f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~  207 (359)
T KOG0660|consen  130 FLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTK  207 (359)
T ss_pred             HHHHHHHhcchhhcc--cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccc
Confidence            578999999999964  599999999999999999999999999998754323333466788999999998754 57999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc-------chhhHHHHhhccc---CCCC---cHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-------DKRKLFRIMDTKL---GGQY---PQKAAHTAA  148 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~---~~~~---~~~~~~~~~  148 (229)
                      +.||||.|||+.||++|++.|.|.+.-..-.+.....+..+       ......+.+....   ...+   -++....+.
T Consensus       208 aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~Ai  287 (359)
T KOG0660|consen  208 AIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAI  287 (359)
T ss_pred             hhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHH
Confidence            99999999999999999999998775332222211111110       0001111111111   1111   124567889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +|+.+||..||.+|+|++|+++.
T Consensus       288 dLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  288 DLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhccCccccCCHHHHhcC
Confidence            99999999999999999999873

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-33  Score=233.67  Aligned_cols=156  Identities=28%  Similarity=0.432  Sum_probs=121.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       216 ~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  293 (374)
T cd05106         216 RFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV  293 (374)
T ss_pred             HHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCc
Confidence            578999999999995  569999999999999999999999999987654332222222334567899999998889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||......                ...............+...+..+.+++.+||+.||.
T Consensus       294 ~~DvwSlGvil~ellt~G~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  357 (374)
T cd05106         294 QSDVWSYGILLWEIFSLGKSPYPGILVN----------------SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPT  357 (374)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCcccccc----------------HHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999997 99999764321                111222222222223333467899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+++
T Consensus       358 ~RPs~~~l~~~l~~~  372 (374)
T cd05106         358 ERPTFSQISQLIQRQ  372 (374)
T ss_pred             hCcCHHHHHHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=225.33  Aligned_cols=158  Identities=30%  Similarity=0.451  Sum_probs=114.7

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC-CCCCCccee-ecccccccccccccccc--CC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVS-TQVMGTHGYAAPEYVAT--GR   78 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~-~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~   78 (229)
                      |++++++||.|||.  +|.||||||+.||||+.+|.|||+|||.+-.+ ..+.+.... ..++||+.|||||++..  ..
T Consensus       131 iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~G  208 (516)
T KOG0582|consen  131 ILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHG  208 (516)
T ss_pred             HHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccC
Confidence            67899999999995  56999999999999999999999999986433 233333333 66789999999999644  47


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      |++|+||||||++..||.+|..||.....-  +.+..-..   .......   ...+..+........+.+++..||++|
T Consensus       209 YdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLq---n~pp~~~---t~~~~~d~~k~~~ksf~e~i~~CL~kD  280 (516)
T KOG0582|consen  209 YDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQ---NDPPTLL---TSGLDKDEDKKFSKSFREMIALCLVKD  280 (516)
T ss_pred             ccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhc---CCCCCcc---cccCChHHhhhhcHHHHHHHHHHhhcC
Confidence            999999999999999999999999764311  10000000   0000000   000111112345668999999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+|||+.++++
T Consensus       281 P~kRptAskLlk  292 (516)
T KOG0582|consen  281 PSKRPTASKLLK  292 (516)
T ss_pred             cccCCCHHHHhc
Confidence            999999999985

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-33  Score=224.34  Aligned_cols=153  Identities=21%  Similarity=0.326  Sum_probs=121.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc--CCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~   79 (229)
                      +++.|++.||.|||+. .+++||||||+|||++.++.+||+|||+++......     ....|+..|+|||++.+  ..+
T Consensus       126 ~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~  199 (283)
T PHA02988        126 DMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEY  199 (283)
T ss_pred             HHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccc
Confidence            5789999999999963 358899999999999999999999999987643221     23467899999999976  678


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|||++|+.||.+.+..                .....+.........+..++..+.+|+.+||+.||
T Consensus       200 ~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp  263 (283)
T PHA02988        200 TIKDDIYSLGVVLWEIFTGKIPFENLTTK----------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS  263 (283)
T ss_pred             cchhhhhHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCc
Confidence            99999999999999999999999864311                11111222222233444567789999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      ++|||+.++++.|+.+.
T Consensus       264 ~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        264 IKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ccCcCHHHHHHHHHHHH
Confidence            99999999999998764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-34  Score=235.58  Aligned_cols=148  Identities=30%  Similarity=0.453  Sum_probs=123.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-   80 (229)
                      +++.||+.|+.|+|..+  |+||||||+|+||+.++.+||+|||+|.....+   ....+.||++.|.+||++.|.+|. 
T Consensus       116 ~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG  190 (786)
T KOG0588|consen  116 HFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDG  190 (786)
T ss_pred             HHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCCC
Confidence            67899999999999764  999999999999999999999999999874433   234567999999999999999985 


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++||||.|||||.||||+.||++.+.                 +.+...+. .-..++|.+++.++.+|+.+||..||+
T Consensus       191 ~~sDVWSCGVILfALLtG~LPFdDdNi-----------------r~LLlKV~-~G~f~MPs~Is~eaQdLLr~ml~VDp~  252 (786)
T KOG0588|consen  191 RPSDVWSCGVILFALLTGKLPFDDDNI-----------------RVLLLKVQ-RGVFEMPSNISSEAQDLLRRMLDVDPS  252 (786)
T ss_pred             CccccchhHHHHHHHHhCCCCCCCccH-----------------HHHHHHHH-cCcccCCCcCCHHHHHHHHHHhccCcc
Confidence            689999999999999999999986541                 11111111 112367788999999999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +|.|+.||++..
T Consensus       253 ~RiT~~eI~kHP  264 (786)
T KOG0588|consen  253 TRITTEEILKHP  264 (786)
T ss_pred             ccccHHHHhhCc
Confidence            999999999854

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=216.73  Aligned_cols=136  Identities=28%  Similarity=0.435  Sum_probs=117.7

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      .+.+|+.||+|||+.  +|++|||||+|||||.+|.+||+|||+++.....     +.+.|||+.|+|||++....++.+
T Consensus       149 YAAeivlAleylH~~--~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynka  221 (355)
T KOG0616|consen  149 YAAEIVLALEYLHSL--DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKA  221 (355)
T ss_pred             HHHHHHHHHHHHHhc--CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcc
Confidence            478999999999964  5999999999999999999999999999875432     456899999999999999999999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      +|.|||||++|||+.|.+||...+                ......+++....  .+|...+..+.+|+.++|+.|-.+|
T Consensus       222 vDWWalGVLIYEMlaG~pPF~~~~----------------~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  222 VDWWALGVLIYEMLAGYPPFYDDN----------------PIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hhHHHHHHHHHHHHcCCCCCcCCC----------------hHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            999999999999999999998754                2334455555554  5677788999999999999999999


Q ss_pred             C
Q 027003          163 P  163 (229)
Q Consensus       163 p  163 (229)
                      .
T Consensus       284 ~  284 (355)
T KOG0616|consen  284 F  284 (355)
T ss_pred             h
Confidence            3

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-33  Score=228.88  Aligned_cols=157  Identities=31%  Similarity=0.443  Sum_probs=121.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++|+||||||+|||++.++.++|+|||++................++..|+|||++.+..++.
T Consensus       177 ~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  254 (337)
T cd05054         177 SYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT  254 (337)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCc
Confidence            578999999999995  569999999999999999999999999998654332222223345677899999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                ......+........+......+.+++.+||+.+|+
T Consensus       255 ~~Di~SlGv~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         255 QSDVWSFGVLLWEIFSLGASPYPGVQID----------------EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cccHHHHHHHHHHHHHcCCCCCCCCCcc----------------HHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence            9999999999999998 99999763311                011111222222223344567789999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       319 ~RPs~~ell~~l~~~~  334 (337)
T cd05054         319 DRPTFSELVEILGDLL  334 (337)
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.9e-33  Score=226.17  Aligned_cols=159  Identities=22%  Similarity=0.365  Sum_probs=122.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++...............++..|++||.+.+..++.
T Consensus       113 ~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  190 (316)
T cd05108         113 NWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH  190 (316)
T ss_pred             HHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCc
Confidence            578999999999995  469999999999999999999999999998754332221122233467899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 ....++........+..+...+.+++.+||+.||+
T Consensus       191 ~~Di~slGv~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  253 (316)
T cd05108         191 QSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISSILEKGERLPQPPICTIDVYMIMVKCWMIDAD  253 (316)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999998 99999764311                 11122222222233334556788999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCC
Q 027003          161 LRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~~  179 (229)
                      +||++.+++..+.++....
T Consensus       254 ~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         254 SRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             hCcCHHHHHHHHHHHHcCC
Confidence            9999999999998876544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=227.70  Aligned_cols=147  Identities=29%  Similarity=0.429  Sum_probs=119.9

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      |+++++.||.|||++  +.+|||||+.|||+..+|.|||+|||++-........  ..+++||+.|||||++.+..|+.+
T Consensus       116 ilre~l~~l~ylH~~--~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~K  191 (467)
T KOG0201|consen  116 ILREVLKGLDYLHSE--KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTK  191 (467)
T ss_pred             ehHHHHHHhhhhhhc--ceecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccch
Confidence            578999999999965  5999999999999999999999999998765443322  356899999999999998899999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      +||||||++.+||++|.+|+.......                .+ -++.....+.....++..+.+|+..||++||+.|
T Consensus       192 ADIWSLGITaiEla~GePP~s~~hPmr----------------vl-flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~R  254 (467)
T KOG0201|consen  192 ADIWSLGITAIELAKGEPPHSKLHPMR----------------VL-FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFR  254 (467)
T ss_pred             hhhhhhhHHHHHHhcCCCCCcccCcce----------------EE-EeccCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence            999999999999999999997754210                11 1111222233344678889999999999999999


Q ss_pred             CCHHHHHH
Q 027003          163 PRMSEVLA  170 (229)
Q Consensus       163 pt~~~v~~  170 (229)
                      |++.++++
T Consensus       255 psA~~LLK  262 (467)
T KOG0201|consen  255 PSAKELLK  262 (467)
T ss_pred             cCHHHHhh
Confidence            99999985

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=234.32  Aligned_cols=148  Identities=26%  Similarity=0.483  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC--CCc
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLT   80 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~   80 (229)
                      .+||++||.|||.  +.|||||||-+|||++- .|.+||+|||-++.....+..  +.++.||..|||||++..+  .|.
T Consensus       681 tkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TETFTGTLQYMAPEvIDqG~RGYG  756 (1226)
T KOG4279|consen  681 TKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDQGPRGYG  756 (1226)
T ss_pred             HHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhccCCcc--ccccccchhhhChHhhccCCcCCC
Confidence            5899999999994  56999999999999965 688999999999987655443  5678899999999999776  588


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++.||.||++||.....               ....++++---+..++.|..++.++..+|.+|+.+||.
T Consensus       757 ~aADIWS~GCT~vEMATGrPPF~Elgs---------------pqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~  821 (1226)
T KOG4279|consen  757 KAADIWSFGCTMVEMATGRPPFVELGS---------------PQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPC  821 (1226)
T ss_pred             chhhhhhccceeEeeccCCCCeeecCC---------------hhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcc
Confidence            899999999999999999999965431               12223333333445678889999999999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      .||++.++++
T Consensus       822 ~R~sA~~LL~  831 (1226)
T KOG4279|consen  822 DRPSAKDLLQ  831 (1226)
T ss_pred             cCccHHHhcc
Confidence            9999999986

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=235.08  Aligned_cols=141  Identities=30%  Similarity=0.475  Sum_probs=117.7

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ++..|+.||.|||+  ++|||||||.+|||||.+|.+||+|||+++..-  .....+.+++||+.|||||++.+..|+.+
T Consensus       473 yaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~a  548 (694)
T KOG0694|consen  473 YAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRA  548 (694)
T ss_pred             HHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccccccC--CCCCccccccCChhhcChhhhccCcccch
Confidence            46788999999995  569999999999999999999999999998642  22334678999999999999999999999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      +|.|||||+|||||+|+.||.+.+++.                ....++.  ....+|..++.+...+++++|.++|++|
T Consensus       549 VDWW~lGVLlyeML~Gq~PF~gddEee----------------~FdsI~~--d~~~yP~~ls~ea~~il~~ll~k~p~kR  610 (694)
T KOG0694|consen  549 VDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDSIVN--DEVRYPRFLSKEAIAIMRRLLRKNPEKR  610 (694)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhc--CCCCCCCcccHHHHHHHHHHhccCcccc
Confidence            999999999999999999999865321                1111221  1235677889999999999999999999


Q ss_pred             CCH
Q 027003          163 PRM  165 (229)
Q Consensus       163 pt~  165 (229)
                      ..+
T Consensus       611 LG~  613 (694)
T KOG0694|consen  611 LGS  613 (694)
T ss_pred             cCC
Confidence            865

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=227.04  Aligned_cols=154  Identities=25%  Similarity=0.356  Sum_probs=124.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc---ceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.+++.||+|||.+  |||||||||+|+||+.+|+|||+|||.+..+..+...   ......+||+.|+|||.+.++.
T Consensus       214 ~ylrDvv~GLEYLH~Q--giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~  291 (576)
T KOG0585|consen  214 KYLRDVVLGLEYLHYQ--GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN  291 (576)
T ss_pred             HHHHHHHHHHHHHHhc--CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC
Confidence            4788999999999965  5999999999999999999999999999865332111   1123368999999999997743


Q ss_pred             ----CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHh
Q 027003           79 ----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        79 ----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  154 (229)
                          .+.+.||||+||+||-|+.|+.||.+..                ......+++...+..+..+++...+.+||.+|
T Consensus       292 ~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~l  355 (576)
T KOG0585|consen  292 SFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRL  355 (576)
T ss_pred             CccccchhhhhhhhhhhHHHhhhccCCcccch----------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHH
Confidence                3568999999999999999999997743                23344456666665555556788999999999


Q ss_pred             ccCCCCCCCCHHHHHHHHH
Q 027003          155 LNNEPKLRPRMSEVLAILE  173 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~  173 (229)
                      |++||++|.++.+|.....
T Consensus       356 L~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  356 LEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             hhcChhheeehhhheecce
Confidence            9999999999999987653

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-33  Score=223.16  Aligned_cols=154  Identities=25%  Similarity=0.430  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++...............++..|+|||.+.++.++.
T Consensus       128 ~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  205 (283)
T cd05091         128 HIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI  205 (283)
T ss_pred             HHHHHHHHHHHHHHH--cCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCc
Confidence            478899999999995  569999999999999999999999999988654333222233345678999999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+...                 ....+.+........+..++..+.+|+.+||+.+|.
T Consensus       206 ~~Dv~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05091         206 DSDIWSYGVVLWEVFSYGLQPYCGYSN-----------------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPS  268 (283)
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcc
Confidence            9999999999999998 8888866431                 111122222222234456677899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.+++..|+.
T Consensus       269 ~RP~~~~i~~~l~~  282 (283)
T cd05091         269 RRPRFKDIHSRLRT  282 (283)
T ss_pred             cCCCHHHHHHHhhC
Confidence            99999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-33  Score=230.43  Aligned_cols=155  Identities=27%  Similarity=0.438  Sum_probs=119.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       218 ~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  295 (375)
T cd05104         218 SFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF  295 (375)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCC
Confidence            578999999999995  469999999999999999999999999998654333222222334567899999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||......                ....+.+........+...+..+.+|+.+||+.||+
T Consensus       296 ~sDi~slG~~l~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  359 (375)
T cd05104         296 ESDVWSYGILLWEIFSLGSSPYPGMPVD----------------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPL  359 (375)
T ss_pred             CCCHHHHHHHHHHHHhcCCCCCCCCCch----------------HHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999998 88888664321                111122222222222333466889999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|++
T Consensus       360 ~RPs~~eil~~l~~  373 (375)
T cd05104         360 KRPTFKQIVQLIEQ  373 (375)
T ss_pred             HCcCHHHHHHHHHh
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-33  Score=226.75  Aligned_cols=164  Identities=25%  Similarity=0.295  Sum_probs=120.4

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCcc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~   81 (229)
                      +++||+.||+|||+  +||+|||||.+|||||.+|.+||+|||+|+.+....... .+..+-|.+|.|||++.|. .|+.
T Consensus       223 ~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~  299 (560)
T KOG0600|consen  223 YMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGT  299 (560)
T ss_pred             HHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCccccc
Confidence            68999999999995  569999999999999999999999999999765544333 4456779999999999886 6999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhcchhhHHHHhh-cccC--CCC-------cHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLFRIMD-TKLG--GQY-------PQKAAHTAAT  149 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~-~~~~--~~~-------~~~~~~~~~~  149 (229)
                      +.|+||.||||.||++|++.|.+.++...-. +.... .|....+. ..++-. ..+.  ..+       ....+....+
T Consensus       300 aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~  378 (560)
T KOG0600|consen  300 AVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALD  378 (560)
T ss_pred             ceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHH
Confidence            9999999999999999999999976532211 11111 11111111 000000 0000  011       1234667889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      |+..+|..||++|.|+.++++
T Consensus       379 Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  379 LLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHHHhccCccccccHHHHhc
Confidence            999999999999999999985

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.2e-33  Score=220.90  Aligned_cols=157  Identities=23%  Similarity=0.376  Sum_probs=121.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .|+.||+.||+|||+  ++++||||||+|||++.++.+||+|||+++...............++..|++||.+.++.++.
T Consensus       113 ~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  190 (279)
T cd05111         113 NWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH  190 (279)
T ss_pred             HHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCc
Confidence            578999999999995  569999999999999999999999999998654332222223345677899999998889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 ....++........+..+...+.+++.+||..||+
T Consensus       191 ~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~  253 (279)
T cd05111         191 QSDVWSYGVTVWEMMSYGAEPYAGMRPH-----------------EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN  253 (279)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999998 99999764311                 11122222222222333455678899999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.|+++.|..+..
T Consensus       254 ~Rps~~el~~~l~~~~~  270 (279)
T cd05111         254 VRPTFKELANEFTRMAR  270 (279)
T ss_pred             cCcCHHHHHHHHHHHHh
Confidence            99999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-33  Score=222.45  Aligned_cols=158  Identities=25%  Similarity=0.410  Sum_probs=123.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++|+||||||+|||++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus       127 ~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  204 (291)
T cd05094         127 HIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT  204 (291)
T ss_pred             HHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCc
Confidence            578999999999995  569999999999999999999999999997654333222233345678899999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.......                 ..+.+........+...+..+.+++.+||+.||+
T Consensus       205 ~~Di~slG~il~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  267 (291)
T cd05094         205 ESDVWSFGVILWEIFTYGKQPWFQLSNTE-----------------VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQ  267 (291)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChh
Confidence            9999999999999999 999986543210                 1111111111222334567789999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|+++...
T Consensus       268 ~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         268 QRLNIKEIYKILHALGKA  285 (291)
T ss_pred             hCcCHHHHHHHHHHHHhh
Confidence            999999999999988553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-32  Score=206.97  Aligned_cols=166  Identities=23%  Similarity=0.266  Sum_probs=120.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.+++.||+|||++  .|+||||||.|+|++.+|.+||+|||+++.+.......  +..+-|.+|.|||.+.|. .|+
T Consensus       105 ~y~~m~LkGl~y~H~~--~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg  180 (318)
T KOG0659|consen  105 SYMLMTLKGLAYCHSK--WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYG  180 (318)
T ss_pred             HHHHHHHHHHHHHHhh--hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccchhcC
Confidence            4688999999999964  59999999999999999999999999999886654432  233679999999999886 689


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch--hHHHhhhhhhcch------hhHHHHh--hcccCCCCcHHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSDK------RKLFRIM--DTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~~~~~~~l  150 (229)
                      ...|+||.|||+.||+-|.+.|.+.+.-+.-  .+.....|....+      ....++.  ........-...+..+.+|
T Consensus       181 ~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldL  260 (318)
T KOG0659|consen  181 TGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDL  260 (318)
T ss_pred             CcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHH
Confidence            9999999999999999998888776532111  1111111221111      1111111  0111111223456677999


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+||..||.+|.++.|++++
T Consensus       261 l~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  261 LSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHhhhccCchhcccHHHHhcc
Confidence            999999999999999999864

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.1e-33  Score=220.01  Aligned_cols=158  Identities=23%  Similarity=0.394  Sum_probs=121.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|++||.+.+..++.
T Consensus       113 ~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  190 (279)
T cd05109         113 NWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH  190 (279)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCc
Confidence            578999999999995  569999999999999999999999999998654322211111223467899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.....                 ......+........+...+..+.+++.+||+.||+
T Consensus       191 ~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  253 (279)
T cd05109         191 QSDVWSYGVTVWELMTFGAKPYDGIPA-----------------REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSE  253 (279)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 8999865431                 111122222222233344567789999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|.++...
T Consensus       254 ~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         254 CRPRFRELVDEFSRMARD  271 (279)
T ss_pred             hCcCHHHHHHHHHHhhcC
Confidence            999999999999877544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=208.28  Aligned_cols=161  Identities=24%  Similarity=0.355  Sum_probs=120.9

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-------eeeccccccccccccc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-------VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~   73 (229)
                      |+|+.+|++||++||+....+.||||||.|||++.++.++|.|||.++...-.-...       .......|..|.|||.
T Consensus       130 L~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPEL  209 (302)
T KOG2345|consen  130 LWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPEL  209 (302)
T ss_pred             HHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchh
Confidence            478999999999999877779999999999999999999999999987542211110       0122357899999999


Q ss_pred             ccc---CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           74 VAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        74 ~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                      +.-   ...+.++|||||||+||+|+.|..||+..-.....              ....+.......+.....+..+.+|
T Consensus       210 f~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS--------------laLAv~n~q~s~P~~~~yse~l~~l  275 (302)
T KOG2345|consen  210 FNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS--------------LALAVQNAQISIPNSSRYSEALHQL  275 (302)
T ss_pred             eecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--------------EEEeeeccccccCCCCCccHHHHHH
Confidence            853   45688999999999999999999999753211000              0001111122223333478899999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHhh
Q 027003          151 ALQCLNNEPKLRPRMSEVLAILERL  175 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~l~~~  175 (229)
                      +..||+.||.+||++.+++..++.+
T Consensus       276 ik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  276 IKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             HHHHhcCCcccCCCHHHHHHHHHhh
Confidence            9999999999999999999988765

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.6e-33  Score=219.21  Aligned_cols=155  Identities=27%  Similarity=0.374  Sum_probs=119.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|++||.+.+..++.
T Consensus       116 ~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  193 (272)
T cd05075         116 KFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTT  193 (272)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcCh
Confidence            568899999999995  569999999999999999999999999998754332221122234577899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||.+....                 ...+.+........+......+.+++.+||+.||+
T Consensus       194 ~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  256 (272)
T cd05075         194 KSDVWSFGVTMWEIATRGQTPYPGVENS-----------------EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPK  256 (272)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999999 88898653211                 01111111111122334567789999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +|||+.++++.|+++
T Consensus       257 ~Rps~~~l~~~l~~~  271 (272)
T cd05075         257 DRPSFETLRCELEKA  271 (272)
T ss_pred             cCcCHHHHHHHHHhh
Confidence            999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.8e-33  Score=237.49  Aligned_cols=151  Identities=27%  Similarity=0.393  Sum_probs=119.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.
T Consensus       147 ~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~  224 (496)
T PTZ00283        147 LLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK  224 (496)
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCc
Confidence            468899999999995  469999999999999999999999999998654332222234567999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                .....+. .......+...+..+.+|+.+||+.||.+
T Consensus       225 k~DVwSlGvilyeLltG~~Pf~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~  287 (496)
T PTZ00283        225 KADMFSLGVLLYELLTLKRPFDGENME----------------EVMHKTL-AGRYDPLPPSISPEMQEIVTALLSSDPKR  287 (496)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccChhh
Confidence            999999999999999999999764311                0111111 11122344556778999999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.+++..
T Consensus       288 RPs~~ell~~  297 (496)
T PTZ00283        288 RPSSSKLLNM  297 (496)
T ss_pred             CcCHHHHHhC
Confidence            9999999863

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.1e-33  Score=225.98  Aligned_cols=147  Identities=27%  Similarity=0.443  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus        99 ~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  174 (323)
T cd05571          99 FYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCc
Confidence            367899999999995  4699999999999999999999999999875322211  123457999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||...+...                ....+...  ....+...+..+.+|+.+||+.||++
T Consensus       175 ~~DiwSlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  236 (323)
T cd05571         175 AVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQ  236 (323)
T ss_pred             cccCcccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999997643210                01111111  12334456778999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       237 R~~~~~~~~~~ll~  250 (323)
T cd05571         237 RLGGGPEDAKEIME  250 (323)
T ss_pred             cCCCCCCCHHHHHc
Confidence            99     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-32  Score=222.93  Aligned_cols=152  Identities=30%  Similarity=0.380  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+. .++
T Consensus       109 ~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  185 (332)
T cd05614         109 FYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHG  185 (332)
T ss_pred             HHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCC
Confidence            467899999999995  46999999999999999999999999998764332221 12345799999999999765 478


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||++|..||..........             .....+. ......+...+..+.+++.+||+.||+
T Consensus       186 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~  251 (332)
T cd05614         186 KAVDWWSLGILIFELLTGASPFTLEGERNTQS-------------EVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPK  251 (332)
T ss_pred             CccccccchhhhhhhhcCCCCCCCCCCCCCHH-------------HHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHH
Confidence            89999999999999999999997543211110             0111110 112233445677889999999999999


Q ss_pred             CCC-----CHHHHHH
Q 027003          161 LRP-----RMSEVLA  170 (229)
Q Consensus       161 ~Rp-----t~~~v~~  170 (229)
                      +||     ++.++++
T Consensus       252 ~R~~~~~~~~~~~l~  266 (332)
T cd05614         252 KRLGAGPQGASEIKE  266 (332)
T ss_pred             HcCCCCCCCHHHHHc
Confidence            999     6667765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.98  E-value=5.5e-33  Score=223.30  Aligned_cols=160  Identities=26%  Similarity=0.408  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.
T Consensus       142 ~i~~~i~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  219 (304)
T cd05096         142 HVALQIASGMKYLSS--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT  219 (304)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc
Confidence            588999999999995  469999999999999999999999999997654333222233445678899999998889999


Q ss_pred             cCceeehhHHHHHHHh--CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|||||||++|||++  +..||.......   .......       .............+..++..+.+|+.+||+.||
T Consensus       220 ~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  289 (304)
T cd05096         220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGE-------FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDC  289 (304)
T ss_pred             hhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHH-------HhhhccccccccCCCCCCHHHHHHHHHHccCCc
Confidence            9999999999999987  556776543211   1000000       000000001111223456788999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 027003          160 KLRPRMSEVLAILE  173 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~  173 (229)
                      ++|||+.+|.+.|+
T Consensus       290 ~~RPs~~~i~~~l~  303 (304)
T cd05096         290 RERPSFSDIHAFLT  303 (304)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.98  E-value=1.6e-32  Score=219.37  Aligned_cols=155  Identities=29%  Similarity=0.458  Sum_probs=120.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       136 ~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  213 (293)
T cd05053         136 SFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH  213 (293)
T ss_pred             HHHHHHHHHHHHHHH--CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence            578999999999995  569999999999999999999999999998654332222122233567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||......                 ...+.+........+......+.+|+.+||..||+
T Consensus       214 ~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  276 (293)
T cd05053         214 QSDVWSFGVLLWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS  276 (293)
T ss_pred             ccceeehhhHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence            9999999999999997 88888764321                 11122222222233344567789999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +|||+.++++.|+.+
T Consensus       277 ~Rps~~eil~~l~~~  291 (293)
T cd05053         277 QRPTFKQLVEDLDRM  291 (293)
T ss_pred             cCcCHHHHHHHHHHh
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=6.8e-33  Score=220.91  Aligned_cols=150  Identities=29%  Similarity=0.449  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.++|+|||++........   .....||..|+|||++.+..++.
T Consensus       106 ~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~  180 (285)
T cd05631         106 FYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTF  180 (285)
T ss_pred             HHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCc
Confidence            468899999999995  5699999999999999999999999999986433221   23456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||..........             .....+ .......+...+..+.+|+.+||+.||.+
T Consensus       181 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~  246 (285)
T cd05631         181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-------------EVDRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKE  246 (285)
T ss_pred             ccCchhHHHHHHHHHhCCCCCCCCCcchhHH-------------HHHHHh-hcccccCCccCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999998754311100             011111 11112334456778899999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      ||+     +.++++
T Consensus       247 R~~~~~~~~~~~~~  260 (285)
T cd05631         247 RLGCRGNGAAGVKQ  260 (285)
T ss_pred             hcCCCCCCHHHHhc
Confidence            997     677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.98  E-value=6.9e-33  Score=216.19  Aligned_cols=166  Identities=25%  Similarity=0.280  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.||+.||+|||++  +|+||||||+||||+++|.+||+|||+++...-...  ..+..++|.+|.|||++.|. .|+
T Consensus       124 ~~m~Qll~gl~~~H~~--~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys  199 (323)
T KOG0594|consen  124 SFMRQLLRGLAFLHSH--GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYS  199 (323)
T ss_pred             HHHHHHHHHHHHHHhC--CeecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCC
Confidence            5789999999999965  599999999999999999999999999996543222  23456789999999999887 789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh--HHHhhhhhhcchhhHHHHhhcc--cCCCC-c-------HHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTK--LGGQY-P-------QKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~-------~~~~~~~~  148 (229)
                      ...||||+|||++||++++.-|.+......-.  +.....|....+.......+-+  ..... +       +.......
T Consensus       200 ~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~  279 (323)
T KOG0594|consen  200 TSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGI  279 (323)
T ss_pred             CCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHH
Confidence            99999999999999999999998865421110  0001111111111111100000  00000 1       11124788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +++.+||+.+|.+|.|+..++.+
T Consensus       280 dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  280 ELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHHHHhccCcccCcCHHHHhcC
Confidence            99999999999999999999875

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.98  E-value=2.1e-32  Score=216.21  Aligned_cols=155  Identities=25%  Similarity=0.410  Sum_probs=120.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       117 ~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  194 (273)
T cd05035         117 KFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS  194 (273)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCc
Confidence            478999999999995  569999999999999999999999999998654333222122233567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 ...+.+........+..++..+.+++.+||+.||.
T Consensus       195 ~~Dv~SlG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  257 (273)
T cd05035         195 KSDVWAFGVTMWEIATRGQTPYPGVENH-----------------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPK  257 (273)
T ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 88988654310                 11111122222233445677899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+++
T Consensus       258 ~Rp~~~e~~~~l~~~  272 (273)
T cd05035         258 DRPTFTKLREVLENI  272 (273)
T ss_pred             hCcCHHHHHHHHHhh
Confidence            999999999998765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.98  E-value=1.5e-32  Score=219.13  Aligned_cols=157  Identities=26%  Similarity=0.414  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+|||++.++.++|+|||+++...............++..|+|||++.+..++.
T Consensus       124 ~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  201 (288)
T cd05093         124 HIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT  201 (288)
T ss_pred             HHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCc
Confidence            578999999999995  569999999999999999999999999987653332222222334577899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |..||......                .....+. .......+...+..+.+|+.+||+.||.
T Consensus       202 ~sDiwslG~il~~l~t~g~~p~~~~~~~----------------~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~  264 (288)
T cd05093         202 ESDVWSLGVVLWEIFTYGKQPWYQLSNN----------------EVIECIT-QGRVLQRPRTCPKEVYDLMLGCWQREPH  264 (288)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999998 89998654311                0111111 1111112233456789999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.+++..|+.+..
T Consensus       265 ~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         265 MRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             hCCCHHHHHHHHHHHHH
Confidence            99999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=1.1e-32  Score=234.06  Aligned_cols=150  Identities=26%  Similarity=0.364  Sum_probs=118.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.
T Consensus       173 ~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  250 (478)
T PTZ00267        173 LLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK  250 (478)
T ss_pred             HHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCc
Confidence            467899999999995  469999999999999999999999999998754433322344567999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+...                ......+... .....+..++..+.+|+.+||+.||++
T Consensus       251 ~~Dv~slG~~l~el~tg~~Pf~~~~~----------------~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~  313 (478)
T PTZ00267        251 KADMWSLGVILYELLTLHRPFKGPSQ----------------REIMQQVLYG-KYDPFPCPVSSGMKALLDPLLSKNPAL  313 (478)
T ss_pred             HHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhC-CCCCCCccCCHHHHHHHHHHhccChhh
Confidence            99999999999999999999976431                0111111111 112233445678999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.+++.
T Consensus       314 Rps~~~~l~  322 (478)
T PTZ00267        314 RPTTQQLLH  322 (478)
T ss_pred             CcCHHHHHh
Confidence            999999874

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=5.6e-33  Score=225.18  Aligned_cols=149  Identities=30%  Similarity=0.441  Sum_probs=127.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.|+.|||  .++|+|||||+.|||++.++.|||+|||+++......  ....+.+||+.|++||++.+.+|+.
T Consensus       110 ~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~  185 (426)
T KOG0589|consen  110 KWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNE  185 (426)
T ss_pred             HHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCc
Confidence            68999999999999  4679999999999999999999999999999865433  2345678999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      |+|||||||++|||++-+.+|.+.+.                 ..+...+......+.+...+.++..||..||..+|..
T Consensus       186 KSDiWsLGC~~yEm~~lk~aF~a~~m-----------------~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~  248 (426)
T KOG0589|consen  186 KSDIWSLGCCLYEMCTLKPAFKASNM-----------------SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEH  248 (426)
T ss_pred             cCcchhhcchHHHHHhcccccCccch-----------------HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCcc
Confidence            99999999999999999999987652                 2222222333345677888999999999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.+++..
T Consensus       249 RPsa~~LL~~  258 (426)
T KOG0589|consen  249 RPSALELLRR  258 (426)
T ss_pred             CCCHHHHhhC
Confidence            9999999864

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.98  E-value=2.1e-32  Score=217.17  Aligned_cols=153  Identities=25%  Similarity=0.419  Sum_probs=118.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++++||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.
T Consensus       126 ~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (280)
T cd05049         126 QIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT  203 (280)
T ss_pred             HHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcch
Confidence            468999999999995  469999999999999999999999999987543322222223334678899999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||......                 .....+........+...+..+.+++.+||+.||+
T Consensus       204 ~~Di~slG~il~e~~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  266 (280)
T cd05049         204 ESDVWSFGVVLWEIFTYGKQPWYGLSNE-----------------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQ  266 (280)
T ss_pred             hhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999998 99998654321                 11111112222223345667899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.|+++.|+
T Consensus       267 ~Rp~~~eil~~l~  279 (280)
T cd05049         267 QRINIKDIHERLQ  279 (280)
T ss_pred             cCCCHHHHHHHhh
Confidence            9999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=7.3e-33  Score=221.05  Aligned_cols=164  Identities=26%  Similarity=0.350  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....   .......||..|+|||++.+..++.
T Consensus       114 ~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  188 (290)
T cd07862         114 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYAT  188 (290)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCC
Confidence            578999999999995  56999999999999999999999999999764332   1223456899999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhh-hhhcchhhHHHHhhccc---CCC----CcHHHHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAK-PYLSDKRKLFRIMDTKL---GGQ----YPQKAAHTAATLAL  152 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~li~  152 (229)
                      ++|||||||++|||++|..||.+...... ..+..... +................   ...    .....+..+.+|+.
T Consensus       189 ~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  268 (290)
T cd07862         189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL  268 (290)
T ss_pred             ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHH
Confidence            99999999999999999999987543211 11111000 00000000000000000   000    01124567789999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||++|||+.++++
T Consensus       269 ~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         269 KCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHhccCchhcCCHHHHhc
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.98  E-value=8.9e-33  Score=213.55  Aligned_cols=164  Identities=23%  Similarity=0.261  Sum_probs=120.1

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCcc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~   81 (229)
                      ++.|++.||+|||.  +.|+|||||++|+|++..|.+||+|||+|+.+++...  ..+..+-|.+|.|||++.|. .|+.
T Consensus       182 L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst  257 (419)
T KOG0663|consen  182 LMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYST  257 (419)
T ss_pred             HHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCc
Confidence            57899999999995  4599999999999999999999999999998765422  24566789999999999886 5899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh--HHHhhhhhhcchhhHHHH-----------hhcccCCCCcHH-HHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRI-----------MDTKLGGQYPQK-AAHTA  147 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~-~~~~~  147 (229)
                      +.|+||+|||+.||+++++.|.+...-..-.  +.....|....+..+...           -...++..+.-. .+...
T Consensus       258 ~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g  337 (419)
T KOG0663|consen  258 AVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQG  337 (419)
T ss_pred             chhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhH
Confidence            9999999999999999999998865422111  111111111111111000           001111111111 56788


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+..+|..||.+|.|+.+.++
T Consensus       338 ~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  338 FDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HHHHHHHhccCccccccHHHhhc
Confidence            89999999999999999999986

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=207.35  Aligned_cols=150  Identities=29%  Similarity=0.492  Sum_probs=118.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC---C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~   78 (229)
                      ++...++.||.||-.. .+|||||+||+|||+|..|++||||||++-...+..   ..+...|.+.|||||.+.-.   .
T Consensus       195 k~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~k  270 (391)
T KOG0983|consen  195 KMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPK  270 (391)
T ss_pred             hhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCc
Confidence            4567789999999864 579999999999999999999999999997654332   23445799999999999643   5


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~  156 (229)
                      |+.++||||||++++||.||+.||.+-+.               +...+.++++.. ....+  ...+..+.+|+..||.
T Consensus       271 YDiRaDVWSlGITlveLaTg~yPy~~c~t---------------dFe~ltkvln~e-PP~L~~~~gFSp~F~~fv~~CL~  334 (391)
T KOG0983|consen  271 YDIRADVWSLGITLVELATGQYPYKGCKT---------------DFEVLTKVLNEE-PPLLPGHMGFSPDFQSFVKDCLT  334 (391)
T ss_pred             cchhhhhhhhccchhhhhcccCCCCCCCc---------------cHHHHHHHHhcC-CCCCCcccCcCHHHHHHHHHHhh
Confidence            88899999999999999999999988542               223333444322 12222  2368889999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      +|+.+||...++++.
T Consensus       335 kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  335 KDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCcccCcchHHHhcC
Confidence            999999999999864

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=1.1e-32  Score=220.66  Aligned_cols=159  Identities=15%  Similarity=0.152  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-----ceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .|+.|++.||+|||+  .+|+||||||+|||++.++.++|+|||+++........     .......||..|+|||++.+
T Consensus       130 ~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~  207 (294)
T PHA02882        130 NIMKDMLTTLEYIHE--HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG  207 (294)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence            478999999999995  46999999999999999999999999999765322110     11223469999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ..++.++|||||||++|||++|+.||.+........... .      ..-..++.....   ....++..+.+++..||.
T Consensus       208 ~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~-~------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  277 (294)
T PHA02882        208 ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA-K------CDFIKRLHEGKI---KIKNANKFIYDFIECVTK  277 (294)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh-H------HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHh
Confidence            999999999999999999999999998753211110000 0      000011111111   112346779999999999


Q ss_pred             CCCCCCCCHHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAIL  172 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~l  172 (229)
                      .+|++||++.++++.|
T Consensus       278 ~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        278 LSYEEKPDYDALIKIF  293 (294)
T ss_pred             CCCCCCCCHHHHHHhh
Confidence            9999999999999876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.3e-32  Score=222.01  Aligned_cols=147  Identities=30%  Similarity=0.405  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  .....+||..|+|||++.+..++.
T Consensus        97 ~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  172 (312)
T cd05585          97 FYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTK  172 (312)
T ss_pred             HHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCC
Confidence            468899999999995  4699999999999999999999999999875322221  133457999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+....                .....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       173 ~~DvwslGvil~el~tg~~pf~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~  234 (312)
T cd05585         173 AVDWWTLGVLLYEMLTGLPPFYDENVN----------------EMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTR  234 (312)
T ss_pred             ccceechhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence            999999999999999999999764311                011111111  12334456778899999999999999


Q ss_pred             CCC---HHHHHH
Q 027003          162 RPR---MSEVLA  170 (229)
Q Consensus       162 Rpt---~~~v~~  170 (229)
                      ||+   +.+++.
T Consensus       235 R~~~~~~~e~l~  246 (312)
T cd05585         235 RLGYNGAQEIKN  246 (312)
T ss_pred             cCCCCCHHHHHc
Confidence            985   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=1e-32  Score=205.37  Aligned_cols=147  Identities=26%  Similarity=0.334  Sum_probs=119.3

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .+.||+++|.|+|.  ++|||||+||+|+||...   --+||+|||++....+   ...-...+||+.|||||+++..+|
T Consensus       115 ~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy  189 (355)
T KOG0033|consen  115 CIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPY  189 (355)
T ss_pred             HHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEEeCC---ccccccccCCCcccCHHHhhcCCC
Confidence            57899999999995  569999999999999543   3489999999987652   223445789999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +..+|||+-|+|||-|+.|..||.+.+.                .+....++...  ...+..+..++...+|+++||..
T Consensus       190 ~kpvDiW~cGViLfiLL~G~~PF~~~~~----------------~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~  253 (355)
T KOG0033|consen  190 SKPVDIWACGVILYILLVGYPPFWDEDQ----------------HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTV  253 (355)
T ss_pred             CCcchhhhhhHHHHHHHhCCCCCCCccH----------------HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhcc
Confidence            9999999999999999999999987431                11222233332  23445677889999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+|.|+.|.++
T Consensus       254 dP~kRIta~EAL~  266 (355)
T KOG0033|consen  254 NPKKRITADEALK  266 (355)
T ss_pred             ChhhhccHHHHhC
Confidence            9999999999884

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.98  E-value=7.8e-33  Score=235.81  Aligned_cols=159  Identities=28%  Similarity=0.464  Sum_probs=136.6

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      |.|+.|||.|++||-++  .+|||||-..|+||+++..|||+|||+++...+.+.++......-...||+||.+..++|+
T Consensus       606 L~iA~QIAaGM~YLs~~--~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT  683 (774)
T KOG1026|consen  606 LHIATQIAAGMEYLSSH--HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT  683 (774)
T ss_pred             HHHHHHHHHHHHHHHhC--cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence            46899999999999964  5999999999999999999999999999988777777766555668899999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .+||||||||+|||+++ |..||.+..                +.+.+ +.+..+.....|.+++..+++||.+||+.+|
T Consensus       684 teSDVWs~GVvLWEIFsyG~QPy~glS----------------n~EVI-e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P  746 (774)
T KOG1026|consen  684 TESDVWSFGVVLWEIFSYGKQPYYGLS----------------NQEVI-ECIRAGQLLSCPENCPTEVYSLMLECWNENP  746 (774)
T ss_pred             chhhhhhhhhhhhhhhccccCcccccc----------------hHHHH-HHHHcCCcccCCCCCCHHHHHHHHHHhhcCc
Confidence            99999999999999997 899988753                22333 3333333378899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCC
Q 027003          160 KLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~~  178 (229)
                      .+||+++||-..|+.....
T Consensus       747 ~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  747 KRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ccCCCHHHHHHHHHHHHhc
Confidence            9999999999999876543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=3.4e-32  Score=214.35  Aligned_cols=154  Identities=23%  Similarity=0.407  Sum_probs=120.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++++||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.
T Consensus       108 ~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  184 (263)
T cd05052         108 YMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSI  184 (263)
T ss_pred             HHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCc
Confidence            578999999999995  56999999999999999999999999998765332211 111223456799999998889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+.+..                 .....+........+...+..+.+++.+||+.||+
T Consensus       185 ~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  247 (263)
T cd05052         185 KSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPS  247 (263)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence            9999999999999998 99998764321                 11122222223334445677899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+.+
T Consensus       248 ~Rp~~~~l~~~l~~~  262 (263)
T cd05052         248 DRPSFAEIHQAFETM  262 (263)
T ss_pred             cCCCHHHHHHHHHhh
Confidence            999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-32  Score=215.07  Aligned_cols=148  Identities=26%  Similarity=0.418  Sum_probs=111.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC------CcEEEcccCCcccCCCCCCcceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~   75 (229)
                      .++.||+.||++||  +++||||||||+||||+..      -.+||+|||+++....+   ....+.+|++.|||||++.
T Consensus       113 ~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  113 HFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             HHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHH
Confidence            46899999999999  4569999999999999764      35899999999986533   2345689999999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhc
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..+|+.|+|+||+|+|+|++++|+.||+..+..+.....               ..........+...+..+.+|+...|
T Consensus       188 ~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~---------------~k~~~~~~~~~~~~s~~~~~Ll~~ll  252 (429)
T KOG0595|consen  188 SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI---------------KKGNEIVPVLPAELSNPLRELLISLL  252 (429)
T ss_pred             hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---------------hccccccCchhhhccCchhhhhhHHH
Confidence            999999999999999999999999999875432111100               00111222334445556667777777


Q ss_pred             cCCCCCCCCHHHHH
Q 027003          156 NNEPKLRPRMSEVL  169 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~  169 (229)
                      +.++..|-+..+..
T Consensus       253 ~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  253 QRNPKDRISFEDFF  266 (429)
T ss_pred             hcCccccCchHHhh
Confidence            77777777665554

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=2.2e-32  Score=218.40  Aligned_cols=157  Identities=27%  Similarity=0.426  Sum_probs=122.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       131 ~i~~~i~~~l~~LH~--~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  208 (290)
T cd05045         131 SFAWQISRGMQYLAE--MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT  208 (290)
T ss_pred             HHHHHHHHHHHHHHH--CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence            578899999999995  569999999999999999999999999987643322211122234567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+...                 ..+............+...+..+.+++.+||+.+|.
T Consensus       209 ~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~  271 (290)
T cd05045         209 QSDVWSFGVLLWEIVTLGGNPYPGIAP-----------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPD  271 (290)
T ss_pred             HhHHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence            9999999999999998 9999976431                 111222222222333445567899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++-.
T Consensus       272 ~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         272 KRPTFADISKELEKMMV  288 (290)
T ss_pred             cCCCHHHHHHHHHHHHh
Confidence            99999999999988743

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=1.9e-32  Score=217.36  Aligned_cols=153  Identities=25%  Similarity=0.406  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.
T Consensus       123 ~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  200 (277)
T cd05062         123 QMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT  200 (277)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCc
Confidence            467899999999995  569999999999999999999999999987654332222122234577899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 ...+..........+...+..+.+++.+||+.||+
T Consensus       201 ~~Di~slG~~l~el~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  263 (277)
T cd05062         201 YSDVWSFGVVLWEIATLAEQPYQGMSNE-----------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPK  263 (277)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 78888764321                 11111111111122334566789999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.++++.|+
T Consensus       264 ~Rps~~e~l~~l~  276 (277)
T cd05062         264 MRPSFLEIISSIK  276 (277)
T ss_pred             hCcCHHHHHHHhh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=2.4e-32  Score=221.67  Aligned_cols=147  Identities=27%  Similarity=0.380  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  .....+||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05602         100 FYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDR  175 (325)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCC
Confidence            368899999999995  4699999999999999999999999999875322211  133457999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||.+.+..                .....+.....  ......+..+.+++.+||+.||.+
T Consensus       176 ~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         176 TVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             ccccccccHHHHHHhcCCCCCCCCCHH----------------HHHHHHHhCCc--CCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999999999999999764321                01111111111  223345678899999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |+++.+.+.
T Consensus       238 R~~~~~~~~  246 (325)
T cd05602         238 RLGAKDDFM  246 (325)
T ss_pred             CCCCCCCHH
Confidence            999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=7.9e-32  Score=218.56  Aligned_cols=147  Identities=28%  Similarity=0.449  Sum_probs=114.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  .....+|+..|+|||++.+..++.
T Consensus       105 ~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~  180 (324)
T cd05589         105 FYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTR  180 (324)
T ss_pred             HHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCc
Confidence            478999999999995  5699999999999999999999999999875322211  123467999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.+..                .....+....  ...+...+..+.+++.+||+.||.+
T Consensus       181 ~~DiwslG~il~el~~G~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~  242 (324)
T cd05589         181 AVDWWGLGVLIYEMLVGESPFPGDDEE----------------EVFDSIVNDE--VRYPRFLSREAISIMRRLLRRNPER  242 (324)
T ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhH
Confidence            999999999999999999999764321                0111111111  1234456778899999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       243 R~~~~~~~~~~l~~  256 (324)
T cd05589         243 RLGSGEKDAEDVKK  256 (324)
T ss_pred             cCCCCCCCHHHHhh
Confidence            99     4566654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=2.8e-32  Score=223.69  Aligned_cols=152  Identities=27%  Similarity=0.399  Sum_probs=114.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      +++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++..     
T Consensus       172 ~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  247 (353)
T PLN00034        172 DVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHG  247 (353)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccC
Confidence            578999999999995  4699999999999999999999999999876532211  1234578999999998843     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ...+.++|||||||++|||++|+.||..........              .............+..++..+.+||.+||+
T Consensus       248 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  313 (353)
T PLN00034        248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS--------------LMCAICMSQPPEAPATASREFRHFISCCLQ  313 (353)
T ss_pred             cCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH--------------HHHHHhccCCCCCCCccCHHHHHHHHHHcc
Confidence            223568999999999999999999997432211111              111111111223344567789999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||++||++.|+++.
T Consensus       314 ~~P~~Rpt~~ell~h  328 (353)
T PLN00034        314 REPAKRWSAMQLLQH  328 (353)
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999863

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=4.7e-32  Score=217.92  Aligned_cols=157  Identities=25%  Similarity=0.411  Sum_probs=121.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  ++++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       141 ~~~~qi~~al~~LH~--~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (304)
T cd05101         141 SCTYQVARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  218 (304)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence            467899999999995  569999999999999999999999999998654332222222334567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 ...+.+........+..++..+.+|+.+||+.+|.
T Consensus       219 ~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  281 (304)
T cd05101         219 QSDVWSFGVLMWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPS  281 (304)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChh
Confidence            9999999999999998 78888654311                 11111222222223345567889999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       282 ~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         282 HRPTFKQLVEDLDRILT  298 (304)
T ss_pred             hCCCHHHHHHHHHHHHH
Confidence            99999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=3e-32  Score=231.12  Aligned_cols=163  Identities=18%  Similarity=0.254  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----------------cEEEcccCCcccCCCCCCcceeeccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------------NAKLSDFGLAKAGPTGDRTHVSTQVMGT   65 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt   65 (229)
                      .|+.||+.||+|||+. .+||||||||+|||++.++                .+||+|||++.....     .....+||
T Consensus       235 ~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt  308 (467)
T PTZ00284        235 QIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVST  308 (467)
T ss_pred             HHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCC
Confidence            5789999999999962 4699999999999998765                499999998764221     12346799


Q ss_pred             cccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHH-Hhhhhhhc---------chhhHHHHhhcc-
Q 027003           66 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS---------DKRKLFRIMDTK-  134 (229)
Q Consensus        66 ~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~-  134 (229)
                      ..|+|||++.+..++.++|||||||++|||++|+.||.+.+........ ........         ....+....... 
T Consensus       309 ~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  388 (467)
T PTZ00284        309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR  388 (467)
T ss_pred             ccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccc
Confidence            9999999999999999999999999999999999999875532111111 00000000         000000000000 


Q ss_pred             -----------cCCC-C-cHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          135 -----------LGGQ-Y-PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       135 -----------~~~~-~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                                 .... . .......+.+||.+||+.||.+|||+.|+++
T Consensus       389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        389 PCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             ccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                       0000 0 0012356789999999999999999999996

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=3.4e-32  Score=221.04  Aligned_cols=148  Identities=26%  Similarity=0.419  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++......  ......+||..|+|||++.+..++.
T Consensus        99 ~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  174 (328)
T cd05593          99 FYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGR  174 (328)
T ss_pred             HHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCc
Confidence            478999999999995  469999999999999999999999999987532211  1123457999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||...+...                ....+..  .....+...+..+.+|+.+||+.||.+
T Consensus       175 ~~DiwslGvil~elltG~~Pf~~~~~~~----------------~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~  236 (328)
T cd05593         175 AVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNK  236 (328)
T ss_pred             cCCccccchHHHHHhhCCCCCCCCCHHH----------------HHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence            9999999999999999999997643210                0001111  111234456678899999999999999


Q ss_pred             CC-----CHHHHHHH
Q 027003          162 RP-----RMSEVLAI  171 (229)
Q Consensus       162 Rp-----t~~~v~~~  171 (229)
                      |+     ++.++++.
T Consensus       237 R~~~~~~~~~~il~h  251 (328)
T cd05593         237 RLGGGPDDAKEIMRH  251 (328)
T ss_pred             cCCCCCCCHHHHhcC
Confidence            97     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=3.5e-32  Score=216.79  Aligned_cols=166  Identities=21%  Similarity=0.252  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......... ......|+..|+|||++.+..++.
T Consensus       104 ~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  180 (287)
T cd07848         104 SYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGK  180 (287)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCC
Confidence            478999999999995  46999999999999999999999999999865332211 123456899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhH-------HHHhhccc------CCCCcHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKL-------FRIMDTKL------GGQYPQKAAHTA  147 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~~------~~~~~~~~~~~~  147 (229)
                      ++|+|||||++|||++|+.||.+.+...... ......+........       ........      ........+..+
T Consensus       181 ~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  260 (287)
T cd07848         181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVL  260 (287)
T ss_pred             chhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHH
Confidence            9999999999999999999998754321110 111000000000000       00000000      001112356679


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+.+||+.||++|||+.++++
T Consensus       261 ~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         261 LDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHHHHccCCcccCCCHHHHhc
Confidence            99999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=4e-32  Score=212.20  Aligned_cols=169  Identities=27%  Similarity=0.367  Sum_probs=122.7

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +..||.+||.|||+  .+|+||||||.|+|+|.+ |.+||||||.|+....+...   .+.+.|..|+|||.+.|. .|+
T Consensus       130 Yt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt  204 (364)
T KOG0658|consen  130 YTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYT  204 (364)
T ss_pred             HHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccC
Confidence            36899999999996  459999999999999987 89999999999987655432   456789999999999885 699


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-------------cCCCCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-------------LGGQYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~  147 (229)
                      .+.||||.||++.||+-|++.|.|.+....  +.....-+..........+...             ...-.......+.
T Consensus       205 ~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~  282 (364)
T KOG0658|consen  205 TSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDA  282 (364)
T ss_pred             ceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHH
Confidence            999999999999999999999998553221  1111111100000000111110             0011234567789


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH--HHHhhcCC
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA--ILERLEAP  178 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~--~l~~~~~~  178 (229)
                      .+|+.++|..+|.+|.++.|++.  .++++..+
T Consensus       283 ~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  283 LDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            99999999999999999999985  45555544

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-32  Score=215.26  Aligned_cols=153  Identities=25%  Similarity=0.421  Sum_probs=119.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++...............++..|+|||.+.++.++.
T Consensus       123 ~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  200 (277)
T cd05032         123 QMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT  200 (277)
T ss_pred             HHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCc
Confidence            478899999999995  569999999999999999999999999987654333222223345678899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++||+++ |..||.+....                 ...+..........+...+..+.+++.+||+.+|+
T Consensus       201 ~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  263 (277)
T cd05032         201 KSDVWSFGVVLWEMATLAEQPYQGLSNE-----------------EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPK  263 (277)
T ss_pred             ccchHHHHHHHHHhhccCCCCCccCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 99998654311                 11111122222233444577899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +|||+.++++.|+
T Consensus       264 ~Rpt~~~l~~~l~  276 (277)
T cd05032         264 MRPTFLEIVSSLK  276 (277)
T ss_pred             hCCCHHHHHHHhc
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=5.6e-32  Score=212.40  Aligned_cols=154  Identities=27%  Similarity=0.391  Sum_probs=119.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++
T Consensus        99 ~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  176 (257)
T cd05116          99 ELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS  176 (257)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcC
Confidence            578999999999995  56999999999999999999999999999865433221 111222345789999999888889


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|+|||||++|||++ |..||......                 .....+........+..++..+.++|.+||+.||
T Consensus       177 ~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p  239 (257)
T cd05116         177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV  239 (257)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence            99999999999999998 99999764311                 1112222222233445567789999999999999


Q ss_pred             CCCCCHHHHHHHHHh
Q 027003          160 KLRPRMSEVLAILER  174 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~  174 (229)
                      ++||++.+|.+.|+.
T Consensus       240 ~~Rp~~~~i~~~l~~  254 (257)
T cd05116         240 DERPGFAVVELRLRN  254 (257)
T ss_pred             hhCcCHHHHHHHHhc
Confidence            999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=1.9e-32  Score=224.31  Aligned_cols=147  Identities=31%  Similarity=0.422  Sum_probs=123.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .|+.+++.||.|||+  .+|+|||+||.|||++..|.+|+||||+++....  .....+.+.||+.|||||++.+..|+.
T Consensus       104 ~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~  179 (808)
T KOG0597|consen  104 AIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDH  179 (808)
T ss_pred             HHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccc
Confidence            478999999999995  4699999999999999999999999999998654  344567788999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      .+|+||||||+||+++|++||-...                 ...+.+.+.. .....|...+..+..|+..+|.+||.+
T Consensus       180 ~sDlWslGcilYE~~~G~PPF~a~s-----------------i~~Lv~~I~~-d~v~~p~~~S~~f~nfl~gLL~kdP~~  241 (808)
T KOG0597|consen  180 TSDLWSLGCILYELYVGQPPFYARS-----------------ITQLVKSILK-DPVKPPSTASSSFVNFLQGLLIKDPAQ  241 (808)
T ss_pred             hhhHHHHHHHHHHHhcCCCCchHHH-----------------HHHHHHHHhc-CCCCCcccccHHHHHHHHHHhhcChhh
Confidence            9999999999999999999996532                 1112222211 122455688899999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |.+..+++.
T Consensus       242 RltW~~Ll~  250 (808)
T KOG0597|consen  242 RLTWTDLLG  250 (808)
T ss_pred             cccHHHHhc
Confidence            999999885

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=5.1e-32  Score=215.53  Aligned_cols=154  Identities=25%  Similarity=0.434  Sum_probs=119.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       128 ~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  205 (283)
T cd05090         128 HIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS  205 (283)
T ss_pred             HHHHHHHHHHHHHHh--cCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence            478899999999995  569999999999999999999999999998654333222233345677899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++ |..||.+....                 .....+........+..++..+.+++.+||+.||.
T Consensus       206 ~~Dv~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05090         206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----------------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPS  268 (283)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence            9999999999999998 99898664310                 11111111111223344567789999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|..
T Consensus       269 ~Rp~~~~i~~~l~~  282 (283)
T cd05090         269 RRPRFKDIHTRLRS  282 (283)
T ss_pred             cCcCHHHHHHHhhc
Confidence            99999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=6.4e-32  Score=218.13  Aligned_cols=157  Identities=26%  Similarity=0.438  Sum_probs=120.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       138 ~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (314)
T cd05099         138 SCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH  215 (314)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence            468899999999995  569999999999999999999999999998654322221112223456799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+++.+||..||+
T Consensus       216 ~~DiwslG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  278 (314)
T cd05099         216 QSDVWSFGILMWEIFTLGGSPYPGIPVE-----------------ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPT  278 (314)
T ss_pred             cchhhHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999999 88888654321                 11111111211223344566788999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       279 ~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         279 QRPTFKQLVEALDKVLA  295 (314)
T ss_pred             cCcCHHHHHHHHHHHHH
Confidence            99999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=5.2e-32  Score=219.51  Aligned_cols=143  Identities=29%  Similarity=0.402  Sum_probs=112.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (323)
T cd05575         100 FYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDR  175 (323)
T ss_pred             HHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCc
Confidence            468999999999995  5699999999999999999999999999875322211  233457899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||...+..                .....+.....  ..+...+..+.+++.+||+.||.+
T Consensus       176 ~~DvwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         176 TVDWWCLGAVLYEMLYGLPPFYSRDTA----------------EMYDNILNKPL--RLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             cccccccchhhhhhhcCCCCCCCCCHH----------------HHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHh
Confidence            999999999999999999999764311                01111111111  223345778899999999999999


Q ss_pred             CCCHH
Q 027003          162 RPRMS  166 (229)
Q Consensus       162 Rpt~~  166 (229)
                      ||++.
T Consensus       238 R~~~~  242 (323)
T cd05575         238 RLGAK  242 (323)
T ss_pred             CCCCC
Confidence            99985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=4.7e-32  Score=215.47  Aligned_cols=153  Identities=23%  Similarity=0.374  Sum_probs=117.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++................++..|+|||.+.+..++.
T Consensus       126 ~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (280)
T cd05092         126 AIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  203 (280)
T ss_pred             HHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc
Confidence            467899999999995  569999999999999999999999999987543322222222334577899999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.......                . ............+..++..+.+|+.+||+.||.
T Consensus       204 ~~Di~slG~il~el~~~g~~p~~~~~~~~----------------~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~  266 (280)
T cd05092         204 ESDIWSFGVVLWEIFTYGKQPWYQLSNTE----------------A-IECITQGRELERPRTCPPEVYAIMQGCWQREPQ  266 (280)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCccCCHHH----------------H-HHHHHcCccCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999998 899986533110                0 111111111222334567789999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.++++.|+
T Consensus       267 ~Rp~~~~l~~~l~  279 (280)
T cd05092         267 QRMVIKDIHSRLQ  279 (280)
T ss_pred             hCCCHHHHHHHHh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.6e-32  Score=222.75  Aligned_cols=150  Identities=26%  Similarity=0.411  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-----
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----   77 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----   77 (229)
                      +-+|++.++.++|.+  ||||.||||.|.|+- .|.+||+|||+|.........-.....+||+.||+||.+...     
T Consensus       465 ywkqML~aV~~IH~~--gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~  541 (677)
T KOG0596|consen  465 YWKQMLLAVKTIHQH--GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRE  541 (677)
T ss_pred             HHHHHHHHHHHHHHh--ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccccc
Confidence            468999999999965  599999999998875 468999999999987766555556678999999999988543     


Q ss_pred             ------CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHH-HHHHHH
Q 027003           78 ------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA-HTAATL  150 (229)
Q Consensus        78 ------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l  150 (229)
                            +.+.++||||||||||+|+.|+.||...               .....++..+.+....-+++..-. .++.++
T Consensus       542 ~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------------~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~  606 (677)
T KOG0596|consen  542 NGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------------INQIAKLHAITDPNHEIEFPDIPENDELIDV  606 (677)
T ss_pred             CCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------------HHHHHHHHhhcCCCccccccCCCCchHHHHH
Confidence                  2467899999999999999999999642               223344555565554444443222 238999


Q ss_pred             HHHhccCCCCCCCCHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ++.||+.||++||++.++|+
T Consensus       607 mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  607 MKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHhcCcccCCCcHHHhc
Confidence            99999999999999999986

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=3.7e-32  Score=220.37  Aligned_cols=142  Identities=30%  Similarity=0.485  Sum_probs=112.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.
T Consensus       105 ~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  180 (323)
T cd05616         105 FYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGK  180 (323)
T ss_pred             HHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCC
Confidence            478999999999995  469999999999999999999999999987532211  1123457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                .....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       181 ~~DiwSlGvil~elltg~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~  242 (323)
T cd05616         181 SVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGK  242 (323)
T ss_pred             ccchhchhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC--CCCCCCcCCHHHHHHHHHHcccCHHh
Confidence            999999999999999999999764321                111111111  12334456778899999999999999


Q ss_pred             CCCH
Q 027003          162 RPRM  165 (229)
Q Consensus       162 Rpt~  165 (229)
                      |++.
T Consensus       243 R~~~  246 (323)
T cd05616         243 RLGC  246 (323)
T ss_pred             cCCC
Confidence            9985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=3.5e-32  Score=220.51  Aligned_cols=147  Identities=28%  Similarity=0.447  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++........  ......||..|+|||++.+..++.
T Consensus        99 ~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  174 (323)
T cd05595          99 FYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCc
Confidence            468999999999995  4699999999999999999999999999875322111  123456899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||...+...                ....+....  ...+...+..+.+|+.+||+.||.+
T Consensus       175 ~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~  236 (323)
T cd05595         175 AVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQ  236 (323)
T ss_pred             hhchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999997643210                111111111  1234456778899999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      |+     ++.++++
T Consensus       237 R~~~~~~~~~~~l~  250 (323)
T cd05595         237 RLGGGPSDAKEVME  250 (323)
T ss_pred             hCCCCCCCHHHHHc
Confidence            98     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=6.1e-32  Score=219.11  Aligned_cols=146  Identities=29%  Similarity=0.423  Sum_probs=114.8

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.+
T Consensus       105 ~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  180 (323)
T cd05584         105 YLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKA  180 (323)
T ss_pred             HHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCc
Confidence            67899999999995  4699999999999999999999999999875322221  1234578999999999988889999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      +|||||||++|||++|+.||...+..                .....+....  ...+...+..+.+|+.+||+.||++|
T Consensus       181 ~DiwslG~il~ell~G~~pf~~~~~~----------------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R  242 (323)
T cd05584         181 VDWWSLGALMYDMLTGAPPFTAENRK----------------KTIDKILKGK--LNLPPYLTPEARDLLKKLLKRNPSSR  242 (323)
T ss_pred             ceecccHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHc
Confidence            99999999999999999999764311                1111222111  23344556788999999999999999


Q ss_pred             C-----CHHHHHH
Q 027003          163 P-----RMSEVLA  170 (229)
Q Consensus       163 p-----t~~~v~~  170 (229)
                      |     ++.++++
T Consensus       243 ~~~~~~~~~~l~~  255 (323)
T cd05584         243 LGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHhc
Confidence            9     7888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=6.3e-32  Score=218.39  Aligned_cols=147  Identities=28%  Similarity=0.467  Sum_probs=114.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++......  ......+||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05592         100 FYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNE  175 (316)
T ss_pred             HHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCC
Confidence            468999999999995  569999999999999999999999999997543222  1233457999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                .....+..  .....+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DvwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         176 SVDWWSFGVLLYEMLIGQSPFHGEDED----------------ELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             cccchhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999765321                00111111  112334445677889999999999999


Q ss_pred             CCCHH-HHHH
Q 027003          162 RPRMS-EVLA  170 (229)
Q Consensus       162 Rpt~~-~v~~  170 (229)
                      ||++. ++++
T Consensus       238 R~~~~~~l~~  247 (316)
T cd05592         238 RLGVDGDIRQ  247 (316)
T ss_pred             cCCChHHHHc
Confidence            99875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=1.5e-31  Score=216.64  Aligned_cols=143  Identities=29%  Similarity=0.425  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++......  .......||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  175 (321)
T cd05603         100 FYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDR  175 (321)
T ss_pred             HHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCC
Confidence            368899999999995  569999999999999999999999999987532211  1133457899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|..||...+..                .....+....  ...+......+.+++.+||+.||.+
T Consensus       176 ~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         176 TVDWWCLGAVLYEMLYGLPPFYSRDVS----------------QMYDNILHKP--LQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             cCcccccchhhhhhhcCCCCCCCCCHH----------------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHhh
Confidence            999999999999999999999764311                0011111111  2233445677899999999999999


Q ss_pred             CCCHH
Q 027003          162 RPRMS  166 (229)
Q Consensus       162 Rpt~~  166 (229)
                      |+++.
T Consensus       238 R~~~~  242 (321)
T cd05603         238 RLGAK  242 (321)
T ss_pred             cCCCC
Confidence            99764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=8.4e-32  Score=219.00  Aligned_cols=163  Identities=24%  Similarity=0.398  Sum_probs=117.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......    .....|+..|+|||++.+..++.
T Consensus       107 ~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~  181 (331)
T cd06649         107 KVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSV  181 (331)
T ss_pred             HHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCc
Confidence            5788999999999963 359999999999999999999999999987543221    23456899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhh----------------------------c---chhhHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL----------------------------S---DKRKLFRI  130 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~  130 (229)
                      ++|||||||++|||++|+.||...+.........  .+..                            .   ........
T Consensus       182 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T cd06649         182 QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDY  259 (331)
T ss_pred             hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCcccccccccccccccccccchhHHHHHHH
Confidence            9999999999999999999997543211110000  0000                            0   00001111


Q ss_pred             hhcccCCC-CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          131 MDTKLGGQ-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       131 ~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +....... .....+..+.+|+.+||+.||++|||+.++++.
T Consensus       260 ~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         260 IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111111 122356789999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=5.1e-32  Score=219.40  Aligned_cols=147  Identities=29%  Similarity=0.437  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++........  ......||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (321)
T cd05591         100 FYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGP  175 (321)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCC
Confidence            468999999999995  4699999999999999999999999999875322221  123457899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||...+..                .....+....  ...+...+..+.+|+.+||+.||++
T Consensus       176 ~~DvwslG~il~el~tg~~Pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         176 SVDWWALGVLMYEMMAGQPPFEADNED----------------DLFESILHDD--VLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             ccceechhHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHH
Confidence            999999999999999999999765421                1111111111  1223345678899999999999999


Q ss_pred             CC-------CHHHHHH
Q 027003          162 RP-------RMSEVLA  170 (229)
Q Consensus       162 Rp-------t~~~v~~  170 (229)
                      |+       ++.++++
T Consensus       238 R~~~~~~~~~~~~~~~  253 (321)
T cd05591         238 RLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCCCCCCCCCHHHHhc
Confidence            99       7777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=4.6e-32  Score=220.34  Aligned_cols=144  Identities=26%  Similarity=0.388  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.....     .....||+.|+|||++.+..++.
T Consensus       122 ~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  194 (329)
T PTZ00263        122 FYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGK  194 (329)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCC
Confidence            367899999999995  46999999999999999999999999999865332     12357899999999999988999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||.+....                .....+....  ...+...+..+.+|+.+||+.||.+
T Consensus       195 ~~DiwslG~il~elltg~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~  256 (329)
T PTZ00263        195 AVDWWTMGVLLYEFIAGYPPFFDDTPF----------------RIYEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTK  256 (329)
T ss_pred             cceeechHHHHHHHHcCCCCCCCCCHH----------------HHHHHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            999999999999999999999764310                1111122111  1233345667889999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      |++     +.+++.
T Consensus       257 R~~~~~~~~~~ll~  270 (329)
T PTZ00263        257 RLGTLKGGVADVKN  270 (329)
T ss_pred             cCCCCCCCHHHHhc
Confidence            996     577764

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=1.1e-31  Score=218.50  Aligned_cols=159  Identities=27%  Similarity=0.424  Sum_probs=122.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       138 ~~~~qi~~al~~LH~--~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (334)
T cd05100         138 SCAYQVARGMEYLAS--QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  215 (334)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence            468899999999995  569999999999999999999999999987654332221122233456799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 ...+.+........+..++..+.+|+.+||+.+|.
T Consensus       216 ~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  278 (334)
T cd05100         216 QSDVWSFGVLLWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPS  278 (334)
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChh
Confidence            9999999999999998 88888664321                 11122222222233444567889999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCC
Q 027003          161 LRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~~  179 (229)
                      +||++.++++.|+++....
T Consensus       279 ~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         279 QRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             hCcCHHHHHHHHHHHhhhc
Confidence            9999999999999886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-32  Score=236.66  Aligned_cols=157  Identities=29%  Similarity=0.454  Sum_probs=130.2

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +.++.|||+|+.||++  +++|||||-..|+||+....|||+|||+|+.+.....+.......-...|||||.+..+.++
T Consensus       805 l~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt  882 (1025)
T KOG1095|consen  805 LAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT  882 (1025)
T ss_pred             HHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccc
Confidence            4689999999999995  56999999999999999999999999999965555544444333456799999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .|+|||||||+|||++| |..||...+                +.+.+...+... +.+.|..++..+.++|.+||+.+|
T Consensus       883 skSDvWsFGVllWEifslG~~PY~~~~----------------n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~p  945 (1025)
T KOG1095|consen  883 SKSDVWSFGVLLWEIFSLGATPYPSRS----------------NFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDP  945 (1025)
T ss_pred             cccchhhhHHHHHHHHhCCCCCCCCcc----------------hHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCCh
Confidence            99999999999999998 899997754                222222233333 667788899999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      ++||++..+++.+..+.
T Consensus       946 e~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  946 EDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             hhCccHHHHHhhhhhhh
Confidence            99999999999877654

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=5.7e-32  Score=218.67  Aligned_cols=146  Identities=29%  Similarity=0.487  Sum_probs=113.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.++|+|||+++.......  ......||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05620         100 FYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTF  175 (316)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCc
Confidence            467899999999995  4699999999999999999999999999874322111  133467899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                 ...+.+.. .....+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DiwslGvil~el~~g~~Pf~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         176 SVDWWSFGVLLYEMLIGQSPFHGDDED-----------------ELFESIRV-DTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHh-CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999764321                 01111110 112233345677899999999999999


Q ss_pred             CCCHH-HHH
Q 027003          162 RPRMS-EVL  169 (229)
Q Consensus       162 Rpt~~-~v~  169 (229)
                      |+++. +++
T Consensus       238 R~~~~~~~~  246 (316)
T cd05620         238 RLGVVGNIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=2.7e-32  Score=221.38  Aligned_cols=149  Identities=27%  Similarity=0.429  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.
T Consensus        99 ~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05594          99 FYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGR  175 (325)
T ss_pred             HHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCC
Confidence            4688999999999962 4699999999999999999999999999875322211  123456999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||.+.+...                ....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DiwslG~il~el~tG~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         176 AVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             ccccccccceeeeeccCCCCCCCCCHHH----------------HHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999997643210                00111111  11233445678899999999999999


Q ss_pred             CC-----CHHHHHHH
Q 027003          162 RP-----RMSEVLAI  171 (229)
Q Consensus       162 Rp-----t~~~v~~~  171 (229)
                      |+     ++.++++.
T Consensus       238 R~~~~~~~~~~il~h  252 (325)
T cd05594         238 RLGGGPDDAKEIMQH  252 (325)
T ss_pred             hCCCCCCCHHHHhcC
Confidence            97     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=5e-32  Score=219.34  Aligned_cols=142  Identities=30%  Similarity=0.478  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++......  .......||..|+|||++.+..++.
T Consensus       100 ~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  175 (320)
T cd05590         100 FYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGP  175 (320)
T ss_pred             HHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCC
Confidence            468899999999995  469999999999999999999999999987532221  1133457999999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.+..                .....+....  ...+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DiwslG~il~el~~g~~Pf~~~~~~----------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         176 SVDWWAMGVLLYEMLCGHAPFEAENED----------------DLFEAILNDE--VVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             ccchhhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999999999999999765321                0111111111  1233345678899999999999999


Q ss_pred             CCCH
Q 027003          162 RPRM  165 (229)
Q Consensus       162 Rpt~  165 (229)
                      |+++
T Consensus       238 R~~~  241 (320)
T cd05590         238 RLGS  241 (320)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=7.4e-32  Score=217.10  Aligned_cols=157  Identities=27%  Similarity=0.427  Sum_probs=121.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       144 ~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  221 (307)
T cd05098         144 SCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  221 (307)
T ss_pred             HHHHHHHHHHHHHHH--CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence            578999999999995  569999999999999999999999999987653322111122223456899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++ |..||.+...                 ....+.+........+...+..+.+|+.+||..+|.
T Consensus       222 ~~DvwslG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  284 (307)
T cd05098         222 QSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS  284 (307)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCcCCH-----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChh
Confidence            9999999999999998 8888865431                 111122222222233445667889999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       285 ~Rps~~evl~~l~~~~~  301 (307)
T cd05098         285 QRPTFKQLVEDLDRILA  301 (307)
T ss_pred             hCcCHHHHHHHHHHHHH
Confidence            99999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=2.1e-32  Score=230.10  Aligned_cols=164  Identities=26%  Similarity=0.352  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++ .+||+|||+++.......   .....||..|+|||++.+. .+
T Consensus       174 ~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  248 (440)
T PTZ00036        174 LYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNY  248 (440)
T ss_pred             HHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCC
Confidence            467899999999995  4699999999999998765 699999999986543222   2245689999999998764 68


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhh-hhhhcchhh----HHHHhh-----cccCCCCcHHHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKRK----LFRIMD-----TKLGGQYPQKAAHTAA  148 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~  148 (229)
                      +.++|||||||++|||++|..||.+....... ...... .+.......    ...+..     ..+....+...+..+.
T Consensus       249 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~  328 (440)
T PTZ00036        249 TTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAI  328 (440)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHH
Confidence            99999999999999999999999875432110 111100 000000000    000000     0000111223456789


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.+++.
T Consensus       329 ~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        329 NFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHCCCChhHCcCHHHHhC
Confidence            9999999999999999999985

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.8e-32  Score=222.13  Aligned_cols=168  Identities=28%  Similarity=0.388  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-cceeecccccccccccccccc--CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT--GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~   78 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++....... .......+||..|+|||++.+  ..
T Consensus       107 ~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  184 (338)
T cd07859         107 FFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK  184 (338)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccc
Confidence            478999999999996  4699999999999999999999999999975432211 111234578999999999866  57


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhH-HHhhh-hhhc--------chhhHHHHhhcccCCCCc---HHHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAK-PYLS--------DKRKLFRIMDTKLGGQYP---QKAAH  145 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~---~~~~~  145 (229)
                      ++.++|||||||++|+|++|+.||.+.+....... ..... +...        ........+.........   .....
T Consensus       185 ~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (338)
T cd07859         185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADP  264 (338)
T ss_pred             cCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCCh
Confidence            88999999999999999999999976543111000 00000 0000        000000001000000000   12345


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+.+++.+||+.||++||++.++++.
T Consensus       265 ~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         265 LALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            67899999999999999999999863

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.9e-32  Score=224.20  Aligned_cols=168  Identities=26%  Similarity=0.332  Sum_probs=118.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+||||||||+|||++.++.++|+|||+++...............||..|+|||++.+..++.
T Consensus       189 ~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  266 (392)
T PHA03207        189 TIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA  266 (392)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCc
Confidence            578999999999995  469999999999999999999999999997654433322233467999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhh-------hhc-chhhHHHH---hhcccCCCC--c-----HH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKP-------YLS-DKRKLFRI---MDTKLGGQY--P-----QK  142 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~-------~~~-~~~~~~~~---~~~~~~~~~--~-----~~  142 (229)
                      ++|||||||++|||++|+.||.+........ +......       +.. ....+.+.   ........+  +     ..
T Consensus       267 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (392)
T PHA03207        267 KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYG  346 (392)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccC
Confidence            9999999999999999999997755432111 1110000       000 00000000   000011111  1     12


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          143 AAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       143 ~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ....+.++|.+||..||.+||++.+++..
T Consensus       347 ~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        347 MHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            34567889999999999999999999874

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=1.1e-31  Score=213.26  Aligned_cols=156  Identities=24%  Similarity=0.353  Sum_probs=120.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       121 ~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  198 (280)
T cd05043         121 HMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSS  198 (280)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCc
Confidence            578899999999995  569999999999999999999999999998653332221122334677899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++||+++ |+.||...+..                 .+...+........+..++..+.+++.+||..||+
T Consensus       199 ~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  261 (280)
T cd05043         199 ASDVWSFGVLLWELMTLGQTPYVEIDPF-----------------EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPE  261 (280)
T ss_pred             hhhHHHhHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 99999764311                 11111111222222334567789999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+.+.
T Consensus       262 ~Rps~~~~~~~l~~~~  277 (280)
T cd05043         262 ERPSFSQLVQCLTDFH  277 (280)
T ss_pred             hCCCHHHHHHHHHHHH
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=9.6e-32  Score=223.31  Aligned_cols=157  Identities=27%  Similarity=0.416  Sum_probs=122.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       241 ~~~~qi~~aL~~LH~--~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  318 (400)
T cd05105         241 SFTYQVARGMEFLAS--KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT  318 (400)
T ss_pred             HHHHHHHHHHHHHHh--CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence            578999999999995  569999999999999999999999999987653332222223345678899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||......                ......+........+..++..+.+++.+||+.||+
T Consensus       319 ~~DiwSlGvil~ellt~g~~P~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  382 (400)
T cd05105         319 LSDVWSYGILLWEIFSLGGTPYPGMIVD----------------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPE  382 (400)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCcccchh----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHh
Confidence            9999999999999997 88998753211                011111222222233445677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++.+.|+++.
T Consensus       383 ~RPt~~~l~~~l~~l~  398 (400)
T cd05105         383 KRPSFLHLSDIVESLL  398 (400)
T ss_pred             HCcCHHHHHHHHHHHc
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.3e-31  Score=214.78  Aligned_cols=154  Identities=28%  Similarity=0.423  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++........   ......+..|+|||.+.+..++.
T Consensus       123 ~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  197 (297)
T cd05089         123 QFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTT  197 (297)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCc
Confidence            578999999999995  5699999999999999999999999999864221111   11122355799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||......                 .....+........+..++..+.+|+.+||+.+|.
T Consensus       198 ~~DvwSlG~il~el~t~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  260 (297)
T cd05089         198 KSDVWSFGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPY  260 (297)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999997 99999764321                 11111222222233344667889999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|..+..
T Consensus       261 ~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         261 ERPPFAQISVQLSRMLE  277 (297)
T ss_pred             hCcCHHHHHHHHHHHHH
Confidence            99999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=8.1e-32  Score=213.76  Aligned_cols=153  Identities=26%  Similarity=0.385  Sum_probs=116.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||+|||+  ++++||||||+||+++.++   .+||+|||+++................+..|+|||++.+..
T Consensus       120 ~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  197 (277)
T cd05036         120 FCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI  197 (277)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC
Confidence            578999999999995  4699999999999998765   58999999998653222111111223456899999998889


Q ss_pred             CcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|||||||++|||++ |..||......                 .....+........+..++..+.+++.+||+.
T Consensus       198 ~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~  260 (277)
T cd05036         198 FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----------------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQH  260 (277)
T ss_pred             cCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            9999999999999999997 99999764321                 11122222222233445567889999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 027003          158 EPKLRPRMSEVLAILE  173 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~  173 (229)
                      +|++||++.++++.|.
T Consensus       261 ~p~~Rps~~~vl~~l~  276 (277)
T cd05036         261 TPEDRPNFATILERIQ  276 (277)
T ss_pred             CcccCcCHHHHHHHhh
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.9e-32  Score=225.31  Aligned_cols=166  Identities=21%  Similarity=0.270  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+||||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.
T Consensus       186 ~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  262 (391)
T PHA03212        186 AIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGP  262 (391)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCc
Confidence            578999999999995  4699999999999999999999999999875322211 1123457999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCcccc-----chhH---HHhhhh----hhcc-hhhHHHHh----hcccC--CC--Cc
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGI-----EQSL---VDWAKP----YLSD-KRKLFRIM----DTKLG--GQ--YP  140 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~-----~~~~---~~~~~~----~~~~-~~~~~~~~----~~~~~--~~--~~  140 (229)
                      ++|||||||++|||++|..||.......     ...+   ......    +... ...+....    .....  ..  ..
T Consensus       263 ~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (391)
T PHA03212        263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLW  342 (391)
T ss_pred             HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCH
Confidence            9999999999999999998775432110     0000   000000    0000 00011110    00000  00  01


Q ss_pred             ---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          141 ---QKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       141 ---~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                         ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       343 ~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        343 TNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               134567889999999999999999999986

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.1e-31  Score=210.49  Aligned_cols=149  Identities=26%  Similarity=0.442  Sum_probs=117.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++||||||+||+++.++.+||+|||++.......     ....++..|+|||++.+..++.
T Consensus       106 ~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~  178 (256)
T cd05082         106 KFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFST  178 (256)
T ss_pred             HHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCc
Confidence            578899999999995  569999999999999999999999999987543221     1223466899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |+.||.....                 ......+........+..++..+.+++.+||+.+|+
T Consensus       179 ~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  241 (256)
T cd05082         179 KSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAA  241 (256)
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChh
Confidence            9999999999999998 9999865321                 111111122222233445677899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +|||+.++++.|++
T Consensus       242 ~Rpt~~~l~~~l~~  255 (256)
T cd05082         242 TRPSFLQLREQLEH  255 (256)
T ss_pred             hCcCHHHHHHHHhc
Confidence            99999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.8e-32  Score=216.67  Aligned_cols=144  Identities=28%  Similarity=0.366  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.....     .....||..|+|||++.+..++.
T Consensus       105 ~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  177 (291)
T cd05612         105 FYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNK  177 (291)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCc
Confidence            478999999999995  46999999999999999999999999998765332     22356899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.+..                .....+....  ...+...+..+.+|+.+||+.||.+
T Consensus       178 ~~DiwSlG~il~~l~~g~~pf~~~~~~----------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~  239 (291)
T cd05612         178 AVDWWALGILIYEMLVGYPPFFDDNPF----------------GIYEKILAGK--LEFPRHLDLYAKDLIKKLLVVDRTR  239 (291)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC--cCCCccCCHHHHHHHHHHcCCCHHH
Confidence            999999999999999999999764311                0111111111  1234445678899999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      |++     +.++++
T Consensus       240 R~~~~~~~~~~~l~  253 (291)
T cd05612         240 RLGNMKNGADDVKN  253 (291)
T ss_pred             ccCCccCCHHHHhc
Confidence            995     777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.3e-31  Score=213.10  Aligned_cols=171  Identities=27%  Similarity=0.432  Sum_probs=123.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||+++........ .......++..|+|||.+.+..++
T Consensus       111 ~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~  188 (283)
T cd05080         111 LFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS  188 (283)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCC
Confidence            578999999999995  56999999999999999999999999998865432211 111223356679999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||++|..||......... ....... ..........+........+...+..+.+++.+||+.||+
T Consensus       189 ~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  266 (283)
T cd05080         189 YASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQG-QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAK  266 (283)
T ss_pred             cccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhccccc-ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChh
Confidence            9999999999999999999998654321110 0000000 0011112222222233333445677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       267 ~Rps~~~i~~~l~~~~  282 (283)
T cd05080         267 FRPTFRSLIPILKEMH  282 (283)
T ss_pred             hCCCHHHHHHHHHHhh
Confidence            9999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=1.3e-31  Score=215.33  Aligned_cols=156  Identities=26%  Similarity=0.418  Sum_probs=120.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++|+|+||||+|||++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus       145 ~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  222 (302)
T cd05055         145 SFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF  222 (302)
T ss_pred             HHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCc
Confidence            578899999999995  469999999999999999999999999987654332221222334677899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.......                ...+..........+...+..+.+++.+||+.+|+
T Consensus       223 ~~DiwslGvil~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  286 (302)
T cd05055         223 ESDVWSYGILLWEIFSLGSNPYPGMPVDS----------------KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPL  286 (302)
T ss_pred             HhHHHHHHHHHHHHHhCCCCCcCCCCchH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCch
Confidence            9999999999999998 999987643211                11112222222222334466899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+++
T Consensus       287 ~Rpt~~ell~~l~~~  301 (302)
T cd05055         287 KRPTFKQIVQLIGKQ  301 (302)
T ss_pred             hCcCHHHHHHHHHhh
Confidence            999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=1.4e-31  Score=210.49  Aligned_cols=153  Identities=22%  Similarity=0.414  Sum_probs=118.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.
T Consensus       107 ~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  183 (261)
T cd05072         107 DFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTI  183 (261)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCCh
Confidence            478899999999995  56999999999999999999999999999865432211 122234567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||......                 .....+............+..+.+++.+||..+|+
T Consensus       184 ~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  246 (261)
T cd05072         184 KSDVWSFGILLYEIVTYGKIPYPGMSNS-----------------DVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAE  246 (261)
T ss_pred             hhhhhhhHHHHHHHHccCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence            9999999999999998 99999754311                 01111111111222234566789999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++.+.|+.
T Consensus       247 ~Rp~~~~i~~~l~~  260 (261)
T cd05072         247 ERPTFDYLQSVLDD  260 (261)
T ss_pred             cCcCHHHHHHHHhc
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1.4e-31  Score=219.98  Aligned_cols=165  Identities=23%  Similarity=0.297  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++.
T Consensus       127 ~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~  201 (359)
T cd07876         127 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKE  201 (359)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCc
Confidence            468899999999995  469999999999999999999999999997543221   123456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHH-hhhhhhcch----hhHHHHhhcccC------------------C
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLSDK----RKLFRIMDTKLG------------------G  137 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~-~~~~~~~~~----~~~~~~~~~~~~------------------~  137 (229)
                      ++|||||||++|+|++|+.||.+.+..... .... ...+.....    ............                  .
T Consensus       202 ~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (359)
T cd07876         202 NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSES  281 (359)
T ss_pred             chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccccc
Confidence            999999999999999999999875421100 0000 000000000    000000000000                  0


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .........+.+|+.+||+.||++|||+.|+++.
T Consensus       282 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         282 ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             ccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0111234678899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=1.3e-31  Score=209.54  Aligned_cols=153  Identities=26%  Similarity=0.408  Sum_probs=116.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.................+..|+|||.+.++.++.
T Consensus        98 ~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  175 (252)
T cd05084          98 QMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS  175 (252)
T ss_pred             HHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCCh
Confidence            478999999999995  569999999999999999999999999987543221111111112345799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++ |..||......                 .....+........+...+..+.+|+.+||+.+|+
T Consensus       176 ~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         176 ESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 88888653211                 11122222223334445577899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.++++.|+
T Consensus       239 ~Rps~~~~~~~l~  251 (252)
T cd05084         239 QRPSFSTVHQELQ  251 (252)
T ss_pred             hCcCHHHHHHHHh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=7e-32  Score=218.87  Aligned_cols=142  Identities=33%  Similarity=0.515  Sum_probs=111.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++........  .....+||..|+|||++.+..++.
T Consensus       105 ~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  180 (324)
T cd05587         105 FYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGK  180 (324)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCc
Confidence            468899999999995  4699999999999999999999999999875322211  133457999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.+..                .....+..  .....+...+..+.+++.+||+.||.+
T Consensus       181 ~~DiwslGvil~elltG~~pf~~~~~~----------------~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~  242 (324)
T cd05587         181 SVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQSIME--HNVSYPKSLSKEAVSICKGLLTKHPAK  242 (324)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            999999999999999999999764311                01111111  112334456678899999999999999


Q ss_pred             CCCH
Q 027003          162 RPRM  165 (229)
Q Consensus       162 Rpt~  165 (229)
                      |++.
T Consensus       243 R~~~  246 (324)
T cd05587         243 RLGC  246 (324)
T ss_pred             cCCC
Confidence            9976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.7e-31  Score=209.61  Aligned_cols=156  Identities=28%  Similarity=0.456  Sum_probs=119.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+  .+++|+||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+..++
T Consensus        99 ~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  176 (257)
T cd05060          99 ELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS  176 (257)
T ss_pred             HHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCC
Confidence            578999999999995  569999999999999999999999999988654332211 11112235679999999888899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++ |..||...+..                 .....+........+..++..+.+++.+||..+|
T Consensus       177 ~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  239 (257)
T cd05060         177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----------------EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRP  239 (257)
T ss_pred             ccchHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCCh
Confidence            99999999999999998 99999764311                 1111111122223344556788999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      ++||++.++++.|+.+.
T Consensus       240 ~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         240 EDRPTFSELESTFRRDP  256 (257)
T ss_pred             hhCcCHHHHHHHHHhcc
Confidence            99999999999997653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=217.65  Aligned_cols=146  Identities=27%  Similarity=0.463  Sum_probs=127.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee-cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +.+.||+.|+.|+|.  -++|||||||+||.+ .+-|-|||.|||++..+..+..   .+..+|+..|.|||++.|..|+
T Consensus       122 kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYD  196 (864)
T KOG4717|consen  122 KYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYD  196 (864)
T ss_pred             HHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccC
Confidence            568999999999995  459999999999765 6779999999999987765544   3567999999999999999987


Q ss_pred             c-cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 T-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~-~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      . ++||||||||||.|++|+.||+..+                +.+.+..+++.+.  ..|...+.++.+||..||..||
T Consensus       197 APAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdP  258 (864)
T KOG4717|consen  197 APAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDP  258 (864)
T ss_pred             CcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCc
Confidence            4 8999999999999999999998754                5567777777766  6688899999999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      .+|.+..+|..
T Consensus       259 kkRAslEeI~s  269 (864)
T KOG4717|consen  259 KKRASLEEIVS  269 (864)
T ss_pred             hhhccHHHHhc
Confidence            99999999874

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=2.5e-31  Score=209.72  Aligned_cols=155  Identities=26%  Similarity=0.447  Sum_probs=119.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++|+|+||||+|||++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus       110 ~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~  187 (266)
T cd05033         110 GMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS  187 (266)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCcc
Confidence            578999999999995  569999999999999999999999999998764222211122233567899999998889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |..||......                 .....+........+..++..+.+|+.+||+.+|+
T Consensus       188 ~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  250 (266)
T cd05033         188 ASDVWSFGIVMWEVMSYGERPYWDMSNQ-----------------DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRN  250 (266)
T ss_pred             ccchHHHHHHHHHHHccCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999998 99998653211                 11111111122223344567889999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+++
T Consensus       251 ~Rp~~~ei~~~l~~~  265 (266)
T cd05033         251 ERPTFSQIVSTLDKM  265 (266)
T ss_pred             cCcCHHHHHHHHHhh
Confidence            999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=1.1e-31  Score=220.18  Aligned_cols=165  Identities=22%  Similarity=0.278  Sum_probs=116.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++.
T Consensus       123 ~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~  197 (355)
T cd07874         123 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKE  197 (355)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCc
Confidence            468899999999995  569999999999999999999999999998643321   123457899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-H-HHhhhhhhc---ch-hhHHHHhhccc------------------CC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-L-VDWAKPYLS---DK-RKLFRIMDTKL------------------GG  137 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~-~~~~~~~~~---~~-~~~~~~~~~~~------------------~~  137 (229)
                      ++|||||||++|+|++|+.||.+.+...... . .....+...   .. ...........                  ..
T Consensus       198 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (355)
T cd07874         198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS  277 (355)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccc
Confidence            9999999999999999999998754321100 0 000000000   00 00000110000                  00


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       278 ~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         278 EHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             ccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            1112234578899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=2e-31  Score=214.28  Aligned_cols=158  Identities=22%  Similarity=0.372  Sum_probs=120.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++...............++..|++||.+.+..++.
T Consensus       113 ~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  190 (303)
T cd05110         113 NWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH  190 (303)
T ss_pred             HHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCCh
Confidence            578999999999995  569999999999999999999999999998654332211122234577899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 .....+........+..+...+.+++.+||..+|+
T Consensus       191 ~~DiwslG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~  253 (303)
T cd05110         191 QSDVWSYGVTIWELMTFGGKPYDGIPTR-----------------EIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDAD  253 (303)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999997 88998664311                 11111111111222233456788999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|.++...
T Consensus       254 ~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         254 SRPKFKELAAEFSRMARD  271 (303)
T ss_pred             hCcCHHHHHHHHHHHHhc
Confidence            999999999999887544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=2.1e-31  Score=209.32  Aligned_cols=155  Identities=24%  Similarity=0.361  Sum_probs=120.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcce-eeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+  ++++||||||+|||++.++.+||+|||++........... .....++..|+|||.+.+..++
T Consensus        99 ~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  176 (257)
T cd05115          99 ELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS  176 (257)
T ss_pred             HHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCC
Confidence            578999999999995  5699999999999999999999999999875433322111 1112235689999999888899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|++++ |..||.....                 ......+........+...+.++.+++.+||..||
T Consensus       177 ~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~  239 (257)
T cd05115         177 SRSDVWSYGITMWEAFSYGQKPYKKMKG-----------------PEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW  239 (257)
T ss_pred             chhhHHHHHHHHHHHhcCCCCCcCcCCH-----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence            99999999999999996 9999976431                 11122222223334455567889999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 027003          160 KLRPRMSEVLAILERL  175 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~  175 (229)
                      ++||++.++.+.|+.+
T Consensus       240 ~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         240 EDRPNFAKVEERMRTY  255 (257)
T ss_pred             hhCcCHHHHHHHHhhh
Confidence            9999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.2e-31  Score=220.84  Aligned_cols=165  Identities=22%  Similarity=0.297  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++......   ......+|..|+|||++.+..++.
T Consensus       130 ~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~  204 (364)
T cd07875         130 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKE  204 (364)
T ss_pred             HHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCc
Confidence            478999999999995  569999999999999999999999999998643321   123456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHH-hhhhhhc---chh-hHHHHhhccc------------------CC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLS---DKR-KLFRIMDTKL------------------GG  137 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~-~~~~~~~---~~~-~~~~~~~~~~------------------~~  137 (229)
                      ++|||||||++|+|++|+.||.+.+..... .+.. ...+...   ... ..........                  ..
T Consensus       205 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
T cd07875         205 NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS  284 (364)
T ss_pred             hhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccc
Confidence            999999999999999999999775432110 0000 0000000   000 0000000000                  00


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .........+.+|+.+||+.||.+|||+.++++.
T Consensus       285 ~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         285 EHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             cccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0111234578899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1e-31  Score=214.48  Aligned_cols=165  Identities=22%  Similarity=0.325  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......++..|+|||++.+ ..++
T Consensus       107 ~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  182 (288)
T cd07871         107 IFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYS  182 (288)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccC
Confidence            468899999999995  4699999999999999999999999999875432221  1233467999999999866 4688


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhH-HHhh-hh------hhcchhhHHHHhhcccCCC----CcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWA-KP------YLSDKRKLFRIMDTKLGGQ----YPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~-~~------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|+.||.+.+....... .... .+      ...................    .....+..+.
T Consensus       183 ~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (288)
T cd07871         183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGI  262 (288)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHH
Confidence            999999999999999999999977543221111 0000 00      0000011111111110000    0112356788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.|+++
T Consensus       263 dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         263 DLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHHHHhcCcCcccCCCHHHHhc
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.2e-31  Score=210.82  Aligned_cols=149  Identities=28%  Similarity=0.415  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCC------------------------------
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG------------------------------   53 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~------------------------------   53 (229)
                      +..++.||+|||..  |||+|||||+||||.++|++-|+||.++......                              
T Consensus       185 aAEvl~ALEYLHml--GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~  262 (459)
T KOG0610|consen  185 AAEVLLALEYLHML--GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRC  262 (459)
T ss_pred             HHHHHHHHHHHHhh--ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccch
Confidence            56889999999954  5999999999999999999999999987432110                              


Q ss_pred             ----CC--------------------cceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCcccc
Q 027003           54 ----DR--------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI  109 (229)
Q Consensus        54 ----~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  109 (229)
                          ..                    ......++||..|+|||+++|...+.++|.|+|||++|||+.|..||.+.+   
T Consensus       263 ~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~---  339 (459)
T KOG0610|consen  263 LSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN---  339 (459)
T ss_pred             hccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC---
Confidence                00                    011225789999999999999999999999999999999999999999865   


Q ss_pred             chhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 027003          110 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLA  170 (229)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~v~~  170 (229)
                                   ..+.+.+++...+........+..+.+||+++|.+||.+|..    +.||.+
T Consensus       340 -------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  340 -------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             -------------chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence                         566777888777766666678899999999999999999997    777764

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-31  Score=219.91  Aligned_cols=151  Identities=27%  Similarity=0.329  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC---------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---------------------------   54 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------------------   54 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++.......                           
T Consensus       105 ~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (350)
T cd05573         105 FYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ  182 (350)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccccc
Confidence            478999999999995  569999999999999999999999999987654332                           


Q ss_pred             CcceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhh--
Q 027003           55 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--  132 (229)
Q Consensus        55 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  132 (229)
                      .........||..|+|||++.+..++.++|||||||++|||++|+.||......                ....++..  
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~----------------~~~~~i~~~~  246 (350)
T cd05573         183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ----------------ETYNKIINWK  246 (350)
T ss_pred             ccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH----------------HHHHHHhccC
Confidence            001123456899999999999999999999999999999999999999765421                11111111  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 027003          133 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAI  171 (229)
Q Consensus       133 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-~~~v~~~  171 (229)
                      ...........+..+.+|+.+||. ||.+|++ +.++++.
T Consensus       247 ~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         247 ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111111112257788999999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=2.8e-31  Score=214.55  Aligned_cols=103  Identities=25%  Similarity=0.372  Sum_probs=84.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee----cCCCcEEEcccCCcccCCCCCC-cceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .++.||+.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++....... ........||..|+|||++.+
T Consensus       112 ~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07868         112 SLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             HHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC
Confidence            478999999999995  469999999999999    4567899999999986543221 111234578999999999977


Q ss_pred             C-CCcccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           77 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        77 ~-~~~~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                      . .++.++|||||||++|+|++|+.||....
T Consensus       190 ~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         190 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            4 57899999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=1.5e-31  Score=213.16  Aligned_cols=164  Identities=24%  Similarity=0.299  Sum_probs=114.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......   .....||..|+|||++.+..++.
T Consensus       112 ~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  186 (288)
T cd07863         112 DLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYAT  186 (288)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCC
Confidence            478999999999995  4699999999999999999999999999876532211   23356899999999998889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhh-hhhcchhhHHHHhhcccC-------CCCcHHHHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAK-PYLSDKRKLFRIMDTKLG-------GQYPQKAAHTAATLAL  152 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~  152 (229)
                      ++|||||||++|+|++|..||.+...... ........ +.................       ..........+.+|+.
T Consensus       187 ~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  266 (288)
T cd07863         187 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLL  266 (288)
T ss_pred             cchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHH
Confidence            99999999999999999999976432111 01111000 000000000000000000       0011234567889999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+|||+.+++.
T Consensus       267 ~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         267 EMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHhccCcccCCCHHHHhc
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.6e-31  Score=209.03  Aligned_cols=156  Identities=28%  Similarity=0.410  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++........  .......++..|+|||.+.+..+
T Consensus       102 ~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  179 (262)
T cd05058         102 GFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF  179 (262)
T ss_pred             HHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCcc
Confidence            467899999999995  56999999999999999999999999998754322111  11112345678999999988889


Q ss_pred             cccCceeehhHHHHHHHhC-CCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.++|||||||++|||++| ..||...+..                 .....+........+...+..+.+++.+||+.+
T Consensus       180 ~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  242 (262)
T cd05058         180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----------------DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPK  242 (262)
T ss_pred             chHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            9999999999999999995 5566543210                 011111111111222334567899999999999


Q ss_pred             CCCCCCHHHHHHHHHhhc
Q 027003          159 PKLRPRMSEVLAILERLE  176 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~  176 (229)
                      |++||++.++++.|+++.
T Consensus       243 p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         243 PEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             hhhCCCHHHHHHHHHHHh
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=6.8e-32  Score=218.38  Aligned_cols=144  Identities=32%  Similarity=0.427  Sum_probs=113.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.
T Consensus       102 ~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~  177 (318)
T cd05582         102 FYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQ  177 (318)
T ss_pred             HHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCC
Confidence            478999999999995  4699999999999999999999999999876433211  133467899999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||...+..                .....+....  ...+...+..+.+|+.+||+.||.+
T Consensus       178 ~~DiwslG~il~el~tg~~p~~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~P~~  239 (318)
T cd05582         178 SADWWSFGVLMFEMLTGSLPFQGKDRK----------------ETMTMILKAK--LGMPQFLSPEAQSLLRALFKRNPAN  239 (318)
T ss_pred             ccceeccceEeeeeccCCCCCCCCCHH----------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHhH
Confidence            999999999999999999999764311                1111111111  1234445678899999999999999


Q ss_pred             CCCHHH
Q 027003          162 RPRMSE  167 (229)
Q Consensus       162 Rpt~~~  167 (229)
                      ||++.+
T Consensus       240 R~~a~~  245 (318)
T cd05582         240 RLGAGP  245 (318)
T ss_pred             cCCCCC
Confidence            999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=2e-31  Score=210.33  Aligned_cols=154  Identities=22%  Similarity=0.390  Sum_probs=118.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+|||++.++.++++|||.+......... ......++..|+|||.+.+..++.
T Consensus       111 ~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  187 (266)
T cd05064         111 GMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSS  187 (266)
T ss_pred             HHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccc
Confidence            578999999999995  56999999999999999999999999987653222111 111233567899999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++||+++ |..||......                 ...+.+........+..++..+.+++.+||+.+|.
T Consensus       188 ~~Di~slG~~l~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~  250 (266)
T cd05064         188 ASDVWSFGIVMWEVMSYGERPYWDMSGQ-----------------DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERG  250 (266)
T ss_pred             hhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCch
Confidence            9999999999999875 99999764311                 11111122222234455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|.++
T Consensus       251 ~RP~~~~i~~~l~~~  265 (266)
T cd05064         251 ERPRFSQIHSILSKM  265 (266)
T ss_pred             hCCCHHHHHHHHHhh
Confidence            999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=3.4e-31  Score=207.69  Aligned_cols=152  Identities=30%  Similarity=0.445  Sum_probs=121.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++||||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.
T Consensus       109 ~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  186 (262)
T cd00192         109 SFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTS  186 (262)
T ss_pred             HHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcch
Confidence            578999999999995  569999999999999999999999999998765433222233455788999999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.....                 ......+........+..++..+.+++.+||+.+|.
T Consensus       187 ~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  249 (262)
T cd00192         187 KSDVWSFGVLLWEIFTLGATPYPGLSN-----------------EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPE  249 (262)
T ss_pred             hhccHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcc
Confidence            9999999999999999 6999976521                 111112222223344555678899999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.++++.|
T Consensus       250 ~Rps~~~l~~~l  261 (262)
T cd00192         250 DRPTFSELVERL  261 (262)
T ss_pred             cCcCHHHHHHhh
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.5e-31  Score=214.01  Aligned_cols=160  Identities=26%  Similarity=0.400  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus       134 ~~~~~i~~al~~LH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  211 (296)
T cd05051         134 YMATQIASGMRYLES--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT  211 (296)
T ss_pred             HHHHHHHHHHHHHHH--cCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCc
Confidence            578999999999995  469999999999999999999999999987654333222233445678899999998888999


Q ss_pred             cCceeehhHHHHHHHh--CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|||||||++|||++  |..||......   .........       .+..........+...+..+.+++.+||+.||
T Consensus       212 ~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  281 (296)
T cd05051         212 KSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVIENAGHF-------FRDDGRQIYLPRPPNCPKDIYELMLECWRRDE  281 (296)
T ss_pred             cchhhhhHHHHHHHHhcCCCCCCCCcChH---HHHHHHHhc-------cccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence            9999999999999998  66777553311   000000000       00000011111223345789999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 027003          160 KLRPRMSEVLAILE  173 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~  173 (229)
                      .+||++.++++.|+
T Consensus       282 ~~Rpt~~el~~~L~  295 (296)
T cd05051         282 EDRPTFREIHLFLQ  295 (296)
T ss_pred             hcCCCHHHHHHHhc
Confidence            99999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=2.3e-31  Score=209.83  Aligned_cols=156  Identities=22%  Similarity=0.365  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.
T Consensus       110 ~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  185 (267)
T cd08228         110 KYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             HHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCc
Confidence            578899999999995  5699999999999999999999999999876533221  122346888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++|..||.......               ......+.. ..........+..+.+++.+||+.+|+
T Consensus       186 ~~Di~slG~~l~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  250 (267)
T cd08228         186 KSDIWSLGCLLYEMAALQSPFYGDKMNL---------------FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPD  250 (267)
T ss_pred             hhhHHHHHHHHHHHhcCCCCCccccccH---------------HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcc
Confidence            9999999999999999999986532110               011111111 111122334567899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.++++.
T Consensus       251 ~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         251 QRPDIGYVHQIAKQMH  266 (267)
T ss_pred             cCcCHHHHHHHHHHhc
Confidence            9999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.6e-31  Score=208.24  Aligned_cols=153  Identities=26%  Similarity=0.408  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||+++......... ......+..|+|||.+.+..++.
T Consensus       107 ~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~  183 (261)
T cd05068         107 DMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSI  183 (261)
T ss_pred             HHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCc
Confidence            578999999999995  569999999999999999999999999998654221111 11122345799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |+.||.+....                 .....+........+...+..+.+++.+||+.+|.
T Consensus       184 ~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  246 (261)
T cd05068         184 KSDVWSFGILLTEIVTYGRMPYPGMTNA-----------------EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPD  246 (261)
T ss_pred             hhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcc
Confidence            9999999999999999 99999764311                 11111112222223345567899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|+.
T Consensus       247 ~Rp~~~~l~~~l~~  260 (261)
T cd05068         247 DRPTFETLQWKLED  260 (261)
T ss_pred             cCCCHHHHHHHHhc
Confidence            99999999998874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=217.37  Aligned_cols=152  Identities=24%  Similarity=0.304  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++.....     ......||..|+|||++.+..++.
T Consensus       105 ~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  177 (333)
T cd05600         105 FYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDF  177 (333)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCC
Confidence            468899999999995  4599999999999999999999999999976433     123457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++|..||...+..... .+..+.           ...............+..+.+|+.+||..+|.
T Consensus       178 ~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~  246 (333)
T cd05600         178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-----------ETLQRPVYDDPRFNLSDEAWDLITKLINDPSR  246 (333)
T ss_pred             ccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-----------ccccCCCCCccccccCHHHHHHHHHHhhChhh
Confidence            999999999999999999999765421110 000000           00000000000123567889999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +||++.++++.
T Consensus       247 rr~s~~~ll~h  257 (333)
T cd05600         247 RFGSLEDIKNH  257 (333)
T ss_pred             hcCCHHHHHhC
Confidence            99999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=2.3e-31  Score=216.27  Aligned_cols=151  Identities=28%  Similarity=0.454  Sum_probs=111.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.
T Consensus       100 ~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (329)
T cd05618         100 FYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGF  175 (329)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCC
Confidence            478899999999995  4699999999999999999999999999875322111  123457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|..||..........        ........+.+.. .....+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--------~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~  246 (329)
T cd05618         176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKE  246 (329)
T ss_pred             ccceecccHHHHHHhhCCCCCccCCCcCCcc--------cccHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHHH
Confidence            9999999999999999999996422110000        0000011111111 112344556778899999999999999


Q ss_pred             CCCH
Q 027003          162 RPRM  165 (229)
Q Consensus       162 Rpt~  165 (229)
                      |+++
T Consensus       247 R~~~  250 (329)
T cd05618         247 RLGC  250 (329)
T ss_pred             cCCC
Confidence            9984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=3.1e-31  Score=208.43  Aligned_cols=153  Identities=29%  Similarity=0.483  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.
T Consensus       106 ~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  182 (260)
T cd05070         106 DMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcc
Confidence            578999999999995  46999999999999999999999999999765332211 112234567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |..||.+.+..                 .....+........+...+..+.+|+.+||..+|.
T Consensus       183 ~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  245 (260)
T cd05070         183 KSDVWSFGILLTELVTKGRVPYPGMNNR-----------------EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPE  245 (260)
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcc
Confidence            9999999999999999 89999654311                 11111222222234445667899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +|||+.++.+.|+.
T Consensus       246 ~Rpt~~~l~~~l~~  259 (260)
T cd05070         246 ERPTFEYLQSFLED  259 (260)
T ss_pred             cCcCHHHHHHHHhc
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=1.6e-31  Score=216.27  Aligned_cols=147  Identities=29%  Similarity=0.495  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  .....+|+..|+|||++.+..++.
T Consensus       100 ~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~  175 (318)
T cd05570         100 FYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGP  175 (318)
T ss_pred             HHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCc
Confidence            478899999999995  4699999999999999999999999999875322211  123456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||.+.+...                ....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DiwslGvil~~l~~G~~pf~~~~~~~----------------~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         176 AVDWWALGVLLYEMLAGQSPFEGDDEDE----------------LFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             chhhhhHHHHHHHHhhCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999997643110                01111111  11233445678899999999999999


Q ss_pred             CCCH-----HHHHH
Q 027003          162 RPRM-----SEVLA  170 (229)
Q Consensus       162 Rpt~-----~~v~~  170 (229)
                      ||++     .++++
T Consensus       238 R~s~~~~~~~~ll~  251 (318)
T cd05570         238 RLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCCCCCCHHHHhc
Confidence            9999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=1.9e-31  Score=214.38  Aligned_cols=165  Identities=22%  Similarity=0.316  Sum_probs=111.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......+|..|+|||++.+. .++
T Consensus       107 ~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  182 (303)
T cd07869         107 LFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYS  182 (303)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCC
Confidence            468899999999995  4599999999999999999999999999875432211  12335689999999998654 578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch--hHHH-hhhhhhcchhhHH---HHhhcccCCCCcH---------HHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD-WAKPYLSDKRKLF---RIMDTKLGGQYPQ---------KAAH  145 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~  145 (229)
                      .++|||||||++|+|++|..||.+.......  .... ...+.........   ...........+.         ....
T Consensus       183 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (303)
T cd07869         183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN  262 (303)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCCh
Confidence            8999999999999999999999864321110  0000 0000000000000   0000000000000         1235


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+.+|+.+||+.||.+|||+.++++
T Consensus       263 ~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         263 HAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHHHHHHHhccCchhccCHHHHhc
Confidence            6789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=3.2e-31  Score=215.10  Aligned_cols=146  Identities=30%  Similarity=0.400  Sum_probs=112.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......  .....+||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05604         100 FYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDN  175 (325)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCC
Confidence            478999999999995  4699999999999999999999999999875322221  133457999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||...+..                .....+.....  ......+..+.+++.+||+.||.+
T Consensus       176 ~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         176 TVDWWCLGAVLYEMLYGLPPFYCRDVA----------------EMYDNILHKPL--VLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             cCccccccceehhhhcCCCCCCCCCHH----------------HHHHHHHcCCc--cCCCCCCHHHHHHHHHHhccCHHh
Confidence            999999999999999999999764321                01111111111  122235667889999999999999


Q ss_pred             CCCHHHHH
Q 027003          162 RPRMSEVL  169 (229)
Q Consensus       162 Rpt~~~v~  169 (229)
                      ||++.+.+
T Consensus       238 R~~~~~~~  245 (325)
T cd05604         238 RLGAKEDF  245 (325)
T ss_pred             cCCCCCCH
Confidence            99886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=221.72  Aligned_cols=144  Identities=28%  Similarity=0.373  Sum_probs=118.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee-cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .|+.+|+.|+.|||+  .|+|||||||+|||+ +..++++|+|||.++.....     ....+-|..|.|||++....++
T Consensus       419 ~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt  491 (612)
T KOG0603|consen  419 QWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYT  491 (612)
T ss_pred             HHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCC
Confidence            488999999999996  569999999999999 68999999999999865433     1123458899999999988999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+||||++||+||+|+.||.....+                   .++.............+..+.+|+.+||+.||.
T Consensus       492 ~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~  552 (612)
T KOG0603|consen  492 EACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPA  552 (612)
T ss_pred             cchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHHhhcCCccccccCHHHHHHHHHhccCChh
Confidence            9999999999999999999999775421                   122222223333467789999999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|+++.++...
T Consensus       553 ~Rl~~~~i~~h  563 (612)
T KOG0603|consen  553 LRLGADEIGAH  563 (612)
T ss_pred             hCcChhhhccC
Confidence            99999999863

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=1.5e-31  Score=218.20  Aligned_cols=145  Identities=23%  Similarity=0.308  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.....     .....||+.|+|||++.+..++.
T Consensus       135 ~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  207 (340)
T PTZ00426        135 FYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGK  207 (340)
T ss_pred             HHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCc
Confidence            468999999999995  56999999999999999999999999999865322     22457899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|..||.+.+..                .....+....  ...+...+..+.+++.+||+.||.+
T Consensus       208 ~~DiwSlGvil~ell~G~~Pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~  269 (340)
T PTZ00426        208 AADWWTLGIFIYEILVGCPPFYANEPL----------------LIYQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTK  269 (340)
T ss_pred             cccccchhhHHHHHhcCCCCCCCCCHH----------------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999999999999999764311                0111111111  1234445677899999999999999


Q ss_pred             CC-----CHHHHHHH
Q 027003          162 RP-----RMSEVLAI  171 (229)
Q Consensus       162 Rp-----t~~~v~~~  171 (229)
                      |+     ++.++++.
T Consensus       270 R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        270 RYGNLKKGAQNVKEH  284 (340)
T ss_pred             cCCCCCCCHHHHHcC
Confidence            95     78887753

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=3.4e-31  Score=212.13  Aligned_cols=160  Identities=24%  Similarity=0.384  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+|||++.++.++|+|||+++...............++..|++||...++.++.
T Consensus       134 ~~~~~i~~al~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  211 (296)
T cd05095         134 FMATQIASGMKYLSS--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT  211 (296)
T ss_pred             HHHHHHHHHHHHHHH--CCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc
Confidence            578999999999995  469999999999999999999999999987653332222222334567899999988888999


Q ss_pred             cCceeehhHHHHHHHh--CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|+|||||++|||++  |..||.......  ....        ................+..++..+.+|+.+||+.||
T Consensus       212 ~~DiwSlG~~l~el~~~~~~~p~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  281 (296)
T cd05095         212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQ--VIEN--------TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA  281 (296)
T ss_pred             hhhhhHHHHHHHHHHHhCCCCCccccChHH--HHHH--------HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence            9999999999999998  778886543211  0000        000000000011112223455788999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 027003          160 KLRPRMSEVLAILE  173 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~  173 (229)
                      ++||++.++.+.|+
T Consensus       282 ~~Rp~~~~i~~~l~  295 (296)
T cd05095         282 KERPSFQEIHATLL  295 (296)
T ss_pred             ccCCCHHHHHHHHh
Confidence            99999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=5.2e-31  Score=208.05  Aligned_cols=153  Identities=27%  Similarity=0.437  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-----cEEEcccCCcccCCCCCCcceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      +++.|++.||.|||+  .+++|+||||+||+++.++     .++|+|||++................++..|+|||.+.+
T Consensus       110 ~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  187 (269)
T cd05044         110 DICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD  187 (269)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc
Confidence            478899999999995  5699999999999999877     899999999875433222222223345778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      +.++.++|||||||++|+|++ |..||...+..                 .....+........+...+..+.+++.+||
T Consensus       188 ~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  250 (269)
T cd05044         188 GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----------------EVLQHVTAGGRLQKPENCPDKIYQLMTNCW  250 (269)
T ss_pred             CCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----------------HHHHHHhcCCccCCcccchHHHHHHHHHHc
Confidence            899999999999999999998 99998654311                 011111111222334456778899999999


Q ss_pred             cCCCCCCCCHHHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAILE  173 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~l~  173 (229)
                      ..+|.+||++.++++.|+
T Consensus       251 ~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         251 AQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CCCcccCCCHHHHHHHHh
Confidence            999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=3.5e-31  Score=209.46  Aligned_cols=155  Identities=26%  Similarity=0.405  Sum_probs=118.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||+++...............++..|++||.+.+..++.
T Consensus       117 ~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  194 (273)
T cd05074         117 RFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT  194 (273)
T ss_pred             HHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccch
Confidence            578999999999995  569999999999999999999999999988654332221122334567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||...+..   .              ..+.+........+...+..+.+++.+||+.+|+
T Consensus       195 ~sDi~slG~il~el~~~g~~p~~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~  257 (273)
T cd05074         195 HSDVWAFGVTMWEIMTRGQTPYAGVENS---E--------------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPK  257 (273)
T ss_pred             hhhhHHHHHHHHHHhhCCCCCCCCCCHH---H--------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 88888654321   0              1111111111112233556899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+.+
T Consensus       258 ~Rps~~~~~~~l~~~  272 (273)
T cd05074         258 CRPSFQHLRDQLELI  272 (273)
T ss_pred             hCcCHHHHHHHHHhh
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=4.6e-31  Score=208.11  Aligned_cols=157  Identities=23%  Similarity=0.368  Sum_probs=120.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  .+++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.
T Consensus       110 ~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~  185 (267)
T cd08229         110 KYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccc
Confidence            568899999999995  56999999999999999999999999998765332211  22346889999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||.+........              ...+.............+..+.+++.+||+.||.+
T Consensus       186 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  251 (267)
T cd08229         186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--------------CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK  251 (267)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcccccchHHHH--------------hhhhhcCCCCCCCcccccHHHHHHHHHhcCCCccc
Confidence            9999999999999999999996543211000              00111111111122346778999999999999999


Q ss_pred             CCCHHHHHHHHHhhc
Q 027003          162 RPRMSEVLAILERLE  176 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~  176 (229)
                      |||+.+|++.++++.
T Consensus       252 Rpt~~~i~~~~~~~~  266 (267)
T cd08229         252 RPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCHHHHHHHHhhhc
Confidence            999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=4.8e-31  Score=207.44  Aligned_cols=153  Identities=29%  Similarity=0.465  Sum_probs=118.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.
T Consensus       106 ~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~  182 (260)
T cd05069         106 DMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcCh
Confidence            578899999999995  56999999999999999999999999999765332211 112234567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |..||.+....                 .....+........+...+..+.+++.+||..||+
T Consensus       183 ~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  245 (260)
T cd05069         183 KSDVWSFGILLTELVTKGRVPYPGMVNR-----------------EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPD  245 (260)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcc
Confidence            9999999999999999 89999764311                 01111111222233445677899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|++
T Consensus       246 ~Rp~~~~i~~~l~~  259 (260)
T cd05069         246 ERPTFEYIQSFLED  259 (260)
T ss_pred             cCcCHHHHHHHHhc
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.1e-32  Score=218.69  Aligned_cols=148  Identities=28%  Similarity=0.353  Sum_probs=110.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.++|+|||+++.......  .....+||..|+|||++.+. .++
T Consensus       100 ~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (330)
T cd05586         100 FYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYT  175 (330)
T ss_pred             HHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCC
Confidence            468899999999995  4699999999999999999999999999875322221  12345799999999998765 478


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|..||...+...                ....+....... .....+..+.+|+.+||+.||.
T Consensus       176 ~~~DvwslGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----------------MYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             CccceeccccEEEEeccCCCCCCCCCHHH----------------HHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHH
Confidence            99999999999999999999997643210                011111111111 1123466788999999999999


Q ss_pred             CCCC----HHHHHH
Q 027003          161 LRPR----MSEVLA  170 (229)
Q Consensus       161 ~Rpt----~~~v~~  170 (229)
                      +||+    +.++++
T Consensus       239 ~R~~~~~~~~~ll~  252 (330)
T cd05586         239 HRLGAHRDAVELKE  252 (330)
T ss_pred             HCCCCCCCHHHHhc
Confidence            9984    556554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=2.4e-31  Score=215.04  Aligned_cols=147  Identities=31%  Similarity=0.495  Sum_probs=113.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05619         100 FYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNT  175 (316)
T ss_pred             HHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCc
Confidence            468999999999995  5699999999999999999999999999875322211  123457899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|..||.+.+...                 ..+.+.. .....+...+..+.+|+.+||+.||.+
T Consensus       176 ~~DvwslG~il~el~~G~~pf~~~~~~~-----------------~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         176 SVDWWSFGVLLYEMLIGQSPFHGHDEEE-----------------LFQSIRM-DNPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             hhhhhhHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHh-CCCCCCccCCHHHHHHHHHHhccCHhh
Confidence            9999999999999999999997643210                 0111110 011233345677899999999999999


Q ss_pred             CCCHH-HHHH
Q 027003          162 RPRMS-EVLA  170 (229)
Q Consensus       162 Rpt~~-~v~~  170 (229)
                      |+++. +++.
T Consensus       238 R~~~~~~l~~  247 (316)
T cd05619         238 RLGVKGDIRQ  247 (316)
T ss_pred             cCCChHHHHc
Confidence            99996 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7.4e-32  Score=223.02  Aligned_cols=147  Identities=23%  Similarity=0.427  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +||.||+.||.|||++.++|||||||.+||+|+.+ |.|||+|+|||.......    ....+||+.|||||++. ..|+
T Consensus       147 ~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~Yn  221 (632)
T KOG0584|consen  147 SWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYN  221 (632)
T ss_pred             HHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcc
Confidence            68999999999999999999999999999999765 899999999998753321    23478999999999995 8899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC-CCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ..+||||||++++||+|+..||..-.                ...++.+.+..+..+ .+..-...++.+||.+||.. .
T Consensus       222 E~VDVYaFGMCmLEMvT~eYPYsEC~----------------n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~  284 (632)
T KOG0584|consen  222 ELVDVYAFGMCMLEMVTSEYPYSECT----------------NPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-K  284 (632)
T ss_pred             hhhhhhhhhHHHHHHHhccCChhhhC----------------CHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-c
Confidence            99999999999999999999996532                222222222222211 11112256789999999999 9


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      ..|+|+.|+|+
T Consensus       285 ~~R~sa~eLL~  295 (632)
T KOG0584|consen  285 SERLSAKELLK  295 (632)
T ss_pred             hhccCHHHHhh
Confidence            99999999996

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=1.9e-31  Score=212.11  Aligned_cols=151  Identities=28%  Similarity=0.456  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+||+++.++.++|+|||++.........  .....||..|+|||++.+..++.
T Consensus       101 ~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~  176 (280)
T cd05608         101 FYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDF  176 (280)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCc
Confidence            478999999999995  46999999999999999999999999998765333221  23456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|+.||.........            ......+...  ....+...+..+.+++.+||+.||++
T Consensus       177 ~~DvwslG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~  242 (280)
T cd05608         177 SVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRILND--SVTYPDKFSPASKSFCEALLAKDPEK  242 (280)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCcchhH------------HHHHHhhccc--CCCCcccCCHHHHHHHHHHhcCCHHH
Confidence            999999999999999999999764321100            0000011111  11234456778999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       243 R~~~~~~~~~~~l~  256 (280)
T cd05608         243 RLGFRDGNCDGLRT  256 (280)
T ss_pred             hcCCCCCCHHHHhc
Confidence            99     5566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.9e-31  Score=212.42  Aligned_cols=160  Identities=22%  Similarity=0.364  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++................++..|+|||.+.++.++.
T Consensus       133 ~i~~~i~~al~~lH~--~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  210 (295)
T cd05097         133 YMAVQIASGMKYLAS--LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT  210 (295)
T ss_pred             HHHHHHHHHHHHHHh--cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCc
Confidence            478999999999995  569999999999999999999999999987643332222223344577899999998888999


Q ss_pred             cCceeehhHHHHHHHh--CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|+|||||++|+|++  |..||.......  ......        ..............+...+..+.+|+.+||+.||
T Consensus       211 ~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  280 (295)
T cd05097         211 ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIENTG--------EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDI  280 (295)
T ss_pred             hhhHHHHHHHHHHHHHcCCCCCCcccChHH--HHHHHH--------HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence            9999999999999998  666776543211  000000        0000000001111222345689999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 027003          160 KLRPRMSEVLAILE  173 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~  173 (229)
                      ++||++.++++.|+
T Consensus       281 ~~RPs~~~i~~~l~  294 (295)
T cd05097         281 KDRPTFNKIHHFLR  294 (295)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=2.7e-31  Score=215.65  Aligned_cols=150  Identities=29%  Similarity=0.450  Sum_probs=112.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.......  .....+||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  175 (327)
T cd05617         100 FYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF  175 (327)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCc
Confidence            478999999999995  4699999999999999999999999999875322111  133467999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||..........          ........+.. .....+...+..+.+++.+||+.||.+
T Consensus       176 ~~DiwslGvil~ell~g~~pf~~~~~~~~~~----------~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~  244 (327)
T cd05617         176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMN----------TEDYLFQVILE-KPIRIPRFLSVKASHVLKGFLNKDPKE  244 (327)
T ss_pred             hheeehhHHHHHHHHhCCCCCCccCCCcccc----------cHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            9999999999999999999996532211100          01111111111 112334456677899999999999999


Q ss_pred             CCCHH
Q 027003          162 RPRMS  166 (229)
Q Consensus       162 Rpt~~  166 (229)
                      |+++.
T Consensus       245 R~~~~  249 (327)
T cd05617         245 RLGCQ  249 (327)
T ss_pred             cCCCC
Confidence            99853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=4e-31  Score=209.04  Aligned_cols=152  Identities=29%  Similarity=0.441  Sum_probs=115.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++........   ......+..|+|||++.+..++.
T Consensus       116 ~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~  190 (270)
T cd05047         116 HFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTT  190 (270)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCc
Confidence            578899999999995  5699999999999999999999999999863221110   11122356799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++ |..||.+.+..                 .....+........+......+.+|+.+||..||.
T Consensus       191 ~~Di~slG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  253 (270)
T cd05047         191 NSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY  253 (270)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCccccCHH-----------------HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChh
Confidence            9999999999999997 99999654311                 11111112122222334556788999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.+++..|.++
T Consensus       254 ~Rps~~~il~~l~~~  268 (270)
T cd05047         254 ERPSFAQILVSLNRM  268 (270)
T ss_pred             hCCCHHHHHHHHHHh
Confidence            999999999999775

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=5.5e-31  Score=206.58  Aligned_cols=154  Identities=27%  Similarity=0.427  Sum_probs=117.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-cceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||+++....... ........++..|+|||.+.+..++
T Consensus       101 ~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~  178 (257)
T cd05040         101 DYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS  178 (257)
T ss_pred             HHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcC
Confidence            468899999999995  5699999999999999999999999999986543221 1112234567889999999888899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++ |..||.......                ....+.........+...+..+.+++.+||+.+|
T Consensus       179 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  242 (257)
T cd05040         179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----------------ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNP  242 (257)
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCc
Confidence            99999999999999998 999996543110                0111111111122233456788999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 027003          160 KLRPRMSEVLAILE  173 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~  173 (229)
                      ++||++.++++.|.
T Consensus       243 ~~Rps~~~~~~~l~  256 (257)
T cd05040         243 ADRPTFAALREFLP  256 (257)
T ss_pred             ccCCCHHHHHHHhc
Confidence            99999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=7e-31  Score=206.84  Aligned_cols=154  Identities=29%  Similarity=0.459  Sum_probs=119.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++||||||+||+++.++.++|+|||+++........ ......++..|+|||+..+..++.
T Consensus       106 ~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~  182 (262)
T cd05071         106 DMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTI  182 (262)
T ss_pred             HHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCc
Confidence            578999999999995  56999999999999999999999999999765432211 122234677899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |..||......                 ..................+..+.+++.+||+.||.
T Consensus       183 ~~DvwslG~~l~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  245 (262)
T cd05071         183 KSDVWSFGILLTELTTKGRVPYPGMVNR-----------------EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE  245 (262)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCChH-----------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcc
Confidence            9999999999999999 88888654311                 01111111122233445677889999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+..
T Consensus       246 ~Rp~~~~~~~~l~~~  260 (262)
T cd05071         246 ERPTFEYLQAFLEDY  260 (262)
T ss_pred             cCCCHHHHHHHHHHh
Confidence            999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=4.5e-31  Score=215.70  Aligned_cols=157  Identities=30%  Similarity=0.408  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++................++..|+|||.+.+..++.
T Consensus       183 ~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  260 (343)
T cd05103         183 CYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI  260 (343)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCc
Confidence            478899999999995  569999999999999999999999999987643322211122234567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||......                ......+........+......+.+++.+||+.||.
T Consensus       261 ~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~  324 (343)
T cd05103         261 QSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  324 (343)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCcccc----------------HHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999997 89998654211                011111111111222223456789999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+.+.
T Consensus       325 ~Rps~~eil~~l~~~~  340 (343)
T cd05103         325 QRPTFSELVEHLGNLL  340 (343)
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=3.8e-31  Score=219.66  Aligned_cols=156  Identities=23%  Similarity=0.391  Sum_probs=121.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++++||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       243 ~~~~qi~~aL~~LH~--~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  320 (401)
T cd05107         243 GFSYQVANGMEFLAS--KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT  320 (401)
T ss_pred             HHHHHHHHHHHHHhc--CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence            477899999999995  569999999999999999999999999997643322111122345678899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.....                .......+........+...+..+.+|+.+||+.+|.
T Consensus       321 ~~DvwslGvil~e~l~~g~~P~~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~  384 (401)
T cd05107         321 LSDVWSFGILLWEIFTLGGTPYPELPM----------------NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFE  384 (401)
T ss_pred             HhHHHHHHHHHHHHHHcCCCCCCCCCc----------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 8888865321                1111122222222333445677899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+++
T Consensus       385 ~RPs~~ell~~L~~~  399 (401)
T cd05107         385 IRPDFSQLVHLVGDL  399 (401)
T ss_pred             HCcCHHHHHHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=4e-31  Score=214.85  Aligned_cols=156  Identities=28%  Similarity=0.474  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  ......+||..|+|||++.+..++.
T Consensus       100 ~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  175 (329)
T cd05588         100 FYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGF  175 (329)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCC
Confidence            478899999999995  469999999999999999999999999987422211  1123467999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||..........        ........+.+... ....+...+..+.+++.+||+.||.+
T Consensus       176 ~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~  246 (329)
T cd05588         176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPD--------QNTEDYLFQVILEK-QIRIPRSLSVKASSVLKGFLNKDPKE  246 (329)
T ss_pred             ccceechHHHHHHHHHCCCCccccccccccc--------ccchHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            9999999999999999999997532211000        00000111111111 11234455678899999999999999


Q ss_pred             CCC------HHHHHH
Q 027003          162 RPR------MSEVLA  170 (229)
Q Consensus       162 Rpt------~~~v~~  170 (229)
                      |++      +.++++
T Consensus       247 R~~~~~~~~~~~i~~  261 (329)
T cd05588         247 RLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCCCCCCCCHHHHhc
Confidence            997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=4.5e-31  Score=212.20  Aligned_cols=155  Identities=28%  Similarity=0.426  Sum_probs=117.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++........   .....++..|+|||.+.+..++.
T Consensus       128 ~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  202 (303)
T cd05088         128 HFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTT  202 (303)
T ss_pred             HHHHHHHHHHHHHHh--CCccccccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcc
Confidence            468899999999995  5699999999999999999999999999864221111   11122456799999998888899


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |..||...+..                 ...+.+........+...+..+.+|+.+||+.+|+
T Consensus       203 ~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  265 (303)
T cd05088         203 NSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY  265 (303)
T ss_pred             cccchhhhhHHHHHHhcCCCCcccCChH-----------------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 99999754321                 11111111112222333456789999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.+++..|.++...
T Consensus       266 ~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         266 ERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             hCcCHHHHHHHHHHHHHh
Confidence            999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-31  Score=207.53  Aligned_cols=152  Identities=27%  Similarity=0.383  Sum_probs=117.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcce-eeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||+++.......... .....++..|+|||++.+..++
T Consensus       108 ~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (263)
T cd06625         108 KYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG  185 (263)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCC
Confidence            578999999999995  5699999999999999999999999999875432211110 1234578899999999998899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||......                ...............+......+.+++.+||..+|.
T Consensus       186 ~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  249 (263)
T cd06625         186 RKADVWSVGCTVVEMLTEKPPWAEFEAM----------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAK  249 (263)
T ss_pred             chhhhHHHHHHHHHHHhCCCCccccchH----------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcc
Confidence            9999999999999999999999653211                111122222222344555677889999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|||+.++++.
T Consensus       250 ~Rpt~~~ll~~  260 (263)
T cd06625         250 KRPSAEELLRH  260 (263)
T ss_pred             cCCCHHHHhhC
Confidence            99999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=3.9e-31  Score=218.08  Aligned_cols=151  Identities=25%  Similarity=0.326  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++......... .....+||+.|+|||++.+.    
T Consensus       146 ~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  222 (370)
T cd05596         146 FYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDG  222 (370)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCC
Confidence            367899999999995  46999999999999999999999999998765332211 12345799999999998653    


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcH--HHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ--KAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l  155 (229)
                      .++.++|||||||++|||++|..||.+....                .....+.........+.  ..+..+.+|+.+||
T Consensus       223 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  286 (370)
T cd05596         223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL  286 (370)
T ss_pred             CCCCceeeeehhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHc
Confidence            3788999999999999999999999765421                11122222111112222  35778899999999


Q ss_pred             cCCCCC--CCCHHHHHHH
Q 027003          156 NNEPKL--RPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~--Rpt~~~v~~~  171 (229)
                      +.+|.+  |+++.++++.
T Consensus       287 ~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         287 TDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cChhhccCCCCHHHHhcC
Confidence            999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.7e-31  Score=223.45  Aligned_cols=168  Identities=22%  Similarity=0.271  Sum_probs=114.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .|+.||+.||.|||+  .+||||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.
T Consensus       264 ~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~  341 (461)
T PHA03211        264 AVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTP  341 (461)
T ss_pred             HHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCc
Confidence            588999999999995  469999999999999999999999999998654332222233457999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccc-c----chhHHH---hhhh----hhcc-hhhHHHHhh----cccCC----CCc
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVG-I----EQSLVD---WAKP----YLSD-KRKLFRIMD----TKLGG----QYP  140 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~-~----~~~~~~---~~~~----~~~~-~~~~~~~~~----~~~~~----~~~  140 (229)
                      ++|||||||++|||++|..++...... .    ...+..   ....    +... ...+.....    .....    ...
T Consensus       342 ~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  421 (461)
T PHA03211        342 SVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAW  421 (461)
T ss_pred             hHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcch
Confidence            999999999999999987655332211 0    011111   1000    0000 000000000    00000    000


Q ss_pred             H---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          141 Q---KAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       141 ~---~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .   .....+.+||.+||+.||.+|||+.|+++.
T Consensus       422 ~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        422 TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1   234478899999999999999999999864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=1.3e-30  Score=216.88  Aligned_cols=99  Identities=30%  Similarity=0.366  Sum_probs=86.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC--cEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +|+.||+.||.+||  +.+|||.||||+||||...+  .+||+|||.++.....     ....+.+..|.|||++.|.+|
T Consensus       293 ~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY  365 (586)
T KOG0667|consen  293 KFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPY  365 (586)
T ss_pred             HHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCceeEEecccccccCCc-----ceeeeeccccccchhhccCCC
Confidence            47899999999999  45699999999999996654  5999999999864322     125678999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCcc
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKV  107 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~  107 (229)
                      +.+.||||||||++||++|.+.|.+.+.
T Consensus       366 ~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  366 DTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             CCccceeehhhhHHhHhcCccccCCCCH
Confidence            9999999999999999999999988765

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=4.2e-31  Score=210.72  Aligned_cols=154  Identities=25%  Similarity=0.368  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.
T Consensus       134 ~~~~~i~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  211 (288)
T cd05050         134 CIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT  211 (288)
T ss_pred             HHHHHHHHHHHHHHh--CCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc
Confidence            578999999999995  569999999999999999999999999987543322221122234566799999998889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |..||.+....                 .....+........+...+..+.+|+.+||+.||.
T Consensus       212 ~~Dv~slG~il~el~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  274 (288)
T cd05050         212 ESDVWAYGVVLWEIFSYGMQPYYGMAHE-----------------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPS  274 (288)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            9999999999999997 88888654311                 01111111111122334567899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.|+++.|++
T Consensus       275 ~Rpt~~el~~~l~~  288 (288)
T cd05050         275 DRPSFASINRILQR  288 (288)
T ss_pred             cCCCHHHHHHHhhC
Confidence            99999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=2.8e-31  Score=210.83  Aligned_cols=153  Identities=26%  Similarity=0.379  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.++|+|||++........   .....|+..|+|||++.+..++.
T Consensus        99 ~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  173 (277)
T cd05607          99 HYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY  173 (277)
T ss_pred             HHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCC
Confidence            467899999999995  5699999999999999999999999999876543221   23356899999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|+.||..........            ............ ......+..+.+|+.+||+.||.+
T Consensus       174 ~~DvwslGv~l~el~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE------------ELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             chhHHHHHHHHHHHHhCCCCCCCCcchhhHH------------HHHHHhhccccc-cccccCCHHHHHHHHHHhccCHhh
Confidence            9999999999999999999997643211100            000111111111 111245677899999999999999


Q ss_pred             CCCHHHHHHHH
Q 027003          162 RPRMSEVLAIL  172 (229)
Q Consensus       162 Rpt~~~v~~~l  172 (229)
                      ||++.|+++.+
T Consensus       241 R~~~~~~~~~~  251 (277)
T cd05607         241 RLGSREKNDDP  251 (277)
T ss_pred             CCCCccchhhh
Confidence            99998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=5.7e-31  Score=206.92  Aligned_cols=152  Identities=28%  Similarity=0.472  Sum_probs=119.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  ++|+|+||||+||+++.++.+||+|||++.........  .....++..|++||.+.+..++.
T Consensus       108 ~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~  183 (261)
T cd05148         108 DMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFST  183 (261)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCc
Confidence            578899999999995  56999999999999999999999999998765332211  12334567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |+.||......                 .....+........+..++..+.+++.+||+.||.
T Consensus       184 ~~DiwslG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  246 (261)
T cd05148         184 KSDVWSFGILLYEMFTYGQVPYPGMNNH-----------------EVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPE  246 (261)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCch
Confidence            9999999999999998 89999764311                 11111122222333455677889999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +|||+.++++.|+.
T Consensus       247 ~Rpt~~~l~~~L~~  260 (261)
T cd05148         247 DRPSFKALREELDN  260 (261)
T ss_pred             hCcCHHHHHHHHhc
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=6e-31  Score=209.95  Aligned_cols=156  Identities=25%  Similarity=0.402  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus       123 ~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  200 (288)
T cd05061         123 QMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT  200 (288)
T ss_pred             HHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCCh
Confidence            478899999999995  569999999999999999999999999987543322222222334577899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++ |..||.+....                 ...+.+........+...+..+.+++.+||+.||.
T Consensus       201 ~~DvwslG~~l~el~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  263 (288)
T cd05061         201 SSDMWSFGVVLWEITSLAEQPYQGLSNE-----------------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPK  263 (288)
T ss_pred             HhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 78888654311                 11111111111122333457899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+...
T Consensus       264 ~Rps~~~ll~~l~~~~  279 (288)
T cd05061         264 MRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HCcCHHHHHHHHHhhc
Confidence            9999999999987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.9e-31  Score=215.72  Aligned_cols=164  Identities=23%  Similarity=0.344  Sum_probs=110.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||+  .+||||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++.
T Consensus       161 ~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  235 (357)
T PHA03209        161 IIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNS  235 (357)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCc
Confidence            578999999999995  469999999999999999999999999987532211   123356899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCc-CCCCccccch-------hHHHhhhh-------hh--cchhhHHHHhhcc--cCCCC---
Q 027003           82 KSDVYSFGVVLLELLSGRCA-VDKTKVGIEQ-------SLVDWAKP-------YL--SDKRKLFRIMDTK--LGGQY---  139 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p-~~~~~~~~~~-------~~~~~~~~-------~~--~~~~~~~~~~~~~--~~~~~---  139 (229)
                      ++|||||||++|||+++..+ |.........       .+......       +.  .........+...  .....   
T Consensus       236 ~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (357)
T PHA03209        236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRY  315 (357)
T ss_pred             hhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCccccc
Confidence            99999999999999985544 4432221111       01100000       00  0000000000000  00000   


Q ss_pred             ----cHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          140 ----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       140 ----~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                          ....+..+.+||.+||+.||.+|||+.|+++
T Consensus       316 ~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        316 PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                0122445667999999999999999999986

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.6e-31  Score=205.41  Aligned_cols=153  Identities=29%  Similarity=0.420  Sum_probs=116.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.+++.||+|||+  ++++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.
T Consensus        97 ~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  174 (251)
T cd05041          97 QMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS  174 (251)
T ss_pred             HHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCc
Confidence            467899999999995  569999999999999999999999999987643222111111223456799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |..||.......                 ....+........+...+..+.+++.+||..+|.
T Consensus       175 ~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         175 ESDVWSYGILLWETFSLGDTPYPGMSNQQ-----------------TRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             chhHHHHHHHHHHHHhccCCCCccCCHHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            9999999999999999 888886643211                 1111112222233445667899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.++++.|+
T Consensus       238 ~Rp~~~ell~~l~  250 (251)
T cd05041         238 NRPSFSEIYNELQ  250 (251)
T ss_pred             hCcCHHHHHHHhh
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-31  Score=216.73  Aligned_cols=162  Identities=23%  Similarity=0.318  Sum_probs=112.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.....     .....||..|+|||++.+ ..++
T Consensus       122 ~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~  194 (343)
T cd07878         122 FLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYN  194 (343)
T ss_pred             HHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCC
Confidence            478999999999995  46999999999999999999999999999864332     223568999999999877 4688


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-hhhc-----chhhHHHHhhcccCCCC-------cHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLS-----DKRKLFRIMDTKLGGQY-------PQKAAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~-------~~~~~~~  146 (229)
                      .++|||||||++|+|++|+.||.+.+..... .+..... +...     ......... ..+....       .......
T Consensus       195 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  273 (343)
T cd07878         195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPL  273 (343)
T ss_pred             chhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHH
Confidence            9999999999999999999999765421100 0000000 0000     000000000 0000000       0112345


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+|+.+||+.||.+|||+.++++.
T Consensus       274 ~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         274 AIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcC
Confidence            7899999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.2e-30  Score=207.28  Aligned_cols=157  Identities=22%  Similarity=0.356  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus       113 ~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  190 (279)
T cd05057         113 NWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH  190 (279)
T ss_pred             HHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCc
Confidence            578999999999995  569999999999999999999999999998654322211111122356799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++||+++ |..||.+....                 .....+........+..++..+.+++.+||..||.
T Consensus       191 ~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~  253 (279)
T cd05057         191 KSDVWSYGVTVWELMTFGAKPYEGIPAV-----------------EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAE  253 (279)
T ss_pred             hhhHHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 99999764321                 11111222222223334556788999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|.++..
T Consensus       254 ~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         254 SRPTFKELINEFSKMAR  270 (279)
T ss_pred             hCCCHHHHHHHHHHHHh
Confidence            99999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=4.1e-31  Score=214.82  Aligned_cols=149  Identities=24%  Similarity=0.289  Sum_probs=113.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------   75 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++......... ......||..|+|||++.      
T Consensus       106 ~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  182 (330)
T cd05601         106 FYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDG  182 (330)
T ss_pred             HHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccc
Confidence            367899999999995  46999999999999999999999999999765433222 223457899999999986      


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHH
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQ  153 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  153 (229)
                      +..++.++|||||||++|+|++|+.||......                ....+++...  .........+..+.+|+..
T Consensus       183 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  246 (330)
T cd05601         183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----------------KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQS  246 (330)
T ss_pred             cCCCCCcceeecccceeeeeccCCCCCCCCCHH----------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHH
Confidence            456778999999999999999999999764321                0111111111  1111122356778999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||. +|.+||++.+++.
T Consensus       247 ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         247 LLC-GQKERLGYEGLCC  262 (330)
T ss_pred             Hcc-ChhhCCCHHHHhC
Confidence            998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=1.1e-31  Score=211.08  Aligned_cols=152  Identities=32%  Similarity=0.521  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||+.  +++|+||+++|||++.++.+||+|||++................+...|+|||.+.+..++.
T Consensus       107 ~i~~~i~~~l~~Lh~~--~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  184 (259)
T PF07714_consen  107 SIAIQIAEALSYLHSN--NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTK  184 (259)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESH
T ss_pred             cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            6899999999999964  59999999999999999999999999998763332222233345678899999999888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||+++|||++ |+.||...+.                 ......+........+..++..+.+++.+||+.||+
T Consensus       185 ksDVysfG~~l~ei~~~~~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~  247 (259)
T PF07714_consen  185 KSDVYSFGMLLYEILTLGKFPFSDYDN-----------------EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPE  247 (259)
T ss_dssp             HHHHHHHHHHHHHHHTTSSGTTTTSCH-----------------HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGG
T ss_pred             ccccccccccccccccccccccccccc-----------------ccccccccccccceeccchhHHHHHHHHHHcCCChh
Confidence            9999999999999999 7888865421                 111122222233344555677899999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.++++.|
T Consensus       248 ~RPs~~~i~~~L  259 (259)
T PF07714_consen  248 KRPSFQEILQEL  259 (259)
T ss_dssp             GS--HHHHHHHH
T ss_pred             hCcCHHHHHhcC
Confidence            999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=212.84  Aligned_cols=144  Identities=30%  Similarity=0.465  Sum_probs=117.4

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      .+.+|+-||++||.  .+||+|||||+|||||+.|+++|+|+|+|..+..+...   ...+||.+|||||++.++.|+..
T Consensus       292 YAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s  366 (591)
T KOG0986|consen  292 YAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFS  366 (591)
T ss_pred             HHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCC
Confidence            46799999999995  56999999999999999999999999999987665543   33489999999999999999999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      .|.|||||+||||+.|+.||.........             +.+.+. ......+++...++++.+|++.+|++||.+|
T Consensus       367 ~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdrr-~~~~~~ey~~kFS~eakslc~~LL~Kdp~~R  432 (591)
T KOG0986|consen  367 PDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDRR-TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKR  432 (591)
T ss_pred             ccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHHH-HhcchhhcccccCHHHHHHHHHHHccCHHHh
Confidence            99999999999999999999765432111             011111 1122346778889999999999999999999


Q ss_pred             CCH
Q 027003          163 PRM  165 (229)
Q Consensus       163 pt~  165 (229)
                      ...
T Consensus       433 LGc  435 (591)
T KOG0986|consen  433 LGC  435 (591)
T ss_pred             ccC
Confidence            754

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=4.7e-31  Score=213.94  Aligned_cols=142  Identities=30%  Similarity=0.481  Sum_probs=111.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..++.
T Consensus       105 ~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  180 (323)
T cd05615         105 FYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGK  180 (323)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCC
Confidence            578999999999995  5699999999999999999999999999875322211  123456899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||.+....                .....+....  ...+...+..+.+++.+||+.+|.+
T Consensus       181 ~~DiwslGvil~elltG~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~  242 (323)
T cd05615         181 SVDWWAYGVLLYEMLAGQPPFDGEDED----------------ELFQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSK  242 (323)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhh
Confidence            999999999999999999999764311                1111122111  2334456678899999999999999


Q ss_pred             CCCH
Q 027003          162 RPRM  165 (229)
Q Consensus       162 Rpt~  165 (229)
                      |++.
T Consensus       243 R~~~  246 (323)
T cd05615         243 RLGC  246 (323)
T ss_pred             CCCC
Confidence            9975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=7.1e-31  Score=206.13  Aligned_cols=151  Identities=25%  Similarity=0.410  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  .+++|+||||+||+++.++.+||+|||+++........ ......++..|++||.+.+..++.
T Consensus       104 ~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~  180 (256)
T cd05113         104 EMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccc
Confidence            578999999999995  56999999999999999999999999998754332211 111233567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |..||.......                 ....+........+...+..+.+++.+||+.||.
T Consensus       181 ~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  243 (256)
T cd05113         181 KSDVWAFGVLMWEVYSLGKMPYERFNNSE-----------------TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE  243 (256)
T ss_pred             hhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999998 999987543210                 1111111111222333467889999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.++++.|
T Consensus       244 ~Rp~~~~ll~~~  255 (256)
T cd05113         244 ERPTFQQLLSSI  255 (256)
T ss_pred             cCCCHHHHHHhh
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=2.8e-31  Score=216.12  Aligned_cols=148  Identities=24%  Similarity=0.317  Sum_probs=112.3

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC-------------------Ccce------
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-------------------RTHV------   58 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------~~~~------   58 (229)
                      +.+++.|++.||..  |+|||||||+|+|||..|++||+||||+.......                   ....      
T Consensus       247 iaE~vlAI~~iH~~--gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (550)
T KOG0605|consen  247 IAETVLAIESIHQL--GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTP  324 (550)
T ss_pred             HHHHHHHHHHHHHc--CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccc
Confidence            56788899999965  59999999999999999999999999985322100                   0000      


Q ss_pred             --------------------eeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhh
Q 027003           59 --------------------STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK  118 (229)
Q Consensus        59 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  118 (229)
                                          ....+||+.|+|||++.+..|+..+|.||||||+||||.|-+||.+.+..          
T Consensus       325 ~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~----------  394 (550)
T KOG0605|consen  325 RSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ----------  394 (550)
T ss_pred             cchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------
Confidence                                01368999999999999999999999999999999999999999886532          


Q ss_pred             hhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 027003          119 PYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLA  170 (229)
Q Consensus       119 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~v~~  170 (229)
                            ....+++.-.  +..+....++.++.+||.+||. ||++|..   +.||.+
T Consensus       395 ------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  395 ------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             ------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence                  1222222222  2223333456889999999999 9999985   555553

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=1.1e-30  Score=204.89  Aligned_cols=151  Identities=25%  Similarity=0.426  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.
T Consensus       104 ~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  180 (256)
T cd05114         104 SMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccch
Confidence            578999999999995  56999999999999999999999999998754322111 112233566899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |+.||...+..                 .....+........+...+..+.+++.+||+.+|.
T Consensus       181 ~~Di~s~G~~l~el~~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~  243 (256)
T cd05114         181 KSDVWSFGVLMWEVFTEGKMPFEKKSNY-----------------EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPE  243 (256)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence            9999999999999999 89999764311                 00111111111112233456789999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.++++.|
T Consensus       244 ~Rps~~~l~~~l  255 (256)
T cd05114         244 GRPTFAELLRAI  255 (256)
T ss_pred             cCcCHHHHHHhh
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=7e-31  Score=213.76  Aligned_cols=164  Identities=24%  Similarity=0.387  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......    .....|+..|+|||++.+..++.
T Consensus       107 ~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  181 (333)
T cd06650         107 KVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSV  181 (333)
T ss_pred             HHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCc
Confidence            5788999999999963 359999999999999999999999999987543221    22346899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHh------------------------hhhhhc---chhhHHHHhhcc
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW------------------------AKPYLS---DKRKLFRIMDTK  134 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~------------------------~~~~~~---~~~~~~~~~~~~  134 (229)
                      ++|+|||||++|+|++|+.||..............                        ..+...   ........+...
T Consensus       182 ~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (333)
T cd06650         182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE  261 (333)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC
Confidence            99999999999999999999976432111100000                        000000   000001111111


Q ss_pred             cCCCC-cHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          135 LGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       135 ~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ..... ....+.++.+|+.+||+.||++|||+.|++.
T Consensus       262 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         262 PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence            11111 1124567899999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=2e-30  Score=204.29  Aligned_cols=156  Identities=24%  Similarity=0.404  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.+++.||.|||+  .+|+||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.
T Consensus       110 ~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~  185 (267)
T cd08224         110 KYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCc
Confidence            578999999999995  56999999999999999999999999998764332211  22346788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcH-HHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||........               ..............+. ..+..+.+++.+||..+|+
T Consensus       186 ~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~  250 (267)
T cd08224         186 KSDIWSLGCLLYEMAALQSPFYGDKMNLY---------------SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPE  250 (267)
T ss_pred             hhcHHHHHHHHHHHHHCCCCcccCCccHH---------------HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcc
Confidence            99999999999999999999865432100               0111111111122222 5567889999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       251 ~Rp~~~~il~~~~~~~  266 (267)
T cd08224         251 KRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCHHHHHHHHHHhc
Confidence            9999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.2e-30  Score=222.69  Aligned_cols=167  Identities=23%  Similarity=0.322  Sum_probs=114.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||+  ++||||||||+|||++.++.+||+|||+++........ .....+||..|+|||++.+..++.
T Consensus       271 ~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  347 (501)
T PHA03210        271 AIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCE  347 (501)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCc
Confidence            478999999999995  46999999999999999999999999999865432221 123457999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCc-CCCCccccchhHHHhhh-------hhhcchhhHHHHhhcccCC----CCcH-----HHH
Q 027003           82 KSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAK-------PYLSDKRKLFRIMDTKLGG----QYPQ-----KAA  144 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p-~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~~~-----~~~  144 (229)
                      ++|||||||++|||++|..+ |..........+.....       .+......+...+......    ..+.     ...
T Consensus       348 ~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  427 (501)
T PHA03210        348 ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLP  427 (501)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCC
Confidence            99999999999999998754 43322211111111110       0111111112221111000    0000     123


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..+.+++.+||+.||.+|||+.|++..
T Consensus       428 ~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        428 ADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             hHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            456788999999999999999999863

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=1.6e-30  Score=203.68  Aligned_cols=148  Identities=30%  Similarity=0.447  Sum_probs=116.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++........  .....|+..|+|||++.+..++.
T Consensus       105 ~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  180 (256)
T cd08529         105 RFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNE  180 (256)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCC
Confidence            578899999999994  57999999999999999999999999998865433221  23346888999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||......                .....+ ........+......+.+++.+||+.+|++
T Consensus       181 ~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  243 (256)
T cd08529         181 KSDVWALGVVLYECCTGKHPFDANNQG----------------ALILKI-IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQ  243 (256)
T ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH-HcCCCCCCccccCHHHHHHHHHHccCCccc
Confidence            999999999999999999999764310                011111 111222333356678999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       244 Rp~~~~ll~  252 (256)
T cd08529         244 RPDTFQLLR  252 (256)
T ss_pred             CcCHHHHhh
Confidence            999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.1e-30  Score=215.23  Aligned_cols=151  Identities=25%  Similarity=0.329  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++......... .....+||+.|+|||++.+..   
T Consensus       146 ~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~  222 (370)
T cd05621         146 FYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDG  222 (370)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCC
Confidence            468899999999995  46999999999999999999999999999865332211 123457999999999997543   


Q ss_pred             -CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHHhc
Q 027003           79 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCL  155 (229)
Q Consensus        79 -~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l  155 (229)
                       ++.++|+|||||++|+|++|+.||.+.+.                .....++.........+  ...+..+.+++..||
T Consensus       223 ~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----------------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L  286 (370)
T cd05621         223 YYGRECDWWSVGVFLFEMLVGDTPFYADSL----------------VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL  286 (370)
T ss_pred             CCCcccCEEeehHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHc
Confidence             77899999999999999999999976432                11112222222111222  245778889999999


Q ss_pred             cCCCCC--CCCHHHHHHH
Q 027003          156 NNEPKL--RPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~--Rpt~~~v~~~  171 (229)
                      ..++.+  |+++.++++.
T Consensus       287 ~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         287 TDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCchhccCCCCHHHHhcC
Confidence            855543  8899999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=8.8e-31  Score=205.49  Aligned_cols=151  Identities=26%  Similarity=0.419  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.
T Consensus       104 ~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~  180 (256)
T cd05059         104 DMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCc
Confidence            578999999999995  46999999999999999999999999998764322111 111122345799999998889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |..||......                 .....+........+...+..+.+++.+||..+|+
T Consensus       181 ~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  243 (256)
T cd05059         181 KSDVWSFGVLMWEVFSEGKMPYERFSNS-----------------EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPE  243 (256)
T ss_pred             hhhHHHHHHHHHHHhccCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChh
Confidence            9999999999999999 89998754311                 01111112222233344677899999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.++++.|
T Consensus       244 ~Rpt~~~~l~~l  255 (256)
T cd05059         244 DRPAFKKLLSQL  255 (256)
T ss_pred             hCcCHHHHHHHh
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.6e-30  Score=204.39  Aligned_cols=153  Identities=27%  Similarity=0.453  Sum_probs=118.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.
T Consensus       106 ~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~  182 (260)
T cd05067         106 DMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCc
Confidence            478899999999995  4699999999999999999999999999876542211 1122334567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||+++|||++ |+.||.+.+..                 .....+........+...+..+.+++.+||+.+|+
T Consensus       183 ~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  245 (260)
T cd05067         183 KSDVWSFGILLTEIVTYGRIPYPGMTNP-----------------EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPE  245 (260)
T ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCChH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999999 99999764311                 11111222222233344567899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.+++..|+.
T Consensus       246 ~Rp~~~~l~~~l~~  259 (260)
T cd05067         246 ERPTFEYLRSVLED  259 (260)
T ss_pred             hCCCHHHHHHHhhc
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=208.23  Aligned_cols=150  Identities=31%  Similarity=0.487  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++........   .....|+..|+|||++.+..++.
T Consensus       106 ~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  180 (285)
T cd05605         106 FYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTF  180 (285)
T ss_pred             HHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCc
Confidence            468999999999995  4699999999999999999999999999876533221   22346899999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.......             ......+. ......+...+..+.+|+.+||+.||.+
T Consensus       181 ~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~  246 (285)
T cd05605         181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGF  246 (285)
T ss_pred             cccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHHhh-hcccccCcccCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999864321100             00111111 1122334456778899999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       247 R~~~~~~~~~~l~~  260 (285)
T cd05605         247 RLGCRGEGAEEVKA  260 (285)
T ss_pred             hcCCCCCCHHHHhc
Confidence            99     7777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.8e-30  Score=206.82  Aligned_cols=168  Identities=26%  Similarity=0.393  Sum_probs=119.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|++.||+|||+  ++++||||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++
T Consensus       113 ~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~  190 (284)
T cd05079         113 KYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY  190 (284)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCC
Confidence            578999999999995  56999999999999999999999999999865432211 112234567789999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc--chhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS--DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|||||||++|||++++.++.......    .....+...  ......+.+........+..++..+.+|+.+||+.|
T Consensus       191 ~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  266 (284)
T cd05079         191 IASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ  266 (284)
T ss_pred             ccccchhhhhhhhhhhcCCCCCccccchh----hhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence            99999999999999999876543211100    000000000  001111222222222334456778999999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 027003          159 PKLRPRMSEVLAILERL  175 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~  175 (229)
                      |++||++.++++.|+.+
T Consensus       267 p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         267 PSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccCcCHHHHHHHHHhh
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=8.9e-31  Score=207.01  Aligned_cols=149  Identities=26%  Similarity=0.364  Sum_probs=112.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.|++.||+|||+  .+|+|+||||+||+++.++.++|+|||++........  ......|+..|+|||++.+     
T Consensus       115 ~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~  190 (272)
T cd06637         115 YICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPD  190 (272)
T ss_pred             HHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcC
Confidence            478899999999995  4699999999999999999999999999876432211  1234568999999999863     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ..++.++|+|||||++|||++|..||.......                ..................+..+.+|+.+||.
T Consensus       191 ~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (272)
T cd06637         191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----------------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLV  254 (272)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----------------HHHHHhcCCCCCCCCCCcCHHHHHHHHHHcC
Confidence            357889999999999999999999996532110                0001111111111223355678999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       255 ~~p~~Rpt~~~il~  268 (272)
T cd06637         255 KNHSQRPTTEQLMK  268 (272)
T ss_pred             CChhhCCCHHHHhh
Confidence            99999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=1.5e-30  Score=210.13  Aligned_cols=103  Identities=25%  Similarity=0.377  Sum_probs=84.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee----cCCCcEEEcccCCcccCCCCCCc-ceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~   76 (229)
                      +++.||+.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++........ .......+|..|+|||++.+
T Consensus       112 ~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07867         112 SLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             HHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC
Confidence            578899999999995  469999999999999    56678999999999865432211 11234568999999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           77 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        77 ~-~~~~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                      . .++.++|||||||++|||+||+.||....
T Consensus       190 ~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         190 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            4 57899999999999999999999997644

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=8.9e-31  Score=216.20  Aligned_cols=167  Identities=25%  Similarity=0.344  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+. .++
T Consensus       107 ~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  183 (372)
T cd07853         107 VFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYT  183 (372)
T ss_pred             HHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCC
Confidence            468999999999995  46999999999999999999999999999764332211 12334678999999998774 478


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhcch----hhHHHHhhc-ccCC-------CCcHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDK----RKLFRIMDT-KLGG-------QYPQKAAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~~~----~~~~~~~~~-~~~~-------~~~~~~~~~  146 (229)
                      .++|||||||++|||++|+.||.+.+...... +.... .+.....    ......+.. ....       ......+..
T Consensus       184 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (372)
T cd07853         184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHE  263 (372)
T ss_pred             cHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHH
Confidence            89999999999999999999998754321111 10000 0000000    000011100 0000       011223567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+|+.+||+.||.+|||+.++++.
T Consensus       264 ~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         264 AVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCChhhCcCHHHHhcC
Confidence            8899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-30  Score=212.36  Aligned_cols=151  Identities=23%  Similarity=0.248  Sum_probs=109.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------------------   56 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------------------   56 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++........                         
T Consensus       105 ~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (377)
T cd05629         105 FYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD  182 (377)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccc
Confidence            368899999999995  46999999999999999999999999998632110000                         


Q ss_pred             --------------------ceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHh
Q 027003           57 --------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW  116 (229)
Q Consensus        57 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~  116 (229)
                                          ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....       
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------  255 (377)
T cd05629         183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE-------  255 (377)
T ss_pred             cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH-------
Confidence                                00012469999999999998899999999999999999999999997643210       


Q ss_pred             hhhhhcchhhHHHHhh--cccCCCCcHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 027003          117 AKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLR---PRMSEVLAI  171 (229)
Q Consensus       117 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~R---pt~~~v~~~  171 (229)
                               ....+..  ...........+..+.+|+.+||. +|.+|   +++.+++..
T Consensus       256 ---------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         256 ---------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             ---------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence                     0111111  011111112346778899999997 77765   589888864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3.2e-30  Score=202.75  Aligned_cols=153  Identities=27%  Similarity=0.501  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.
T Consensus       106 ~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~  182 (260)
T cd05073         106 DFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCc
Confidence            478899999999995  5699999999999999999999999999876533221 1122234567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|++++ |..||...+..                 .....+........+...+..+.+++.+||+.+|+
T Consensus       183 ~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  245 (260)
T cd05073         183 KSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE  245 (260)
T ss_pred             cccchHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcc
Confidence            9999999999999999 99999764311                 01111112222223344567899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|+.
T Consensus       246 ~Rp~~~~l~~~L~~  259 (260)
T cd05073         246 ERPTFEYIQSVLDD  259 (260)
T ss_pred             cCcCHHHHHHHHhc
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=2.2e-30  Score=204.43  Aligned_cols=155  Identities=27%  Similarity=0.481  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCccee-eccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++............ .....+..|+|||++.+..++
T Consensus       111 ~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  188 (268)
T cd05063         111 GMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT  188 (268)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence            578999999999995  56999999999999999999999999998765432221111 112234579999999888899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|+|||||++|||++ |..||.....                 ....+.+........+...+..+.+++.+||+.+|
T Consensus       189 ~~~Dv~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p  251 (268)
T cd05063         189 SASDVWSFGIVMWEVMSFGERPYWDMSN-----------------HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDR  251 (268)
T ss_pred             hHhHHHHHHHHHHHHHhCCCCCCCcCCH-----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence            99999999999999997 9999965331                 11111122222223333456788999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 027003          160 KLRPRMSEVLAILERL  175 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~  175 (229)
                      ++||++.++++.|+++
T Consensus       252 ~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         252 ARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ccCcCHHHHHHHHHhh
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=1.2e-30  Score=204.53  Aligned_cols=149  Identities=24%  Similarity=0.346  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++........  ......|+..|+|||++.+..++.
T Consensus       104 ~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  179 (255)
T cd08219         104 QWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNN  179 (255)
T ss_pred             HHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCc
Confidence            578999999999995  5699999999999999999999999999876533221  123456889999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||...+..                 .....+........+...+..+.+|+.+||+.||++
T Consensus       180 ~~Dv~slG~i~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  242 (255)
T cd08219         180 KSDIWSLGCILYELCTLKHPFQANSWK-----------------NLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRS  242 (255)
T ss_pred             hhhhhhhchhheehhhccCCCCCCCHH-----------------HHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCccc
Confidence            999999999999999999999764311                 001111111122234455677899999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.+++..
T Consensus       243 Rp~~~~il~~  252 (255)
T cd08219         243 RPSATTILSR  252 (255)
T ss_pred             CCCHHHHhhc
Confidence            9999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=233.54  Aligned_cols=151  Identities=27%  Similarity=0.403  Sum_probs=121.1

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCC--
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGR--   78 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--   78 (229)
                      +..|++.|+.|||.+  |||||||||.||+|+.+|.+|++|||.|.........  .......||+.|||||++.+..  
T Consensus      1339 yt~qll~gla~LH~~--gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~k 1416 (1509)
T KOG4645|consen 1339 YTKQLLEGLAYLHEH--GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGK 1416 (1509)
T ss_pred             HHHHHHHHHHHHHhc--CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccC
Confidence            357999999999965  5999999999999999999999999999876443211  1122468999999999997643  


Q ss_pred             -CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           79 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 -~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                       ...++|||||||++.||+||+.||...+.               +.... -.+..+..++.|..++.+..+|+.+||+.
T Consensus      1417 G~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------------e~aIM-y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~ 1480 (1509)
T KOG4645|consen 1417 GHGGAADIWSLGCVVLEMATGKRPWAELDN---------------EWAIM-YHVAAGHKPQIPERLSSEGRDFLEHCLEQ 1480 (1509)
T ss_pred             CCCcchhhhcccceEEEeecCCCchhhccc---------------hhHHH-hHHhccCCCCCchhhhHhHHHHHHHHHhc
Confidence             45689999999999999999999976431               22222 22334555677888999999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027003          158 EPKLRPRMSEVLAI  171 (229)
Q Consensus       158 dP~~Rpt~~~v~~~  171 (229)
                      ||.+|.++.|+++.
T Consensus      1481 dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1481 DPKMRWTASQLLEH 1494 (1509)
T ss_pred             CchhhhHHHHHHHh
Confidence            99999999888864

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=2.2e-30  Score=203.02  Aligned_cols=148  Identities=23%  Similarity=0.410  Sum_probs=116.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.+++.||+|||+  ++++||||||+||+++.++.++|+|||++........  ......++..|+|||++.+..++.
T Consensus       106 ~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  181 (257)
T cd08223         106 EWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNY  181 (257)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCc
Confidence            578999999999995  5699999999999999999999999999876533221  223456889999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||...+..                .....+. .......+...+..+.+++.+||+.||.+
T Consensus       182 ~~Dv~slG~il~~l~~g~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~  244 (257)
T cd08223         182 KSDVWALGCCVYEMATLKHAFNAKDMN----------------SLVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEK  244 (257)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHH-hcCCCCCccccCHHHHHHHHHHhccCccc
Confidence            999999999999999999999754311                0011111 11112334456778999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       245 Rp~~~~~l~  253 (257)
T cd08223         245 RPSVKSILR  253 (257)
T ss_pred             CCCHHHHhc
Confidence            999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=2e-30  Score=203.19  Aligned_cols=148  Identities=30%  Similarity=0.509  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.......     .....+..|+|||.+.+..++.
T Consensus       104 ~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~  176 (254)
T cd05083         104 QFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSS  176 (254)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCc
Confidence            478899999999995  569999999999999999999999999987543211     1223456799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |+.||.......                 .............+...+..+.+++.+||+.+|+
T Consensus       177 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (254)
T cd05083         177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPK  239 (254)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 999997643211                 1111122222233345567889999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.++++.|+
T Consensus       240 ~Rp~~~~l~~~l~  252 (254)
T cd05083         240 KRPSFHKLREKLE  252 (254)
T ss_pred             hCcCHHHHHHHHc
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=2.3e-30  Score=214.39  Aligned_cols=151  Identities=25%  Similarity=0.290  Sum_probs=110.2

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC---------------------------
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR---------------------------   55 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---------------------------   55 (229)
                      ++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......                           
T Consensus       106 ~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (381)
T cd05626         106 YIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC  183 (381)
T ss_pred             HHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccccccccc
Confidence            57899999999995  5699999999999999999999999999753211000                           


Q ss_pred             ------------------cceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhh
Q 027003           56 ------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA  117 (229)
Q Consensus        56 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  117 (229)
                                        .......+||..|+|||++.+..++.++|||||||++|||++|..||...+...        
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------  255 (381)
T cd05626         184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE--------  255 (381)
T ss_pred             ccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH--------
Confidence                              000123579999999999988889999999999999999999999997643211        


Q ss_pred             hhhhcchhhHHHHhh--cccCCCCcHHHHHHHHHHHHHh--ccCCCCCCCCHHHHHHH
Q 027003          118 KPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQC--LNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       118 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~--l~~dP~~Rpt~~~v~~~  171 (229)
                              ....+..  ...........+..+.+|+.+|  +..++..|+++.+++..
T Consensus       256 --------~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         256 --------TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             --------HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                    1111111  1111112223567788899884  45566669999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=4e-30  Score=203.20  Aligned_cols=156  Identities=25%  Similarity=0.354  Sum_probs=119.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.
T Consensus       111 ~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~  187 (270)
T cd05056         111 LYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTS  187 (270)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCc
Confidence            468899999999995  569999999999999999999999999987654332111 11223456899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++||+++ |..||.......                .. ..+........+..++..+.+++.+||..+|+
T Consensus       188 ~~Di~slG~il~el~~~g~~pf~~~~~~~----------------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  250 (270)
T cd05056         188 ASDVWMFGVCMWEILMLGVKPFQGVKNND----------------VI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPS  250 (270)
T ss_pred             hhhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999986 999997653210                00 11111112223345567899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+.+..
T Consensus       251 ~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         251 KRPRFTELKAQLSDILQ  267 (270)
T ss_pred             hCcCHHHHHHHHHHHHh
Confidence            99999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-30  Score=192.70  Aligned_cols=147  Identities=28%  Similarity=0.400  Sum_probs=123.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .+..|+|.||.|+|  .++||||||||+|+|++.+|..||+|||-+.....+.    ....+||..|.+||+..+...+.
T Consensus       128 ~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~  201 (281)
T KOG0580|consen  128 TYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDK  201 (281)
T ss_pred             HHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccc
Confidence            35789999999999  5679999999999999999999999999988754332    34678999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      .+|+|++|++.||++.|..||....                ..+...++.....  .+|..++..+.+||.+||..+|.+
T Consensus       202 ~Vd~w~lgvl~yeflvg~ppFes~~----------------~~etYkrI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~  263 (281)
T KOG0580|consen  202 FVDLWSLGVLCYEFLVGLPPFESQS----------------HSETYKRIRKVDL--KFPSTISGGAADLISRLLVKNPIE  263 (281)
T ss_pred             hhhHHHHHHHHHHHHhcCCchhhhh----------------hHHHHHHHHHccc--cCCcccChhHHHHHHHHhccCccc
Confidence            9999999999999999999997643                1223333333222  455778899999999999999999


Q ss_pred             CCCHHHHHHHH
Q 027003          162 RPRMSEVLAIL  172 (229)
Q Consensus       162 Rpt~~~v~~~l  172 (229)
                      |.+..|+++.-
T Consensus       264 r~~l~~v~~hp  274 (281)
T KOG0580|consen  264 RLALTEVMDHP  274 (281)
T ss_pred             cccHHHHhhhH
Confidence            99999998753

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-30  Score=213.92  Aligned_cols=150  Identities=27%  Similarity=0.307  Sum_probs=111.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------------------------   57 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------------------------   57 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.++|+|||++..........                        
T Consensus       105 ~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (364)
T cd05599         105 FYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK  182 (364)
T ss_pred             HHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccccc
Confidence            478899999999995  469999999999999999999999999987542211000                        


Q ss_pred             ------------eeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchh
Q 027003           58 ------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  125 (229)
Q Consensus        58 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  125 (229)
                                  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+...                
T Consensus       183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~----------------  246 (364)
T cd05599         183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE----------------  246 (364)
T ss_pred             ccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH----------------
Confidence                        0112469999999999998899999999999999999999999997653210                


Q ss_pred             hHHHHhhcc--cCCCCcHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 027003          126 KLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLA  170 (229)
Q Consensus       126 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~v~~  170 (229)
                      ....++...  .........+..+.+|+.+||. +|.+|++   +.++++
T Consensus       247 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         247 TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            111111111  1111111346678899999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=2.2e-30  Score=206.09  Aligned_cols=171  Identities=26%  Similarity=0.343  Sum_probs=119.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++
T Consensus       112 ~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  189 (284)
T cd05081         112 LYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFS  189 (284)
T ss_pred             HHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcC
Confidence            578999999999995  569999999999999999999999999998654322211 11112234569999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||++|..++.............. .........+...+........+..++..+.+|+.+||..+|+
T Consensus       190 ~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  268 (284)
T cd05081         190 VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPS  268 (284)
T ss_pred             hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChh
Confidence            999999999999999998776543321100000000 0000000111222222222233345567899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +|||+.++++.|+.+
T Consensus       269 ~Rpt~~ei~~~l~~~  283 (284)
T cd05081         269 QRPSFSELALQVEAI  283 (284)
T ss_pred             hCCCHHHHHHHHHhc
Confidence            999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=3.3e-30  Score=201.39  Aligned_cols=152  Identities=29%  Similarity=0.445  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.
T Consensus        97 ~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  173 (250)
T cd05085          97 KFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSS  173 (250)
T ss_pred             HHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCc
Confidence            578899999999995  5699999999999999999999999999875432211 1111223466799999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||+++|++++ |..||.......                 ....+........+...+..+.+++.+||..+|+
T Consensus       174 ~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         174 ESDVWSYGILLWETFSLGVCPYPGMTNQQ-----------------AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             hhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            9999999999999998 999997543210                 0111111222233344567899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.++++.|.
T Consensus       237 ~Rp~~~~l~~~l~  249 (250)
T cd05085         237 NRPKFSELQKELA  249 (250)
T ss_pred             cCCCHHHHHHHhc
Confidence            9999999998774

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=4.7e-30  Score=202.74  Aligned_cols=155  Identities=25%  Similarity=0.453  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccc---cccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM---GTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~   78 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++................   .+..|++||.+.+..
T Consensus       110 ~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  187 (269)
T cd05065         110 GMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK  187 (269)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc
Confidence            578899999999995  569999999999999999999999999987543322111111111   245799999998889


Q ss_pred             CcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|||||||++|||++ |..||......                 .....+........+..++..+.+++.+||+.
T Consensus       188 ~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~  250 (269)
T cd05065         188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------------DVINAIEQDYRLPPPMDCPTALHQLMLDCWQK  250 (269)
T ss_pred             ccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCC
Confidence            9999999999999999886 99998664311                 01111111112222334566788999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 027003          158 EPKLRPRMSEVLAILERL  175 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~  175 (229)
                      +|.+||++.+++..|+++
T Consensus       251 ~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         251 DRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ChhhCcCHHHHHHHHHhh
Confidence            999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.2e-30  Score=202.22  Aligned_cols=149  Identities=27%  Similarity=0.479  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++.......     ....+..|+|||.+.++.++.
T Consensus       106 ~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~  178 (256)
T cd05039         106 GFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFST  178 (256)
T ss_pred             HHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCc
Confidence            578999999999995  5699999999999999999999999999986522211     223466899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++ |..||......                 .....+........+...+..+.+++.+||..+|.
T Consensus       179 ~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  241 (256)
T cd05039         179 KSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPA  241 (256)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChh
Confidence            9999999999999997 99998654311                 11111111222223344567889999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|+.
T Consensus       242 ~Rp~~~~l~~~l~~  255 (256)
T cd05039         242 KRPTFKQLREQLAL  255 (256)
T ss_pred             hCcCHHHHHHHHhc
Confidence            99999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=2e-30  Score=207.74  Aligned_cols=150  Identities=27%  Similarity=0.377  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.
T Consensus       120 ~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  195 (296)
T cd06654         120 AVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP  195 (296)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCc
Confidence            578899999999995  56999999999999999999999999998754332211  22346889999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||.......  ....             ...........+......+.+++.+||..||++
T Consensus       196 ~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  260 (296)
T cd06654         196 KVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL-------------IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK  260 (296)
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH-------------HhcCCCCCCCCccccCHHHHHHHHHHCcCCccc
Confidence            9999999999999999999997643210  0000             000000111223445677889999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       261 Rpt~~eil~  269 (296)
T cd06654         261 RGSAKELLQ  269 (296)
T ss_pred             CcCHHHHhh
Confidence            999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=2.3e-30  Score=205.70  Aligned_cols=170  Identities=27%  Similarity=0.369  Sum_probs=122.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|++.||+|||+  ++++|+||||+||+++.++.++|+|||++......... .......++..|++||.+.+..++
T Consensus       113 ~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~  190 (284)
T cd05038         113 LFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS  190 (284)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCC
Confidence            578999999999995  56999999999999999999999999999875432211 111122345679999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|||++|..||.............  .............+........+..++..+.+|+.+||+.+|.
T Consensus       191 ~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  268 (284)
T cd05038         191 SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQ  268 (284)
T ss_pred             cccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChh
Confidence            99999999999999999999886533211100000  0000011122222333333333445567899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++.++++.|+.+
T Consensus       269 ~Rpt~~ei~~~l~~i  283 (284)
T cd05038         269 DRPSFADLILIVDRL  283 (284)
T ss_pred             hCCCHHHHHHHHhhc
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=1.8e-30  Score=206.93  Aligned_cols=150  Identities=33%  Similarity=0.504  Sum_probs=114.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++........   .....|+..|+|||++.+..++.
T Consensus       106 ~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~  180 (285)
T cd05630         106 FYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF  180 (285)
T ss_pred             HHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCC
Confidence            468899999999995  5699999999999999999999999999876433221   12346899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||..........             ....... ......+......+.+|+.+||+.||.+
T Consensus       181 ~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~  246 (285)
T cd05630         181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------------EVERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKE  246 (285)
T ss_pred             ccccHHHHHHHHHHHhCCCCCCCCCccchHH-------------HHHhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999997643211100             0000000 0111223345667899999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      |||     +.++++
T Consensus       247 R~s~~~~~~~~~~~  260 (285)
T cd05630         247 RLGCQGGGAREVKE  260 (285)
T ss_pred             ccCCCCCchHHHHc
Confidence            999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=3.8e-30  Score=212.25  Aligned_cols=152  Identities=25%  Similarity=0.294  Sum_probs=112.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++........ .....+||+.|+|||++.+..   
T Consensus       146 ~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~  222 (371)
T cd05622         146 FYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG  222 (371)
T ss_pred             HHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCc
Confidence            367899999999995  56999999999999999999999999999865332211 123457999999999997543   


Q ss_pred             -CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhc
Q 027003           79 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 -~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  155 (229)
                       ++.++|||||||++|||++|..||...+..                ....+++...  .........+..+.+|+..||
T Consensus       223 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  286 (371)
T cd05622         223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL  286 (371)
T ss_pred             cCCCccceeehhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHc
Confidence             788999999999999999999999765421                1111222211  111222346778899999999


Q ss_pred             cCCCCC--CCCHHHHHHHH
Q 027003          156 NNEPKL--RPRMSEVLAIL  172 (229)
Q Consensus       156 ~~dP~~--Rpt~~~v~~~l  172 (229)
                      ..++.+  |+++.++++..
T Consensus       287 ~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         287 TDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CChhhhcCCCCHHHHhcCc
Confidence            844433  67898888743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=2.8e-30  Score=213.92  Aligned_cols=150  Identities=26%  Similarity=0.319  Sum_probs=109.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC---------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---------------------------   54 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------------------   54 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++.......                           
T Consensus       105 ~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (382)
T cd05625         105 FYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN  182 (382)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccccc
Confidence            367899999999995  469999999999999999999999999975321000                           


Q ss_pred             ------------------CcceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHh
Q 027003           55 ------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW  116 (229)
Q Consensus        55 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~  116 (229)
                                        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..        
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------  254 (382)
T cd05625         183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL--------  254 (382)
T ss_pred             ccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH--------
Confidence                              000012357999999999999999999999999999999999999999765321        


Q ss_pred             hhhhhcchhhHHHHhh--cccCCCCcHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 027003          117 AKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLA  170 (229)
Q Consensus       117 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~v~~  170 (229)
                              .....+..  ...........+..+.+++.+|+ .+|.+|++   +.+++.
T Consensus       255 --------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         255 --------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             --------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence                    11111111  11111122345677888888876 59999997   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=212.23  Aligned_cols=145  Identities=30%  Similarity=0.438  Sum_probs=118.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc---CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~   78 (229)
                      .|+.+.+.||+|||+++  .||||||..||||++.|.|||+|||.+......      .+++||+.|||||++..   +.
T Consensus       130 Ai~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGq  201 (948)
T KOG0577|consen  130 AITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQ  201 (948)
T ss_pred             HHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCch------hcccCCccccchhHheeccccc
Confidence            37899999999999876  999999999999999999999999998765332      35789999999999854   67


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      |+.++||||||++..||...++|+...+.                ...+..+-.+....-..+..+..+..|+..||++-
T Consensus       202 YdgkvDvWSLGITCIELAERkPPlFnMNA----------------MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKi  265 (948)
T KOG0577|consen  202 YDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI  265 (948)
T ss_pred             cCCccceeeccchhhhhhhcCCCccCchH----------------HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhC
Confidence            99999999999999999999999765431                22223333332222335678899999999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+|||..+++.
T Consensus       266 pqeRptse~ll~  277 (948)
T KOG0577|consen  266 PQERPTSEELLK  277 (948)
T ss_pred             cccCCcHHHHhh
Confidence            999999998874

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=2e-30  Score=209.01  Aligned_cols=165  Identities=24%  Similarity=0.341  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.......  ......++..|+|||++.+ ..++
T Consensus       108 ~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  183 (309)
T cd07872         108 IFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYS  183 (309)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCC
Confidence            467899999999995  5699999999999999999999999999875432221  1223467899999998865 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHH-Hh-hhhh------hcchhhHHHHhhcccCC----CCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPY------LSDKRKLFRIMDTKLGG----QYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~-~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|+.||.+.+........ .. ..+.      .................    ......+..+.
T Consensus       184 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T cd07872         184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGI  263 (309)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHH
Confidence            8999999999999999999999776532211111 00 0000      00000000000000000    01123456788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.|+++
T Consensus       264 ~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         264 ELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHHHHhccCChhhCCCHHHHhc
Confidence            9999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=3e-30  Score=212.42  Aligned_cols=152  Identities=25%  Similarity=0.321  Sum_probs=109.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC--------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--------------------------   55 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------------------------   55 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.......                          
T Consensus       105 ~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (363)
T cd05628         105 FYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA  182 (363)
T ss_pred             HHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccccccc
Confidence            468899999999995  5699999999999999999999999999875422110                          


Q ss_pred             -------cceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHH
Q 027003           56 -------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  128 (229)
Q Consensus        56 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (229)
                             .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+....                ....
T Consensus       183 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~----------------~~~~  246 (363)
T cd05628         183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ----------------ETYK  246 (363)
T ss_pred             chhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH----------------HHHH
Confidence                   00012357999999999999999999999999999999999999999764321                1111


Q ss_pred             HHhhcccCCCCc--HHHHHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 027003          129 RIMDTKLGGQYP--QKAAHTAATLALQCLN--NEPKLRPRMSEVLAI  171 (229)
Q Consensus       129 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~--~dP~~Rpt~~~v~~~  171 (229)
                      ++.........+  ...+..+.+|+.+|+.  .++..||++.++++.
T Consensus       247 ~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         247 KVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            111111111111  1245677888888654  233456899999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=1.7e-29  Score=205.50  Aligned_cols=151  Identities=21%  Similarity=0.292  Sum_probs=110.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++......... .....+||..|+|||++.+     
T Consensus       106 ~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  182 (332)
T cd05623         106 FYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGK  182 (332)
T ss_pred             HHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCC
Confidence            467899999999995  56999999999999999999999999998754322211 1233579999999999863     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCC---cHHHHHHHHHHHHH
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQ  153 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~  153 (229)
                      ..++.++|||||||++|||++|+.||...+..                .....+.........   ...++..+.+|+.+
T Consensus       183 ~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~  246 (332)
T cd05623         183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR  246 (332)
T ss_pred             CCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----------------HHHHHHhCCCccccCCCccccCCHHHHHHHHH
Confidence            45788999999999999999999999764311                111122211111111   12456788999999


Q ss_pred             hccCCCCC--CCCHHHHHHH
Q 027003          154 CLNNEPKL--RPRMSEVLAI  171 (229)
Q Consensus       154 ~l~~dP~~--Rpt~~~v~~~  171 (229)
                      ||..++.+  |+++.++++.
T Consensus       247 ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         247 LICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HccChhhhcCCCCHHHHhCC
Confidence            98665444  6789998864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=195.85  Aligned_cols=153  Identities=24%  Similarity=0.280  Sum_probs=118.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .|++||+.|+.|||+.+  |.||||||+|+|...   +-.+||+|||+++......   ...+.+-|+.|.|||++...+
T Consensus       165 eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eK  239 (400)
T KOG0604|consen  165 EIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEK  239 (400)
T ss_pred             HHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchh
Confidence            47899999999999765  999999999999954   4568999999998754322   234567899999999998899


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      |+..+|+||+||++|-|++|-+||......          ..  ...-..++....  +..+.+...+....++|+.+|.
T Consensus       240 ydkscdmwSlgVimYIlLCGyPPFYS~hg~----------ai--spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLk  307 (400)
T KOG0604|consen  240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------AI--SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLK  307 (400)
T ss_pred             cCCCCCccchhHHHHHhhcCCCcccccCCc----------cC--ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhc
Confidence            999999999999999999999999654321          00  011111222222  2334456778899999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .+|.+|.|+.++++.
T Consensus       308 t~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  308 TEPTERLTIEEVMDH  322 (400)
T ss_pred             CCchhheeHHHhhcC
Confidence            999999999999863

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=3.9e-30  Score=204.40  Aligned_cols=154  Identities=25%  Similarity=0.409  Sum_probs=115.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||++.......    .....|+..|+|||++.+..++.
T Consensus        99 ~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  172 (279)
T cd06619          99 RIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGI  172 (279)
T ss_pred             HHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCC
Confidence            478999999999995  569999999999999999999999999987643321    23357899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC-CcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||..........          ................ .....+..+.+++.+||+.+|+
T Consensus       173 ~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  242 (279)
T cd06619         173 HSDVWSLGISFMELALGRFPYPQIQKNQGSL----------MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPK  242 (279)
T ss_pred             cchHHHHHHHHHHHHhCCCCchhhccccccc----------chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChh
Confidence            9999999999999999999996532111000          0000011111111111 1223456788999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +||++.++++.
T Consensus       243 ~Rp~~~eil~~  253 (279)
T cd06619         243 ERPAPENLMDH  253 (279)
T ss_pred             hCCCHHHHhcC
Confidence            99999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=5.1e-30  Score=202.27  Aligned_cols=150  Identities=28%  Similarity=0.417  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-cceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++
T Consensus       110 ~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  187 (266)
T cd06651         110 KYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG  187 (266)
T ss_pred             HHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCC
Confidence            478999999999995  5699999999999999999999999999875432111 1112234578899999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|||++|+.||.....                ................+......+.+++ +||..+|+
T Consensus       188 ~~~Dv~slG~i~~el~~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~  250 (266)
T cd06651         188 RKADVWSLGCTVVEMLTEKPPWAEYEA----------------MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEAR  250 (266)
T ss_pred             chhhhHHHHHHHHHHHHCCCCccccch----------------HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChh
Confidence            999999999999999999999975421                1111111111222334455566777787 68889999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       251 ~Rp~~~eil~  260 (266)
T cd06651         251 HRPSAEELLR  260 (266)
T ss_pred             hCcCHHHHhc
Confidence            9999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=5.5e-30  Score=203.69  Aligned_cols=150  Identities=25%  Similarity=0.371  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........  ......++..|+|||++.     +
T Consensus       107 ~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  182 (282)
T cd06643         107 VVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKD  182 (282)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCC
Confidence            478999999999995  4699999999999999999999999999875432211  123356899999999984     3


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|+|||||++|+|++|+.||...+..                ......... ......+...+..+.+|+.+||
T Consensus       183 ~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  246 (282)
T cd06643         183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPM----------------RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCL  246 (282)
T ss_pred             CCCCccchhhhHHHHHHHHccCCCCccccCHH----------------HHHHHHhhcCCCCCCCccccCHHHHHHHHHHc
Confidence            45778999999999999999999999764310                011111111 0111223345678899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      +.||.+||++.++++.
T Consensus       247 ~~~p~~Rp~~~~il~~  262 (282)
T cd06643         247 EKNVDARWTTTQLLQH  262 (282)
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=5.2e-30  Score=202.11  Aligned_cols=150  Identities=27%  Similarity=0.457  Sum_probs=116.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc----ceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----HVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      +++.|++.||+|||+  .+++||||+|+||+++.++.++|+|||+++........    .......|+..|+|||.+.+.
T Consensus       110 ~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~  187 (267)
T cd06628         110 NFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT  187 (267)
T ss_pred             HHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC
Confidence            578999999999995  56999999999999999999999999998765422111    111234578899999999888


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      .++.++|+|||||++|+|++|+.||.....                .....+... ......+...+..+.+++.+||+.
T Consensus       188 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~  250 (267)
T cd06628         188 SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------------LQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEI  250 (267)
T ss_pred             CCCchhhhHHHHHHHHHHhhCCCCCCCccH----------------HHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccC
Confidence            899999999999999999999999976431                011111111 122233445677889999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+||++.++++
T Consensus       251 ~p~~Rp~~~~il~  263 (267)
T cd06628         251 DHNKRPTAAELLK  263 (267)
T ss_pred             CchhCcCHHHHhh
Confidence            9999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=210.66  Aligned_cols=148  Identities=26%  Similarity=0.437  Sum_probs=116.9

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----cC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TG   77 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~   77 (229)
                      +|+|++.||.|||+.  .|||||||..|||++-+|.++|+|||.+-....  .......++||+.|||||+..     ..
T Consensus       135 vc~q~ldALn~LHs~--~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~  210 (1187)
T KOG0579|consen  135 VCYQVLDALNWLHSQ--NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQ  210 (1187)
T ss_pred             HHHHHHHHHHHHhhc--chhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCC
Confidence            689999999999964  599999999999999999999999999754221  112234689999999999873     46


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhcc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~  156 (229)
                      +|++++||||||++|.||..+.+|-...+.                .+.+.++..... ....|...+..+.+++.+||.
T Consensus       211 PYDykaDiWSlGITLIEMAqiEPPHhelnp----------------MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~  274 (1187)
T KOG0579|consen  211 PYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLV  274 (1187)
T ss_pred             CchhhhhHHhhhhHHHHHhccCCCccccch----------------HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHh
Confidence            899999999999999999999988765431                222222222211 123456788899999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      +||..||+++++++
T Consensus       275 Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  275 KNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCCccCCCHHHHhh
Confidence            99999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=4.5e-30  Score=202.76  Aligned_cols=152  Identities=24%  Similarity=0.395  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++.......   ......|+..|++||.+.+..++.
T Consensus       117 ~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~  192 (269)
T cd08528         117 NIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGE  192 (269)
T ss_pred             HHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCch
Confidence            5788999999999952 469999999999999999999999999998654332   233456889999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|+.||.......                ....+.............+..+.+++.+||+.||++
T Consensus       193 ~~Dv~slG~ll~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  256 (269)
T cd08528         193 KADVWAFGCILYQMCTLQPPFYSTNMLS----------------LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEA  256 (269)
T ss_pred             HHHHHHHHHHHHHHHhCCCcccccCHHH----------------HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCcc
Confidence            9999999999999999999986543110                011111111111111234567899999999999999


Q ss_pred             CCCHHHHHHHHH
Q 027003          162 RPRMSEVLAILE  173 (229)
Q Consensus       162 Rpt~~~v~~~l~  173 (229)
                      ||++.|+..+++
T Consensus       257 Rp~~~e~~~~~~  268 (269)
T cd08528         257 RPDIIQVSAMIS  268 (269)
T ss_pred             CCCHHHHHHHhc
Confidence            999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=3.2e-30  Score=204.98  Aligned_cols=149  Identities=26%  Similarity=0.361  Sum_probs=111.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      .++.||+.||.|||+  .+|+|+||||+||+++.++.++|+|||++........  ......|+..|+|||.+.     +
T Consensus       125 ~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~  200 (282)
T cd06636         125 YICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPD  200 (282)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcC
Confidence            467899999999995  4699999999999999999999999999875432211  123356899999999885     3


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ..++.++|+|||||++|||++|..||......                .....+............++..+.+|+.+||+
T Consensus       201 ~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  264 (282)
T cd06636         201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----------------RALFLIPRNPPPKLKSKKWSKKFIDFIEGCLV  264 (282)
T ss_pred             cCCCcccchhHHHHHHHHHHhCCCCccccCHH----------------hhhhhHhhCCCCCCcccccCHHHHHHHHHHhC
Confidence            45788999999999999999999999653211                00111111111111122456789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+||++.++++
T Consensus       265 ~~p~~Rp~~~ell~  278 (282)
T cd06636         265 KNYLSRPSTEQLLK  278 (282)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=5.2e-30  Score=202.53  Aligned_cols=157  Identities=24%  Similarity=0.300  Sum_probs=110.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++...............++..|+|||++.+.    
T Consensus       104 ~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  181 (269)
T cd05087         104 RMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL  181 (269)
T ss_pred             HHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccc
Confidence            467899999999995  56999999999999999999999999998754332222222234578889999998642    


Q ss_pred             ---CCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHH
Q 027003           78 ---RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ  153 (229)
Q Consensus        78 ---~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  153 (229)
                         .++.++|+|||||++|||++ |..||..........   ..         .................+..+.+++..
T Consensus       182 ~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~~  249 (269)
T cd05087         182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT---------VREQQLKLPKPRLKLPLSDRWYEVMQF  249 (269)
T ss_pred             cccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH---------hhcccCCCCCCccCCCCChHHHHHHHH
Confidence               35789999999999999996 999996543211000   00         000000000111112245567889999


Q ss_pred             hccCCCCCCCCHHHHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLAILE  173 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~~l~  173 (229)
                      || .+|++|||+.+|+..|+
T Consensus       250 c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         250 CW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Hh-cCcccCCCHHHHHHHhc
Confidence            99 68999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.9e-30  Score=201.64  Aligned_cols=153  Identities=29%  Similarity=0.474  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.
T Consensus       107 ~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~  183 (261)
T cd05034         107 DMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTI  183 (261)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhccCCcCc
Confidence            578899999999995  5699999999999999999999999999876543211 1112223466899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|++++ |+.||.+....                 .....+........+...+..+.+++.+||+.+|.
T Consensus       184 ~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  246 (261)
T cd05034         184 KSDVWSFGILLTEIVTYGRVPYPGMTNR-----------------EVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPE  246 (261)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            9999999999999998 99999654311                 11111111222223334467889999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +||++.++++.|+.
T Consensus       247 ~Rp~~~~l~~~l~~  260 (261)
T cd05034         247 ERPTFEYLQSFLED  260 (261)
T ss_pred             cCCCHHHHHHHHhc
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=7.5e-30  Score=201.04  Aligned_cols=144  Identities=26%  Similarity=0.396  Sum_probs=108.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc-------EEEcccCCcccCCCCCCcceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   74 (229)
                      +++.||+.||+|||+  ++|+||||||+|||++.++.       ++++|||++......      ....++..|+|||.+
T Consensus       109 ~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~  180 (262)
T cd05077         109 KVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECV  180 (262)
T ss_pred             HHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhh
Confidence            578999999999995  56999999999999987664       899999998754221      224578899999988


Q ss_pred             c-cCCCcccCceeehhHHHHHHH-hCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHH
Q 027003           75 A-TGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  152 (229)
Q Consensus        75 ~-~~~~~~~~Di~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  152 (229)
                      . +..++.++|||||||++|||+ +|..||.........                 ........  ........+.+|+.
T Consensus       181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----------------~~~~~~~~--~~~~~~~~~~~li~  241 (262)
T cd05077         181 EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----------------RFYEGQCM--LVTPSCKELADLMT  241 (262)
T ss_pred             cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----------------HHHhcCcc--CCCCChHHHHHHHH
Confidence            6 456889999999999999998 588887654321100                 01111111  11112456889999


Q ss_pred             HhccCCCCCCCCHHHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      +||+.||.+||++.++++.+
T Consensus       242 ~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         242 HCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHcCCChhhCcCHHHHHHhc
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=2.7e-30  Score=204.10  Aligned_cols=152  Identities=26%  Similarity=0.332  Sum_probs=109.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      +++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++................++..|+|||++..     
T Consensus       104 ~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  181 (269)
T cd05042         104 RMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL  181 (269)
T ss_pred             HHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccc
Confidence            578899999999995  4699999999999999999999999999865332221111222345678999998743     


Q ss_pred             --CCCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc----cCCCCcHHHHHHHHH
Q 027003           77 --GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAAHTAAT  149 (229)
Q Consensus        77 --~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  149 (229)
                        ..++.++|||||||++|||++ |..||.......                .....+...    .....+...+..+.+
T Consensus       182 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (269)
T cd05042         182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----------------VLKQVVREQDIKLPKPQLDLKYSDRWYE  245 (269)
T ss_pred             cccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----------------HHHHHhhccCccCCCCcccccCCHHHHH
Confidence              356789999999999999999 788886542110                011111100    111223345667788


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      ++..|| .||++||++.+|++.|
T Consensus       246 ~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         246 VMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             HHHHHh-cCcccccCHHHHHHHh
Confidence            999998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=220.31  Aligned_cols=165  Identities=26%  Similarity=0.439  Sum_probs=138.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceee-ccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.+|+.|+.||-+.  ++|||||-..|||++.+-.+|++|||+++...+......++ .-.-...|.|||.+...+++
T Consensus       735 gMLrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFT  812 (996)
T KOG0196|consen  735 GMLRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFT  812 (996)
T ss_pred             HHHHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccC
Confidence            4689999999999965  59999999999999999999999999999875544221111 11224689999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++||||||+++||.++ |..||....                 .+...+.+....+.+.|.+++..+.+|+..||++|.
T Consensus       813 sASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR  875 (996)
T KOG0196|consen  813 SASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDR  875 (996)
T ss_pred             chhhccccceEEEEecccCCCcccccc-----------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHh
Confidence            99999999999999886 998886643                 345667778888889999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCcC
Q 027003          160 KLRPRMSEVLAILERLEAPKNSAKLS  185 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~~~~~~~~~  185 (229)
                      .+||.+.+|+..|+++...+.+....
T Consensus       876 ~~RP~F~qiV~~lDklIrnP~SLk~~  901 (996)
T KOG0196|consen  876 NRRPKFAQIVSTLDKLIRNPNSLKTI  901 (996)
T ss_pred             hcCCCHHHHHHHHHHHhcCchhhccc
Confidence            99999999999999988766654443

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=5.7e-30  Score=204.07  Aligned_cols=150  Identities=30%  Similarity=0.436  Sum_probs=113.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++........   .....|+..|+|||.+.+..++.
T Consensus       106 ~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~  180 (285)
T cd05632         106 FYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTL  180 (285)
T ss_pred             HHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCc
Confidence            578999999999995  4699999999999999999999999999875432221   22346899999999998889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|..||..........             .....+. ......+...+..+.+|+.+||+.||++
T Consensus       181 ~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~  246 (285)
T cd05632         181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE-------------EVDRRVL-ETEEVYSAKFSEEAKSICKMLLTKDPKQ  246 (285)
T ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHHhhh-ccccccCccCCHHHHHHHHHHccCCHhH
Confidence            9999999999999999999997643211000             0001010 0111233445667889999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      ||+     +.+++.
T Consensus       247 R~~~~~~~~~~l~~  260 (285)
T cd05632         247 RLGCQEEGAGEVKR  260 (285)
T ss_pred             cCCCcccChHHHHc
Confidence            999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=206.06  Aligned_cols=148  Identities=26%  Similarity=0.408  Sum_probs=123.4

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ++..+++|++|||++  +||+|||||+|++|+.+|-+||.|||+++....+..   +.+++||+.|.|||++.+...+.+
T Consensus       525 ~~acv~EAfeYLH~k--~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~a  599 (732)
T KOG0614|consen  525 YVACVLEAFEYLHRK--GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRA  599 (732)
T ss_pred             hHHHHHHHHHHHHhc--CceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchh
Confidence            356789999999964  599999999999999999999999999998766544   567899999999999999999999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      +|.||||+++|||++|.+||.+.+.                ......++.....-.+|..+.....+||+++...+|.+|
T Consensus       600 vDyWaLGIli~ELL~G~pPFs~~dp----------------mktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ER  663 (732)
T KOG0614|consen  600 VDYWALGILIYELLTGSPPFSGVDP----------------MKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTER  663 (732)
T ss_pred             hHHHHHHHHHHHHHcCCCCCCCCch----------------HHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhh
Confidence            9999999999999999999998652                222333333333446677888999999999999999999


Q ss_pred             CC-----HHHHHHH
Q 027003          163 PR-----MSEVLAI  171 (229)
Q Consensus       163 pt-----~~~v~~~  171 (229)
                      ..     +.++.+.
T Consensus       664 LG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  664 LGYQKGGINDIKKH  677 (732)
T ss_pred             hccccCChHHHHhh
Confidence            75     5666543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=1.7e-30  Score=214.79  Aligned_cols=151  Identities=26%  Similarity=0.317  Sum_probs=110.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC---------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---------------------------   54 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------------------   54 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++..+....                           
T Consensus       105 ~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (376)
T cd05598         105 FYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR  182 (376)
T ss_pred             HHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence            367899999999995  469999999999999999999999999975321000                           


Q ss_pred             --------------CcceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhh
Q 027003           55 --------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY  120 (229)
Q Consensus        55 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  120 (229)
                                    ........+||..|+|||++.+..++.++|||||||++|||++|+.||.+.......         
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---------  253 (376)
T cd05598         183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ---------  253 (376)
T ss_pred             ccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHH---------
Confidence                          000012357999999999999989999999999999999999999999775421110         


Q ss_pred             hcchhhHHHHhh--cccCCCCcHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 027003          121 LSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRP---RMSEVLAI  171 (229)
Q Consensus       121 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~~v~~~  171 (229)
                             ..+..  ...........+..+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       254 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         254 -------LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             -------HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence                   01111  01111112235667888888876 5999999   88998863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=1.1e-29  Score=200.49  Aligned_cols=155  Identities=26%  Similarity=0.447  Sum_probs=117.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcce-eeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+  .+++||||||+|||++.++.++|+|||++........... .....++..|++||.+.+..++
T Consensus       110 ~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~  187 (267)
T cd05066         110 GMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT  187 (267)
T ss_pred             HHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccC
Confidence            578999999999995  5699999999999999999999999999986543222111 1112235679999999888899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|+|||||++|++++ |..||.......                 ....+........+...+..+.+++.+||+.+|
T Consensus       188 ~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  250 (267)
T cd05066         188 SASDVWSYGIVMWEVMSYGERPYWEMSNQD-----------------VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDR  250 (267)
T ss_pred             chhhhHHHHHHHHHHhcCCCCCcccCCHHH-----------------HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence            99999999999999886 999987643210                 011111111222233456778999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 027003          160 KLRPRMSEVLAILERL  175 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~  175 (229)
                      .+||++.++++.|+++
T Consensus       251 ~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         251 NERPKFEQIVSILDKL  266 (267)
T ss_pred             hhCCCHHHHHHHHHhh
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.8e-29  Score=187.32  Aligned_cols=145  Identities=23%  Similarity=0.216  Sum_probs=108.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.|++.||.|||+.+        ||+|||++.++.+|+  ||++......       ...||..|+|||++.+..++.
T Consensus        21 ~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~~~~~~   83 (176)
T smart00750       21 AVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQGQSYTE   83 (176)
T ss_pred             HHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcCCCCcc
Confidence            57899999999999642        999999999999999  9998764332       125889999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHH--HHHHHHHHhccC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAH--TAATLALQCLNN  157 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~li~~~l~~  157 (229)
                      ++|||||||++|||+||+.||....... ..+..+           .........  ...+.....  .+.+++.+||+.
T Consensus        84 ~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~  151 (176)
T smart00750       84 KADIYSLGITLYEALDYELPYNEERELS-AILEIL-----------LNGMPADDPRDRSNLESVSAARSFADFMRVCASR  151 (176)
T ss_pred             hhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHH-----------HHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence            9999999999999999999996532110 000000           000000000  011223333  689999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 027003          158 EPKLRPRMSEVLAILERL  175 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~  175 (229)
                      ||.+||++.++++.+..+
T Consensus       152 ~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      152 LPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ccccccCHHHHHHHHHHH
Confidence            999999999999987655

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=1.4e-29  Score=200.08  Aligned_cols=152  Identities=21%  Similarity=0.314  Sum_probs=108.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.||+.||+|||+  .+++||||||+|||++.++.++|+|||++................++..|+|||++.+     
T Consensus       103 ~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (268)
T cd05086         103 RMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL  180 (268)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence            467899999999995  4699999999999999999999999999864322221112234567889999998853     


Q ss_pred             --CCCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc----cCCCCcHHHHHHHHH
Q 027003           77 --GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAAHTAAT  149 (229)
Q Consensus        77 --~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  149 (229)
                        ..++.++|||||||++|||++ |..||......                .....++...    ............+.+
T Consensus       181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (268)
T cd05086         181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----------------EVLNHVIKDQQVKLFKPQLELPYSERWYE  244 (268)
T ss_pred             ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHhhcccccCCCccCCCCcHHHHH
Confidence              235678999999999999997 56677543211                0011111110    111222234567888


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      ++..|| .+|++||++.++++.|
T Consensus       245 l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         245 VLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             HHHHHh-hCcccCCCHHHHHHHh
Confidence            999999 6799999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=207.30  Aligned_cols=149  Identities=26%  Similarity=0.333  Sum_probs=123.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC----CcEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.|++.++.|||+  .||+||||||+|+|+...    +.+|++|||++.....   .......+||+.|+|||++.+.
T Consensus       139 ~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~  213 (382)
T KOG0032|consen  139 GIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGR  213 (382)
T ss_pred             HHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCC
Confidence            478999999999996  569999999999999543    4799999999998654   2335668999999999999989


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  155 (229)
                      .++..+|+||+|+++|.|++|..||.+....                .....+....  ...+.....+..+.+++..||
T Consensus       214 ~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----------------~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll  277 (382)
T KOG0032|consen  214 PYGDEVDVWSIGVILYILLSGVPPFWGETEF----------------EIFLAILRGDFDFTSEPWDDISESAKDFIRKLL  277 (382)
T ss_pred             CCCcccchhHHHHHHHHHhhCCCCCcCCChh----------------HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhc
Confidence            9999999999999999999999999886522                1222333332  344566778999999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      ..||.+|+|+.++++.
T Consensus       278 ~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  278 EFDPRKRLTAAQALQH  293 (382)
T ss_pred             ccCcccCCCHHHHhcC
Confidence            9999999999999984

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=6.8e-30  Score=200.75  Aligned_cols=144  Identities=27%  Similarity=0.380  Sum_probs=108.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc--------EEEcccCCcccCCCCCCcceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   73 (229)
                      +++.||+.||+|||+  ++|+||||||+||+++.++.        ++++|||++.....      .....++..|+|||+
T Consensus       104 ~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~  175 (258)
T cd05078         104 EVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPEC  175 (258)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchh
Confidence            578999999999995  56999999999999987764        69999999865422      123457889999999


Q ss_pred             cccC-CCcccCceeehhHHHHHHHhCC-CcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           74 VATG-RLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        74 ~~~~-~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      +.+. .++.++|||||||++|+|++|. .||.......                 .......  ....+......+.+|+
T Consensus       176 ~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~~~~~li  236 (258)
T cd05078         176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----------------KLQFYED--RHQLPAPKWTELANLI  236 (258)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----------------HHHHHHc--cccCCCCCcHHHHHHH
Confidence            9764 5789999999999999999984 5554422110                 0011111  1123333456789999


Q ss_pred             HHhccCCCCCCCCHHHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      .+||+.||++|||+.++++.|
T Consensus       237 ~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         237 NQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHhccChhhCCCHHHHHHhc
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=1.9e-29  Score=223.74  Aligned_cols=149  Identities=26%  Similarity=0.361  Sum_probs=111.2

Q ss_pred             hhHHHHHHHHHHhhcCC-----CCceeecCCCCCeeecC-----------------CCcEEEcccCCcccCCCCCCccee
Q 027003            2 KVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLDA-----------------EFNAKLSDFGLAKAGPTGDRTHVS   59 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~-----~~ivHrDlkp~Nill~~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~   59 (229)
                      .|+.||+.||.|||+.+     .+||||||||+||||+.                 .+.+||+|||++.......   ..
T Consensus       122 ~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~  198 (1021)
T PTZ00266        122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MA  198 (1021)
T ss_pred             HHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cc
Confidence            57899999999999743     46999999999999964                 2348999999998653322   12


Q ss_pred             ecccccccccccccccc--CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC
Q 027003           60 TQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  137 (229)
Q Consensus        60 ~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (229)
                      ...+||+.|+|||++.+  ..++.++||||||||||+|++|..||......                ..+...+..... 
T Consensus       199 ~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~----------------~qli~~lk~~p~-  261 (1021)
T PTZ00266        199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF----------------SQLISELKRGPD-  261 (1021)
T ss_pred             cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH----------------HHHHHHHhcCCC-
Confidence            34579999999999865  35788999999999999999999999754310                011111111111 


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ......+..+.+||..||+.+|.+||++.+++.
T Consensus       262 lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        262 LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            111234567899999999999999999999984

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=3.8e-29  Score=203.40  Aligned_cols=151  Identities=21%  Similarity=0.322  Sum_probs=110.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++......... ......||..|+|||++.+     
T Consensus       106 ~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  182 (331)
T cd05624         106 FYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGM  182 (331)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCC
Confidence            367899999999995  56999999999999999999999999998765332221 1223569999999999875     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc---HHHHHHHHHHHHH
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQ  153 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~  153 (229)
                      +.++.++|+|||||++|+|++|+.||...+..                .....+.........+   ...+..+.+|+.+
T Consensus       183 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~  246 (331)
T cd05624         183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR  246 (331)
T ss_pred             CCCCCcccEEeeehhhhhhhhCCCCccCCCHH----------------HHHHHHHcCCCcccCCCccccCCHHHHHHHHH
Confidence            45788999999999999999999999764321                1111121111111111   2346788999999


Q ss_pred             hccCCCCC--CCCHHHHHHH
Q 027003          154 CLNNEPKL--RPRMSEVLAI  171 (229)
Q Consensus       154 ~l~~dP~~--Rpt~~~v~~~  171 (229)
                      ||..++.+  |+++.++++.
T Consensus       247 ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         247 LICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HccCchhhcCCCCHHHHhcC
Confidence            99866544  4578887753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1.3e-29  Score=199.12  Aligned_cols=151  Identities=27%  Similarity=0.349  Sum_probs=119.6

Q ss_pred             hhHHHHHHHHHHhhcC---CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDA---ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~---~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||..   +.+++|+||||+||+++.++.+||+|||++.........  .....++..|++||.+.+..
T Consensus       109 ~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~  186 (265)
T cd08217         109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMS  186 (265)
T ss_pred             HHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCC
Confidence            5789999999999933   346999999999999999999999999999876443321  22346899999999998888


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|+||||+++|+|++|+.||...+..                 ...+.+........+...+..+.+++.+||+.+
T Consensus       187 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  249 (265)
T cd08217         187 YDEKSDIWSLGCLIYELCALSPPFTARNQL-----------------QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVD  249 (265)
T ss_pred             CCchhHHHHHHHHHHHHHHCCCcccCcCHH-----------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence            999999999999999999999999764311                 111112222223344566788999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027003          159 PKLRPRMSEVLAI  171 (229)
Q Consensus       159 P~~Rpt~~~v~~~  171 (229)
                      |++||++.++++.
T Consensus       250 p~~Rp~~~~il~~  262 (265)
T cd08217         250 PDKRPSTEELLQL  262 (265)
T ss_pred             cccCCCHHHHhhC
Confidence            9999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=7.8e-30  Score=223.79  Aligned_cols=149  Identities=30%  Similarity=0.467  Sum_probs=111.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCC------C----------CCCcceeeccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP------T----------GDRTHVSTQVMGT   65 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~------~----------~~~~~~~~~~~gt   65 (229)
                      +++.+|++||.|+|+  .|||||||||.||+|+.++.|||+|||+++...      .          +......+..+||
T Consensus       701 rLFreIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT  778 (1351)
T KOG1035|consen  701 RLFREILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT  778 (1351)
T ss_pred             HHHHHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence            578999999999995  569999999999999999999999999997611      0          0111134568999


Q ss_pred             cccccccccccCC---CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC--Cc
Q 027003           66 HGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YP  140 (229)
Q Consensus        66 ~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  140 (229)
                      ..|+|||++.+..   |+.|.|+||||+||+||+.   ||...-               .....+..+....+...  +.
T Consensus       779 alYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---------------ERa~iL~~LR~g~iP~~~~f~  840 (1351)
T KOG1035|consen  779 ALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---------------ERASILTNLRKGSIPEPADFF  840 (1351)
T ss_pred             eeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH---------------HHHHHHHhcccCCCCCCcccc
Confidence            9999999997754   9999999999999999985   354421               12222222222222222  12


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          141 QKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       141 ~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ......-..+|+.|++.||++|||+.|++.
T Consensus       841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  841 DPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            334455668999999999999999999984

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=1.6e-29  Score=197.94  Aligned_cols=151  Identities=30%  Similarity=0.483  Sum_probs=116.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++............ ...++..|++||.+.+..++.
T Consensus       107 ~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~  183 (258)
T smart00219      107 SFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTS  183 (258)
T ss_pred             HHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCc
Confidence            578999999999995  46999999999999999999999999999765443222111 223678899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++ |..||.....                 ......+........+...+..+.+++.+||..||.
T Consensus       184 ~~Di~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  246 (258)
T smart00219      184 KSDVWSFGVLLWEIFTLGESPYPGMSN-----------------EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPE  246 (258)
T ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChh
Confidence            9999999999999998 7888865321                 111111122222233344677899999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +|||+.++++.|
T Consensus       247 ~Rpt~~~ll~~l  258 (258)
T smart00219      247 DRPTFSELVEIL  258 (258)
T ss_pred             hCcCHHHHHhhC
Confidence            999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.96  E-value=3.9e-30  Score=211.50  Aligned_cols=150  Identities=27%  Similarity=0.348  Sum_probs=109.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------------------   56 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------------------   56 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.++|+|||++.........                         
T Consensus       105 ~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (360)
T cd05627         105 FYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA  182 (360)
T ss_pred             HHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccccc
Confidence            468899999999995  56999999999999999999999999998754221100                         


Q ss_pred             --------ceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHH
Q 027003           57 --------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  128 (229)
Q Consensus        57 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (229)
                              ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....                ...
T Consensus       183 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~----------------~~~  246 (360)
T cd05627         183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE----------------TYR  246 (360)
T ss_pred             ccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHH----------------HHH
Confidence                    00123579999999999999999999999999999999999999997654211                111


Q ss_pred             HHhhcccCCCCc--HHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 027003          129 RIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEVLA  170 (229)
Q Consensus       129 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt---~~~v~~  170 (229)
                      ++.........+  ...+..+.+|+.+|+ .||.+|++   +.++++
T Consensus       247 ~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         247 KVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             HHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            111111111111  124567888998877 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=5.2e-30  Score=204.37  Aligned_cols=151  Identities=29%  Similarity=0.448  Sum_probs=113.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC---C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~   78 (229)
                      +++.|++.||+|||+. .+++||||||+||+++.++.++|+|||++........   .....|+..|+|||++.+.   .
T Consensus       111 ~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  186 (288)
T cd06616         111 KIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDG  186 (288)
T ss_pred             HHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccC
Confidence            5789999999999953 4699999999999999999999999999875432211   1233578899999999776   6


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhh---cccCCCCcHHHHHHHHHHHHHhc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD---TKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ++.++|||||||++|+|++|+.||......     .          ....+...   ..+.......++..+.+|+.+||
T Consensus       187 ~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  251 (288)
T cd06616         187 YDVRSDVWSLGITLYEVATGKFPYPKWNSV-----F----------DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCL  251 (288)
T ss_pred             CcchhhhhHHHHHHHHHHhCCCCchhcchH-----H----------HHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHc
Confidence            889999999999999999999999754310     0          00111110   01111122345678999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      +.||++|||+.+++..
T Consensus       252 ~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         252 IKDESKRPKYKELLEH  267 (288)
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=9.2e-30  Score=202.49  Aligned_cols=165  Identities=25%  Similarity=0.257  Sum_probs=111.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      .++.||+.||.|||+  .+|+||||||+||+++.++.++|+|||+++........  .....++..|+|||++.+.. ++
T Consensus       103 ~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  178 (284)
T cd07839         103 SFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYS  178 (284)
T ss_pred             HHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccC
Confidence            578999999999995  46999999999999999999999999998764332211  22345788999999987654 68


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch--hHHHhhh-hhhcchhhHHHHhhcccC---------CCCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAK-PYLSDKRKLFRIMDTKLG---------GQYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|..||.........  .+..... +.................         .......+..+.
T Consensus       179 ~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (284)
T cd07839         179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR  258 (284)
T ss_pred             cHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHH
Confidence            8999999999999999998886433221100  0000000 000000000000000000         011123467888


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.++++
T Consensus       259 ~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         259 DLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHHHHHhcCChhhcCCHHHHhc
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=1.1e-29  Score=203.63  Aligned_cols=149  Identities=28%  Similarity=0.400  Sum_probs=115.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.
T Consensus       119 ~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  194 (296)
T cd06655         119 AVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP  194 (296)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCc
Confidence            578899999999995  46999999999999999999999999998764332221  22346888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||...+....                ...+... ......+...+..+.+++.+||..||.
T Consensus       195 ~~Dv~slGvil~~lltg~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  258 (296)
T cd06655         195 KVDIWSLGIMAIEMVEGEPPYLNENPLRA----------------LYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE  258 (296)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChh
Confidence            99999999999999999999976432110                0011100 001122334566788999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.+++.
T Consensus       259 ~Rpt~~~il~  268 (296)
T cd06655         259 KRGSAKELLQ  268 (296)
T ss_pred             hCCCHHHHhh
Confidence            9999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=1.1e-29  Score=198.99  Aligned_cols=151  Identities=27%  Similarity=0.450  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.++.++.
T Consensus       104 ~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~  180 (256)
T cd05112         104 GMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcCh
Confidence            467899999999995  46999999999999999999999999998754322111 111223567899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|||++ |..||......                 .....+........+...+..+.+|+.+||+.+|+
T Consensus       181 ~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~  243 (256)
T cd05112         181 KSDVWSFGVLMWEVFSEGKTPYENRSNS-----------------EVVETINAGFRLYKPRLASQSVYELMQHCWKERPE  243 (256)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChh
Confidence            9999999999999998 99998754311                 01111111111112223457799999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.++++.|
T Consensus       244 ~Rp~~~~~l~~l  255 (256)
T cd05112         244 DRPSFSLLLHQL  255 (256)
T ss_pred             hCCCHHHHHHhh
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.96  E-value=1.1e-29  Score=198.81  Aligned_cols=149  Identities=29%  Similarity=0.420  Sum_probs=115.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++........  ......++..|+|||++.+..++.
T Consensus       103 ~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  178 (256)
T cd06612         103 AILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNN  178 (256)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCc
Confidence            578999999999995  5699999999999999999999999999886543321  123345788999999998889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhh-cccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||+++|+|++|+.||.........                ..+.. .......+......+.+++.+||+.||+
T Consensus       179 ~~Di~s~G~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  242 (256)
T cd06612         179 KADIWSLGITAIEMAEGKPPYSDIHPMRAI----------------FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPE  242 (256)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcchhhhh----------------hhhccCCCCCCCchhhcCHHHHHHHHHHHhcChh
Confidence            999999999999999999999764321100                00000 0001112334567789999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       243 ~Rps~~~il~  252 (256)
T cd06612         243 ERPSAIQLLQ  252 (256)
T ss_pred             hCcCHHHHhc
Confidence            9999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.5e-29  Score=198.42  Aligned_cols=144  Identities=27%  Similarity=0.381  Sum_probs=109.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-------cEEEcccCCcccCCCCCCcceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   74 (229)
                      +++.||+.||+|||+  .+|+||||||+|||++.++       .+||+|||++.....      .....++..|+|||++
T Consensus       105 ~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~  176 (259)
T cd05037         105 DVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECI  176 (259)
T ss_pred             HHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhh
Confidence            578999999999995  5699999999999999887       799999999886433      1223467789999999


Q ss_pred             ccC--CCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           75 ATG--RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        75 ~~~--~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      .+.  .++.++|+|||||++|+|++ |..||..........                 ......  ..+......+.+++
T Consensus       177 ~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~li  237 (259)
T cd05037         177 RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-----------------FYQDQH--RLPMPDCAELANLI  237 (259)
T ss_pred             cCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-----------------HHhcCC--CCCCCCchHHHHHH
Confidence            876  78899999999999999999 577776543111000                 000000  01111126788999


Q ss_pred             HHhccCCCCCCCCHHHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      .+||..+|.+||++.++++.|
T Consensus       238 ~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         238 NQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             HHHhccChhhCCCHHHHHHhc
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-29  Score=200.64  Aligned_cols=148  Identities=28%  Similarity=0.400  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||+++.......  ......++..|+|||.+.+..++.
T Consensus       102 ~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  177 (274)
T cd06609         102 FILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDE  177 (274)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCc
Confidence            578999999999995  5699999999999999999999999999976543321  123456888999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHH-HHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|+.||...+...                .. ..+........... .+..+.+++.+||..+|+
T Consensus       178 ~sDv~slG~il~~l~tg~~p~~~~~~~~----------------~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~  240 (274)
T cd06609         178 KADIWSLGITAIELAKGEPPLSDLHPMR----------------VL-FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPK  240 (274)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcccCchHH----------------HH-HHhhhcCCCCCcccccCHHHHHHHHHHhhCChh
Confidence            9999999999999999999997543110                00 01111111122222 566789999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       241 ~Rpt~~~il~  250 (274)
T cd06609         241 ERPSAKELLK  250 (274)
T ss_pred             hCcCHHHHhh
Confidence            9999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=1.1e-29  Score=203.16  Aligned_cols=149  Identities=26%  Similarity=0.373  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+||+++.++.++|+|||++........  ......|+..|+|||.+.+..++.
T Consensus       122 ~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  197 (292)
T cd06658         122 TVCLSVLRALSYLHNQ--GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGT  197 (292)
T ss_pred             HHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCc
Confidence            5789999999999964  699999999999999999999999999875432221  123356889999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|+||||+++|||++|..||.......                .. ..+......  ......+..+.+++.+||..||
T Consensus       198 ~~Dv~slGvil~el~~g~~p~~~~~~~~----------------~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  260 (292)
T cd06658         198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQ----------------AM-RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP  260 (292)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HH-HHHHhcCCCccccccccCHHHHHHHHHHccCCh
Confidence            9999999999999999999997543110                00 001111111  1112345678899999999999


Q ss_pred             CCCCCHHHHHHH
Q 027003          160 KLRPRMSEVLAI  171 (229)
Q Consensus       160 ~~Rpt~~~v~~~  171 (229)
                      .+|||+.++++.
T Consensus       261 ~~Rpt~~~il~~  272 (292)
T cd06658         261 SQRATAQELLQH  272 (292)
T ss_pred             hHCcCHHHHhhC
Confidence            999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.4e-29  Score=196.77  Aligned_cols=149  Identities=28%  Similarity=0.387  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC---C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~   78 (229)
                      .++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++........  ......++..|++||.+.+.   .
T Consensus       105 ~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~  180 (262)
T cd06613         105 YVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGG  180 (262)
T ss_pred             HHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCC
Confidence            478999999999995  4699999999999999999999999999876433211  12335688899999999776   7


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc---cCCCCcHHHHHHHHHHHHHhc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ++.++|+|||||++|+|++|..||.......                .........   .........+..+.+++.+||
T Consensus       181 ~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  244 (262)
T cd06613         181 YDGKCDIWALGITAIELAELQPPMFDLHPMR----------------ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCL  244 (262)
T ss_pred             cCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhccCCCccccchhhhhHHHHHHHHHHc
Confidence            8899999999999999999999997643110                000111110   011123345677899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      ..+|.+||++.+++.
T Consensus       245 ~~~p~~Rpt~~~il~  259 (262)
T cd06613         245 TKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCChhhCCCHHHHhc
Confidence            999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=1.3e-29  Score=201.41  Aligned_cols=149  Identities=28%  Similarity=0.409  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||+|||+  .+|+||||||+|||++.++.++|+|||++.......    .....|+..|+|||.+.+ ..++
T Consensus       101 ~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  174 (279)
T cd05633         101 FYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYD  174 (279)
T ss_pred             HHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCC
Confidence            478999999999995  459999999999999999999999999987543221    123468999999999864 5678


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|+|++|..||..........              .... ........+...+..+.+++.+||..||.
T Consensus       175 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRM-TLTVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             chhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------------HHHH-hhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            99999999999999999999997643211111              0010 11112234455677899999999999999


Q ss_pred             CCC-----CHHHHHHH
Q 027003          161 LRP-----RMSEVLAI  171 (229)
Q Consensus       161 ~Rp-----t~~~v~~~  171 (229)
                      +|+     ++.++++.
T Consensus       240 ~R~~~~~~~~~~~~~h  255 (279)
T cd05633         240 KRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HhcCCCCCCHHHHHhC
Confidence            999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=2.4e-29  Score=199.55  Aligned_cols=149  Identities=26%  Similarity=0.405  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++........  ......++..|+|||++.+..++.
T Consensus       105 ~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  180 (277)
T cd06642         105 TILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDF  180 (277)
T ss_pred             HHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCch
Confidence            468999999999995  5699999999999999999999999999876533221  122345788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|+.||........                 ...+............+..+.+++.+||+.+|++
T Consensus       181 ~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  243 (277)
T cd06642         181 KADIWSLGITAIELAKGEPPNSDLHPMRV-----------------LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRF  243 (277)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCcccchhhH-----------------HhhhhcCCCCCCCcccCHHHHHHHHHHccCCccc
Confidence            99999999999999999999865431100                 0011111112223345677899999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.+++..
T Consensus       244 Rp~~~~il~~  253 (277)
T cd06642         244 RPTAKELLKH  253 (277)
T ss_pred             CcCHHHHHHh
Confidence            9999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=3.4e-29  Score=199.49  Aligned_cols=151  Identities=28%  Similarity=0.472  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .++.|++.||.|||+. .+|+||||||+||+++.++.++|+|||++.......    .....++..|+|||.+.+..   
T Consensus       106 ~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  180 (286)
T cd06622         106 RITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQ  180 (286)
T ss_pred             HHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCc
Confidence            5788999999999952 469999999999999999999999999987543221    22345788999999986543   


Q ss_pred             ---CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhc
Q 027003           79 ---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 ---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                         ++.++|+|||||++|+|++|..||.........             .....+. .......+..++..+.+|+.+||
T Consensus       181 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  246 (286)
T cd06622         181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQLSAIV-DGDPPTLPSGYSDDAQDFVAKCL  246 (286)
T ss_pred             cCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HHHHHHh-hcCCCCCCcccCHHHHHHHHHHc
Confidence               478999999999999999999999653211000             0011111 11223344557788999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      +.+|++||++.++++.
T Consensus       247 ~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         247 NKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ccCcccCCCHHHHhcC
Confidence            9999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=4.3e-30  Score=201.57  Aligned_cols=154  Identities=29%  Similarity=0.470  Sum_probs=113.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-cCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~   80 (229)
                      .++.|+++||.+||+.  +|+|+||||+||+++.++.++|+|||++.....  .........++..|+|||++. +..++
T Consensus       102 ~~~~qi~~~L~~Lh~~--~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~  177 (260)
T PF00069_consen  102 KIAYQILEALAYLHSK--GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYT  177 (260)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBS
T ss_pred             cccccccccccccccc--ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            5789999999999964  699999999999999999999999999875311  112234567899999999998 77899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+||||+++|+|++|..||..............         ..........  .........+.+++.+||+.||+
T Consensus       178 ~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~  246 (260)
T PF00069_consen  178 RKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK---------ILKRPLPSSS--QQSREKSEELRDLIKKMLSKDPE  246 (260)
T ss_dssp             THHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH---------HHHTHHHHHT--TSHTTSHHHHHHHHHHHSSSSGG
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhh---------cccccccccc--cccchhHHHHHHHHHHHccCChh
Confidence            999999999999999999999987521111111000         0000000000  00011137899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       247 ~R~~~~~l~~  256 (260)
T PF00069_consen  247 QRPSAEELLK  256 (260)
T ss_dssp             GSTTHHHHHT
T ss_pred             HCcCHHHHhc
Confidence            9999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=2.8e-29  Score=197.91  Aligned_cols=150  Identities=27%  Similarity=0.392  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++
T Consensus       110 ~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  187 (265)
T cd06652         110 KYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG  187 (265)
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCC
Confidence            578999999999995  46999999999999999999999999998754321111 112234588899999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|+|++|+.||.....                .....+..........+......+.+++.+||. +|+
T Consensus       188 ~~~Dv~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~  250 (265)
T cd06652         188 RKADIWSVGCTVVEMLTEKPPWAEFEA----------------MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAK  250 (265)
T ss_pred             cchhHHHHHHHHHHHhhCCCCCCccch----------------HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-Chh
Confidence            999999999999999999999965321                111112222222333455677788999999995 999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       251 ~Rp~~~~il~  260 (265)
T cd06652         251 LRPSADELLR  260 (265)
T ss_pred             hCCCHHHHhc
Confidence            9999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=2.8e-29  Score=199.51  Aligned_cols=150  Identities=31%  Similarity=0.442  Sum_probs=112.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc----C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----G   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~   77 (229)
                      +++.|++.||+|||++ .+++||||||+||+++.++.+||+|||++........   .....++..|+|||.+.+    .
T Consensus       107 ~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  182 (283)
T cd06617         107 KIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQK  182 (283)
T ss_pred             HHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCccccc
Confidence            5789999999999963 2699999999999999999999999999876432211   223457889999998865    3


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      .++.++|+|||||++|+|++|+.||......               ...+................+..+.+++.+||..
T Consensus       183 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  247 (283)
T cd06617         183 GYDVKSDVWSLGITMIELATGRFPYDSWKTP---------------FQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKK  247 (283)
T ss_pred             ccCccccchhhHHHHHHHHhCCCCCCccccC---------------HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccC
Confidence            4688999999999999999999999643211               0111111111111111123567789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      +|.+||++.++++
T Consensus       248 ~p~~Rp~~~~il~  260 (283)
T cd06617         248 NYKERPNYPELLQ  260 (283)
T ss_pred             ChhhCcCHHHHhc
Confidence            9999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=1.7e-29  Score=200.96  Aligned_cols=165  Identities=23%  Similarity=0.249  Sum_probs=112.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||+|||+  .+|+||||||+||+++.++.++|+|||++........  ......++..|+|||++.+. .++
T Consensus       105 ~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  180 (285)
T cd07861         105 SYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYS  180 (285)
T ss_pred             HHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcC
Confidence            478999999999995  5699999999999999999999999999875432211  12233568899999988654 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-h-HHHhhhhh------hcchhhHHHHhhccc---CCCCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-S-LVDWAKPY------LSDKRKLFRIMDTKL---GGQYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~-~~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  149 (229)
                      .++|+|||||++|+|+||+.||.+....... . ...+..+.      ...............   ........+.++.+
T Consensus       181 ~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (285)
T cd07861         181 TPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLD  260 (285)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHH
Confidence            8999999999999999999999765421110 0 00000000      000000000000000   00011224667889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ++.+||+.||.+|||+.++++
T Consensus       261 li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         261 LLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHHhcCChhhCCCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=2.4e-29  Score=199.21  Aligned_cols=153  Identities=27%  Similarity=0.366  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++......... ......++..|++||.+.+..++.
T Consensus       121 ~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~  197 (275)
T cd05046         121 ALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFST  197 (275)
T ss_pred             HHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCc
Confidence            478999999999995  46999999999999999999999999998754322111 122335677899999998888899


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||+++|+|++ |..||......                ...............+..++..+.+++.+||+.+|.
T Consensus       198 ~~Di~slG~~l~~l~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~  261 (275)
T cd05046         198 KSDVWSFGVLMWEVFTQGELPFYGLSDE----------------EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPK  261 (275)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCccccchH----------------HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999998 78888653211                011111111111122334567899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +||++.+++..|.
T Consensus       262 ~Rp~~~~~l~~l~  274 (275)
T cd05046         262 DRPSFSELVSALG  274 (275)
T ss_pred             cCCCHHHHHHHhc
Confidence            9999999998874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=4.5e-29  Score=199.45  Aligned_cols=149  Identities=25%  Similarity=0.379  Sum_probs=111.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........  ......++..|+|||++.+     
T Consensus       114 ~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  189 (292)
T cd06644         114 VICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKD  189 (292)
T ss_pred             HHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccC
Confidence            478999999999995  5699999999999999999999999999865322211  1233467889999999853     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|+|||||++|+|++|..||...+..  .              ...+...... ....+...+..+.+++.+||
T Consensus       190 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (292)
T cd06644         190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM--R--------------VLLKIAKSEPPTLSQPSKWSMEFRDFLKTAL  253 (292)
T ss_pred             CCCCchhhhHhHHHHHHHHhcCCCCCccccHH--H--------------HHHHHhcCCCccCCCCcccCHHHHHHHHHHh
Confidence            34678999999999999999999998654310  0              0111111000 11123345567889999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.||++||++.++++
T Consensus       254 ~~~p~~Rp~~~~il~  268 (292)
T cd06644         254 DKHPETRPSAAQLLE  268 (292)
T ss_pred             cCCcccCcCHHHHhc
Confidence            999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=3.9e-29  Score=198.39  Aligned_cols=149  Identities=26%  Similarity=0.408  Sum_probs=117.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.
T Consensus       105 ~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~  180 (277)
T cd06640         105 TMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDS  180 (277)
T ss_pred             HHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCcc
Confidence            468899999999995  5699999999999999999999999999876533221  122346788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|..||.......                 .................+..+.+++.+||+.+|++
T Consensus       181 ~~Dv~slG~il~el~tg~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  243 (277)
T cd06640         181 KADIWSLGITAIELAKGEPPNSDMHPMR-----------------VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSF  243 (277)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcChHh-----------------HhhhhhcCCCCCCchhhhHHHHHHHHHHcccCccc
Confidence            9999999999999999999997543110                 00111111223344567788999999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.+++..
T Consensus       244 Rp~~~~il~~  253 (277)
T cd06640         244 RPTAKELLKH  253 (277)
T ss_pred             CcCHHHHHhC
Confidence            9999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=2.1e-29  Score=206.59  Aligned_cols=165  Identities=24%  Similarity=0.296  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++.......   .....++..|+|||++.+..++.
T Consensus       122 ~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  196 (353)
T cd07850         122 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKE  196 (353)
T ss_pred             HHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCC
Confidence            468999999999995  4699999999999999999999999999986533221   22346788999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHH-hhhhhh---cch----------------hhHHHHhhccc----C
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYL---SDK----------------RKLFRIMDTKL----G  136 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~-~~~~~~---~~~----------------~~~~~~~~~~~----~  136 (229)
                      ++|||||||++|+|++|+.||...+..... .+.. ...+..   ...                ...........    .
T Consensus       197 ~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (353)
T cd07850         197 NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS  276 (353)
T ss_pred             chhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCccc
Confidence            999999999999999999999765421100 0000 000000   000                00000000000    0


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          137 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       137 ~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ...+......+.+++.+||+.||.+|||+.++++.
T Consensus       277 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         277 ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             ccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00122346678899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=2.3e-29  Score=199.52  Aligned_cols=147  Identities=25%  Similarity=0.367  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-   80 (229)
                      +++.||+.|+.|+|  .++++|||||.+|||||.++++||+|||++..+...+   ...+++|++.|.+||++.|.+|. 
T Consensus       157 hfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~G  231 (668)
T KOG0611|consen  157 HFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKG  231 (668)
T ss_pred             HHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCC
Confidence            57999999999999  5679999999999999999999999999998765433   35678999999999999998885 


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ..+|-||||++||.|+.|..||++.+.                 ..+.+.+..+.-  ..+..+....-||+.||..||+
T Consensus       232 PEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------------k~lvrQIs~GaY--rEP~~PSdA~gLIRwmLmVNP~  292 (668)
T KOG0611|consen  232 PEVDSWSLGVLLYTLVYGTMPFDGRDH-----------------KRLVRQISRGAY--REPETPSDASGLIRWMLMVNPE  292 (668)
T ss_pred             CccchhhHHHHHHHHhhcccccCCchH-----------------HHHHHHhhcccc--cCCCCCchHHHHHHHHHhcCcc
Confidence            689999999999999999999998652                 112222221110  1122345677899999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +|.|+.+|....
T Consensus       293 RRATieDiAsHW  304 (668)
T KOG0611|consen  293 RRATIEDIASHW  304 (668)
T ss_pred             cchhHHHHhhhh
Confidence            999999998643

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=8.8e-30  Score=200.90  Aligned_cols=151  Identities=26%  Similarity=0.336  Sum_probs=111.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++........  ......++..|+|||.+.   ...
T Consensus       110 ~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  185 (267)
T cd06646         110 YVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGG  185 (267)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCC
Confidence            468899999999995  4699999999999999999999999999876532211  122346888999999884   345


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC---CCCcHHHHHHHHHHHHHhc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l  155 (229)
                      ++.++|+|||||++|||++|+.||.........                ..+......   .......+..+.+|+.+||
T Consensus       186 ~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  249 (267)
T cd06646         186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----------------FLMSKSNFQPPKLKDKTKWSSTFHNFVKISL  249 (267)
T ss_pred             CcchhhHHHHHHHHHHHHhCCCCccccchhhhh----------------eeeecCCCCCCCCccccccCHHHHHHHHHHh
Confidence            778999999999999999999998543211000                000000000   0111234568899999999


Q ss_pred             cCCCCCCCCHHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~l  172 (229)
                      +.+|++||++.++++.+
T Consensus       250 ~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         250 TKNPKKRPTAERLLTHL  266 (267)
T ss_pred             hCChhhCcCHHHHhcCC
Confidence            99999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=1.6e-29  Score=223.10  Aligned_cols=159  Identities=20%  Similarity=0.266  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC----------------cceeeccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----------------THVSTQVMGT   65 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----------------~~~~~~~~gt   65 (229)
                      +++.||+.||+|||+  .+|+||||||+|||++.++.++|+|||+++.......                .......+||
T Consensus       117 ~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT  194 (932)
T PRK13184        117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGT  194 (932)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCC
Confidence            578899999999995  4699999999999999999999999999976421100                0111235799


Q ss_pred             cccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHH
Q 027003           66 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH  145 (229)
Q Consensus        66 ~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (229)
                      +.|+|||++.+..++.++|||||||++|||+||+.||..........               ...+............+.
T Consensus       195 ~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~---------------~~~i~~P~~~~p~~~iP~  259 (932)
T PRK13184        195 PDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY---------------RDVILSPIEVAPYREIPP  259 (932)
T ss_pred             CCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh---------------hhhccChhhccccccCCH
Confidence            99999999999999999999999999999999999997633210000               000000000001123456


Q ss_pred             HHHHHHHHhccCCCCCCC-CHHHHHHHHHhhcC
Q 027003          146 TAATLALQCLNNEPKLRP-RMSEVLAILERLEA  177 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rp-t~~~v~~~l~~~~~  177 (229)
                      .+.+++.+||+.||++|+ ++.++++.|+....
T Consensus       260 ~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        260 FLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            788999999999999997 56677777776543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=195.61  Aligned_cols=137  Identities=30%  Similarity=0.499  Sum_probs=114.3

Q ss_pred             HHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccCc
Q 027003            5 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD   84 (229)
Q Consensus         5 ~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D   84 (229)
                      ..|+.||.|||+.  +||+||||.+|.|||++|++||+|||+++..  .........++||+.|+|||++....|..++|
T Consensus       275 aEIvsAL~YLHs~--~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVD  350 (516)
T KOG0690|consen  275 AEIVSALGYLHSR--NIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVD  350 (516)
T ss_pred             HHHHHHhhhhhhC--CeeeeechhhhheeccCCceEeeecccchhc--ccccceeccccCChhhcCchhhccccccceee
Confidence            5789999999964  5999999999999999999999999999863  33334466799999999999999999999999


Q ss_pred             eeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 027003           85 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP  163 (229)
Q Consensus        85 i~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  163 (229)
                      .|.+||++|||++|+.||...+                 ...++.++... ...+|...++++..|+..+|.+||.+|.
T Consensus       351 WWG~GVVMYEMmCGRLPFyn~d-----------------h~kLFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  351 WWGVGVVMYEMMCGRLPFYNKD-----------------HEKLFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hhhhhHHHHHHHhccCcccccc-----------------hhHHHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            9999999999999999997643                 23333332211 1256777888999999999999999996

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=3.7e-29  Score=201.54  Aligned_cols=165  Identities=25%  Similarity=0.434  Sum_probs=116.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+. .+++|+||||+|||++.++.++|+|||++.......    .....++..|+|||.+.+..++.
T Consensus       103 ~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~  177 (308)
T cd06615         103 KISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTV  177 (308)
T ss_pred             HHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCc
Confidence            5789999999999962 469999999999999999999999999987543221    23356889999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc----------------chhhHHHHhh---cccCCCCc-H
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS----------------DKRKLFRIMD---TKLGGQYP-Q  141 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~---~~~~~~~~-~  141 (229)
                      ++|+|||||++|+|++|+.||...+................                ......+...   .......+ .
T Consensus       178 ~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (308)
T cd06615         178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG  257 (308)
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCc
Confidence            99999999999999999999975442211111100000000                0000001111   11111111 1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..+..+.+|+.+||..||++||++.++++.
T Consensus       258 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         258 AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            246678999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.7e-29  Score=197.73  Aligned_cols=149  Identities=30%  Similarity=0.447  Sum_probs=112.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++........  ......++..|+|||++...    
T Consensus       117 ~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  192 (275)
T cd06608         117 YILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPD  192 (275)
T ss_pred             HHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhccccccc
Confidence            478899999999995  4699999999999999999999999999875433221  12345688999999988542    


Q ss_pred             -CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhc
Q 027003           78 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 -~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l  155 (229)
                       .++.++|||||||++|+|++|..||......                .....+..... ....+...+..+.+|+.+||
T Consensus       193 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (275)
T cd06608         193 ASYDARSDVWSLGITAIELADGKPPLCDMHPM----------------RALFKIPRNPPPTLKSPENWSKKFNDFISECL  256 (275)
T ss_pred             CCccccccHHHhHHHHHHHHhCCCCccccchH----------------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHh
Confidence             4677899999999999999999999653211                01111111111 11122335678899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      ..||++|||+.++++
T Consensus       257 ~~dp~~Rpt~~~ll~  271 (275)
T cd06608         257 IKNYEQRPFMEELLE  271 (275)
T ss_pred             hcChhhCcCHHHHhc
Confidence            999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.2e-29  Score=225.57  Aligned_cols=148  Identities=20%  Similarity=0.249  Sum_probs=102.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-------------------CcEEEcccCCcccCCCCCC-------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------FNAKLSDFGLAKAGPTGDR-------   55 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~-------   55 (229)
                      +++.||+.||+|||+  ++||||||||+||||+..                   +.+|++|||+++.......       
T Consensus        84 ~i~~qi~~al~~lH~--~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~  161 (793)
T PLN00181         84 HVFRQIVEIVNAAHS--QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLE  161 (793)
T ss_pred             HHHHHHHHHHHHHHh--CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhh
Confidence            578999999999995  569999999999999653                   4456666666653211000       


Q ss_pred             -------cceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHH
Q 027003           56 -------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  128 (229)
Q Consensus        56 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (229)
                             .......+||+.|+|||++.+..++.++|||||||+||||++|..|+.....    ...              
T Consensus       162 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~--------------  223 (793)
T PLN00181        162 EVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMS--------------  223 (793)
T ss_pred             ccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHH--------------
Confidence                   0001124688899999999999999999999999999999998877653210    000              


Q ss_pred             HHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+..... .............++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        224 SLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            0000000 0000111234567889999999999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=208.98  Aligned_cols=160  Identities=33%  Similarity=0.472  Sum_probs=130.4

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceee-ccccccccccccccccCCC
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~   79 (229)
                      ++++.+.|.||+|||+  +++|||||-.+|+|++.++.+||+|||+++...   ...... ...-...|+|||.+..+-+
T Consensus       265 ~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~  339 (474)
T KOG0194|consen  265 LRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIF  339 (474)
T ss_pred             HHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCcc
Confidence            3678999999999995  459999999999999999999999999988643   111111 1224678999999999999


Q ss_pred             cccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.++|||||||++||+.+ |..||.+...                .....++.....+...+...+..+..++.+||..|
T Consensus       340 s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----------------~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~  403 (474)
T KOG0194|consen  340 SFKTDVWSFGVLLWEIFENGAEPYPGMKN----------------YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKD  403 (474)
T ss_pred             ccccchhheeeeEEeeeccCCCCCCCCCH----------------HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCC
Confidence            999999999999999998 8889987542                22233444556666777788889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCC
Q 027003          159 PKLRPRMSEVLAILERLEAPKNS  181 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~~~~~~  181 (229)
                      |++||++.++.+.++.+......
T Consensus       404 p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  404 PEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             hhhccCHHHHHHHHHHHHhcccc
Confidence            99999999999999988765443

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=4.2e-29  Score=195.79  Aligned_cols=149  Identities=26%  Similarity=0.375  Sum_probs=116.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++........  ......++..|+|||.+.+..++.
T Consensus       105 ~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~  180 (256)
T cd08221         105 WYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNF  180 (256)
T ss_pred             HHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCC
Confidence            468899999999995  4599999999999999999999999999876533221  123456899999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|..||......                .....+..... ...+...+..+.+++.+||+.+|.+
T Consensus       181 ~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~  243 (256)
T cd08221         181 KSDIWALGCVLYELLTLKRTFDATNPL----------------NLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQDPEK  243 (256)
T ss_pred             cchhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCCC-CCCccccCHHHHHHHHHHcccCccc
Confidence            999999999999999999999764311                11111111111 1223445678899999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.++++.
T Consensus       244 R~s~~~ll~~  253 (256)
T cd08221         244 RPTADEVLDQ  253 (256)
T ss_pred             CCCHHHHhhC
Confidence            9999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=2.8e-29  Score=198.01  Aligned_cols=149  Identities=25%  Similarity=0.342  Sum_probs=110.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.......  .......|+..|+|||++.   ...
T Consensus       110 ~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  185 (267)
T cd06645         110 YVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGG  185 (267)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCC
Confidence            478899999999995  469999999999999999999999999987543221  1123456899999999874   456


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC---CcHHHHHHHHHHHHHhc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l  155 (229)
                      ++.++|+|||||++|+|++|..||........                ............   .....+..+.+++.+||
T Consensus       186 ~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  249 (267)
T cd06645         186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRA----------------LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL  249 (267)
T ss_pred             CCchhhhHHHHHHHHHHhcCCCCcccccchhh----------------HHhhhccCCCCCcccccCCCCHHHHHHHHHHc
Confidence            78899999999999999999999865331110                000000000000   01123456889999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.+|++||++.++++
T Consensus       250 ~~~P~~R~~~~~ll~  264 (267)
T cd06645         250 TKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCchhCcCHHHHhc
Confidence            999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=1.7e-29  Score=202.80  Aligned_cols=165  Identities=22%  Similarity=0.297  Sum_probs=112.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||+|||+  .+|+|+||||+|||++.++.++|+|||++.........  .....++..|+|||++.+. .++
T Consensus       108 ~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~  183 (301)
T cd07873         108 LFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYS  183 (301)
T ss_pred             HHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCc
Confidence            467899999999995  56999999999999999999999999998754322211  2234568899999988664 478


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhcchhhH------HHHhhcccCC----CCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKL------FRIMDTKLGG----QYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|+.||...+...... ..... .+........      ..........    ......+..+.
T Consensus       184 ~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (301)
T cd07873         184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA  263 (301)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHH
Confidence            89999999999999999999997654321110 00000 0000000000      0000000000    01113456788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.++++
T Consensus       264 ~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         264 ELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHHHHHhcCCcccCcCHHHHhc
Confidence            9999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=1.9e-29  Score=202.30  Aligned_cols=150  Identities=25%  Similarity=0.360  Sum_probs=114.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........  ......|+..|+|||++.+..++.
T Consensus       121 ~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  196 (297)
T cd06659         121 TVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGT  196 (297)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCc
Confidence            578999999999995  4699999999999999999999999999875433221  123356899999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++|..||.......  .              ...+.... .........+..+.+++.+||+.+|.
T Consensus       197 ~~Dv~slG~il~el~~g~~p~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~  260 (297)
T cd06659         197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQ--A--------------MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ  260 (297)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHH--H--------------HHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcc
Confidence            9999999999999999999997543110  0              00000000 00111223456788999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +||++.++++.
T Consensus       261 ~Rps~~~ll~~  271 (297)
T cd06659         261 ERATAQELLDH  271 (297)
T ss_pred             cCcCHHHHhhC
Confidence            99999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.8e-29  Score=202.77  Aligned_cols=151  Identities=25%  Similarity=0.351  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------------------------   57 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------------------------   57 (229)
                      .++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++..........                        
T Consensus       107 ~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (316)
T cd05574         107 FYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE  184 (316)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhccc
Confidence            467899999999995  569999999999999999999999999986542221100                        


Q ss_pred             ---eeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc
Q 027003           58 ---VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  134 (229)
Q Consensus        58 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (229)
                         .....+|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+..                ....++....
T Consensus       185 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----------------~~~~~~~~~~  248 (316)
T cd05574         185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD----------------ETFSNILKKE  248 (316)
T ss_pred             ccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH----------------HHHHHHhcCC
Confidence               011346888999999999888999999999999999999999999765421                1111222222


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 027003          135 LGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLA  170 (229)
Q Consensus       135 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~v~~  170 (229)
                      .........+..+.+++.+||+.||++||+    +.+++.
T Consensus       249 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         249 VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211222235788999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=1.3e-29  Score=203.18  Aligned_cols=149  Identities=27%  Similarity=0.387  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++||||||+|||++.++.++|+|||++.........  .....++..|++||.+.+..++.
T Consensus       119 ~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  194 (297)
T cd06656         119 AVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP  194 (297)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCc
Confidence            578899999999995  46999999999999999999999999998764332211  22346888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhh-cccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||...+.....                ..... .......+...+..+.+|+.+||+.+|+
T Consensus       195 ~~Di~slGvil~~l~tg~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  258 (297)
T cd06656         195 KVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------------YLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD  258 (297)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCcchhe----------------eeeccCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence            999999999999999999999764321000                00000 0001112334566788999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       259 ~Rps~~~il~  268 (297)
T cd06656         259 RRGSAKELLQ  268 (297)
T ss_pred             hCcCHHHHhc
Confidence            9999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=4.1e-29  Score=199.57  Aligned_cols=149  Identities=30%  Similarity=0.425  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.........  .....|+..|+|||.+...    
T Consensus       132 ~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  207 (291)
T cd06639         132 YILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYD  207 (291)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcc
Confidence            478999999999995  46999999999999999999999999998764332211  2234678899999988643    


Q ss_pred             -CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhc
Q 027003           78 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 -~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l  155 (229)
                       .++.++|+|||||++|+|++|+.||......                ..+.++..... ....+......+.+|+.+||
T Consensus       208 ~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  271 (291)
T cd06639         208 YSYDARCDVWSLGITAIELGDGDPPLFDMHPV----------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCL  271 (291)
T ss_pred             cccCCccchHHHHHHHHHHhhCCCCCCCCcHH----------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHh
Confidence             3678999999999999999999999754311                01111111100 01112334567899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.+|++||++.++++
T Consensus       272 ~~~p~~Rps~~~il~  286 (291)
T cd06639         272 IKDFEARPSVTHLLE  286 (291)
T ss_pred             hcChhhCcCHHHHhc
Confidence            999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=3.4e-29  Score=196.31  Aligned_cols=148  Identities=24%  Similarity=0.382  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.........  .....|+..|+|||++.+..++.
T Consensus       105 ~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~  180 (256)
T cd08218         105 DWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNN  180 (256)
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCC
Confidence            578999999999995  56999999999999999999999999998765332211  22345788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|..||...+..                .....+. .......+...+..+.+++.+||+.+|++
T Consensus       181 ~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~  243 (256)
T cd08218         181 KSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRD  243 (256)
T ss_pred             ccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhCChhh
Confidence            999999999999999999998653210                0111111 11122234456778999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       244 Rp~~~~vl~  252 (256)
T cd08218         244 RPSVNSILE  252 (256)
T ss_pred             CcCHHHHhh
Confidence            999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.96  E-value=4.6e-29  Score=196.97  Aligned_cols=150  Identities=25%  Similarity=0.449  Sum_probs=112.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC--
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--   78 (229)
                      .++.||+.||+|||+  ++|+||||||+||+++. ++.++|+|||++.........  .....++..|+|||.+.+..  
T Consensus       112 ~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  187 (268)
T cd06624         112 FYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRG  187 (268)
T ss_pred             HHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhhhcccccc
Confidence            467899999999995  56999999999999976 678999999998764332221  22345788999999986643  


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|+||||+++|+|++|..||........               ..............+......+.+++.+||+.+
T Consensus       188 ~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  252 (268)
T cd06624         188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQA---------------AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD  252 (268)
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCCccccChhh---------------hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCC
Confidence            78899999999999999999999865321100               000111111122344556778899999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+||++.+++.
T Consensus       253 p~~Rpt~~~ll~  264 (268)
T cd06624         253 PDKRASAHDLLQ  264 (268)
T ss_pred             chhCCCHHHHHh
Confidence            999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=9.1e-29  Score=199.12  Aligned_cols=146  Identities=29%  Similarity=0.424  Sum_probs=111.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+  .+|+||||+|+||+++.++.++|+|||++......      ....++..|+|||++.   ...
T Consensus       119 ~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~  190 (307)
T cd06607         119 AICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQ  190 (307)
T ss_pred             HHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCC
Confidence            478899999999995  56999999999999999999999999998754322      2345788999999884   356


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++||||||+++|||++|..||...+...                ....+.............+..+.+++.+||+.|
T Consensus       191 ~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  254 (307)
T cd06607         191 YDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKI  254 (307)
T ss_pred             CCcccchHHHHHHHHHHHcCCCCCCCccHHH----------------HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCC
Confidence            7889999999999999999999986643111                001111111111112345677899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027003          159 PKLRPRMSEVLAI  171 (229)
Q Consensus       159 P~~Rpt~~~v~~~  171 (229)
                      |++||++.+++..
T Consensus       255 p~~Rp~~~~il~~  267 (307)
T cd06607         255 PQDRPSSEELLKH  267 (307)
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=3.9e-29  Score=196.97  Aligned_cols=151  Identities=25%  Similarity=0.384  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC----CcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD----RTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.|++.||+|||+  .+|+|+||||+||+++.++.++|+|||++.......    .........++..|+|||.+.+.
T Consensus       106 ~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  183 (265)
T cd06631         106 KYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES  183 (265)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC
Confidence            467899999999995  469999999999999999999999999987542211    11112235688999999999888


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhcc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      .++.++|+|||||++|+|++|..||...+....                ...+... ......+...+..+.+++.+||+
T Consensus       184 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  247 (265)
T cd06631         184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----------------MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLT  247 (265)
T ss_pred             CCcchhhHHHHHHHHHHHHhCCCccccCChHHH----------------HHHhhhccCCCCCCCCCCCHHHHHHHHHHhc
Confidence            899999999999999999999999975431100                0000000 11122334466788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .+|++||++.+++.
T Consensus       248 ~~p~~Rp~~~~~l~  261 (265)
T cd06631         248 RDQHERPSALQLLR  261 (265)
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=3.3e-29  Score=197.24  Aligned_cols=152  Identities=31%  Similarity=0.491  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||++........    ....++..|+|||.+.+..++.
T Consensus       104 ~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~  178 (265)
T cd06605         104 KIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSV  178 (265)
T ss_pred             HHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCc
Confidence            578999999999996 15699999999999999999999999999875432211    1256888999999998889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHH-HHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||.......... .          ........ ......+.. .+..+.++|.+||..||+
T Consensus       179 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~----------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~  246 (265)
T cd06605         179 KSDIWSLGLSLIELATGRFPYPPENDPPDGI-F----------ELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPR  246 (265)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCccccccccH-H----------HHHHHHhc-CCCCCCChhhcCHHHHHHHHHHcCCCch
Confidence            9999999999999999999997543211000 0          01111111 111122222 677899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.+++.
T Consensus       247 ~Rpt~~~ll~  256 (265)
T cd06605         247 ERPSYKELLE  256 (265)
T ss_pred             hCcCHHHHhh
Confidence            9999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.4e-29  Score=202.10  Aligned_cols=151  Identities=23%  Similarity=0.273  Sum_probs=108.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+     
T Consensus       106 ~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  182 (331)
T cd05597         106 FYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGK  182 (331)
T ss_pred             HHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccc
Confidence            467899999999995  46999999999999999999999999998754332221 1223468999999999863     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC---CcHHHHHHHHHHHHH
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQ  153 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~  153 (229)
                      ..++.++|||||||++|+|++|+.||.+....                .....+........   .....+..+.+|+.+
T Consensus       183 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~  246 (331)
T cd05597         183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR  246 (331)
T ss_pred             cCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----------------HHHHHHHcCCCcccCCCccCCCCHHHHHHHHH
Confidence            34678999999999999999999999764321                01111111111111   112356778899999


Q ss_pred             hccCCCC--CCCCHHHHHHH
Q 027003          154 CLNNEPK--LRPRMSEVLAI  171 (229)
Q Consensus       154 ~l~~dP~--~Rpt~~~v~~~  171 (229)
                      ||..+++  .|+++.++++.
T Consensus       247 ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         247 LICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HccCcccccCCCCHHHHhcC
Confidence            8865443  37899998864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=4.9e-29  Score=198.52  Aligned_cols=150  Identities=28%  Similarity=0.384  Sum_probs=111.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+++........  .....|+..|+|||++..     
T Consensus       128 ~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  203 (286)
T cd06638         128 YILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLD  203 (286)
T ss_pred             HHHHHHHHHHHHHHh--CCccccCCCHHhEEECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhcc
Confidence            378899999999995  46999999999999999999999999998765332211  223468999999998853     


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|+|||||++|+|++|+.||.......                ........ ......+......+.+|+.+||
T Consensus       204 ~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  267 (286)
T cd06638         204 STYDARCDVWSLGITAIELGDGDPPLADLHPMR----------------ALFKIPRNPPPTLHQPELWSNEFNDFIRKCL  267 (286)
T ss_pred             ccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----------------HHhhccccCCCcccCCCCcCHHHHHHHHHHc
Confidence            347889999999999999999999997543110                00000000 0001112234567889999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      +.||++||++.++++.
T Consensus       268 ~~~p~~Rps~~ell~~  283 (286)
T cd06638         268 TKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCcccCCCHHHHhhc
Confidence            9999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.3e-29  Score=194.67  Aligned_cols=168  Identities=23%  Similarity=0.300  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC----CcEEEcccCCcccCCCCCCcc-eeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~   76 (229)
                      +|+.||+.|+.|||+..  |+||||||.|||+..+    |.|||+|||+++.+.+.-... ....++-|.+|.|||.+.|
T Consensus       136 silwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG  213 (438)
T KOG0666|consen  136 SILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG  213 (438)
T ss_pred             HHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence            47899999999999755  9999999999999877    899999999999875432221 1234567999999999988


Q ss_pred             C-CCcccCceeehhHHHHHHHhCCCcCCCCccccchh----------HHH-hhhhhhcchhhHHHHhh-----cccCCCC
Q 027003           77 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS----------LVD-WAKPYLSDKRKLFRIMD-----TKLGGQY  139 (229)
Q Consensus        77 ~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~  139 (229)
                      . .|+.+.|+|+.|||+.||+|-++.|.+........          +.. ...|...++..+.+.-+     ..++..+
T Consensus       214 a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~  293 (438)
T KOG0666|consen  214 ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHY  293 (438)
T ss_pred             cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhh
Confidence            6 58999999999999999999999998765432211          000 00111111111111000     0000000


Q ss_pred             cH------------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          140 PQ------------KAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       140 ~~------------~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..            ..++...+|+.++|+.||.+|.|+.+.++.
T Consensus       294 ~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  294 YDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             cCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            00            112347799999999999999999999874

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=5.8e-29  Score=198.29  Aligned_cols=149  Identities=27%  Similarity=0.368  Sum_probs=113.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||+|+||+++.++.++|+|||++........  ......|+..|+|||.+.+..++.
T Consensus       119 ~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  194 (285)
T cd06648         119 TVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGT  194 (285)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCC
Confidence            578999999999995  4699999999999999999999999998765432221  123356889999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|+.||...+...                ....+.... .........+..+.+++.+||+.+|+
T Consensus       195 ~~Dv~slGv~l~ell~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (285)
T cd06648         195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQ----------------AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA  258 (285)
T ss_pred             cccHHHHHHHHHHHHhCCCCCcCCCHHH----------------HHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChh
Confidence            9999999999999999999986533110                000111000 00111222556899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       259 ~Rpt~~~il~  268 (285)
T cd06648         259 QRATAAELLN  268 (285)
T ss_pred             hCcCHHHHcc
Confidence            9999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=1.1e-28  Score=195.18  Aligned_cols=151  Identities=26%  Similarity=0.439  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC--C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--L   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~   79 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..  +
T Consensus       112 ~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  189 (272)
T cd06629         112 FFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGY  189 (272)
T ss_pred             HHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCC
Confidence            367899999999995  469999999999999999999999999987643322222223346888999999987654  7


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc----cCCCCcHHHHHHHHHHHHHhc
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l  155 (229)
                      +.++|+||||+++|++++|..||......                ....+.....    ........++..+.+++.+||
T Consensus       190 ~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (272)
T cd06629         190 SAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------------AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACF  253 (272)
T ss_pred             CccchhHHHHHHHHHHHhCCCCCcCcchH----------------HHHHHhhccccCCcCCccccccCCHHHHHHHHHHh
Confidence            88999999999999999999999643210                0011111111    111122345678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      ..+|++||++.+++.
T Consensus       254 ~~~p~~Rps~~~il~  268 (272)
T cd06629         254 TINPDNRPTARELLQ  268 (272)
T ss_pred             cCChhhCCCHHHHhh
Confidence            999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=8.8e-29  Score=194.84  Aligned_cols=154  Identities=29%  Similarity=0.416  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~   78 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++.........  .......|+..|++||++... .
T Consensus       106 ~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~  183 (267)
T cd06610         106 TVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG  183 (267)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccC
Confidence            468999999999995  56999999999999999999999999998765443222  122345688999999998776 7


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC-CcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|+|||||++|+|++|+.||.......  .+......           ........ .....+..+.+++.+||+.
T Consensus       184 ~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~  250 (267)
T cd06610         184 YDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN-----------DPPSLETGADYKKYSKSFRKMISLCLQK  250 (267)
T ss_pred             cCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC-----------CCCCcCCccccccccHHHHHHHHHHcCC
Confidence            8899999999999999999999997643210  01100000           00000000 1124567889999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||++||++.++++
T Consensus       251 ~p~~Rp~~~~ll~  263 (267)
T cd06610         251 DPSKRPTAEELLK  263 (267)
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=6.4e-29  Score=197.36  Aligned_cols=148  Identities=29%  Similarity=0.436  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.......    .....|+..|+|||.+.++ .++
T Consensus       101 ~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  174 (278)
T cd05606         101 FYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYD  174 (278)
T ss_pred             HHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCC
Confidence            578999999999995  469999999999999999999999999987543322    1234689999999998754 688


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||..........              ..+.. .......+...+..+.+++.+||..+|.
T Consensus       175 ~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             cccchHhHHHHHHHHHhCCCCCCCCCccchHH--------------HHHHh-hccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            99999999999999999999997653211110              00111 1112233444577899999999999999


Q ss_pred             CCC-----CHHHHHH
Q 027003          161 LRP-----RMSEVLA  170 (229)
Q Consensus       161 ~Rp-----t~~~v~~  170 (229)
                      +||     ++.++++
T Consensus       240 ~R~~~~~~~~~~ll~  254 (278)
T cd05606         240 RRLGCLGRGAQEVKE  254 (278)
T ss_pred             hccCCCCCCHHHHHh
Confidence            999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=196.13  Aligned_cols=140  Identities=32%  Similarity=0.500  Sum_probs=116.5

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      .+..|+.||-|||+  +|||+||||.+||||+.+|++||+|||+++..--.  ...+.+++||+.|+|||++...+|+.+
T Consensus       455 YAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgks  530 (683)
T KOG0696|consen  455 YAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKS  530 (683)
T ss_pred             hhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEecccccc
Confidence            46789999999995  56999999999999999999999999999853222  223567899999999999999999999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      +|.||||++||||+.|++||++.+..                +....+.+..  ..+|...+.++..++...|.+.|.+|
T Consensus       531 vDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kR  592 (683)
T KOG0696|consen  531 VDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKR  592 (683)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccc
Confidence            99999999999999999999986532                1122223222  36778889999999999999999999


Q ss_pred             CC
Q 027003          163 PR  164 (229)
Q Consensus       163 pt  164 (229)
                      ..
T Consensus       593 LG  594 (683)
T KOG0696|consen  593 LG  594 (683)
T ss_pred             cC
Confidence            64

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=8.7e-29  Score=194.69  Aligned_cols=150  Identities=28%  Similarity=0.408  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.......   ......++..|++||.+.+..++.
T Consensus        97 ~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~  171 (262)
T cd05572          97 FYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF  171 (262)
T ss_pred             HHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCC
Confidence            467899999999995  569999999999999999999999999998654332   123346888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||.......              ......+.........+...+..+.+++.+||+.+|++
T Consensus       172 ~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  237 (262)
T cd05572         172 SVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE  237 (262)
T ss_pred             hhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence            9999999999999999999997654210              11111222112233444455788999999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      ||+     +.|+++
T Consensus       238 R~~~~~~~~~~l~~  251 (262)
T cd05572         238 RLGNLKGGIKDIKK  251 (262)
T ss_pred             CcCCcccCHHHHhc
Confidence            999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-29  Score=207.40  Aligned_cols=153  Identities=23%  Similarity=0.384  Sum_probs=127.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|||.||.||.+  +++|||||-..|+||-....|||+|||+.+.+..+... .+.....-...|+|||.++...++
T Consensus       216 dya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS  293 (1039)
T KOG0199|consen  216 DYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS  293 (1039)
T ss_pred             HHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc
Confidence            468999999999995  56999999999999999999999999999987655433 222333446789999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|+|+|||+||||+| |+.||.+..                 ...+.+.++.+.+...+..+++.+++++.+||..+|
T Consensus       294 haSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~p  356 (1039)
T KOG0199|consen  294 HASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNP  356 (1039)
T ss_pred             ccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCc
Confidence            99999999999999998 889998753                 223344455666677788899999999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 027003          160 KLRPRMSEVLAILE  173 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~  173 (229)
                      .+||++..+.+.+-
T Consensus       357 aDRptFsair~~~~  370 (1039)
T KOG0199|consen  357 ADRPTFSAIREDLV  370 (1039)
T ss_pred             cccccHHHHHHhHH
Confidence            99999999986543

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=1e-28  Score=193.45  Aligned_cols=147  Identities=29%  Similarity=0.449  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.+++.||+|||+  ++++|+||||+||+++.++ .++|+|||++........   .....++..|+|||.+.+..++
T Consensus       105 ~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~  179 (256)
T cd08220         105 HFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYN  179 (256)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCC
Confidence            578899999999995  5699999999999998654 579999999986543221   2235688899999999888889


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+||||+++|+|++|..||...+...                ....+. .......+...+..+.+++.+||+.+|+
T Consensus       180 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----------------~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~  242 (256)
T cd08220         180 QKSDIWALGCVLYELASLKRAFEAANLPA----------------LVLKIM-SGTFAPISDRYSPDLRQLILSMLNLDPS  242 (256)
T ss_pred             cccchHHHHHHHHHHHhCCCCcccCchHH----------------HHHHHH-hcCCCCCCCCcCHHHHHHHHHHccCChh
Confidence            99999999999999999999997643211                011111 1111223344667889999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.+++.
T Consensus       243 ~Rpt~~~ll~  252 (256)
T cd08220         243 KRPQLSQIMA  252 (256)
T ss_pred             hCCCHHHHhh
Confidence            9999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=4.3e-29  Score=198.86  Aligned_cols=166  Identities=26%  Similarity=0.366  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||.|||.  .+++|+||+|+||+++.++.+||+|||++......... ......++..|+|||++.+. .++
T Consensus       104 ~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~  180 (288)
T cd07833         104 SYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYG  180 (288)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcC
Confidence            478899999999995  46999999999999999999999999998865443321 12345678899999999888 788


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhHHH---Hhhc-c---------cCCCCcHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFR---IMDT-K---------LGGQYPQKAAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~-~---------~~~~~~~~~~~~  146 (229)
                      .++|+||||+++|+|++|+.||.+........ .................   .... .         ....++..++..
T Consensus       181 ~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (288)
T cd07833         181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP  260 (288)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchH
Confidence            99999999999999999999997643211100 00000000000000000   0000 0         000122234678


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||..+|++||++.++++
T Consensus       261 ~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         261 ALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHHHHHhccCchhcccHHHHhc
Confidence            999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=1.8e-28  Score=198.35  Aligned_cols=149  Identities=29%  Similarity=0.437  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+  .+|+||||+|+||+++.++.++|+|||++.....      .....++..|+|||.+.   ++.
T Consensus       129 ~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~  200 (317)
T cd06635         129 AITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQ  200 (317)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCC
Confidence            468899999999995  5699999999999999999999999999865332      12346788999999874   456


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|+|||||++|+|++|..||.....                ......+.............+..+.+++.+||+.+
T Consensus       201 ~~~~~Dv~slGvil~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  264 (317)
T cd06635         201 YDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI  264 (317)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCccH----------------HHHHHHHHhccCCCCCCccccHHHHHHHHHHccCC
Confidence            88899999999999999999999865321                11111111111111222345667899999999999


Q ss_pred             CCCCCCHHHHHHHHHh
Q 027003          159 PKLRPRMSEVLAILER  174 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~  174 (229)
                      |.+||++.++++.+..
T Consensus       265 p~~Rpt~~~il~~~~~  280 (317)
T cd06635         265 PQDRPTSEELLKHMFV  280 (317)
T ss_pred             cccCcCHHHHHhChhh
Confidence            9999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-29  Score=209.23  Aligned_cols=155  Identities=28%  Similarity=0.394  Sum_probs=130.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      ..+.||+.||.|||+  +.+|||||-..|||+....-|||+|||+++...+...+... ...-...|||||.+.-.+++.
T Consensus       495 ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTt  571 (974)
T KOG4257|consen  495 LYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTT  571 (974)
T ss_pred             HHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccc
Confidence            368999999999996  45999999999999999999999999999998777666544 334567899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||-|||++||++. |..||.+-...                 ...-.+.++.+.++|++++..++.|+.+||..+|.
T Consensus       572 ASDVWMFgVCmWEIl~lGvkPfqgvkNs-----------------DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~  634 (974)
T KOG4257|consen  572 ASDVWMFGVCMWEILSLGVKPFQGVKNS-----------------DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPS  634 (974)
T ss_pred             hhhHHHHHHHHHHHHHhcCCcccccccc-----------------ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcc
Confidence            9999999999999975 99999875421                 11222345666788999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++...|..+.
T Consensus       635 kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  635 KRPRFTEIKAILSDVL  650 (974)
T ss_pred             cCCcHHHHHHHHHHHH
Confidence            9999999998776653

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=6.7e-29  Score=201.63  Aligned_cols=167  Identities=21%  Similarity=0.279  Sum_probs=110.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-c----ceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-T----HVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~----~~~~~~~gt~~y~aPE~~~~   76 (229)
                      +++.|++.||+|||+  .+|+||||||+|||++.++.++++||+.......... .    .......++..|+|||++.+
T Consensus       105 ~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  182 (327)
T cd08227         105 YILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ  182 (327)
T ss_pred             HHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhc
Confidence            578999999999995  4699999999999999999999999986543211110 0    01122356778999999976


Q ss_pred             --CCCcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhh--HHHH---------------------
Q 027003           77 --GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRK--LFRI---------------------  130 (229)
Q Consensus        77 --~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~---------------------  130 (229)
                        ..++.++|||||||++|||++|..||.......... ......+...+...  ....                     
T Consensus       183 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (327)
T cd08227         183 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVST  262 (327)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCC
Confidence              358899999999999999999999997543211000 00000000000000  0000                     


Q ss_pred             ----hhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          131 ----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       131 ----~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                          .............+..+.+|+.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         263 PRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                0000001112234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=9e-29  Score=196.83  Aligned_cols=165  Identities=23%  Similarity=0.313  Sum_probs=113.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+ ..++
T Consensus       104 ~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  179 (286)
T cd07847         104 KIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYG  179 (286)
T ss_pred             HHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcC
Confidence            578999999999995  56999999999999999999999999999865433211  223457889999999876 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhH------HH-HhhcccCCC-----CcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKL------FR-IMDTKLGGQ-----YPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~-~~~~~~~~~-----~~~~~~~~~  147 (229)
                      .++|+|||||++|+|++|..||.+........ ...............      .. .........     .....+..+
T Consensus       180 ~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (286)
T cd07847         180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPA  259 (286)
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHH
Confidence            89999999999999999999997654321110 000000000000000      00 000000000     011235678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+.+||+.||++||++.+++.
T Consensus       260 ~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         260 LSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHHHHHHhcCCccccCCHHHHhc
Confidence            89999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=213.98  Aligned_cols=157  Identities=26%  Similarity=0.434  Sum_probs=128.1

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecc-ccccccccccccccCCC
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV-MGTHGYAAPEYVATGRL   79 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~   79 (229)
                      ++++.|||.|++||++  .++|||||-..|||+..+..+||+|||+++.......+...... .-...|||||.+....|
T Consensus       421 lsfa~QIa~GMe~L~~--~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f  498 (609)
T KOG0200|consen  421 LSFAYQIANGMEYLAS--VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF  498 (609)
T ss_pred             HHHHHHHHHHHHHHhh--CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence            4689999999999995  45999999999999999999999999999965444444322111 12456999999999999


Q ss_pred             cccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.++||||||++||||+| |..||.+..                ....+.+.+..+.+...|..+..++.++++.||+.+
T Consensus       499 t~kSDVWSfGI~L~EifsLG~~PYp~~~----------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~  562 (609)
T KOG0200|consen  499 TSKSDVWSFGILLWEIFTLGGTPYPGIP----------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNAD  562 (609)
T ss_pred             cccchhhHHHHHHHHHhhCCCCCCCCCC----------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCC
Confidence            999999999999999998 888887621                112234455666667778888999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 027003          159 PKLRPRMSEVLAILERL  175 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~  175 (229)
                      |++||++.++.+.++..
T Consensus       563 p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  563 PEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cccCCCHHHHHHHHHHH
Confidence            99999999999999874

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=7.6e-29  Score=196.57  Aligned_cols=144  Identities=31%  Similarity=0.445  Sum_probs=107.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-------cEEEcccCCcccCCCCCCcceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   74 (229)
                      +++.|++.||+|||+  ++|+||||||+|||++..+       .+|++|||++......      ....++..|+|||.+
T Consensus       121 ~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~  192 (274)
T cd05076         121 TVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECV  192 (274)
T ss_pred             HHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhh
Confidence            578999999999995  5699999999999997643       3799999987643221      123467889999988


Q ss_pred             cc-CCCcccCceeehhHHHHHHH-hCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHH
Q 027003           75 AT-GRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  152 (229)
Q Consensus        75 ~~-~~~~~~~Di~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  152 (229)
                      .+ ..++.++|+|||||++|||+ +|..||.........                 .......  ..+......+.+++.
T Consensus       193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~~~li~  253 (274)
T cd05076         193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-----------------RFYEKKH--RLPEPSCKELATLIS  253 (274)
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-----------------HHHHhcc--CCCCCCChHHHHHHH
Confidence            65 46789999999999999995 689988764321100                 1111111  111222346889999


Q ss_pred             HhccCCCCCCCCHHHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      +||+.+|++||++.++++.|
T Consensus       254 ~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         254 QCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHcccChhhCcCHHHHHHhh
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=9.1e-29  Score=196.44  Aligned_cols=160  Identities=23%  Similarity=0.282  Sum_probs=112.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||+|||+  .+++||||||+||+++. +.+||+|||+++.......   .....++..|+|||.+.+ ..++
T Consensus       104 ~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  177 (282)
T cd07831         104 SYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYG  177 (282)
T ss_pred             HHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCC
Confidence            578999999999995  56999999999999999 9999999999976533222   123457889999997654 4568


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhhhhhcchhhHHHHhhcc--cCCCC-----------cHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYLSDKRKLFRIMDTK--LGGQY-----------PQKAAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------~~~~~~~  146 (229)
                      .++|+|||||++|||++|..||.+.+.... .........   ....+.......  .....           ....+..
T Consensus       178 ~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (282)
T cd07831         178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT---PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAE  254 (282)
T ss_pred             cchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCC---CCHHHHHhhcccccccccCcccccccHHHHcccccHH
Confidence            899999999999999999999976543111 001100000   000000000000  00000           1234688


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||+.+|++||++.++++
T Consensus       255 ~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         255 GLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHHHHHhccCcccccCHHHHhh
Confidence            999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-28  Score=200.42  Aligned_cols=166  Identities=27%  Similarity=0.351  Sum_probs=113.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeecccccccccccccccc-CCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~   79 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||++......... .......|+..|+|||.+.+ ..+
T Consensus       110 ~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  187 (336)
T cd07849         110 YFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY  187 (336)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCC
Confidence            468899999999995  46999999999999999999999999998764332211 11223568899999998755 468


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhHHHHhhc-------cc--CCCC-----cHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMDT-------KL--GGQY-----PQKAA  144 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~-----~~~~~  144 (229)
                      +.++|||||||++|+|++|+.||.+.+...... .......  ........+...       ..  ....     ....+
T Consensus       188 ~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (336)
T cd07849         188 TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT--PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNAD  265 (336)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC--CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccC
Confidence            889999999999999999999997654211100 0000000  000000000000       00  0000     11235


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..+.+++.+||+.||++|||+.++++.
T Consensus       266 ~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         266 PKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            678899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=9.1e-29  Score=193.81  Aligned_cols=148  Identities=30%  Similarity=0.465  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      .++.|++.||+|||+  .+++|+||+|+||+++.++.+||+|||++.......   ......++..|++||.+.... ++
T Consensus       106 ~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~  180 (258)
T cd06632         106 LYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYG  180 (258)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCC
Confidence            468899999999995  469999999999999999999999999987643322   123456889999999987766 88


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|+|++|+.||......                ...............+......+.+++.+||+.+|+
T Consensus       181 ~~~D~~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  244 (258)
T cd06632         181 LAADIWSLGCTVLEMATGKPPWSQLEGV----------------AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS  244 (258)
T ss_pred             chhhhHHHHHHHHHHHhCCCCcccCcHH----------------HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcc
Confidence            9999999999999999999999764310                011111111112233445567889999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.+++.
T Consensus       245 ~Rp~~~~~l~  254 (258)
T cd06632         245 LRPTAAELLE  254 (258)
T ss_pred             cCcCHHHHhc
Confidence            9999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=1.5e-28  Score=193.81  Aligned_cols=154  Identities=26%  Similarity=0.457  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.|++.||.|||+  ++++|+||||+||+++.++ .++|+|||++.........  .......++..|+|||.+.+..
T Consensus       107 ~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  184 (268)
T cd06630         107 NYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ  184 (268)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC
Confidence            578999999999995  4699999999999998776 5899999998765332111  1122356888999999998888


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|+|||||++|+|++|..||.........             ...............+......+.+++.+||+.+
T Consensus       185 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  251 (268)
T cd06630         185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-------------ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ  251 (268)
T ss_pred             CCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-------------HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCC
Confidence            999999999999999999999999654321110             1111111122233455667788999999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |++||++.++++
T Consensus       252 p~~R~~~~~ll~  263 (268)
T cd06630         252 PEDRPPSRELLK  263 (268)
T ss_pred             cccCcCHHHHhc
Confidence            999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=4.7e-29  Score=202.94  Aligned_cols=167  Identities=26%  Similarity=0.337  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeecccccccccccccccc-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT-GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~   78 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++........  .......|+..|+|||.+.+ ..
T Consensus       109 ~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  186 (332)
T cd07857         109 SFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS  186 (332)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCC
Confidence            478999999999995  56999999999999999999999999999764332211  11233578999999998766 46


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhh-hhhh-------cch-hhHHHHhhcccCCC---CcHHHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWA-KPYL-------SDK-RKLFRIMDTKLGGQ---YPQKAAH  145 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~-~~~~-------~~~-~~~~~~~~~~~~~~---~~~~~~~  145 (229)
                      ++.++|+|||||++|+|++|..||...+.... ....... .+..       ... ..............   .......
T Consensus       187 ~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (332)
T cd07857         187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP  266 (332)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCH
Confidence            78999999999999999999999976542110 0000000 0000       000 00000000000000   0112356


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+.+|+.+||+.||.+|||+.+++.
T Consensus       267 ~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         267 LALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhc
Confidence            7889999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=5.2e-29  Score=199.15  Aligned_cols=165  Identities=24%  Similarity=0.307  Sum_probs=114.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      +++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+.. ++
T Consensus       110 ~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  185 (293)
T cd07843         110 CLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYS  185 (293)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCcccc
Confidence            578999999999995  46999999999999999999999999998865433211  22345788999999987654 68


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHH-hhhhhhcchh-----------hHHHHhhcccCCCCcHH-HHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKR-----------KLFRIMDTKLGGQYPQK-AAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-~~~~  146 (229)
                      .++|+||||+++|+|++|..||.......... +.. +..+......           ..............+.. .+..
T Consensus       186 ~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (293)
T cd07843         186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDN  265 (293)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChH
Confidence            89999999999999999999997654321110 000 0000000000           00000000111112222 4677


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+++.+||+.||++|||+.|+++
T Consensus       266 ~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         266 GFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHHHHhccCccccCCHHHHhc
Confidence            889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1e-28  Score=196.15  Aligned_cols=150  Identities=31%  Similarity=0.445  Sum_probs=113.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      +++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++........  ......++..|++||.+.     +
T Consensus       107 ~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  182 (280)
T cd06611         107 YVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKD  182 (280)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCC
Confidence            578999999999995  5699999999999999999999999999875433221  123356899999999875     3


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|+|||||++|+|++|..||......                ....++.... .....+...+..+.+++.+||
T Consensus       183 ~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  246 (280)
T cd06611         183 NPYDYKADIWSLGITLIELAQMEPPHHELNPM----------------RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCL  246 (280)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCcccCCHH----------------HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHh
Confidence            34677999999999999999999999764311                0011111110 011223345678899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      +.+|.+||++.++++.
T Consensus       247 ~~~p~~Rps~~~il~~  262 (280)
T cd06611         247 VKDPDDRPTAAELLKH  262 (280)
T ss_pred             ccChhhCcCHHHHhcC
Confidence            9999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=1.1e-28  Score=197.62  Aligned_cols=151  Identities=30%  Similarity=0.446  Sum_probs=112.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      +++.|++.||.|||+. .+|+||||+|+||+++.++.+||+|||++........   .....++..|+|||.+.+..   
T Consensus       118 ~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  193 (296)
T cd06618         118 KMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNP  193 (296)
T ss_pred             HHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCcc
Confidence            5889999999999962 4699999999999999999999999999875433221   12235788999999987654   


Q ss_pred             -CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC-CCCcHHHHHHHHHHHHHhcc
Q 027003           79 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 -~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~  156 (229)
                       ++.++|+||||+++|+|++|+.||......               ...+......... ......+...+.+|+.+||+
T Consensus       194 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (296)
T cd06618         194 KYDIRADVWSLGISLVELATGQFPYKNCKTE---------------FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLT  258 (296)
T ss_pred             ccccchhHHHHHHHHHHHHhCCCCCCcchhH---------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHcc
Confidence             788999999999999999999999653211               0111111111110 01111345678999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||.+||++.+++..
T Consensus       259 ~~p~~Rp~~~~il~~  273 (296)
T cd06618         259 KDHRKRPKYRELLQH  273 (296)
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7e-29  Score=195.02  Aligned_cols=147  Identities=26%  Similarity=0.336  Sum_probs=112.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++.....      .....++..|++||.+.+..++.
T Consensus       101 ~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~  172 (260)
T cd05611         101 QYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDK  172 (260)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcc
Confidence            578999999999995  4699999999999999999999999999875432      22345788999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|+||||+++|+|++|..||...+....                ...+....  ........++..+.+++.+||+.+|
T Consensus       173 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         173 MSDWWSLGCVIFEFLFGYPPFHAETPDAV----------------FDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             hhhhHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence            99999999999999999999976432110                00111111  1111222456789999999999999


Q ss_pred             CCCCCHHHHHHHH
Q 027003          160 KLRPRMSEVLAIL  172 (229)
Q Consensus       160 ~~Rpt~~~v~~~l  172 (229)
                      ++||++.++.+.+
T Consensus       237 ~~R~~~~~~~~~l  249 (260)
T cd05611         237 AKRLGANGYQEIK  249 (260)
T ss_pred             HHccCCCcHHHHH
Confidence            9999776554433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=1e-28  Score=201.39  Aligned_cols=168  Identities=29%  Similarity=0.362  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc---ceeecccccccccccccccc-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVAT-G   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~   77 (229)
                      .++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.........   .......|+..|+|||.+.+ .
T Consensus       111 ~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  188 (337)
T cd07852         111 YIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST  188 (337)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccc
Confidence            478999999999995  56999999999999999999999999998765433221   12234568999999998765 4


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhcch-----hhHHHHhhcc---cCC---CCcHHHH
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDK-----RKLFRIMDTK---LGG---QYPQKAA  144 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~-----~~~~~~~~~~---~~~---~~~~~~~  144 (229)
                      .++.++|+|||||++|+|++|+.||.+........ ...... +.....     .....++...   ...   ......+
T Consensus       189 ~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (337)
T cd07852         189 RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKAS  268 (337)
T ss_pred             cccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCC
Confidence            57889999999999999999999997644321110 000000 000000     0000001000   000   0111246


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..+.+++.+||+.||++|||+.++++.
T Consensus       269 ~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         269 DDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHHhccCCcccccCHHHHhhC
Confidence            778999999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=1.4e-28  Score=211.77  Aligned_cols=163  Identities=19%  Similarity=0.219  Sum_probs=105.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---   77 (229)
                      +++.||+.||.|||+  .+|+||||||+|||++. ++.+||+|||+++........ .....++++.|+|||.+...   
T Consensus       259 ~i~~qll~aL~yLH~--~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~  335 (566)
T PLN03225        259 TIMRQILFALDGLHS--TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQT  335 (566)
T ss_pred             HHHHHHHHHHHHHHH--CCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCC
Confidence            478899999999995  46999999999999986 578999999999764332221 23456789999999976432   


Q ss_pred             -------------------CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC-
Q 027003           78 -------------------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG-  137 (229)
Q Consensus        78 -------------------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  137 (229)
                                         .++.++|||||||++|||+++..+++.........+.    ....+...+.......... 
T Consensus       336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~----~~~~~~~~~~~~~~~~~~~~  411 (566)
T PLN03225        336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLK----RNDYDLVAWRKLVEPRASPD  411 (566)
T ss_pred             CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHH----hcCCcHHHHHHhhccccchh
Confidence                               2344679999999999999977654432110000000    0000001111111111000 


Q ss_pred             -----CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          138 -----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       138 -----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                           ...+.......+|+.+||+.||.+|||+.++++.
T Consensus       412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence                 0011122345689999999999999999999974

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=1.8e-28  Score=197.54  Aligned_cols=147  Identities=29%  Similarity=0.405  Sum_probs=112.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++......      ....++..|+|||.+.   ...
T Consensus       119 ~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~  190 (308)
T cd06634         119 AVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQ  190 (308)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCC
Confidence            467899999999995  56999999999999999999999999998754321      2345788999999874   346


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|+|++|..||......                ...................+..+.+|+.+||+.+
T Consensus       191 ~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  254 (308)
T cd06634         191 YDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI  254 (308)
T ss_pred             CCcccchHHHHHHHHHHHcCCCCCccccHH----------------HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCC
Confidence            788999999999999999999998653211                0011111111111122345677899999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 027003          159 PKLRPRMSEVLAIL  172 (229)
Q Consensus       159 P~~Rpt~~~v~~~l  172 (229)
                      |.+||++.++++..
T Consensus       255 P~~Rp~~~~ll~~~  268 (308)
T cd06634         255 PQDRPTSEVLLKHR  268 (308)
T ss_pred             cccCCCHHHHhhCc
Confidence            99999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-28  Score=193.97  Aligned_cols=164  Identities=24%  Similarity=0.293  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.
T Consensus       111 ~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~  185 (287)
T cd07838         111 DLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYAT  185 (287)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCC
Confidence            578999999999995  4699999999999999999999999999876533221   12235788999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-hh----hcchhhHHHHhhcccC---CCCcHHHHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PY----LSDKRKLFRIMDTKLG---GQYPQKAAHTAATLAL  152 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~  152 (229)
                      ++|+|||||++|+|++|..||.+....... ...+... +.    ................   ..........+.+++.
T Consensus       186 ~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  265 (287)
T cd07838         186 PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLK  265 (287)
T ss_pred             cchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHH
Confidence            999999999999999999999764422110 0000000 00    0000000000000000   0111234677889999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+||++.+++.
T Consensus       266 ~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         266 KMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHhccCCccCCCHHHHhc
Confidence            999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=2.9e-28  Score=191.64  Aligned_cols=151  Identities=28%  Similarity=0.481  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcce--eeccccccccccccccccCC-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV--STQVMGTHGYAAPEYVATGR-   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-   78 (229)
                      +++.+++.||.|||+  .+|+|+||+|+||+++.++.+||+|||++...........  .....++..|++||.+.+.. 
T Consensus       103 ~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  180 (264)
T cd06626         103 VYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG  180 (264)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCC
Confidence            478999999999995  5699999999999999999999999999886543322111  11245788999999998766 


Q ss_pred             --CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcH--HHHHHHHHHHHHh
Q 027003           79 --LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ--KAAHTAATLALQC  154 (229)
Q Consensus        79 --~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~  154 (229)
                        .+.++||||||+++|++++|+.||.......               .....+ ........+.  .....+.+++.+|
T Consensus       181 ~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---------------~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~  244 (264)
T cd06626         181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---------------QIMFHV-GAGHKPPIPDSLQLSPEGKDFLDRC  244 (264)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCccCCcchH---------------HHHHHH-hcCCCCCCCcccccCHHHHHHHHHH
Confidence              7899999999999999999999997543110               000011 1111112222  2367788999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 027003          155 LNNEPKLRPRMSEVLA  170 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~  170 (229)
                      |+.+|.+||++.+++.
T Consensus       245 l~~~p~~R~~~~~i~~  260 (264)
T cd06626         245 LESDPKKRPTASELLQ  260 (264)
T ss_pred             ccCCcccCCCHHHHhc
Confidence            9999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=1.3e-28  Score=195.93  Aligned_cols=165  Identities=24%  Similarity=0.262  Sum_probs=111.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      +++.|++.||+|||+  .+++|+||+|+||+++.++.+||+|||++.........  .....++..|+|||.+.+.. ++
T Consensus       104 ~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  179 (284)
T cd07860         104 SYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYS  179 (284)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCC
Confidence            578899999999995  46999999999999999999999999998754332211  22234688899999887654 57


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhc-------chhhHHHHhhcccCC---CCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLS-------DKRKLFRIMDTKLGG---QYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~~~~~---~~~~~~~~~~~~  149 (229)
                      .++|+|||||++|+|+||+.||.+....... ...........       ...............   .........+.+
T Consensus       180 ~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (284)
T cd07860         180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRD  259 (284)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHH
Confidence            8999999999999999999999764321100 00000000000       000000000000000   001123556789


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ++.+||+.||.+||++.++++
T Consensus       260 li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         260 LLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhcCCCcccCCCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=2.1e-28  Score=190.67  Aligned_cols=147  Identities=29%  Similarity=0.454  Sum_probs=114.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++........   .....++..|++||.+.+..++.
T Consensus       102 ~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~  176 (253)
T cd05122         102 YVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDY  176 (253)
T ss_pred             HHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCc
Confidence            478999999999995  5699999999999999999999999999876543321   23456888999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|+||||+++|+|++|+.||...+..                ........ ......+  ...+..+.+++.+||+.||
T Consensus       177 ~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p  239 (253)
T cd05122         177 KADIWSLGITAIELAEGKPPYSELPPM----------------KALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNP  239 (253)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCchH----------------HHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCCh
Confidence            999999999999999999999764310                00001111 1111111  1226778999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      .+|||+.++++
T Consensus       240 ~~R~t~~~~l~  250 (253)
T cd05122         240 EKRPTAEQLLK  250 (253)
T ss_pred             hhCCCHHHHhc
Confidence            99999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=2e-28  Score=192.46  Aligned_cols=153  Identities=26%  Similarity=0.404  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+. .+++||||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.
T Consensus       103 ~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~  179 (264)
T cd06623         103 YIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSY  179 (264)
T ss_pred             HHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCc
Confidence            5789999999999951 56999999999999999999999999998865332221  12346788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHH-HHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|+|++|+.||........              ....+.+........+.. .+..+.+++.+||..+|+
T Consensus       180 ~~Dv~slG~il~~l~tg~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  245 (264)
T cd06623         180 AADIWSLGLTLLECALGKFPFLPPGQPSF--------------FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPK  245 (264)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCccccccCH--------------HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChh
Confidence            99999999999999999999976532100              011111111222223333 677899999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +||++.++++.
T Consensus       246 ~R~~~~~ll~~  256 (264)
T cd06623         246 KRPSAAELLQH  256 (264)
T ss_pred             hCCCHHHHHhC
Confidence            99999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.9e-28  Score=195.74  Aligned_cols=165  Identities=24%  Similarity=0.281  Sum_probs=111.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||+++........  .....++..|+|||.+.+. .++
T Consensus       107 ~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  182 (291)
T cd07870         107 LFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCC
Confidence            468899999999995  46999999999999999999999999998754322211  2234578899999998764 578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhh---hhhhcchhhHHH------Hhhcc-cCCCC---c--HHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA---KPYLSDKRKLFR------IMDTK-LGGQY---P--QKAAH  145 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~-~~~~~---~--~~~~~  145 (229)
                      .++|+|||||++|+|++|..||.+...........+.   .+.......+..      ..... .....   .  .....
T Consensus       183 ~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (291)
T cd07870         183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP  262 (291)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCCh
Confidence            8999999999999999999999765432111111000   000000000000      00000 00000   0  01145


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+.+++.+||+.||.+|||+.+++.
T Consensus       263 ~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         263 KAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HHHHHHHHHhCcCcccCcCHHHHhc
Confidence            7789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=2.8e-28  Score=190.82  Aligned_cols=146  Identities=27%  Similarity=0.398  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+++|+||+|+||+++.++.+||+|||++......    ......++..|++||.+.+..++.
T Consensus       107 ~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~  180 (256)
T cd08530         107 RIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSY  180 (256)
T ss_pred             HHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCc
Confidence            578899999999995  56999999999999999999999999998765433    122345788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|+.||...+..                 ..............+......+.+++.+||+.+|++
T Consensus       181 ~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  243 (256)
T cd08530         181 KSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKL  243 (256)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCccc
Confidence            999999999999999999999765321                 111111222223344467788999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       244 Rp~~~~~l~  252 (256)
T cd08530         244 RPNCDKILA  252 (256)
T ss_pred             CCCHHHHhc
Confidence            999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-28  Score=192.79  Aligned_cols=150  Identities=25%  Similarity=0.346  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-cceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++
T Consensus       110 ~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  187 (264)
T cd06653         110 RYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG  187 (264)
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCC
Confidence            578899999999995  4699999999999999999999999999976432111 1112235688999999999888889


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|+|++|+.||.....                ................+......+.+++.+||+ ++.
T Consensus       188 ~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~  250 (264)
T cd06653         188 RKADVWSVACTVVEMLTEKPPWAEYEA----------------MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEK  250 (264)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCccCH----------------HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-Ccc
Confidence            999999999999999999999975321                111222222223344566778889999999999 579


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.+++.
T Consensus       251 ~r~~~~~~~~  260 (264)
T cd06653         251 RRPTAEFLLR  260 (264)
T ss_pred             cCccHHHHhc
Confidence            9999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-28  Score=198.93  Aligned_cols=167  Identities=23%  Similarity=0.279  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC----CCcEEEcccCCcccCCCCCC-cceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~----~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.    ++.+||+|||++........ ........++..|+|||++.+
T Consensus       112 ~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  189 (316)
T cd07842         112 SLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG  189 (316)
T ss_pred             HHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhC
Confidence            478899999999995  46999999999999999    89999999999886543322 111223467889999998876


Q ss_pred             C-CCcccCceeehhHHHHHHHhCCCcCCCCccccch-------hHHHhhhhhhc----------chhhHHHHhhcccCCC
Q 027003           77 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLVDWAKPYLS----------DKRKLFRIMDTKLGGQ  138 (229)
Q Consensus        77 ~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~----------~~~~~~~~~~~~~~~~  138 (229)
                      . .++.++|+|||||++|+|++|+.||.+.......       .+.....-...          ................
T Consensus       190 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (316)
T cd07842         190 ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKT  269 (316)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCC
Confidence            4 5788999999999999999999999865543200       00000000000          0000000000000011


Q ss_pred             Cc-----H------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          139 YP-----Q------KAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       139 ~~-----~------~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+     .      .....+.+++.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         270 YPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             CCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11     0      23456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=1.2e-28  Score=193.59  Aligned_cols=151  Identities=27%  Similarity=0.430  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC------cceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------THVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~   75 (229)
                      +++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++........      ........++..|++||.+.
T Consensus        97 ~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  174 (265)
T cd05579          97 IYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL  174 (265)
T ss_pred             HHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhc
Confidence            578999999999995  5699999999999999999999999999876433211      01223456788999999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHH--HHHHHHHHHHH
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--AAHTAATLALQ  153 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~  153 (229)
                      +...+.++|+||||+++|+|++|..||......                ...........  ..+..  .+..+.+++.+
T Consensus       175 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~  236 (265)
T cd05579         175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----------------EIFQNILNGKI--EWPEDVEVSDEAIDLISK  236 (265)
T ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcCCc--CCCccccCCHHHHHHHHH
Confidence            888899999999999999999999999754311                00111111111  11222  36788999999


Q ss_pred             hccCCCCCCCCHHHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~~l  172 (229)
                      ||+.+|.+|||+.++.+.|
T Consensus       237 ~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         237 LLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HhcCCHhhcCCCccHHHHh
Confidence            9999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=7.5e-29  Score=194.68  Aligned_cols=162  Identities=22%  Similarity=0.269  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC--------------------CCcEEEcccCCcccCCCCCCcceeec
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--------------------EFNAKLSDFGLAKAGPTGDRTHVSTQ   61 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~   61 (229)
                      .|+.|++++++|||+  .+++|.||||+|||+.+                    +-.++|+|||.++.....     ...
T Consensus       196 ~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~  268 (415)
T KOG0671|consen  196 HMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HST  268 (415)
T ss_pred             HHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cce
Confidence            478999999999995  45999999999999931                    224899999999864322     245


Q ss_pred             cccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHH-hhhhhhcch--hh-HHHHhhcc---
Q 027003           62 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLSDK--RK-LFRIMDTK---  134 (229)
Q Consensus        62 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~--~~-~~~~~~~~---  134 (229)
                      .+.|..|.|||++.|-++++.+||||+||||+|+.||...|.+.+..+.-.... ...|.....  +. ..+....+   
T Consensus       269 iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rld  348 (415)
T KOG0671|consen  269 IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLD  348 (415)
T ss_pred             eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccccc
Confidence            678999999999999999999999999999999999999998876322111110 011111100  00 00000000   


Q ss_pred             -----------------c----CCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          135 -----------------L----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       135 -----------------~----~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                                       .    .....+.....+.+|+++||..||.+|+|+.|++.
T Consensus       349 w~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  349 WPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             CccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence                             0    00112345667999999999999999999999986

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=2e-28  Score=194.94  Aligned_cols=160  Identities=27%  Similarity=0.439  Sum_probs=115.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++.......    .....|+..|+|||++.+..++.
T Consensus       107 ~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~  181 (284)
T cd06620         107 KIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTV  181 (284)
T ss_pred             HHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCc
Confidence            5688999999999952 369999999999999999999999999986532211    22356899999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc-HHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||............   .  .........+.... ....+ ...+..+.+|+.+||+.||+
T Consensus       182 ~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~  255 (284)
T cd06620         182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---P--MGILDLLQQIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPT  255 (284)
T ss_pred             cchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---h--hHHHHHHHHHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcc
Confidence            999999999999999999999764421110000   0  00000011111111 11111 22566789999999999999


Q ss_pred             CCCCHHHHHHHH
Q 027003          161 LRPRMSEVLAIL  172 (229)
Q Consensus       161 ~Rpt~~~v~~~l  172 (229)
                      +||++.|+++..
T Consensus       256 ~Rpt~~e~~~~~  267 (284)
T cd06620         256 ERPTPQQLCAMP  267 (284)
T ss_pred             cCcCHHHHhcCc
Confidence            999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=2e-28  Score=196.98  Aligned_cols=154  Identities=23%  Similarity=0.336  Sum_probs=112.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-------------ceeecccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------HVSTQVMGTHGY   68 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~gt~~y   68 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+++........             .......++..|
T Consensus       105 ~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  182 (305)
T cd05609         105 MYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY  182 (305)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccc
Confidence            467899999999995  46999999999999999999999999998642111000             011124578899


Q ss_pred             ccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC-CCCcHHHHHHH
Q 027003           69 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTA  147 (229)
Q Consensus        69 ~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  147 (229)
                      +|||.+.+..++.++|+|||||++|||++|..||.+....                ............ .......+..+
T Consensus       183 ~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~  246 (305)
T cd05609         183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----------------ELFGQVISDDIEWPEGDEALPADA  246 (305)
T ss_pred             cCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcccCCCCccccCCHHH
Confidence            9999998888999999999999999999999999754311                001111111110 11112356778


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAILE  173 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~l~  173 (229)
                      .+++.+||+.||++||+..++.+.|+
T Consensus       247 ~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         247 QDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHHHhccChhhccCccCHHHHHh
Confidence            99999999999999999766666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=4.7e-28  Score=195.45  Aligned_cols=166  Identities=20%  Similarity=0.303  Sum_probs=113.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-----cceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||.+........     ........++..|+|||++.+
T Consensus       105 ~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  182 (314)
T cd08216         105 FILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ  182 (314)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcC
Confidence            478899999999995  4699999999999999999999999998865432211     011223457788999999866


Q ss_pred             C--CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhh--h-hhc------chhhH--------HHHhhcccCC
Q 027003           77 G--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK--P-YLS------DKRKL--------FRIMDTKLGG  137 (229)
Q Consensus        77 ~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~--~-~~~------~~~~~--------~~~~~~~~~~  137 (229)
                      .  .++.++|+|||||++|||++|..||......... ......  + ...      .....        ..........
T Consensus       183 ~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (314)
T cd08216         183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML-LEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDH  261 (314)
T ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhc
Confidence            3  5788999999999999999999999764321100 000000  0 000      00000        0000001111


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .........+.+|+.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         262 PYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             chhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            223345678899999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=204.41  Aligned_cols=155  Identities=23%  Similarity=0.386  Sum_probs=131.4

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      |.++.||..|++||.  .+++|||||-..|+|+.++..|||+|||+++.+.... +.......-...|.|||.+....++
T Consensus       368 lyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFS  444 (1157)
T KOG4278|consen  368 LYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFS  444 (1157)
T ss_pred             HHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccc
Confidence            357899999999999  5569999999999999999999999999999875433 3223333346789999999889999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .|+|||+|||+|||+.| |-.||.+-+                 ..++..++.+..+-..|..|+..+++||+.||+.+|
T Consensus       445 iKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsP  507 (1157)
T KOG4278|consen  445 IKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSP  507 (1157)
T ss_pred             cchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCc
Confidence            99999999999999988 888887753                 234556777788888889999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 027003          160 KLRPRMSEVLAILERL  175 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~  175 (229)
                      ..||+++|+-+.++.+
T Consensus       508 sDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  508 SDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccCccHHHHHHHHHHH
Confidence            9999999999887654

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=2.8e-28  Score=196.13  Aligned_cols=166  Identities=23%  Similarity=0.288  Sum_probs=111.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCC-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGR-   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-   78 (229)
                      +++.|++.||.|||++  +++|+||||+||+++.++.+||+|||++.........  .......++..|+|||.+.+.. 
T Consensus       123 ~i~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  200 (310)
T cd07865         123 KVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD  200 (310)
T ss_pred             HHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcc
Confidence            5789999999999954  6999999999999999999999999998765332211  1122345788999999887653 


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhh-hhhh----cchhhHHHHhhc-ccCCCC---------cHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA-KPYL----SDKRKLFRIMDT-KLGGQY---------PQKA  143 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~-~~~~~~---------~~~~  143 (229)
                      ++.++|+||||+++|+|++|..||.+.+........... ....    ..... ...... ......         ....
T Consensus       201 ~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~  279 (310)
T cd07865         201 YGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDK-LELFKKMELPQGQKRKVKERLKPYVK  279 (310)
T ss_pred             cCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc-hhhhhhccCCCccchhhHHhcccccC
Confidence            688999999999999999999999765432111111100 0000    00000 000000 000000         0012


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          144 AHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       144 ~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ...+.+||.+||..||.+|||+.++++
T Consensus       280 ~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         280 DPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            346678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-28  Score=194.37  Aligned_cols=148  Identities=26%  Similarity=0.397  Sum_probs=112.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++.........  .....|+..|+|||.+.++ .++
T Consensus       105 ~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  180 (277)
T cd06917         105 VIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYD  180 (277)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccc
Confidence            478899999999995  56999999999999999999999999998765433211  2334688999999988654 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcH-HHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP  159 (229)
                      .++|+|||||++|+|++|..||..........                 ..........+. .....+.+++.+||+.||
T Consensus       181 ~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  243 (277)
T cd06917         181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMM-----------------LIPKSKPPRLEDNGYSKLLREFVAACLDEEP  243 (277)
T ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----------------ccccCCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence            89999999999999999999997643211000                 000000011111 245678899999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      ++||++.+++.
T Consensus       244 ~~R~~~~~il~  254 (277)
T cd06917         244 KERLSAEELLK  254 (277)
T ss_pred             ccCcCHHHHhh
Confidence            99999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=3.8e-28  Score=193.49  Aligned_cols=149  Identities=30%  Similarity=0.441  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+..++.
T Consensus       120 ~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  195 (286)
T cd06614         120 YVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGP  195 (286)
T ss_pred             HHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCC
Confidence            478999999999995  5699999999999999999999999999865432211  122345788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|+|++|..||.......                ....+..... .......++..+.+++.+||+.+|.
T Consensus       196 ~~Dv~slGvil~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  259 (286)
T cd06614         196 KVDIWSLGIMCIEMAEGEPPYLREPPLR----------------ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE  259 (286)
T ss_pred             ccccHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChh
Confidence            9999999999999999999987543210                0011111111 1111223567889999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.++++
T Consensus       260 ~Rpt~~~il~  269 (286)
T cd06614         260 KRPSAEELLQ  269 (286)
T ss_pred             hCcCHHHHhh
Confidence            9999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=2.5e-28  Score=191.03  Aligned_cols=152  Identities=28%  Similarity=0.439  Sum_probs=119.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||.+................++..|++||.+.+...+.
T Consensus       105 ~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  182 (260)
T cd06606         105 KYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR  182 (260)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCc
Confidence            578999999999995  569999999999999999999999999988765443211123456888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||......               ......+.........+...+..+.+++.+||+.||++
T Consensus       183 ~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~  247 (260)
T cd06606         183 AADIWSLGCTVIEMATGKPPWSELGNP---------------MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKK  247 (260)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhh
Confidence            999999999999999999999765410               01111111112223345556788999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.+++.
T Consensus       248 Rp~~~~ll~  256 (260)
T cd06606         248 RPTADELLQ  256 (260)
T ss_pred             CCCHHHHhh
Confidence            999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-28  Score=194.62  Aligned_cols=165  Identities=23%  Similarity=0.306  Sum_probs=109.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++........  .....++..|+|||++.+ ..++
T Consensus       107 ~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  182 (291)
T cd07844         107 LFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccC
Confidence            467899999999995  56999999999999999999999999998753221111  122346788999999876 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh--HHHhhh-hhhcchhhHHH---HhhcccCC-------CCcHHH--HH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAK-PYLSDKRKLFR---IMDTKLGG-------QYPQKA--AH  145 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~---~~~~~~~~-------~~~~~~--~~  145 (229)
                      .++|||||||++|+|++|+.||.+........  ...... +..........   ........       ......  ..
T Consensus       183 ~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (291)
T cd07844         183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIP  262 (291)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCch
Confidence            89999999999999999999997654211110  000000 00000000000   00000000       000011  25


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+.+++.+||+.+|.+||++.+++.
T Consensus       263 ~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         263 HGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hHHHHHHHHhccCcccccCHHHHhc
Confidence            7789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=1.3e-28  Score=200.44  Aligned_cols=168  Identities=24%  Similarity=0.334  Sum_probs=115.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeecccccccccccccccc-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT-GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~   78 (229)
                      .++.||+.||.|||+  ++|+||||||+||+++.++.+||+|||++.........  .......++..|+|||.+.+ ..
T Consensus       111 ~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  188 (334)
T cd07855         111 YFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE  188 (334)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcc
Confidence            578999999999995  56999999999999999999999999998764332211  11223568899999998865 45


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhh--hhhhc-----chhhHHHHhhcc-cCCCC-----cHHHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA--KPYLS-----DKRKLFRIMDTK-LGGQY-----PQKAAH  145 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~-~~~~~-----~~~~~~  145 (229)
                      ++.++|+|||||++|+|++|+.||.+.+...........  .+...     ......+..... .....     ....+.
T Consensus       189 ~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (334)
T cd07855         189 YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASP  268 (334)
T ss_pred             cccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCH
Confidence            789999999999999999999999765432111000000  00000     000000111100 00011     123467


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+.+++.+||+.+|.+||++.+++..
T Consensus       269 ~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         269 EALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhC
Confidence            89999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=1.9e-28  Score=196.00  Aligned_cols=165  Identities=21%  Similarity=0.231  Sum_probs=110.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~   79 (229)
                      .++.||+.||.|||+  .+|+||||||+||+++. ++.+||+|||++.........  .....++..|+|||.+.+ ..+
T Consensus       114 ~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  189 (295)
T cd07837         114 SFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHY  189 (295)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCC
Confidence            578999999999995  46999999999999998 889999999998754322111  122346788999998865 457


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhh-hhhhc---chhhHHHHhh-cccCC----CCcHHHHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLS---DKRKLFRIMD-TKLGG----QYPQKAAHTAAT  149 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~-~~~~~---~~~~~~~~~~-~~~~~----~~~~~~~~~~~~  149 (229)
                      +.++|+||||+++|+|++|..||.+....... .+.... .+...   .......... .....    ......+..+.+
T Consensus       190 ~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (295)
T cd07837         190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD  269 (295)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHH
Confidence            89999999999999999999999764321100 000000 00000   0000000000 00000    001234667889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ||.+||+.||.+||++.+++.
T Consensus       270 ~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         270 LLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHccCChhhcCCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=2.6e-28  Score=194.93  Aligned_cols=144  Identities=24%  Similarity=0.371  Sum_probs=113.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+|||++.++.+||+|||++......     .....++..|+|||.+.+...+.
T Consensus       105 ~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  177 (290)
T cd05580         105 FYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGK  177 (290)
T ss_pred             HHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCc
Confidence            468899999999995  56999999999999999999999999998865433     22346889999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||......                .....+...  ....+...+..+.+++.+||+.||.+
T Consensus       178 ~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~  239 (290)
T cd05580         178 AVDWWALGILIYEMLAGYPPFFDDNPI----------------QIYEKILEG--KVRFPSFFSPDAKDLIRNLLQVDLTK  239 (290)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcC--CccCCccCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999764310                011111111  11233445678889999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      |+     ++.++++
T Consensus       240 R~~~~~~~~~~l~~  253 (290)
T cd05580         240 RLGNLKNGVNDIKN  253 (290)
T ss_pred             ccCcccCCHHHHHc
Confidence            99     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=2.8e-28  Score=192.64  Aligned_cols=147  Identities=23%  Similarity=0.301  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++ .++|+|||++......      ....++..|+|||++.+..++
T Consensus       113 ~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~  184 (267)
T PHA03390        113 KIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYD  184 (267)
T ss_pred             HHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCC
Confidence            578999999999995  4599999999999999998 9999999998764322      223578899999999988899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|+|++|..||........ ...           .+....  ......+...+..+.+|+.+||+.+|.
T Consensus       185 ~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~-----------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~  250 (267)
T PHA03390        185 VSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLE-----------SLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNIN  250 (267)
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHH-----------HHHHhh--cccCCcccccCHHHHHHHHHHhccChh
Confidence            999999999999999999999975432110 000           111111  111123345678899999999999999


Q ss_pred             CCCC-HHHHHH
Q 027003          161 LRPR-MSEVLA  170 (229)
Q Consensus       161 ~Rpt-~~~v~~  170 (229)
                      +|++ +.++++
T Consensus       251 ~R~~~~~~~l~  261 (267)
T PHA03390        251 YRLTNYNEIIK  261 (267)
T ss_pred             hCCchHHHHhc
Confidence            9996 588874

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=2e-28  Score=194.25  Aligned_cols=150  Identities=31%  Similarity=0.475  Sum_probs=113.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++........   .....++..|++||.+.+..++.
T Consensus        99 ~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~  173 (277)
T cd05577          99 FYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF  173 (277)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCCHHHhcCCCCCc
Confidence            467899999999995  5699999999999999999999999999876432111   22345788999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|+.||..........             .+.... .......+...+..+.+++.+||+.||.+
T Consensus       174 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (277)
T cd05577         174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEK  239 (277)
T ss_pred             hhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhcc-ccccccCCccCCHHHHHHHHHHccCChhH
Confidence            9999999999999999999997654211100             000100 01112233445778899999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.+++.
T Consensus       240 R~~~~~~~~~~ll~  253 (277)
T cd05577         240 RLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCCcccHHHHHh
Confidence            99     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=2.6e-28  Score=194.21  Aligned_cols=167  Identities=22%  Similarity=0.289  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.||+.||+|||+.  +++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++
T Consensus       103 ~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  179 (286)
T cd07832         103 SYMRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYD  179 (286)
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCC
Confidence            5789999999999964  599999999999999999999999999886543321 112234688999999998655 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHH-hhhh------hhcchhhHHHHhhcccC----CCCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKP------YLSDKRKLFRIMDTKLG----GQYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~-~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|..+|.+........ ... ...+      ..........+......    .....+....+.
T Consensus       180 ~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (286)
T cd07832         180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL  259 (286)
T ss_pred             chhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHH
Confidence            89999999999999999988886543211100 000 0000      00000000000000000    000113357889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +|+.+||+.||.+||++.+++..
T Consensus       260 ~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         260 DLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHHHHHhccChhhCCCHHHHhhC
Confidence            99999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=4.3e-28  Score=195.80  Aligned_cols=145  Identities=30%  Similarity=0.458  Sum_probs=110.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....      .....|+..|+|||++.   +..
T Consensus       125 ~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~  196 (313)
T cd06633         125 AITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQ  196 (313)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCC
Confidence            468899999999995  5699999999999999999999999999864321      12346888999999984   356


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|+|||||++|+|++|..||...+..                .....+.............+..+.+|+.+||+.+
T Consensus       197 ~~~~sDv~slGvil~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  260 (313)
T cd06633         197 YDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI  260 (313)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence            788999999999999999999998664311                0011111111111112234567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+||++.+++.
T Consensus       261 P~~Rp~~~~~l~  272 (313)
T cd06633         261 PQERPASAELLR  272 (313)
T ss_pred             hhhCcCHHHHhc
Confidence            999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=3.5e-28  Score=190.20  Aligned_cols=148  Identities=26%  Similarity=0.386  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.+++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......  .......|+..|+|||.+.+..++.
T Consensus       107 ~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~  182 (258)
T cd08215         107 DWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNY  182 (258)
T ss_pred             HHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCc
Confidence            578999999999995  469999999999999999999999999987654332  1233456888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||......                 ..............+...+..+.+++.+||..+|++
T Consensus       183 ~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  245 (258)
T cd08215         183 KSDIWSLGCVLYELCTLKHPFEGENLL-----------------ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEE  245 (258)
T ss_pred             cccHHHHHHHHHHHHcCCCCCCCCcHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence            999999999999999999999664311                 111111111222334456678899999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       246 Rp~~~~ll~  254 (258)
T cd08215         246 RPSIAQILQ  254 (258)
T ss_pred             CcCHHHHhc
Confidence            999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-28  Score=194.72  Aligned_cols=165  Identities=27%  Similarity=0.302  Sum_probs=115.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||.+.......  .......++..|+|||.+.+. .++
T Consensus       102 ~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~  177 (283)
T cd05118         102 SYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCC
Confidence            578999999999995  469999999999999999999999999987654432  112234578899999998776 788


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHH-hhhhhhcchhhHHH---H----hhcccC---CCCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFR---I----MDTKLG---GQYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~---~----~~~~~~---~~~~~~~~~~~~  148 (229)
                      .++|+||||+++|+|++|+.+|...+...... ... ...+..........   .    ......   .......+..+.
T Consensus       178 ~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (283)
T cd05118         178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQAL  257 (283)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHH
Confidence            99999999999999999999997654311110 000 00000000000000   0    000000   011234577899


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +++.+||+.||.+||++.+++.
T Consensus       258 ~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         258 DLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHHHHHhccCcccCcCHHHHhh
Confidence            9999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-28  Score=195.44  Aligned_cols=165  Identities=22%  Similarity=0.222  Sum_probs=111.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.|++.||+|||+  .+++||||+|+||+++.++.++|+|||++.........  .....++..|+|||++.+. .++
T Consensus       103 ~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  178 (283)
T cd07835         103 SYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYS  178 (283)
T ss_pred             HHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccC
Confidence            578999999999995  46999999999999999999999999998754322111  1223568899999988664 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhhhhhc-------chhhHHHHhhcc---cCCCCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYLS-------DKRKLFRIMDTK---LGGQYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~~~~~  149 (229)
                      .++|+||||+++|+|++|..||...+.... ............       ............   .........+..+.+
T Consensus       179 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (283)
T cd07835         179 TPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLD  258 (283)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHH
Confidence            899999999999999999999976432110 001100000000       000000000000   000111234467889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ++.+||+.||.+||++.++++
T Consensus       259 li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         259 LLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HHHHHhcCChhhCcCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.95  E-value=3.1e-28  Score=196.20  Aligned_cols=165  Identities=25%  Similarity=0.274  Sum_probs=112.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.........  .....++..|+|||.+.+ ..++
T Consensus       112 ~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  187 (309)
T cd07845         112 CLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYT  187 (309)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcC
Confidence            578999999999995  45999999999999999999999999999865432211  122345788999999866 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhHHHHhh--cc--cCC-C------CcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMD--TK--LGG-Q------YPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~--~~~-~------~~~~~~~~~~  148 (229)
                      .++|+|||||++|+|++|..||...+...... +...................  ..  ... .      .....+..+.
T Consensus       188 ~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T cd07845         188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGL  267 (309)
T ss_pred             chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHH
Confidence            99999999999999999999997654321111 11100000000000000000  00  000 0      0012366788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||.+||+.||.+|||+.+++.
T Consensus       268 ~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         268 RLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HHHHHHhcCChhhCcCHHHHhc
Confidence            9999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=202.12  Aligned_cols=163  Identities=25%  Similarity=0.417  Sum_probs=130.4

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      ++||.||+.|++||.+.  ++|||||.+.|+|++.++++||+|||+++...++..+......+-...|||+|.+.-++++
T Consensus       640 vsi~tqiasgmaYLes~--nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFt  717 (807)
T KOG1094|consen  640 VSICTQIASGMAYLESL--NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT  717 (807)
T ss_pred             HHHHHHHHHHHHHHHhh--chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcccc
Confidence            47899999999999975  4999999999999999999999999999988888888888888889999999999999999


Q ss_pred             ccCceeehhHHHHHHHh--CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|+|+||+++||+++  .+.||.....+.   ..+-...+....       ....-...|.-++..+.+++.+||..|
T Consensus       718 taSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~-------~~~~~l~~P~~cp~~lyelml~Cw~~e  787 (807)
T KOG1094|consen  718 TASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQ-------GRQVVLSRPPACPQGLYELMLRCWRRE  787 (807)
T ss_pred             chhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCC-------CcceeccCCCcCcHHHHHHHHHHhchh
Confidence            99999999999999864  777886543211   111001111110       011112345678889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 027003          159 PKLRPRMSEVLAILERL  175 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~  175 (229)
                      -.+||+++++...|.+.
T Consensus       788 s~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  788 SEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhcCCCHHHHHHHHHHh
Confidence            99999999999888754

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=4e-28  Score=197.88  Aligned_cols=166  Identities=27%  Similarity=0.328  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++......  .......++..|+|||.+.+ ..++
T Consensus       112 ~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  187 (337)
T cd07858         112 YFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYT  187 (337)
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCC
Confidence            478999999999995  469999999999999999999999999998653321  11233467889999998865 4688


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhc------chhhHHHHhhcccCC------CCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLS------DKRKLFRIMDTKLGG------QYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~~  147 (229)
                      .++|+|||||++|+|++|+.||.+.+...... ..........      ......+.+......      ......+..+
T Consensus       188 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (337)
T cd07858         188 TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLA  267 (337)
T ss_pred             CcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHH
Confidence            99999999999999999999997654211110 0000000000      000111111100000      0112356778


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+|+.+||+.+|.+|||+.++++.
T Consensus       268 ~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         268 IDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHHHHHHhcCChhhccCHHHHHcC
Confidence            999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=3.2e-28  Score=194.74  Aligned_cols=150  Identities=27%  Similarity=0.370  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.........  .....++..|++||.+.+..++.
T Consensus       119 ~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~  194 (293)
T cd06647         119 AVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP  194 (293)
T ss_pred             HHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCc
Confidence            478899999999995  56999999999999999999999999988754332221  22346888999999998888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHh-hcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|++++|+.||...+......                .+. ........+...+..+.+++.+||+.+|.
T Consensus       195 ~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (293)
T cd06647         195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALY----------------LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE  258 (293)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCChhhhee----------------ehhcCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence            9999999999999999999997643211000                000 00011112334566788999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +||++.+++..
T Consensus       259 ~Rp~~~~il~h  269 (293)
T cd06647         259 KRGSAKELLQH  269 (293)
T ss_pred             hCcCHHHHhcC
Confidence            99999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=3.2e-28  Score=190.72  Aligned_cols=148  Identities=25%  Similarity=0.398  Sum_probs=113.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc-EEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++. ++|+|||.+........  ......|+..|+|||.+.+..++
T Consensus       105 ~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~  180 (257)
T cd08225         105 SWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYN  180 (257)
T ss_pred             HHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCC
Confidence            578899999999995  46999999999999998864 69999999876543221  12234588899999999888899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+||||+++|+|++|..||...+..                .......... ........+..+.+++.+||+.+|+
T Consensus       181 ~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~  243 (257)
T cd08225         181 NKTDIWSLGCVLYELCTLKHPFEGNNLH----------------QLVLKICQGY-FAPISPNFSRDLRSLISQLFKVSPR  243 (257)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHhccc-CCCCCCCCCHHHHHHHHHHhccChh
Confidence            9999999999999999999999654311                0011111111 1122234556799999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +||++.+++.
T Consensus       244 ~Rpt~~~ll~  253 (257)
T cd08225         244 DRPSITSILK  253 (257)
T ss_pred             hCcCHHHHhh
Confidence            9999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.3e-28  Score=201.13  Aligned_cols=167  Identities=22%  Similarity=0.347  Sum_probs=113.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.++|+|||+++.....     .....++..|+|||.+.+ ..++
T Consensus       121 ~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  193 (342)
T cd07879         121 YLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYN  193 (342)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccC
Confidence            468899999999995  45999999999999999999999999998754321     123457889999999876 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh---hhhc---chhhHHHHhhc--cc-CCCC---cHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK---PYLS---DKRKLFRIMDT--KL-GGQY---PQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~---~~~~---~~~~~~~~~~~--~~-~~~~---~~~~~~~~  147 (229)
                      .++|+|||||++|||++|+.||.+.+...... ......   +...   ...........  .. ....   ....+..+
T Consensus       194 ~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (342)
T cd07879         194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQA  273 (342)
T ss_pred             chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHH
Confidence            89999999999999999999998654211100 000000   0000   00000000000  00 0000   01234568


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH--HHhh
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI--LERL  175 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~--l~~~  175 (229)
                      .+|+.+||+.||.+||++.+++..  ++..
T Consensus       274 ~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         274 VDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            899999999999999999999853  5444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=2.7e-28  Score=195.40  Aligned_cols=165  Identities=24%  Similarity=0.269  Sum_probs=112.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      +++.||++||.|||+  .+|+|+||||+||+++.++.++|+|||+++........  .....++..|+|||.+.+ ..++
T Consensus       106 ~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  181 (298)
T cd07841         106 SYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYG  181 (298)
T ss_pred             HHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCC
Confidence            578999999999995  46999999999999999999999999999865432211  122346788999998865 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhh-hhhhcchh---hHHHHhhcccCC-----CCcHHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKR---KLFRIMDTKLGG-----QYPQKAAHTAATL  150 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~l  150 (229)
                      .++|+|||||++|+|++|..+|.+....... ...... .+......   ............     ......+..+.++
T Consensus       182 ~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  261 (298)
T cd07841         182 VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDL  261 (298)
T ss_pred             cHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHH
Confidence            8999999999999999998888654321100 000000 00000000   000000000000     0112346778899


Q ss_pred             HHHhccCCCCCCCCHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+||+.||++||++.++++
T Consensus       262 i~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         262 LQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             HHHHhcCCcccCcCHHHHhh
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=7.2e-28  Score=193.82  Aligned_cols=167  Identities=24%  Similarity=0.314  Sum_probs=112.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc---------ceeecccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---------HVSTQVMGTHGYAAPE   72 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~gt~~y~aPE   72 (229)
                      .++.|+++||+|||+  .+|+|+||||+||+++.++.++|+|||++.........         .......++..|+|||
T Consensus       119 ~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (311)
T cd07866         119 CYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE  196 (311)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChH
Confidence            478999999999995  46999999999999999999999999998754332211         1112345788899999


Q ss_pred             ccccC-CCcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhcchhhHHHHhhc---ccCCCCc------
Q 027003           73 YVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDKRKLFRIMDT---KLGGQYP------  140 (229)
Q Consensus        73 ~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~------  140 (229)
                      .+.+. .++.++|||||||++|||++|..||.+.+...... +..... +..............   ......+      
T Consensus       197 ~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (311)
T cd07866         197 LLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER  276 (311)
T ss_pred             HhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH
Confidence            88654 57889999999999999999999997654321111 010000 000000000000000   0000000      


Q ss_pred             -HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          141 -QKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       141 -~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                       ......+.+++.+||+.||.+|||+.+++.
T Consensus       277 ~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         277 FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             112356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=4.5e-28  Score=190.22  Aligned_cols=148  Identities=26%  Similarity=0.351  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|+++||.|||+  .+++|+||||+||+++.++.++|+|||++.......   ......|+..|+|||.+.+..++.
T Consensus       104 ~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~  178 (258)
T cd05578         104 FWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSV  178 (258)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCC
Confidence            478999999999995  469999999999999999999999999987654322   123356888999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||..........              ....... .....+...+..+.+++.+||+.||.+
T Consensus       179 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~  243 (258)
T cd05578         179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ--------------IRAKQET-ADVLYPATWSTEAIDAINKLLERDPQK  243 (258)
T ss_pred             cccchhhHHHHHHHHhCCCCCCCCCccHHHH--------------HHHHhcc-ccccCcccCcHHHHHHHHHHccCChhH
Confidence            9999999999999999999998654321111              1111111 222344456688999999999999999


Q ss_pred             CCCH--HHHH
Q 027003          162 RPRM--SEVL  169 (229)
Q Consensus       162 Rpt~--~~v~  169 (229)
                      ||++  .|++
T Consensus       244 R~~~~~~~l~  253 (258)
T cd05578         244 RLGDNLKDLK  253 (258)
T ss_pred             cCCccHHHHh
Confidence            9999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=2.1e-28  Score=190.08  Aligned_cols=136  Identities=27%  Similarity=0.323  Sum_probs=106.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+  .+|+||||||+||+++.++.++++|||.+.......     ....++..|+|||.+.+..++.
T Consensus        89 ~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~  161 (237)
T cd05576          89 RWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETE  161 (237)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCc
Confidence            578999999999995  569999999999999999999999999876543221     1234567899999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|..+|.......                      ........+...+..+.+++.+||+.||++
T Consensus       162 ~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         162 ACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             hhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcccCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999998775422100                      000011233445677899999999999999


Q ss_pred             CCCHH
Q 027003          162 RPRMS  166 (229)
Q Consensus       162 Rpt~~  166 (229)
                      |+++.
T Consensus       220 R~~~~  224 (237)
T cd05576         220 RLGAG  224 (237)
T ss_pred             hcCCC
Confidence            99973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=6.5e-28  Score=191.39  Aligned_cols=149  Identities=27%  Similarity=0.413  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++........  ......++..|++||.+.+..++.
T Consensus       105 ~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  180 (277)
T cd06641         105 TILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDS  180 (277)
T ss_pred             HHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCc
Confidence            478999999999995  5699999999999999999999999999875433221  122346788999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|+|++|..||.......                 ....+............+..+.+++.+||+.+|.+
T Consensus       181 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  243 (277)
T cd06641         181 KADIWSLGITAIELAKGEPPHSELHPMK-----------------VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF  243 (277)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCccchHH-----------------HHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence            9999999999999999999996533110                 00111111112233345677889999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.+++..
T Consensus       244 Rp~~~~~l~~  253 (277)
T cd06641         244 RPTAKELLKH  253 (277)
T ss_pred             CcCHHHHHhC
Confidence            9999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.1e-27  Score=194.55  Aligned_cols=172  Identities=27%  Similarity=0.345  Sum_probs=118.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.++|+|||++......... .......++..|+|||.+.+. .+
T Consensus       107 ~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  184 (330)
T cd07834         107 YFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY  184 (330)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCC
Confidence            478999999999995  46999999999999999999999999999865433210 112334678899999999887 78


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhc------chhhHHHHhhc-ccC-----CCCcHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLS------DKRKLFRIMDT-KLG-----GQYPQKAAHT  146 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~-~~~-----~~~~~~~~~~  146 (229)
                      +.++|+|||||++|+|++|..||.+.+...... +.........      ........+.. ...     .......+..
T Consensus       185 ~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T cd07834         185 TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE  264 (330)
T ss_pred             CcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHH
Confidence            999999999999999999999997765321110 1110000000      00000001100 000     0011224677


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH--HHhh
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLAI--LERL  175 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~~--l~~~  175 (229)
                      +.+++.+||+.+|++||++.+++..  ++.+
T Consensus       265 ~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         265 AIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            8999999999999999999999973  5444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=4.2e-28  Score=197.02  Aligned_cols=166  Identities=23%  Similarity=0.353  Sum_probs=110.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC-Cc----ceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RT----HVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~----~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .++.|++.||+|||+  ++|+||||||+|||++.++.++++||+.+....... ..    .......++..|++||++.+
T Consensus       105 ~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  182 (328)
T cd08226         105 NILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ  182 (328)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcC
Confidence            578999999999995  569999999999999999999999997643221111 00    00111234567999999976


Q ss_pred             C--CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhh----h----hcchhhHH------------------
Q 027003           77 G--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP----Y----LSDKRKLF------------------  128 (229)
Q Consensus        77 ~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~----~~~~~~~~------------------  128 (229)
                      .  .++.++|||||||++|+|++|..||......... ......+    .    ........                  
T Consensus       183 ~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (328)
T cd08226         183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAA  261 (328)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcc
Confidence            4  4788999999999999999999999764321100 0000000    0    00000000                  


Q ss_pred             ----HHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          129 ----RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       129 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                          ..............+...+.+|+.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         262 GMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                000001111223456778999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=189.26  Aligned_cols=150  Identities=25%  Similarity=0.363  Sum_probs=112.5

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc--CCCc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLT   80 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~   80 (229)
                      |....+.||.||-.. -.|||||+||+||||+..|.+||||||++-...+.   -..+.-.|...|||||.+..  ..|+
T Consensus       172 ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyD  247 (361)
T KOG1006|consen  172 ITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYD  247 (361)
T ss_pred             eeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcc
Confidence            344567899999863 46999999999999999999999999998754332   12334568999999999954  3589


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC----CCcHHHHHHHHHHHHHhcc
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG----QYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~  156 (229)
                      .++|+||||++|||+.||..||.+.+..               .+++..++......    ...-+.+..+..+|.-||-
T Consensus       248 iRSDvWSLGITL~EvAtG~fPyr~w~sv---------------feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~  312 (361)
T KOG1006|consen  248 IRSDVWSLGITLYEVATGNFPYRKWDSV---------------FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLI  312 (361)
T ss_pred             hhhhhhhhcceEeeeecCCCCcchHHHH---------------HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhh
Confidence            9999999999999999999999876421               11122222211110    1112357788999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      +|-..||...++++.
T Consensus       313 Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  313 KDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccCcchhhhhcC
Confidence            999999999998863

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=8.2e-28  Score=191.77  Aligned_cols=156  Identities=28%  Similarity=0.369  Sum_probs=115.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC--C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--L   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~   79 (229)
                      .++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+++........ ......|+..|++||.+.+..  .
T Consensus       109 ~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  185 (288)
T cd05583         109 VYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGH  185 (288)
T ss_pred             HHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCC
Confidence            467899999999995  56999999999999999999999999998764332211 122346889999999987654  6


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|+||||+++|+|++|..||.........             ....+.... .....+......+.+++.+||+.||
T Consensus       186 ~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p  251 (288)
T cd05583         186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-------------SEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDP  251 (288)
T ss_pred             cchhhhHHHHHHHHHHHhCCCCcccCcccchH-------------HHHHHHHHc-cCCCCCcccCHHHHHHHHHHhcCCH
Confidence            88999999999999999999999643211000             000111111 1123344456778999999999999


Q ss_pred             CCCCCHHHHHHHHHh
Q 027003          160 KLRPRMSEVLAILER  174 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~  174 (229)
                      ++|||+.++.+.|..
T Consensus       252 ~~R~t~~~~~~~l~~  266 (288)
T cd05583         252 KKRLGANGADEIKNH  266 (288)
T ss_pred             hhccCcchHHHHhcC
Confidence            999998888776643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=4.1e-28  Score=193.13  Aligned_cols=165  Identities=25%  Similarity=0.365  Sum_probs=113.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++........  ......++..|+|||++.+. .++
T Consensus       104 ~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  179 (286)
T cd07846         104 KYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYG  179 (286)
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccC
Confidence            578899999999995  4699999999999999999999999999876533321  12335678899999998653 467


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhhhhhcchhhHH---HHhhcccCC---------CCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYLSDKRKLF---RIMDTKLGG---------QYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~~~  147 (229)
                      .++|||||||++|||++|..+|........ ..+...............   .+.......         ......+..+
T Consensus       180 ~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (286)
T cd07846         180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV  259 (286)
T ss_pred             chHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHH
Confidence            899999999999999999999975432110 011111110000000000   000000000         0112346779


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+.+||+.+|++||++.++++
T Consensus       260 ~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         260 LDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHHHHHhcCCcccchhHHHHhc
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.6e-28  Score=180.57  Aligned_cols=169  Identities=24%  Similarity=0.283  Sum_probs=118.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc--eeeccccccccccccccccC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVATG-R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~   78 (229)
                      ++++++..||.|+|+.+  |+|||+|+.|+||+.+|.+||+|||+++.+.......  ..+..+-|.+|.+||.+.|. .
T Consensus       128 k~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~  205 (376)
T KOG0669|consen  128 KVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE  205 (376)
T ss_pred             HHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccc
Confidence            46899999999999654  9999999999999999999999999998764332221  12344569999999999886 6


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHH-h-------hhhhhcchhhHHHHhhcccCCC----C-----cH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-W-------AKPYLSDKRKLFRIMDTKLGGQ----Y-----PQ  141 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~----~-----~~  141 (229)
                      ++.+.|||+-|||+.||+||.+.+.+......-.+++ .       .+|......-+..+-...+...    .     +-
T Consensus       206 yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~  285 (376)
T KOG0669|consen  206 YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPY  285 (376)
T ss_pred             cCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccc
Confidence            8899999999999999999999998865432222221 1       1111111111111100000000    0     11


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      ...++..+|+.++|..||.+|+++.+++...
T Consensus       286 ~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  286 VKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            1234788999999999999999999998643

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=8.7e-28  Score=192.19  Aligned_cols=148  Identities=24%  Similarity=0.352  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++........  ......|+..|++||.+.+..++.
T Consensus       120 ~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~  195 (292)
T cd06657         120 AVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGP  195 (292)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCc
Confidence            478999999999995  4699999999999999999999999999875433221  123356889999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|+||||+++|+|++|..||.+.......                 ..+.....  .......+..+.+++.+||+.||
T Consensus       196 ~~Dv~slGvil~el~tg~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P  258 (292)
T cd06657         196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----------------KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP  258 (292)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence            999999999999999999999764321000                 00100110  01112345678899999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      .+||++.+++.
T Consensus       259 ~~R~~~~~ll~  269 (292)
T cd06657         259 AQRATAAELLK  269 (292)
T ss_pred             ccCcCHHHHhc
Confidence            99999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=2.8e-27  Score=216.57  Aligned_cols=167  Identities=34%  Similarity=0.529  Sum_probs=121.5

Q ss_pred             hhHHHHHHHHHHhhcC-CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~-~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +|+.|++.||+|||.. .++|+||||||+||+++.++..++. ||.......      .....+|..|+|||++.+..++
T Consensus       784 ~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~  856 (968)
T PLN00113        784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDIT  856 (968)
T ss_pred             HHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCC
Confidence            5789999999999954 4579999999999999999888775 555443211      1123578999999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|||||||++|||+||+.||+.... .......|....... ......++.....  .........+.+++.+||+.|
T Consensus       857 ~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~  934 (968)
T PLN00113        857 EKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD  934 (968)
T ss_pred             cccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence            999999999999999999999954322 222333333322111 1112222222211  233455667889999999999


Q ss_pred             CCCCCCHHHHHHHHHhhcC
Q 027003          159 PKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~~  177 (229)
                      |++||++.++++.|+++..
T Consensus       935 P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        935 PTARPCANDVLKTLESASR  953 (968)
T ss_pred             chhCcCHHHHHHHHHHhhc
Confidence            9999999999999988754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-27  Score=188.92  Aligned_cols=179  Identities=23%  Similarity=0.297  Sum_probs=126.4

Q ss_pred             hhHHHHHHHHHHhhc-------CCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHD-------AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~-------~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   74 (229)
                      +|+..+++||+|||+       ++++|+|||||..||||.+|+++.|+|||+|..+..+.........+||..|||||++
T Consensus       311 ria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvL  390 (534)
T KOG3653|consen  311 RIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVL  390 (534)
T ss_pred             HHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHH
Confidence            688999999999995       4567999999999999999999999999999877655444334457899999999999


Q ss_pred             ccCC-Cc-----ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhHHHHhhcccCCCCcHH-----
Q 027003           75 ATGR-LT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----  142 (229)
Q Consensus        75 ~~~~-~~-----~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  142 (229)
                      .|.- +.     .+.||||+|.+||||+++...+....+...+- +.........-.+-...++..+.+...+..     
T Consensus       391 Egainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~  470 (534)
T KOG3653|consen  391 EGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHA  470 (534)
T ss_pred             hhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCc
Confidence            7642 22     36899999999999999765554222221111 111111111111111223334444444442     


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 027003          143 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN  180 (229)
Q Consensus       143 ~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~~~~  180 (229)
                      ....+.+.+..||+.|++.|.|+.=+.+++.++.....
T Consensus       471 ~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  471 GMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            35678899999999999999999999988888765443

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=1.1e-27  Score=190.99  Aligned_cols=153  Identities=30%  Similarity=0.413  Sum_probs=113.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......    .....++..|++||.+.+..++.
T Consensus       109 ~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~  182 (287)
T cd06621         109 KIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSI  182 (287)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCc
Confidence            578999999999995  569999999999999999999999999987543221    12345788999999998889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccc--cchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHHhccC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVG--IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNN  157 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  157 (229)
                      ++|+|||||++|+|++|..||......  .......+....          ..........  ...+..+.+++.+||+.
T Consensus       183 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~  252 (287)
T cd06621         183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----------PNPELKDEPGNGIKWSEEFKDFIKQCLEK  252 (287)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----------CchhhccCCCCCCchHHHHHHHHHHHcCC
Confidence            999999999999999999999765321  001111110000          0000000001  12456789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      +|.+|||+.|+++
T Consensus       253 ~p~~Rpt~~eil~  265 (287)
T cd06621         253 DPTRRPTPWDMLE  265 (287)
T ss_pred             CcccCCCHHHHHh
Confidence            9999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=9.2e-28  Score=190.94  Aligned_cols=166  Identities=24%  Similarity=0.325  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||+|||+  .+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+. .++
T Consensus       104 ~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~  180 (287)
T cd07840         104 CYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYG  180 (287)
T ss_pred             HHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCC
Confidence            578999999999995  46999999999999999999999999999865443211 12234567889999987654 578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhcchhhHHHH-----hh------cccCCCCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDKRKLFRI-----MD------TKLGGQYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~~  147 (229)
                      .++||||||+++|+|++|..||...+...... +..... +...........     ..      ..........++..+
T Consensus       181 ~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (287)
T cd07840         181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSA  260 (287)
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHH
Confidence            89999999999999999999997654321110 110000 000000000000     00      000000011126678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+++.+||+.+|.+||++.++++
T Consensus       261 ~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         261 LDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhh
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=1.2e-27  Score=191.28  Aligned_cols=165  Identities=23%  Similarity=0.264  Sum_probs=110.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||+|||+  ++++|+||||+||+++. ++.+||+|||++........  ......++..|+|||.+.+. .+
T Consensus       106 ~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~  181 (294)
T PLN00009        106 TYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHY  181 (294)
T ss_pred             HHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCC
Confidence            467899999999995  56999999999999985 55799999999975432211  12234578899999988664 57


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccch-hHHH-hhhhhhcc---hhhHHHHh--hcccCCC----CcHHHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLSD---KRKLFRIM--DTKLGGQ----YPQKAAHTAA  148 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~-~~~~~~~~---~~~~~~~~--~~~~~~~----~~~~~~~~~~  148 (229)
                      +.++|+|||||++|+|+||..||......... .... ...+....   ...+....  .......    .....+..+.
T Consensus       182 ~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (294)
T PLN00009        182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGV  261 (294)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHH
Confidence            88999999999999999999999764321110 0000 00000000   00000000  0000000    0122356688


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +++.+||+.+|++||++.++++
T Consensus       262 ~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        262 DLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999986

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-27  Score=186.32  Aligned_cols=148  Identities=31%  Similarity=0.495  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.........  .....++..|++||.+.+..++.
T Consensus       103 ~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~  178 (254)
T cd06627         103 VYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGAST  178 (254)
T ss_pred             HHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCc
Confidence            478999999999995  56999999999999999999999999999865443321  23346788999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|+||+++|+|++|..||......                ....... .......+...+..+.+++.+||..+|++
T Consensus       179 ~~Dv~~lG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  241 (254)
T cd06627         179 ASDIWSLGCTVIELLTGNPPYYDLNPM----------------AALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNL  241 (254)
T ss_pred             chhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhh
Confidence            999999999999999999999754310                0011111 11122334455678899999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.+++.
T Consensus       242 R~~~~~~l~  250 (254)
T cd06627         242 RPTAKQLLK  250 (254)
T ss_pred             CcCHHHHhc
Confidence            999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=3.8e-27  Score=187.29  Aligned_cols=164  Identities=23%  Similarity=0.299  Sum_probs=112.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.+|.|||+  ++++|+||+|+||+++.++.++|+|||++........   .....++..|+|||++.+ ..++
T Consensus       103 ~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  177 (283)
T cd07830         103 SIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcC
Confidence            578999999999995  5699999999999999999999999999876533222   123467889999998854 4578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcc----hhhHHHHhhcccCC-------CCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD----KRKLFRIMDTKLGG-------QYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~~  148 (229)
                      .++|+||||+++|+|++|..||......... ............    ..............       .........+.
T Consensus       178 ~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (283)
T cd07830         178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI  257 (283)
T ss_pred             CccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHH
Confidence            9999999999999999999999765432111 011100000000    00000000000000       00011246788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +++.+||+.||++||++.|++.
T Consensus       258 ~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         258 DLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             HHHHHhcccCcccCCCHHHHhh
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=1.1e-27  Score=192.07  Aligned_cols=166  Identities=25%  Similarity=0.278  Sum_probs=111.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||++......... ......++..|++||.+.+. .++
T Consensus       120 ~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~  196 (302)
T cd07864         120 SFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYG  196 (302)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCC
Confidence            578999999999995  56999999999999999999999999998765433211 11223457789999988654 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhcchhhHHHH-----hhccc-----CCCCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLFRI-----MDTKL-----GGQYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|+.||.......... +.... .+...........     .+...     ........+..+.
T Consensus       197 ~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (302)
T cd07864         197 PAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPAL  276 (302)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHH
Confidence            89999999999999999999997543211110 00000 0000000000000     00000     0000112356789


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +++.+||+.||.+||++.+++.
T Consensus       277 ~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         277 DLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=1.6e-27  Score=189.58  Aligned_cols=165  Identities=24%  Similarity=0.316  Sum_probs=112.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........  ......++..|++||.+.+. .++
T Consensus       104 ~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  179 (284)
T cd07836         104 SFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYS  179 (284)
T ss_pred             HHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCC
Confidence            578999999999995  4699999999999999999999999999875432211  12234568899999988664 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHh-hhhhhcchhhHHH--HhhcccC-------CCCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDKRKLFR--IMDTKLG-------GQYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~~~  149 (229)
                      .++|+|||||++|+|++|..||.+.+..... ..... ..+.......+..  .......       .......+..+.+
T Consensus       180 ~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (284)
T cd07836         180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID  259 (284)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHH
Confidence            8999999999999999999999765432110 01000 0000000000000  0000000       0011234567889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ++.+||+.||.+||++.++++
T Consensus       260 ~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         260 LLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHHhcCCcccCCCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.1e-27  Score=193.23  Aligned_cols=163  Identities=24%  Similarity=0.320  Sum_probs=112.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......     .....++..|+|||.+.+ ..++
T Consensus       124 ~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  196 (345)
T cd07877         124 FLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYN  196 (345)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCC
Confidence            478999999999995  46999999999999999999999999998764321     223467889999998866 4678


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-------hhhcc--hhhHHHHhhcccCCCC---cHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-------PYLSD--KRKLFRIMDTKLGGQY---PQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-------~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||...+..... .+.....       .....  .......+........   ....+..+
T Consensus       197 ~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (345)
T cd07877         197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA  276 (345)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHH
Confidence            8999999999999999999999754321110 0000000       00000  0000000000000000   01235568


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+|+.+||+.||.+||++.+++..
T Consensus       277 ~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         277 VDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHcCCChhhcCCHHHHhcC
Confidence            899999999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.5e-27  Score=189.41  Aligned_cols=165  Identities=23%  Similarity=0.281  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.|++.||.|||+  .+|+||||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++
T Consensus       102 ~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  177 (282)
T cd07829         102 SIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYS  177 (282)
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCC
Confidence            578999999999995  46999999999999999999999999998765332211  2223457789999998776 788


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcc-hhhHH-----HHhhcccCC----CCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD-KRKLF-----RIMDTKLGG----QYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~-~~~~~-----~~~~~~~~~----~~~~~~~~~~~~  149 (229)
                      .++|+|||||++|||++|..||......... ............ .....     .........    .........+.+
T Consensus       178 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (282)
T cd07829         178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID  257 (282)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHH
Confidence            9999999999999999999999765421110 000000000000 00000     000000000    001123567999


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ++.+||+.||++||++.+++.
T Consensus       258 ~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         258 LLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHHhhccCcccCCCHHHHhh
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=1.8e-27  Score=188.67  Aligned_cols=149  Identities=27%  Similarity=0.411  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc------------------ceeeccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------HVSTQVM   63 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------------------~~~~~~~   63 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.........                  .......
T Consensus       106 ~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (280)
T cd05581         106 FYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV  183 (280)
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccccccccc
Confidence            578999999999995  46999999999999999999999999998765432211                  1223456


Q ss_pred             cccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHH
Q 027003           64 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA  143 (229)
Q Consensus        64 gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (229)
                      ++..|++||++.+..++.++|+||||++++++++|+.||......                .......  ......+...
T Consensus       184 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~--~~~~~~~~~~  245 (280)
T cd05581         184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----------------LTFQKIL--KLEYSFPPNF  245 (280)
T ss_pred             CCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHH--hcCCCCCCcc
Confidence            788999999998888899999999999999999999999765410                1111111  1122334445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 027003          144 AHTAATLALQCLNNEPKLRPRM----SEVLA  170 (229)
Q Consensus       144 ~~~~~~li~~~l~~dP~~Rpt~----~~v~~  170 (229)
                      +..+.+++.+||+.+|.+||++    .+++.
T Consensus       246 ~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         246 PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            7788999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=187.90  Aligned_cols=155  Identities=23%  Similarity=0.337  Sum_probs=131.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.|++|||.+  +|||.||-..|++|++.-.|||+|-.+++..-..+.............||++|.+.+..|+.
T Consensus       400 ~masQla~am~hlh~~--~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yss  477 (563)
T KOG1024|consen  400 LMASQLAMAMEHLHNH--GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSS  477 (563)
T ss_pred             HHHHHHHHHHHHHHhc--CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcc
Confidence            4789999999999965  49999999999999999999999999998654444433334445678999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+||||+++|||+| |+.|+-.-+                 .......++.+.+...|.++++++..++.-||..+|+
T Consensus       478 asDvWsfGVllWELmtlg~~PyaeID-----------------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpe  540 (563)
T KOG1024|consen  478 ASDVWSFGVLLWELMTLGKLPYAEID-----------------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPE  540 (563)
T ss_pred             hhhhHHHHHHHHHHHhcCCCCccccC-----------------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcc
Confidence            9999999999999998 888886543                 2344456667777778889999999999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +||++++++..|.+.
T Consensus       541 eRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  541 ERPSFSQLVICLSEF  555 (563)
T ss_pred             cCCCHHHHHHHHHHH
Confidence            999999999988764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.6e-27  Score=194.85  Aligned_cols=162  Identities=23%  Similarity=0.325  Sum_probs=112.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++......     .....++..|+|||.+.+. .++
T Consensus       122 ~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  194 (343)
T cd07851         122 FLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYN  194 (343)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCC
Confidence            578999999999995  46999999999999999999999999998765332     2234578899999988653 678


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhhhhh----c--chhhHHHHhhccc---CCCC---cHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYL----S--DKRKLFRIMDTKL---GGQY---PQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~----~--~~~~~~~~~~~~~---~~~~---~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||.+...... ..+........    .  ........+....   ....   ....+..+
T Consensus       195 ~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  274 (343)
T cd07851         195 QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLA  274 (343)
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHH
Confidence            899999999999999999999976543111 01111000000    0  0000000111000   0000   01236678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+++.+||+.||.+|||+.+++.
T Consensus       275 ~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         275 IDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHhCCCChhhCCCHHHHhc
Confidence            99999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=4.4e-27  Score=184.77  Aligned_cols=147  Identities=27%  Similarity=0.423  Sum_probs=113.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||||+||+++. +.++|+|||++........  ......|+..|++||.+.+..++.
T Consensus       110 ~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~  184 (260)
T cd08222         110 EWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDS  184 (260)
T ss_pred             HHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCc
Confidence            468899999999995  56999999999999975 5699999999876533221  123356788999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|+|++|..||......                ....... .......+...+..+.+++.+||..+|++
T Consensus       185 ~~Dv~slG~~~~~l~~~~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~  247 (260)
T cd08222         185 KSDIWSLGCILYEMCCLAHAFEGQNFL----------------SVVLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSL  247 (260)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhh
Confidence            999999999999999999999653210                0011111 11222334566778999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       248 Rp~~~~il~  256 (260)
T cd08222         248 RPSAAEILR  256 (260)
T ss_pred             CcCHHHHhh
Confidence            999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.94  E-value=2.2e-27  Score=193.94  Aligned_cols=167  Identities=20%  Similarity=0.303  Sum_probs=110.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcc-eeecccccccccccccccc-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVAT-GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~   78 (229)
                      .++.||+.||.|||+  .+|+||||||+||+++. ++.++|+|||+++......... ......++..|+|||.+.+ ..
T Consensus       118 ~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  195 (342)
T cd07854         118 LFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN  195 (342)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccc
Confidence            478999999999995  46999999999999975 5578999999987543221111 1122357889999998754 45


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc--chhhHH----HHhh-cccCCCC-----cHHHHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS--DKRKLF----RIMD-TKLGGQY-----PQKAAHT  146 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~----~~~~-~~~~~~~-----~~~~~~~  146 (229)
                      ++.++|||||||++|+|++|+.||.+.+............+...  ......    .... .......     .......
T Consensus       196 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (342)
T cd07854         196 YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE  275 (342)
T ss_pred             cCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHH
Confidence            78899999999999999999999976542111110000000000  000000    0000 0000000     1124567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||+.||.+|||+.+++.
T Consensus       276 ~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         276 ALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHhCCCchhccCHHHHhC
Confidence            889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=182.68  Aligned_cols=165  Identities=22%  Similarity=0.320  Sum_probs=117.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .|+.|++.|+.|||+  .||+||||||+||++..+..+||.|||+++.....   -..+..+.|..|.|||++.+..+..
T Consensus       122 ~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke  196 (369)
T KOG0665|consen  122 YILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKE  196 (369)
T ss_pred             HHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcc
Confidence            478999999999995  56999999999999999999999999999864332   2355678899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHH-hhhh---hhcchhhHHHHh----------------hcc-cC--C
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKP---YLSDKRKLFRIM----------------DTK-LG--G  137 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~-~~~~---~~~~~~~~~~~~----------------~~~-~~--~  137 (229)
                      .+||||+||++.||++|...|.+.+--..- ...+ ...+   +..+.....+..                ... ..  .
T Consensus       197 ~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~  276 (369)
T KOG0665|consen  197 NVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVL  276 (369)
T ss_pred             cchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccc
Confidence            999999999999999999999865431100 0000 0000   000000000000                000 00  0


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+......+.+|+.+||..||++|.++.+++..
T Consensus       277 e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  277 EGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1112335567899999999999999999999863

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.2e-27  Score=183.12  Aligned_cols=144  Identities=31%  Similarity=0.412  Sum_probs=112.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+...+.
T Consensus        97 ~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~  172 (250)
T cd05123          97 FYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGK  172 (250)
T ss_pred             HHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCc
Confidence            468899999999995  5699999999999999999999999999876533221  123456788999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+||||+++|++++|..||...+.                ......+..  .....+...+..+.+++.+||..||++
T Consensus       173 ~~D~~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~  234 (250)
T cd05123         173 AVDWWSLGVLLYEMLTGKPPFYAEDR----------------KEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTK  234 (250)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence            99999999999999999999965431                001111111  122344445778899999999999999


Q ss_pred             CCCHHH
Q 027003          162 RPRMSE  167 (229)
Q Consensus       162 Rpt~~~  167 (229)
                      ||++.+
T Consensus       235 R~~~~~  240 (250)
T cd05123         235 RLGSGG  240 (250)
T ss_pred             CCCccc
Confidence            999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=6e-28  Score=175.81  Aligned_cols=101  Identities=33%  Similarity=0.473  Sum_probs=85.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc----C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----G   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~   77 (229)
                      +|+..++.||.|||++ -.+||||+||+|||++.+|+||+||||++-...+.-   ..+...|...|||||.+..    .
T Consensus       152 kIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~  227 (282)
T KOG0984|consen  152 KIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQK  227 (282)
T ss_pred             HhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcc
Confidence            5788999999999985 469999999999999999999999999987654321   1233458889999998854    3


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                      .|+.++||||||+++.||.+++.||+...
T Consensus       228 gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  228 GYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             cceeehhhhhhhhhhhhhhhccccccccC
Confidence            68899999999999999999999997654

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=2.8e-27  Score=192.73  Aligned_cols=167  Identities=23%  Similarity=0.263  Sum_probs=111.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC------------Ccceeeccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD------------RTHVSTQVMGTHGYA   69 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~   69 (229)
                      .++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++.......            .........++..|+
T Consensus       123 ~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  200 (335)
T PTZ00024        123 CILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR  200 (335)
T ss_pred             HHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCC
Confidence            478999999999995  569999999999999999999999999987643110            001112234678899


Q ss_pred             cccccccC-CCcccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-hhhcchhhHHHHh-hcccCC-------C
Q 027003           70 APEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSDKRKLFRIM-DTKLGG-------Q  138 (229)
Q Consensus        70 aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~-~~~~~~-------~  138 (229)
                      |||.+.+. .++.++|+|||||++|+|++|..||.+.+..... .+..... +............ ......       .
T Consensus       201 aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (335)
T PTZ00024        201 APELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT  280 (335)
T ss_pred             CChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH
Confidence            99998764 4688999999999999999999999765431110 0100000 0000000000000 000000       0


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       139 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .....+..+.+++.+||+.+|++||++.+++.
T Consensus       281 ~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        281 IFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            01123567889999999999999999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=6.7e-28  Score=204.98  Aligned_cols=147  Identities=31%  Similarity=0.468  Sum_probs=112.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CC--cEEEcccCCcccCCCCCCc-ceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EF--NAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~--~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~   75 (229)
                      .++.|++.||++||+.  +||||||||.||||+.   ++  .++|+|||+++....+... .......||-+|+|||++.
T Consensus       610 ~~l~q~~~GlaHLHsl--~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~  687 (903)
T KOG1027|consen  610 SVLSQIASGLAHLHSL--KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLR  687 (903)
T ss_pred             HHHHHHHHHHHHHHhc--ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHh
Confidence            4678999999999975  5999999999999976   34  5899999999987654332 2234567999999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhC-CCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc---CCCCcHHHHHHHHHHH
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL---GGQYPQKAAHTAATLA  151 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li  151 (229)
                      ....+.++|||||||++|+.++| ..||.....                  .-.+++....   ......++  +..+||
T Consensus       688 ~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~------------------R~~NIl~~~~~L~~L~~~~d~--eA~dLI  747 (903)
T KOG1027|consen  688 EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE------------------RQANILTGNYTLVHLEPLPDC--EAKDLI  747 (903)
T ss_pred             ccccCcccchhhcCceEEEEecCCccCCCchHH------------------hhhhhhcCccceeeeccCchH--HHHHHH
Confidence            98888999999999999999986 899976321                  1111111111   00111112  788999


Q ss_pred             HHhccCCCCCCCCHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|++.+|..||++.+|+.
T Consensus       748 ~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  748 SRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHhcCCCcccCCCHHHHhC
Confidence            9999999999999999984

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=4.7e-27  Score=187.56  Aligned_cols=152  Identities=30%  Similarity=0.382  Sum_probs=110.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC--CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~   79 (229)
                      .++.|++.||.|||+  .+++||||||+|||++.++.+||+|||++......... ......|+..|++||.+.+.  .+
T Consensus       109 ~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  185 (290)
T cd05613         109 IYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGH  185 (290)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCC
Confidence            356799999999995  56999999999999999999999999998765332211 12245688999999998753  46


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++||||||+++|+|++|..||.........             ......+.. .....+......+.+++.+||+.||
T Consensus       186 ~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------------~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p  251 (290)
T cd05613         186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-------------AEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDP  251 (290)
T ss_pred             CccccHHHHHHHHHHHhcCCCCCCcCCccccH-------------HHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCH
Confidence            78999999999999999999999643211000             001111111 1122344466788899999999999


Q ss_pred             CCCC-----CHHHHHH
Q 027003          160 KLRP-----RMSEVLA  170 (229)
Q Consensus       160 ~~Rp-----t~~~v~~  170 (229)
                      ++|+     ++.+++.
T Consensus       252 ~~R~~~~~~~~~~l~~  267 (290)
T cd05613         252 KKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHhcCCCCCCHHHHHc
Confidence            9997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.3e-28  Score=181.85  Aligned_cols=167  Identities=26%  Similarity=0.398  Sum_probs=117.8

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCcc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~   81 (229)
                      +.+||++||+|||+  .+|.||||||.|.|++.+-.+||||||+++......... .+..+-|..|.|||++.|. .|+.
T Consensus       161 FlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~  237 (449)
T KOG0664|consen  161 FVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTG  237 (449)
T ss_pred             hHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcC
Confidence            46899999999996  459999999999999999999999999999865444333 3445568899999999886 5899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhH-HHh-hhhhhcchh-----hHHHHhhcccCCC---------CcHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDKR-----KLFRIMDTKLGGQ---------YPQKAAH  145 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~-~~~~~~~~~-----~~~~~~~~~~~~~---------~~~~~~~  145 (229)
                      +.||||.|||+.|++.++..|...+.-..-.+ .+. ..|.....+     ....++......+         .+.....
T Consensus       238 AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~h  317 (449)
T KOG0664|consen  238 AVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNH  317 (449)
T ss_pred             ccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccch
Confidence            99999999999999999988877553221111 111 112111111     1111111111111         1123344


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      +...++.++|..||++|.+..+.+..+
T Consensus       318 eav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  318 EAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHHHHhCCCCcccccHhhhcccc
Confidence            566788899999999999999888654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=4.2e-27  Score=192.32  Aligned_cols=162  Identities=22%  Similarity=0.291  Sum_probs=111.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++......     .....++..|++||.+.+ ..++
T Consensus       122 ~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  194 (343)
T cd07880         122 FLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYT  194 (343)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCC
Confidence            478999999999995  46999999999999999999999999998764322     123457889999999876 3578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhhhhh----c--chhhHHHHhhcc--cCC----CCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYL----S--DKRKLFRIMDTK--LGG----QYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~----~--~~~~~~~~~~~~--~~~----~~~~~~~~~~  147 (229)
                      .++|+|||||++|++++|..||.+.+.... ...........    .  ............  ...    ......+..+
T Consensus       195 ~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (343)
T cd07880         195 QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLA  274 (343)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHH
Confidence            899999999999999999999976542110 00000000000    0  000000000000  000    0112345568


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+++.+||+.||.+|||+.+++.
T Consensus       275 ~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         275 VNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhc
Confidence            89999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-28  Score=187.30  Aligned_cols=149  Identities=30%  Similarity=0.401  Sum_probs=117.5

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ++.+.+.||+|||..  .=||||||..||||+-+|.+||+|||.+....+..-  ....++||+.|||||++..-.|+.+
T Consensus       134 iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~  209 (502)
T KOG0574|consen  134 VLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTK  209 (502)
T ss_pred             HHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccHHHHHHhccchh
Confidence            577889999999964  379999999999999999999999999876543221  1345789999999999998899999


Q ss_pred             CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHh-hcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           83 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        83 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      +||||||++..||..|++||..-..-                +.++-+- .......-|...+..+-+++++||-++|++
T Consensus       210 ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~  273 (502)
T KOG0574|consen  210 ADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEE  273 (502)
T ss_pred             hhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHH
Confidence            99999999999999999999654311                0011000 111122345677889999999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      |.|+.++++.
T Consensus       274 R~TA~~L~~H  283 (502)
T KOG0574|consen  274 RKTALRLCEH  283 (502)
T ss_pred             HHHHHHHhhh
Confidence            9999888753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1e-26  Score=197.65  Aligned_cols=160  Identities=23%  Similarity=0.371  Sum_probs=133.4

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      |.|+.||++||.|||  +.++|||||-..|||+.....+||.|||+++...............-.+.|||-|.++...++
T Consensus       801 Lnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~t  878 (1177)
T KOG1025|consen  801 LNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYT  878 (1177)
T ss_pred             HHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCC
Confidence            468999999999999  556999999999999999999999999999976554333222223346789999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++||++| |..|+++...                 +.+.+++....+...|+.++..+..++.+||..|+
T Consensus       879 hqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~  941 (1177)
T KOG1025|consen  879 HQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDA  941 (1177)
T ss_pred             chhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCc
Confidence            99999999999999998 9999987542                 23445555666677888899999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCCC
Q 027003          160 KLRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~~~  179 (229)
                      ..||+++++...+.++....
T Consensus       942 ~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  942 DSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             ccCccHHHHHHHHHHHhcCc
Confidence            99999999999988775543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=2e-26  Score=187.18  Aligned_cols=163  Identities=26%  Similarity=0.377  Sum_probs=112.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++......     .....++..|+|||.+.+ ..++
T Consensus       112 ~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  184 (328)
T cd07856         112 YFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYD  184 (328)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcC
Confidence            467899999999995  46999999999999999999999999998754221     123457889999998866 5688


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcc------hhhHHHHhhc-ccCCCCc-----HHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD------KRKLFRIMDT-KLGGQYP-----QKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~-----~~~~~~~  147 (229)
                      .++|+|||||++|+|++|+.||......... .+.+.......+      .....+.... ......+     ...+..+
T Consensus       185 ~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (328)
T cd07856         185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSA  264 (328)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHH
Confidence            9999999999999999999999764321110 011100000000      0000011100 0011111     1245788


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+++.+||+.+|++||++.+++..
T Consensus       265 ~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         265 IDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcC
Confidence            999999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=3.2e-27  Score=195.29  Aligned_cols=145  Identities=26%  Similarity=0.417  Sum_probs=118.8

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc-c
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-T   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~   81 (229)
                      ++.|+..|++|||++  .|||||||.+||||+.+.++||+|||++..+..+   ....+.+|++.|.|||++.|..++ .
T Consensus       160 ~F~q~vsaveYcH~k--~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gp  234 (596)
T KOG0586|consen  160 KFRQIVSAVEYCHSK--NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGP  234 (596)
T ss_pred             hhHHHHHHHHHHhhc--ceeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCc
Confidence            578999999999964  5999999999999999999999999999876533   234568999999999999998764 6


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      .+|+|++|+++|-|+.|..||++.+......                +.+..++  ..+.-++.++.+||+++|..+|.+
T Consensus       235 e~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~----------------rvl~gk~--rIp~~ms~dce~lLrk~lvl~Psk  296 (596)
T KOG0586|consen  235 EVDIWSLGVVLYALVEGSLPFDGQNLKELRP----------------RVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSK  296 (596)
T ss_pred             ceehhhhhhhheeeeecccccCCcccccccc----------------hheeeee--cccceeechhHHHHHHhhccCccc
Confidence            8999999999999999999999866422111                1122222  234446778999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |+++.++.+
T Consensus       297 r~~~dqim~  305 (596)
T KOG0586|consen  297 RGPCDQIMK  305 (596)
T ss_pred             cCCHHHhhh
Confidence            999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=180.44  Aligned_cols=146  Identities=29%  Similarity=0.537  Sum_probs=112.6

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccC
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS   83 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~   83 (229)
                      ...|+.||.|||+  +|||+||||.+|||++..|.+||+|+|+++....  ....+.+++||+.|.|||+++|..|.+.+
T Consensus       357 s~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsv  432 (593)
T KOG0695|consen  357 SAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSV  432 (593)
T ss_pred             hHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchhhcCCC--CCcccccccCCCcccchhhhcccccCcee
Confidence            3568899999995  5699999999999999999999999999986432  33346678999999999999999999999


Q ss_pred             ceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHH-hhcccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 027003           84 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR  162 (229)
Q Consensus        84 Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  162 (229)
                      |.|+||++++||+.|+.||+.-......         .+...-++.+ +...+  ..|..++-....+++.-|.+||.+|
T Consensus       433 dwwalgvlmfemmagrspfdivgm~n~d---------~ntedylfqvilekqi--riprslsvkas~vlkgflnkdp~er  501 (593)
T KOG0695|consen  433 DWWALGVLMFEMMAGRSPFDIVGMDNPD---------MNTEDYLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKER  501 (593)
T ss_pred             hHHHHHHHHHHHHcCCCCcceecCCCcc---------cchhHHHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHh
Confidence            9999999999999999999754322111         1111122222 22222  3455566677789999999999999


Q ss_pred             CC
Q 027003          163 PR  164 (229)
Q Consensus       163 pt  164 (229)
                      ..
T Consensus       502 lg  503 (593)
T KOG0695|consen  502 LG  503 (593)
T ss_pred             cC
Confidence            63

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=2.2e-26  Score=178.11  Aligned_cols=148  Identities=32%  Similarity=0.444  Sum_probs=114.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.+++.+|.|||.  .+++|+||+|+||+++.++.++|+|||.+.......   ......++..|++||.+.+..++.
T Consensus        91 ~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~  165 (244)
T smart00220       91 FYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGK  165 (244)
T ss_pred             HHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCc
Confidence            578999999999995  469999999999999999999999999998654332   123456788999999998888899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHH--HHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--AAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dP  159 (229)
                      ++|+|+||+++|+|++|..||.....                .....+.+...........  .+..+.+++.+||..+|
T Consensus       166 ~~Di~slG~~l~~l~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  229 (244)
T smart00220      166 AVDVWSLGVILYELLTGKPPFPGDDQ----------------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP  229 (244)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCc----------------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence            99999999999999999999866311                1111111111111111111  56788999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      ++||++.++++
T Consensus       230 ~~Rp~~~~~~~  240 (244)
T smart00220      230 EKRLTAEEALQ  240 (244)
T ss_pred             hhccCHHHHhh
Confidence            99999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=178.61  Aligned_cols=165  Identities=25%  Similarity=0.290  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCcccCCCCCCcc-----eeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~   73 (229)
                      ++.++|+.||.|||  .+||.||||||+|||......   +|||||.+...........     ...+.+|+..|||||+
T Consensus       180 ~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEV  257 (463)
T KOG0607|consen  180 RVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEV  257 (463)
T ss_pred             HHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhH
Confidence            46789999999999  567999999999999976554   7999998865332221111     1234679999999997


Q ss_pred             ccc-----CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-cc--CCCCcHHHHH
Q 027003           74 VAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KL--GGQYPQKAAH  145 (229)
Q Consensus        74 ~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~  145 (229)
                      ..-     .-|+.++|.||||+|+|-||.|.+||.+.-... .. .+...+.......+++.+.. ..  ....+..++.
T Consensus       258 Vd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d-CG-WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~  335 (463)
T KOG0607|consen  258 VDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD-CG-WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISS  335 (463)
T ss_pred             HhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-CC-ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhH
Confidence            732     357889999999999999999999998754311 00 00001222223344443332 22  2233456788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +..+|+..+|..|+.+|.++.+++.
T Consensus       336 eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  336 EAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccHHhhhhhhhccC
Confidence            9999999999999999999999886

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.7e-26  Score=199.06  Aligned_cols=148  Identities=25%  Similarity=0.351  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----CC
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GR   78 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~   78 (229)
                      +..|+.||.-||+.  |+|||||||+|||||..|++||+|||.+-.+...... .....+||+-|++||++..     +.
T Consensus       181 ~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~  257 (1317)
T KOG0612|consen  181 TAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGE  257 (1317)
T ss_pred             HHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccc
Confidence            46788999999964  5999999999999999999999999998776543332 2455789999999999952     56


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~  156 (229)
                      |+..+|.||+||++|||+.|..||....                -.+.+.+++.-+-...+|  ..++..+.+||.+.+.
T Consensus       258 yG~ecDwWSlGV~~YEMlyG~TPFYads----------------lveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~  321 (1317)
T KOG0612|consen  258 YGRECDWWSLGVFMYEMLYGETPFYADS----------------LVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC  321 (1317)
T ss_pred             cCCccchhhhHHHHHHHHcCCCcchHHH----------------HHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc
Confidence            8899999999999999999999996633                234455555554333444  4578899999998764


Q ss_pred             CCCCCCCC---HHHHHHH
Q 027003          157 NEPKLRPR---MSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt---~~~v~~~  171 (229)
                       +|+.|..   +.++...
T Consensus       322 -~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  322 -DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             -ChhhhcccccHHHHHhC
Confidence             7778877   8888753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.92  E-value=6.4e-26  Score=162.25  Aligned_cols=165  Identities=25%  Similarity=0.308  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      +++.|+++||.|+|+++  +.||||||.|.||+.+|..||+|||+++.++-.  ..+....+-|.+|.+|.++.|.+ |+
T Consensus       105 sfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfgakly~  180 (292)
T KOG0662|consen  105 SFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_pred             HHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhc
Confidence            46789999999999865  999999999999999999999999999986443  22344456799999999998875 78


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHH--hhhhhhcchhhHHHHhhcccCCCC---------cHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD--WAKPYLSDKRKLFRIMDTKLGGQY---------PQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  148 (229)
                      ...|+||-|||+.|+.. |++.|.+.++...-..+-  ...+....+..+.+.-+-..-..+         .+.....-+
T Consensus       181 tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~gr  260 (292)
T KOG0662|consen  181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGR  260 (292)
T ss_pred             cchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhH
Confidence            89999999999999975 788888876543221111  111111111111111111111111         124455678


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|++++|..+|.+|.++.+.++
T Consensus       261 dllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  261 DLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             HHHHHHhccCcccccCHHHHhc
Confidence            9999999999999999988775

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.92  E-value=3.7e-26  Score=186.53  Aligned_cols=145  Identities=23%  Similarity=0.293  Sum_probs=116.0

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +..||+.||.|||.  ++|||.||||+||||...   -.+||||||+++.++..   ......+||+.|+|||+++.+.|
T Consensus       669 lvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFRrsVVGTPAYLaPEVLrnkGy  743 (888)
T KOG4236|consen  669 LVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFRRSVVGTPAYLAPEVLRNKGY  743 (888)
T ss_pred             HHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeecchh---hhhhhhcCCccccCHHHHhhccc
Confidence            46899999999994  569999999999999654   35899999999987543   23456789999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +..-|+||.|+|+|--+.|..||.....-                  -..+....  .....+.+++....+||..+|+.
T Consensus       744 NrSLDMWSVGVIiYVsLSGTFPFNEdEdI------------------ndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV  805 (888)
T KOG4236|consen  744 NRSLDMWSVGVIIYVSLSGTFPFNEDEDI------------------NDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV  805 (888)
T ss_pred             cccccceeeeEEEEEEecccccCCCccch------------------hHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence            99999999999999999999999764311                  01111111  12234457788899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      .=.+|.++...+.
T Consensus       806 km~kRysvdk~ls  818 (888)
T KOG4236|consen  806 KMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHhcchHhhcc
Confidence            9999999887763

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.5e-25  Score=184.99  Aligned_cols=142  Identities=29%  Similarity=0.404  Sum_probs=104.4

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCC---------CCCCcc-----------------
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP---------TGDRTH-----------------   57 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~---------~~~~~~-----------------   57 (229)
                      +..+..|+++.|  +.|+|||||||+|||||.+|++||+||||+.-+.         .++...                 
T Consensus       735 IAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~l  812 (1034)
T KOG0608|consen  735 IAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCL  812 (1034)
T ss_pred             HHHHHHHHHHHH--hccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccc
Confidence            456788999999  5679999999999999999999999999985321         111000                 


Q ss_pred             --------------eeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhc
Q 027003           58 --------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLS  122 (229)
Q Consensus        58 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~  122 (229)
                                    .....+||..|+|||++....++..+|.||.|||||||+.|+.||........+. +..|.     
T Consensus       813 kvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~-----  887 (1034)
T KOG0608|consen  813 KVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR-----  887 (1034)
T ss_pred             hHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh-----
Confidence                          0013679999999999999999999999999999999999999997765443332 22221     


Q ss_pred             chhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 027003          123 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP  163 (229)
Q Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  163 (229)
                                .-+...+..+++.++.+||.++ ..+++.|.
T Consensus       888 ----------~~l~~~~~~~ls~e~~~li~kL-c~sad~RL  917 (1034)
T KOG0608|consen  888 ----------NFLHIPYQGNLSKEALDLIQKL-CCSADSRL  917 (1034)
T ss_pred             ----------hccccccccccCHHHHHHHHHH-hcChhhhh
Confidence                      1122234455677888888773 45667776

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=3.2e-25  Score=194.99  Aligned_cols=93  Identities=22%  Similarity=0.290  Sum_probs=69.5

Q ss_pred             ccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC-CCCcH
Q 027003           63 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQ  141 (229)
Q Consensus        63 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  141 (229)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....                ....++..... .....
T Consensus       541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~----------------~~~~il~~~~~~p~~~~  604 (669)
T cd05610         541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ----------------VFQNILNRDIPWPEGEE  604 (669)
T ss_pred             eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhcCCCCCcccc
Confidence            56899999999999999999999999999999999999997643210                11111111110 11112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+...+.+++..||..||.+||++.+++..
T Consensus       605 ~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h  634 (669)
T cd05610         605 KLSVNAQNAIEILLTMDPTKRAGLKELKQH  634 (669)
T ss_pred             cCCHHHHHHHHHHcccChhHCcCHHHHHhC
Confidence            345678899999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.91  E-value=5.2e-25  Score=184.87  Aligned_cols=100  Identities=30%  Similarity=0.449  Sum_probs=86.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee--cCCCc--EEEcccCCcccCCCCCCcceeeccccccccccccccc-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~   76 (229)
                      .++.+++.||.|||  +++||||||||.||++  +.+|+  .||+|||.|+...++.   ...+++||..|.+||++. .
T Consensus       124 ~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q  198 (732)
T KOG4250|consen  124 DLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQ  198 (732)
T ss_pred             HHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhc
Confidence            46789999999999  5679999999999998  34444  6999999999876544   466789999999999998 4


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                      +.|+..+|.|||||++|+.+||..||....
T Consensus       199 ~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  199 KKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            789999999999999999999999997644

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=3.5e-25  Score=180.37  Aligned_cols=163  Identities=21%  Similarity=0.206  Sum_probs=115.9

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .+.|+..||..|-  ..+|+|.||||+|||+++.. .+||||||.|.....+.    .+.+.-+..|.|||++.|..|+.
T Consensus       541 YaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~  614 (752)
T KOG0670|consen  541 YAQQLFLALKLLK--KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDY  614 (752)
T ss_pred             HHHHHHHHHHHHH--hcCeeecccCccceEeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccC
Confidence            5789999999999  45699999999999998764 57999999987654432    22344577899999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccc-hhHHHhhhhhhcch------------------------------------
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYLSDK------------------------------------  124 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~------------------------------------  124 (229)
                      .-|+||.||+||||.||+..|.+...... ..+.+...++....                                    
T Consensus       615 ~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~  694 (752)
T KOG0670|consen  615 PIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVN  694 (752)
T ss_pred             CccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecc
Confidence            99999999999999999999988654211 11111111111100                                    


Q ss_pred             ----hhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          125 ----RKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       125 ----~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                          ..+...+... ....-.......+.+|+.+||..||++|.|..++|..
T Consensus       695 vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  695 VKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             cCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                0011111110 0111223456788999999999999999999998763

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.2e-24  Score=183.80  Aligned_cols=162  Identities=22%  Similarity=0.237  Sum_probs=107.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||.+....   
T Consensus       313 ~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~  389 (507)
T PLN03224        313 GVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCP  389 (507)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCC
Confidence            468899999999995  469999999999999999999999999987543322111 11223578999999885422   


Q ss_pred             -------------------CcccCceeehhHHHHHHHhCCC-cCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC
Q 027003           79 -------------------LTTKSDVYSFGVVLLELLSGRC-AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  138 (229)
Q Consensus        79 -------------------~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (229)
                                         ...+.|+||+||++|+|++|.. ||........ .+    .....+...+...........
T Consensus       390 ~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~----~~~~~~~~~~r~~~~~~~~~~  464 (507)
T PLN03224        390 RAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-EL----RQYDNDLNRWRMYKGQKYDFS  464 (507)
T ss_pred             ccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HH----hhccchHHHHHhhcccCCCcc
Confidence                               1124799999999999999875 6643221100 00    000001111111111122222


Q ss_pred             CcHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 027003          139 YPQKAAHTAATLALQCLNNEP---KLRPRMSEVLAI  171 (229)
Q Consensus       139 ~~~~~~~~~~~li~~~l~~dP---~~Rpt~~~v~~~  171 (229)
                      ..+..+....+|+.+||..+|   .+|+|+.|++++
T Consensus       465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            334567889999999999866   689999999863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.7e-25  Score=176.97  Aligned_cols=126  Identities=20%  Similarity=0.327  Sum_probs=85.9

Q ss_pred             EEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccc---c-chhHH
Q 027003           39 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG---I-EQSLV  114 (229)
Q Consensus        39 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~---~-~~~~~  114 (229)
                      |||+|||-|+....     ..+.-+.|..|.|||++.|..|+..+||||++|++|||+||...|+.....   . +.++.
T Consensus       393 vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  393 VKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             EEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            45666665554211     134456789999999999999999999999999999999999999765432   1 11111


Q ss_pred             H-----------------hhhhhhcchhhH-----------HHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHH
Q 027003          115 D-----------------WAKPYLSDKRKL-----------FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS  166 (229)
Q Consensus       115 ~-----------------~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  166 (229)
                      .                 +.+.++...+.+           .+++..+  ..++.....++.+|+.-||+.+|++|||+.
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eK--Y~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEK--YEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHH--hCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            1                 111222221111           1222111  245567788999999999999999999999


Q ss_pred             HHHHH
Q 027003          167 EVLAI  171 (229)
Q Consensus       167 ~v~~~  171 (229)
                      ++++.
T Consensus       546 ~cl~h  550 (590)
T KOG1290|consen  546 QCLKH  550 (590)
T ss_pred             HHhcC
Confidence            99863

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.4e-25  Score=175.69  Aligned_cols=165  Identities=26%  Similarity=0.386  Sum_probs=118.4

Q ss_pred             ChhHHHHHHHHHHhhc-----C-CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-c-eeecccccccccccc
Q 027003            1 MKVAIGAAKGLTFLHD-----A-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-H-VSTQVMGTHGYAAPE   72 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~-----~-~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~-~~~~~~gt~~y~aPE   72 (229)
                      ++++..+|.||++||.     + ++.|.|||||..|||+.++|.+.|+|+|+|......... . .....+||..|||||
T Consensus       311 l~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPE  390 (513)
T KOG2052|consen  311 LKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPE  390 (513)
T ss_pred             HHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChH
Confidence            4789999999999994     2 345999999999999999999999999999765443211 1 123468999999999


Q ss_pred             ccccCC----C--cccCceeehhHHHHHHHhC----------CCcCCCCccccchhHHHhhhhhhcchhhHHH-Hhhccc
Q 027003           73 YVATGR----L--TTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKL  135 (229)
Q Consensus        73 ~~~~~~----~--~~~~Di~slG~il~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  135 (229)
                      ++...-    +  -..+||||||.++||+..+          +.||.+.           .....+. +.+.+ +...++
T Consensus       391 vLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~-----------Vp~DPs~-eeMrkVVCv~~~  458 (513)
T KOG2052|consen  391 VLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV-----------VPSDPSF-EEMRKVVCVQKL  458 (513)
T ss_pred             HhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC-----------CCCCCCH-HHHhcceeeccc
Confidence            996431    2  2368999999999999763          3444322           1111111 12222 233344


Q ss_pred             CCCCcH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          136 GGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       136 ~~~~~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      ++..++     .....+.+||+.||..+|..|.|+-.+.+.|.++..
T Consensus       459 RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  459 RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            444333     556778899999999999999999999999987753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=173.10  Aligned_cols=156  Identities=24%  Similarity=0.378  Sum_probs=117.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCc-----ceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~   73 (229)
                      .|+.||+.||.||.....+|||-||||.||||..   -|.+||+|||+++.+.+....     ..+....||.+|++||.
T Consensus       572 SIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEc  651 (775)
T KOG1151|consen  572 SIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPEC  651 (775)
T ss_pred             HHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcce
Confidence            4789999999999988889999999999999954   478999999999987665433     23445779999999998


Q ss_pred             cccC----CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHh-hcccCCCCcHHHHHHHH
Q 027003           74 VATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAA  148 (229)
Q Consensus        74 ~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  148 (229)
                      +.-+    ..+.++||||+|||+|.-+.|+.||.....  .+.+...           .-++ ......+.-+..+.+..
T Consensus       652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILqe-----------NTIlkAtEVqFP~KPvVsseAk  718 (775)
T KOG1151|consen  652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQE-----------NTILKATEVQFPPKPVVSSEAK  718 (775)
T ss_pred             eecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHhh-----------hchhcceeccCCCCCccCHHHH
Confidence            8543    468899999999999999999999976321  1111110           0011 11122233345778899


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .||++||+..-+.|....++..
T Consensus       719 aFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  719 AFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHHHHHHhhhhhhhhHHHHcc
Confidence            9999999999999988777653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=186.13  Aligned_cols=148  Identities=28%  Similarity=0.415  Sum_probs=117.3

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-----
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----   77 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----   77 (229)
                      |++.++.||.+||  .+.++|||||-.|||++.++.|||+|||++......-.  ...+.+||+.|||||++.-.     
T Consensus       128 I~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~  203 (953)
T KOG0587|consen  128 ILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDA  203 (953)
T ss_pred             HHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCC
Confidence            6789999999999  45699999999999999999999999999876543322  23457899999999999543     


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhcc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      .|+..+|+||||++..||..|.+|+-+..                ..+.++.+..+. .....+...+..+.++|..||.
T Consensus       204 tyd~R~D~WsLGITaIEladG~PPl~DmH----------------PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~  267 (953)
T KOG0587|consen  204 TYDYRSDLWSLGITAIEMAEGAPPLCDMH----------------PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLV  267 (953)
T ss_pred             CcccccchhhccceeehhcCCCCCccCcc----------------hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHh
Confidence            47789999999999999999999986533                122222222211 1223466788999999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      +|-.+||++.++++
T Consensus       268 Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  268 KDYEQRPSTEELLK  281 (953)
T ss_pred             hccccCcchhhhcc
Confidence            99999999998874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=7.3e-24  Score=160.39  Aligned_cols=152  Identities=24%  Similarity=0.378  Sum_probs=103.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec--CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC--
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--   77 (229)
                      +++.|++.||+|||+.  .+||||||.+||||-  +..++||||||+.+..+..-     ....-+..|.+||.....  
T Consensus       125 ~v~~ql~SAi~fMHsk--nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~n  197 (378)
T KOG1345|consen  125 KVFAQLLSAIEFMHSK--NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVN  197 (378)
T ss_pred             HHHHHHHHHHHHhhcc--chhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccc
Confidence            5789999999999965  499999999999992  34579999999988643321     122346679999977432  


Q ss_pred             ---CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHh
Q 027003           78 ---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        78 ---~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  154 (229)
                         .....+|+|.||+++|..+||..||+..... .+....|.. +.       .-..... +......+..+..+.++-
T Consensus       198 e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~-w~-------~rk~~~~-P~~F~~fs~~a~r~Fkk~  267 (378)
T KOG1345|consen  198 EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ-WL-------KRKNPAL-PKKFNPFSEKALRLFKKS  267 (378)
T ss_pred             cceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH-Hh-------cccCccC-chhhcccCHHHHHHHHHh
Confidence               3467899999999999999999999854322 222222211 00       0000001 111123466788899999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 027003          155 LNNEPKLRPRMSEVLA  170 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~  170 (229)
                      |..++++|--+.++.+
T Consensus       268 lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  268 LTPRFKDRCKIWTAKK  283 (378)
T ss_pred             cCCcccccchhHHHHH
Confidence            9999999954444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=9.3e-23  Score=175.71  Aligned_cols=157  Identities=20%  Similarity=0.252  Sum_probs=118.6

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCCCc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++|++.|++|||+.  ||.|||||++|+++..+|.+||+|||.+..+......  .....++|+..|+|||++.+..|+
T Consensus       425 ~fKqL~~Gv~y~h~~--GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd  502 (601)
T KOG0590|consen  425 FFKQLLRGVKYLHSM--GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYD  502 (601)
T ss_pred             HHHHHHHHHHHHHhc--CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccC
Confidence            579999999999964  5999999999999999999999999998765443322  445667899999999999999987


Q ss_pred             c-cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 T-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~-~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      . ..||||.|+++..|++|+.||........................         .......++.....+|.+||+.||
T Consensus       503 pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~lp~~~~~~~~~~l~~~P  573 (601)
T KOG0590|consen  503 PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG---------PNRLLSLLPRETRIIIYRMLQLDP  573 (601)
T ss_pred             cchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC---------hHHHHHhchhhHHHHHHHHccCCh
Confidence            5 689999999999999999999765543222100000000000000         011223456778889999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      .+|.|+.+|++
T Consensus       574 ~~R~ti~~i~~  584 (601)
T KOG0590|consen  574 TKRITIEQILN  584 (601)
T ss_pred             hheecHHHHhh
Confidence            99999999986

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.87  E-value=4.7e-22  Score=147.37  Aligned_cols=162  Identities=20%  Similarity=0.266  Sum_probs=112.1

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCcc
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT   81 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~   81 (229)
                      +.+++.||.|+||.  ||+|||+||.|++++.. -.++|+|+|++.....+.....   .+.+..|--||.+-.. .|+.
T Consensus       138 ~~elLkALdyCHS~--GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDY  212 (338)
T KOG0668|consen  138 IYELLKALDYCHSM--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDY  212 (338)
T ss_pred             HHHHHHHHhHHHhc--CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccc
Confidence            67999999999965  59999999999999875 4589999999987665544432   3457778899988765 5789


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-----------hHHHhhhhhhc-chhhHHHHhhcccCC--------CCcH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-----------SLVDWAKPYLS-DKRKLFRIMDTKLGG--------QYPQ  141 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~~~~~~~~~--------~~~~  141 (229)
                      .-|+|||||+|..|+..+.||-......++           .+..+...+.- -......++....+.        +...
T Consensus       213 SLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h  292 (338)
T KOG0668|consen  213 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH  292 (338)
T ss_pred             cHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccc
Confidence            999999999999999999998544332111           11111111100 011111122111111        1112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      -.++++.+|+.++|..|-.+|+|+.|.+.
T Consensus       293 l~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  293 LVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCChHHHHHHHHHHhhccccccchHHHhc
Confidence            23578999999999999999999999885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.86  E-value=8.2e-22  Score=148.91  Aligned_cols=117  Identities=36%  Similarity=0.603  Sum_probs=99.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.+++.+|.+||+  .+++|+||+|.||+++. ++.++|+|||.+........  ......+...|++||.+... ..
T Consensus        96 ~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~  171 (215)
T cd00180          96 RILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYY  171 (215)
T ss_pred             HHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCC
Confidence            478899999999995  46999999999999999 89999999999876543321  12234578889999999777 78


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.+.|+|+||+++++|                                                 ..+.+++.+|++.+|
T Consensus       172 ~~~~D~~~lg~~~~~l-------------------------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         172 SEKSDIWSLGVILYEL-------------------------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             CchhhhHHHHHHHHHH-------------------------------------------------HHHHHHHHHHhhCCc
Confidence            8999999999999998                                                 356789999999999


Q ss_pred             CCCCCHHHHHHH
Q 027003          160 KLRPRMSEVLAI  171 (229)
Q Consensus       160 ~~Rpt~~~v~~~  171 (229)
                      ++||++.++++.
T Consensus       203 ~~R~~~~~l~~~  214 (215)
T cd00180         203 EKRPSAKEILEH  214 (215)
T ss_pred             ccCcCHHHHhhC
Confidence            999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.83  E-value=7.5e-22  Score=162.78  Aligned_cols=95  Identities=27%  Similarity=0.460  Sum_probs=82.9

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc-c
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-T   81 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~   81 (229)
                      |+.|++.|+++||++  +|||||||-+||+++.+|-+||+|||.+-...++.    ...++||..|.|||++.|.+|- .
T Consensus       675 IFkQV~agi~hlh~~--~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk  748 (772)
T KOG1152|consen  675 IFKQVVAGIKHLHDQ--GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGK  748 (772)
T ss_pred             HHHHHHhcccccccc--CceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCC
Confidence            789999999999965  59999999999999999999999999987644332    3457899999999999998874 5


Q ss_pred             cCceeehhHHHHHHHhCCCcCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVD  103 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~  103 (229)
                      .-|||+||++||.++....||.
T Consensus       749 ~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  749 PQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhhhheeeEEEeccCCCc
Confidence            6899999999999998888774

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.83  E-value=1.3e-20  Score=150.15  Aligned_cols=167  Identities=28%  Similarity=0.351  Sum_probs=108.6

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCC-------C------------C-------
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTG-------D------------R-------   55 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~-------~------------~-------   55 (229)
                      .++.+..||.++|.  +|||||||||+|+|.+.. +.-.|+|||++......       .            .       
T Consensus       137 Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~  214 (418)
T KOG1167|consen  137 YLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVA  214 (418)
T ss_pred             HHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccc
Confidence            46789999999994  569999999999999765 56799999998721000       0            0       


Q ss_pred             ----------------cceeeccccccccccccccccC-CCcccCceeehhHHHHHHHhCCCcCCCCccccch--hHH--
Q 027003           56 ----------------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLV--  114 (229)
Q Consensus        56 ----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~--  114 (229)
                                      ........||++|.|||++... ..+.+.||||.|+|+.-+++++.||-........  .+.  
T Consensus       215 ~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ti  294 (418)
T KOG1167|consen  215 TASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATI  294 (418)
T ss_pred             cccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHH
Confidence                            0001134699999999999765 4688999999999999999999998554332111  000  


Q ss_pred             -------H----------hhh-h--hhcch----hhH-HHHhhcc----cC-CCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 027003          115 -------D----------WAK-P--YLSDK----RKL-FRIMDTK----LG-GQYPQKAAHTAATLALQCLNNEPKLRPR  164 (229)
Q Consensus       115 -------~----------~~~-~--~~~~~----~~~-~~~~~~~----~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt  164 (229)
                             .          |.. .  ...+.    +.+ .+.+...    .. ....+..+..+.+|+.+||+.||.+|.|
T Consensus       295 fG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit  374 (418)
T KOG1167|consen  295 FGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT  374 (418)
T ss_pred             hChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc
Confidence                   0          000 0  00000    000 0111110    00 0111223457889999999999999999


Q ss_pred             HHHHHHH
Q 027003          165 MSEVLAI  171 (229)
Q Consensus       165 ~~~v~~~  171 (229)
                      +++.|+.
T Consensus       375 AEeALkH  381 (418)
T KOG1167|consen  375 AEDALKH  381 (418)
T ss_pred             HHHHhcC
Confidence            9999863

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=9.7e-21  Score=148.21  Aligned_cols=132  Identities=20%  Similarity=0.239  Sum_probs=90.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      .+..|+++.+++||++  |+||+||||+|++++.+|.++|+||+.....+.  ...  . ...+..|.+||.....    
T Consensus       149 ~lT~Q~I~lvA~Lh~~--GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~--~-~~~~~~~~PPe~~~~~~~~~  221 (288)
T PF14531_consen  149 SLTVQMIRLVANLHSY--GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYR--C-SEFPVAFTPPELESCAGQFG  221 (288)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEE--G-GGS-TTTS-HHHHHHHTSCH
T ss_pred             HHHHHHHHHHHHHhhc--ceEecccceeeEEEcCCCCEEEcChHHHeecCc--eee--c-cCCCcccCChhhhhhhcccC
Confidence            4568999999999965  599999999999999999999999988765432  111  1 2345779999977432    


Q ss_pred             ----CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHH
Q 027003           78 ----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ  153 (229)
Q Consensus        78 ----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  153 (229)
                          .++.+.|.|+||+++|.|++|..||...........                     .-..+. +.+..+..||..
T Consensus       222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~  279 (288)
T PF14531_consen  222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRG  279 (288)
T ss_dssp             HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHH
T ss_pred             cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHH
Confidence                468899999999999999999999986542211110                     112344 788999999999


Q ss_pred             hccCCCCCC
Q 027003          154 CLNNEPKLR  162 (229)
Q Consensus       154 ~l~~dP~~R  162 (229)
                      +|+.||.+|
T Consensus       280 lL~~~~~~R  288 (288)
T PF14531_consen  280 LLQRNPEDR  288 (288)
T ss_dssp             HT-SSGGGS
T ss_pred             HccCCcccC
Confidence            999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=7.5e-21  Score=155.71  Aligned_cols=142  Identities=29%  Similarity=0.410  Sum_probs=102.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC----CcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD----RTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.|++.|++|     ++.+|+|+||.||+...+..+||.|||+........    .....+..+||..||+||++.+.
T Consensus       363 ~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~  437 (516)
T KOG1033|consen  363 DIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ  437 (516)
T ss_pred             HHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh
Confidence            578899999999     359999999999999999999999999987654433    12234567899999999999999


Q ss_pred             CCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           78 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        78 ~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      .|+.++||||||+||+|++. -...|+.                   ......+.+..+.+.... ..+.-..|+.++|.
T Consensus       438 ~y~~kvdIyaLGlil~EL~~~f~T~~er-------------------~~t~~d~r~g~ip~~~~~-d~p~e~~ll~~lls  497 (516)
T KOG1033|consen  438 QYSEKVDIYALGLILAELLIQFSTQFER-------------------IATLTDIRDGIIPPEFLQ-DYPEEYTLLQQLLS  497 (516)
T ss_pred             hhhhhcchhhHHHHHHHHHHHhccHHHH-------------------HHhhhhhhcCCCChHHhh-cCcHHHHHHHHhcC
Confidence            99999999999999999997 3322221                   111111111111111111 12234579999999


Q ss_pred             CCCCCCCCHHHH
Q 027003          157 NEPKLRPRMSEV  168 (229)
Q Consensus       157 ~dP~~Rpt~~~v  168 (229)
                      +.|.+||++.++
T Consensus       498 ~~p~~RP~~~~~  509 (516)
T KOG1033|consen  498 PSPEERPSAIEV  509 (516)
T ss_pred             CCcccCchHHHH
Confidence            999999955443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.80  E-value=4.3e-20  Score=154.62  Aligned_cols=147  Identities=27%  Similarity=0.376  Sum_probs=109.4

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccc---ccCCC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV---ATGRL   79 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~   79 (229)
                      +++..++||+|||+.  +=+|||||-.|||++..|.+|++|||.+-.+..  .......++||+.|||||+.   +.+.|
T Consensus       117 vcRetl~gl~ylhs~--gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggy  192 (829)
T KOG0576|consen  117 VCRETLQGLKYLHSQ--GKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGY  192 (829)
T ss_pred             HHhhhhccchhhhcC--CcccccccccceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccc
Confidence            467788999999964  479999999999999999999999999865432  22224568999999999976   45678


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc---CCCCcHHHHHHHHHHHHHhcc
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL---GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ...+|||++|++..|+-.-++|.....                ..+.++-......   ..+........+.+|++.||.
T Consensus       193 nqlcdiwa~gitAiel~eLqpplfdlh----------------pmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~alt  256 (829)
T KOG0576|consen  193 NQLCDIWALGITAIELGELQPPLFDLH----------------PMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALT  256 (829)
T ss_pred             cccccccccccchhhhhhcCCcccccc----------------hHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhc
Confidence            999999999999999977776643321                1111111111111   112234567788999999999


Q ss_pred             CCCCCCCCHHHHH
Q 027003          157 NEPKLRPRMSEVL  169 (229)
Q Consensus       157 ~dP~~Rpt~~~v~  169 (229)
                      ++|.+||++..++
T Consensus       257 knpKkRptaeklL  269 (829)
T KOG0576|consen  257 KNPKKRPTAEKLL  269 (829)
T ss_pred             CCCccCCChhhhe
Confidence            9999999988765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.78  E-value=2.3e-19  Score=137.42  Aligned_cols=100  Identities=33%  Similarity=0.409  Sum_probs=84.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccc-ccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-ATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~   80 (229)
                      .++.+++.+|.+||.  .+++|+||++.||+++.++.++|+|||++........ .......++..|++||.+ ....++
T Consensus       102 ~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~  178 (225)
T smart00221      102 FYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYG  178 (225)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCC
Confidence            468899999999995  4699999999999999999999999999887544320 012334678889999998 666778


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDK  104 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~  104 (229)
                      .++|+|+||+++++|++|+.||..
T Consensus       179 ~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      179 EAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             chhhHHHHHHHHHHHHHCCCCccc
Confidence            899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=1.4e-19  Score=158.27  Aligned_cols=140  Identities=26%  Similarity=0.312  Sum_probs=105.5

Q ss_pred             HHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-------------ceeecccccccccccc
Q 027003            6 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------HVSTQVMGTHGYAAPE   72 (229)
Q Consensus         6 ~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~gt~~y~aPE   72 (229)
                      +++.+++|||+  .+|+|||+||+|.+|..-|++|++|||+++........             ......+||+.|.|||
T Consensus       151 dmvla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  151 DMVLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhhHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            44788999995  46999999999999999999999999998754322111             1123568999999999


Q ss_pred             ccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           73 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        73 ~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      ++....|...+|.|++|+|+||.+.|..||.+...+... .++...                ....+-......++.+++
T Consensus       229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~----------------i~wpE~dea~p~Ea~dli  292 (1205)
T KOG0606|consen  229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD----------------IEWPEEDEALPPEAQDLI  292 (1205)
T ss_pred             hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh----------------ccccccCcCCCHHHHHHH
Confidence            999999999999999999999999999999886432111 111100                001111223456788999


Q ss_pred             HHhccCCCCCCC
Q 027003          152 LQCLNNEPKLRP  163 (229)
Q Consensus       152 ~~~l~~dP~~Rp  163 (229)
                      .++|+.+|..|-
T Consensus       293 ~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  293 EQLLRQNPLCRL  304 (1205)
T ss_pred             HHHHHhChHhhc
Confidence            999999999996

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=1.1e-18  Score=153.24  Aligned_cols=151  Identities=25%  Similarity=0.331  Sum_probs=104.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC--CCCCCccee---ecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG--PTGDRTHVS---TQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~--~~~~~~~~~---~~~~gt~~y~aPE~~~~   76 (229)
                      -|+-|++.||.-+|  ..||+|||||.+||||+.=+.+.|+||...+..  ...+.....   .+...-..|+|||.+-.
T Consensus       124 WiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~  201 (1431)
T KOG1240|consen  124 WIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS  201 (1431)
T ss_pred             HHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence            36889999999999  456999999999999999999999999877642  122221111   11123347999998843


Q ss_pred             C----------C-CcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHH
Q 027003           77 G----------R-LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA  144 (229)
Q Consensus        77 ~----------~-~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (229)
                      .          . .+.+.||||+||+++||++ |+++|.-.      .+..+......+.+...+    .+       ..
T Consensus       202 ~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le----~I-------ed  264 (1431)
T KOG1240|consen  202 ALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLE----KI-------ED  264 (1431)
T ss_pred             cccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccCccCHHHHHH----hC-------cC
Confidence            1          1 5678999999999999987 78888642      122222111111111111    11       12


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..++.|+..|++.||.+|.++.+.++.
T Consensus       265 ~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  265 VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            257889999999999999999999976

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=4.5e-18  Score=137.85  Aligned_cols=163  Identities=20%  Similarity=0.191  Sum_probs=115.5

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-----CcEEEcccCCcc--cCCCCCC----cc-e-eeccccccc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-----FNAKLSDFGLAK--AGPTGDR----TH-V-STQVMGTHG   67 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-----~~~kl~Dfg~~~--~~~~~~~----~~-~-~~~~~gt~~   67 (229)
                      ++|+.|++.+|++||+  .|+|||||||+|++++..     ..+.|.|||+++  .......    .. . ...+.||..
T Consensus       125 l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~r  202 (322)
T KOG1164|consen  125 LRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLR  202 (322)
T ss_pred             HHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccc
Confidence            4689999999999995  569999999999999765     358999999998  3222211    11 1 234569999


Q ss_pred             cccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHH
Q 027003           68 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA  147 (229)
Q Consensus        68 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (229)
                      |+++....+...+.+.|+||++.++.|++.|..||.+.......             ...................+..+
T Consensus       203 y~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~  269 (322)
T KOG1164|consen  203 YASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-------------SKFEKDPRKLLTDRFGDLKPEEF  269 (322)
T ss_pred             cccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-------------HHHHHHhhhhccccccCCChHHH
Confidence            99999999999999999999999999999999999765432111             01111111111110122234556


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      .++...+-..+...+|....+...++.....
T Consensus       270 ~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  270 AKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            6666666678999999999999888766443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=5.7e-18  Score=140.76  Aligned_cols=166  Identities=22%  Similarity=0.334  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .+.++|+.||+|||... ...|+.|+..|++++....+||+|||+.................-..-|.|||.+++..   
T Consensus        52 s~~rdi~~Gl~ylh~s~-i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~  130 (484)
T KOG1023|consen   52 SFIRDISKGLAYLHNSP-IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS  130 (484)
T ss_pred             HHHHHHHHHHHHHhcCc-ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc
Confidence            46789999999999643 23999999999999999999999999987653211111122223456799999997641   


Q ss_pred             ----CcccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHH
Q 027003           79 ----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLA  151 (229)
Q Consensus        79 ----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li  151 (229)
                          .+.++||||||++++|+++.+.||......... .+......          .-....+....  ......+..++
T Consensus       131 ~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~----------~~~~~~rP~i~~~~e~~~~l~~l~  200 (484)
T KOG1023|consen  131 LESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK----------GGSNPFRPSIELLNELPPELLLLV  200 (484)
T ss_pred             ccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh----------cCCCCcCcchhhhhhcchHHHHHH
Confidence                467899999999999999999999875432221 11111100          00000111111  13344788999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          152 LQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      .+||..+|.+||++.++...++.+-..
T Consensus       201 ~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  201 ARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HHhcccChhhCccHHHHHhhhhhhccc
Confidence            999999999999999999888766543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.74  E-value=2.4e-18  Score=131.00  Aligned_cols=151  Identities=21%  Similarity=0.368  Sum_probs=118.6

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEc--ccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      ++++.++++|++|||+.+.-|.---|....|++|++.+.+|.  |--++...         ....-.+.||+||.+...+
T Consensus       292 v~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe---------~gr~y~pawmspealqrkp  362 (448)
T KOG0195|consen  292 VRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---------VGRAYSPAWMSPEALQRKP  362 (448)
T ss_pred             HHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---------cccccCcccCCHHHHhcCc
Confidence            468999999999999986545555799999999999887763  43333221         1112477899999997664


Q ss_pred             Cc---ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhc
Q 027003           79 LT---TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 ~~---~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      .+   .++|+|||++++|||.|...||....                ..+--.++-...++...|+..+..+..|+.-|+
T Consensus       363 ed~n~raadmwsfaillwel~trevpfadls----------------pmecgmkialeglrv~ippgis~hm~klm~icm  426 (448)
T KOG0195|consen  363 EDLNIRAADMWSFAILLWELNTREVPFADLS----------------PMECGMKIALEGLRVHIPPGISRHMNKLMNICM  426 (448)
T ss_pred             hhcchhhhhHHHHHHHHHHhhccccccccCC----------------chhhhhhhhhccccccCCCCccHHHHHHHHHHh
Confidence            33   47999999999999999999997643                223334556677788889999999999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhc
Q 027003          156 NNEPKLRPRMSEVLAILERLE  176 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~l~~~~  176 (229)
                      ..||.+||.+..++-.|+++.
T Consensus       427 nedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  427 NEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCcCCCcceehhhHHHhc
Confidence            999999999999999888763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.2e-18  Score=145.55  Aligned_cols=130  Identities=32%  Similarity=0.458  Sum_probs=106.9

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccC
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS   83 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~   83 (229)
                      ...++-+++++|.  .+|+|||+|++||+++.+|.+++.|||+++.......      .+||..|||||++.  ....++
T Consensus       103 ~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~  172 (612)
T KOG0603|consen  103 LAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAA  172 (612)
T ss_pred             HHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcc
Confidence            3467889999995  4599999999999999999999999999986544322      28999999999997  567899


Q ss_pred             ceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 027003           84 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP  163 (229)
Q Consensus        84 Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  163 (229)
                      |.||||++.+||+||..||.+                    .....++..  ....|...+..+.+++..++..+|.+|.
T Consensus       173 D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  173 DWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA--ELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             cchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            999999999999999999975                    122233322  2367788899999999999999999998


Q ss_pred             CH
Q 027003          164 RM  165 (229)
Q Consensus       164 t~  165 (229)
                      -.
T Consensus       231 g~  232 (612)
T KOG0603|consen  231 GA  232 (612)
T ss_pred             cc
Confidence            55

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.74  E-value=7.8e-18  Score=135.15  Aligned_cols=155  Identities=32%  Similarity=0.434  Sum_probs=112.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcc----eeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTH----VSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~   76 (229)
                      .++.|++.++.|+|+.  +++|||+||+||+++..+ .++++|||++..........    ......|+..|++||.+.+
T Consensus       105 ~~~~~~~~~l~~~H~~--~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         105 FILAQILSALEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             HHHHHHHHHHHHHHhC--CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence            4688999999999964  599999999999999998 79999999987544332211    2356789999999999987


Q ss_pred             ---CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc----CCCCc----HHHHH
Q 027003           77 ---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYP----QKAAH  145 (229)
Q Consensus        77 ---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~  145 (229)
                         ...+...|+|++|++++++++|..||......             .........+....    .....    .....
T Consensus       183 ~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (384)
T COG0515         183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-------------SATSQTLKIILELPTPSLASPLSPSNPELISK  249 (384)
T ss_pred             CCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-------------ccHHHHHHHHHhcCCcccccccCccccchhhH
Confidence               57888999999999999999999997665421             00000001111000    00111    12235


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+.+++.+|+..+|..|.+..+....
T Consensus       250 ~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         250 AASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            78899999999999999988876653

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=7.9e-18  Score=134.15  Aligned_cols=148  Identities=22%  Similarity=0.271  Sum_probs=103.3

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeee--cCCC--cEEEcccCCcccCCCCC----Ccceeecccccccccccccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEF--NAKLSDFGLAKAGPTGD----RTHVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~   74 (229)
                      |+.|+++|+.|||.++  |.|||||.+|||+  +.|+  ...|+|||.+-......    ........-|.-.-||||+.
T Consensus       346 ~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            5789999999999664  9999999999999  3443  36899999875422211    11112233467788999988


Q ss_pred             ccCC------CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHH
Q 027003           75 ATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA  148 (229)
Q Consensus        75 ~~~~------~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (229)
                      ...+      .-.++|.|+.|.+.||+++...||.+......            +.+.    .........+..++..+.
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------------~~r~----Yqe~qLPalp~~vpp~~r  487 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------------DTRT----YQESQLPALPSRVPPVAR  487 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------------chhh----hhhhhCCCCcccCChHHH
Confidence            5432      12589999999999999999999976321100            0011    111222345667788899


Q ss_pred             HHHHHhccCCCCCCCCHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEV  168 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v  168 (229)
                      +|+...|+.||++|++..-.
T Consensus       488 qlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  488 QLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             HHHHHHhcCCccccCCccHH
Confidence            99999999999999975433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.65  E-value=8.6e-16  Score=119.92  Aligned_cols=104  Identities=22%  Similarity=0.342  Sum_probs=88.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-----cEEEcccCCcccCCCCCCc-----ceeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-----~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aP   71 (229)
                      -|++|++.-++|+|++  .+|+|||||+|.||...+     .+.++|||+++.+.+....     ....+..||..||+-
T Consensus       128 miA~Qmi~rie~vH~k--~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  128 MIAKQMITRIEYVHEK--DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             HHHHHHHHHHHHHHhc--ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEe
Confidence            4789999999999965  499999999999997544     4899999999976554322     234567799999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCcc
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV  107 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~  107 (229)
                      ....|.+.+.+.|+-|||-++.+.|-|..||.+...
T Consensus       206 NTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  206 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             eccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            999999999999999999999999999999998654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.60  E-value=1.4e-15  Score=113.95  Aligned_cols=155  Identities=21%  Similarity=0.219  Sum_probs=109.9

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCc-----ceeecccccccccccccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~   74 (229)
                      ++-|++.-++|+|.  +++|||||||+|.|+.-+   ..+.|+|||+++.+.+....     .......||..|.+-...
T Consensus       116 LaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh  193 (341)
T KOG1163|consen  116 LADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAH  193 (341)
T ss_pred             HHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhh
Confidence            57899999999995  569999999999999654   45899999999876554322     223456799999998888


Q ss_pred             ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc---HHHHHHHHHHH
Q 027003           75 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLA  151 (229)
Q Consensus        75 ~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li  151 (229)
                      .+...+.+.|+-|+|.+|.++.-|..||++....             ...++..++...+......   ...+.++.-.+
T Consensus       194 ~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-------------tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl  260 (341)
T KOG1163|consen  194 LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-------------TKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYL  260 (341)
T ss_pred             hhhhhhhhhhhhhhcceeeeeecCCCcccccchh-------------hHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHH
Confidence            7778889999999999999999999999986532             1222333333333322211   12355566666


Q ss_pred             HHhccCCCCCCCCHHHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l  172 (229)
                      .-|-..--++-|+..-+.+.+
T Consensus       261 ~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  261 NYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HHHhhcCCCCCCcHHHHHHHH
Confidence            667666666667665555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.55  E-value=5.4e-15  Score=120.55  Aligned_cols=83  Identities=19%  Similarity=0.190  Sum_probs=63.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecC-CCCCeeecCCCcEEEcccCCcccCCCCCCcc------eeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRTH------VSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~   74 (229)
                      +++.++++||.|||+  .||+|||| ||+|||++.++.+||+|||+++.........      --....+++.|++||.+
T Consensus       115 ~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        115 AWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             HHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            478899999999995  56999999 9999999999999999999998654332111      01356788899999998


Q ss_pred             ccCC------CcccCcee
Q 027003           75 ATGR------LTTKSDVY   86 (229)
Q Consensus        75 ~~~~------~~~~~Di~   86 (229)
                      ...+      .+..+|-|
T Consensus       193 ~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        193 TPRERKILARKSLPSRIW  210 (365)
T ss_pred             ChhhhccccccccccCcE
Confidence            6542      23446666

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.52  E-value=5e-15  Score=110.90  Aligned_cols=103  Identities=19%  Similarity=0.161  Sum_probs=75.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecC-CCCCeeecCCCcEEEcccCCcccCCCCCCc----c-------eeeccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRT----H-------VSTQVMGTHGYA   69 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~-------~~~~~~gt~~y~   69 (229)
                      .++.|++.+|.++|+  .||+|||| ||+|||++.++.++|+|||++.........    .       .......++.|+
T Consensus        95 ~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l  172 (218)
T PRK12274         95 AYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAAL  172 (218)
T ss_pred             HHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            367899999999995  46999999 799999999999999999999864432210    0       011122567777


Q ss_pred             cccccccC-CCc-ccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           70 APEYVATG-RLT-TKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        70 aPE~~~~~-~~~-~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                      .|+...-- ..+ ...+.++.|+-+|.++|+..++.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        173 TPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            77754322 333 45677889999999999998876544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=1.2e-13  Score=122.91  Aligned_cols=98  Identities=20%  Similarity=0.164  Sum_probs=80.5

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-------CCcEEEcccCCcccCCCCCCcceeeccccccccccccc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   73 (229)
                      |.++.|++.-++.||.+  +|||+||||+|.||..       .-.++|+|||.+--+.--.........++|-.+-.+|+
T Consensus       797 ~~~~~qml~ive~lH~~--~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM  874 (974)
T KOG1166|consen  797 MFFSCQMLRIVEHLHAM--GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEM  874 (974)
T ss_pred             hHHHHHHHHHHHHHHhc--ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHH
Confidence            45789999999999965  5999999999999932       23489999998754322223333556788999999999


Q ss_pred             cccCCCcccCceeehhHHHHHHHhCCC
Q 027003           74 VATGRLTTKSDVYSFGVVLLELLSGRC  100 (229)
Q Consensus        74 ~~~~~~~~~~Di~slG~il~elltg~~  100 (229)
                      ..|..+++..|.|.|+.+++-||.|+.
T Consensus       875 ~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  875 REGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             hcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999999999999999999999974

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=7e-15  Score=127.24  Aligned_cols=154  Identities=27%  Similarity=0.351  Sum_probs=115.5

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCC-CCCcceeecccc-ccccccccccccC-C
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPT-GDRTHVSTQVMG-THGYAAPEYVATG-R   78 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~   78 (229)
                      .+.|+..++.|+|. +.++.|+||||+|.+++..+ ..+++|||++..+.. ..........+| ++.|+|||...+. .
T Consensus       128 ~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~  206 (601)
T KOG0590|consen  128 YLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY  206 (601)
T ss_pred             hhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence            46789999999995 35699999999999999999 999999999987765 333333445678 9999999999874 4


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .....|+||.|+++.-+++|..||......... ...|..    .        .................+++.+++..+
T Consensus       207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~----~--------~~~~~~~~~~~~~~~~~~~l~k~l~~~  273 (601)
T KOG0590|consen  207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS----N--------KGRFTQLPWNSISDQAHDLLHKILKEN  273 (601)
T ss_pred             cCCCcccccccccccccccCCCCcccccccccc-ceeecc----c--------ccccccCccccCChhhhhcccccccCC
Confidence            457899999999999999999999765432211 111110    0        011112334556677888999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |+.|.+..++..
T Consensus       274 ~~~r~s~~~~~~  285 (601)
T KOG0590|consen  274 PSNRLSIEELKL  285 (601)
T ss_pred             chhccccccccc
Confidence            999999888754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.41  E-value=6.1e-14  Score=107.00  Aligned_cols=78  Identities=13%  Similarity=0.151  Sum_probs=59.1

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ...+++.+|..||.  .|++|||+||+||+++.+| ++|+|||...........              -..+....++.+
T Consensus       140 ~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~  202 (232)
T PRK10359        140 VKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIK  202 (232)
T ss_pred             HHHHHHHHHHHHHH--cCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhccc
Confidence            35689999999995  4699999999999999988 999999987654221110              003334456679


Q ss_pred             CceeehhHHHHHHHh
Q 027003           83 SDVYSFGVVLLELLS   97 (229)
Q Consensus        83 ~Di~slG~il~ellt   97 (229)
                      +|+|+||+++..+..
T Consensus       203 ~di~~lg~~~~~~~~  217 (232)
T PRK10359        203 NEIKDLGYYLLIYKK  217 (232)
T ss_pred             ccccceeEeehHHHH
Confidence            999999999887643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=4.9e-13  Score=104.69  Aligned_cols=148  Identities=20%  Similarity=0.306  Sum_probs=97.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC--CcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +|+.||+.||.|||+..+.|+|+++..+.|++..+|-+|+.--.-........  .........+-++|.+||.-...+.
T Consensus       180 kw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~  259 (458)
T KOG1266|consen  180 KWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT  259 (458)
T ss_pred             HHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc
Confidence            68999999999999999999999999999999999999986422211111111  1111122345678999997766677


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||+||....+|..+..--......   .         .......+.+. .+       ....-..++.+|++..|
T Consensus       260 ~~a~dIy~fgmcAlemailEiq~tnseS~---~---------~~ee~ia~~i~-~l-------en~lqr~~i~kcl~~eP  319 (458)
T KOG1266|consen  260 TGASDIYKFGMCALEMAILEIQSTNSESK---V---------EVEENIANVII-GL-------ENGLQRGSITKCLEGEP  319 (458)
T ss_pred             ccchhhhhhhHHHHHHHHheeccCCCcce---e---------ehhhhhhhhee-ec-------cCccccCcCcccccCCC
Confidence            88999999999999998875432111100   0         00000001000 00       01112357899999999


Q ss_pred             CCCCCHHHHH
Q 027003          160 KLRPRMSEVL  169 (229)
Q Consensus       160 ~~Rpt~~~v~  169 (229)
                      ..||++++++
T Consensus       320 ~~rp~ar~ll  329 (458)
T KOG1266|consen  320 NGRPDARLLL  329 (458)
T ss_pred             CCCcchhhhh
Confidence            9999999886

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=5.2e-13  Score=113.49  Aligned_cols=151  Identities=21%  Similarity=0.319  Sum_probs=108.0

Q ss_pred             HHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-------eeeccccccccccccccccC
Q 027003            5 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-------VSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         5 ~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .+++.||.|+|.+ .++||++|.|++|.++..+.+||+.|+++..........       ......-...|.|||.+.+.
T Consensus       106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4566899999975 579999999999999999999999999876543322111       11112345689999999888


Q ss_pred             CCcccCceeehhHHHHHHH-hCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           78 RLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        78 ~~~~~~Di~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ..+.++|+|||||++|.+. .|+..+............              ......-...+..+.+.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHhc
Confidence            8889999999999999998 566666554322211111              1111111223345677888999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .+...||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999997776653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.28  E-value=2.2e-12  Score=96.75  Aligned_cols=46  Identities=13%  Similarity=0.216  Sum_probs=40.3

Q ss_pred             hhHHHHHHHHHHh-hcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            2 KVAIGAAKGLTFL-HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         2 ~i~~~i~~~l~~L-H~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      +++.|++.+|.|| |+  .+|+||||||+|||++ ++.++|+|||++...
T Consensus       121 ~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         121 ELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            5789999999999 64  4699999999999998 478999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.28  E-value=2.4e-12  Score=96.57  Aligned_cols=47  Identities=15%  Similarity=0.115  Sum_probs=42.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      +++.|++.+|.+||+. .||+||||||+|||++ ++.++|+|||++...
T Consensus       121 ~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         121 ELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             HHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            5789999999999961 5699999999999999 889999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.11  E-value=7.5e-10  Score=90.02  Aligned_cols=168  Identities=18%  Similarity=0.233  Sum_probs=108.7

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----   75 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----   75 (229)
                      ++++..++.+.+-||.+  |.+-+|+.++|+|+++++.|.|.|-........+.   ...-.+|...|.+||.-.     
T Consensus       120 lrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~  194 (637)
T COG4248         120 LRVARNLASAFATLHEH--GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFV  194 (637)
T ss_pred             HHHHHHHHHHHHHHHhc--CCcccccCccceeeecCceEEEEcccceeeccCCc---eEecccCccccCCHHHhcccccc
Confidence            35788999999999965  48889999999999999999999854433322221   122346899999999654     


Q ss_pred             cCCCcccCceeehhHHHHHHHhC-CCcCCCCccccch------hHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHH
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQ------SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA  148 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (229)
                      +..-+...|.|.||+++++++.| +.||.+-......      .+......+..+.   ..-.............+..+.
T Consensus       195 g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~---~~g~~p~P~~~P~~~Lpp~vq  271 (637)
T COG4248         195 GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ---RRGLKPPPRSIPLSMLPPDVQ  271 (637)
T ss_pred             ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhc---cCCCCCCCCCCChhhcCHHHH
Confidence            33456789999999999999876 9999774322111      1110000000000   000000001111234567788


Q ss_pred             HHHHHhccCC--CCCCCCHHHHHHHHHhhc
Q 027003          149 TLALQCLNNE--PKLRPRMSEVLAILERLE  176 (229)
Q Consensus       149 ~li~~~l~~d--P~~Rpt~~~v~~~l~~~~  176 (229)
                      .|..+|+...  +.-|||++..+..|..++
T Consensus       272 AlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         272 ALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            8999998654  568999999988776654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.06  E-value=1.3e-10  Score=90.23  Aligned_cols=45  Identities=29%  Similarity=0.287  Sum_probs=40.8

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .+.+++.+|.+||+  .||+||||||.|||++.++.++|+|||.+..
T Consensus       147 ~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        147 QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            46789999999995  5699999999999999999999999999875

>smart00090 RIO RIO-like kinase

Probab=99.06  E-value=1.3e-10  Score=90.08  Aligned_cols=45  Identities=13%  Similarity=0.132  Sum_probs=41.0

Q ss_pred             hhHHHHHHHHHHhhcCCCC-ceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~-ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++.|++.+|.+||+  .+ |+||||||+||+++ ++.++|+|||.+..
T Consensus       152 ~i~~qi~~~l~~LH~--~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      152 ELYDDILEEMRKLYK--EGELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             HHHHHHHHHHHHHHh--cCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            578999999999995  56 99999999999999 88999999999874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.05  E-value=2e-10  Score=86.71  Aligned_cols=48  Identities=17%  Similarity=0.129  Sum_probs=43.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   51 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~   51 (229)
                      .++.+++.++.++|+  .+|+||||||+||+++.++.++|+|||++....
T Consensus       129 ~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         129 EVLDEILEEIVKAYK--HGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             HHHHHHHHHHHHHHH--CCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            468899999999995  569999999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.04  E-value=2.4e-10  Score=101.42  Aligned_cols=145  Identities=24%  Similarity=0.315  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCC----------C-------------------
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG----------D-------------------   54 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~----------~-------------------   54 (229)
                      ...+..+++|||+.  .++|+|++|.|+|...+|..++.|||........          .                   
T Consensus       910 i~~~vqs~e~L~s~--~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~  987 (1205)
T KOG0606|consen  910 ILERVQSLESLHSS--LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSAD  987 (1205)
T ss_pred             hHHHHhhhhccccc--hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccc
Confidence            34567889999964  3899999999999999999999999843211110          0                   


Q ss_pred             CcceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc
Q 027003           55 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  134 (229)
Q Consensus        55 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (229)
                      .........||+.|.+||...+......+|.|++|++++|.++|..||......                +....+....
T Consensus       988 ~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq----------------~~f~ni~~~~ 1051 (1205)
T KOG0606|consen  988 EARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ----------------QIFENILNRD 1051 (1205)
T ss_pred             hhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh----------------hhhhccccCC
Confidence            001123467899999999999999999999999999999999999999764321                1111111111


Q ss_pred             c-CCCCcHHHHHHHHHHHHHhccCCCCCCCCHH
Q 027003          135 L-GGQYPQKAAHTAATLALQCLNNEPKLRPRMS  166 (229)
Q Consensus       135 ~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  166 (229)
                      . ...-+...+....+++...+..++.+|..+.
T Consensus      1052 ~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1052 IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            1 1122345567788899999999999998775

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=3e-10  Score=95.34  Aligned_cols=147  Identities=27%  Similarity=0.411  Sum_probs=102.8

Q ss_pred             HHHHHH----HHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcc---eeeccccccccccccccc
Q 027003            4 AIGAAK----GLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTH---VSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         4 ~~~i~~----~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~   75 (229)
                      +.+...    ||.++|+  ++++|-|+||.||++..+ ...+++|||+...+....-..   ......|...|++||.. 
T Consensus       224 ~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-  300 (524)
T KOG0601|consen  224 LRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-  300 (524)
T ss_pred             HhhhhhcccccccccCC--CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-
Confidence            345555    9999995  459999999999999999 789999999998776554221   12233567789999988 


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhc
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      .+-++...|+|+||.++.+..++...........      |.     ..+.      ..+..++.......+...+.+|+
T Consensus       301 ~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~-----~~r~------~~ip~e~~~~~s~~l~~~~~~~~  363 (524)
T KOG0601|consen  301 NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS-----QLRQ------GYIPLEFCEGGSSSLRSVTSQML  363 (524)
T ss_pred             ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc-----cccc------ccCchhhhcCcchhhhhHHHHhc
Confidence            4567889999999999999999876654432110      00     0000      00111222233445556899999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.++-.|++.+.+..
T Consensus       364 d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  364 DEDPRLRLTAQILTA  378 (524)
T ss_pred             CcchhhhhHHHHHhc
Confidence            999999999887764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.92  E-value=9.5e-10  Score=82.15  Aligned_cols=47  Identities=17%  Similarity=0.085  Sum_probs=41.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      +++.+++.++.++|.. .+|+||||||+||+++ ++.++|+|||.+...
T Consensus       118 ~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         118 ELYDQILELMRKLYRE-AGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             HHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            4788999999999961 5699999999999999 899999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.91  E-value=9e-10  Score=83.62  Aligned_cols=43  Identities=23%  Similarity=0.205  Sum_probs=34.7

Q ss_pred             hHHHHHHHH-HHhhcCCCCceeecCCCCCeeecC----CCcEEEcccCCc
Q 027003            3 VAIGAAKGL-TFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLA   47 (229)
Q Consensus         3 i~~~i~~~l-~~LH~~~~~ivHrDlkp~Nill~~----~~~~kl~Dfg~~   47 (229)
                      ++.+++.++ +|||++  +||||||||+|||++.    ++.++|+||+.+
T Consensus       109 ~~~~~L~~l~~yLh~~--~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        109 QLRQLLKKLKRYLLDN--RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHHHHHHHC--CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            467888777 999964  5999999999999974    347999995544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.87  E-value=2.2e-09  Score=80.99  Aligned_cols=45  Identities=27%  Similarity=0.379  Sum_probs=40.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++.+++.+|.+||+  .+++|||++|.||+++ ++.++++|||++..
T Consensus        94 ~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            478899999999995  5699999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.84  E-value=2.9e-09  Score=81.03  Aligned_cols=45  Identities=29%  Similarity=0.384  Sum_probs=40.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++.+++.+|.+||+  .+++|||++|.|||++ ++.++|+|||.+..
T Consensus        99 ~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         99 ELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            578899999999995  4699999999999999 78899999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.84  E-value=1.8e-09  Score=93.54  Aligned_cols=45  Identities=24%  Similarity=0.366  Sum_probs=40.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      +++.+++.+|.|||+  .+++||||||+|||+ .++.++|+|||+++.
T Consensus       432 ~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        432 ELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            478999999999995  469999999999999 678899999999875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.70  E-value=6e-08  Score=82.94  Aligned_cols=90  Identities=16%  Similarity=0.303  Sum_probs=67.1

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccC
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS   83 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~   83 (229)
                      +.||+.||.|||. +++++|++|.-+.|+++..|.+||++|.++.........  ......-..|..|+.+....  ...
T Consensus       110 l~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  110 LFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cch
Confidence            6899999999996 467999999999999999999999999988654332210  11112233466676553222  467


Q ss_pred             ceeehhHHHHHHHhC
Q 027003           84 DVYSFGVVLLELLSG   98 (229)
Q Consensus        84 Di~slG~il~elltg   98 (229)
                      |.|.|||+++|++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.68  E-value=2.7e-08  Score=71.04  Aligned_cols=48  Identities=25%  Similarity=0.204  Sum_probs=42.1

Q ss_pred             hhHHHHHHHHHHhhcCC-CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~-~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++.+++.+|++||... .+++|+||+|+||+++..+.++++|||.+..
T Consensus        90 ~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          90 DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            46788999999999642 4699999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.64  E-value=1.8e-08  Score=84.85  Aligned_cols=145  Identities=20%  Similarity=0.205  Sum_probs=96.0

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeecccccccc-ccccccccCC
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-AAPEYVATGR   78 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~   78 (229)
                      +++..|++.++.++|+  +.++|+|+||+||++..+ +..++.|||......-..    ......+..| .+++......
T Consensus       369 ~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~  442 (524)
T KOG0601|consen  369 LRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYP  442 (524)
T ss_pred             hhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccccccccccceec----ccccccccccccchhhccccc
Confidence            3567899999999995  559999999999999886 677999999876421111    1111223334 3555555667


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +..+.|+|+||..+.+.+++..--....                   .+..+.. ..- .........+..+...+...+
T Consensus       443 ~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------------~~~~i~~-~~~-p~~~~~~~~~q~~~kv~~~~~  501 (524)
T KOG0601|consen  443 HLSKADIFSLGLSVDEAITGSPLSESGV-------------------QSLTIRS-GDT-PNLPGLKLQLQVLLKVMINPD  501 (524)
T ss_pred             cccccccccccccccccccCcccCcccc-------------------cceeeec-ccc-cCCCchHHhhhhhhhhhcCCc
Confidence            8889999999999999998754322211                   0001110 100 111222366777888899999


Q ss_pred             CCCCCCHHHHHHHH
Q 027003          159 PKLRPRMSEVLAIL  172 (229)
Q Consensus       159 P~~Rpt~~~v~~~l  172 (229)
                      +..||.+.++....
T Consensus       502 ~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  502 RKRRPSAVELSLHS  515 (524)
T ss_pred             cccchhhhhhcccc
Confidence            99999988776543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.54  E-value=7e-08  Score=72.25  Aligned_cols=45  Identities=11%  Similarity=0.103  Sum_probs=38.3

Q ss_pred             hHHHHHHHHHHh-hcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            3 VAIGAAKGLTFL-HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         3 i~~~i~~~l~~L-H~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      +..+++.+|..| |.  .+|||+||++.|||++ ++.++|+|||.+...
T Consensus       129 i~~~i~~~l~~l~H~--~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         129 AYYQVLSMMKQLYKE--CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHHHHHHHHHHHHh--CCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            467899999988 74  5699999999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.47  E-value=2.1e-07  Score=68.24  Aligned_cols=46  Identities=28%  Similarity=0.168  Sum_probs=38.7

Q ss_pred             hHHHHHHHHHHhhcCC---CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            3 VAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~---~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ++.+++++|+.||+.+   .+++|+|+++.||+++ ++.++++|||.+..
T Consensus        88 ~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          88 NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4678999999999653   1259999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=5.2e-07  Score=66.05  Aligned_cols=44  Identities=25%  Similarity=0.366  Sum_probs=37.8

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ++..+-.-+.-||  ..+|||+||.++||+++.++ +.++|||++..
T Consensus        97 ~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          97 LLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             HHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            5667777889999  45799999999999998776 99999999864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.32  E-value=7.5e-07  Score=75.19  Aligned_cols=47  Identities=19%  Similarity=0.163  Sum_probs=38.4

Q ss_pred             hHHHHHH-HHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCC
Q 027003            3 VAIGAAK-GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   51 (229)
Q Consensus         3 i~~~i~~-~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~   51 (229)
                      ++..++. .+..+|.  .|++|+|+||.||+++.++.++|+|||++....
T Consensus       261 ia~~~~~~~l~ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       261 LAENLARSFLNQVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            4455555 4677884  569999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.21  E-value=1.2e-06  Score=69.15  Aligned_cols=46  Identities=17%  Similarity=0.184  Sum_probs=39.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-------CCcEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-------~~~~kl~Dfg~~~~   49 (229)
                      +++.+++..+.-||.  .||+|+||++.|||++.       ++.+.|+||+.++.
T Consensus       142 ~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        142 MLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            467889999999995  56999999999999975       46789999998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.20  E-value=1.3e-06  Score=66.31  Aligned_cols=46  Identities=26%  Similarity=0.311  Sum_probs=40.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~   49 (229)
                      .++.+++..+.-||.  .||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       122 ~ll~~l~~~i~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  122 ELLRALARLIAKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            467899999999995  5699999999999998887   799999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.20  E-value=1.8e-06  Score=63.19  Aligned_cols=46  Identities=37%  Similarity=0.499  Sum_probs=38.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~   49 (229)
                      .++..|-+.+.-||.  ++|||+||..+||+|..++.   +.++|||++..
T Consensus       117 ~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  117 ELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            357888899999995  56999999999999976653   58999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.08  E-value=5.4e-06  Score=61.82  Aligned_cols=45  Identities=24%  Similarity=0.358  Sum_probs=33.4

Q ss_pred             hHHHHHHHHHH-hhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            3 VAIGAAKGLTF-LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         3 i~~~i~~~l~~-LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      ++.+++..+.. +|  ..||||+||.+.|||++.+ .+.|+|||.+...
T Consensus       111 ~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  111 LLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            56677775555 56  4579999999999999888 8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.54  E-value=7e-05  Score=64.59  Aligned_cols=34  Identities=18%  Similarity=0.226  Sum_probs=29.9

Q ss_pred             CCceeecCCCCCeeecCCC----cEEEcccCCcccCCC
Q 027003           19 SQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPT   52 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~----~~kl~Dfg~~~~~~~   52 (229)
                      .|++|+|+||.||+++.+|    .++++|||++.....
T Consensus       279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4699999999999999888    899999999876543

>PRK09902 hypothetical protein; Provisional

Probab=97.44  E-value=0.00013  Score=55.06  Aligned_cols=46  Identities=13%  Similarity=0.070  Sum_probs=39.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc--EEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~~   49 (229)
                      .+..+|+..+.-||+  .|+.|+|+-+.|||++.+|.  ++++||.-++.
T Consensus       132 ~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        132 AMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            467899999999995  46999999999999987677  89999977653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.38  E-value=0.00021  Score=54.33  Aligned_cols=43  Identities=16%  Similarity=0.119  Sum_probs=35.9

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...+.+++.-||..  |++|+|..|.|++++.++ ++++||+..+.
T Consensus       141 ~~ki~~~ikqlH~~--G~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  141 AEKIVEAIKQLHKH--GFYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHHc--CCccCCCCcCcEEEECCc-EEEEECccccc
Confidence            45688999999964  599999999999998654 99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.22  E-value=0.00036  Score=54.51  Aligned_cols=44  Identities=14%  Similarity=0.080  Sum_probs=32.7

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      +..|++-+.-+-  ..||||+|+..-||+++.+|.++++||-.+..
T Consensus       208 l~~il~~~~~~~--~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         208 LDKILEEVRKAY--RRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             HHHHHHHHHHHH--HcCccccCCchheEEEecCCCEEEEeCccccc
Confidence            344444443333  24699999999999999999999999976543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.97  E-value=0.00097  Score=51.51  Aligned_cols=46  Identities=17%  Similarity=0.135  Sum_probs=37.2

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      +..++++.+.-|-. ..++||+||..-|||+. ++.+.|+|||.+...
T Consensus       171 ~~~~~v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         171 LYEDVVEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHHHHHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            34566777776664 35799999999999999 889999999988754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=96.81  E-value=0.0037  Score=53.09  Aligned_cols=77  Identities=17%  Similarity=0.311  Sum_probs=58.7

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ++.|+..||.++|+.  |+.-+-|.+.+||++.+.+++|..-|+.........                |-+.+   -.+
T Consensus       398 y~~QLtaaL~sIHss--GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq  456 (655)
T KOG3741|consen  398 YISQLTAALYSIHSS--GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLES---QQQ  456 (655)
T ss_pred             HHHHHHHHHHHHHhc--CceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchhH---Hhh
Confidence            578999999999965  588899999999999999999988777655433220                11111   245


Q ss_pred             CceeehhHHHHHHHhCCC
Q 027003           83 SDVYSFGVVLLELLSGRC  100 (229)
Q Consensus        83 ~Di~slG~il~elltg~~  100 (229)
                      -|.=.||.+++.|.||..
T Consensus       457 ~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  457 NDLRDLGLLLLALATGTE  474 (655)
T ss_pred             hhHHHHHHHHHHHhhccc
Confidence            688889999999999853

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=96.75  E-value=0.0011  Score=50.43  Aligned_cols=31  Identities=19%  Similarity=0.353  Sum_probs=27.1

Q ss_pred             CCceeecCCCCCeeecC--CCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDA--EFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~--~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            45899999999999998  56789999998865

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.68  E-value=0.0028  Score=58.62  Aligned_cols=138  Identities=21%  Similarity=0.271  Sum_probs=89.9

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCC---CeeecCCCcEEEc--ccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKAS---NILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      +..++..||.|+|+..  ..|.-|..+   +-..+..+.+.++  ||+.+........   ......+..+.++|.....
T Consensus       291 ~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~  365 (1351)
T KOG1035|consen  291 LHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKEN  365 (1351)
T ss_pred             HHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccc
Confidence            4678899999999753  555555554   4444556667766  8888876544332   2223445667888877665


Q ss_pred             CCcc--cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhc
Q 027003           78 RLTT--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~--~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  155 (229)
                      .++.  ..|+|.+|..+..+..|..+-....                   ....++..        .......++..+|+
T Consensus       366 ~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~  418 (1351)
T KOG1035|consen  366 TAKKSRLTDLWCLGLLLLQLSQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCL  418 (1351)
T ss_pred             cchhhhhhHHHHHHHHHhhhhhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhc
Confidence            5544  4799999999999988764322110                   11111110        01115677889999


Q ss_pred             cCCCCCCCCHHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAIL  172 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~l  172 (229)
                      ..+.++|+++.+++...
T Consensus       419 ~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  419 DEDSEERLSALELLTHP  435 (1351)
T ss_pred             chhhhhccchhhhhhch
Confidence            99999999999998754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.42  E-value=0.005  Score=49.51  Aligned_cols=32  Identities=28%  Similarity=0.228  Sum_probs=27.6

Q ss_pred             CCCceeecCCCCCeeecCC----CcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~   49 (229)
                      ...++|+|+.+.|||++.+    +.++|+||..+..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            3468999999999999885    8899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.41  E-value=0.0049  Score=49.76  Aligned_cols=32  Identities=28%  Similarity=0.327  Sum_probs=27.9

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            35799999999999999988778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.39  E-value=0.0022  Score=51.99  Aligned_cols=31  Identities=26%  Similarity=0.308  Sum_probs=26.8

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++||+|+.+.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999999766668999998764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.38  E-value=0.0029  Score=48.96  Aligned_cols=31  Identities=19%  Similarity=0.243  Sum_probs=26.5

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.|||++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4589999999999998776667999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.36  E-value=0.0067  Score=46.75  Aligned_cols=31  Identities=19%  Similarity=0.209  Sum_probs=26.9

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34578999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.31  E-value=0.0039  Score=47.56  Aligned_cols=39  Identities=26%  Similarity=0.184  Sum_probs=34.0

Q ss_pred             HHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCC
Q 027003            8 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL   46 (229)
Q Consensus         8 ~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~   46 (229)
                      +.+|.-.|+...+.+|+|-.|+||+-|+.|-+||.|=+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            456788897777899999999999999999999999553

The function of this family is unknown.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.29  E-value=0.0054  Score=45.85  Aligned_cols=49  Identities=18%  Similarity=0.101  Sum_probs=40.8

Q ss_pred             ChhHHHHHHHHHHhhcCCCC-ceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            1 MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~-ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ++|+.++++.+.+++....+ +.-.|++++|+-++++|++|++|...+..
T Consensus        62 ~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   62 AKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            36899999999999964223 56689999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.19  E-value=0.0026  Score=55.39  Aligned_cols=89  Identities=24%  Similarity=0.229  Sum_probs=67.5

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccC
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS   83 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~   83 (229)
                      +..-.++|++||+..  =+|+|    ||+..+ +..+..||+....+....   ......++..+++||+..+..+..+.
T Consensus       342 ~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p  411 (829)
T KOG0576|consen  342 LRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCP  411 (829)
T ss_pred             hhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCC
Confidence            344567899999642  38888    777655 678999999987654332   23456799999999999999999999


Q ss_pred             ceeehhHHHHHHHhCCCcC
Q 027003           84 DVYSFGVVLLELLSGRCAV  102 (229)
Q Consensus        84 Di~slG~il~elltg~~p~  102 (229)
                      |.|++|.--.++--|..|-
T Consensus       412 ~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  412 DSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CccCCCcchhhcCCCCCCC
Confidence            9999998766666666554

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.08  E-value=0.00045  Score=65.43  Aligned_cols=93  Identities=14%  Similarity=0.104  Sum_probs=71.4

Q ss_pred             HHHHHHhhcC---CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccCc
Q 027003            8 AKGLTFLHDA---ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD   84 (229)
Q Consensus         8 ~~~l~~LH~~---~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D   84 (229)
                      +.+..-+|+.   +.-.+|++||+-|.+|..+..+|++++|+.+..  .......+..++++.|+.+++...-.++.++|
T Consensus      1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSD 1422 (2724)
T ss_pred             HhccchhhhcccCCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHH
Confidence            3344444433   233689999999999999999999999999832  22222345567888999999887778888899


Q ss_pred             eeehhHHHHHHHhCCCcC
Q 027003           85 VYSFGVVLLELLSGRCAV  102 (229)
Q Consensus        85 i~slG~il~elltg~~p~  102 (229)
                      +|..|+.+|+.-.|..+|
T Consensus      1423 ilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHHHhcccHHH
Confidence            999999999988877665

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.06  E-value=0.004  Score=48.07  Aligned_cols=31  Identities=19%  Similarity=0.252  Sum_probs=26.9

Q ss_pred             CCceeecCCCCCeeecC-CCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDA-EFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~   49 (229)
                      .+++|+|+.+.|||++. ++.+.|+||..+..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            35899999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10271 thiK thiamine kinase; Provisional

Probab=96.01  E-value=0.0049  Score=45.83  Aligned_cols=29  Identities=24%  Similarity=0.251  Sum_probs=25.5

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..+|+|+.|.||+++.++ ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            368999999999998877 88999999864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=95.99  E-value=0.0034  Score=48.05  Aligned_cols=31  Identities=29%  Similarity=0.362  Sum_probs=21.6

Q ss_pred             CCCceeecCCCCCeeec-CCCcEEEcccCCcc
Q 027003           18 ESQVIYRDFKASNILLD-AEFNAKLSDFGLAK   48 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~   48 (229)
                      ...++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccce
Confidence            45699999999999999 66667899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.87  E-value=0.013  Score=47.29  Aligned_cols=30  Identities=23%  Similarity=0.307  Sum_probs=25.9

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            56999999999999987 6789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.80  E-value=0.0055  Score=49.06  Aligned_cols=31  Identities=29%  Similarity=0.329  Sum_probs=27.3

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4699999999999999987789999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.73  E-value=0.0075  Score=47.32  Aligned_cols=29  Identities=24%  Similarity=0.274  Sum_probs=25.8

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++|+|+.+.||+++.++ +.|+||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=95.70  E-value=0.008  Score=46.72  Aligned_cols=31  Identities=23%  Similarity=0.154  Sum_probs=27.1

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            4589999999999999987789999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.69  E-value=0.016  Score=45.86  Aligned_cols=46  Identities=17%  Similarity=0.123  Sum_probs=35.0

Q ss_pred             HHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003            4 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus         4 ~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      +..+-.++.-.+....-++|.|+.++|+|.+..+.++|+||..|..
T Consensus       138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444455555553213489999999999999999999999988864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.45  E-value=0.0082  Score=45.64  Aligned_cols=30  Identities=30%  Similarity=0.380  Sum_probs=21.2

Q ss_pred             CceeecCCCCCeee-cCCCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILL-DAEFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill-~~~~~~kl~Dfg~~~~   49 (229)
                      .++|.||.+.|||+ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47899999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.20  E-value=0.016  Score=46.11  Aligned_cols=31  Identities=26%  Similarity=0.419  Sum_probs=26.1

Q ss_pred             CCceeecCCCCCeeecCCCc-EEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFN-AKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~-~kl~Dfg~~~~   49 (229)
                      ..++|+|+++.|||++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999998875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=95.16  E-value=0.017  Score=43.49  Aligned_cols=31  Identities=26%  Similarity=0.314  Sum_probs=25.7

Q ss_pred             CCceeecCCCCCeeecCCC-----cEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEF-----NAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~-----~~kl~Dfg~~~~   49 (229)
                      +.++|||+.+.||++..++     .+.|+||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4689999999999997543     589999998764

subfamily of choline kinases

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.07  E-value=0.02  Score=46.32  Aligned_cols=31  Identities=16%  Similarity=0.200  Sum_probs=28.1

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .+++|+|+.++|||++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4699999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=95.06  E-value=0.013  Score=47.49  Aligned_cols=31  Identities=26%  Similarity=0.434  Sum_probs=23.9

Q ss_pred             CceeecCCCCCeeecC------------------CCcEEEcccCCcccC
Q 027003           20 QVIYRDFKASNILLDA------------------EFNAKLSDFGLAKAG   50 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~------------------~~~~kl~Dfg~~~~~   50 (229)
                      ..+|-||||+|||+=.                  ...++|-||.+++..
T Consensus       299 nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  299 NFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             eeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            4899999999999922                  233678888888764

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=94.95  E-value=0.018  Score=49.70  Aligned_cols=33  Identities=24%  Similarity=0.260  Sum_probs=29.9

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCcccCCC
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   52 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~   52 (229)
                      |++|.|..|.||+++.+|.+.+.|||+......
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            599999999999999999999999999876543

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.94  E-value=0.019  Score=46.80  Aligned_cols=29  Identities=28%  Similarity=0.450  Sum_probs=26.0

Q ss_pred             ceeecCCCCCeeecCCCc-EEEcccCCccc
Q 027003           21 VIYRDFKASNILLDAEFN-AKLSDFGLAKA   49 (229)
Q Consensus        21 ivHrDlkp~Nill~~~~~-~kl~Dfg~~~~   49 (229)
                      +||+|+.+.||+++.+.. +.++||+-+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            899999999999999874 89999998753

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.80  E-value=0.012  Score=47.48  Aligned_cols=31  Identities=29%  Similarity=0.494  Sum_probs=22.5

Q ss_pred             CceeecCCCCCeeecC-C-----------------CcEEEcccCCcccC
Q 027003           20 QVIYRDFKASNILLDA-E-----------------FNAKLSDFGLAKAG   50 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~-~-----------------~~~kl~Dfg~~~~~   50 (229)
                      ..+|-||||+|||+-. +                 ..++|-||.+++..
T Consensus       303 nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  351 (444)
T PHA03111        303 NFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA  351 (444)
T ss_pred             eeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence            4899999999999922 2                 23566777777653

>PLN02236 choline kinase

Probab=94.77  E-value=0.02  Score=47.03  Aligned_cols=31  Identities=19%  Similarity=0.268  Sum_probs=26.5

Q ss_pred             CCceeecCCCCCeeecC-CCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDA-EFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+++.|||++. ++.+.|+||..+..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            35899999999999976 46799999988764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.63  E-value=0.038  Score=45.41  Aligned_cols=47  Identities=28%  Similarity=0.320  Sum_probs=35.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      +|+.+++.-+.-+.. +-..=||||.-.||||+ +|.+.|+||-+++.-
T Consensus       325 sff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         325 SFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             HHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            345555554544443 34578999999999999 999999999999853

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.54  E-value=0.032  Score=45.20  Aligned_cols=31  Identities=23%  Similarity=0.477  Sum_probs=28.5

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      .++|+|+.+.||+++.++.+-|.||+++...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            5999999999999999988999999998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.39  E-value=0.047  Score=44.51  Aligned_cols=30  Identities=20%  Similarity=0.252  Sum_probs=24.9

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            34689999999999995 4 578999998764

>PRK06148 hypothetical protein; Provisional

Probab=94.01  E-value=0.078  Score=49.91  Aligned_cols=32  Identities=44%  Similarity=0.454  Sum_probs=26.5

Q ss_pred             CCCceeecCCCCCeeecCCC--cE-EEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEF--NA-KLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~--~~-kl~Dfg~~~~   49 (229)
                      ..++||+|+.+.|||++.++  .+ -|+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            34699999999999998875  45 4999998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.57  E-value=0.056  Score=44.18  Aligned_cols=30  Identities=20%  Similarity=0.257  Sum_probs=25.7

Q ss_pred             CceeecCCCCCeeecC-CCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDA-EFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~   49 (229)
                      .++|.||.+.|||++. ++.++++||..+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            3789999999999975 57899999998754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=93.03  E-value=0.064  Score=46.12  Aligned_cols=83  Identities=29%  Similarity=0.310  Sum_probs=44.4

Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .|+|||++|.++.++.-|...+..........  -...-+..+.....-....    ...-.+....+++..+|+-..|.
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~--~i~k~~~~d~~~~~~a~e~----~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLE--ILLKYYTDDQELLSTAMEH----LIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHH--HHHHhccCchhHHHHHHHH----HHHHhhhHhHHHHhccCCccccc
Confidence            59999999999999998876554322111100  0000001111000000000    11223455677788889999998


Q ss_pred             CCCCHHHHH
Q 027003          161 LRPRMSEVL  169 (229)
Q Consensus       161 ~Rpt~~~v~  169 (229)
                      .||...++.
T Consensus       184 ir~l~~~~~  192 (725)
T KOG1093|consen  184 IRPLPMELS  192 (725)
T ss_pred             cccchhHHh
Confidence            888655443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=92.59  E-value=0.17  Score=41.25  Aligned_cols=37  Identities=22%  Similarity=0.232  Sum_probs=29.7

Q ss_pred             HHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcc
Q 027003           10 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   48 (229)
Q Consensus        10 ~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~   48 (229)
                      -+--|-  ..|+||+|..-=||++..++.++++||-.+.
T Consensus       214 ~Iv~la--~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  214 LIVRLA--NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             HHHHHH--HcCceecccchheeEEecCCCEEEeechHhh
Confidence            334454  3469999999999999999999999996543

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=92.38  E-value=0.12  Score=41.39  Aligned_cols=30  Identities=33%  Similarity=0.398  Sum_probs=24.8

Q ss_pred             CceeecCCCCCeeecCC--C---cEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAE--F---NAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~--~---~~kl~Dfg~~~~   49 (229)
                      -++|||++..|||+..+  |   .+++.||-+++.
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence            48999999999999654  3   589999987764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=92.34  E-value=0.13  Score=43.21  Aligned_cols=31  Identities=19%  Similarity=0.278  Sum_probs=26.2

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...++|||+.+.||++..+ .++|+||-++..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            3469999999999999776 589999987764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=91.79  E-value=0.34  Score=36.53  Aligned_cols=35  Identities=26%  Similarity=0.384  Sum_probs=24.2

Q ss_pred             HHHHhhcCCCCceeecCCCCCeeecCC--C--cEEEcc-cCC
Q 027003           10 GLTFLHDAESQVIYRDFKASNILLDAE--F--NAKLSD-FGL   46 (229)
Q Consensus        10 ~l~~LH~~~~~ivHrDlkp~Nill~~~--~--~~kl~D-fg~   46 (229)
                      -..||-+  .+|+.+||+|.||++...  +  .+.|+| ||-
T Consensus       130 f~~~l~~--~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  130 FKRYLLD--HHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             HHHHHHH--cCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence            3445553  349999999999999543  2  477888 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=91.50  E-value=0.17  Score=41.78  Aligned_cols=31  Identities=16%  Similarity=0.205  Sum_probs=25.6

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...++||||.+.||+++.++ ++++|+.++..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            34699999999999997764 77999987764

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK06149 hypothetical protein; Provisional

Probab=91.01  E-value=0.25  Score=46.45  Aligned_cols=32  Identities=19%  Similarity=0.202  Sum_probs=25.7

Q ss_pred             CCCceeecCCCCCeeecCCC--c---EEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEF--N---AKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~--~---~kl~Dfg~~~~   49 (229)
                      ..++||+|+...|||++.+.  .   .-|+|||-+..
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            35699999999999998652  3   37999998753

>PRK10593 hypothetical protein; Provisional

Probab=89.66  E-value=0.33  Score=39.07  Aligned_cols=28  Identities=18%  Similarity=0.278  Sum_probs=22.1

Q ss_pred             CCceeecCCCCCeeecCC-Cc-EEEcccCC
Q 027003           19 SQVIYRDFKASNILLDAE-FN-AKLSDFGL   46 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~-~~-~kl~Dfg~   46 (229)
                      ..++|||+.+.||+++.+ +. +.|.|...
T Consensus       193 psLlHGDlw~gNvl~~~~~~~i~~liDPa~  222 (297)
T PRK10593        193 CVLVHGNFTLRSMLKDPRSDQLLAMLNPGL  222 (297)
T ss_pred             CeeEeCCCCcccEEECCCCCceEEEECchH
Confidence            468999999999999865 44 67887653

>PLN02876 acyl-CoA dehydrogenase

Probab=89.29  E-value=0.32  Score=44.97  Aligned_cols=30  Identities=17%  Similarity=0.370  Sum_probs=24.6

Q ss_pred             CceeecCCCCCeeecCC-Cc-EEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAE-FN-AKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~-~~-~kl~Dfg~~~~   49 (229)
                      .+||+|+++.|||++.+ +. .-|.||.++..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            49999999999999853 33 57899998765

>PRK12396 5-methylribose kinase; Reviewed

Probab=89.04  E-value=0.34  Score=40.56  Aligned_cols=30  Identities=17%  Similarity=0.283  Sum_probs=25.2

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++||||.+.|||++.+ ..|++|.-++..
T Consensus       227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy  256 (409)
T PRK12396        227 QALIHGDLHTGSVFVKND-STKVIDPEFAFY  256 (409)
T ss_pred             hhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence            459999999999999986 589999777654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=87.33  E-value=0.96  Score=39.44  Aligned_cols=33  Identities=24%  Similarity=0.209  Sum_probs=28.0

Q ss_pred             CceeecCCCCCeeecC----CCcEEEcccCCcccCCC
Q 027003           20 QVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPT   52 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~----~~~~kl~Dfg~~~~~~~   52 (229)
                      |++|.|=.|.||++..    ++.+.+.|||+......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            5999999999999984    56799999999876543

>PLN02756 S-methyl-5-thioribose kinase

Probab=84.34  E-value=0.89  Score=38.32  Aligned_cols=31  Identities=10%  Similarity=0.216  Sum_probs=25.0

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...++||||.+.||+++.++ .+++|..++..
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~  259 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY  259 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence            34699999999999999876 78888665543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	229
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-34
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-04
3soa_A	444	Full-Length Human Camkii Length = 444		7e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 79/194 (40%), Positives = 119/194 (61%), Gaps = 5/194 (2%)
Query: 2   KVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++A+G+A+GL +LHD  + ++I+RD KA+NILLD EF A + DFGLAK     D  HV  
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXX 201
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAK 118
            V GT G+ APEY++TG+ + K+DV+ +GV+LLEL++G+ A D  ++  +    L+DW K
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L +K KL  ++D  L G Y  +       +AL C  + P  RP+MSEV+ +LE     
Sbjct: 262 GLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320
Query: 179 KNSAKLSQSEPHRQ 192
           +   +  + E  RQ
Sbjct: 321 ERWEEWQKEEMFRQ 334

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/194 (40%), Positives = 118/194 (60%), Gaps = 5/194 (2%)
Query: 2   KVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++A+G+A+GL +LHD  + ++I+RD KA+NILLD EF A + DFGLAK     D  HV  
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXX 193
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAK 118
            V G  G+ APEY++TG+ + K+DV+ +GV+LLEL++G+ A D  ++  +    L+DW K
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L +K KL  ++D  L G Y  +       +AL C  + P  RP+MSEV+ +LE     
Sbjct: 254 GLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
Query: 179 KNSAKLSQSEPHRQ 192
           +   +  + E  RQ
Sbjct: 313 ERWEEWQKEEMFRQ 326

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  124 bits (311), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 71/173 (41%), Positives = 102/173 (58%), Gaps = 3/173 (1%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++ IGAA+GL +LH     +I+RD K+ NILLD  F  K++DFG++K G   D+TH+  
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
            V GT GY  PEY   GRLT KSDVYSFGVVL E+L  R A+ ++      +L +WA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             +  +L +I+D  L  +   ++       A++CL    + RP M +VL  LE
Sbjct: 260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 70/173 (40%), Positives = 101/173 (58%), Gaps = 3/173 (1%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++ IGAA+GL +LH     +I+RD K+ NILLD  F  K++DFG++K G    +TH+  
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
            V GT GY  PEY   GRLT KSDVYSFGVVL E+L  R A+ ++      +L +WA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             +  +L +I+D  L  +   ++       A++CL    + RP M +VL  LE
Sbjct: 260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 108/176 (61%), Gaps = 6/176 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A GAA G+ FLH  E+  I+RD K++NILLD  F AK+SDFGLA+A     +T + ++
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           ++GT  Y APE +  G +T KSD+YSFGVVLLE+++G  AVD+ +    Q L+D  +   
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIE 251
Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
            +++ +   +D K+       +     ++A QCL+ +   RP + +V  +L+ + A
Sbjct: 252 DEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 107/176 (60%), Gaps = 6/176 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A GAA G+ FLH  E+  I+RD K++NILLD  F AK+SDFGLA+A     +T +  +
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           ++GT  Y APE +  G +T KSD+YSFGVVLLE+++G  AVD+ +    Q L+D  +   
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIE 251
Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
            +++ +   +D K+       +     ++A QCL+ +   RP + +V  +L+ + A
Sbjct: 252 DEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/176 (38%), Positives = 106/176 (60%), Gaps = 6/176 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A GAA G+ FLH  E+  I+RD K++NILLD  F AK+SDFGLA+A     +  +  +
Sbjct: 131 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           ++GT  Y APE +  G +T KSD+YSFGVVLLE+++G  AVD+ +    Q L+D  +   
Sbjct: 189 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIE 245
Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
            +++ +   +D K+       +     ++A QCL+ +   RP + +V  +L+ + A
Sbjct: 246 DEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/176 (38%), Positives = 104/176 (59%), Gaps = 6/176 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A GAA G+ FLH  E+  I+RD K++NILLD  F AK+SDFGLA+A     +    ++
Sbjct: 128 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           ++GT  Y APE +  G +T KSD+YSFGVVLLE+++G  AVD+ +    Q L+D  +   
Sbjct: 186 IVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIE 242
Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
            +++ +   +D K        +     ++A QCL+ +   RP + +V  +L+   A
Sbjct: 243 DEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTA 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   AKG+ +LH+    +++RD K+ N+L+D ++  K+ DFGL++          S 
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSK 197
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
              GT  + APE +       KSDVYSFGV+L EL      + +    +  + V  A  +
Sbjct: 198 XAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL----ATLQQPWGNLNPAQVVAAVGF 253
Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              + ++ R ++       PQ AA         C  NEP  RP  + ++ +L  L
Sbjct: 254 KCKRLEIPRNLN-------PQVAAIIEG-----CWTNEPWKRPSFATIMDLLRPL 296

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 140 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   AKG+ +LH+    +++R+ K+ N+L+D ++  K+ DFGL++   +   T +S+
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS---TFLSS 196
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           +   GT  + APE +       KSDVYSFGV+L EL      + +    +  + V  A  
Sbjct: 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL----ATLQQPWGNLNPAQVVAAVG 252
Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +   + ++ R ++       PQ AA         C  NEP  RP  + ++ +L  L
Sbjct: 253 FKCKRLEIPRNLN-------PQVAAIIEG-----CWTNEPWKRPSFATIMDLLRPL 296

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 133 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 141 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 132 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 133 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 143 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+L++   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ F+   +   I+RD +A+NIL+ A    K++DFGLA+     + T           
Sbjct: 121 AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK- 177
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           + APE +  G  T KSDV+SFG++L+E+++ GR                   P +S+  +
Sbjct: 178 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PGMSNP-E 220
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
           + R ++       P+        + ++C  N P+ RP    + ++L+  E
Sbjct: 221 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 59/102 (57%), Gaps = 10/102 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  A+G+ +L  AE + ++RD  A N +LD  F  K++DFGLA+     DR + S 
Sbjct: 127 ISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182
Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           Q    H      + A E + T R TTKSDV+SFGV+L ELL+
Sbjct: 183 Q-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD    + +  GT  Y 
Sbjct: 131 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYI 186
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +   +     D +SFGV+L E+L G+
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 134 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 191
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 192 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 250
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 251 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 297

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 142 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 253
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 254 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 140 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 197
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 251
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 252 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 135 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 192
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 251
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 252 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 298

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 109 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 166
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 167 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 225
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 226 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 272

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 223
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 224 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 270

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 142 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 253
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 254 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 201 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 312
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 313 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 112 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 228
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 229 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 275

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 223
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 224 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 270

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 147 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 204
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 258
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 259 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 294

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 127 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 185 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 243
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 244 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 290

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 112 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 228
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 229 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 275

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T    + + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T    + + T  
Sbjct: 140 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 143 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL 200
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 254
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 255 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 39/180 (21%)
Query: 4   AIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGD 54
           A+  A+G+ +LHD A   +I+RD K+SNIL+  +           K++DFGLA+      
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------ 164
Query: 55  RTHVSTQV--MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC---AVDKTKVGI 109
             H +T++   G + + APE +     +  SDV+S+GV+L ELL+G      +D   V  
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA- 223
Query: 110 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                             + +   KL    P       A L   C N +P  RP  + +L
Sbjct: 224 ------------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+       D  H  T    
Sbjct: 143 VAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 200
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 254
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 255 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 164
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 223
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 224 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 135 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192
Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 251
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 252 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 298

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD    +    GT  Y 
Sbjct: 130 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYI 185
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           APE +   +     D +SFGV+L E+L G+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 31/167 (18%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ F+   +   I+RD +A+NIL+ A    K++DFGLA+ G                 
Sbjct: 288 AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK----------- 334
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           + APE +  G  T KSDV+SFG++L+E+++ GR                   P +S+  +
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PGMSNP-E 377
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           + R ++       P+        + ++C  N P+ RP    + ++L+
Sbjct: 378 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NIL+ A    K+ DFG+A+A   +G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ F+   +   I+RD +A+NIL+ A    K++DFGLA+     + T           
Sbjct: 294 AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK- 350
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           + APE +  G  T KSDV+SFG++L+E+++ GR                   P +S+  +
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PGMSNP-E 393
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           + R ++       P+        + ++C  N P+ RP    + ++L+
Sbjct: 394 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 111 IDIARQTARGMDYLH-AKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE 168
Query: 61  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGR 99
           Q+ G+  + APE +    +   + +SDVY+FG+VL EL++G+
Sbjct: 169 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/89 (40%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  +IYRD K  NILLD   + K++DFG AK  P      V+  + GT  Y 
Sbjct: 118 ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYI 170
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE V+T       D +SFG+++ E+L+G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQVMG 64
           G A G+ +L  A    ++RD  A NIL+++    K+SDFGL++      + T+ ++    
Sbjct: 155 GIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-D 123
              + APE ++  + T+ SDV+SFG+V+ E+++                    +PY    
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG-----------------ERPYWELS 255
Query: 124 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSA 182
             ++ + ++       P         L +QC   E   RP+ +++++IL++L  AP +  
Sbjct: 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315
Query: 183 KLSQSEP 189
            L+  +P
Sbjct: 316 TLADFDP 322

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 123 IDIARQTARGMDYLH-AKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 61  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGR 99
           Q+ G+  + APE +    +   + +SDVY+FG+VL EL++G+
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 123 IDIARQTARGMDYLH-AKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 61  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGR 99
           Q+ G+  + APE +    +   + +SDVY+FG+VL EL++G+
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYA 69
           L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G   GD T   +   GT  Y 
Sbjct: 134 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYI 188
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D ++ GV++ E+++GR   D   VG   +      P  + +  LF+
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLFQ 240
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  K   + P+  +  AA++    LN +PK R
Sbjct: 241 VILEK-QIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYA 69
           L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G   GD T   +   GT  Y 
Sbjct: 119 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYI 173
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D ++ GV++ E+++GR   D   VG   +      P  + +  LF+
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLFQ 225
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  K   + P+  +  AA++    LN +PK R
Sbjct: 226 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYA 69
           L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G   GD T   +   GT  Y 
Sbjct: 166 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYI 220
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D ++ GV++ E+++GR   D   VG   +      P  + +  LF+
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLFQ 272
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  K   + P+  +  AA++    LN +PK R
Sbjct: 273 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYA 69
           L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G   GD T   +   GT  Y 
Sbjct: 123 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYI 177
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D ++ GV++ E+++GR   D   VG   +      P  + +  LF+
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLFQ 229
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  K   + P+  +  AA++    LN +PK R
Sbjct: 230 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ + H     V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YA
Sbjct: 128 GVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYA 182
Query: 70  APEYVATGRLTT--KSDVYSFGVVLLELLSGRCAVDKTKV 107
           APE V +GRL    + D++S GV+L  LL G    D   V
Sbjct: 183 APE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 28/180 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHV 58
           M   +  ++G+ +LH  + + +I+RD K  N+LL A     K+ DFG A       +TH+
Sbjct: 106 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM 161
Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
            T   G+  + APE       + K DV+S+G++L E+++ R                  K
Sbjct: 162 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------------------K 202
Query: 119 PYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           P+       FRIM     G  P   +       +L  +C + +P  RP M E++ I+  L
Sbjct: 203 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 133 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 190
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 233
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    PK+RP   E++ +L+
Sbjct: 234 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +G+    +
Sbjct: 136 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 130 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 187
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 188 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 230
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    PK+RP   E++ +L+
Sbjct: 231 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 28/180 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHV 58
           M   +  ++G+ +LH  + + +I+RD K  N+LL A     K+ DFG A       +TH+
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM 160
Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
            T   G+  + APE       + K DV+S+G++L E+++ R                  K
Sbjct: 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------------------K 201
Query: 119 PYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           P+       FRIM     G  P   +       +L  +C + +P  RP M E++ I+  L
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 21/172 (12%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQVMG 64
           G   G+ +L D     ++RD  A N+L+D+    K+SDFGL++      D  + +T    
Sbjct: 159 GVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-D 123
              + APE +A    ++ SDV+SFGVV+ E+L+                    +PY +  
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG-----------------ERPYWNMT 259
Query: 124 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            R +   ++       P    H    L L C + +   RPR S+++++L+ L
Sbjct: 260 NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 28/152 (18%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YAAPE V +GRL 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLY 187
Query: 81  T--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 138
              + D++S GV+L  LL G    D   V           P L  K +         GG 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PTLFKKIR---------GGV 227
Query: 139 Y--PQKAAHTAATLALQCLNNEPKLRPRMSEV 168
           +  P+    + ATL +  L  +P  R  + ++
Sbjct: 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+          H  T    
Sbjct: 141 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKL 198
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 252
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 253 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 133 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 233
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    PK+RP   E++ +L+
Sbjct: 234 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/78 (44%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +IYRD K  NILLD E + KL+DFGL+K   + D    +    GT  Y APE V     T
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 81  TKSDVYSFGVVLLELLSG 98
             +D +SFGV++ E+L+G
Sbjct: 205 QSADWWSFGVLMFEMLTG 222

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 161 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 218
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 272
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 273 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 308

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 134 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 191
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 245
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 246 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 281

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 142 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 253
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 254 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/78 (44%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +IYRD K  NILLD E + KL+DFGL+K   + D    +    GT  Y APE V     T
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 81  TKSDVYSFGVVLLELLSG 98
             +D +SFGV++ E+L+G
Sbjct: 206 QSADWWSFGVLMFEMLTG 223

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 142 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 253
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 254 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/78 (44%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +IYRD K  NILLD E + KL+DFGL+K   + D    +    GT  Y APE V     T
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 81  TKSDVYSFGVVLLELLSG 98
             +D +SFGV++ E+L+G
Sbjct: 205 QSADWWSFGVLMFEMLTG 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 160 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 217
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 271
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 272 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 307

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 137 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 248
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 249 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 139 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 196
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 250
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 251 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 141 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 198
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 252
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 253 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQV 62
           G   G+ +L D     ++RD  A N+L+D+    K+SDFGL++     P    T    ++
Sbjct: 159 GVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216
Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A    ++ SDV+SFGVV+ E+L+                    +PY +
Sbjct: 217 --PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG-----------------ERPYWN 257
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              R +   ++       P    H    L L C + +   RPR S+++++L+ L
Sbjct: 258 MTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL FLH  +  +IYRD K  N++LD+E + K++DFG+ K       T  + +  GT  Y 
Sbjct: 132 GLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYI 187
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           APE +A        D +++GV+L E+L+G+   D
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 132 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 190 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 232
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    PK+RP   E++ +L+
Sbjct: 233 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH    +++YRD K  NILLD   + ++SD GLA   P G         +GT GY 
Sbjct: 298 GLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYM 352
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
           APE V   R T   D ++ G +L E+++G+    + K  I++  V+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMG 64
            AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H  T    
Sbjct: 140 VAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 197
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
              + A E + T + TTKSDV+SFGV+L EL++ R A     V      V     YL   
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQG 251
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           R+L +          P+        + L+C + + ++RP  SE+++
Sbjct: 252 RRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH    +++YRD K  NILLD   + ++SD GLA   P G         +GT GY 
Sbjct: 298 GLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYM 352
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
           APE V   R T   D ++ G +L E+++G+    + K  I++  V+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 28/152 (18%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YAAPE V +GRL 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-VISGRLY 187
Query: 81  T--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 138
              + D++S GV+L  LL G    D   V           P L  K +         GG 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PTLFKKIR---------GGV 227
Query: 139 Y--PQKAAHTAATLALQCLNNEPKLRPRMSEV 168
           +  P+    + ATL +  L  +P  R  + ++
Sbjct: 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 133 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 190
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 233
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    P +RP   E++ +L+
Sbjct: 234 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 129 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 182
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 68
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y
Sbjct: 151 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 205
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 256
Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 257 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 119 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 172
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 137 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 190
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 139 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 192
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 139 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 192
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 68
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y
Sbjct: 153 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 207
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 258
Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 259 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 117 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 170
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 61/98 (62%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++ +
Sbjct: 111 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANE 165
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 123 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 176
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 32/180 (17%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++RD  A N ++  +F  K+ DFG+     T D    + 
Sbjct: 133 IQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGM-----TRDIYETAY 185
Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
              G  G     + APE +  G  TT SD++SFGVVL E+                SL +
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE 230
Query: 116 WAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             +PY  LS+++ L  +MD     Q P         L   C    PK+RP   E++ +L+
Sbjct: 231 --QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH      I+RD KA NILL+ E +AKL+DFG+  AG   D       V+GT  +
Sbjct: 136 KGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFW 191
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +        +D++S G+  +E+  G+
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 68
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y
Sbjct: 127 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 181
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 232
Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 233 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 59/98 (60%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   +GL +L + + Q+++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 118 KVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 172
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y APE +     + +SD++S G+ L+EL  GR
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGLA+     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLARV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L FLHD    +IYRD K  N+LLD E + KL+DFG+ K G     T  +    GT  Y A
Sbjct: 137 LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIA 192
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +         D ++ GV+L E+L G
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 482 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 535
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 481 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 534
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 170 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 224
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A GL  LH     +IYRD K  NILLD E + KL+DFGL+K     D    +    GT  
Sbjct: 140 ALGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVE 195
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE V     +  +D +S+GV++ E+L+G
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 67
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 207
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 258
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           + +         P+     A+ L  + L+ +P LRP ++E+L
Sbjct: 259 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 126 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 226
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 227 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 286 GFREVSFYYSEENK 299

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 5/167 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTH 66
            +G+ +LH      I+RD  A N+LLD +   K+ DFGLAKA P G   + V        
Sbjct: 144 CEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV 201
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +   +    SDV+SFGV L ELL+  C   ++       L+  A+  ++  R 
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLR- 259
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           L  +++       P K       L   C   E   RP    ++ IL+
Sbjct: 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 115 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 231
Query: 127 L 127
           +
Sbjct: 232 I 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 24/163 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 67
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 137 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 191
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 242
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           + +         P+     A+ L  + L+ +P LRP ++E+L 
Sbjct: 243 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELLT 276

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 67
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPN 207
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 258
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           + +         P+     A+ L  + L+ +P LRP ++E+L
Sbjct: 259 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A GL FL      +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 452 AIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPD 507
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           Y APE +A        D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D  +  ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 135 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 189
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 67
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPN 207
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 258
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           + +         P+     A+ L  + L+ +P LRP ++E+L
Sbjct: 259 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 135 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 235
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 236 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 295 GFREVSFYYSEENK 308

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 143 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 198
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 241
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 242 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 301
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 302 LKIITSAAAR 311

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 126 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 181
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 224
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 225 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 284
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 285 LKIITSAAAR 294

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GFVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 134 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 234
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 235 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 178 PKNSAKLSQSEPHR-QTGPV 196
                    SE ++ +  PV
Sbjct: 294 GFREVSFYYSEENKMENNPV 313

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 127 L 127
           +
Sbjct: 234 I 234

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 11/93 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 67
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D      Q   THG  
Sbjct: 123 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENXYKAQ---THGKW 176
Query: 68  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 126 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 181
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 224
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 225 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 284
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 285 LKIITSAAAR 294

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 153 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 208
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 251
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 252 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 311
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 312 LKIITSAAAR 321

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 23/198 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 141 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 241
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 242 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 178 PKNSAKLSQSEPHRQTGP 195
                    SE ++   P
Sbjct: 301 GFREVSFYYSEENKLPEP 318

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 126
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-XQEYSDWKEKKTYLNPWKK 232
Query: 127 L 127
           +
Sbjct: 233 I 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A GL FL      +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 131 AIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPD 186
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           Y APE +A        D ++FGV+L E+L+G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 23/198 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 141 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 241
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 242 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 178 PKNSAKLSQSEPHRQTGP 195
                    SE ++   P
Sbjct: 301 GFREVSFYYSEENKLPEP 318

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 33/182 (18%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++     +G+ FL     Q I+RD  A N L+D +   K+SDFG+ +     D  +VS+
Sbjct: 107 LEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS 162
Query: 61  QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVD---KTKVGIEQSL 113
             +GT     ++APE     + ++KSDV++FG+++ E+ S G+   D    ++V ++   
Sbjct: 163 --VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--- 217
Query: 114 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
                  +S   +L+R          P  A+ T   +   C +  P+ RP   ++L+ +E
Sbjct: 218 -------VSQGHRLYR----------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
Query: 174 RL 175
            L
Sbjct: 261 PL 262

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 127 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 181
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 130 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFW 185
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 229
Query: 129 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 230 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 269

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 68
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y
Sbjct: 133 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNY 187
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 238
Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 239 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 68
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y
Sbjct: 129 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNY 183
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 234
Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 235 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 68
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y
Sbjct: 129 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNY 183
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 234
Query: 129 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 235 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH     +I+RD K++NI L      K+ DFGLA        +    
Sbjct: 135 IDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 61  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSG 98
           Q  G+  + APE +        + +SDVYS+G+VL EL++G
Sbjct: 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL++     D     +
Sbjct: 153 ISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           Q      + A E +     TT+SDV+SFGV+L E+++         +G          PY
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPY 253
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                 +LF ++ T    + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 73/167 (43%), Gaps = 33/167 (19%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH      I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  +
Sbjct: 127 KGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFW 182
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD---KR 125
            APE +       K+D++S G+  +EL  G                   +P  SD    R
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKG-------------------EPPNSDLHPMR 223
Query: 126 KLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            LF I       L GQ+ +            CLN +P+ RP   E+L
Sbjct: 224 VLFLIPKNSPPTLEGQHSKPFKEFVEA----CLNKDPRFRPTAKELL 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 118 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 176 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 132 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 232
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 233 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 292 GFREVSFYYSEENK 305

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 120 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 178 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 128 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 228
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 229 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 288 GFREVSFYYSEENK 301

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 131 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 231
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 232 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 291 GFREVSFYYSEENK 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 25/190 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L D     ++RD  A NIL+++    K+SDFGL +     D    +    G 
Sbjct: 155 GIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGG 210
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + +PE +A  + T+ SDV+S+G+VL E++S                    +PY  
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-----------------ERPYWE 253
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + +D       P         L L C   +   RP+  ++++IL++L     S
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
Query: 182 AKLSQSEPHR 191
            K+  S   R
Sbjct: 314 LKIITSAAAR 323

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 134 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 234
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 235 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 294 GFREVSFYYSEENK 307

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 25/187 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G   G+ +L D  +  ++RD  A NIL+++    K+SDFG+++     D    +    G 
Sbjct: 139 GIGSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGG 194
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A  + T+ SDV+S+G+V+ E++S                    +PY  
Sbjct: 195 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPYWD 237
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + ++       P         L L C   E   RP+  +++ +L++L    NS
Sbjct: 238 MSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNS 297
Query: 182 AKLSQSE 188
            K + SE
Sbjct: 298 LKRTGSE 304

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 115 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFW 170
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 214
Query: 129 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 215 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 254

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 135 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 235
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 236 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 295 GFREVSFYYSEENK 308

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 112 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 170 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 121 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 179 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL++     D     +
Sbjct: 153 ISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           Q      + A E +     TT+SDV+SFGV+L E+++         +G          PY
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPY 253
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                 +LF ++ T    + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 163 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 263
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 264 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 323 GFREVSFYYSEENK 336

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 182
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE V       K D++S G++ +E++ G 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 21/152 (13%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y A
Sbjct: 261 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 317
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 360
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+     A +L    L  +PK R
Sbjct: 361 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 114 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 172 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 122 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 180 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 113 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 171 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 21/152 (13%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y A
Sbjct: 264 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 320
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 363
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+     A +L    L  +PK R
Sbjct: 364 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 118 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 176 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 112 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 170 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 115 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFW 170
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 214
Query: 129 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 215 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 254

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L  A+   ++RD  A NIL+++    K+SDFGL++     D   V T   G 
Sbjct: 153 GIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-IEDDPEAVYTTTGGK 209
Query: 66  H--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS- 122
               + APE +   + T+ SDV+S+G+V+ E++S                    +PY   
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPYWDM 252
Query: 123 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSA 182
             + + + ++       P         L L C   E   RP+  +++ IL+++    NSA
Sbjct: 253 SNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNPNSA 312

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 117 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 175 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 112 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 170 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL++     D     +
Sbjct: 153 ISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           Q      + A E +     TT+SDV+SFGV+L E+++         +G          PY
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPY 253
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                 +LF ++ T    + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 112 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 170 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 33/167 (19%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  +
Sbjct: 131 KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFW 186
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD---KR 125
            APE +      +K+D++S G+  +EL  G                   +P  SD    R
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKG-------------------EPPNSDMHPMR 227
Query: 126 KLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            LF I       L G + +    +       CLN +P  RP   E+L
Sbjct: 228 VLFLIPKNNPPTLVGDFTK----SFKEFIDACLNKDPSFRPTAKELL 270

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++R+  A N ++  +F  K+ DFG+ +     D      
Sbjct: 133 IQMAAEIADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 233
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    P +RP   E++ +L+
Sbjct: 234 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 5/167 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTH 66
            +G+ +LH      I+R+  A N+LLD +   K+ DFGLAKA P G   + V        
Sbjct: 127 CEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 184
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +   +    SDV+SFGV L ELL+  C   ++       L+  A+  ++  R 
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLR- 242
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           L  +++       P K       L   C   E   RP    ++ IL+
Sbjct: 243 LTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L  AE   ++RD  A NIL+++    K+SDFGL++           T  +G 
Sbjct: 126 GIASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A  + T+ SD +S+G+V+ E++S          G         +PY  
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS---------FG--------ERPYWD 226
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              + +   ++       P     +   L L C   +   RPR  +V++ L+++
Sbjct: 227 MSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+    + ++R+  A N ++  +F  K+ DFG+ +     D      
Sbjct: 134 IQMAAEIADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + APE +  G  TT SD++SFGVVL E+                SL +  +PY
Sbjct: 192 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPY 234
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             LS+++ L  +MD     Q P         L   C    P +RP   E++ +L+
Sbjct: 235 QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 25/187 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G   G+ +L D     ++RD  A NIL+++    K+SDFG+++     D    +    G 
Sbjct: 118 GIGSGMKYLSDM--SYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGG 173
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A  + T+ SDV+S+G+V+ E++S                    +PY  
Sbjct: 174 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPYWD 216
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + ++       P         L L C   E   RP+  +++ +L++L    NS
Sbjct: 217 MSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNS 276
Query: 182 AKLSQSE 188
            K + SE
Sbjct: 277 LKRTGSE 283

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 25/187 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G   G+ +L D     ++RD  A NIL+++    K+SDFG+++     D    +    G 
Sbjct: 124 GIGSGMKYLSDM--SYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGG 179
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A  + T+ SDV+S+G+V+ E++S                    +PY  
Sbjct: 180 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPYWD 222
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
              + + + ++       P         L L C   E   RP+  +++ +L++L    NS
Sbjct: 223 MSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNS 282
Query: 182 AKLSQSE 188
            K + SE
Sbjct: 283 LKRTGSE 289

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 135 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFW 190
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 128
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 234
Query: 129 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 235 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 274

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y A
Sbjct: 123 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLA 179
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 222
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+     A +L    L  +PK R
Sbjct: 223 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     + T    
Sbjct: 107 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 164
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 165 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y A
Sbjct: 122 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLA 178
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 221
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+     A +L    L  +PK R
Sbjct: 222 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y A
Sbjct: 121 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLA 177
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 220
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+     A +L    L  +PK R
Sbjct: 221 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 5/167 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTH 66
            +G+ +LH      I+R+  A N+LLD +   K+ DFGLAKA P G   + V        
Sbjct: 127 CEGMAYLH--AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 184
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +   +    SDV+SFGV L ELL+  C   ++       L+  A+  ++  R 
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLR- 242
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           L  +++       P K       L   C   E   RP    ++ IL+
Sbjct: 243 LTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N  +  +F  K+ DFG+ +     D      
Sbjct: 128 IQMAGEIADGMAYLN--ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+                +L +  +PY
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPY 228
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AILERLEA 177
             LS+++ L  +M+  L  + P         L   C    PK+RP   E++ +I E +E 
Sbjct: 229 QGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 178 PKNSAKLSQSEPHR 191
                    SE ++
Sbjct: 288 GFREVSFYYSEENK 301

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G A G+ +L  AE   ++RD  A NIL+++    K+SDFGL++           T  +G 
Sbjct: 124 GIASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A  + T+ SD +S+G+V+ E++S          G         +PY  
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS---------FG--------ERPYWD 224
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              + +   ++       P     +   L L C   +   RPR  +V++ L+++
Sbjct: 225 MSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 304 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 357
Query: 70  APEYVATG-RLTTKSDVYSFGVVLLELLSG 98
           APE +  G    + +D +S G +L +LL G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 303 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 356
Query: 70  APEYVATG-RLTTKSDVYSFGVVLLELLSG 98
           APE +  G    + +D +S G +L +LL G
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 304 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 357
Query: 70  APEYVATG-RLTTKSDVYSFGVVLLELLSG 98
           APE +  G    + +D +S G +L +LL G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 304 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 357
Query: 70  APEYVATG-RLTTKSDVYSFGVVLLELLSG 98
           APE +  G    + +D +S G +L +LL G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+   HD   ++++RD K  NIL+D+    K+ DFG+AKA      T  +  V+GT  Y 
Sbjct: 123 GIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYF 179
Query: 70  APEYVATGRLTTK-SDVYSFGVVLLELLSGR 99
           +PE  A G  T + +D+YS G+VL E+L G 
Sbjct: 180 SPEQ-AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 366 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 421
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 471
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   EP+ RP    + A LE     
Sbjct: 472 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--- 521
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 522 -----FTSTEPQXQPG 532

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     + T    
Sbjct: 107 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE    GR T KSDV+SFG++L EL +      K +V           PY
Sbjct: 165 AKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------PY 206
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
                R++   ++       P +   +   L  QC   EP+ RP    + A LE      
Sbjct: 207 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY---- 262
Query: 180 NSAKLSQSEPHRQTG 194
                + +EP  Q G
Sbjct: 263 ----FTSTEPQYQPG 273

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 6/86 (6%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V  G+L
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKL 183
Query: 80  TT--KSDVYSFGVVLLELLSGRCAVD 103
               + DV+S G+VL  +L GR   D
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 110 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 165
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           Q       + APE    GR T KSDV+SFG++L EL +      K +V           P
Sbjct: 166 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------P 208
Query: 120 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y     R++   ++       P +   +   L  QC   EP+ RP    + A LE     
Sbjct: 209 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--- 265
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 266 -----FTSTEPQYQPG 276

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       I+RD +++NIL+      K++DFGLA+     + T    
Sbjct: 108 VDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG 165
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE    GR T KSDV+SFG++L EL      V K +V           PY
Sbjct: 166 AKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTEL------VTKGRV-----------PY 207
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
              + R++   ++       PQ    +   L + C   +P+ RP    + + LE      
Sbjct: 208 PGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDY---- 263
Query: 180 NSAKLSQSEPHRQTG 194
                + +EP  Q G
Sbjct: 264 ----FTATEPQYQPG 274

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + ++RD  A NIL+++E + K++DFGLAK  P  D+ +   +  G   
Sbjct: 125 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 181
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             + APE ++    + +SDV+SFGVVL EL +
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 57/110 (51%), Gaps = 4/110 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVS 59
           +K A+   KG+ +L     Q ++RD  A N+L+++E   K+ DFGL KA  T  +   V 
Sbjct: 129 LKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 186
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 109
                   + APE +   +    SDV+SFGV L ELL+  C  D + + +
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMAL 235

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + ++RD  A NIL+++E + K++DFGLAK  P  D+ +   +  G   
Sbjct: 124 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 180
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             + APE ++    + +SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 81/189 (42%), Gaps = 31/189 (16%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTH 66
           A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + Q      
Sbjct: 121 ASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPI 176
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKR 125
            + APE    GR T KSDV+SFG++L EL +      K +V           PY     R
Sbjct: 177 KWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------PYPGMVNR 219
Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLS 185
           ++   ++       P +   +   L  QC   EP+ RP    + A LE           +
Sbjct: 220 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--------FT 271
Query: 186 QSEPHRQTG 194
            +EP  Q G
Sbjct: 272 STEPQYQPG 280

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + ++RD  A NIL+++E + K++DFGLAK  P  D+ +   +  G   
Sbjct: 137 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 193
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             + APE ++    + +SDV+SFGVVL EL +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 57/110 (51%), Gaps = 4/110 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVS 59
           +K A+   KG+ +L     Q ++RD  A N+L+++E   K+ DFGL KA  T  +   V 
Sbjct: 117 LKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 174
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 109
                   + APE +   +    SDV+SFGV L ELL+  C  D + + +
Sbjct: 175 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMAL 223

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  RT +S    GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLD 172
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 219
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQS 187
            R+  T     +P      A  L  + L + P  RP + EV   LE      NS+K S S
Sbjct: 220 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWITANSSKPSNS 271
Query: 188 E 188
           +
Sbjct: 272 Q 272

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG  A+  P   +    ++++GT  
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPY 181
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           + APE V       K D++S G++ +E++ G 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTH 66
            KG+ +L     + ++RD  A NIL+++E + K++DFGLAK  P   D   V        
Sbjct: 121 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            + APE ++    + +SDV+SFGVVL EL +
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 29/188 (15%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ ++       ++RD +A+NIL+      K++DFGLA+     + T           
Sbjct: 121 ASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK- 177
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE    GR T KSDV+SFG++L EL +      K +V           PY     R+
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------PYPGMVNRE 220
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ 186
           +   ++       P +   +   L  QC   EP+ RP    + A LE           + 
Sbjct: 221 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--------FTS 272
Query: 187 SEPHRQTG 194
           +EP  Q G
Sbjct: 273 TEPQYQPG 280

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+R+ K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 128 QALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 183
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE V       K D++S G++ +E++ G 
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 27/184 (14%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVM 63
           G A G+ +L  A+   ++RD  A NIL+++    K+SDFGL++     T D T+  T  +
Sbjct: 143 GIAAGMKYL--ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSAL 198
Query: 64  GTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           G      + APE +   + T+ SDV+S+G+V+ E++S                    +PY
Sbjct: 199 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPY 241
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
                + +   ++       P         L L C   +   RP+  +++  L+++    
Sbjct: 242 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 301
Query: 180 NSAK 183
           NS K
Sbjct: 302 NSLK 305

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  S  V GT  +
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYW 182
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE V       K D++S G++ +E++ G 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T++ GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  S  V GT  +
Sbjct: 128 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYW 183
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE V       K D++S G++ +E++ G 
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 25/174 (14%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G + G+ +L D     ++RD  A NIL+++    K+SDFGL++     D    +    G 
Sbjct: 132 GISAGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGG 187
Query: 66  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 122
                + APE +A  + T+ SDV+S+G+V+ E++S                    +PY  
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYG-----------------ERPYWE 230
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
              + + + ++       P         L L C   E   RP+  E++ +L++L
Sbjct: 231 MTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 283 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 338
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 388
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   EP+ RP    + A LE     
Sbjct: 389 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--- 438
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 439 -----FTSTEPQXQPG 449

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 283 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 338
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 388
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   EP+ RP    + A LE     
Sbjct: 389 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--- 438
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 439 -----FTSTEPQXQPG 449

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 283 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 338
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 388
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   EP+ RP    + A LE     
Sbjct: 389 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--- 438
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 439 -----FTSTEPQYQPG 449

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 144 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 197
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 244
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 245 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+R+ +A+NIL+    + K++DFGLA+     + T    
Sbjct: 108 LDMAAQIAEGMAFIE--ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 165
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE +  G  T KSDV+SFG++L E+++
Sbjct: 166 AKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 108 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 163
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           Q       + APE    GR T KSDV+SFG++L EL +      K +V           P
Sbjct: 164 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------P 206
Query: 120 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y     R++   ++       P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 207 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 263
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 264 -----FTSTEPQYQPG 274

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 176
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 31/194 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ- 61
           +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + Q 
Sbjct: 119 MAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQG 174
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
                 + APE    GR T KSDV+SFG++L EL +      K +V           PY 
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------PYP 217
Query: 122 S-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
               R++   ++       P +   +   L  QC   +P+ RP    + A LE       
Sbjct: 218 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY----- 272
Query: 181 SAKLSQSEPHRQTG 194
               + +EP  Q G
Sbjct: 273 ---FTSTEPQYQPG 283

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 66
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D   +    +    
Sbjct: 155 AAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE +  G+ +  SD++S+GVVL E+ S          G++        PY     + 
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQ--------PYCGYSNQD 255
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
           +  ++  +     P         L ++C N  P  RPR  ++
Sbjct: 256 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 66
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 66
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 172
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 222
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 223 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 272
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 273 -----FTSTEPQYQPG 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 106 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 161
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           Q       + APE    GR T KSDV+SFG++L EL +      K +V           P
Sbjct: 162 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------P 204
Query: 120 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y     R++   ++       P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 205 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 261
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 262 -----FTSTEPQYQPG 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++     +  G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYD 190
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 66
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 172
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           Q       + APE    GR T KSDV+SFG++L EL +      K +V           P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------P 215
Query: 120 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y     R++   ++       P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 216 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 272
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 273 -----FTSTEPQYQPG 283

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 172
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           Q       + APE    GR T KSDV+SFG++L EL +      K +V           P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------P 215
Query: 120 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y     R++   ++       P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 216 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 272
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 273 -----FTSTEPQYQPG 283

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 172
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 222
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 223 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 272
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 273 -----FTSTEPQYQPG 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     D  + + 
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTAR 172
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           Q       + APE    GR T KSDV+SFG++L EL +      K +V           P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------P 215
Query: 120 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y     R++   ++       P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 216 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 272
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 273 -----FTSTEPQYQPG 283

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 135 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 188
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 236 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 172
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 219
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 220 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     + T    
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE    GR T KSDV+SFG++L EL +      K +V           PY
Sbjct: 175 AKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------PY 216
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
                R++   ++       P +   +   L  QC   +P+ RP    + A LE      
Sbjct: 217 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY---- 272
Query: 180 NSAKLSQSEPHRQTG 194
                + +EP  Q G
Sbjct: 273 ----FTSTEPQYQPG 283

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 176
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  A    ++RD    N L+ A    K+ DFG+++   + D   V  
Sbjct: 136 LHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             M    +  PE +   + TT+SDV+SFGV+L E+ +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D   +    +    
Sbjct: 138 AAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE +  G+ +  SD++S+GVVL E+ S          G++        PY     + 
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQ--------PYCGYSNQD 238
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
           +  ++  +     P         L ++C N  P  RPR  ++
Sbjct: 239 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 176
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 174
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTH 66
            +G+ +LH      I+R   A N+LLD +   K+ DFGLAKA P G   + V        
Sbjct: 121 CEGMAYLH--AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 178
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            + APE +   +    SDV+SFGV L ELL+
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTH 66
            +G+ +LH      I+R   A N+LLD +   K+ DFGLAKA P G   + V        
Sbjct: 122 CEGMAYLH--AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 179
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            + APE +   +    SDV+SFGV L ELL+
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 176
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 178
Query: 80  TT--KSDVYSFGVVLLELLSGRCAVDKTKV 107
               + DV+S GV+L  +L  R   D   +
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 208

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 188
Query: 80  TT--KSDVYSFGVVLLELLSGRCAVDKTKV 107
               + DV+S GV+L  +L  R   D   +
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 218

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 80/183 (43%), Gaps = 28/183 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDR 55
           +++ +  A G+ ++ +    +++RD ++ NI L     +A   AK++DFGL++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----- 179
Query: 56  THVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 113
            H  + ++G   + APE +       T K+D YSF ++L  +L+G    D+   G     
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----- 234
Query: 114 VDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
                     K K   ++ +  L    P+        +   C + +PK RP  S ++  L
Sbjct: 235 ----------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 173 ERL 175
             L
Sbjct: 285 SEL 287

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y A
Sbjct: 123 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLA 178
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  +LF +
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFEL 221
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+  +  A +L    L  +PK R
Sbjct: 222 ILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 117 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 170
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 217
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 218 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 170 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 227
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 228 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 270
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 271 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 122 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 175
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 222
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 223 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 174
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 182
Query: 80  TT--KSDVYSFGVVLLELLSGRCAVDKTKV 107
               + DV+S GV+L  +L  R   D   +
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 187
Query: 80  TT--KSDVYSFGVVLLELLSGRCAVDKTKV 107
               + DV+S GV+L  +L  R   D   +
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y 
Sbjct: 120 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 175
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 218
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 219 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 129
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 130 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 115 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 168
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 215
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 216 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 22/152 (14%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y A
Sbjct: 118 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 173
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE +         D +  GVV+ E++ GR                    Y  D  +LF +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFEL 216
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +  +   ++P+  +  A +L    L  +PK R
Sbjct: 217 ILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 177 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV 234
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 235 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 277
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 278 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 18  ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           + ++++RD KA N+LLDA+ N K++DFG +     G +        G+  YAAPE     
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGK 185
Query: 78  RLTT-KSDVYSFGVVLLELLSGRCAVD 103
           +    + DV+S GV+L  L+SG    D
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 197
Query: 61  QVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 240
Query: 119 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 241 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 177 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 234
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 235 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 277
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 278 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTH 66
           +GL ++H A  QVI+RD K SN+L++     K+ DFG+A+   T    H    T+ + T 
Sbjct: 170 RGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 67  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            Y APE + +    T++ D++S G +  E+L+ R
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 172 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 229
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 230 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 272
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 273 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 190
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 135 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 187
Query: 61  QVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 230
Query: 119 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 231 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 190
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 190
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 154 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 254
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD  A+NIL+      K++DFGLA+     D  + + 
Sbjct: 117 VDMAAQIASGMAYVE--RMNYVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTAR 172
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 222
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 223 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 272
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 273 -----FTSTEPQYQPG 283

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 183
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 144 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLD 197
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 244
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 245 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+ +   K L  L +   ++I+RD K SNILLD   N KL DFG+  +G   D     T+
Sbjct: 129 KITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSI-AKTR 184
Query: 62  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGR 99
             G   Y APE +    +      +SDV+S G+ L EL +GR
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 17/166 (10%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            A+G+ FL  +  + I+RD  A NILL      K+ DFGLA+                  
Sbjct: 208 VARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +     +TKSDV+S+GV+L E+ S          G     V   + + S  R+
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFS--------LGGSPYPGVQMDEDFCSRLRE 317
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             R+       + P+ +      + L C + +PK RPR +E++  L
Sbjct: 318 GMRM-------RAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 18  ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           + ++++RD KA N+LLDA+ N K++DFG +     G +        G   YAAPE     
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGK 188
Query: 78  RLTT-KSDVYSFGVVLLELLSGRCAVD 103
           +    + DV+S GV+L  L+SG    D
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGT 65
           +GL +LH  ++  I+RD KA NILL  + + +++DFG++    TG    R  V    +GT
Sbjct: 132 EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 66  HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 98
             + APE +   R    K+D++SFG+  +EL +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT--GDRTHVSTQVMGTH 66
           +GL ++H A  QVI+RD K SN+L++     K+ DFG+A+   T   +  +  T+ + T 
Sbjct: 169 RGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 67  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            Y APE + +    T++ D++S G +  E+L+ R
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGT 65
           +GL +LH  ++  I+RD KA NILL  + + +++DFG++    TG    R  V    +GT
Sbjct: 127 EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 66  HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 98
             + APE +   R    K+D++SFG+  +EL +G
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLD + N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYD 191
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 31/194 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+    
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDXXK 207
Query: 63  MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T+G     + APE +     T +SDV+SFGV+L E+ +         +G         
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------G 250
Query: 118 KPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
            PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ 
Sbjct: 251 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310
Query: 177 A-PKNSAKLSQSEP 189
           A   N   L  S P
Sbjct: 311 ALTSNQEXLDLSMP 324

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++        G   YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYD 190
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGL +     D  + + 
Sbjct: 284 VDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLGRL--IEDNEYTAR 339
Query: 61  Q-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 118
           Q       + APE    GR T KSDV+SFG++L EL + GR             +V+  +
Sbjct: 340 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVN--R 389
Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L    + +R+         P +   +   L  QC   +P+ RP    + A LE     
Sbjct: 390 EVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY--- 439
Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 440 -----FTSTEPQXQPG 450

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLD 176
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 24/178 (13%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 131 LHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
             M    +  PE +   + TT+SDV+S GVVL E+ + G+                  +P
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------------QP 230
Query: 120 Y--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +  LS+   +  I   ++  Q P+        L L C   EP +R  +  +  +L+ L
Sbjct: 231 WYQLSNNEVIECITQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 120 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLD 173
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 220
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 221 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--G 67
           G+ +L   E   ++RD  A N+LL     AK+SDFGL+KA    D ++ + +  G     
Sbjct: 122 GMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLK 178
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +   + +++SDV+S+GV + E LS
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K+++FG +   P+  R    T + GT  
Sbjct: 120 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLD 173
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 220
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 221 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 74
           H    +V++RD K +N+ + A    KL D GL +   +  +T  +  ++GT  Y +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 208
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
                  KSD++S G +L E+ + +                   P+  DK  L+ +    
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCKKI 250
Query: 135 LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
               YP       +     L   C+N +P+ RP ++ V  + +R+ A
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 6   GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVM 63
           G A G+ +L  A+   ++R   A NIL+++    K+SDFGL++     T D T+  T  +
Sbjct: 117 GIAAGMKYL--ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSAL 172
Query: 64  GTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           G      + APE +   + T+ SDV+S+G+V+ E++S                    +PY
Sbjct: 173 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPY 215
Query: 121 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 179
                + +   ++       P         L L C   +   RP+  +++  L+++    
Sbjct: 216 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 275
Query: 180 NSAK 183
           NS K
Sbjct: 276 NSLK 279

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K+++FG +   P+  R    T + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLD 174
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 16  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 75
           D    V++RD K +N+ LD + N KL DFGLA+       T  +   +GT  Y +PE + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 76  TGRLTTKSDVYSFGVVLLELLSGRCAV 102
                 KSD++S G +L EL    CA+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL----CAL 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLD 174
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 175 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 232
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 233 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 277
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 278 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLD 174
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 124 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESP 180
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 218

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+  
Sbjct: 142 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 194
Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
               T+G     + APE +     T +SDV+SFGV+L E+ +         +G       
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG------- 238
Query: 116 WAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
              PY      +LF+++        P    +    +   C +  P  RP   +++  L+R
Sbjct: 239 -GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 297
Query: 175 LEA 177
           + A
Sbjct: 298 IVA 300

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 16  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 75
           D    V++RD K +N+ LD + N KL DFGLA+       T  +   +GT  Y +PE + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMN 189
Query: 76  TGRLTTKSDVYSFGVVLLELLSGRCAV 102
                 KSD++S G +L EL    CA+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL----CAL 212

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ ++       I+RD +A+N+L+      K++DFGLA+     + T           
Sbjct: 120 AEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 176
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +  G  T KSDV+SFG++L E+++
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+    
Sbjct: 140 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 192
Query: 63  MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T+G     + APE +     T +SDV+SFGV+L E+ +         +G         
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------G 235
Query: 118 KPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
            PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ 
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 177 A 177
           A
Sbjct: 296 A 296

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLD 172
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 219
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 220 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 118 ANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLD 171
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQDTYKRI 218
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+    
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 63  MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T+G     + APE +     T +SDV+SFGV+L E+ +         +G         
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------G 250
Query: 118 KPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
            PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ 
Sbjct: 251 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310
Query: 177 A 177
           A
Sbjct: 311 A 311

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+  
Sbjct: 145 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 197
Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
               T+G     + APE +     T +SDV+SFGV+L E+ +         +G       
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG------- 241
Query: 116 WAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
              PY      +LF+++        P    +    +   C +  P  RP   +++  L+R
Sbjct: 242 -GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 300
Query: 175 LEA 177
           + A
Sbjct: 301 IVA 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+    
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 63  MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T+G     + APE +     T +SDV+SFGV+L E+ +         +G         
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------G 250
Query: 118 KPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
            PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ 
Sbjct: 251 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310
Query: 177 A 177
           A
Sbjct: 311 A 311

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 31/194 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+    
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 63  MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T+G     + APE +     T +SDV+SFGV+L E+ +         +G         
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------G 250
Query: 118 KPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
            PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ 
Sbjct: 251 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310
Query: 177 A-PKNSAKLSQSEP 189
           A   N   L  S P
Sbjct: 311 ALTSNQEYLDLSMP 324

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 123 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 179
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 217

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/117 (38%), Positives = 64/117 (54%), Gaps = 25/117 (21%)
Query: 3   VAIGAAKGLTFLHD---------AESQVIYRDFKASNILLDAEFNAKLSDFGLA----KA 49
           VA   ++GL++LH+          +  + +RDFK+ N+LL ++  A L+DFGLA      
Sbjct: 117 VAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPG 176
Query: 50  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLT------TKSDVYSFGVVLLELLSGRC 100
            P GD TH   QV GT  Y APE V  G +        + D+Y+ G+VL EL+S RC
Sbjct: 177 KPPGD-TH--GQV-GTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVS-RC 227

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +++RD KA N+LLDA+ N K++DFG +     G++        G   YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYD 190
Query: 81  T-KSDVYSFGVVLLELLSGRCAVD 103
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLD 174
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 124 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 180
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 142 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 198
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 236

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 128 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 184
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 222

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 122 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 178
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V         
Sbjct: 168 AQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 225
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           + APE +     T +SDV+S+G++L E+ S         +G+         P +    K 
Sbjct: 226 WMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSKF 270
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 271 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 317

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+    
Sbjct: 148 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 200
Query: 63  MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T+G     + APE +     T +SDV+SFGV+L E+ +         +G         
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG--------G 243
Query: 118 KPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
            PY      +LF+++        P    +    +   C +  P  RP   +++  L+R+ 
Sbjct: 244 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303
Query: 177 A 177
           A
Sbjct: 304 A 304

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 79/183 (43%), Gaps = 28/183 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDR 55
           +++ +  A G+ ++ +    +++RD ++ NI L     +A   AK++DFG ++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS----- 179
Query: 56  THVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 113
            H  + ++G   + APE +       T K+D YSF ++L  +L+G    D+   G     
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----- 234
Query: 114 VDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
                     K K   ++ +  L    P+        +   C + +PK RP  S ++  L
Sbjct: 235 ----------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 173 ERL 175
             L
Sbjct: 285 SEL 287

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 127 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 183
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 221

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 124 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 180
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V         
Sbjct: 174 AQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           + APE +     T +SDV+S+G++L E+ S         +G+         P +    K 
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSKF 276
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 142 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 198
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 127 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 183
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  ++ Q I+R+  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 142 LHFAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK- 194
Query: 61  QVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 237
Query: 119 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 238 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 131 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 187
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + ++FLH   + +++RD K  NILLD     +LSDFG +     G++     ++ GT GY
Sbjct: 211 EAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGY 265
Query: 69  AAPEYVATGRLTT------KSDVYSFGVVLLELLSG 98
            APE +      T      + D+++ GV+L  LL+G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 127 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 183
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 221

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 275
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K A  T D   + 
Sbjct: 292 LKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            +      + APE +   + +TKSDV+SFG++L E+ S
Sbjct: 350 VK------WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 129 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 185
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 16  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 75
           D    V++RD K +N+ LD + N KL DFGLA+          + + +GT  Y +PE + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQMN 189
Query: 76  TGRLTTKSDVYSFGVVLLELLSGRCAV 102
                 KSD++S G +L EL    CA+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL----CAL 212

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 161 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 263
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 264 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   K L  LH   S VI+RD K SN+L++A    K+ DFG+  +G   D     T 
Sbjct: 157 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDSV-AKTI 212
Query: 62  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             G   Y APE +         + KSD++S G+ ++EL   R   D            W 
Sbjct: 213 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WG 261
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            P+    ++L ++++         K +        QCL    K RP   E++
Sbjct: 262 TPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 155 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 211
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 249

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P  D+     +  G   
Sbjct: 130 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESP 186
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 224

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 169 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 271
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 272 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 319

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L +A   VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 106 LGMCLDVCEGMAYLEEA--SVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 162
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K A  T D   + 
Sbjct: 105 LKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            +      + APE +   + +TKSDV+SFG++L E+ S
Sbjct: 163 VK------WTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H  E+++++RD K  N+L++     KL DFGLA+A      T  S  V  T  Y
Sbjct: 119 QGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWY 174
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            AP+ +   R  +T  D++S G +L E+++G+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 79/183 (43%), Gaps = 28/183 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDR 55
           +++ +  A G+ ++ +    +++RD ++ NI L     +A   AK++DF L++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS----- 179
Query: 56  THVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 113
            H  + ++G   + APE +       T K+D YSF ++L  +L+G    D+   G     
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----- 234
Query: 114 VDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
                     K K   ++ +  L    P+        +   C + +PK RP  S ++  L
Sbjct: 235 ----------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 173 ERL 175
             L
Sbjct: 285 SEL 287

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L++LH+    VI+RD K+ +ILL ++   KLSDFG            VS +V
Sbjct: 146 VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEV 195
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++     T+ D++S G++++E++ G
Sbjct: 196 PKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L +A   VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 107 LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 163
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH- 66
            KG+ +L     + I+R+    NIL++ E   K+ DFGL K  P  D+ +   +  G   
Sbjct: 125 CKGMEYL--GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESP 181
Query: 67  -GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
             + APE +   + +  SDV+SFGVVL EL +    ++K+K
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSK 219

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L +A   VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 109 LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 165
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 138 LAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K A  T D   + 
Sbjct: 120 LKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            +      + APE +   + +TKSDV+SFG++L E+ S
Sbjct: 178 VK------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+  
Sbjct: 194 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246
Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
               T+G     + APE +     T +SDV+SFGV+L E+ +         +G       
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG------- 290
Query: 116 WAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
              PY      +LF+++        P    +    +   C +  P  RP   +++  L+R
Sbjct: 291 -GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 175 LEA 177
           + A
Sbjct: 350 IVA 352

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 22/177 (12%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  +E + ++RD    N L+      K++DFGL++   + D      
Sbjct: 177 LCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  +  PE +   R TT+SDV+++GVVL E+ S          G++        PY
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGLQ--------PY 277
Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
             ++ +  ++ + D  +    P+        L   C +  P  RP    +  IL+R+
Sbjct: 278 YGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/80 (41%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 80
           +IYRD K  NILLD+  +  L+DFGL+K     D T  +    GT  Y AP+ V  G   
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 81  TKS--DVYSFGVVLLELLSG 98
                D +S GV++ ELL+G
Sbjct: 239 HDKAVDWWSLGVLMYELLTG 258

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 132 LAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L   E  +++R+  A N+LL +    +++DFG+A   P  D+  + +
Sbjct: 136 LNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 193
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           +      + A E +  G+ T +SDV+S+GV + EL++
Sbjct: 194 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L +LH     ++YRD K  NILLD++ +  L+DFGL K     + T  ++   GT  
Sbjct: 149 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L +A   VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 104 LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 160
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L +A   VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 106 LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 162
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL +LH  +  +++RD K +N+LLD     KL+DFGLAK+  + +R +    V  T  Y
Sbjct: 123 QGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWY 178
Query: 69  AAPEYVATGRLT-TKSDVYSFGVVLLELL 96
            APE +   R+     D+++ G +L ELL
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L +A   VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 126 LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 182
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 183 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL+F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLSFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 161 LAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 74/174 (42%), Gaps = 27/174 (15%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVM 63
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+     P   R   +   +
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 123
               + APE +     T +SDV+SFGV+L E+ S         +G        A PY   
Sbjct: 215 ---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGV 254
Query: 124 K--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           K   +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L   E  +++R+  A N+LL +    +++DFG+A   P  D+  + +
Sbjct: 118 LNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           +      + A E +  G+ T +SDV+S+GV + EL++
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K A  T D   + 
Sbjct: 111 LKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 168
Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
            +      + APE +     +TKSDV+SFG++L E+ S
Sbjct: 169 VK------WTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM---TGYVATRWY 195
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 242
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 243 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 275

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM---TGYVATRWY 195
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 19  SQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYA 69
           S VI+RD K SN+L+++  + K+ DFGLA+         + PTG ++ + T+ + T  Y 
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TEYVATRWYR 189
Query: 70  APEYVAT-GRLTTKSDVYSFGVVLLELLSGR 99
           APE + T  + +   DV+S G +L EL   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 19  SQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYA 69
           S VI+RD K SN+L+++  + K+ DFGLA+         + PTG ++ + T+ + T  Y 
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TEXVATRWYR 189
Query: 70  APEYVAT-GRLTTKSDVYSFGVVLLELLSGR 99
           APE + T  + +   DV+S G +L EL   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 209 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 309
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 207 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 307
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 159 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 259
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 260 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM---TGYVATRWY 195
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 118 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 173
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 211
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 258
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 259 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 291

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 170
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 194 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 294
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 208
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 255
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 256 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 288

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRC 100
            APE +   +  +T  D++S G +  E+++ R 
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 240
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 241 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 273

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 121 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRC 100
            APE +   +  +T  D++S G +  E+++ R 
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 199
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 246
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 247 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 279

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 240
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 241 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 273

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 200
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 247
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 248 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 280

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 200
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 247
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 248 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 280

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 302
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 121 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 207
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 254
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 255 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 287

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 165 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 217
Query: 69  AAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 99
            APE +          D++S G ++ ELL+GR
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 200
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 247
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 248 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 280

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 198
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 241
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 242 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 274

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 208
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 64
           +  L +LH  E+++I+RD K  NI+L         K+ D G AK    G+   + T+ +G
Sbjct: 132 SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 186
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T  Y APE +   + T   D +SFG +  E ++G
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--G 67
           G+ +L   E   ++R+  A N+LL     AK+SDFGL+KA    D ++ + +  G     
Sbjct: 448 GMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLK 504
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +   + +++SDV+S+GV + E LS
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 300
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE +     T +SDV+SFGV++ E+ +         +G          PY      +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LG--------GSPYPGIPVEE 267
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLS 185
           LF+++        P    +    +   C +  P  RP   +++  L+R L    N   L 
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 186 QSEPHRQ 192
            S+P  Q
Sbjct: 328 LSQPLEQ 334

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 199
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 246
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 247 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 279

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 207
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 64
           +  L +LH  E+++I+RD K  NI+L         K+ D G AK    G+   + T+ +G
Sbjct: 131 SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T  Y APE +   + T   D +SFG +  E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 119 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 62  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+++L D   ++++RD  A N+L+ +  + K++DFGLA+     +  + +        
Sbjct: 129 AKGMSYLEDV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 186
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + A E +   R T +SDV+S+GV + EL++                   AKPY     R+
Sbjct: 187 WMALESILRRRFTHQSDVWSYGVTVWELMTFG-----------------AKPYDGIPARE 229
Query: 127 LFRIMDTKLGGQYPQKAAHT--AATLALQCLNNEPKLRPRMSEVLAILERL 175
           +  +++   G + PQ    T     + ++C   + + RPR  E+++   R+
Sbjct: 230 IPDLLEK--GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 135 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 187
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 126
           + APE +     T +SDV+SFGV++ E+ +         +G          PY      +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LG--------GSPYPGIPVEE 267
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLS 185
           LF+++        P    +    +   C +  P  RP   +++  L+R L    N   L 
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 186 QSEPHRQ 192
            S+P  Q
Sbjct: 328 LSQPLEQ 334

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ ++       I+RD +A+N+L+      K++DFGLA+     + T           
Sbjct: 119 AEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 175
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +  G  T KS+V+SFG++L E+++
Sbjct: 176 WTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 195
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 29/166 (17%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTH 66
            KG+ ++H    ++I+RD K SNI L      K+ DFGL  +    G RT    +  GT 
Sbjct: 146 TKGVDYIH--SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT----RSKGTL 199
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            Y +PE +++     + D+Y+ G++L ELL     V  T     +   D     +SD   
Sbjct: 200 RYMSPEQISSQDYGKEVDLYALGLILAELLH----VCDTAFETSKFFTDLRDGIISD--- 252
Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
              I D K              TL  + L+ +P+ RP  SE+L  L
Sbjct: 253 ---IFDKK------------EKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 240
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 241 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 273

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGXVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 134 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 186
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 233
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 234 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 266

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 184
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 37/189 (19%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + I  A+ + FLH     +++RD K SNI    +   K+ DFGL  A    +      
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 61  QVM----------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGI 109
             M          GT  Y +PE +     + K D++S G++L ELL S    +++ ++  
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-- 282
Query: 110 EQSLVDWAKPYLSDKRKL-FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                      ++D R L F ++ T+   +YPQ+       +    L+  P  RP  +++
Sbjct: 283 -----------ITDVRNLKFPLLFTQ---KYPQEHM-----MVQDMLSPSPTERPEATDI 323
Query: 169 L--AILERL 175
           +  AI E L
Sbjct: 324 IENAIFENL 332

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 184
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 231
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 232 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 264

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 168
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 168
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 115 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 62  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 119 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 62  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 184
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 185
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 115 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 62  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 185
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 118 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 173
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 69  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 99
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   K L  LH   S VI+RD K SN+L++A    K+ DFG+  +G   D       
Sbjct: 113 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDID 169
Query: 62  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             G   Y APE +         + KSD++S G+ ++EL   R   D            W 
Sbjct: 170 A-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WG 217
Query: 118 KPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            P+    ++L ++++     Q P  K +        QCL    K RP   E++
Sbjct: 218 TPF----QQLKQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 153 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 253
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 125 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 62  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 241
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 242 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 274

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 7   AAKGLTFLHDAESQV-IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           AA G+ +L   ES+  I+RD  A N L+  +   K+SDFG+++    G            
Sbjct: 222 AAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVP 278
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
             + APE +  GR +++SDV+SFG++L E  S         +G        A PY +   
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFS---------LG--------ASPYPNLSN 321
Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 175
           +  R    K GG+ P       A   L  QC   EP  RP  S +   L+ +
Sbjct: 322 QQTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D       
Sbjct: 115 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHX 168
Query: 62  VMGTH-----GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           VM  H      + APE + T   +  SD + FGV L E+ +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 17/109 (15%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA------KAGPTG-------D 54
           A G+ +LH     +I+RD  + N L+    N  ++DFGLA      K  P G       D
Sbjct: 118 ASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 55  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           R    T V+G   + APE +       K DV+SFG+VL E++ GR   D
Sbjct: 176 RKKRYT-VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 153 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 124
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY   K  
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 253
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 254 EEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D       
Sbjct: 125 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHX 178
Query: 62  VMGTH-----GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           VM  H      + APE + T   +  SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVAT 205
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 28/172 (16%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L   H  + ++++RD K+ NI L  +   +L DFG+A+         ++   +GT  Y +
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLS 193
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           PE         KSD+++ G VL EL + + A +                  S K  + +I
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----------------SMKNLVLKI 237
Query: 131 MDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLA---ILERLE 176
               + G +P  + H +    +L  Q     P+ RP ++ +L    I +R+E
Sbjct: 238 ----ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 7   AAKGLTFLHDAESQV-IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           AA G+ +L   ES+  I+RD  A N L+  +   K+SDFG+++    G            
Sbjct: 222 AAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
             + APE +  GR +++SDV+SFG++L E  S         +G        A PY +   
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFS---------LG--------ASPYPNLSN 321
Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 175
           +  R    K GG+ P       A   L  QC   EP  RP  S +   L+ +
Sbjct: 322 QQTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAK--AGPTGDRTHVSTQVMGT 65
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG +K  AG        +    GT
Sbjct: 133 EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI----NPCTETFTGT 186
Query: 66  HGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 123
             Y APE +  G       +D++S G  ++E+ +G+               +  +P    
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK-----------PPFYELGEP---- 231
Query: 124 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 183
           +  +F++   K+  + P+  +  A    L+C   +P  R   +++L      E  K S+K
Sbjct: 232 QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD----EFLKVSSK 287
Query: 184 LSQSEP 189
             +++P
Sbjct: 288 KKKTQP 293

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     +++RD   SN+LL    N K++DFGLA         H +  + GT  Y 
Sbjct: 124 GMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 107
           +PE         +SDV+S G +   LL GR   D   V
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 11/91 (12%)
Query: 19  SQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYA 69
           S VI+RD K SN+L+++  + K+ DFGLA+         + PTG ++ +  + + T  Y 
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-VEFVATRWYR 189
Query: 70  APEYVAT-GRLTTKSDVYSFGVVLLELLSGR 99
           APE + T  + +   DV+S G +L EL   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 28/157 (17%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
             Y APE +       ++ D++S G ++ ELL+GR     T              ++   
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQL 232
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
           + + R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 233 KLILRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGYVAT 208
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 122 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 121 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +     +  SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T++H  +  +++RD K  NILL++   + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTA 187
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D+GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T     + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ EL+ G C + +    I+Q
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG-CVIFQGTDHIDQ 233

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T++H  +  +++RD K  NILL++   + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTA 187
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 181
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 34/177 (19%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           KGL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 155 KGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 204
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
             Y APE + +     ++ D++S G ++ E+L+G+                  K YL   
Sbjct: 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK-------------GKDYLDQL 251
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK-----LRPRMS-EVLAILERL 175
            ++ ++     G ++ QK    AA   +Q L   P+     L PR S +   +LE++
Sbjct: 252 TQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 307

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L   E ++++RD  A N+L+ +  + K++DFGLA+     ++ + + 
Sbjct: 143 LNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +   + T +SDV+S+GV + EL++
Sbjct: 201 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 122 ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLD 175
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y  PE +       K D++S GV+  E L G
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGL +   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 146 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 30/169 (17%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFG----LAKAGPTGDRTHVSTQVM 63
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG    LA   P       +    
Sbjct: 119 EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC------TETFT 170
Query: 64  GTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 121
           GT  Y APE +  G       +D++S G  ++E+ +G+               +  +P  
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK-----------PPFYELGEP-- 217
Query: 122 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
             +  +F++   K+  + P+  +  A    L+C   +P  R   +++L 
Sbjct: 218 --QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 264

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L   E ++++RD  A N+L+ +  + K++DFGLA+     ++ + + 
Sbjct: 120 LNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +   + T +SDV+S+GV + EL++
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 150 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 146 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR- 78
            +++RD K  NILLD + N KL+DFG +     G++     +V GT  Y APE +     
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMN 187
Query: 79  -----LTTKSDVYSFGVVLLELLSG 98
                   + D++S GV++  LL+G
Sbjct: 188 DNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 144 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 198
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 199 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 53/86 (61%), Gaps = 3/86 (3%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 74
           H  + ++++RD K  N+L++++   KL+DFGLA+A     R++  T  + T  Y AP+ +
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVL 191
Query: 75  -ATGRLTTKSDVYSFGVVLLELLSGR 99
             + + +T  D++S G +  E+++G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR- 78
            +++RD K  NILLD + N KL+DFG +     G++     +V GT  Y APE +     
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMN 200
Query: 79  -----LTTKSDVYSFGVVLLELLSG 98
                   + D++S GV++  LL+G
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 137 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 191
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T++H  +  +++RD K  NILL++   + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 139 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 193
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 34/177 (19%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 65
           KGL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 137 KGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 186
Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
             Y APE + +     ++ D++S G ++ E+L+G+                  K YL   
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK-------------GKDYLDQL 233
Query: 125 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK-----LRPRMS-EVLAILERL 175
            ++ ++     G ++ QK    AA   +Q L   P+     L PR S +   +LE++
Sbjct: 234 TQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 139 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 193
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 53/86 (61%), Gaps = 3/86 (3%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 74
           H  + ++++RD K  N+L++++   KL+DFGLA+A     R++  T  + T  Y AP+ +
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVL 191
Query: 75  -ATGRLTTKSDVYSFGVVLLELLSGR 99
             + + +T  D++S G +  E+++G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 132 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 186
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 148 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 132 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 186
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V     + L +LH     VI+RD K+ +ILL  +   KLSDFG   A  + D       +
Sbjct: 146 VCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPK-RKXL 201
Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +GT  + APE ++     T+ D++S G++++E++ G
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +        SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 138 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 192
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +PE +        SD+++ G ++ +L++G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 176 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 230
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 213 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 270
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 2/84 (2%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 74
           H  +  +IYRD K  NI+L+ + + KL+DFGL K     D T V+    GT  Y APE +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHXFCGTIEYMAPEIL 193
Query: 75  ATGRLTTKSDVYSFGVVLLELLSG 98
                    D +S G ++ ++L+G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 176 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 230
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGY 68
            L +LHD  +++I+RD KA NIL   + + KL+DFG+ AK   T  R       +GT  +
Sbjct: 147 ALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYW 201
Query: 69  AAPEYVATGR-----LTTKSDVYSFGVVLLEL 95
            APE V            K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 21  VIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           +++RD K  N+L    D E    +SDFGL+K    GD   V +   GT GY APE +A  
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEVLAQK 197
Query: 78  RLTTKSDVYSFGVVLLELLSG 98
             +   D +S GV+   LL G
Sbjct: 198 PYSKAVDCWSIGVIAYILLCG 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 19/97 (19%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVST-----Q 61
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+        TH         
Sbjct: 161 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKD 210
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 211 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKF 194
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 195 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 237
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEY 73
           H  +  +IYRD K  NI+L+ + + KL+DFGL K     G  TH      GT  Y APE 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGTIEYMAPEI 192
Query: 74  VATGRLTTKSDVYSFGVVLLELLSG 98
           +         D +S G ++ ++L+G
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 154 ARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 211
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 212 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 19/97 (19%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVST-----Q 61
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+        TH         
Sbjct: 162 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKD 211
Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 212 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 188 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDPSQVYELLEKDYRME 230
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 252 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 301
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 302 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 60/115 (52%), Gaps = 22/115 (19%)
Query: 3   VAIGAAKGLTFLHD--------AESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGP 51
           +A   A+GL +LH+         +  + +RD K+ N+LL     A ++DFGLA   +AG 
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 52  TGDRTHVSTQVMGTHGYAAPEYVATGRLT------TKSDVYSFGVVLLELLSGRC 100
           +   TH   QV GT  Y APE V  G +        + D+Y+ G+VL EL S RC
Sbjct: 186 SAGDTH--GQV-GTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS-RC 235

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y 
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR 167
Query: 70  APEYV-ATGRLTTKSDVYSFGVVLLELLSG 98
           AP+ +  + + +T  D++S G +  E+++G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKF 190
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 191 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 233
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 234 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 9   KGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ----- 61
           + L+++H   SQ +I+RD K  NI +D   N K+ DFGLAK    + D   + +Q     
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 62  ------VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 96
                  +GT  Y A E +  TG    K D+YS G++  E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 81
           I+RD  A N L+      K++DFGL++   TGD             + APE +A  + + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 82  KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYP 140
           KSDV++FGV+L E+ +          G+         PY   D  +++ +++     + P
Sbjct: 190 KSDVWAFGVLLWEIAT---------YGM--------SPYPGIDPSQVYELLEKDYRMERP 232
Query: 141 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +        L   C    P  RP  +E+    E +
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 23  YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 82
           +RD K  NIL+ A+  A L DFG+A A      T +   V GT  Y APE  +    T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 83  SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           +D+Y+   VL E L+G       ++ +  + ++ A P
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIP 252

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 159 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 216
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ------ 61
           + L+++H     +I+RD K  NI +D   N K+ DFGLAK    + D   + +Q      
Sbjct: 127 EALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 62  -----VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 96
                 +GT  Y A E +  TG    K D+YS G++  E++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 156 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 213
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 214 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 195 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 237
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 143 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 197
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 194 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 236
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y 
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYR 167
Query: 70  APEYV-ATGRLTTKSDVYSFGVVLLELLSG 98
           AP+ +  + + +T  D++S G +  E+++G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 195 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 237
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y 
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYR 167
Query: 70  APEYV-ATGRLTTKSDVYSFGVVLLELLSG 98
           AP+ +  + + +T  D++S G +  E+++G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 195 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 237
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 9/85 (10%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR- 78
            +++RD K  NILLD + N KL+DFG +     G++      V GT  Y APE +     
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAPEIIECSMN 200
Query: 79  -----LTTKSDVYSFGVVLLELLSG 98
                   + D++S GV++  LL+G
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 188 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDPSQVYELLEKDYRME 230
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 192 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 234
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 235 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 195 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 237
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T     + T  + T  Y 
Sbjct: 136 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN---FMMTPYVVTRYYR 190
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCA------VDKTKVGIEQ 111
           APE +         D++S G ++ EL+ G         +D+    IEQ
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 139 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 193
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 190 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 232
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 190 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 232
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 190 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 232
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 132 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 186
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 81
           I+RD  A N L+      K++DFGL++   TGD             + APE +A  + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 82  KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYP 140
           KSDV++FGV+L E+ +          G+         PY   D  +++ +++     + P
Sbjct: 192 KSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRMERP 234
Query: 141 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +        L   C    P  RP  +E+    E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
            KG+ ++H    ++I RD K SNI L      K+ DFGL  +     +   S    GT  
Sbjct: 132 TKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK---GTLR 186
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y +PE +++     + D+Y+ G++L ELL     V  T     +   D     +SD    
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLH----VCDTAFETSKFFTDLRDGIISD---- 238
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             I D K              TL  + L+ +P+ RP  SE+L  L
Sbjct: 239 --IFDKK------------EKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+  FGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 22  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 81
           I+RD  A N L+      K++DFGL++   TGD             + APE +A  + + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 82  KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYP 140
           KSDV++FGV+L E+ +          G+         PY   D  +++ +++     + P
Sbjct: 193 KSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRMERP 235
Query: 141 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +        L   C    P  RP  +E+    E +
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 190 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 232
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 192 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 234
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 235 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DF LA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 190 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 232
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAPAGAKFPIKWTAPESLAYNKF 191
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 192 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 234
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 235 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 202
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 203 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 245
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 246 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V  GA +GL +LH     +I+RD KA NILL      KL DFG A      +        
Sbjct: 159 VTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XF 210
Query: 63  MGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 95
           +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 2/95 (2%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
            A   AKG+ FL       ++RD  A N+L+      K+ DFGLA+   +     V    
Sbjct: 177 FAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234
Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                + APE +  G  T KSDV+S+G++L E+ S
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 11  LTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT G
Sbjct: 129 VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE +A    +   D +S GV+   LL G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 243
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 244 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 299
Query: 176 E 176
           E
Sbjct: 300 E 300

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT 
Sbjct: 128 AVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           GY APE +A    +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 243
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 244 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 299
Query: 176 E 176
           E
Sbjct: 300 E 300

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V  GA +GL +LH     +I+RD KA NILL      KL DFG A      +        
Sbjct: 120 VTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XF 171
Query: 63  MGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 95
           +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 170 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 270
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 271 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 326
Query: 176 E 176
           E
Sbjct: 327 E 327

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 160 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 260
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 261 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 316
Query: 176 E 176
           E
Sbjct: 317 E 317

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT 
Sbjct: 128 AVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           GY APE +A    +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 175 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 224
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 225 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 135 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 235
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 236 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 291
Query: 176 E 176
           E
Sbjct: 292 E 292

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 144 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 244
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 245 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 300
Query: 176 E 176
           E
Sbjct: 301 E 301

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 144 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 244
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 245 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 300
Query: 176 E 176
           E
Sbjct: 301 E 301

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 150 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 250
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 251 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 306
Query: 176 E 176
           E
Sbjct: 307 E 307

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 11  LTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT G
Sbjct: 129 VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPG 183
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y APE +A    +   D +S GV+   LL G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 158 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 258
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 259 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 314
Query: 176 E 176
           E
Sbjct: 315 E 315

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 9/114 (7%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+ +   K L +L +    VI+RD K SNILLD     KL DFG+  +G   D      +
Sbjct: 128 KMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGI--SGRLVD-DKAKDR 183
Query: 62  VMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 110
             G   Y APE +            ++DV+S G+ L+EL +G+      K   E
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 9/91 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LHD  +++I+RD KA NIL   + + KL+DFG++       +   S   +GT  + 
Sbjct: 147 ALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWM 202
Query: 70  APEYVATGR-----LTTKSDVYSFGVVLLEL 95
           APE V            K+DV+S G+ L+E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPEVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 161 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 218
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 219 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 261
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 262 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 317
Query: 176 E 176
           E
Sbjct: 318 E 318

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 158 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 258
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 259 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 314
Query: 176 E 176
           E
Sbjct: 315 E 315

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 130 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 179
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 180 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 12/106 (11%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-- 58
           + + +  A+ + FLH     +++RD K SNI    +   K+ DFGL  A    +      
Sbjct: 121 LHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 59  --------STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 96
                    T  +GT  Y +PE +     + K D++S G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALTPVVVTLWY 185
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 158 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 258
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 259 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 314
Query: 176 E 176
           E
Sbjct: 315 E 315

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+R+  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 435
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 436 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 478
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 479 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+      +++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 154 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 211
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 212 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 144 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 244
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 245 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 300
Query: 176 E 176
           E
Sbjct: 301 E 301

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 184 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                M    +  PE    G  T+K+D +SFGV+L E+ S         +G         
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGY-------- 284
Query: 118 KPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            PY S   +      T  GG+   P+        +  QC  ++P+ RP  +    ILER+
Sbjct: 285 MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA---IILERI 340
Query: 176 E 176
           E
Sbjct: 341 E 341

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 132 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 181
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 182 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 122 ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLD 175
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y  PE +       K D++S GV+  E L G
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T+ H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 138 GITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX---KDKIGTA 192
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDA-EFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T+LH  +  +++RD K  N+LL++ E +A  K+ DFGL+       +     + +GT 
Sbjct: 148 GVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTA 202
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V   +   K DV+S GV+L  LL+G
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNIL-LDAEFNAKL--SDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +++RD K  N+L L  E N+K+  +DFGL+K    G    + +   GT 
Sbjct: 118 AVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           GY APE +A    +   D +S GV+   LL G
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 26/179 (14%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++  +  A G+ +L  +    I+RD  A N +L  +    ++DFGL++   +GD      
Sbjct: 140 VRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
                  + A E +A    T  SDV++FGV + E+++ G+        GIE +       
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ----TPYAGIENA------- 246
Query: 120 YLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                     I +  +GG   + P +       L  QC + +PK RP  + +   LE +
Sbjct: 247 ---------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+R+  A N L+      K++DFGL++   TGD             + APE +A  + 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQ 138
           + KSDV++FGV+L E+ +          G+         PY   D  +++ +++     +
Sbjct: 397 SIKSDVWAFGVLLWEIAT---------YGM--------SPYPGIDLSQVYELLEKDYRME 439
Query: 139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+        L   C    P  RP  +E+    E +
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 7/95 (7%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KG+ +LH    ++I+RD K SN+L+  + + K++DFG++      D    +T  +GT  +
Sbjct: 148 KGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--VGTPAF 203
Query: 69  AAPEYVATGR--LTTKS-DVYSFGVVLLELLSGRC 100
            APE ++  R   + K+ DV++ GV L   + G+C
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 23/171 (13%)
Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   K L  LH   S VI+RD K SN+L++A    K  DFG+  +G   D       
Sbjct: 140 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGI--SGYLVDDVAKDID 196
Query: 62  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             G   Y APE +         + KSD++S G+  +EL   R   D            W 
Sbjct: 197 A-GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS-----------WG 244
Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
            P+    ++L ++++         K +        QCL    K RP   E+
Sbjct: 245 TPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 130 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 22/117 (18%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT---------- 52
           V     K + +LH     +++RD K SNILL+AE + K++DFGL+++             
Sbjct: 114 VVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 53  ---------GDRTHVSTQVMGTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 99
                     D   + T  + T  Y APE  + + + T   D++S G +L E+L G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + +    + T  Y 
Sbjct: 140 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMVPFVVTRYYR 194
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE +         D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARH--TDDEM---TGYVATRWY 188
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 161
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+   +     V T+      Y
Sbjct: 139 KGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WY 191
Query: 69  AAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 99
            APE +    R T   D++S G ++ E+++G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 121 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 170
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 171 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 120 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 9/91 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LHD  +++I+RD KA NIL   + + KL+DFG++               +GT  + 
Sbjct: 147 ALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--XIQRRDXFIGTPYWM 202
Query: 70  APEYVATGR-----LTTKSDVYSFGVVLLEL 95
           APE V            K+DV+S G+ L+E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+        +V+T+      Y
Sbjct: 134 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WY 186
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 11/93 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L FLH    ++I+RD KA N+L+  E + +L+DFG+ AK   T  +       +GT  
Sbjct: 128 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPY 182
Query: 68  YAAPEYVATGRLTT-----KSDVYSFGVVLLEL 95
           + APE V    +       K+D++S G+ L+E+
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 120 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 125 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 174
Query: 63  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 175 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 120 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 124 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 121 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 123 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+    G    +  +V+ T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-TRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 120 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 121 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 120 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 127 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 127 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 122 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 11/93 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 67
           + L FLH    ++I+RD KA N+L+  E + +L+DFG+ AK   T  +       +GT  
Sbjct: 120 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPY 174
Query: 68  YAAPEYVATGRLTT-----KSDVYSFGVVLLEL 95
           + APE V    +       K+D++S G+ L+E+
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 122 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 11/96 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHG 67
           +GL+ LH  + +VI+RD K  N+LL      KL DFG++      DRT       +GT  
Sbjct: 140 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPY 194
Query: 68  YAAPEYVATGR-----LTTKSDVYSFGVVLLELLSG 98
           + APE +A           KSD++S G+  +E+  G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 126 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 184 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 123 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 123 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G T+LH  +  +++RD K  N+LL+++      K+ DFGL+     G +     + +GT 
Sbjct: 133 GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTA 187
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V   +   K DV+S GV+L  LL G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 123 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 127 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 114 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 67/127 (52%), Gaps = 13/127 (10%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           +G+ +LH  ++ +++ D K  NILL + +   + K+ DFG+++    G    +  ++MGT
Sbjct: 142 EGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGT 196
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 120
             Y APE +    +TT +D+++ G++   LL+           +T + I Q  VD+++  
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 121 LSDKRKL 127
            S   +L
Sbjct: 257 FSSVSQL 263

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 145 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFGLAK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+        +V+T+      Y
Sbjct: 142 RGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 100
            APE +       ++ D++S G ++ ELL G+ 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+        +V+T+      Y
Sbjct: 142 RGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 100
            APE +       ++ D++S G ++ ELL G+ 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           ++   K + +L       ++RD    NIL+ +    KL DFGL++     D    S   +
Sbjct: 131 SLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS 122
               + +PE +   R TT SDV+ F V + E+LS G+                  +P+  
Sbjct: 189 PIK-WMSPESINFRRFTTASDVWMFAVCMWEILSFGK------------------QPFFW 229
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
            + + +  +++       P        TL  +C + +P  RPR +E++  L
Sbjct: 230 LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 17/96 (17%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGL----AKAGPTGDRTHVSTQV 62
           G+ +LH  +  +++RD K  NILL+ +    N K+ DFGL    +K     DR       
Sbjct: 158 GICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR------- 208
Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +GT  Y APE V   +   K DV+S GV++  LL G
Sbjct: 209 LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   K++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR- 78
           ++I+RD K  NILLD   +  ++DF +A   P    T ++T + GT  Y APE  ++ + 
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPYMAPEMFSSRKG 191
Query: 79  --LTTKSDVYSFGVVLLELLSGR 99
              +   D +S GV   ELL GR
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           ++   K + +L       ++RD    NIL+ +    KL DFGL++     D    S   +
Sbjct: 115 SLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS 122
               + +PE +   R TT SDV+ F V + E+LS G+                  +P+  
Sbjct: 173 PIK-WMSPESINFRRFTTASDVWMFAVCMWEILSFGK------------------QPFFW 213
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
            + + +  +++       P        TL  +C + +P  RPR +E++  L
Sbjct: 214 LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+    G    +  +V+ T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-TRYYR 192
Query: 70  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 111
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 169 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 223
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 281
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 282 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 331
Query: 185 SQSE 188
           +  E
Sbjct: 332 TPLE 335

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   K++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   K++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   K++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 221
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 279
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 329
Query: 185 SQSE 188
           +  E
Sbjct: 330 TPLE 333

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G T+LH  +  +++RD K  N+LL+++      K+ DFGL+     G +     + +GT 
Sbjct: 116 GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTA 170
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V   +   K DV+S GV+L  LL G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           ++   K + +L       ++RD    NIL+ +    KL DFGL++     D    S   +
Sbjct: 119 SLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS 122
               + +PE +   R TT SDV+ F V + E+LS G+                  +P+  
Sbjct: 177 PIK-WMSPESINFRRFTTASDVWMFAVCMWEILSFGK------------------QPFFW 217
Query: 123 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
            + + +  +++       P        TL  +C + +P  RPR +E++  L
Sbjct: 218 LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 221
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 279
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 329
Query: 185 SQSE 188
           +  E
Sbjct: 330 TPLE 333

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 171 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 225
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 283
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 284 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 333
Query: 185 SQSE 188
           +  E
Sbjct: 334 TPLE 337

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 212 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 266
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 324
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 325 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 374
Query: 185 SQSE 188
           +  E
Sbjct: 375 TPLE 378

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            ++ +HD    V++RD K  N+L   E      K+ DFG A+  P  D   + T     H
Sbjct: 118 AVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLH 174
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            YAAPE +         D++S GV+L  +LSG+
Sbjct: 175 -YAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 146 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 200
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 258
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 259 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 308
Query: 185 SQSE 188
           +  E
Sbjct: 309 TPLE 312

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 161 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 215
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 273
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 274 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 323
Query: 185 SQSE 188
           +  E
Sbjct: 324 TPLE 327

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 152 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 206
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 264
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 265 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 314
Query: 185 SQSE 188
           +  E
Sbjct: 315 TPLE 318

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + L + HD  + +I+RD K  N+LL ++ N+   KL DFG+A     G+   V+   +GT
Sbjct: 141 EALRYCHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGT 196
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V         DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 138 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 192
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 250
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 251 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 300
Query: 185 SQSE 188
           +  E
Sbjct: 301 TPLE 304

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 145 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 199
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 257
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 307
Query: 185 SQSE 188
           +  E
Sbjct: 308 TPLE 311

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 141 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 195
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 253
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 254 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 303
Query: 185 SQSE 188
           +  E
Sbjct: 304 TPLE 307

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 137 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 191
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 249
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 250 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 299
Query: 185 SQSE 188
           +  E
Sbjct: 300 TPLE 303

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYA 69
           LTF +     +IYRD K  N+L+D +   +++DFG AK      R   +T  + GT  Y 
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGATWTLCGTPEYL 226
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE + +       D ++ GV++ E+ +G
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+             V+ T  Y
Sbjct: 123 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALAPVVVTLWY 177
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 145 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 199
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 257
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 307
Query: 185 SQSE 188
           +  E
Sbjct: 308 TPLE 311

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 134 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 188
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 246
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 247 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 296
Query: 185 SQSE 188
           +  E
Sbjct: 297 TPLE 300

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 23/109 (21%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------- 62
           G  F+H  ES +I+RD K +N LL+ + + K+ DFGLA+   +   T++   +       
Sbjct: 141 GENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 63  -------------MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 97
                        + T  Y APE +      TKS D++S G +  ELL+
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ A    KL DFGL++          ST    + G     + APE +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 184
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 225
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 16/110 (14%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG- 53
           +++A+ AA GL  LH        +  + +RDFK+ N+L+ +     ++D GLA     G 
Sbjct: 108 LRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGS 167
Query: 54  DRTHVSTQ-VMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLEL 95
           D   +     +GT  Y APE V   ++ T        +D+++FG+VL E+
Sbjct: 168 DYLDIGNNPRVGTKRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+             V+ T  Y
Sbjct: 123 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALDPVVVTLWY 177
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   K++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ A    KL DFGL++          ST    + G     + APE +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 564
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 565 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 605
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  A+G+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 117 LNWCVQIAEGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   +++DFGLAK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 15/101 (14%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ------ 61
           + L+++H     +I+R+ K  NI +D   N K+ DFGLAK    + D   + +Q      
Sbjct: 127 EALSYIH--SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 62  -----VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 96
                 +GT  Y A E +  TG    K D YS G++  E +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           KGL FLH     +I+RD K  NI +     + K+ D GLA    T  R   +  V+GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPE 195
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLE 94
           + APE     +     DVY+FG   LE
Sbjct: 196 FXAPEXYEE-KYDESVDVYAFGXCXLE 221

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 23/156 (14%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           + ++RD  A N+L+ +    KL DFGL++          S   +    + APE +   R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESINFRRF 189
Query: 80  TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ- 138
           T+ SDV+ FGV + E+                 L+   KP+   K     ++     G+ 
Sbjct: 190 TSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRIENGER 230
Query: 139 --YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
              P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M +AI +   L ++H        RD K  NIL+D   + +L+DFG +      D T  S+
Sbjct: 184 MVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSS 234
Query: 61  QVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGR 99
             +GT  Y +PE +       GR   + D +S GV + E+L G 
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 187
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 188 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 228
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 229 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 269

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+             V+ T  Y
Sbjct: 123 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALFPVVVTLWY 177
Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELL 96
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/83 (39%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT--- 76
           +I+RD K  N+LLD   + KL+DFG   K   TG   H  T V GT  Y +PE + +   
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVHCDTAV-GTPDYISPEVLKSQGG 252
Query: 77  -GRLTTKSDVYSFGVVLLELLSG 98
            G    + D +S GV L E+L G
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 10  GLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            L + H     V+++D K  NIL  D   ++  K+ DFGLA+   + +    ST   GT 
Sbjct: 136 ALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190
Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKR 125
            Y APE V    +T K D++S GVV+  LL+G      T +   Q    + +P Y  + R
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249
Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            L            PQ     A  L  Q L  +P+ RP  ++VL
Sbjct: 250 PL-----------TPQ-----AVDLLKQMLTKDPERRPSAAQVL 277

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L + H  E +VI+RD K  N+L+  +   K++DFG +   P+  R      + GT  
Sbjct: 124 ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLD 177
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           Y  PE +       K D++  GV+  E L G    D
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 227
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 186
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 187 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 227
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 228 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 268

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 212
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 213 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 253
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 254 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 294

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L + H  E +VI+RD K  N+L+  +   K++DFG +   P+  R      + GT  
Sbjct: 125 ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLD 178
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 103
           Y  PE +       K D++  GV+  E L G    D
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 189
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 190 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 230
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYA 69
           LTF +     +IYRD K  N+L+D +   +++DFG AK      R    T  + GT  Y 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYL 206
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE + +       D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
             I+RD  A N L+      K++DFGL++   TGD             + APE +A    
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 80  TTKSDVYSFGVVLLEL 95
           + KSDV++FGV+L E+
Sbjct: 209 SIKSDVWAFGVLLWEI 224

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+       +PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 127 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             R M+       +PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 185 SQSE 188
           +  E
Sbjct: 296 TPLE 299

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYA 69
           LTF +     +IYRD K  N+L+D +   +++DFG AK      R    T  + GT  Y 
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYL 191
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE + +       D ++ GV++ E+ +G
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 181
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 182 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 222
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 184
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 225
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 2/95 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K  +  A G+ +L  +    ++RD  A N +L  +    ++DFGL+K   +GD      
Sbjct: 150 LKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 95
                  + A E +A    T+KSDV++FGV + E+
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 227
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 199
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 184
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 225
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 73/178 (41%), Gaps = 35/178 (19%)
Query: 15  HDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVS--TQVMGTHGYAAP 71
           H     V++RD K  NIL+D     AKL DFG      +G   H    T   GT  Y+ P
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG------SGALLHDEPYTDFDGTRVYSPP 207
Query: 72  EYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 130
           E+++  +     + V+S G++L +++ G    ++ +  +E  L                 
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL----------------- 250
Query: 131 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 188
                   +P   +     L  +CL  +P  RP + E+L +   ++ P     L+ S+
Sbjct: 251 -------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL-LDPWMQTPAEDVPLNPSK 300

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 199
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 201
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 193
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLXGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 74
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 564
Query: 75  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 134
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 565 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 605
Query: 135 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     ++ + + 
Sbjct: 122 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     ++ + + 
Sbjct: 122 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYA 69
           LTF +     +IYRD K  N+L+D +   +++DFG AK      R    T  + GT  Y 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLAGTPEYL 205
Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSG 98
           APE + +       D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     ++ + + 
Sbjct: 124 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     ++ + + 
Sbjct: 120 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     ++ + + 
Sbjct: 122 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     ++ + + 
Sbjct: 127 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
                  + A E +     T +SDV+S+GV + EL++
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y
Sbjct: 111 RGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWY 166
Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 99
             P+  + +   +T+ D++  G +  E+ +GR
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL F H     V++RD K  N+L++     KL+DFGLA+A     R + +  V  T  Y
Sbjct: 112 KGLGFCH--SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWY 167
Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLEL 95
             P+ +   +L +T  D++S G +  EL
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 26/112 (23%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------- 62
           G  F+H  ES +I+RD K +N LL+ + + K+ DFGLA+   +    H+   +       
Sbjct: 143 GEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 63  ----------------MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 97
                           + T  Y APE +      T S D++S G +  ELL+
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+++D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + L ++H     + +RD K  N+LLD      KL DFG AK    G+    +   + +  
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICSRY 206
Query: 68  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
           Y APE +      TT  D++S G V+ EL+ G+  +   + GI+Q LV+  K   +  R+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQ-LVEIIKVLGTPSRE 264
Query: 127 LFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 184
             + M+   +  ++PQ   H  + +           RPR   + + ++ RL     SA+L
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKV----------FRPRTPPDAIDLISRLLEYTPSARL 314
Query: 185 SQSE 188
           +  E
Sbjct: 315 TAIE 318

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M +AI +   L ++H        RD K  N+LLD   + +L+DFG +      D T  S+
Sbjct: 184 MVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSS 234
Query: 61  QVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGR 99
             +GT  Y +PE +       G+   + D +S GV + E+L G 
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFG---------LAKAGPTGDRT 56
           A +GL +LH    ++++ D KA N+LL ++  +A L DFG         L K+  TGD  
Sbjct: 194 ALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD-- 249
Query: 57  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                + GT  + APE V       K DV+S   ++L +L+G
Sbjct: 250 ----YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           M +AI +   L ++H        RD K  N+LLD   + +L+DFG +      D T  S+
Sbjct: 200 MVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSS 250
Query: 61  QVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGR 99
             +GT  Y +PE +       G+   + D +S GV + E+L G 
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           Q ++RD  A N L++ +   K+SDFGL++     + T           ++ PE +   + 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMYSKF 198
Query: 80  TTKSDVYSFGVVLLELLS 97
           ++KSD+++FGV++ E+ S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 76
           Q ++RD  A N L++ +   K+SDFGL++     D  + S+  +G+     ++ PE +  
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMY 175
Query: 77  GRLTTKSDVYSFGVVLLELLS 97
            + ++KSD+++FGV++ E+ S
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 76
           Q ++RD  A N L++ +   K+SDFGL++     D  + S+  +G+     ++ PE +  
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMY 179
Query: 77  GRLTTKSDVYSFGVVLLELLS 97
            + ++KSD+++FGV++ E+ S
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYS 200

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 76
           Q ++RD  A N L++ +   K+SDFGL++     D  + S+  +G+     ++ PE +  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMY 195
Query: 77  GRLTTKSDVYSFGVVLLELLS 97
            + ++KSD+++FGV++ E+ S
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 76
           Q ++RD  A N L++ +   K+SDFGL++     D  + S++  G+     ++ PE +  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSR--GSKFPVRWSPPEVLMY 180
Query: 77  GRLTTKSDVYSFGVVLLELLS 97
            + ++KSD+++FGV++ E+ S
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 76
           Q ++RD  A N L++ +   K+SDFGL++     D  + S+  +G+     ++ PE +  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMY 180
Query: 77  GRLTTKSDVYSFGVVLLELLS 97
            + ++KSD+++FGV++ E+ S
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 20  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 76
           Q ++RD  A N L++ +   K+SDFGL++     D  + S+  +G+     ++ PE +  
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMY 186
Query: 77  GRLTTKSDVYSFGVVLLELLS 97
            + ++KSD+++FGV++ E+ S
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYS 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 5/91 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + + F H  +   I+RD K  NIL+      KL DFG A+   TG   +   +V  T  Y
Sbjct: 113 QAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARL-LTGPSDYYDDEV-ATRWY 168
Query: 69  AAPE-YVATGRLTTKSDVYSFGVVLLELLSG 98
            +PE  V   +     DV++ G V  ELLSG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 126 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 180
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 126 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 180
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 132 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 186
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLA---KAGPTGDRTHVSTQV 62
           A +GL +LH    ++++ D KA N+LL ++  +A L DFG A   +    G        +
Sbjct: 175 ALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            GT  + APE V       K DV+S   ++L +L+G
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 125 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 179
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 126 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 180
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL F H     V++RD K  N+L++     KL++FGLA+A     R + +  V  T  Y
Sbjct: 112 KGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWY 167
Query: 69  AAPEYVATGRL-TTKSDVYSFGVVLLEL 95
             P+ +   +L +T  D++S G +  EL
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           P  + +       D ++ GV++ E+ +G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFG---------LAKAGPTGDRT 56
           A +GL +LH    ++++ D KA N+LL ++ + A L DFG         L K+  TGD  
Sbjct: 175 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD-- 230
Query: 57  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                + GT  + APE V       K D++S   ++L +L+G
Sbjct: 231 ----YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFG---------LAKAGPTGDRT 56
           A +GL +LH    ++++ D KA N+LL ++ + A L DFG         L K+  TGD  
Sbjct: 159 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD-- 214
Query: 57  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                + GT  + APE V       K D++S   ++L +L+G
Sbjct: 215 ----YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFG---------LAKAGPTGDRT 56
           A +GL +LH    ++++ D KA N+LL ++ + A L DFG         L K+  TGD  
Sbjct: 173 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD-- 228
Query: 57  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
                + GT  + APE V       K D++S   ++L +L+G
Sbjct: 229 ----YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 77/184 (41%), Gaps = 36/184 (19%)
Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K A+  A+G+ FLH  E  +      + ++++D +  A++S   +  +  +  R +   
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY--- 170
Query: 61  QVMGTHGYAAPEYVATGRLTTK--------SDVYSFGVVLLELLSGRCAVDKTKVGIEQS 112
                    AP +VA   L  K        +D++SF V+L EL++            E  
Sbjct: 171 ---------APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR-----------EVP 210
Query: 113 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             D     LS+     ++    L    P   +   + L   C+N +P  RP+   ++ IL
Sbjct: 211 FAD-----LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
Query: 173 ERLE 176
           E+++
Sbjct: 266 EKMQ 269

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 37/199 (18%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
             + APE V    L  ++D++S GV+   LLSG                  A P+L D +
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTK 222
Query: 126 K--LFRI--MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 181
           +  L  +  ++ +   +Y    +  A     + L  +PK R      + I + L+ P   
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR------MTIQDSLQHPWIK 276
Query: 182 AKLSQSEPHRQTGPVTVRK 200
            K +Q    R+   V + K
Sbjct: 277 PKDTQQALSRKASAVNMEK 295

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 26/113 (23%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAK---AGP 51
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 125 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 52  TGDRTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSFGVVLLELLS 97
           +  RT+++    GT G+ APE +          RLT   D++S G V   +LS
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD        KL DFG+A     G+       + GT
Sbjct: 127 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 120
             + APE V    L  ++D++S GV+   LLSG          +T   I     D+ + Y
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 150
            S+  +L +    +L  + P++    A +L
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRMXIAQSL 271

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 251 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 305
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 51/116 (43%), Gaps = 21/116 (18%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGP-TGDRTHVSTQV 62
            A  L FLH+    + +RD K  NIL +        K+ DFGL       GD + +ST  
Sbjct: 120 VASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 63  M----GTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLS------GRCAVD 103
           +    G+  Y APE V            + D++S GV+L  LLS      GRC  D
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD        KL DFG+A     G+       + GT
Sbjct: 120 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 174
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 120
             + APE V    L  ++D++S GV+   LLSG          +T   I     D+ + Y
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 150
            S+  +L +    +L  + P++    A +L
Sbjct: 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 14  LHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LH  +  V++RD K  N+LL ++      KL+DFGLA     GD+        GT GY +
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLS 174
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +         D+++ GV+L  LL G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 125 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 179
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 125 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 179
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 247
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 248 -IIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 265 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 319
Query: 67  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD        KL DFG+A     G+       + GT
Sbjct: 141 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 195
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 120
             + APE V    L  ++D++S GV+   LLSG          +T   I     D+ + Y
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 255
Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 150
            S+  +L +    +L  + P++    A +L
Sbjct: 256 FSNTSELAKDFIRRLLVKDPKRRMXIAQSL 285

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 247
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 248 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 247
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 248 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 132
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 215
Query: 133 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 216 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT    A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEALA 206
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 26/178 (14%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHG 67
           G+ F H     +I+RD K  NIL+      KL DFG A+  A P      V    + T  
Sbjct: 136 GIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYDDEVATRW 189
Query: 68  YAAPE-YVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQSLVDWAKPY 120
           Y APE  V   +     DV++ G ++ E      L  G   +D+    I   L +    +
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMCLGNLIPRH 248
Query: 121 --LSDKRKLF---RIMDTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             L +K  +F   R+ + K    L  +YP K +     LA +CL+ +P  RP  +E+L
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYP-KLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 10  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           + + +LH  E+ +++RD K  N+L      DA    K++DFGL+K     +   +   V 
Sbjct: 159 EAVAYLH--ENGIVHRDLKPENLLYATPAPDAPL--KIADFGLSK---IVEHQVLMKTVC 211
Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           GT GY APE +       + D++S G++   LL G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 22/109 (20%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAKAGPTGD 54
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 143 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 55  ---RTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLS 97
              R +++    GT G+ APE +      RLT   D++S G V   +LS
Sbjct: 201 XXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 22/109 (20%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAKAGPTGD 54
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 143 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 55  ---RTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLS 97
              R +++    GT G+ APE +      RLT   D++S G V   +LS
Sbjct: 201 XXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 45/100 (45%), Gaps = 13/100 (13%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           +A+ A   + F+H        RD K  N+LLD   + KL+DFG              T V
Sbjct: 184 LALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 63  MGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSG 98
            GT  Y +PE + +    G    + D +S GV L E+L G
Sbjct: 236 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 45/100 (45%), Gaps = 13/100 (13%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           +A+ A   + F+H        RD K  N+LLD   + KL+DFG              T V
Sbjct: 179 LALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 63  MGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSG 98
            GT  Y +PE + +    G    + D +S GV L E+L G
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 45/100 (45%), Gaps = 13/100 (13%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 62
           +A+ A   + F+H        RD K  N+LLD   + KL+DFG              T V
Sbjct: 184 LALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 63  MGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSG 98
            GT  Y +PE + +    G    + D +S GV L E+L G
Sbjct: 236 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   + +     T
Sbjct: 123 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---T 175
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +   T  Y APE +   +     D++S GV++  LL G
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + L + HD  + +I+RD K   +LL ++ N+   KL  FG+A     G+   V+   +GT
Sbjct: 143 EALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 198
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
             + APE V         DV+  GV+L  LLSG                    P+   K 
Sbjct: 199 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------------------CLPFYGTKE 240
Query: 126 KLFRIMDTKLGGQY---PQKAAH---TAATLALQCLNNEPKLRPRMSEVL 169
           +LF   +  + G+Y   P++ +H   +A  L  + L  +P  R  + E L
Sbjct: 241 RLF---EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 287

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 53
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 54  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 105
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 202 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 257
Query: 106 KVGIEQSLVDWAKPY 120
             GI +   D+  PY
Sbjct: 258 --GIHE---DYQLPY 267

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + L + HD  + +I+RD K   +LL ++ N+   KL  FG+A     G+   V+   +GT
Sbjct: 141 EALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 196
Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V         DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 53
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162
Query: 54  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 105
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 163 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 218
Query: 106 KVGIEQSLVDWAKPY 120
             GI +   D+  PY
Sbjct: 219 --GIHE---DYQLPY 228

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 53
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 104 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 163
Query: 54  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 105
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 164 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 219
Query: 106 KVGIEQSLVDWAKPY 120
             GI +   D+  PY
Sbjct: 220 --GIHE---DYQLPY 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 53
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 129 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 188
Query: 54  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 105
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 189 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 244
Query: 106 KVGIEQSLVDWAKPY 120
             GI +   D+  PY
Sbjct: 245 --GIHE---DYQLPY 254

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 28/114 (24%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-------------GPTGDRT 56
           G+ ++H A   +++RD K +N L++ + + K+ DFGLA+               P  D  
Sbjct: 168 GVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 57  HVST---------QVMG---THGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 97
           ++ T         Q+ G   T  Y APE +      T++ DV+S G +  ELL+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 53
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 109 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 168
Query: 54  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 105
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 169 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 224
Query: 106 KVGIEQSLVDWAKPY 120
             GI +   D+  PY
Sbjct: 225 --GIHE---DYQLPY 234

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 53
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 106 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 165
Query: 54  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 105
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 166 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 221
Query: 106 KVGIEQSLVDWAKPY 120
             GI +   D+  PY
Sbjct: 222 --GIHE---DYQLPY 231

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L + H    +VI+RD K  N+LL  +   K++DFG +   P+  R      + GT  
Sbjct: 133 ADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGTLD 186
Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           Y  PE +       K D++  GV+  ELL G
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 169 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 222
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 223 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 14  LHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LH  +  V++RD K  N+LL ++      KL+DFGLA       +        GT GY +
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLS 192
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +         D+++ GV+L  LL G
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 125 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 178
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 179 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 130 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 183
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 184 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 129 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 182
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 183 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 175 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 228
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 229 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 131 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 184
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 185 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 123 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 176
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 177 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 124 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 177
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 178 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 15/89 (16%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG----LAKAGPTGDRTHVSTQVMGT 65
             +++H+ E  + +RD K SNIL+D     KLSDFG    +      G R        GT
Sbjct: 163 SFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--------GT 213
Query: 66  HGYAAPEYVATGRLTT--KSDVYSFGVVL 92
           + +  PE+ +        K D++S G+ L
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 22/133 (16%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK-----AGPTGDRTHVST 60
           G+ +LH   + V++RD K +NIL+  E       K++D G A+       P  D      
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----D 193
Query: 61  QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
            V+ T  Y APE +   R  TK+ D+++ G +  ELL+        +  I+ S      P
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS-----NP 248
Query: 120 YLSDK-RKLFRIM 131
           Y  D+  ++F +M
Sbjct: 249 YHHDQLDRIFNVM 261

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 232
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 139 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 192
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 193 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA--KLSDFGLAKAGPTGDRTHVST 60
           +IG A  + +LH     + +RD K  N+L  ++  NA  KL+DFG AK   T     ++T
Sbjct: 125 SIGEA--IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT 178
Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 179 PCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 219
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 199
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 199
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 21  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 205
Query: 78  RLTTKSDVYSFGVVLLELLSG 98
             +   D+++ GV+L  LL G
Sbjct: 206 PYSKPVDIWACGVILYILLVG 226

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 200
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 200
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 200
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGY 68
           GL  LH  E+ V++RD    NILL    +  + DF LA+      ++TH  T       Y
Sbjct: 146 GLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWY 199
Query: 69  AAPEYVATGRLTTK-SDVYSFGVVLLELLS 97
            APE V   +  TK  D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGY 68
           GL  LH  E+ V++RD    NILL    +  + DF LA+      ++TH  T       Y
Sbjct: 146 GLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWY 199
Query: 69  AAPEYVATGRLTTK-SDVYSFGVVLLELLS 97
            APE V   +  TK  D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 184
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 27/217 (12%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNIL-LDAEFN---AKLSDFGLAKAGPTGDRTHV 58
           V     K + +LH     V++RD K SNIL +D   N    ++ DFG AK     +   +
Sbjct: 121 VLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           +     T  + APE +         D++S GV+L  +L+G                    
Sbjct: 179 TP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN-------------G 223
Query: 119 PYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL---AILE 173
           P  + +  L RI   K  L G Y    + TA  L  + L+ +P  R   + VL    I+ 
Sbjct: 224 PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283
Query: 174 RLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPL 210
             + P+      Q  PH   G +    S + + +SP+
Sbjct: 284 WDQLPQYQLN-RQDAPHLVKGAMAATYSALNRNQSPV 319

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 184
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           G+++ H    QV +RD K  N LLD       K++DFG +KA     +       +GT  
Sbjct: 127 GVSYAH--AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPA 181
Query: 68  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 98
           Y APE +       K +DV+S GV L  +L G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 183
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 207
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 21  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 181
Query: 78  RLTTKSDVYSFGVVLLELLSG 98
             +   D+++ GV+L  LL G
Sbjct: 182 PYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 21  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 78  RLTTKSDVYSFGVVLLELLSG 98
             +   D+++ GV+L  LL G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 26/113 (23%)
Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAKAGPTGD 54
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 125 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 55  ---RTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSFGVVLLELLS 97
              R +++    GT G+ APE +          RLT   D++S G V   +LS
Sbjct: 183 XXFRXNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 21  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 77
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 78  RLTTKSDVYSFGVVLLELLSG 98
             +   D+++ GV+L  LL G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 51/120 (42%), Gaps = 21/120 (17%)
Query: 3   VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGP-TGDRTHV 58
           V    A  L FLH+    + +RD K  NIL +        K+ DF L       GD + +
Sbjct: 116 VVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 59  STQVM----GTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLS------GRCAVD 103
           ST  +    G+  Y APE V            + D++S GV+L  LLS      GRC  D
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           G+++ H    Q+ +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 128 GVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 182
Query: 68  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 98
           Y APE +       K +DV+S GV L  +L G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMG 64
           A +GL  +H  E  +++ D K  NI+ + +   + K+ DFGLA      +   V+T    
Sbjct: 158 ACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---A 212
Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T  +AAPE V    +   +D+++ GV+   LLSG
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 73
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 74  VATGRLTTKS-DVYSFGVVLLELLSG 98
           +   R   +S  V+S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           G+++ H    QV +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 127 GVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 181
Query: 68  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 98
           Y APE +       K +DV+S GV L  +L G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 13/98 (13%)
Query: 5   IGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNA--KLSDFGLAKAGPTGDRTHVSTQ 61
           IG A  + FLH     + +RD K  N+L  + E +A  KL+DFG AK     + T  + Q
Sbjct: 118 IGTA--IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-----ETTQNALQ 168
Query: 62  V-MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 169 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 10  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           G+++ H    QV +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 126 GVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 180
Query: 68  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 98
           Y APE +       K +DV+S GV L  +L G
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 15  HDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 71
           H  +  +++RD K  N+LL ++      KL+DFGLA       +        GT GY +P
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLSP 202
Query: 72  EYVATGRLTTKSDVYSFGVVLLELLSG 98
           E +         D+++ GV+L  LL G
Sbjct: 203 EVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 13/98 (13%)
Query: 5   IGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNA--KLSDFGLAKAGPTGDRTHVSTQ 61
           IG A  + FLH     + +RD K  N+L  + E +A  KL+DFG AK     + T  + Q
Sbjct: 137 IGTA--IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-----ETTQNALQ 187
Query: 62  V-MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
               T  Y APE +   +     D++S GV++  LL G
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 38/85 (44%), Gaps = 4/85 (4%)
Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L   H     +++ D K +NI L      KL DFGL     T     V     G   Y A
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMA 224
Query: 71  PEYVATGRLTTKSDVYSFGVVLLEL 95
           PE +  G   T +DV+S G+ +LE+
Sbjct: 225 PELL-QGSYGTAADVFSLGLTILEV 248

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 64
             KGL  +H  E+  ++ D K  NI+   + +   KL DFGL           V+T   G
Sbjct: 158 VCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---G 212
Query: 65  THGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 98
           T  +AAPE VA G+ +   +D++S GV+   LLSG
Sbjct: 213 TAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 14  LHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           LH  +  V++R+ K  N+LL ++      KL+DFGLA       +        GT GY +
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLS 181
Query: 71  PEYVATGRLTTKSDVYSFGVVLLELLSG 98
           PE +         D+++ GV+L  LL G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 7   AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 64
             KGL  +H  E+  ++ D K  NI+   + +   KL DFGL           V+T   G
Sbjct: 264 VCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---G 318
Query: 65  THGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 98
           T  +AAPE VA G+ +   +D++S GV+   LLSG
Sbjct: 319 TAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSG 352

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	229
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-109
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-102
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-91
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-31
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-27
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-21
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-19
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-17
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-16
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-15
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-14
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-14
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-14
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-14
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-13
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-13
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-12
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-12
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-11
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-11
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-10
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-10
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-10
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  314 bits (807), Expect = e-109
 Identities = 68/177 (38%), Positives = 109/177 (61%), Gaps = 6/177 (3%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
            K+A GAA G+ FLH  E+  I+RD K++NILLD  F AK+SDFGLA+A     +T +++
Sbjct: 136 CKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +++GT  Y APE +  G +T KSD+YSFGVVLLE+++G  AVD+ +    Q L+D  +  
Sbjct: 194 RIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEI 250

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
             +++ +   +D K+       +     ++A QCL+ +   RP + +V  +L+ + A
Sbjct: 251 EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  298 bits (765), Expect = e-102
 Identities = 74/182 (40%), Positives = 106/182 (58%), Gaps = 3/182 (1%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++ IGAA+GL +LH     +I+RD K+ NILLD  F  K++DFG++K G   D+TH+ST
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
            V GT GY  PEY   GRLT KSDVYSFGVVL E+L  R A+ ++      +L +WA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 180
             +  +L +I+D  L  +   ++       A++CL    + RP M +VL  LE     + 
Sbjct: 260 H-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

Query: 181 SA 182
           S 
Sbjct: 319 SV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  269 bits (691), Expect = 5e-91
 Identities = 79/195 (40%), Positives = 121/195 (62%), Gaps = 5/195 (2%)

Query: 1   MKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 59
            ++A+G+A+GL +LH   + ++I+RD KA+NILLD EF A + DFGLAK     D THV+
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 192

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWA 117
           T V GT G+ APEY++TG+ + K+DV+ +GV+LLEL++G+ A D  ++  +    L+DW 
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
           K  L +K+ L  ++D  L G Y  +       +AL C  + P  RP+MSEV+ +LE    
Sbjct: 253 KGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

Query: 178 PKNSAKLSQSEPHRQ 192
            +   +  + E  RQ
Sbjct: 312 AERWEEWQKEEMFRQ 326

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  149 bits (378), Expect = 4e-44
 Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 18/194 (9%)

Query: 1   MKVAIGAAKGLTFLHDAESQ--------VIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 52
             +A   A+GL +LH+            + +RD K+ N+LL     A ++DFGLA     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 53  GDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKV 107
           G     +   +GT  Y APE +            + D+Y+ G+VL EL S   A D    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

Query: 108 GIEQSLVD--WAKPYLSDKRKL--FRIMDTKLGGQYPQKAAHTA-ATLALQCLNNEPKLR 162
                  +     P L D +++   +     L   + + A          +C +++ + R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 163 PRMSEVLAILERLE 176
                V   + +++
Sbjct: 304 LSAGCVGERITQMQ 317

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  123 bits (310), Expect = 3e-34
 Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 28/200 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHV 58
           M   +  ++G+ +LH  + + +I+RD K  N+LL A     K+ DFG A      D    
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTH 159

Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
            T   G+  + APE       + K DV+S+G++L E+++ R                  K
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------------------K 201

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQ--KAAHTA-ATLALQCLNNEPKLRPRMSEVLAILERL 175
           P+       FRIM     G  P   K       +L  +C + +P  RP M E++ I+  L
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

Query: 176 EAPKNSAKLSQSEPHRQTGP 195
                 A      P + + P
Sbjct: 262 MRYFPGADEPLQYPCQHSLP 281

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  119 bits (301), Expect = 7e-33
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   AKG+ +LH+    +++R+ K+ N+L+D ++  K+ DFGL++   +   +  S 
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SK 197

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
              GT  + APE +       KSDVYSFGV+L EL + +                  +P+
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------------------QPW 239

Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
             L+  + +  +       + P+      A +   C  NEP  RP  + ++ +L  L   
Sbjct: 240 GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL--- 296

Query: 179 KNSAKLSQSEPHR 191
               K +   P+R
Sbjct: 297 ---IKSAVPPPNR 306

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  116 bits (293), Expect = 5e-32
 Identities = 37/181 (20%), Positives = 73/181 (40%), Gaps = 30/181 (16%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K A+  A+G+ FLH  E  +      + ++++D +  A++S   +         +  S 
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSP 166

Query: 61  QVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             M    + APE             +D++SF V+L EL++                    
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------ 208

Query: 118 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            P+  LS+     ++    L    P   +   + L   C+N +P  RP+   ++ ILE++
Sbjct: 209 VPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

Query: 176 E 176
           +
Sbjct: 269 Q 269

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  116 bits (293), Expect = 9e-32
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 29/184 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH     +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 123 IDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180

Query: 61  QVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE      +   + +SDVY+FG+VL EL++G+                  
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL----------------- 223

Query: 118 KPY--LSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 171
            PY  ++++ ++  ++          +           L  +CL  +   RP    +LA 
Sbjct: 224 -PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

Query: 172 LERL 175
           +E L
Sbjct: 283 IEEL 286

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  115 bits (290), Expect = 2e-31
 Identities = 38/183 (20%), Positives = 74/183 (40%), Gaps = 28/183 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-----AEFNAKLSDFGLAKAGPTGDR 55
           +++ +  A G+ ++ +    +++RD ++ NI L      A   AK++DFGL++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QS 179

Query: 56  THVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 112
            H  + ++G   + APE          T K+D YSF ++L  +L+G    D         
Sbjct: 180 VHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234

Query: 113 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
            + +      +  +             P+        +   C + +PK RP  S ++  L
Sbjct: 235 KIKFINMIREEGLRP----------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

Query: 173 ERL 175
             L
Sbjct: 285 SEL 287

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  116 bits (292), Expect = 2e-31
 Identities = 36/219 (16%), Positives = 71/219 (32%), Gaps = 30/219 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQ-------VIYRDFKASNILLDAEFNAKLSDFGLAK----- 48
            ++A    +GL +LH    +       + +RD  + N+L+  +    +SDFGL+      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 49  -AGPTGDRTHVSTQVMGTHGYAAPEY-------VATGRLTTKSDVYSFGVVLLELLSGRC 100
                G+  + +   +GT  Y APE                + D+Y+ G++  E+   RC
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RC 232

Query: 101 AVDKTKVGIEQSLVDWAK-----PYLSDKRKLFRIMDTKL----GGQYPQKAAHTAATLA 151
                   + +  + +       P   D + L      +       +    A  +     
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 152 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 190
             C + + + R         +  L       K      H
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  113 bits (286), Expect = 1e-30
 Identities = 40/208 (19%), Positives = 71/208 (34%), Gaps = 29/208 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------------ 48
           +  A   A G+ +LH     +I+RD  + N L+    N  ++DFGLA+            
Sbjct: 111 VSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168

Query: 49  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 108
                        V+G   + APE +       K DV+SFG+VL E++    A       
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----D 224

Query: 109 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                +D+         +             P     +   + ++C + +P+ RP   ++
Sbjct: 225 YLPRTMDFGLNVRGFLDRYC-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKL 273

Query: 169 LAILERLEAPKNSAKLSQSEPHRQTGPV 196
              LE L            +  +     
Sbjct: 274 EHWLETLRMHLAGHLPLGPQLEQLDRGF 301

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  109 bits (274), Expect = 4e-29
 Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 33/186 (17%)

Query: 1   MKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEF--------NAKLSDFGLAKAGP 51
           +  A+  A+G+ +LHD A   +I+RD K+SNIL+  +           K++DFGLA+   
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--- 164

Query: 52  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 111
              RT   +   G + + APE +     +  SDV+S+GV+L ELL+G             
Sbjct: 165 EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV----------- 212

Query: 112 SLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                  P+  +      + +   KL    P       A L   C N +P  RP  + +L
Sbjct: 213 -------PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

Query: 170 AILERL 175
             L  +
Sbjct: 266 DQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (271), Expect = 2e-28
 Identities = 41/205 (20%), Positives = 73/205 (35%), Gaps = 43/205 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTH 57
            ++A    KG+ +LH     ++++D K+ N+  D      ++DFGL         G R  
Sbjct: 133 RQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189

Query: 58  VSTQVMGTHGYAAPEYVATGRL---------TTKSDVYSFGVVLLELLSGRCAVDKTKVG 108
                 G   + APE +              +  SDV++ G +  EL +           
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW-------- 241

Query: 109 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA----ATLALQCLNNEPKLRPR 164
                     P+    +    I+     G  P  +        + + L C   E + RP 
Sbjct: 242 ----------PF--KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPT 289

Query: 165 MSEVLAILERLEAPKNSAKLSQSEP 189
            ++++ +LE+L  PK       S P
Sbjct: 290 FTKLMDMLEKL--PKR--NRRLSHP 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  106 bits (266), Expect = 8e-28
 Identities = 42/200 (21%), Positives = 72/200 (36%), Gaps = 30/200 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KAGPT 52
           +++ +  A GL  LH           + +RD K+ NIL+       ++D GLA   +  T
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167

Query: 53  GDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT- 105
                 +   +GT  Y APE       V       + D+++FG+VL E+   R   +   
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIV 226

Query: 106 ---------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 156
                     V  + S  D  K    D+++   I +           A     L  +C  
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFSDPTLTSLAK----LMKECWY 281

Query: 157 NEPKLRPRMSEVLAILERLE 176
             P  R     +   L +++
Sbjct: 282 QNPSARLTALRIKKTLTKID 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  106 bits (266), Expect = 1e-27
 Identities = 43/205 (20%), Positives = 72/205 (35%), Gaps = 32/205 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KAGPT 52
           +K+A  +  GL  LH           + +RD K+ NIL+       ++D GLA      T
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196

Query: 53  GDRTHVSTQVMGTHGYAAPEYVATGRL-------TTKSDVYSFGVVLLELLSGRCAVDKT 105
            +        +GT  Y  PE V    L          +D+YSFG++L E+   RC     
Sbjct: 197 NEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGI 254

Query: 106 ----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 155
                      V  + S  D  +     K +     +     +  ++       L  +C 
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP-SFPNRWSSDECLRQMGK----LMTECW 309

Query: 156 NNEPKLRPRMSEVLAILERLEAPKN 180
            + P  R     V   L ++   ++
Sbjct: 310 AHNPASRLTALRVKKTLAKMSESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  101 bits (252), Expect = 1e-25
 Identities = 41/199 (20%), Positives = 70/199 (35%), Gaps = 20/199 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KAGPT 52
           +K+A+  A GL  LH           + +RD K+ NIL+       ++D GLA      T
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201

Query: 53  GDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
                     +GT  Y APE       +       ++D+Y+ G+V  E+   RC++    
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIH 260

Query: 107 VGIEQSLVDWAKPYLSDKRKLFRIMDTKL-----GGQYPQKAAHTAATLALQCLNNEPKL 161
              +    D      S +     + + KL           +A    A +  +C       
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320

Query: 162 RPRMSEVLAILERLEAPKN 180
           R     +   L +L   + 
Sbjct: 321 RLTALRIKKTLSQLSQQEG 339

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 97.5 bits (243), Expect = 3e-24
 Identities = 49/237 (20%), Positives = 86/237 (36%), Gaps = 38/237 (16%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
            + +  +H     +++ D K +N L+  +   KL DFG+A        + V    +GT  
Sbjct: 118 LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 68  YAAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 116
           Y  PE             +  +++ KSDV+S G +L  +  G+                 
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---------------- 218

Query: 117 AKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--- 170
             P+   ++   KL  I+D     ++P         +   CL  +PK R  + E+LA   
Sbjct: 219 --PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276

Query: 171 ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 227
           +  +       AK +  E     G +    SP    ++   +    S   SH  S  
Sbjct: 277 VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 333

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 95.1 bits (237), Expect = 1e-23
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 29/163 (17%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTH 66
            KG+ ++H    ++I RD K SNI L      K+ DFGL  +    G RT       GT 
Sbjct: 132 TKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSK-GTL 185

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            Y +PE +++     + D+Y+ G++L ELL                            + 
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDTAFETSKF 227

Query: 127 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
              + D  +   + +K       L  + L+ +P+ RP  SE+L
Sbjct: 228 FTDLRDGIISDIFDKKEKT----LLQKLLSKKPEDRPNTSEIL 266

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 95.1 bits (237), Expect = 2e-23
 Identities = 37/163 (22%), Positives = 57/163 (34%), Gaps = 25/163 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
              L  LH     +++ D K +NI L      KL DFGL     T        Q  G   
Sbjct: 167 LLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPR 221

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y APE +  G   T +DV+S G+ +LE+                                
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACN-------------------MELPHGGEGW 261

Query: 128 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
            ++    L  ++    +    ++ +  L  +PKLR     +LA
Sbjct: 262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 94.8 bits (236), Expect = 3e-23
 Identities = 43/231 (18%), Positives = 87/231 (37%), Gaps = 36/231 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTH 66
              L  +HD   ++++RD K+ NI L  +   +L DFG+A+    T +       + GT 
Sbjct: 135 CLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI-GTP 189

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            Y +PE         KSD+++ G VL EL + +                    + +   K
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK------------------HAFEAGSMK 231

Query: 127 --LFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAP 178
             + +I+     G +       ++   +L  Q     P+ RP ++ +L    I +R+E  
Sbjct: 232 NLVLKIIS----GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287

Query: 179 KNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 229
            +   +++    +       +  P ++  S  N           + + +  
Sbjct: 288 LSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYG 338

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.4 bits (232), Expect = 7e-23
 Identities = 38/175 (21%), Positives = 66/175 (37%), Gaps = 37/175 (21%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----------GPTGDRTH 57
           A+ + FLH     +++RD K SNI    +   K+ DFGL  A                  
Sbjct: 174 AEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T  +GT  Y +PE +     + K D++S G++L ELL            +E+  +   
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QMERVRI--- 282

Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEPKLRPRMSEVL 169
              ++D R            ++P            +    L+  P  RP  ++++
Sbjct: 283 ---ITDVRN----------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 93.1 bits (232), Expect = 7e-23
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 27/187 (14%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
              L  +H    +V++RD K +N+ + A    KL D GL +   +   T   + V GT  
Sbjct: 146 CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPY 201

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           Y +PE +       KSD++S G +L E+ + +                   P+  DK  L
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNL 243

Query: 128 FRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 183
           + +        YP       +     L   C+N +P+ RP ++ V  + +R+ A   ++ 
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT-ASS 302

Query: 184 LSQSEPH 190
           L     H
Sbjct: 303 LEHHHHH 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 93.1 bits (232), Expect = 8e-23
 Identities = 38/176 (21%), Positives = 68/176 (38%), Gaps = 35/176 (19%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
            + +  +H     +++ D K +N L+  +   KL DFG+A        + V    +GT  
Sbjct: 137 LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193

Query: 68  YAAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 116
           Y  PE             +  +++ KSDV+S G +L  +  G+                 
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---------------- 237

Query: 117 AKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             P+   ++   KL  I+D     ++P         +   CL  +PK R  + E+L
Sbjct: 238 --PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 93.3 bits (232), Expect = 2e-22
 Identities = 48/236 (20%), Positives = 86/236 (36%), Gaps = 38/236 (16%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + +  +H  +  +++ D K +N L+  +   KL DFG+A        + V    +G   Y
Sbjct: 166 EAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222

Query: 69  AAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             PE             +  +++ KSDV+S G +L  +  G+                  
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------ 264

Query: 118 KPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---I 171
            P+   ++   KL  I+D     ++P         +   CL  +PK R  + E+LA   +
Sbjct: 265 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

Query: 172 LERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 227
             +       AK +  E     G +    SP    ++   +    S   SH  S  
Sbjct: 325 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 380

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.2 bits (227), Expect = 4e-22
 Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 3/99 (3%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +       L   H A     +RD K  NIL+ A+  A L DFG+A A      T +  
Sbjct: 137 VAIVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
             +GT  Y APE  +    T ++D+Y+   VL E L+G 
Sbjct: 195 -TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 89.6 bits (223), Expect = 1e-21
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 3/99 (3%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +        G+   HD   ++++RD K  NIL+D+    K+ DFG+AKA      T  + 
Sbjct: 114 INFTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH 171

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            V+GT  Y +PE          +D+YS G+VL E+L G 
Sbjct: 172 -VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 35/178 (19%), Positives = 67/178 (37%), Gaps = 39/178 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-------------AGPTGDR 55
           + L+++H     +I+RD K  NI +D   N K+ DFGLAK                 G  
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 56  THVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 114
            ++++ + GT  Y A E +  TG    K D+YS G++  E++                  
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF--------------- 228

Query: 115 DWAKPYLSDKRKLFRIM---DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                   ++  + + +     +    +          +    ++++P  RP    +L
Sbjct: 229 ----STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 88.6 bits (220), Expect = 3e-21
 Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 27/165 (16%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           KGL FLH     +I+RD K  NI +     + K+ D GLA       R   +  V+GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPE 195

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKR 125
           + APE           DVY+FG+ +LE+ +                     PY    +  
Sbjct: 196 FMAPEMYEEK-YDESVDVYAFGMCMLEMATSEY------------------PYSECQNAA 236

Query: 126 KLFRIMDTKLGGQYPQKAAHTAAT-LALQCLNNEPKLRPRMSEVL 169
           +++R + + +      K A      +   C+      R  + ++L
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.6 bits (225), Expect = 3e-21
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 31/159 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH    +++YRD K  NILLD   + ++SD GLA   P G       +V GT GY 
Sbjct: 298 GLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL-- 127
           APE V   R T   D ++ G +L E+++G+                   P+   K+K+  
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS------------------PFQQRKKKIKR 394

Query: 128 ----FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
                 + +     +Y ++ +  A +L  Q L  +P  R
Sbjct: 395 EEVERLVKEVPE--EYSERFSPQARSLCSQLLCKDPAER 431

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.5 bits (220), Expect = 4e-21
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 3/100 (3%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++V   A + L F H     +I+RD K +NI++ A    K+ DFG+A+A      +   T
Sbjct: 119 IEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 61  -QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
             V+GT  Y +PE      +  +SDVYS G VL E+L+G 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 88.5 bits (220), Expect = 8e-21
 Identities = 48/190 (25%), Positives = 77/190 (40%), Gaps = 39/190 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++   AA G+ +L       I+RD  A N L+  +   K+SDFG+++    G       
Sbjct: 216 LQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA---- 269

Query: 61  QVMGTHGY-----AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
              G          APE +  GR +++SDV+SFG++L E  S G                
Sbjct: 270 -ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS-------------- 314

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               PY  LS+++    +     GG    P+        L  QC   EP  RP  S +  
Sbjct: 315 ----PYPNLSNQQTREFVEK---GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

Query: 171 ILERL-EAPK 179
            L+ + +  +
Sbjct: 368 ELQSIRKRHR 377

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.6 bits (222), Expect = 8e-21
 Identities = 47/157 (29%), Positives = 66/157 (42%), Gaps = 28/157 (17%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  +H     V+YRD K +NILLD   + ++SD GLA       + H    V GTHGY 
Sbjct: 304 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYM 357

Query: 70  APEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVGIEQSLVDWAKPYLSDKRK 126
           APE +  G     S D +S G +L +LL G       KTK                DK +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------------DKHE 401

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           + R  +   +  + P   +    +L    L  +   R
Sbjct: 402 IDRMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRR 436

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 87.4 bits (217), Expect = 9e-21
 Identities = 41/195 (21%), Positives = 70/195 (35%), Gaps = 39/195 (20%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----------GPTGDRTH 57
           A+ + FLH     +++RD K SNI    +   K+ DFGL  A                  
Sbjct: 128 AEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             T  +GT  Y +PE +     + K D++S G++L ELL            +E+      
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST------QMERVRT--- 236

Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEPKLRPRMSEVLA--IL 172
                    L  + +     ++P            +    L+  P  RP    ++   + 
Sbjct: 237 ---------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

Query: 173 ERLEAPKNSAKLSQS 187
           E L+ P  +    +S
Sbjct: 284 EDLDFPGKTVLRQRS 298

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.1 bits (221), Expect = 1e-20
 Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 30/159 (18%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA     G          GT G+ 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFM 356

Query: 70  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK--- 126
           APE +         D ++ GV L E+++ R                   P+ +   K   
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARG------------------PFRARGEKVEN 398

Query: 127 --LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
             L + +++  +   YP K +  +       L  +P+ R
Sbjct: 399 KELKQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKR 435

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.1 bits (213), Expect = 1e-19
 Identities = 27/100 (27%), Positives = 40/100 (40%), Gaps = 12/100 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
           +   +     L++LH     ++Y D K  NI+L  E   KL D G        G      
Sbjct: 185 IAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------ 235

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
             + GT G+ APE +     T  +D+Y+ G  L  L    
Sbjct: 236 -YLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL 273

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 84.6 bits (210), Expect = 1e-19
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G     T   T    GT  Y
Sbjct: 122 ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +  G     S D ++ GV++ E+++GR   D               P  + +  L
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNPDQNTEDYL 227

Query: 128 FR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           F+ I++ ++  + P+  +  AA++    LN +PK R
Sbjct: 228 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 41/175 (23%), Positives = 63/175 (36%), Gaps = 31/175 (17%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRT-HVSTQ 61
             GL  LH     +++RD K  NIL+       +  A +SDFGL K    G  +    + 
Sbjct: 128 TSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 62  VMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           V GT G+ APE +        T   D++S G V   ++S                     
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH----------------- 228

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEVLA 170
           P+    ++   I+             H    A  L  + +  +P+ RP    VL 
Sbjct: 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 83.1 bits (206), Expect = 2e-19
 Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 27/174 (15%)

Query: 10  GLTFLHD---AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGT 65
            L   H        V++RD K +N+ LD + N KL DFGLA+            T V GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GT 179

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
             Y +PE +       KSD++S G +L EL +                   A        
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFSQKELAG 226

Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLE 176
           K+      ++  +Y  +       +  + LN +   RP + E+L    ILE   
Sbjct: 227 KIREGKFRRIPYRYSDELNE----IITRMLNLKDYHRPSVEEILENPLILEHHH 276

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 84.3 bits (209), Expect = 3e-19
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G     T   T    GT  Y
Sbjct: 165 ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
            APE +  G     S D ++ GV++ E+++GR   D               P  + +  L
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNPDQNTEDYL 270

Query: 128 FR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           F+ I++ ++  + P+  +  AA++    LN +PK R
Sbjct: 271 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 304

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 82.5 bits (204), Expect = 9e-19
 Identities = 42/225 (18%), Positives = 74/225 (32%), Gaps = 42/225 (18%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTH 57
           +K+     + +  +H  +  +I+RD K  N+LL  +   KL DFG A      P    + 
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 58  VSTQVM-------GTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCA-VDKTK 106
               ++        T  Y  PE +       +  K D+++ G +L  L   +    D  K
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258

Query: 107 VGIEQSLVDW--AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 164
           + I              +    L R M                       L   P+ R  
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAM-----------------------LQVNPEERLS 295

Query: 165 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSP 209
           ++EV+  L+ + A +N   ++   P  +              R P
Sbjct: 296 IAEVVHQLQEIAAARN---VNPKSPITELLEQNGGYGSATLSRGP 337

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 1e-18
 Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 30/157 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L FLH  +  +IYRD K  N+LLD E + KL+DFG+ K G     T   T    GT  Y
Sbjct: 136 ALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDY 190

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE +    L   + D ++ GV+L E+L G                    P    ++  
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHA------------------PFEAENEDD 231

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           LF  I++ ++   YP      A  +    +   P +R
Sbjct: 232 LFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 82.1 bits (203), Expect = 1e-18
 Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 9/96 (9%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
               +++H  E  + +RD K SNIL+D     KLSDFG ++               GT+ 
Sbjct: 161 LNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK---G-SRGTYE 215

Query: 68  YAAPEYVATGRLTT---KSDVYSFGVVLLELLSGRC 100
           +  PE   +   +    K D++S G+ L  +     
Sbjct: 216 FMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.9 bits (203), Expect = 1e-18
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 30/157 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L +LH     V+YRD K  N++LD + + K++DFGL K G +   T    +   GT  Y
Sbjct: 117 ALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEY 171

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE V       ++ D +  GVV+ E++ GR                   P Y  D  +
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PFYNQDHER 212

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           LF  I+  ++  ++P+  +  A +L    L  +PK R
Sbjct: 213 LFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 247

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.4 bits (202), Expect = 2e-18
 Identities = 49/158 (31%), Positives = 67/158 (42%), Gaps = 32/158 (20%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L  LH     +IYRD K  NILLD E + KL+DFGL+K     ++         GT  Y
Sbjct: 138 ALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEY 192

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--YLSDKR 125
            APE V   R  T+S D +SFGV++ E+L+G                          D++
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT-------------------LPFQGKDRK 232

Query: 126 KLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           +    I+  KL    PQ  +  A +L        P  R
Sbjct: 233 ETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.5 bits (202), Expect = 2e-18
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 30/157 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD     T    GT  Y
Sbjct: 130 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE +  G+    S D +SFGV+L E+L G+                   P +  D+ +
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEE 225

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           LF  I        YP+     A  L ++    EP+ R
Sbjct: 226 LFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKR 260

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 81.3 bits (201), Expect = 2e-18
 Identities = 37/162 (22%), Positives = 63/162 (38%), Gaps = 27/162 (16%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK--AGPTGDRTHVSTQVM-G 64
           +GL +LH    ++++ D KA N+LL ++   A L DFG A         ++ ++   + G
Sbjct: 161 EGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 122
           T  + APE V       K D++S   ++L +L+G                    P+    
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------------------HPWTQYF 260

Query: 123 DKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 163
                 +I  +     + P   A   A    + L  EP  R 
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.5 bits (202), Expect = 2e-18
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 30/157 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
           GL FL      +IYRD K  N++LD+E + K++DFG+ K       T   T+   GT  Y
Sbjct: 133 GLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 187

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE +   +   KS D ++FGV+L E+L+G+                   P    D+ +
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGEDEDE 228

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           LF+ IM+  +   YP+  +  A  +    +   P  R
Sbjct: 229 LFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 80.0 bits (198), Expect = 4e-18
 Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 17/182 (9%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K A+   KG+ +L     Q ++RD  A N+L+++E   K+ DFGL KA  T    +   
Sbjct: 129 LKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
                       + APE +   +    SDV+SFGV L ELL+  C  D + + +   ++ 
Sbjct: 187 D----DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIG 241

Query: 116 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILE 173
                ++  R +  + +   G + P           L  +C   +P  R     ++   E
Sbjct: 242 PTHGQMTVTRLVNTLKE---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

Query: 174 RL 175
            L
Sbjct: 299 AL 300

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.6 bits (201), Expect = 4e-18
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 30/157 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
           GL FL      +IYRD K  N++LD+E + K++DFG+ K       T   T+   GT  Y
Sbjct: 454 GLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 508

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE +   +   KS D ++FGV+L E+L+G+                   P    D+ +
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGEDEDE 549

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           LF+ IM+  +   YP+  +  A  +    +   P  R
Sbjct: 550 LFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.9 bits (200), Expect = 5e-18
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 29/157 (18%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T    +   GT  Y
Sbjct: 260 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEY 315

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE V       ++ D +  GVV+ E++ GR                   P Y  D  K
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PFYNQDHEK 356

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           LF  I+  ++  ++P+     A +L    L  +PK R
Sbjct: 357 LFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.4 bits (199), Expect = 6e-18
 Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 30/157 (19%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L +LH     ++YRD K  NILLD++ +  L+DFGL K     + T   T    GT  Y
Sbjct: 151 ALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 126
            APE V   +   ++ D +  G VL E+L G                    P Y  +  +
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLP------------------PFYSRNTAE 246

Query: 127 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           ++  I++  L  Q      ++A  L    L  +   R
Sbjct: 247 MYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKR 281

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 79.6 bits (197), Expect = 8e-18
 Identities = 40/181 (22%), Positives = 73/181 (40%), Gaps = 36/181 (19%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
            +  AKG+ +L   + ++++RD  A N+L+    + K++DFGLAK     ++ +      
Sbjct: 123 CVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----H 175

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 117
              G     + A E +     T +SDV+S+GV + EL++ G                   
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS------------------ 217

Query: 118 KPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           KPY  D      I      G+    P         +  +C   +   RP+  E++    +
Sbjct: 218 KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275

Query: 175 L 175
           +
Sbjct: 276 M 276

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 79.9 bits (197), Expect = 8e-18
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 21/106 (19%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG            VS Q
Sbjct: 135 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQ 181

Query: 62  --------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
                    +GT  Y +PE +     + +SD++S G+ L+E+  GR
Sbjct: 182 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 80.1 bits (197), Expect = 8e-18
 Identities = 22/165 (13%), Positives = 43/165 (26%), Gaps = 18/165 (10%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
            +    L      +++  F   N+ +  +    L D        T               
Sbjct: 204 IRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSVPVT 256

Query: 68  YAAPEYV--ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
           YA  E++  +T   T   + +  G+ +  +            GI+             + 
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG---------SWKRP 307

Query: 126 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
            L       L             TL  + LN + + R    E + 
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.5 bits (197), Expect = 8e-18
 Identities = 40/158 (25%), Positives = 61/158 (38%), Gaps = 32/158 (20%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 68
            L  LH  +  +IYRD K  NI+L+ + + KL+DFGL K           T    GT  Y
Sbjct: 133 ALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEY 187

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--YLSDKR 125
            APE +       ++ D +S G ++ ++L+G                    P     +++
Sbjct: 188 MAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA-------------------PPFTGENRK 227

Query: 126 KLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
           K    I+  KL    P      A  L  + L      R
Sbjct: 228 KTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 79.7 bits (196), Expect = 1e-17
 Identities = 17/110 (15%), Positives = 37/110 (33%), Gaps = 19/110 (17%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++ +   + L  LH     +++   +  +I+LD      L+ F          R     
Sbjct: 209 LQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARV 260

Query: 61  QVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGR 99
               + G+  PE  A              +T   D ++ G+V+  +    
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 78.4 bits (194), Expect = 1e-17
 Identities = 29/92 (31%), Positives = 42/92 (45%), Gaps = 6/92 (6%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L + H  E +VI+RD K  N+L+  +   K++DFG +   P   R        GT  
Sbjct: 124 ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLD 177

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           Y  PE +       K D++  GV+  E L G 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 78.4 bits (194), Expect = 1e-17
 Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 37/179 (20%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+A+   K L  LH  +  VI+RD K SN+L++A    K+ DFG+  +G   D       
Sbjct: 113 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDID 169

Query: 62  VMGTHGYAAPEYVATGRL----TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             G   Y APE +         + KSD++S G+ ++EL   R                  
Sbjct: 170 A-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR------------------ 210

Query: 118 KPYLSDK---RKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            PY S     ++L ++++    +L   ++  +     +    QCL    K RP   E++
Sbjct: 211 FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS----QCLKKNSKERPTYPELM 265

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 2e-17
 Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 33/161 (20%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +L     ++I+RD K  NILLD   +  ++DF +A   P   +    T + GT  Y 
Sbjct: 127 ALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYM 181

Query: 70  APEYVATGRLT--TKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL----S 122
           APE  ++ +    + + D +S GV   ELL GR                  +PY     +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR------------------RPYHIRSST 223

Query: 123 DKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
             +++      T +   YP   +    +L  + L   P  R
Sbjct: 224 SSKEIVHTFETTVV--TYPSAWSQEMVSLLKKLLEPNPDQR 262

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 78.2 bits (193), Expect = 2e-17
 Identities = 41/188 (21%), Positives = 68/188 (36%), Gaps = 27/188 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTH 57
           + + +G  +GL  +H       +RD K +NILL  E    L D G          G R  
Sbjct: 137 LWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 58  VSTQVM----GTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 110
           ++ Q       T  Y APE  +      +  ++DV+S G VL  ++ G    D      +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 111 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
                      S    +   +      ++          L    +  +P  RP +  +L+
Sbjct: 255 -----------SVALAVQNQLSIPQSPRHSSALWQ----LLNSMMTVDPHQRPHIPLLLS 299

Query: 171 ILERLEAP 178
            LE L+ P
Sbjct: 300 QLEALQPP 307

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 78.9 bits (194), Expect = 2e-17
 Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 18/109 (16%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++ +   + L  LH     +++   +  +I+LD      L+ F          R   S 
Sbjct: 214 LQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGASA 265

Query: 61  QVMGTHGYAAPEYVA----------TGRLTTKSDVYSFGVVLLELLSGR 99
                 G+A PE  A             +T   D ++ G+ +  +    
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 2e-17
 Identities = 53/178 (29%), Positives = 72/178 (40%), Gaps = 37/178 (20%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV----- 62
           AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                   
Sbjct: 203 AKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260

Query: 63  -MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 120
            M      APE +     T +SDV+SFGV+L E+ S         +G        A PY 
Sbjct: 261 WM------APETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYP 297

Query: 121 -LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +    +  R +  K G +   P           L C + EP  RP  SE++  L  L
Sbjct: 298 GVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 51/180 (28%), Positives = 76/180 (42%), Gaps = 19/180 (10%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A    +G+ +LH      I+RD  A N+LLD +   K+ DFGLAKA P G         +
Sbjct: 140 AQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRV 193

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              G     + APE +   +    SDV+SFGV L ELL+  C  D ++    + L     
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HC--DSSQSPPTKFLELIGI 250

Query: 119 PYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                +  + R+ +    G+    P K       L   C   E   RP    ++ IL+ +
Sbjct: 251 AQ--GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 3e-17
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  RT     + GT  
Sbjct: 119 ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D-LCGTLD 172

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           Y  PE +       K D++S GV+  E L G+
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 77.3 bits (191), Expect = 3e-17
 Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 20/181 (11%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
                KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P         +  
Sbjct: 120 TSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE-- 175

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              G     + APE +   + +  SDV+SFGVVL EL +             + +     
Sbjct: 176 --PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI--GND 231

Query: 119 PYLSDKRKLFRIMDTKLGGQY----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
                +  +F +++  L        P         +  +C NN    RP   ++   +++
Sbjct: 232 KQ--GQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288

Query: 175 L 175
           +
Sbjct: 289 I 289

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 77.8 bits (192), Expect = 3e-17
 Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 18/194 (9%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           +    KG+ +L     + ++RD  A NIL+++E + K++DFGLAK  P          V+
Sbjct: 133 SSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVV 186

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              G     + APE ++    + +SDV+SFGVVL EL +  C    +       ++   +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCER 245

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILERL- 175
              +  R L  + +   G + P   A  A    L   C    P+ RP  S +   L+ L 
Sbjct: 246 DVPALSRLLELLEE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302

Query: 176 EAPKNSAKLSQSEP 189
              +     + +  
Sbjct: 303 SGSRGCETHAFTAH 316

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 32/169 (18%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG +K          +    GT  
Sbjct: 133 EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQ 188

Query: 68  YAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
           Y APE +     G     +D++S G  ++E+ +G+                   P+  + 
Sbjct: 189 YMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK------------------PPF-YEL 228

Query: 125 RK----LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            +    +F++   K+  + P+  +  A    L+C   +P  R   +++L
Sbjct: 229 GEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 77.4 bits (191), Expect = 4e-17
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 57/212 (26%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTHVS 59
           K+ +   K L +L + +  VI+RD K SNILLD     KL DFG++     G        
Sbjct: 128 KMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAK 181

Query: 60  TQVMGTHGYAAPEYVATGRL-----TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 114
            +  G   Y APE +            ++DV+S G+ L+EL +G+               
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--------------- 226

Query: 115 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 169
               PY  + +  F ++   L  + P    H   +         CL  + + RP+ +++L
Sbjct: 227 ---FPY-KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282

Query: 170 A--------------------ILERLEAPKNS 181
                                ++ + E+P++ 
Sbjct: 283 EHSFIKRYETLEVDVASWFKDVMAKTESPRSG 314

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 78.3 bits (193), Expect = 5e-17
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 35/180 (19%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     + T       
Sbjct: 286 AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK 342

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY-- 120
               + APE    GR T KSDV+SFG++L EL + GR                   PY  
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------------------VPYPG 384

Query: 121 LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + ++  L ++     M        P +   +   L  QC   EP+ RP    + A LE  
Sbjct: 385 MVNREVLDQVERGYRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 77.4 bits (191), Expect = 5e-17
 Identities = 45/220 (20%), Positives = 87/220 (39%), Gaps = 36/220 (16%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
            +  AKG+ +L   E  +++R+  A N+LL +    +++DFG+A   P  D      Q++
Sbjct: 121 GVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLL 173

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 117
            +       + A E +  G+ T +SDV+S+GV + EL++ G                   
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA------------------ 215

Query: 118 KPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           +PY     +L  + D    G+    PQ        + ++C   +  +RP   E+     R
Sbjct: 216 EPY--AGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273

Query: 175 LEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTP 214
           +        + + E      P         ++   + + P
Sbjct: 274 MARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 77.9 bits (192), Expect = 6e-17
 Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 36/202 (17%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   +  + +L   +   I+R+  A N L+      K++DFGL++   TGD      
Sbjct: 321 LYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHA 377

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 119
                  + APE +A  + + KSDV++FGV+L E+ + G                    P
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------------------SP 419

Query: 120 Y--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
           Y  +   +    +     M+       P+        L   C    P  RP  +E+    
Sbjct: 420 YPGIDLSQVYELLEKDYRMER------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

Query: 173 ERL-EAPKNSAKLSQSEPHRQT 193
           E + +    S ++ +    R T
Sbjct: 474 ETMFQESSISDEVEKELGKRGT 495

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 77.0 bits (190), Expect = 7e-17
 Identities = 37/111 (33%), Positives = 51/111 (45%), Gaps = 26/111 (23%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
           K+ +   K L  L +   ++I+RD K SNILLD   N KL DFG            +S Q
Sbjct: 129 KITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFG------------ISGQ 175

Query: 62  VM---------GTHGYAAPEYVATGRL----TTKSDVYSFGVVLLELLSGR 99
           ++         G   Y APE +           +SDV+S G+ L EL +GR
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.0 bits (190), Expect = 8e-17
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 39/213 (18%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +  G A G+ +L  ++   ++RD  A NIL+++    K+SDFGL +          +T
Sbjct: 150 VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207

Query: 61  QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
           +  G      + +PE +A  + T+ SDV+S+G+VL E++S G                  
Sbjct: 208 R--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE----------------- 248

Query: 117 AKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVL 169
            +PY  +S++  +  + +   G + P       A +    L L C   +   RP+  +++
Sbjct: 249 -RPYWEMSNQDVIKAVDE---GYRLPPPMDCPAALY---QLMLDCWQKDRNNRPKFEQIV 301

Query: 170 AILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 202
           +IL++L     S K+  S   R +  +  + + 
Sbjct: 302 SILDKLIRNPGSLKIITSAAARPSNLLLDQSNV 334

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 18/180 (10%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
                KG+ +L     + I+RD    NIL++ E   K+ DFGL K  P     +      
Sbjct: 151 TSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK--- 205

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              G     + APE +   + +  SDV+SFGVVL EL +             + + +  +
Sbjct: 206 -EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264

Query: 119 PYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
             +     +  + +          P         +  +C NN    RP   ++   ++++
Sbjct: 265 GQMIVFHLIELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.1 bits (188), Expect = 1e-16
 Identities = 28/90 (31%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 143 LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 71  PEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           PE + T +   KS D+++ G ++ +L++G 
Sbjct: 201 PE-LLTEKSACKSSDLWALGCIIYQLVAGL 229

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.7 bits (187), Expect = 1e-16
 Identities = 45/202 (22%), Positives = 73/202 (36%), Gaps = 37/202 (18%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
            ++    + G+ +L   E   ++RD  A N+LL     AK+SDFGL+KA    D  + + 
Sbjct: 113 AELLHQVSMGMKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
                 G     + APE +   + +++SDV+S+GV + E LS G+               
Sbjct: 171 S----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------- 211

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLA 170
              KPY  +     +  I     G +             L   C   + + RP    V  
Sbjct: 212 ---KPYKKMKGPEVMAFIEQ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265

Query: 171 ILERLEAPKNSAKLSQSEPHRQ 192
            +        S        H  
Sbjct: 266 RMRACYYSLASKVEGHHHHHHH 287

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 76.2 bits (188), Expect = 1e-16
 Identities = 40/181 (22%), Positives = 74/181 (40%), Gaps = 36/181 (19%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
            +  AKG+ +L   + ++++RD  A N+L+    + K++DFGLAK     ++ +      
Sbjct: 123 CVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----H 175

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 117
              G     + A E +     T +SDV+S+GV + EL++ G                   
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS------------------ 217

Query: 118 KPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 174
           KPY  D      I      G+    P         + ++C   +   RP+  E++    +
Sbjct: 218 KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275

Query: 175 L 175
           +
Sbjct: 276 M 276

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 42/188 (22%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHV 58
           +   +  AKG+ +L  A  + ++RD  A N +LD +F  K++DFGLA+     +    H 
Sbjct: 131 IGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188

Query: 59  STQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 111
            T        M      A E + T + TTKSDV+SFGV+L EL++ G             
Sbjct: 189 KTGAKLPVKWM------ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------ 230

Query: 112 SLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSE 167
                  PY  ++       ++    G     P+        + L+C + + ++RP  SE
Sbjct: 231 ------PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281

Query: 168 VLAILERL 175
           +++ +  +
Sbjct: 282 LVSRISAI 289

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 76.2 bits (188), Expect = 2e-16
 Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 45/186 (24%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K          S+
Sbjct: 292 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASS 341

Query: 61  QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
                     + APE +   + +TKSDV+SFG++L E+ S GR                 
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------- 385

Query: 117 AKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             PY  +  K  + R+     MD       P         +   C + +   RP   ++ 
Sbjct: 386 --PYPRIPLKDVVPRVEKGYKMDA------PDGCPPAVYDVMKNCWHLDAATRPTFLQLR 437

Query: 170 AILERL 175
             LE +
Sbjct: 438 EQLEHI 443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 76.5 bits (188), Expect = 2e-16
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 35/180 (19%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     + T       
Sbjct: 369 AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK 425

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY-- 120
               + APE    GR T KSDV+SFG++L EL + GR                   PY  
Sbjct: 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------------------VPYPG 467

Query: 121 LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + ++  L ++     M        P +   +   L  QC   EP+ RP    + A LE  
Sbjct: 468 MVNREVLDQVERGYRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 76.3 bits (188), Expect = 2e-16
 Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 41/186 (22%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  +   A+G+ F+   +   I+RD +A+NIL+ A    K++DFGLA+     D  + + 
Sbjct: 287 IDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAR 342

Query: 61  QVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
           +  G      + APE +  G  T KSDV+SFG++L+E+++ GR                 
Sbjct: 343 E--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI---------------- 384

Query: 117 AKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             PY  +S+   +  +     M        P+        + ++C  N P+ RP    + 
Sbjct: 385 --PYPGMSNPEVIRALERGYRMPR------PENCPEELYNIMMRCWKNRPEERPTFEYIQ 436

Query: 170 AILERL 175
           ++L+  
Sbjct: 437 SVLDDF 442

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.4 bits (186), Expect = 3e-16
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 27/159 (16%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L  LH  +  +IYRD K  NILLD+  +  L+DFGL+K     +         GT  Y 
Sbjct: 171 ALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYM 227

Query: 70  APEYVATGRL-TTKS-DVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAKPYLSDK 124
           AP+ V  G     K+ D +S GV++ ELL+G        +                   +
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----------------SQ 271

Query: 125 RKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
            ++ R I+ ++    YPQ+ +  A  L  + L  +PK R
Sbjct: 272 AEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKR 308

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.0 bits (185), Expect = 3e-16
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 36/182 (19%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +  
Sbjct: 127 AVQVAEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-- 182

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 117
             H      + APE + T   +  SD + FGV L E+ + G+                  
Sbjct: 183 --HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------ 222

Query: 118 KPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILE 173
           +P+        +I+    K G + P+          + +QC  ++P+ RP    +   L 
Sbjct: 223 EPW--IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

Query: 174 RL 175
             
Sbjct: 281 EA 282

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 76.3 bits (187), Expect = 3e-16
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMG 64
           +  L +LH  E+++I+RD K  NI+L         K+ D G AK    G    + T+ +G
Sbjct: 131 SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVG 185

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           T  Y APE +   + T   D +SFG +  E ++G 
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 74.5 bits (184), Expect = 4e-16
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 32/167 (19%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTH 66
             G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V     GT 
Sbjct: 125 VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTP 179

Query: 67  GYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 125
            Y APE V + +  + + DV+S G ++  LL G+   + + +                 +
Sbjct: 180 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------------K 221

Query: 126 KLF-RIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           + + RI       +Y  P+     AA+L  + L  +P  RP ++E+L
Sbjct: 222 ETYLRIKK----NEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 74.5 bits (184), Expect = 4e-16
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTH 66
             G+ +LH     +++RD   SN+LL    N K++DFGLA +     ++ +      GT 
Sbjct: 122 ITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTP 176

Query: 67  GYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            Y +PE +AT      +SDV+S G +   LL GR
Sbjct: 177 NYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 74.3 bits (183), Expect = 6e-16
 Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 40/198 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHV 58
           ++  +  A G+ +L  +    I+RD  A N +L  +    ++DFGL++   +GD  R   
Sbjct: 140 VRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197

Query: 59  STQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
           ++++    +      A E +A    T  SDV++FGV + E+++ G+              
Sbjct: 198 ASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ-------------- 237

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                PY  + +      ++    G   + P +       L  QC + +PK RP  + + 
Sbjct: 238 ----TPYAGIENAEIYNYLIG---GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290

Query: 170 AILERLEAPKNSAKLSQS 187
             LE +    +    SQ 
Sbjct: 291 MELENILGHLSVLSTSQD 308

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 74.3 bits (183), Expect = 7e-16
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 39/206 (18%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +  G A G+ +L  A    ++RD  A NIL+++    K+SDFGL++          +T
Sbjct: 150 VGMLRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207

Query: 61  QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
              G      + APE ++  + T+ SDV+SFG+V+ E+++ G                  
Sbjct: 208 S--GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE----------------- 248

Query: 117 AKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVL 169
            +PY  LS+   +  I D   G + P       A +    L +QC   E   RP+ ++++
Sbjct: 249 -RPYWELSNHEVMKAIND---GFRLPTPMDCPSAIY---QLMMQCWQQERARRPKFADIV 301

Query: 170 AILERLEAPKNSAKLSQSEPHRQTGP 195
           +IL++L    +S K       R +  
Sbjct: 302 SILDKLIRAPDSLKTLADFDPRVSIR 327

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 73.8 bits (182), Expect = 7e-16
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 10  GLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           G+ +LH    Q +I+RD K SN+L+  + + K++DFG++     G    +S  V GT  +
Sbjct: 149 GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLSNTV-GTPAF 203

Query: 69  AAPEYVATGRLT---TKSDVYSFGVVLLELLSGRC 100
            APE ++  R        DV++ GV L   + G+C
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 74.8 bits (184), Expect = 7e-16
 Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 48/191 (25%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKLSDFGLAK---AGP 51
           A G+  LH    ++I+RD K  NIL+                    +SDFGL K   +G 
Sbjct: 125 ASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 52  TGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 104
           +  RT+++    GT G+ APE            RLT   D++S G V   +LS       
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------ 235

Query: 105 TKVGIEQSLVDWAKPYLSDKRKLFRIMD-----TKLGGQYPQKAAHTAATLALQCLNNEP 159
              G          P+     +   I+       ++   + +     A  L  Q ++++P
Sbjct: 236 ---GKH--------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284

Query: 160 KLRPRMSEVLA 170
             RP   +VL 
Sbjct: 285 LKRPTAMKVLR 295

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 74.9 bits (184), Expect = 8e-16
 Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   +  L +L     + ++RD  A N+L+ +    KL DFGL++          ST
Sbjct: 494 ILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDST 545

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
               + G     + APE +   R T+ SDV+ FGV + E+L  G                
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--------------- 590

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
              KP+  + +   + RI +   G     P     T  +L  +C   +P  RPR +E+ A
Sbjct: 591 ---KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

Query: 171 ILERL 175
            L  +
Sbjct: 645 QLSTI 649

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 73.9 bits (182), Expect = 9e-16
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTH 66
             G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V     GT 
Sbjct: 151 VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTP 205

Query: 67  GYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
            Y APE V + +  + + DV+S G ++  LL G+
Sbjct: 206 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 42/206 (20%), Positives = 76/206 (36%), Gaps = 44/206 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   +  + +L   +   I+RD  A N L+      K++DFGL++         ++ 
Sbjct: 114 LYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTG 163

Query: 61  QVMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 112
                H  A       APE +A  + + KSDV++FGV+L E+ + G              
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 211

Query: 113 LVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                 PY  +   +    +         + P+        L   C    P  RP  +E+
Sbjct: 212 ------PYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

Query: 169 LAILERL-EAPKNSAKLSQSEPHRQT 193
               E + +    S ++ +    R T
Sbjct: 263 HQAFETMFQESSISDEVEKELGKRGT 288

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.0 bits (180), Expect = 1e-15
 Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 40/191 (20%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           ++   K + +L       ++RD    NIL+ +    KL DFGL++     D  +      
Sbjct: 119 SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-- 172

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 117
                    + +PE +   R TT SDV+ F V + E+LS G+                  
Sbjct: 173 --VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK------------------ 212

Query: 118 KPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           +P+  L +K  +  +     G     P        TL  +C + +P  RPR +E++  L 
Sbjct: 213 QPFFWLENKDVIGVLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269

Query: 174 RL-EAPKNSAK 183
            + +  K+ A 
Sbjct: 270 DVYQMEKDIAM 280

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 41/207 (19%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHV 58
           +++A   A G+ +L    ++ ++RD  A N ++  +F  K+ DFG+ +     D  R   
Sbjct: 141 IQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198

Query: 59  STQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
              +    M      +PE +  G  TT SDV+SFGVVL E+ +                 
Sbjct: 199 KGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 238

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
               +PY  LS+++ L  +M+   GG    P         L   C    PK+RP   E++
Sbjct: 239 ----QPYQGLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

Query: 170 AILER-LEAPKNSAKLSQSEPHRQTGP 195
           + ++  +E          SE ++   P
Sbjct: 292 SSIKEEMEPGFREVSFYYSEENKLPEP 318

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 42/201 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++            
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EV 194

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
            V  T G     + A E +     TT SDV+S+GV+L E++S G                
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------- 239

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               PY  ++      ++     G   + P         L  QC   +P  RP  +++L 
Sbjct: 240 ---TPYCGMTCAELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293

Query: 171 ILER-LEAPKNSAKLSQSEPH 190
            L R LE  K     +  E  
Sbjct: 294 SLNRMLEERKTYVNTTLYEKF 314

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 49/196 (25%), Positives = 70/196 (35%), Gaps = 53/196 (27%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPT 52
           ++VA   A  + FL   E+ +I+ +  A NILL  E +         KLSD G++     
Sbjct: 116 LEVAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--- 170

Query: 53  GDRTHVSTQVMGTHGY------AAPEYVATGRL-TTKSDVYSFGVVLLELLS-GRCAVDK 104
                    V+             PE +   +     +D +SFG  L E+ S G      
Sbjct: 171 ---------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD----- 216

Query: 105 TKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
                        KP   L  +RKL    D     Q P   A   A L   C++ EP  R
Sbjct: 217 -------------KPLSALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHR 260

Query: 163 PRMSEVLAILERLEAP 178
           P    ++  L  L  P
Sbjct: 261 PSFRAIIRDLNSLFTP 276

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 42/188 (22%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRT 56
           +   +  A+G+ +L  AE + ++RD  A N +LD  F  K++DFGLA+          + 
Sbjct: 127 ISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184

Query: 57  HVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 111
           H   ++           A E + T R TTKSDV+SFGV+L ELL+ G             
Sbjct: 185 HRHARLPVKWT------ALESLQTYRFTTKSDVWSFGVLLWELLTRGA------------ 226

Query: 112 SLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSE 167
                  PY  +        +     G     P+    +   +  QC   +P +RP    
Sbjct: 227 ------PPYRHIDPFDLTHFLAQ---GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRV 277

Query: 168 VLAILERL 175
           ++  +E++
Sbjct: 278 LVGEVEQI 285

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 40/187 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ FL  A  + ++RD  A N +LD +F  K++DFGLA+     D      
Sbjct: 195 IGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEF 247

Query: 61  QVMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 112
             +     A       A E + T + TTKSDV+SFGV+L EL++ G              
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------- 294

Query: 113 LVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                 PY  ++       ++    G     P+        + L+C + + ++RP  SE+
Sbjct: 295 -----PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346

Query: 169 LAILERL 175
           ++ +  +
Sbjct: 347 VSRISAI 353

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 72.3 bits (178), Expect = 2e-15
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 11/99 (11%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
               + G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    +  + +    
Sbjct: 123 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-- 178

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
             HG     + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 179 --HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 73.8 bits (181), Expect = 2e-15
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 11/99 (11%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
               + G+ +L   E   ++R+  A N+LL     AK+SDFGL+KA    D  + +    
Sbjct: 442 LHQVSMGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-- 497

Query: 64  GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 97
              G     + APE +   + +++SDV+S+GV + E LS
Sbjct: 498 --AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 72.3 bits (178), Expect = 3e-15
 Identities = 42/186 (22%), Positives = 75/186 (40%), Gaps = 40/186 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHV 58
           +K  +  A G+ +L  +    ++RD  A N +L  +    ++DFGL+K   +GD  R   
Sbjct: 150 LKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207

Query: 59  STQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
             ++    +      A E +A    T+KSDV++FGV + E+ + G               
Sbjct: 208 IAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGM-------------- 247

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                PY  + +      ++    G   + P+        +   C   +P  RP  S + 
Sbjct: 248 ----TPYPGVQNHEMYDYLLH---GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300

Query: 170 AILERL 175
             LE+L
Sbjct: 301 LQLEKL 306

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 72.3 bits (178), Expect = 3e-15
 Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 40/186 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  
Sbjct: 161 LAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218

Query: 61  QV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
           +       M       PE +   + TT+SDV+SFGVVL E+ + G+              
Sbjct: 219 RTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK-------------- 258

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
               +P+  LS+   +  I     G   + P+        +   C   EP+ R  + +V 
Sbjct: 259 ----QPWYQLSNTEAIDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311

Query: 170 AILERL 175
           A L+ L
Sbjct: 312 ARLQAL 317

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 71.9 bits (177), Expect = 3e-15
 Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 43/184 (23%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
           A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+         +     
Sbjct: 115 AAQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLAR--------LIEDNEY 164

Query: 64  GTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 115
                A       APE +  G  T KSDV+SFG++L E+++ GR                
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--------------- 209

Query: 116 WAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 171
              PY  +++   +  +     G +   P         L   C    P+ RP    + ++
Sbjct: 210 ---PYPGMTNPEVIQNLER---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263

Query: 172 LERL 175
           LE  
Sbjct: 264 LEDF 267

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 72.3 bits (177), Expect = 4e-15
 Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 15/111 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----------DAEFNAKLSDFGLAKA 49
           +  A+     +  +HD E  +I+ D K  N +L           D      L D G +  
Sbjct: 175 ISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 50  GPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
                +  + T    T G+   E + + +    + D +     +  +L G 
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.9 bits (177), Expect = 4e-15
 Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 39/186 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  +   A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+     D  + S 
Sbjct: 167 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSN 219

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
            ++  +      + APE +     T +SDV+S+G++L E+ S G                
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN-------------- 265

Query: 115 DWAKPY---LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
               PY   L + +    + D   G Q   P  A     ++   C   EP  RP   ++ 
Sbjct: 266 ----PYPGILVNSKFYKLVKD---GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318

Query: 170 AILERL 175
           + L+  
Sbjct: 319 SFLQEQ 324

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 72.2 bits (177), Expect = 4e-15
 Identities = 38/196 (19%), Positives = 61/196 (31%), Gaps = 37/196 (18%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHV----STQVM 63
           K L ++H      ++R  KAS+IL+  +    LS           G R  V        +
Sbjct: 139 KALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 64  GTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR---CAVDKTKV------GIEQS 112
               + +PE +         KSD+YS G+   EL +G      +  T++      G    
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

Query: 113 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL-------------------Q 153
           L+D +     +            G       +    +                      Q
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 154 CLNNEPKLRPRMSEVL 169
           CL   P  RP  S +L
Sbjct: 317 CLQRNPDARPSASTLL 332

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.5 bits (176), Expect = 5e-15
 Identities = 53/178 (29%), Positives = 72/178 (40%), Gaps = 37/178 (20%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+     D       V     
Sbjct: 158 AKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKGDA 210

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 120
                + APE +     T +SDV+SFGV+L E+ S G                    PY 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------------------PYP 252

Query: 121 -LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +    +  R +  K G   + P           L C + EP  RP  SE++  L  L
Sbjct: 253 GVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.5 bits (176), Expect = 5e-15
 Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           GL +LH     ++++D K  N+LL      K+S  G+A+A              G+  + 
Sbjct: 121 GLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 70  APEYVATGRLT---TKSDVYSFGVVLLELLSGR 99
            PE +A G  T    K D++S GV L  + +G 
Sbjct: 179 PPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 71.1 bits (175), Expect = 5e-15
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 41/183 (22%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
                +G+ FL     Q I+RD  A N L+D +   K+SDFG+        R  +  Q +
Sbjct: 110 CYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT-------RYVLDDQYV 160

Query: 64  GTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
            + G      ++APE     + ++KSDV++FG+++ E+ S G+                 
Sbjct: 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK----------------- 203

Query: 117 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             PY   ++   + ++     G     P  A+ T   +   C +  P+ RP   ++L+ +
Sbjct: 204 -MPYDLYTNSEVVLKVSQ---GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259

Query: 173 ERL 175
           E L
Sbjct: 260 EPL 262

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 71.1 bits (175), Expect = 5e-15
 Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   +  L +L     + ++RD  A N+L+ +    KL DFGL++          ST
Sbjct: 119 ILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDST 170

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
               + G     + APE +   R T+ SDV+ FGV + E+L  G                
Sbjct: 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--------------- 215

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
              KP+  + +   + RI +   G     P     T  +L  +C   +P  RPR +E+ A
Sbjct: 216 ---KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269

Query: 171 ILERL 175
            L  +
Sbjct: 270 QLSTI 274

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.5 bits (176), Expect = 5e-15
 Identities = 47/185 (25%), Positives = 72/185 (38%), Gaps = 51/185 (27%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ FL  A    I+RD  A NILL      K+ DFGLA+             +     
Sbjct: 155 AKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLAR------------DIKNDSN 200

Query: 68  YA------------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
           Y             APE +     T +SDV+S+G+ L EL S G                
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-------------- 246

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               PY  +    K ++++  K G     P+ A      +   C + +P  RP   +++ 
Sbjct: 247 ----PYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 171 ILERL 175
           ++E+ 
Sbjct: 301 LIEKQ 305

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 70.7 bits (174), Expect = 6e-15
 Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 41/183 (22%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
            +   +G+ +L   E+ VI+RD  A N L+      K+SDFG+        R  +  Q  
Sbjct: 110 CLDVCEGMAYL--EEACVIHRDLAARNCLVGENQVIKVSDFGMT-------RFVLDDQYT 160

Query: 64  GTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
            + G      +A+PE  +  R ++KSDV+SFGV++ E+ S G+                 
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK----------------- 203

Query: 117 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             PY   S+   +  I     G     P+ A+     +   C    P+ RP  S +L  L
Sbjct: 204 -IPYENRSNSEVVEDIST---GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

Query: 173 ERL 175
             +
Sbjct: 260 AEI 262

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 38/185 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +      A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D  ++  
Sbjct: 206 VSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
               T+G     + APE +     T +SDV+SFGV++ E+ + G                
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-------------- 304

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               PY  +  +     + +   G     P    +    +   C +  P  RP   +++ 
Sbjct: 305 ----PYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

Query: 171 ILERL 175
            L+R+
Sbjct: 358 DLDRI 362

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 70.7 bits (174), Expect = 7e-15
 Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 47/187 (25%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL        +   ST
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASST 170

Query: 61  QVMG------THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
           Q  G      T    APE +   + +TKSDV+SFG++L E+ S GR              
Sbjct: 171 QDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRV------------- 213

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEV 168
                PY  +  K  + R+      G     P         +   C + +  +RP   ++
Sbjct: 214 -----PYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264

Query: 169 LAILERL 175
              LE +
Sbjct: 265 REQLEHI 271

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 71.2 bits (175), Expect = 7e-15
 Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 43/188 (22%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +  G   G+ +L  ++   ++RD  A N+L+D+    K+SDFGL++          +T
Sbjct: 154 VGMLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
                 G     + APE +A    ++ SDV+SFGVV+ E+L+ G                
Sbjct: 212 T----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE--------------- 252

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSE 167
              +PY  ++++  +  + +   G + P       A H    L L C + +   RPR S+
Sbjct: 253 ---RPYWNMTNRDVISSVEE---GYRLPAPMGCPHALH---QLMLDCWHKDRAQRPRFSQ 303

Query: 168 VLAILERL 175
           ++++L+ L
Sbjct: 304 IVSVLDAL 311

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.2 bits (175), Expect = 8e-15
 Identities = 48/203 (23%), Positives = 82/203 (40%), Gaps = 39/203 (19%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +      A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D  ++  
Sbjct: 160 VSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212

Query: 61  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
               T+G     + APE +     T +SDV+SFGV++ E+ + G                
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-------------- 258

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               PY  +  +     + +   G     P    +    +   C +  P  RP   +++ 
Sbjct: 259 ----PYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

Query: 171 ILER-LEAPKNSAKLSQSEPHRQ 192
            L+R L    N   L  S+P  Q
Sbjct: 312 DLDRILTLTTNEEYLDLSQPLEQ 334

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 70.7 bits (174), Expect = 9e-15
 Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 41/183 (22%)

Query: 4   AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
                + + +L     Q ++RD  A N L++ +   K+SDFGL+       R  +  +  
Sbjct: 126 CKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYT 176

Query: 64  GTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 116
            + G      ++ PE +   + ++KSD+++FGV++ E+ S G+                 
Sbjct: 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK----------------- 219

Query: 117 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
             PY   ++      I     G     P  A+    T+   C + +   RP    +L+ +
Sbjct: 220 -MPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

Query: 173 ERL 175
             +
Sbjct: 276 LDV 278

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 70.3 bits (173), Expect = 1e-14
 Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 40/186 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L  A    ++RD    N L+ A    K+ DFG+++   + D   V  
Sbjct: 136 LHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193

Query: 61  QV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
                   M       PE +   + TT+SDV+SFGV+L E+ + G+              
Sbjct: 194 HTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQ------------- 234

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                P+  LS+   +  I     G   + P+        + L C   EP+ R  + E+ 
Sbjct: 235 -----PWFQLSNTEVIECITQ---GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIY 286

Query: 170 AILERL 175
            IL  L
Sbjct: 287 KILHAL 292

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 127 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 182

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            APE V       K D++S G++ +E++ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 1e-14
 Identities = 42/185 (22%), Positives = 67/185 (36%), Gaps = 51/185 (27%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           AKG+ FL       ++RD  A N+L+      K+ DFGLA+             +M    
Sbjct: 182 AKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR------------DIMSDSN 227

Query: 68  YA------------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 114
           Y             APE +  G  T KSDV+S+G++L E+ S G                
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------------- 273

Query: 115 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               PY  +      ++++  + G     P  A      +   C   + + RP    + +
Sbjct: 274 ----PYPGIPVDANFYKLI--QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327

Query: 171 ILERL 175
            L   
Sbjct: 328 FLGCQ 332

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.9 bits (172), Expect = 1e-14
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 70  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 99
           APE +   R       DV+S G+VL  +L+G 
Sbjct: 175 APE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 33/157 (21%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            L +LH     +IYRD K  NILLD   + K++DFG AK     D T+  T + GT  Y 
Sbjct: 118 ALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY--T-LCGTPDYI 170

Query: 70  APEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--YLSDKRK 126
           APE V + +   KS D +SFG+++ E+L+G                       Y S+  K
Sbjct: 171 APE-VVSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMK 210

Query: 127 LF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 162
            + +I++ +L  ++P         L  + +  +   R
Sbjct: 211 TYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQR 245

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 11/104 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            + +L      +I+RD K  NI++  +F  KL DFG A     G   +      GT  Y 
Sbjct: 142 AVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYC 196

Query: 70  APEYVATGRLTT--KSDVYSFGVVLLELLSGR---CAVDKTKVG 108
           APE V  G      + +++S GV L  L+      C +++T   
Sbjct: 197 APE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 5/91 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
            G+  LH A   +I+RD K SNI++ ++   K+ DFGLA    T   + + T  + T  Y
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +         D++S G ++ E++ G 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 50/167 (29%), Positives = 73/167 (43%), Gaps = 33/167 (19%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH    + I+RD KA+N+LL      KL+DFG+A    T  +   +T  +GT  +
Sbjct: 130 KGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-FVGTPFW 185

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK---R 125
            APE +      +K+D++S G+  +EL  G                   +P  S+    +
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARG-------------------EPPHSELHPMK 226

Query: 126 KLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            LF I       L G Y +            CLN EP  RP   E+L
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 69.8 bits (171), Expect = 2e-14
 Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 17/104 (16%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
             G+  L   E+ +++R+ K  NI+     D +   KL+DFG A+     D     +   
Sbjct: 122 VGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY- 176

Query: 64  GTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 99
           GT  Y  P+      L            D++S GV      +G 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 70.3 bits (172), Expect = 2e-14
 Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 17/104 (16%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 63
             G+  L   E+ +++R+ K  NI+     D +   KL+DFG A+     D     +   
Sbjct: 122 VGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY- 176

Query: 64  GTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 99
           GT  Y  P+      L            D++S GV      +G 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 70  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 99
           APE +   R       DV+S G+VL  +L+G 
Sbjct: 175 APE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L +LH     VI+RD K+ +ILL  +   KLSDFG   A  + D     + V GT  +
Sbjct: 152 QALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLV-GTPYW 207

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            APE ++     T+ D++S G++++E++ G
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 38/178 (21%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           ++G+ +L  AE ++++RD  A NIL+      K+SDFGL++     D     + V  + G
Sbjct: 160 SQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYEEDSYVKRSQG 212

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 120
                + A E +     TT+SDV+SFGV+L E+++ G                    PY 
Sbjct: 213 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------------------PYP 254

Query: 121 -LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
            +  +R    +     G   + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 255 GIPPERLFNLLKT---GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
             +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT   T + GT    A
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCGTPEALA 206

Query: 71  PEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           PE +   +   K+ D ++ GV++ E+ +G 
Sbjct: 207 PE-IILSKGYNKAVDWWALGVLIYEMAAGY 235

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 68.9 bits (169), Expect = 4e-14
 Identities = 25/182 (13%), Positives = 57/182 (31%), Gaps = 48/182 (26%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLD-------------------AEFNAKLSDFGLAK 48
            +GL ++H     +++ D K SNI +                     +   K+ D G   
Sbjct: 125 GRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 49  AGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 107
                  +    +  G   + A E +        K+D+++  + ++              
Sbjct: 183 R-----ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA--------- 227

Query: 108 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 167
                     +P   +  +   I   +L  + PQ  +     L    ++ +P+ RP    
Sbjct: 228 ----------EPLPRNGDQWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMA 276

Query: 168 VL 169
           ++
Sbjct: 277 LV 278

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 69.7 bits (171), Expect = 4e-14
 Identities = 46/195 (23%), Positives = 82/195 (42%), Gaps = 38/195 (19%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           A+G+ +L  A  + I+RD  A N+L+  +   K++DFGLA+     D  H+      T+G
Sbjct: 201 ARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNG 253

Query: 68  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 120
                + APE +     T +SDV+SFGV+L E+ + G                    PY 
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------------PYP 295

Query: 121 -LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
            +  +     + +   G     P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 296 GVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352

Query: 178 PKNSAKLSQSEPHRQ 192
             ++ ++     H  
Sbjct: 353 LTSNQEMGYYHHHHH 367

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 69.3 bits (170), Expect = 4e-14
 Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 40/186 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHV 58
           + +A   A G+ +L  +E + ++RD    N L+      K++DFGL++   + D  +   
Sbjct: 177 LCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234

Query: 59  STQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
           +  +    M       PE +   R TT+SDV+++GVVL E+ S G               
Sbjct: 235 NDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------------- 275

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                PY  ++ +  ++ + D   G     P+        L   C +  P  RP    + 
Sbjct: 276 -----PYYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327

Query: 170 AILERL 175
            IL+R+
Sbjct: 328 RILQRM 333

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.4 bits (168), Expect = 6e-14
 Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 40/184 (21%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHV 58
           + +    A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D  +   
Sbjct: 131 VHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 59  STQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 113
           ++ +    M      APE +  G+ +  SD++S+GVVL E+ S G               
Sbjct: 189 NSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL-------------- 228

Query: 114 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
               +PY   S++  +  I +         P         L ++C N  P  RPR  ++ 
Sbjct: 229 ----QPYCGYSNQDVVEMIRN---RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 281

Query: 170 AILE 173
           + L 
Sbjct: 282 SRLR 285

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.0 bits (169), Expect = 6e-14
 Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 8/95 (8%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            +  +H  +   ++RD K  NIL+D   + +L+DFG             S  V GT  Y 
Sbjct: 187 AIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 243

Query: 70  APEYVATGRLTTKS-----DVYSFGVVLLELLSGR 99
           +PE +              D +S GV + E+L G 
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.0 bits (167), Expect = 8e-14
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            + + H     V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YA
Sbjct: 123 AVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177

Query: 70  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 99
           APE V +GRL    + D++S GV+L  LL G 
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.5 bits (168), Expect = 8e-14
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YA
Sbjct: 120 AIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174

Query: 70  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 99
           APE V  G+L    + DV+S G+VL  +L GR
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 68.6 bits (168), Expect = 9e-14
 Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 10/97 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            +  +H      ++RD K  NILLD   + +L+DFG                V GT  Y 
Sbjct: 174 AIDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYL 230

Query: 70  APEYVATGRLTTKSDVY-------SFGVVLLELLSGR 99
           +PE +        +  Y       + GV   E+  G+
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 68.6 bits (168), Expect = 9e-14
 Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 27/165 (16%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+ +LH     +++RD K  NILL   ++  N K+ DFGL+       +       +GT 
Sbjct: 158 GICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTA 212

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 126
            Y APE V   +   K DV+S GV++  LL G                   +   +D+  
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF-------------GGQ---NDQDI 255

Query: 127 LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
           + ++   K        +  +  A  L    L  +   R    E L
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 30/164 (18%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 69
            + + H  + ++++RD KA N+LLDA+ N K++DFG +     G +        G   YA
Sbjct: 126 AVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYA 180

Query: 70  APEYVATGRLTT--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 127
           APE +  G+     + DV+S GV+L  L+SG    D       Q+L           ++L
Sbjct: 181 APE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNL-----------KEL 222

Query: 128 FRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
              +   L G+Y  P   +     L  + L   P  R  + +++
Sbjct: 223 RERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 31/93 (33%), Positives = 41/93 (44%), Gaps = 7/93 (7%)

Query: 11  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 70
           L  +H      I+RD K  N+LLD   + KL+DFG              T V GT  Y +
Sbjct: 181 LDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237

Query: 71  PEYV----ATGRLTTKSDVYSFGVVLLELLSGR 99
           PE +      G    + D +S GV L E+L G 
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 41/204 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTH 57
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+         
Sbjct: 184 LHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY- 240

Query: 58  VSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 111
                 G           PE    G  T+K+D +SFGV+L E+ S G             
Sbjct: 241 ----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------------ 284

Query: 112 SLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSE 167
                  PY   S++  L  +     GG    P+        +  QC  ++P+ RP  + 
Sbjct: 285 ------MPYPSKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335

Query: 168 VLAILERLEAPKNSAKLSQSEPHR 191
           +L  +E      +    +    + 
Sbjct: 336 ILERIEYCTQDPDVINTALPIEYG 359

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 67.8 bits (166), Expect = 2e-13
 Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 34/190 (17%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
            G+T+LH     +++RD K  N+LL   + +   K+ DFGL+       +     + +GT
Sbjct: 147 SGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGT 201

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDK 124
             Y APE V   +   K DV+S GV+L  LL+G                    P      
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------------------PPFGGQTD 242

Query: 125 RKLFR-IMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAP 178
           +++ R +   K        +  +  A  L  Q L  + + R    + L    I E     
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

Query: 179 KNSAKLSQSE 188
           ++  +L    
Sbjct: 303 ESGIELPSLA 312

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 49/205 (23%), Positives = 76/205 (37%), Gaps = 43/205 (20%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD--R 55
           + VA   A G  +L   E+  I+RD  A N LL        AK+ DFG+A+        R
Sbjct: 143 LHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200

Query: 56  THVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 110
                 +    M       PE    G  T+K+D +SFGV+L E+ S G            
Sbjct: 201 KGGCAMLPVKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY----------- 243

Query: 111 QSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMS 166
                   PY   S++  L  +     GG    P+        +  QC  ++P+ RP  +
Sbjct: 244 -------MPYPSKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293

Query: 167 EVLAILERLEAPKNSAKLSQSEPHR 191
            +L  +E      +    +    + 
Sbjct: 294 IILERIEYCTQDPDVINTALPIEYG 318

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 67.4 bits (165), Expect = 2e-13
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 9/94 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
            G+T++H    ++++RD K  N+LL     + N ++ DFGL+       +       +GT
Sbjct: 137 SGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
             Y APE V  G    K DV+S GV+L  LLSG 
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL +LH    + I+RD KA NILL+ E +AKL+DFG+A    T      +T + GT  +
Sbjct: 136 KGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVI-GTPFW 191

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            APE +        +D++S G+  +E+  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.2 bits (164), Expect = 3e-13
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 5/91 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
            G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229

Query: 69  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            APE +         D++S G ++ E++  +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 66.4 bits (162), Expect = 4e-13
 Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAK---AGPTGDRTHVSTQVMG 64
            L +LH     + +RD K  N L     +   KL DFGL+K       G+   ++T+  G
Sbjct: 180 ALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-G 236

Query: 65  THGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 99
           T  + APE + T       K D +S GV+L  LL G 
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 66.1 bits (162), Expect = 4e-13
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 11/96 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + +  LH     +++RD K  NILLD + N KL+DFG +     G++     +V GT  Y
Sbjct: 135 EVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSY 189

Query: 69  AAPE------YVATGRLTTKSDVYSFGVVLLELLSG 98
            APE               + D++S GV++  LL+G
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 5e-13
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 10/94 (10%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           G+++ H    Q+ +RD K  N LLD       K+ DFG +K+     +    + V GT  
Sbjct: 128 GVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPA 182

Query: 68  YAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 99
           Y APE V   +      +DV+S GV L  +L G 
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.3 bits (162), Expect = 5e-13
 Identities = 36/81 (44%), Positives = 49/81 (60%), Gaps = 6/81 (7%)

Query: 21  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL- 79
           V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YAAPE V +GRL 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLY 192

Query: 80  -TTKSDVYSFGVVLLELLSGR 99
              + D++S GV+L  LL G 
Sbjct: 193 AGPEVDIWSSGVILYALLCGT 213

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGT 65
           +GL +LH  ++  I+RD KA NILL  + + +++DFG++     G    R  V    +GT
Sbjct: 132 EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 66  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
             + APE +   R    K+D++SFG+  +EL +G 
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+T++H     +++RD K  NILL   + + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y APE V  G    K DV+S GV+L  LLSG 
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 6/81 (7%)

Query: 21  VIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           V++RD K  NIL+D      KL DFG   A              GT  Y+ PE++   R 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWIRYHRY 225

Query: 80  T-TKSDVYSFGVVLLELLSGR 99
               + V+S G++L +++ G 
Sbjct: 226 HGRSAAVWSLGILLYDMVCGD 246

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 9/92 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            L + H     V+++D K  NIL          K+ DFGLA+   + + +   T   GT 
Sbjct: 136 ALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE V    +T K D++S GVV+  LL+G
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 2e-12
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 67
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 68  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 45/173 (26%), Positives = 69/173 (39%), Gaps = 39/173 (22%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL+ LH  + +VI+RD K  N+LL      KL DFG++ A         +T  +GT  +
Sbjct: 140 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRRNT-FIGTPYW 195

Query: 69  AAPEYVATGRLT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 123
            APE +A           KSD++S G+  +E+  G                    P L D
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------------------APPLCD 236

Query: 124 K---RKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
               R LF I      +L   ++ +K           CL      RP   +++
Sbjct: 237 MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE----SCLVKNHSQRPATEQLM 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.9 bits (156), Expect = 2e-12
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 6/81 (7%)

Query: 21  VIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
           V++RD K  NIL+D      KL DFG   A    +         GT  Y+ PE+++  + 
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYSPPEWISRHQY 215

Query: 80  T-TKSDVYSFGVVLLELLSGR 99
               + V+S G++L +++ G 
Sbjct: 216 HALPATVWSLGILLYDMVCGD 236

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 63.7 bits (156), Expect = 3e-12
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 9/94 (9%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 64
              + +LH+  + +++RD K  N+L    +      ++DFGL+K    G    + +   G
Sbjct: 116 LSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACG 169

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T GY APE +A    +   D +S GV+   LL G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
             + +LH+  + +I+RD K  N+LL   + +   K++DFG +K             + GT
Sbjct: 250 LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGT 304

Query: 66  HGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 98
             Y APE    V T       D +S GV+L   LSG
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.9 bits (156), Expect = 3e-12
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
            GL  LH+A   V++RD    NILL    +  + DF LA+           T  +    Y
Sbjct: 145 LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWY 199

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE V   +  TK  D++S G V+ E+ + +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 63.2 bits (154), Expect = 5e-12
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 11/96 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + ++FLH   + +++RD K  NILLD     +LSDFG +     G++     ++ GT GY
Sbjct: 211 EAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGY 265

Query: 69  AAPE------YVATGRLTTKSDVYSFGVVLLELLSG 98
            APE               + D+++ GV+L  LL+G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 62.2 bits (152), Expect = 7e-12
 Identities = 28/93 (30%), Positives = 39/93 (41%), Gaps = 9/93 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
             + + H     V +RD K  N L      +   KL DFGLA     G         +GT
Sbjct: 117 SAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             Y +P+ V  G    + D +S GV++  LL G
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 62.3 bits (152), Expect = 8e-12
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + L FLH    ++I+RD KA N+L+  E + +L+DFG++ A          + + GT  +
Sbjct: 128 EALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFI-GTPYW 183

Query: 69  AAPEYVATGRLT-----TKSDVYSFGVVLLELLSG 98
            APE V    +       K+D++S G+ L+E+   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 62.2 bits (152), Expect = 9e-12
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
            G+T++H     +++RD K  NILL   + + + K+ DFGL+       +       +GT
Sbjct: 132 SGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAK-AGPTGDRTHVSTQVMGTH 66
           +GL ++H A   V++RD K +N+ ++ E    K+ DFGLA+   P        ++ + T 
Sbjct: 131 RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 67  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            Y +P  + +    TK+ D+++ G +  E+L+G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 9/94 (9%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 64
              + FLH     + +RD K  N+L    E +A  KL+DFG AK         + T    
Sbjct: 138 GTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-Y 191

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T  Y APE +   +     D++S GV++  LL G
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 30/99 (30%), Positives = 42/99 (42%), Gaps = 23/99 (23%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ------V 62
           +GL +LH     +I+RD KA NILL      KL DFG             ++        
Sbjct: 165 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFG------------SASIMAPANSF 210

Query: 63  MGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSG 98
           +GT  + APE +          K DV+S G+  +EL   
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 50/230 (21%), Positives = 84/230 (36%), Gaps = 35/230 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVM 63
            K + +LH     V++RD K SNIL  D   N    ++ DFG AK     +   +     
Sbjct: 126 TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPC 181

Query: 64  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 123
            T  + APE +         D++S GV+L  +L+G                    P  + 
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF-------------ANGPDDTP 228

Query: 124 KRKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILER 174
           +  L RI      G++          + TA  L  + L+ +P  R   + VL    I+  
Sbjct: 229 EEILARIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

Query: 175 LEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 224
            + P+       +    +   +    S + + +SP+      S L   R 
Sbjct: 285 DQLPQYQLNRQDAPHLVKGA-MAATYSALNRNQSPVLEPVGRSTLAQRRG 333

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 67
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+        T     V+ T  
Sbjct: 131 RGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TLW 184

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           Y APE +      T  D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGT 65
           + +  LH     V +RD K  N+L++      KL DFG AK   P+      + ++    
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--- 196

Query: 66  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
             Y APE +   +  TT  D++S G +  E++ G 
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 22/111 (19%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           K + +LH     +++RD K SNILL+AE + K++DFGL+++     R   +  +      
Sbjct: 120 KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 69  AAP--------EYVAT------------GRLTTKSDVYSFGVVLLELLSGR 99
                      +YVAT             + T   D++S G +L E+L G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 61.0 bits (149), Expect = 2e-11
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 67
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+        T     V+ T  
Sbjct: 131 RGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLW 184

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
           Y APE +      T  D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 17/103 (16%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           + +  LH +   VI+RD K SN+L+++  + K+ DFGLA+     D +            
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR---IIDESAADNSEPTGQQS 177

Query: 69  AAPEYVAT------------GRLTTKSDVYSFGVVLLELLSGR 99
              E+VAT             + +   DV+S G +L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 61.1 bits (149), Expect = 2e-11
 Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 7/92 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           + L FLH     + + D +  NI+     ++  K+ +FG A+    GD   +   +    
Sbjct: 113 EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE      ++T +D++S G ++  LLSG
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 60.7 bits (148), Expect = 3e-11
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 9/93 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI+L   +      KL DFG+A     G+       + GT
Sbjct: 120 GVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 174

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 41/216 (18%), Positives = 70/216 (32%), Gaps = 33/216 (15%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 64
              ++ +HD    V++RD K  N+L    +     K+ DFG A+  P  +          
Sbjct: 116 VSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCF 171

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 124
           T  YAAPE +         D++S GV+L  +LSG+                 +       
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTC 218

Query: 125 RKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERL 175
                IM     G +       +  +  A  L    L  +P  R +MS +     + +  
Sbjct: 219 TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

Query: 176 EAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 211
           +   N        P           + ++      N
Sbjct: 279 QLSSN----PLMTPDILGSSGAAVHTCVKATFHAFN 310

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        +V T+      Y
Sbjct: 137 KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----Y 189

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE + +     ++ D++S G ++ E+L+G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 61.3 bits (149), Expect = 3e-11
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           GL  +H  E  +++ D K  NI+ + +  +  K+ DFGLA      +   +      T  
Sbjct: 161 GLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAE 215

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           +AAPE V    +   +D+++ GV+   LLSG
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.8 bits (148), Expect = 3e-11
 Identities = 28/92 (30%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           KGL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+   +    +V T+      Y
Sbjct: 139 KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +      T++ D++S G ++ E+++G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           G+ +LH  ++ +++ D K  NILL       + K+ DFG+++             +MGT 
Sbjct: 143 GVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE +    +TT +D+++ G++   LL+ 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 60.3 bits (147), Expect = 4e-11
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 9/93 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI+L D        KL DFGLA     G        + GT
Sbjct: 127 GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 60.4 bits (147), Expect = 5e-11
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 9/93 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    ++ + D K  NI+L D        KL DFGLA     G        + GT
Sbjct: 127 GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 60.4 bits (147), Expect = 5e-11
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+           T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWY 195

Query: 69  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 60.6 bits (147), Expect = 5e-11
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 22/104 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLAKA--GPTGDRTHVSTQV 62
            G+ +LH   + V++RD K +NIL+  E       K++D G A+    P      +   V
Sbjct: 139 DGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 63  MGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
           + T  Y APE       Y      T   D+++ G +  ELL+  
Sbjct: 197 V-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 60.3 bits (147), Expect = 5e-11
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A   PT    +   +V+ T 
Sbjct: 111 RGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y  P+       Y      +T+ D++  G +  E+ +GR
Sbjct: 165 WYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 60.4 bits (147), Expect = 5e-11
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 64
            + + +LH  E+ +++RD K  N+L      +   K++DFGL+K             V G
Sbjct: 158 LEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCG 212

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T GY APE +       + D++S G++   LL G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 59.8 bits (146), Expect = 6e-11
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
            G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A   P    TH   +++ T 
Sbjct: 111 NGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TL 164

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y AP+       Y      +T  D++S G +  E+++G 
Sbjct: 165 WYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 59.9 bits (146), Expect = 7e-11
 Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
           +G+   H    ++++RD K  N+L++++   KL+DFGLA+A   P    TH   +V+ T 
Sbjct: 130 RGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TL 183

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y AP+       Y      +T  D++S G +  E+++G+
Sbjct: 184 WYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 60.1 bits (146), Expect = 7e-11
 Identities = 26/121 (21%), Positives = 47/121 (38%), Gaps = 23/121 (19%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
            G  F+H++   +I+RD K +N LL+ + + K+ DFGLA+   +   T++   +      
Sbjct: 140 LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 69  AAP---------EYVAT------------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 107
                        +V T               T   D++S G +  ELL+   +      
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 108 G 108
            
Sbjct: 258 N 258

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 60.2 bits (146), Expect = 7e-11
 Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 7/92 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           KGL  +H  E+  ++ D K  NI+         KL DFGL           V     GT 
Sbjct: 266 KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 320

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            +AAPE      +   +D++S GV+   LLSG
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 59.5 bits (145), Expect = 8e-11
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
           +GL F H+  +++++RD K  N+L++     KL DFGLA+A   P    +    +V+ T 
Sbjct: 119 QGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y AP+       Y      +T  D++S G +L E+++G+
Sbjct: 173 WYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 59.6 bits (145), Expect = 8e-11
 Identities = 23/95 (24%), Positives = 47/95 (49%), Gaps = 11/95 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG-PTGDRTH-VSTQVMGT 65
           K L + H     +++RD K  N+++D E    +L D+GLA+   P  +    V+++    
Sbjct: 141 KALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 195

Query: 66  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 99
             +  PE +   ++   S D++S G +L  ++  +
Sbjct: 196 --FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 59.6 bits (145), Expect = 8e-11
 Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 17/100 (17%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
            GL ++H   +++++RD KA+N+L+  +   KL+DFGLA+A       + +  T  + T 
Sbjct: 135 NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y  PE       Y          D++  G ++ E+ +  
Sbjct: 193 WYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 11/95 (11%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 66
            + +LH+  + +I+RD K  N+LL   + +   K++DFG +K             + GT 
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTP 180

Query: 67  GYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 98
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 59.1 bits (144), Expect = 1e-10
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + + + H   + +++R+ K  N+LL ++      KL+DFGLA      +         GT
Sbjct: 116 ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 170

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            GY +PE +     +   D+++ GV+L  LL G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 34/104 (32%), Positives = 46/104 (44%), Gaps = 15/104 (14%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 63
           A  L FLH+    + +RD K  NIL    +     K+ DF L       GD + +ST  +
Sbjct: 121 ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 64  ----GTHGYAAPEYVATGRLTTKS-----DVYSFGVVLLELLSG 98
               G+  Y APE V              D++S GV+L  LLSG
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 59.5 bits (145), Expect = 1e-10
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
           +GL +LH     +++RD K +N+LLD     KL+DFGLAK+   P    TH   QV+ T 
Sbjct: 123 QGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TR 176

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y APE       Y          D+++ G +L ELL   
Sbjct: 177 WYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           + + F+H     + +RD K  N+L++++ N  KL DFG AK     +   V+     +  
Sbjct: 152 RAVGFIHSL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC--SRF 206

Query: 68  YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
           Y APE +      T   D++S G V  EL+ G+
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 58.8 bits (143), Expect = 1e-10
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 9/93 (9%)

Query: 10  GLTFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           G+ +LH    Q+ + D K  NI+L   +      K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 58.7 bits (143), Expect = 1e-10
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
           KGL F H     V++RD K  N+L++     KL++FGLA+A   P    +    +V+ T 
Sbjct: 112 KGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TL 165

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y  P+       Y      +T  D++S G +  EL +  
Sbjct: 166 WYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAG 199

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 7/91 (7%)

Query: 10  GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
           G+  +H  +  +++ D K  NIL         K+ DFGLA+     ++        GT  
Sbjct: 199 GIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPE 253

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           + APE V    ++  +D++S GV+   LLSG
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 11/95 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGT 65
           + L ++H     + +RD K  N+LLD      KL DFG AK           + ++    
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--- 206

Query: 66  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
             Y APE +      TT  D++S G V+ EL+ G+
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 64
            + + +LH     + +RD K  N+L      NA  KL+DFG AK   + +   ++T    
Sbjct: 171 GEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-Y 225

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
           T  Y APE +   +     D++S GV++  LL G
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 57.8 bits (140), Expect = 5e-10
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 11/95 (11%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGD--RTHVSTQVMGT 65
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+   +++ ++    
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221

Query: 66  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 99
             Y APE +      T+  DV+S G VL ELL G+
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + + + H   + +++R+ K  N+LL ++      KL+DFGLA      +         GT
Sbjct: 139 ESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 193

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            GY +PE +     +   D+++ GV+L  LL G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 56.8 bits (138), Expect = 8e-10
 Identities = 32/100 (32%), Positives = 42/100 (42%), Gaps = 21/100 (21%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
           + + F H      I+RD K  NIL+      KL DFG A+   GP+        +V  T 
Sbjct: 113 QAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVA-TR 166

Query: 67  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y +PE       Y          DV++ G V  ELLSG 
Sbjct: 167 WYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 7/93 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + L + H  ++ +I+RD K   +LL   +     KL  FG+A     G+   V+   +GT
Sbjct: 141 EALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 196

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
             + APE V         DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 56.1 bits (136), Expect = 1e-09
 Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 9/94 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 66
            G+ F H     +I+RD K  NIL+      KL DFG A+    P         +V  T 
Sbjct: 135 NGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---EVA-TR 188

Query: 67  GYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 99
            Y APE  V   +     DV++ G ++ E+  G 
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 26/105 (24%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA-----KLSDFGLAKA--GPTGDRTHVSTQ 61
            G+ F H    + ++RD K  N+LL     +     K+ DFGLA+A   P    TH   +
Sbjct: 143 NGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---E 197

Query: 62  VMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 99
           ++ T  Y  PE       Y      +T  D++S   +  E+L   
Sbjct: 198 II-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 7/93 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGT 65
           + +   H  +  V++R+ K  N+LL      A  KL+DFGLA                GT
Sbjct: 121 EAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGT 176

Query: 66  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
            GY +PE +         D+++ GV+L  LL G
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.2 bits (133), Expect = 3e-09
 Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 28/115 (24%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 68
            G+ ++H A   +++RD K +N L++ + + K+ DFGLA+     +  +    +      
Sbjct: 167 VGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 69  AAP--------------EYVAT------------GRLTTKSDVYSFGVVLLELLS 97
                             +V T               T   DV+S G +  ELL+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.1 bits (120), Expect = 1e-07
 Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 7/93 (7%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 66
             L FL   E  +I+ D K  NILL     +  K+ DFG +          +   +    
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF 223

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y +PE +         D++S G +L+E+ +G 
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 21/97 (21%), Positives = 41/97 (42%), Gaps = 12/97 (12%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGPTGDRTHVSTQV 62
            GL ++H     +I+ D K  N+L++           K++D G A         H +  +
Sbjct: 142 LGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196

Query: 63  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
                Y +PE +        +D++S   ++ EL++G 
Sbjct: 197 QTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 9/93 (9%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 66
           + L  LH    ++I+ D K  NILL  +  +  K+ DFG +      +   V T +    
Sbjct: 211 QCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264

Query: 67  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
            Y APE +   R     D++S G +L ELL+G 
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 12/99 (12%), Positives = 21/99 (21%), Gaps = 31/99 (31%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           ++     A      H A   V       S + +  + +  L+                  
Sbjct: 132 IRAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA--------------- 174

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 99
                                + D+   G  L  LL  R
Sbjct: 175 -------TMPDA-------NPQDDIRGIGASLYALLVNR 199

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.9 bits (99), Expect = 7e-05
 Identities = 25/94 (26%), Positives = 37/94 (39%), Gaps = 29/94 (30%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 64
            + + +LH     + +RD K  N+L      NA  KL+DFG AK            +  G
Sbjct: 127 GEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTG 172

Query: 65  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 98
              Y               D++S GV++  LL G
Sbjct: 173 -EKY-----------DKSCDMWSLGVIMYILLCG 194

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 42.2 bits (99), Expect = 8e-05
 Identities = 24/140 (17%), Positives = 41/140 (29%), Gaps = 55/140 (39%)

Query: 9   KGLTFLHDAESQVIYRDFKASNILLDAE-------------------------------- 36
           +GL +LH  + ++I+ D K  NILL                                   
Sbjct: 157 QGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 37  -----------------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 79
                               K++D G A          + T+      Y + E +     
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGY 270

Query: 80  TTKSDVYSFGVVLLELLSGR 99
            T +D++S   +  EL +G 
Sbjct: 271 NTPADIWSTACMAFELATGD 290

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	229
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.98
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.98
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.98
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.98
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.98
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.98
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.98
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.98
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.98
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.98
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.98
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.98
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.98
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.98
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.98
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.98
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.98
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.98
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.98
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.98
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.98
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.98
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.98
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.72
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.5
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.25
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.85
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.93
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.81
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.67
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.61
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.58
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.15
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	95.99
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	95.81
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	95.58
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	95.4
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.32
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.87
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	94.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.39
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	94.39
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.28
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.15
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.09
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	93.61
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.34
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.33
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	92.25
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	91.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	90.92
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.72

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=285.72  Aligned_cols=159  Identities=26%  Similarity=0.463  Sum_probs=121.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc---CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~   78 (229)
                      +|+.||+.||+|||++  +||||||||+||||+.++.+||+|||+|+..............+||+.|||||++.+   +.
T Consensus       136 ~i~~qia~gL~yLH~~--~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~  213 (307)
T 3omv_A          136 DIARQTAQGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP  213 (307)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCC
T ss_pred             HHHHHHHHHHHHHHHC--CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCC
Confidence            6899999999999964  599999999999999999999999999987544333333455789999999999964   35


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc----CCCCcHHHHHHHHHHHHHh
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~  154 (229)
                      ++.++|||||||++|||+||+.||.+.+..                ..+...+....    ....+..++..+.+|+.+|
T Consensus       214 y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----------------~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~c  277 (307)
T 3omv_A          214 FSFQSDVYSYGIVLYELMTGELPYSHINNR----------------DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADC  277 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------------HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHH
T ss_pred             CCcHHHhHhHHHHHHHHHHCCCCCCCCChH----------------HHHHHHHhcCCCCCCcccccccchHHHHHHHHHH
Confidence            899999999999999999999999764321                11111221111    1223456678899999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          155 LNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      |+.||++|||+.+|++.|+.++.+
T Consensus       278 l~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          278 VKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             TCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             cCCCHhHCcCHHHHHHHHHHHhcc
Confidence            999999999999999999887643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=286.93  Aligned_cols=157  Identities=25%  Similarity=0.388  Sum_probs=121.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++..............+||+.|||||++.+..++.
T Consensus       162 ~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~  239 (329)
T 4aoj_A          162 AVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  239 (329)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHHhc--CCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc
Confidence            589999999999996  459999999999999999999999999998765444444445678999999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |+.||.+.+.                . .....+........|..++..+.+|+.+||+.||+
T Consensus       240 ~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----------------~-~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~  302 (329)
T 4aoj_A          240 ESDVWSFGVVLWEIFTYGKQPWYQLSN----------------T-EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQ  302 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTCSSCH----------------H-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTT
T ss_pred             cccccchHHHHHHHHcCCCCCCCCCCH----------------H-HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChh
Confidence            9999999999999999 8999976531                1 11122223334455667788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.||++.|+.+..
T Consensus       303 ~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          303 QRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             TSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHhh
Confidence            99999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.4e-44  Score=286.13  Aligned_cols=155  Identities=24%  Similarity=0.413  Sum_probs=129.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||++  +||||||||+||||+.++.+||+|||+++...........+..+||+.|||||++.++.++.
T Consensus       149 ~i~~qia~gl~yLH~~--~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~  226 (308)
T 4gt4_A          149 HLVAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI  226 (308)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCc
Confidence            5899999999999964  59999999999999999999999999998654433333345568999999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |+.||.+.+.                 ..+...+......+.+..++..+.+|+.+||+.||+
T Consensus       227 ksDVwSfGvvl~El~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~  289 (308)
T 4gt4_A          227 DSDIWSYGVVLWEVFSYGLQPYCGYSN-----------------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPS  289 (308)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             cchhhhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChh
Confidence            9999999999999998 8999977532                 112222333344456677888999999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +|||+.||++.|+.+
T Consensus       290 ~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          290 RRPRFKDIHSRLRAW  304 (308)
T ss_dssp             GSCCHHHHHHHHHTS
T ss_pred             HCcCHHHHHHHHHhc
Confidence            999999999999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6e-44  Score=290.07  Aligned_cols=157  Identities=30%  Similarity=0.408  Sum_probs=132.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|||.||+|||++  +||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.
T Consensus       189 ~~~~qia~gl~yLH~~--~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~  266 (353)
T 4ase_A          189 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI  266 (353)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHhHhhC--CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCC
Confidence            5789999999999964  59999999999999999999999999998765554444455678999999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |+.||.+...                ...+.+.+........|..++..+.+|+.+||+.||+
T Consensus       267 ksDVwS~Gv~l~El~t~G~~Pf~~~~~----------------~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~  330 (353)
T 4ase_A          267 QSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  330 (353)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCC----------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             cccEeehHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChh
Confidence            9999999999999998 9999987532                1223334444445566677788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+++.
T Consensus       331 ~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          331 QRPTFSELVEHLGNLL  346 (353)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.3e-44  Score=284.54  Aligned_cols=157  Identities=25%  Similarity=0.422  Sum_probs=129.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||++  +||||||||+||||+.++.+||+|||+++...............||+.|||||++.+..++.
T Consensus       132 ~i~~qia~gl~yLH~~--~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~  209 (299)
T 4asz_A          132 HIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT  209 (299)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCc
Confidence            5899999999999964  59999999999999999999999999998654443333334457999999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |+.||.+.+.                 ..+...+........|..++..+.+|+.+||+.||+
T Consensus       210 k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~  272 (299)
T 4asz_A          210 ESDVWSLGVVLWEIFTYGKQPWYQLSN-----------------NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPH  272 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChh
Confidence            9999999999999999 8999987531                 111222223333455667788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.+|++.|+++..
T Consensus       273 ~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          273 MRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHHh
Confidence            99999999999988753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-44  Score=289.52  Aligned_cols=148  Identities=24%  Similarity=0.422  Sum_probs=121.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .|+.||+.||+|||+  ++||||||||+||||+.+|.+||+|||+++.....  .......+||+.|||||++.+..|+.
T Consensus       129 ~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~  204 (350)
T 4b9d_A          129 DWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNN  204 (350)
T ss_dssp             HHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCc
Confidence            478999999999996  45999999999999999999999999999875322  11234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||+||+.||.+.+.                ...+.+++.... ...+..++..+.+||.+||+.||++
T Consensus       205 ~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~  267 (350)
T 4b9d_A          205 KSDIWALGCVLYELCTLKHAFEAGSM----------------KNLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRD  267 (350)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHcCCC-CCCCccCCHHHHHHHHHHccCChhH
Confidence            99999999999999999999987542                111222222222 2344556788999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |||+.|+++
T Consensus       268 R~s~~e~l~  276 (350)
T 4b9d_A          268 RPSVNSILE  276 (350)
T ss_dssp             SCCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-42  Score=280.23  Aligned_cols=157  Identities=25%  Similarity=0.264  Sum_probs=121.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCc---ceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.||+.||+|||+  ++||||||||+||||+.+| .+||+|||+++........   .....++||+.|||||++.+.
T Consensus       154 ~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~  231 (336)
T 4g3f_A          154 YYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK  231 (336)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC
Confidence            578999999999995  4699999999999999988 5999999999875433211   112346799999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhcc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~  156 (229)
                      .++.++|||||||++|||+||+.||.+.+....                ..++..... ....+..++..+.+||.+||+
T Consensus       232 ~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~  295 (336)
T 4g3f_A          232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----------------CLKIASEPPPIREIPPSCAPLTAQAIQEGLR  295 (336)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----------------HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTC
T ss_pred             CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHHHcCCCCchhcCccCCHHHHHHHHHHcc
Confidence            999999999999999999999999987543211                111111111 012345567889999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhc
Q 027003          157 NEPKLRPRMSEVLAILERLE  176 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~l~~~~  176 (229)
                      .||.+|||+.|+++.|....
T Consensus       296 ~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          296 KEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHHHHH
Confidence            99999999999998886643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-42  Score=274.54  Aligned_cols=148  Identities=24%  Similarity=0.444  Sum_probs=115.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .|+.||+.||+|||+++.+||||||||+||||+. +|.+||+|||+|+.....    .....+||+.|||||++.+ .++
T Consensus       133 ~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~  207 (290)
T 3fpq_A          133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYD  207 (290)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCC
T ss_pred             HHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCC
Confidence            5789999999999976556999999999999974 799999999999864322    2345789999999999864 699


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||+||+.||.+....                ..+.+.+.... ....+...+..+.+||.+||+.||
T Consensus       208 ~~~DiwSlGvilyelltg~~Pf~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP  271 (290)
T 3fpq_A          208 ESVDVYAFGMCMLEMATSEYPYSECQNA----------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK  271 (290)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSH----------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSG
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCcH----------------HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCCh
Confidence            9999999999999999999999764311                11111111111 111223345678999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      ++|||+.|+++
T Consensus       272 ~~R~s~~e~l~  282 (290)
T 3fpq_A          272 DERYSIKDLLN  282 (290)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hHCcCHHHHhc
Confidence            99999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-42  Score=279.03  Aligned_cols=149  Identities=24%  Similarity=0.333  Sum_probs=120.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+||||+.+|.+||+|||+++.......  .....+||+.|||||++.+..|+.
T Consensus       174 ~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~  249 (346)
T 4fih_A          174 AVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGP  249 (346)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCc
Confidence            5789999999999964  599999999999999999999999999987543322  244678999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++|+.||.+.+..                ..+..+.... .....+..++..+.+||.+||+.||+
T Consensus       250 ~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~  313 (346)
T 4fih_A          250 EVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA  313 (346)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999999764321                1111121111 12233456778899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.|+++
T Consensus       314 ~R~ta~e~l~  323 (346)
T 4fih_A          314 QRATAAELLK  323 (346)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhc
Confidence            9999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.9e-43  Score=278.17  Aligned_cols=149  Identities=23%  Similarity=0.370  Sum_probs=122.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+||||+.+|.+||+|||+|+..............+||+.|||||++.+..++.
T Consensus       136 ~~~~qi~~al~ylH~~--~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~  213 (311)
T 4aw0_A          136 FYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK  213 (311)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH
T ss_pred             HHHHHHHHHHHHHHHC--CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc
Confidence            4789999999999964  59999999999999999999999999998765444333455678999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||+||+.||.+.+.                .....++....  ...+..++..+.+||.+||+.||++
T Consensus       214 ~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~  275 (311)
T 4aw0_A          214 SSDLWALGCIIYQLVAGLPPFRAGNE----------------GLIFAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATK  275 (311)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGG
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhH
Confidence            99999999999999999999987542                11122233222  2345566788999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |||+.|++.
T Consensus       276 R~t~~e~~~  284 (311)
T 4aw0_A          276 RLGCEEMEG  284 (311)
T ss_dssp             STTSGGGTC
T ss_pred             CcChHHHcC
Confidence            999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-41  Score=267.39  Aligned_cols=146  Identities=27%  Similarity=0.405  Sum_probs=110.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||+|+......   .....+||+.|+|||++.+..+ +
T Consensus       116 ~~~~qi~~al~ylH~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~  190 (275)
T 3hyh_A          116 RFFQQIISAVEYCHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAG  190 (275)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCC
T ss_pred             HHHHHHHHHHHHHHHC--CcccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCC
Confidence            5789999999999964  59999999999999999999999999998654322   2345789999999999988876 5


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|+||+.||.+.+..                .....+....  ...+...+..+.+|+.+||+.||+
T Consensus       191 ~~~DiwSlGvily~lltg~~PF~~~~~~----------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~  252 (275)
T 3hyh_A          191 PEVDVWSCGVILYVMLCRRLPFDDESIP----------------VLFKNISNGV--YTLPKFLSPGAAGLIKRMLIVNPL  252 (275)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred             ChhhhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCChh
Confidence            7999999999999999999999764321                1111122221  234455678899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.|+++
T Consensus       253 ~R~s~~eil~  262 (275)
T 3hyh_A          253 NRISIHEIMQ  262 (275)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHc
Confidence            9999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=280.25  Aligned_cols=149  Identities=24%  Similarity=0.333  Sum_probs=120.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+||||+.+|.+||+|||+++.......  .....+||+.|||||++.+..|+.
T Consensus       251 ~~~~qil~aL~ylH~~--~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~  326 (423)
T 4fie_A          251 AVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGP  326 (423)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCc
Confidence            5789999999999964  599999999999999999999999999987543322  234678999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++|+.||.+.+..                ..+..+.... .....+..++..+.+||.+||+.||+
T Consensus       327 ~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~  390 (423)
T 4fie_A          327 EVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA  390 (423)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999999764321                1111111111 11223345678899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.|+++
T Consensus       391 ~R~ta~ell~  400 (423)
T 4fie_A          391 QRATAAELLK  400 (423)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhc
Confidence            9999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-41  Score=271.06  Aligned_cols=174  Identities=23%  Similarity=0.332  Sum_probs=123.2

Q ss_pred             hhHHHHHHHHHHhhcC------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||+|||++      ..+||||||||+||||+.++.+||+|||+++........  ......+||+.|||||+
T Consensus       104 ~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~  183 (303)
T 3hmm_A          104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHH
Confidence            6889999999999964      237999999999999999999999999999865433221  12234679999999999


Q ss_pred             cccC------CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHH-HhhcccCCCCcH-----
Q 027003           74 VATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQ-----  141 (229)
Q Consensus        74 ~~~~------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----  141 (229)
                      +.+.      .++.++|||||||++|||+||..||.......... .... +.......+.+ +.....+...+.     
T Consensus       184 l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~  261 (303)
T 3hmm_A          184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSC  261 (303)
T ss_dssp             HTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSS
T ss_pred             hcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcc-cccchHHHHHHHHhcccCCCCCCccccch
Confidence            9764      36789999999999999999988876543211100 0000 00001111122 223333333332     


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      .....+.+|+.+||+.||++|||+.||++.|+++..
T Consensus       262 ~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          262 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            456788999999999999999999999999988754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-41  Score=270.42  Aligned_cols=142  Identities=33%  Similarity=0.444  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+|||++.+|.+||+|||+|+.......  .....+||+.|||||++.+..++.
T Consensus       130 ~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~  205 (304)
T 3ubd_A          130 FYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQ  205 (304)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCC
Confidence            4789999999999964  599999999999999999999999999986433222  234578999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||+||+.||.+.+.                ......+....  ...+..++..+.+||.+||+.||++
T Consensus       206 ~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~  267 (304)
T 3ubd_A          206 SADWWSFGVLMFEMLTGTLPFQGKDR----------------KETMTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPAN  267 (304)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             CCcccchHHHHHHHHhCCCCCCCcCH----------------HHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHH
Confidence            99999999999999999999987542                11122222222  2345567788999999999999999


Q ss_pred             CCCH
Q 027003          162 RPRM  165 (229)
Q Consensus       162 Rpt~  165 (229)
                      |||+
T Consensus       268 R~ta  271 (304)
T 3ubd_A          268 RLGA  271 (304)
T ss_dssp             STTC
T ss_pred             CCCC
Confidence            9985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-40  Score=262.79  Aligned_cols=148  Identities=25%  Similarity=0.396  Sum_probs=105.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc----------ceeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------HVSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aP   71 (229)
                      +++.||+.||+|||++  +||||||||+|||++.+|.+||+|||+|+........          ...+..+||+.||||
T Consensus       122 ~i~~qi~~al~ylH~~--~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          122 HIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCH
T ss_pred             HHHHHHHHHHHHHHHC--cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence            4789999999999964  5999999999999999999999999999875432211          112346799999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      |++.+..++.++|||||||++|||++   ||.+...               ....+..+..... ..........+.+|+
T Consensus       200 E~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---------------~~~~~~~~~~~~~-p~~~~~~~~~~~~li  260 (299)
T 4g31_A          200 EQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---------------RVRTLTDVRNLKF-PPLFTQKYPCEYVMV  260 (299)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---------------HHHHHHHHHTTCC-CHHHHHHCHHHHHHH
T ss_pred             HHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---------------HHHHHHHHhcCCC-CCCCcccCHHHHHHH
Confidence            99999999999999999999999996   6654210               0011111111111 111223445678899


Q ss_pred             HHhccCCCCCCCCHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+||+.||.+|||+.|+++
T Consensus       261 ~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          261 QDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCChhHCcCHHHHhc
Confidence            9999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=262.38  Aligned_cols=166  Identities=26%  Similarity=0.331  Sum_probs=116.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC--CcceeeccccccccccccccccC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATG-R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~   78 (229)
                      .++.||+.||+|||++  +||||||||+|||++.+|.+||+|||+++......  ........+||+.|+|||++.+. .
T Consensus       162 ~~~~qil~al~ylH~~--~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~  239 (398)
T 4b99_A          162 YFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE  239 (398)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC
T ss_pred             HHHHHHHHHHHHHHHC--cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCC
Confidence            4789999999999964  59999999999999999999999999998654321  12224467899999999998876 4


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhcc-----hhhHHHHhhcccCC--CCc-----HHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSD-----KRKLFRIMDTKLGG--QYP-----QKAA  144 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~~~--~~~-----~~~~  144 (229)
                      ++.++||||+||++|||++|+.||.+.+...... +..... +....     .......+. ....  ..+     ...+
T Consensus       240 ~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s  318 (398)
T 4b99_A          240 YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGAD  318 (398)
T ss_dssp             CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCC
T ss_pred             CCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCC
Confidence            6899999999999999999999998765322111 111000 00000     000001110 1110  111     1235


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ..+.+||.+||+.||.+|||+.|+++
T Consensus       319 ~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          319 RQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            67899999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-38  Score=258.44  Aligned_cols=167  Identities=27%  Similarity=0.331  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCC-------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDR-------------------------   55 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~-------------------------   55 (229)
                      .++.||+.||+|||++  |||||||||+|||++.+ +.+||+|||+|+.......                         
T Consensus       121 ~~~~qll~al~ylH~~--gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (361)
T 4f9c_A          121 EYMLNLFKALKRIHQF--GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLS  198 (361)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-------------------
T ss_pred             HHHHHHHHHHHHHHHC--CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccc
Confidence            4789999999999964  59999999999999877 7999999999975433211                         


Q ss_pred             -cceeeccccccccccccccccC-CCcccCceeehhHHHHHHHhCCCcCCCCccccch--hHHHhhh---------hh--
Q 027003           56 -THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAK---------PY--  120 (229)
Q Consensus        56 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~---------~~--  120 (229)
                       .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.........  .+.....         .+  
T Consensus       199 ~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~  278 (361)
T 4f9c_A          199 RRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGK  278 (361)
T ss_dssp             -------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTE
T ss_pred             ccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccc
Confidence             0112345799999999999876 4889999999999999999999999654432111  0000000         00  


Q ss_pred             ---------hcchhhHHHHhhc---------------ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          121 ---------LSDKRKLFRIMDT---------------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       121 ---------~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                               ..+.....+.+..               ..........+..+.+|+.+||+.||.+|+|+.|+++
T Consensus       279 ~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          279 SILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             EEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     0000000000000               0001112234667899999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-37  Score=266.10  Aligned_cols=148  Identities=28%  Similarity=0.385  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||+|||+  ++||||||||+||||+.+|.+||+|||+|+......    ....+||+.|||||++.+ ..|+
T Consensus       296 ~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~  369 (689)
T 3v5w_A          296 FYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYD  369 (689)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCC
Confidence            468999999999995  469999999999999999999999999998754332    235689999999999964 5799


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|+|||||++|||++|..||.+.+......             ....+..  .....+..++..+.+||.+||+.||.
T Consensus       370 ~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-------------i~~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~  434 (689)
T 3v5w_A          370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-------------IDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVN  434 (689)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-------------HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGG
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------HHHhhcC--CCCCCCccCCHHHHHHHHHHccCCHh
Confidence            99999999999999999999997654321111             1111111  12345566788899999999999999


Q ss_pred             CCCC-----HHHHHH
Q 027003          161 LRPR-----MSEVLA  170 (229)
Q Consensus       161 ~Rpt-----~~~v~~  170 (229)
                      +|++     +.|+++
T Consensus       435 ~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          435 RRLGCLGRGAQEVKE  449 (689)
T ss_dssp             GCTTCSSSTHHHHTT
T ss_pred             HCCCCCCCCHHHHhc
Confidence            9998     577764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-36  Score=244.33  Aligned_cols=175  Identities=22%  Similarity=0.309  Sum_probs=126.8

Q ss_pred             hhHHHHHHHHHHhhcC--------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDA--------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~--------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||.|||+.        ..+|+||||||+|||++.++.+||+|||+++...............||..|+|||+
T Consensus       125 ~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             HHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhh
Confidence            5789999999999954        11699999999999999999999999999976544333322344679999999999


Q ss_pred             cccC-----CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHH-hhcccCCCCc-----HH
Q 027003           74 VATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYP-----QK  142 (229)
Q Consensus        74 ~~~~-----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~  142 (229)
                      +.+.     .++.++|||||||++|||++|+.||.+................. ........ .........+     ..
T Consensus       205 ~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (322)
T 3soc_A          205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHA  283 (322)
T ss_dssp             HTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSH
T ss_pred             cccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-chhhhhhhhhcccCCCCccccccccc
Confidence            9763     45678999999999999999999998755432222111111111 11111111 1222222221     24


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          143 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       143 ~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      ....+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       284 ~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          284 GMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            56779999999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-36  Score=248.76  Aligned_cols=156  Identities=26%  Similarity=0.409  Sum_probs=127.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.
T Consensus       207 ~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  284 (370)
T 2psq_A          207 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  284 (370)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence            4789999999999964  59999999999999999999999999998654433332233456788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 .+...+........+..++..+.+|+.+||+.||.
T Consensus       285 ~~DvwslG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  347 (370)
T 2psq_A          285 QSDVWSFGVLMWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS  347 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 99999765321                 12222333333445556778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       348 ~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          348 QRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-36  Score=261.07  Aligned_cols=148  Identities=22%  Similarity=0.295  Sum_probs=119.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC--CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||+|||++  +|+||||||+|||++.+  +.+||+|||+++......   .....+||+.|||||++.+..+
T Consensus       259 ~~~~qi~~al~ylH~~--~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y  333 (573)
T 3uto_A          259 EYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPV  333 (573)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHHC--CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCC
Confidence            4789999999999964  59999999999999854  889999999998764432   2345689999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|||++|..||.+.+.                ...+..+.....  .......++..+.+||.+||+.
T Consensus       334 ~~~~DiWSlGvilyeml~G~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~  397 (573)
T 3uto_A          334 GYYTDMWSVGVLSYILLSGLSPFGGEND----------------DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA  397 (573)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccC
Confidence            9999999999999999999999987542                111222222221  1222345677899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+|||+.|+++
T Consensus       398 dp~~R~t~~e~l~  410 (573)
T 3uto_A          398 DPNTRMTIHQALE  410 (573)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHhc
Confidence            9999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.6e-36  Score=242.08  Aligned_cols=159  Identities=28%  Similarity=0.444  Sum_probs=118.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+.+.+|+||||||+|||++.++.+||+|||+++......  .......||..|+|||++.+..++.
T Consensus       141 ~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  218 (309)
T 3p86_A          141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNE  218 (309)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCc
Confidence            57899999999999643349999999999999999999999999997543321  1133457999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.+..                .....+.........+..++..+.+|+.+||+.||.+
T Consensus       219 ~~DiwslG~il~elltg~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  282 (309)
T 3p86_A          219 KSDVYSFGVILWELATLQQPWGNLNPA----------------QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWK  282 (309)
T ss_dssp             THHHHHHHHHHHHHHHCCCTTTTSCHH----------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            999999999999999999999765321                1111121222333455567788999999999999999


Q ss_pred             CCCHHHHHHHHHhhcCC
Q 027003          162 RPRMSEVLAILERLEAP  178 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~~~  178 (229)
                      |||+.++++.|+.+...
T Consensus       283 Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          283 RPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             SCCHHHHHHHHHHHHC-
T ss_pred             CcCHHHHHHHHHHHHHh
Confidence            99999999999887653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-36  Score=244.77  Aligned_cols=158  Identities=22%  Similarity=0.395  Sum_probs=124.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       119 ~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (325)
T 3kex_A          119 NWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH  196 (325)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCCh
Confidence            5789999999999964  59999999999999999999999999998765544433344566888999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+.....                 ....+........+..++..+.+|+.+||+.||.
T Consensus       197 ~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  259 (325)
T 3kex_A          197 QSDVWSYGVTVWELMTFGAEPYAGLRLAE-----------------VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN  259 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----------------HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTT
T ss_pred             hhHhHHhHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChh
Confidence            9999999999999999 999998754221                 1122222222233444556788999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|+++...
T Consensus       260 ~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          260 IRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TSCCHHHHHHHHHHHTTS
T ss_pred             hCcCHHHHHHHHHHHHhc
Confidence            999999999999988654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-36  Score=242.85  Aligned_cols=173  Identities=42%  Similarity=0.651  Sum_probs=133.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.
T Consensus       143 ~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  220 (321)
T 2qkw_B          143 EICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE  220 (321)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCT
T ss_pred             HHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCc
Confidence            578999999999996  469999999999999999999999999998654333332334456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+...........|...... ...+...+............+..+.+++.+||+.||++
T Consensus       221 ~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  299 (321)
T 2qkw_B          221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED  299 (321)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGG
T ss_pred             ccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCccc
Confidence            99999999999999999999987654433333333211111 11111222333444566788999999999999999999


Q ss_pred             CCCHHHHHHHHHhhcC
Q 027003          162 RPRMSEVLAILERLEA  177 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~~  177 (229)
                      |||+.++++.|+.+..
T Consensus       300 Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          300 RPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SCCHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHHhh
Confidence            9999999999987653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-36  Score=244.15  Aligned_cols=158  Identities=23%  Similarity=0.370  Sum_probs=126.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       121 ~~~~qi~~~l~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  198 (327)
T 3poz_A          121 NWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH  198 (327)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhhC--CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCc
Confidence            5789999999999964  59999999999999999999999999998654443333333455788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       199 ~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  261 (327)
T 3poz_A          199 QSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISSILEKGERLPQPPICTIDVYMIMVKCWMIDAD  261 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGG
T ss_pred             hhhhhhhHHHHHHHHhcCCCCccCCCHH-----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 99999775421                 12233333333444555677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|+++...
T Consensus       262 ~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          262 SRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             GSCCHHHHHHHHHHHHTS
T ss_pred             hCCCHHHHHHHHHHHHhh
Confidence            999999999999887643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.7e-36  Score=244.91  Aligned_cols=157  Identities=30%  Similarity=0.407  Sum_probs=127.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.
T Consensus       197 ~~~~ql~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  274 (359)
T 3vhe_A          197 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI  274 (359)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCc
Confidence            5789999999999964  59999999999999999999999999998765444443445567899999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                ......+........+..++..+.+++.+||+.||.
T Consensus       275 ~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  338 (359)
T 3vhe_A          275 QSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  338 (359)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhhhhHHHHHHHHHhcCCCCCCccchh----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999998 99999775421                112222333333444555677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+++.
T Consensus       339 ~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          339 QRPTFSELVEHLGNLL  354 (359)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCCCHHHHHHHHHHHH
Confidence            9999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=243.15  Aligned_cols=158  Identities=23%  Similarity=0.362  Sum_probs=121.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       121 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  198 (327)
T 3lzb_A          121 NWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH  198 (327)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhhC--CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCCh
Confidence            5789999999999964  59999999999999999999999999998754433332233445788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       199 ~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  261 (327)
T 3lzb_A          199 QSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISSILEKGERLPQPPICTIDVYMIMRKCWMIDAD  261 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 99999775421                 12223333333444555677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|+++...
T Consensus       262 ~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          262 SRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             GSCCHHHHHHHHHHHHTS
T ss_pred             HCcCHHHHHHHHHHHHhC
Confidence            999999999999988654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-35  Score=239.55  Aligned_cols=159  Identities=23%  Similarity=0.367  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       141 ~i~~qi~~al~~LH~~--~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (323)
T 3qup_A          141 RFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV  218 (323)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHcC--CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCC
Confidence            5789999999999964  59999999999999999999999999998654443333333455788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       219 ~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  281 (323)
T 3qup_A          219 HSDVWAFGVTMWEIMTRGQTPYAGIENA-----------------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPK  281 (323)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred             ccchhhHHHHHHHHHhCCCCCccccChH-----------------HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChh
Confidence            9999999999999999 99999775421                 11122222222334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCC
Q 027003          161 LRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~~  179 (229)
                      +|||+.++++.|+++....
T Consensus       282 ~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          282 QRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             GSCCHHHHHHHHHHHHHC-
T ss_pred             hCcCHHHHHHHHHHHHHHh
Confidence            9999999999999876543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=243.20  Aligned_cols=158  Identities=27%  Similarity=0.420  Sum_probs=129.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       195 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  272 (382)
T 3tt0_A          195 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  272 (382)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc
Confidence            5789999999999964  69999999999999999999999999998765443333344456788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+...                 ......+........+..++..+.+|+.+||+.||.
T Consensus       273 ~~DiwslG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  335 (382)
T 3tt0_A          273 QSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS  335 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGG
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 9999976532                 122233333333444556677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +|||+.++++.|+++...
T Consensus       336 ~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          336 QRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             GSCCHHHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHHHH
Confidence            999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-35  Score=240.75  Aligned_cols=160  Identities=26%  Similarity=0.363  Sum_probs=128.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++................||..|+|||++.+..++.
T Consensus       176 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  253 (344)
T 1rjb_A          176 CFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI  253 (344)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh
Confidence            4789999999999964  69999999999999999999999999998654443333344556788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|+| |..||.+....                ......+........+...+..+.+|+.+||+.||.
T Consensus       254 ~~Di~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  317 (344)
T 1rjb_A          254 KSDVWSYGILLWEIFSLGVNPYPGIPVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR  317 (344)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hHhHHHHHHHHHHHHcCCCCCcccCCcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCch
Confidence            9999999999999998 99999775421                112233333333444555678899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCC
Q 027003          161 LRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~~  179 (229)
                      +||++.++++.|+.+....
T Consensus       318 ~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          318 KRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             GSCCHHHHHHHHHHHC---
T ss_pred             hCcCHHHHHHHHHHHHHHH
Confidence            9999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8e-35  Score=230.74  Aligned_cols=155  Identities=25%  Similarity=0.483  Sum_probs=122.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc-----EEEcccCCcccCCCCCCcceeeccccccccccccccc-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-   75 (229)
                      +++.|++.||+|||+++.+|+||||||+|||++.++.     +||+|||+++....     ......||..|+|||++. 
T Consensus       126 ~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~  200 (287)
T 4f0f_A          126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGA  200 (287)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSC
T ss_pred             HHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhcc
Confidence            5789999999999965434999999999999988776     99999999975332     133467999999999984 


Q ss_pred             -cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHh
Q 027003           76 -TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        76 -~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  154 (229)
                       +..++.++|||||||++|+|++|+.||.........              ..............+..++..+.+|+.+|
T Consensus       201 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~  266 (287)
T 4f0f_A          201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--------------FINMIREEGLRPTIPEDCPPRLRNVIELC  266 (287)
T ss_dssp             SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--------------HHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--------------HHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence             445788999999999999999999999765432111              11122233334445566778899999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhh
Q 027003          155 LNNEPKLRPRMSEVLAILERL  175 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~~~  175 (229)
                      |+.||.+|||+.++++.|+++
T Consensus       267 l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          267 WSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             TCSSGGGSCCHHHHHHHHHTC
T ss_pred             hcCChhhCcCHHHHHHHHHhC
Confidence            999999999999999999753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.8e-35  Score=236.03  Aligned_cols=157  Identities=29%  Similarity=0.419  Sum_probs=127.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       154 ~i~~qi~~~l~~lH~~--~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  231 (314)
T 2ivs_A          154 SFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT  231 (314)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHHC--CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc
Confidence            5789999999999964  59999999999999999999999999998654433322233445788999999999988999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       232 ~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  294 (314)
T 2ivs_A          232 QSDVWSFGVLLWEIVTLGGNPYPGIPPE-----------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPD  294 (314)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChh
Confidence            9999999999999999 99999765421                 12222333333344556678899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       295 ~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          295 KRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHHh
Confidence            99999999999988643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-35  Score=244.08  Aligned_cols=156  Identities=26%  Similarity=0.391  Sum_probs=124.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.
T Consensus       217 ~~~~qi~~~l~~LH~~--~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  294 (377)
T 3cbl_A          217 QMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS  294 (377)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEH
T ss_pred             HHHHHHHHHHHHHHHC--CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCc
Confidence            5789999999999964  59999999999999999999999999998643322111112223577899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+...                 ......+........+..++..+.+|+.+||+.||+
T Consensus       295 ~~DvwslG~il~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  357 (377)
T 3cbl_A          295 ESDVWSFGILLWETFSLGASPYPNLSN-----------------QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPG  357 (377)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCch
Confidence            9999999999999998 9999976432                 112222333333445556677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+++.
T Consensus       358 ~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          358 QRPSFSTIYQELQSIR  373 (377)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.8e-35  Score=233.00  Aligned_cols=149  Identities=28%  Similarity=0.400  Sum_probs=119.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ......||..|+|||++.+..++.
T Consensus       120 ~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  195 (297)
T 3fxz_A          120 AVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP  195 (297)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCT
T ss_pred             HHHHHHHHHHHHHHhC--CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCc
Confidence            5789999999999964  599999999999999999999999999886543322  234467999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHh-hcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++|..||.+.+...                ....+. ........+...+..+.+|+.+||+.||.
T Consensus       196 ~~DiwslG~il~ell~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  259 (297)
T 3fxz_A          196 KVDIWSLGIMAIEMIEGEPPYLNENPLR----------------ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE  259 (297)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence            9999999999999999999997643210                111111 11122234556677899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.++++
T Consensus       260 ~Rps~~ell~  269 (297)
T 3fxz_A          260 KRGSAKELLQ  269 (297)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhh
Confidence            9999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=237.40  Aligned_cols=159  Identities=28%  Similarity=0.453  Sum_probs=124.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++......... ......+|..|+|||++.+..++
T Consensus       155 ~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  232 (325)
T 3kul_A          155 GMLRGVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS  232 (325)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHC--CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCC
Confidence            5789999999999964  59999999999999999999999999998764432221 12233467789999999989999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++ |..||.+...                 ......+........+..++..+.+|+.+||+.||
T Consensus       233 ~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  295 (325)
T 3kul_A          233 SASDVWSFGVVMWEVLAYGERPYWNMTN-----------------RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDR  295 (325)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             cHHHHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCCh
Confidence            99999999999999999 9999976432                 11222223333344555677889999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCCC
Q 027003          160 KLRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~~~  179 (229)
                      .+||++.++++.|+.+....
T Consensus       296 ~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          296 AQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             GGSCCHHHHHHHHHHHHHSC
T ss_pred             hhCcCHHHHHHHHHHHHhCc
Confidence            99999999999999886543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4e-35  Score=235.00  Aligned_cols=158  Identities=27%  Similarity=0.432  Sum_probs=127.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       149 ~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  226 (313)
T 1t46_A          149 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF  226 (313)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh
Confidence            5789999999999964  69999999999999999999999999998765544433344456788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                ......+........+...+..+.+|+.+||+.||.
T Consensus       227 ~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  290 (313)
T 1t46_A          227 ESDVWSYGIFLWELFSLGSSPYPGMPVD----------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL  290 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCSS----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcccch----------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCch
Confidence            9999999999999999 99999775421                112222233333334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+++..
T Consensus       291 ~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          291 KRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHHH
Confidence            99999999999987653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.1e-35  Score=232.38  Aligned_cols=161  Identities=16%  Similarity=0.182  Sum_probs=122.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc-----EEEcccCCcccCCCCCCc-----ceeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aP   71 (229)
                      +++.||+.||.|||+  .+|+||||||+|||++.++.     +||+|||+++........     .......||..|+||
T Consensus       110 ~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          110 MAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCc
Confidence            579999999999995  46999999999999987776     999999999865433221     113456799999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC---CCcHHHHHHHH
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAA  148 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  148 (229)
                      |++.+..++.++|||||||++|+|++|+.||.+............             +.......   .....++..+.
T Consensus       188 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~l~  254 (298)
T 1csn_A          188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-------------IGEKKQSTPLRELCAGFPEEFY  254 (298)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-------------HHHHHHHSCHHHHTTTSCHHHH
T ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-------------HHhhccCccHHHHHhhCcHHHH
Confidence            999999999999999999999999999999987543222111110             00000000   00113456889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      +|+.+||+.||.+||++.++++.|+++..
T Consensus       255 ~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          255 KYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            99999999999999999999999988754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.5e-35  Score=235.73  Aligned_cols=172  Identities=44%  Similarity=0.753  Sum_probs=131.4

Q ss_pred             hhHHHHHHHHHHhhcC-CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~-~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .|+.|++.||+|||+. ..+|+||||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++
T Consensus       135 ~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~  213 (326)
T 3uim_A          135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSS  213 (326)
T ss_dssp             HHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEEC
T ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCC
Confidence            5789999999999964 12699999999999999999999999999987543322 223445699999999999988999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccc--cchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVG--IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|||||||++|+|++|+.||......  .......|...... ................+...+..+.+++.+||+.|
T Consensus       214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  292 (326)
T 3uim_A          214 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS  292 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSC
T ss_pred             ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcC
Confidence            9999999999999999999999643211  11122222222111 11222233334445667788899999999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 027003          159 PKLRPRMSEVLAILERL  175 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~  175 (229)
                      |.+|||+.++++.|+..
T Consensus       293 P~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          293 PMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             GGGSCCHHHHHHHHHTS
T ss_pred             CccCCCHHHHHHHhcCc
Confidence            99999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-34  Score=231.16  Aligned_cols=156  Identities=26%  Similarity=0.430  Sum_probs=117.6

Q ss_pred             hhHHHHHHHHHHhhcCC-CCceeecCCCCCeeecCCCc-EEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~-~~ivHrDlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+|||++......     .....||..|+|||++.+..+
T Consensus       106 ~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  180 (307)
T 2eva_A          106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNY  180 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCC
Confidence            57889999999999632 57999999999999998886 799999999754322     223468999999999999899


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|+|++|+.||........               ..............+..++..+.+|+.+||+.||
T Consensus       181 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  245 (307)
T 2eva_A          181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------------RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDP  245 (307)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---------------HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSG
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCchhhCccHH---------------HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCCh
Confidence            9999999999999999999999975432110               0111111222233444566788999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcC
Q 027003          160 KLRPRMSEVLAILERLEA  177 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~  177 (229)
                      .+|||+.++++.|+.+..
T Consensus       246 ~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          246 SQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             GGSCCHHHHHHHHHHHGG
T ss_pred             hhCcCHHHHHHHHHHHHH
Confidence            999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=243.11  Aligned_cols=157  Identities=26%  Similarity=0.373  Sum_probs=123.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++   .+||+|||+++...............||..|+|||++.+..
T Consensus       185 ~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  262 (367)
T 3l9p_A          185 HVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI  262 (367)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC
Confidence            5789999999999964  599999999999999655   49999999997432222222233456899999999999999


Q ss_pred             CcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|||||||++|||++ |..||.....                 ......+........+..++..+.+|+.+||+.
T Consensus       263 ~~~~~DvwslG~il~ellt~g~~pf~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~  325 (367)
T 3l9p_A          263 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----------------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQH  325 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            9999999999999999998 9999976431                 112222233333344555677899999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcC
Q 027003          158 EPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      ||.+||++.++++.|+.+..
T Consensus       326 dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          326 QPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999987754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.6e-35  Score=231.30  Aligned_cols=158  Identities=28%  Similarity=0.508  Sum_probs=113.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............||..|+|||++.   +..
T Consensus       124 ~i~~qi~~~L~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  201 (289)
T 3og7_A          124 DIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP  201 (289)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CC
T ss_pred             HHHHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCC
Confidence            5789999999999964  59999999999999999999999999997654322222234467899999999986   566


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-c---CCCCcHHHHHHHHHHHHHh
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L---GGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~li~~~  154 (229)
                      ++.++|||||||++|+|++|+.||......                ......+... .   .......++..+.+|+.+|
T Consensus       202 ~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  265 (289)
T 3og7_A          202 YSFQSDVYAFGIVLYELMTGQLPYSNINNR----------------DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC  265 (289)
T ss_dssp             SCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----------------HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHH
T ss_pred             CCcccchHHHHHHHHHHHHCCCCccccchH----------------HHHHHHhcccccCcchhhccccCCHHHHHHHHHH
Confidence            888999999999999999999999764321                1111111111 1   1112335567899999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhcC
Q 027003          155 LNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      |+.||.+||++.++++.|+++..
T Consensus       266 l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          266 LKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccCChhhCCCHHHHHHHHHHHhh
Confidence            99999999999999999988753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-34  Score=237.83  Aligned_cols=167  Identities=17%  Similarity=0.164  Sum_probs=122.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec--CCCcEEEcccCCcccCCCCCCc-----ceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~   74 (229)
                      +|+.||+.||+|||+.  +|+||||||+|||++  .++.+||+|||+++........     .......||..|+|||++
T Consensus       156 ~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  233 (364)
T 3op5_A          156 QLSLRILDILEYIHEH--EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH  233 (364)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHC--CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence            5899999999999964  699999999999998  8899999999999765332111     112345699999999999


Q ss_pred             ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHh
Q 027003           75 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        75 ~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  154 (229)
                      .+..++.++|||||||++|||++|+.||.+.......  .......  .......++...+.   ...++..+.+|+..|
T Consensus       234 ~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~li~~c  306 (364)
T 3op5_A          234 NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--VRDSKIR--YRENIASLMDKCFP---AANAPGEIAKYMETV  306 (364)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH--HHHHHHH--HHHCHHHHHHHHSC---TTCCCHHHHHHHHHH
T ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH--HHHHHHH--hhhhHHHHHHHhcc---cccCHHHHHHHHHHH
Confidence            9999999999999999999999999999864322111  1100000  00111122222211   122356788999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhcC
Q 027003          155 LNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      |+.||.+||++.++++.|+.+..
T Consensus       307 l~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          307 KLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             HTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hcCCCCCCCCHHHHHHHHHHHHH
Confidence            99999999999999999987654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.1e-35  Score=233.83  Aligned_cols=157  Identities=30%  Similarity=0.407  Sum_probs=126.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.
T Consensus       152 ~~~~qi~~al~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  229 (316)
T 2xir_A          152 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI  229 (316)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccc
Confidence            4789999999999964  59999999999999999999999999998765444333344556889999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                ......+........+...+..+.+++.+||+.||.
T Consensus       230 ~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  293 (316)
T 2xir_A          230 QSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  293 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCcccchh----------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 99999765421                111122222222334445667899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+.+.
T Consensus       294 ~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          294 QRPTFSELVEHLGNLL  309 (316)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.7e-35  Score=234.92  Aligned_cols=153  Identities=26%  Similarity=0.351  Sum_probs=118.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..+ +
T Consensus       109 ~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  186 (323)
T 3tki_A          109 RFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA  186 (323)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCH
T ss_pred             HHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCC
Confidence            578999999999996  4699999999999999999999999999986543333333345679999999999988775 7


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||.........               .................+..+.+|+.+||+.||.
T Consensus       187 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  251 (323)
T 3tki_A          187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS  251 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             CcccHHHHHHHHHHHHhCCCCCCCCchHHHH---------------HHHHhcccccCCccccCCHHHHHHHHHHccCChh
Confidence            7899999999999999999999765432111               1111111111222344567788999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|||+.|+++.
T Consensus       252 ~R~t~~eil~h  262 (323)
T 3tki_A          252 ARITIPDIKKD  262 (323)
T ss_dssp             TSCCHHHHTTC
T ss_pred             hCcCHHHHhhC
Confidence            99999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=237.87  Aligned_cols=168  Identities=17%  Similarity=0.189  Sum_probs=121.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC--cEEEcccCCcccCCCCCCc-----ceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~   74 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++  .+||+|||+++........     .......||..|+|||++
T Consensus       155 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  232 (345)
T 2v62_A          155 QLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH  232 (345)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence            5789999999999964  699999999999998887  9999999999765322111     111345799999999999


Q ss_pred             ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHh
Q 027003           75 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        75 ~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  154 (229)
                      .+..++.++|||||||++|||++|+.||.+........ ............   ..+....   ....++..+.+|+.+|
T Consensus       233 ~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~---~~~~~~~~l~~li~~~  305 (345)
T 2v62_A          233 KGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV-QTAKTNLLDELP---QSVLKWA---PSGSSCCEIAQFLVCA  305 (345)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH-HHHHHHHHHTTT---HHHHHHS---CTTSCCHHHHHHHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH-HHHHHhhccccc---HHHHhhc---cccccHHHHHHHHHHH
Confidence            99899999999999999999999999996532211110 000000000000   0000000   0013456899999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          155 LNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      |+.||++||++.++++.|+.+...
T Consensus       306 l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          306 HSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             hhcCcccCCCHHHHHHHHhccCCc
Confidence            999999999999999999876543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.1e-35  Score=240.46  Aligned_cols=152  Identities=24%  Similarity=0.399  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++ ++.+||+|||+++..............+||+.|+|||++.+     
T Consensus       159 ~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  235 (390)
T 2zmd_A          159 SYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR  235 (390)
T ss_dssp             HHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC----
T ss_pred             HHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccc
Confidence            578999999999995  4699999999999995 58899999999987644333222345679999999999865     


Q ss_pred             ------CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           77 ------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        77 ------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                            ..++.++|||||||++|||++|+.||.....               ....+..++........+...+..+.+|
T Consensus       236 ~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l  300 (390)
T 2zmd_A          236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------QISKLHAIIDPNHEIEFPDIPEKDLQDV  300 (390)
T ss_dssp             --------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------------HHHHHHHHHCTTSCCCCCCCSCHHHHHH
T ss_pred             cccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---------------HHHHHHHHhCccccCCCCccchHHHHHH
Confidence                  3688899999999999999999999975321               1112223333333333444446778999


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+||+.||.+||++.++++.
T Consensus       301 i~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          301 LKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHcccChhhCCCHHHHhhC
Confidence            999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.6e-34  Score=233.02  Aligned_cols=147  Identities=29%  Similarity=0.462  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       109 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  184 (337)
T 1o6l_A          109 FYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCc
Confidence            4688999999999964  699999999999999999999999999986432221  234567999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|+.||.+.+..                .....+....  ...+...+..+.+||.+||+.||.+
T Consensus       185 ~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~  246 (337)
T 1o6l_A          185 AVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQ  246 (337)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred             hhhcccchhHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            999999999999999999999764311                1111222221  2344556788999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       247 R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          247 RLGGGPSDAKEVME  260 (337)
T ss_dssp             STTCSTTTHHHHHT
T ss_pred             hcCCCCCCHHHHHc
Confidence            99     8999886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.5e-35  Score=231.61  Aligned_cols=162  Identities=20%  Similarity=0.322  Sum_probs=119.7

Q ss_pred             hhHHHHHHHHHHhhcC------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc--eeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||+|||+.      ..+|+||||||+|||++.++.+||+|||+++.........  ......||..|+|||+
T Consensus       109 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (301)
T 3q4u_A          109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV  188 (301)
T ss_dssp             HHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhh
Confidence            5789999999999932      3469999999999999999999999999997543322211  1223479999999999


Q ss_pred             cccC------CCcccCceeehhHHHHHHHhC----------CCcCCCCccccchhHHHhhhhhhcchhhHHHHh-hcccC
Q 027003           74 VATG------RLTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLG  136 (229)
Q Consensus        74 ~~~~------~~~~~~Di~slG~il~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  136 (229)
                      +.+.      .++.++|||||||++|||++|          ..||.........            ........ .....
T Consensus       189 ~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~------------~~~~~~~~~~~~~~  256 (301)
T 3q4u_A          189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS------------FEDMRKVVCVDQQR  256 (301)
T ss_dssp             HTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC------------HHHHHHHHTTSCCC
T ss_pred             hcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc------------hhhhhHHHhccCCC
Confidence            9876      455799999999999999999          7777543221110            01111111 11111


Q ss_pred             CCC-----cHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 027003          137 GQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  175 (229)
Q Consensus       137 ~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~  175 (229)
                      ...     ....+..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          257 PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            122     235778899999999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=235.00  Aligned_cols=179  Identities=17%  Similarity=0.240  Sum_probs=122.9

Q ss_pred             hhHHHHHHHHHHhhcC-------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC------cceeecccccccc
Q 027003            2 KVAIGAAKGLTFLHDA-------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------THVSTQVMGTHGY   68 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~-------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y   68 (229)
                      +++.||+.||.|||+.       ..+|+||||||+|||++.++.+||+|||+++.......      ........||..|
T Consensus       115 ~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y  194 (336)
T 3g2f_A          115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY  194 (336)
T ss_dssp             HHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGG
T ss_pred             HHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccce
Confidence            5789999999999964       11699999999999999999999999999986543211      1112345799999


Q ss_pred             cccccccc-------CCCcccCceeehhHHHHHHHhCCCcCCCCcc-ccchhHHHhhhhhhcchhhHHHHh-hcccCCCC
Q 027003           69 AAPEYVAT-------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKV-GIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQY  139 (229)
Q Consensus        69 ~aPE~~~~-------~~~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  139 (229)
                      +|||++.+       ..++.++|||||||++|||++|..||..... ........................ ........
T Consensus       195 ~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (336)
T 3g2f_A          195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF  274 (336)
T ss_dssp             CCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             eCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCC
Confidence            99999976       3566789999999999999999777644322 111110000000000011111111 11111222


Q ss_pred             ------cHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 027003          140 ------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN  180 (229)
Q Consensus       140 ------~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~~~~  180 (229)
                            ....+..+.+|+.+||+.||++|||+.++++.|+++.....
T Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          275 PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence                  23467789999999999999999999999999998865443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.9e-34  Score=228.28  Aligned_cols=170  Identities=38%  Similarity=0.598  Sum_probs=128.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++................||..|+|||++.+ .++.
T Consensus       137 ~i~~~i~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~  213 (307)
T 2nru_A          137 KIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITP  213 (307)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECT
T ss_pred             HHHHHHHHHHHHHhcC--CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCc
Confidence            5789999999999964  599999999999999999999999999987544333333344679999999998864 5889


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||..........  .+..........+...+... ....+...+..+.+++.+||+.||.+
T Consensus       214 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~  290 (307)
T 2nru_A          214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLL--DIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNK  290 (307)
T ss_dssp             HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--HHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTT
T ss_pred             cchhHHHHHHHHHHHHCCCCcccCcchHHHH--HHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCccc
Confidence            9999999999999999999998754322111  11111111111122222222 23456678889999999999999999


Q ss_pred             CCCHHHHHHHHHhhcC
Q 027003          162 RPRMSEVLAILERLEA  177 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~~  177 (229)
                      ||++.++++.|+++.+
T Consensus       291 Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          291 RPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SCCHHHHHHHHHHHC-
T ss_pred             CcCHHHHHHHHHHHhc
Confidence            9999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-34  Score=230.02  Aligned_cols=161  Identities=21%  Similarity=0.228  Sum_probs=122.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCc-----ceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~   73 (229)
                      .++.||+.||.|||++  +|+||||||+|||+   +.++.+||+|||+++........     .......||..|+|||+
T Consensus       109 ~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 4hgt_A          109 LLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHH
Confidence            5789999999999964  59999999999999   78899999999999865443221     11234679999999999


Q ss_pred             cccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC---CcHHHHHHHHHH
Q 027003           74 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATL  150 (229)
Q Consensus        74 ~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  150 (229)
                      +.+..++.++|||||||++|+|++|+.||.+...........             .+........   ....++..+.+|
T Consensus       187 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~l  253 (296)
T 4hgt_A          187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-------------RISEKKMSTPIEVLCKGYPSEFATY  253 (296)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH-------------HHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred             hcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh-------------hhhcccccchhhhhhccCCHHHHHH
Confidence            999999999999999999999999999998754322111111             0000000000   011235678999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          151 ALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      +.+||+.||++|||+.++++.|+++..
T Consensus       254 i~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          254 LNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            999999999999999999999988754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-34  Score=232.45  Aligned_cols=156  Identities=24%  Similarity=0.363  Sum_probs=118.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus       151 ~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  228 (313)
T 3brb_A          151 KFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS  228 (313)
T ss_dssp             HHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCH
T ss_pred             HHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccc
Confidence            578999999999995  469999999999999999999999999998654433222233456788999999999989999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       229 ~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  291 (313)
T 3brb_A          229 KSDVWAFGVTMWEIATRGMTPYPGVQNH-----------------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPL  291 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGG
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCccCCHH-----------------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChh
Confidence            9999999999999999 89999765321                 11122222223344555677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       292 ~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          292 DRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-35  Score=238.13  Aligned_cols=158  Identities=24%  Similarity=0.346  Sum_probs=123.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       178 ~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  255 (343)
T 1luf_A          178 CIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT  255 (343)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc
Confidence            4789999999999964  59999999999999999999999999987643322222233456889999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       256 ~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  318 (343)
T 1luf_A          256 ESDVWAYGVVLWEIFSYGLQPYYGMAHE-----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA  318 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             ccccHHHHHHHHHHHhcCCCcCCCCChH-----------------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence            9999999999999999 99999764311                 11111222222334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +||++.++++.|+++...
T Consensus       319 ~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          319 DRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             GSCCHHHHHHHHHHTTC-
T ss_pred             cCCCHHHHHHHHHHHHhh
Confidence            999999999999987653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-35  Score=236.86  Aligned_cols=152  Identities=25%  Similarity=0.402  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++ ++.+||+|||+++..............+||+.|+|||++.+     
T Consensus       112 ~i~~qi~~al~~lH~~--~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  188 (343)
T 3dbq_A          112 SYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR  188 (343)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC---
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccc
Confidence            5789999999999964  599999999999997 67899999999987644433333445679999999999865     


Q ss_pred             ------CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           77 ------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        77 ------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                            ..++.++|||||||++|+|++|+.||.....               .......++........+...+..+.+|
T Consensus       189 ~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l  253 (343)
T 3dbq_A          189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------QISKLHAIIDPNHEIEFPDIPEKDLQDV  253 (343)
T ss_dssp             --------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------------HHHHHHHHHCTTSCCCCCCCSCHHHHHH
T ss_pred             cccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---------------HHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence                  6788899999999999999999999975321               1112223333333344455556778999


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+||+.||.+|||+.++++.
T Consensus       254 i~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          254 LKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHcCCChhHCCCHHHHHhC
Confidence            999999999999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-35  Score=237.40  Aligned_cols=157  Identities=27%  Similarity=0.406  Sum_probs=125.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       168 ~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  245 (333)
T 2i1m_A          168 HFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV  245 (333)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhcC--CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh
Confidence            4789999999999964  69999999999999999999999999998654333333334456788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                ......+........+...+..+.+|+.+||+.||.
T Consensus       246 ~~Di~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  309 (333)
T 2i1m_A          246 QSDVWSYGILLWEIFSLGLNPYPGILVN----------------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPT  309 (333)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCSS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCcccchh----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChh
Confidence            9999999999999998 99999765321                112222233333334444567889999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+++.
T Consensus       310 ~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          310 HRPTFQQICSFLQEQA  325 (333)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-34  Score=234.05  Aligned_cols=146  Identities=27%  Similarity=0.436  Sum_probs=117.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-   80 (229)
                      .++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++........   ....+||+.|+|||++.+..+. 
T Consensus       118 ~~~~qi~~al~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  192 (328)
T 3fe3_A          118 SKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDG  192 (328)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCS
T ss_pred             HHHHHHHHHHHHHHHC--CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCC
Confidence            5789999999999964  599999999999999999999999999986543322   3456799999999999888765 


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||.+.+..                .....+....  ...+...+..+.+|+.+||+.||.
T Consensus       193 ~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~  254 (328)
T 3fe3_A          193 PEVDVWSLGVILYTLVSGSLPFDGQNLK----------------ELRERVLRGK--YRIPFYMSTDCENLLKRFLVLNPI  254 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHCCSSTT
T ss_pred             chhhhhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC--CCCCCCCCHHHHHHHHHHCCCChh
Confidence            7899999999999999999999875421                1111122221  233444677889999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.++++
T Consensus       255 ~R~t~~eil~  264 (328)
T 3fe3_A          255 KRGTLEQIMK  264 (328)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhc
Confidence            9999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.9e-35  Score=230.24  Aligned_cols=155  Identities=26%  Similarity=0.364  Sum_probs=113.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||++.+..++.
T Consensus       120 ~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  196 (281)
T 1mp8_A          120 LYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTS  196 (281)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSH
T ss_pred             HHHHHHHHHHHHHHhC--CeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCC
Confidence            5789999999999964  6999999999999999999999999999865433221 122345678999999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+.....                 ....+........+..++..+.+++.+||+.||+
T Consensus       197 ~~Di~slG~~l~ell~~g~~pf~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~  259 (281)
T 1mp8_A          197 ASDVWMFGVCMWEILMHGVKPFQGVKNND-----------------VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS  259 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             ccCchHHHHHHHHHHhcCCCCCCcCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999997 999997654211                 1111122222334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+++.
T Consensus       260 ~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          260 RRPRFTELKAQLSTIL  275 (281)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.5e-35  Score=248.19  Aligned_cols=160  Identities=21%  Similarity=0.250  Sum_probs=122.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCc-----ceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~   73 (229)
                      .|+.||+.||+|||++  +||||||||+||||   +.++.+||+|||+++........     .......||..|+|||+
T Consensus       107 ~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  184 (483)
T 3sv0_A          107 MLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT  184 (483)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHH
Confidence            5789999999999964  59999999999999   58899999999999865443221     11235679999999999


Q ss_pred             cccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC---CCcHHHHHHHHHH
Q 027003           74 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATL  150 (229)
Q Consensus        74 ~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  150 (229)
                      +.+..++.++|||||||++|||++|+.||.+............             +.......   .....++..+.+|
T Consensus       185 ~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------------i~~~~~~~~~~~l~~~~p~~l~~l  251 (483)
T 3sv0_A          185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-------------ISEKKVATSIEALCRGYPTEFASY  251 (483)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH-------------HHHHHHHSCHHHHHTTSCHHHHHH
T ss_pred             hcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH-------------HhhccccccHHHHhcCCcHHHHHH
Confidence            9999999999999999999999999999987654322211111             00000000   0011235678999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHhhc
Q 027003          151 ALQCLNNEPKLRPRMSEVLAILERLE  176 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~l~~~~  176 (229)
                      +..||+.||++||++.+|++.|+.+.
T Consensus       252 i~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          252 FHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999988764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-34  Score=244.19  Aligned_cols=156  Identities=26%  Similarity=0.492  Sum_probs=125.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.
T Consensus       288 ~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  364 (454)
T 1qcf_A          288 DFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTI  364 (454)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCc
Confidence            5789999999999964  59999999999999999999999999998753321 11122334678899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||.+...                 ......+........+..++..+.+|+.+||+.||+
T Consensus       365 ~~DvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~  427 (454)
T 1qcf_A          365 KSDVWSFGILLMEIVTYGRIPYPGMSN-----------------PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE  427 (454)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999999 9999976431                 111122223333444556778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+.+..
T Consensus       428 ~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          428 ERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             GSCCHHHHHHHHHTSSS
T ss_pred             HCcCHHHHHHHHHHHHh
Confidence            99999999999988754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.4e-34  Score=230.99  Aligned_cols=160  Identities=20%  Similarity=0.219  Sum_probs=121.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc-----EEEcccCCcccCCCCCCcc-----eeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aP   71 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.     +||+|||+++.........     ......||..|+||
T Consensus       109 ~i~~qi~~~l~~LH~~--~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          109 MIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccCh
Confidence            5789999999999964  5999999999999999887     9999999998654332211     12456799999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC---CcHHHHHHHH
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAA  148 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  148 (229)
                      |++.+..++.++|||||||++|||++|+.||.+............             +........   .....+ .+.
T Consensus       187 E~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~-------------i~~~~~~~~~~~~~~~~p-~~~  252 (330)
T 2izr_A          187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK-------------IGDTKRATPIEVLCENFP-EMA  252 (330)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH-------------HHHHHHHSCHHHHTTTCH-HHH
T ss_pred             HHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH-------------HHhhhccCCHHHHhccCh-HHH
Confidence            999999999999999999999999999999987543222111110             000000000   001123 889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      +|+..||+.||.+||++.++++.|+++..
T Consensus       253 ~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          253 TYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            99999999999999999999999987653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-34  Score=234.04  Aligned_cols=157  Identities=25%  Similarity=0.408  Sum_probs=125.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       161 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence            4789999999999964  59999999999999999999999999998765433322233445788999999999888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       239 ~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  301 (334)
T 2pvf_A          239 QSDVWSFGVLMWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS  301 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCcCCHH-----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChh
Confidence            9999999999999999 99999764321                 11122222223334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       302 ~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          302 QRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHHh
Confidence            99999999999988743

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.2e-34  Score=240.44  Aligned_cols=164  Identities=22%  Similarity=0.300  Sum_probs=113.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++......   .....+||+.|+|||++.+..++.
T Consensus       168 ~~~~qil~aL~~lH~~--~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  242 (464)
T 3ttj_A          168 YLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKE  242 (464)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCH
Confidence            4789999999999964  59999999999999999999999999998654322   234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHHh-hhhh---hcc-hhhHHHHhhcccC---------------CC--
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPY---LSD-KRKLFRIMDTKLG---------------GQ--  138 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~-~~~~---~~~-~~~~~~~~~~~~~---------------~~--  138 (229)
                      ++|||||||++|||++|+.||.+.+..... .+... ..+.   ... .......+.....               ..  
T Consensus       243 ~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (464)
T 3ttj_A          243 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS  322 (464)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccc
Confidence            999999999999999999999876532111 01000 0000   000 0011111111000               00  


Q ss_pred             -CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          139 -YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       139 -~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                       .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       323 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             01123677999999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-35  Score=234.70  Aligned_cols=159  Identities=25%  Similarity=0.383  Sum_probs=120.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc------------eeeccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------------VSTQVMGTHGYA   69 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------------~~~~~~gt~~y~   69 (229)
                      +++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++.........            ......||+.|+
T Consensus       112 ~i~~qi~~al~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  189 (310)
T 3s95_A          112 SFAKDIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM  189 (310)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGC
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCccee
Confidence            5789999999999964  59999999999999999999999999998654332211            011457999999


Q ss_pred             cccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHH
Q 027003           70 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT  149 (229)
Q Consensus        70 aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (229)
                      |||++.+..++.++|||||||++|+|++|..||..........           ...........    .+..++..+.+
T Consensus       190 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----------~~~~~~~~~~~----~~~~~~~~l~~  254 (310)
T 3s95_A          190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----------GLNVRGFLDRY----CPPNCPPSFFP  254 (310)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------SBCHHHHHHHT----CCTTCCTTHHH
T ss_pred             CHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------hhhhhcccccc----CCCCCCHHHHH
Confidence            9999999999999999999999999999999987643221110           00011111111    12334567889


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          150 LALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      |+.+||+.||++|||+.++++.|+.+..
T Consensus       255 li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          255 ITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999988753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.9e-35  Score=237.15  Aligned_cols=147  Identities=29%  Similarity=0.461  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.+|.+||+|||+++......  ......+||+.|+|||++.+..++.
T Consensus       128 ~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  203 (353)
T 3txo_A          128 FYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGP  203 (353)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHHC--CCcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCC
Confidence            4789999999999964  59999999999999999999999999998543222  2234568999999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+.                ......+....  ...+...+..+.+|+.+||+.||.+
T Consensus       204 ~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~  265 (353)
T 3txo_A          204 AVDWWAMGVLLYEMLCGHAPFEAENE----------------DDLFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTM  265 (353)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             ccCCCcchHHHHHHHhCCCCCCCCCH----------------HHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHH
Confidence            99999999999999999999977542                11122222222  2344456778999999999999999


Q ss_pred             CCCH------HHHHH
Q 027003          162 RPRM------SEVLA  170 (229)
Q Consensus       162 Rpt~------~~v~~  170 (229)
                      ||++      .++++
T Consensus       266 R~~~~~~~~~~~il~  280 (353)
T 3txo_A          266 RLGSLTQGGEHAILR  280 (353)
T ss_dssp             STTSGGGTCTHHHHT
T ss_pred             ccCCcccCCHHHHhh
Confidence            9998      67764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.8e-34  Score=225.42  Aligned_cols=157  Identities=25%  Similarity=0.409  Sum_probs=123.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++......... ......+|..|+|||++.+..++.
T Consensus       108 ~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  184 (268)
T 3sxs_A          108 EMCYDVCEGMAFLESH--QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSS  184 (268)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEET
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCch
Confidence            5789999999999964  6999999999999999999999999999865443222 123345677899999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||......                 .....+........+...+..+.+++.+||+.||.
T Consensus       185 ~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  247 (268)
T 3sxs_A          185 KSDVWAFGILMWEVFSLGKMPYDLYTNS-----------------EVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPE  247 (268)
T ss_dssp             THHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGG
T ss_pred             hhhhHHHHHHHHHHHcCCCCCccccChH-----------------HHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChh
Confidence            9999999999999999 99999764321                 11111122222233444567899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +|||+.++++.|+.+...
T Consensus       248 ~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          248 KRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             GSCCHHHHHHHHGGGCC-
T ss_pred             hCcCHHHHHHHHHHhhhc
Confidence            999999999999988653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-34  Score=230.09  Aligned_cols=165  Identities=22%  Similarity=0.348  Sum_probs=119.9

Q ss_pred             hhHHHHHHHHHHhhcC------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc--eeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||.|||+.      ..+|+||||||+|||++.++.+||+|||+++.........  ......||..|+|||+
T Consensus       138 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  217 (337)
T 3mdy_A          138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV  217 (337)
T ss_dssp             HHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhh
Confidence            5789999999999965      2279999999999999999999999999997654332211  1124579999999999


Q ss_pred             cccCCCccc------CceeehhHHHHHHHhC----------CCcCCCCccccchhHHHhhhhhhcchhhHHH-HhhcccC
Q 027003           74 VATGRLTTK------SDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLG  136 (229)
Q Consensus        74 ~~~~~~~~~------~Di~slG~il~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  136 (229)
                      +.+...+..      +|||||||++|||++|          +.||........            ....... .......
T Consensus       218 ~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~  285 (337)
T 3mdy_A          218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP------------SYEDMREIVCIKKLR  285 (337)
T ss_dssp             HTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSCCC
T ss_pred             cccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC------------chhhhHHHHhhhccC
Confidence            987766554      9999999999999999          455543221110            0011111 1112222


Q ss_pred             CCCc-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          137 GQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       137 ~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      ...+     ..++..+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            2232     26788899999999999999999999999999987643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-34  Score=232.38  Aligned_cols=157  Identities=24%  Similarity=0.383  Sum_probs=123.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus       142 ~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  219 (322)
T 1p4o_A          142 QMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT  219 (322)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHC--CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCc
Confidence            4789999999999964  59999999999999999999999999997643332222223345788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       220 ~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  282 (322)
T 1p4o_A          220 YSDVWSFGVVLWEIATLAEQPYQGLSNE-----------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPK  282 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTSCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHhcCCCccccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            9999999999999999 89999764321                 11111112222233445677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+++..
T Consensus       283 ~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          283 MRPSFLEIISSIKEEME  299 (322)
T ss_dssp             GSCCHHHHHHHHGGGSC
T ss_pred             cCcCHHHHHHHHHHhhc
Confidence            99999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-34  Score=227.88  Aligned_cols=149  Identities=25%  Similarity=0.370  Sum_probs=115.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..   
T Consensus       141 ~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  216 (298)
T 2zv2_A          141 FYFQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIF  216 (298)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCE
T ss_pred             HHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCC
Confidence            5789999999999964  599999999999999999999999999987543321  233457999999999997765   


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|+|++|+.||.......                ....+.............+..+.+|+.+||+.|
T Consensus       217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  280 (298)
T 2zv2_A          217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMC----------------LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKN  280 (298)
T ss_dssp             ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSC
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCccHHH----------------HHHHHhcccCCCCCccccCHHHHHHHHHHhhcC
Confidence            3678999999999999999999997643110                011111122222222345678899999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+||++.++++
T Consensus       281 p~~R~s~~e~l~  292 (298)
T 2zv2_A          281 PESRIVVPEIKL  292 (298)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-34  Score=228.90  Aligned_cols=162  Identities=21%  Similarity=0.225  Sum_probs=122.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCc-----ceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||.|||++  +|+||||||+|||+   +.++.+||+|||++.........     .......||..|+|||+
T Consensus       109 ~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 3uzp_A          109 LLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhh
Confidence            5789999999999964  59999999999999   47889999999999865443221     11234579999999999


Q ss_pred             cccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC---CcHHHHHHHHHH
Q 027003           74 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATL  150 (229)
Q Consensus        74 ~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  150 (229)
                      +.+..++.++|||||||++|+|++|+.||.+...........             .+........   ....++..+.+|
T Consensus       187 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~l  253 (296)
T 3uzp_A          187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-------------RISEKKMSTPIEVLCKGYPSEFATY  253 (296)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH-------------HHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred             hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh-------------hhcccccCCchHHHHhhCCHHHHHH
Confidence            999999999999999999999999999998754322111110             0000000000   012235678999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          151 ALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      +.+||+.||.+||++.++++.|+++...
T Consensus       254 i~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          254 LNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            9999999999999999999999887543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-34  Score=238.97  Aligned_cols=168  Identities=24%  Similarity=0.309  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC-------------------Ccceeecc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-------------------RTHVSTQV   62 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------~~~~~~~~   62 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++......                   ........
T Consensus       113 ~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (388)
T 3oz6_A          113 YVVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY  190 (388)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------C
T ss_pred             HHHHHHHHHHHHHHhC--CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCC
Confidence            4688999999999964  59999999999999999999999999998653211                   01123346


Q ss_pred             cccccccccccccc-CCCcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhc--------chhhHHHHh
Q 027003           63 MGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLS--------DKRKLFRIM  131 (229)
Q Consensus        63 ~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~--------~~~~~~~~~  131 (229)
                      +||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...... +.... .+...        ........+
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~  270 (388)
T 3oz6_A          191 VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESL  270 (388)
T ss_dssp             CCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHH
T ss_pred             cccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC
Confidence            79999999999977 578999999999999999999999998765321110 00000 00000        000000000


Q ss_pred             hcc-------cCCC------------CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          132 DTK-------LGGQ------------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       132 ~~~-------~~~~------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ...       ....            .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          271 KEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            000       0000            001235678999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.4e-35  Score=231.54  Aligned_cols=173  Identities=23%  Similarity=0.318  Sum_probs=124.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++
T Consensus       118 ~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  195 (295)
T 3ugc_A          118 QYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS  195 (295)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHhcC--CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCC
Confidence            5789999999999964  6999999999999999999999999999865433221 122334577889999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|..||............... ............+........+..++..+.+|+.+||+.||+
T Consensus       196 ~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  274 (295)
T 3ugc_A          196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK-QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVN  274 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC-CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGG
T ss_pred             hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc-ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChh
Confidence            9999999999999999999988653211100000000 000001122233333444455667788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+++..
T Consensus       275 ~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          275 QRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             hCCCHHHHHHHHHHHHH
Confidence            99999999999988754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.2e-34  Score=226.37  Aligned_cols=154  Identities=31%  Similarity=0.496  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCC-CceeecCCCCCeeecC--------CCcEEEcccCCcccCCCCCCcceeecccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAES-QVIYRDFKASNILLDA--------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE   72 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~-~ivHrDlkp~Nill~~--------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE   72 (229)
                      +++.|++.||.|||+.+. +|+||||||+|||++.        ++.+||+|||+++......    .....||..|+|||
T Consensus       109 ~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE  184 (271)
T 3dtc_A          109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPE  184 (271)
T ss_dssp             HHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHH
T ss_pred             HHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHH
Confidence            578999999999996532 2899999999999986        6789999999997653322    22356899999999


Q ss_pred             ccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHH
Q 027003           73 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  152 (229)
Q Consensus        73 ~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  152 (229)
                      ++.+..++.++|||||||++|+|++|+.||.+...                ................+..++..+.+++.
T Consensus       185 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (271)
T 3dtc_A          185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----------------LAVAYGVAMNKLALPIPSTCPEPFAKLME  248 (271)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHhhhcCCCCCCCCcccCHHHHHHHH
Confidence            99999999999999999999999999999976431                11122223333334455566788999999


Q ss_pred             HhccCCCCCCCCHHHHHHHHHhh
Q 027003          153 QCLNNEPKLRPRMSEVLAILERL  175 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~~l~~~  175 (229)
                      +||+.||.+|||+.++++.|+++
T Consensus       249 ~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          249 DCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHhcCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.8e-34  Score=234.88  Aligned_cols=150  Identities=29%  Similarity=0.465  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +||||||||+|||++.+|.+||+|||+++......  ......+||+.|+|||++.+..++.
T Consensus       157 ~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~  232 (396)
T 4dc2_A          157 FYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGF  232 (396)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CEEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCCh
Confidence            4689999999999964  59999999999999999999999999998532222  1244578999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHH-HHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++|+.||.........        .......+. .+...  ....+..++..+.+||.+||+.||.
T Consensus       233 ~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~  302 (396)
T 4dc2_A          233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPK  302 (396)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHh
Confidence            999999999999999999999754321100        000111111 12222  2244556778899999999999999


Q ss_pred             CCCCH
Q 027003          161 LRPRM  165 (229)
Q Consensus       161 ~Rpt~  165 (229)
                      +||++
T Consensus       303 ~R~~~  307 (396)
T 4dc2_A          303 ERLGC  307 (396)
T ss_dssp             TSTTC
T ss_pred             HcCCC
Confidence            99986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-34  Score=228.75  Aligned_cols=164  Identities=24%  Similarity=0.287  Sum_probs=116.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.......   .....||..|+|||++.+..++.
T Consensus       124 ~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  198 (308)
T 3g33_A          124 DLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYAT  198 (308)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCS
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCc
Confidence            5789999999999964  599999999999999999999999999986543222   34567899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhcchhhHHHHhhcccCC--C-----CcHHHHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDKRKLFRIMDTKLGG--Q-----YPQKAAHTAATLAL  152 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~li~  152 (229)
                      ++|||||||++|+|++|+.||.+........ +..... +..................  .     .....+..+.+|+.
T Consensus       199 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  278 (308)
T 3g33_A          199 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL  278 (308)
T ss_dssp             THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHH
Confidence            9999999999999999999997754321110 000000 0000000000000000000  0     01134567889999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+|||+.|+++
T Consensus       279 ~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          279 EMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHTCSSTTTSCCHHHHHT
T ss_pred             HHhcCCCccCCCHHHHhc
Confidence            999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.2e-34  Score=236.90  Aligned_cols=153  Identities=23%  Similarity=0.295  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .|+.||+.||.|||+.  +|+||||||+|||++.   ++.+||+|||+++.......   ....+||..|+|||++.+..
T Consensus       165 ~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~  239 (400)
T 1nxk_A          165 EIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEK  239 (400)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCC
T ss_pred             HHHHHHHHHHHHHHHC--CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCC
Confidence            5789999999999964  5999999999999987   78899999999986543221   33567899999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+.......            ......+......  ......++..+.+||.+||+
T Consensus       240 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  307 (400)
T 1nxk_A          240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK  307 (400)
T ss_dssp             SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC------------CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSC
T ss_pred             CCCcccHHHHHHHHHHHHhCCCCCCCCcccccc------------HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCC
Confidence            999999999999999999999999765422100            0011111111111  11123467789999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||.+|||+.++++.
T Consensus       308 ~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          308 TEPTQRMTITEFMNH  322 (400)
T ss_dssp             SSGGGSCCHHHHHHS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-34  Score=237.69  Aligned_cols=159  Identities=26%  Similarity=0.442  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++......... ......++..|+|||++.+..++
T Consensus       151 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  228 (373)
T 2qol_A          151 GMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT  228 (373)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHC--CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcC
Confidence            5789999999999964  59999999999999999999999999998654332111 11123457789999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||++ |+.||.....                 ......+........+..++..+.+|+.+||+.||
T Consensus       229 ~~~Dv~SlG~il~ellt~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp  291 (373)
T 2qol_A          229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----------------QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDR  291 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------------HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSG
T ss_pred             chhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcCh
Confidence            99999999999999998 9999976431                 11122222233333444567789999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCCC
Q 027003          160 KLRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~~~  179 (229)
                      .+||++.++++.|+++....
T Consensus       292 ~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          292 NNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             GGSCCHHHHHHHHHHHHHCG
T ss_pred             hhCcCHHHHHHHHHHHHhCc
Confidence            99999999999999876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.5e-34  Score=232.42  Aligned_cols=147  Identities=29%  Similarity=0.463  Sum_probs=117.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       125 ~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  200 (353)
T 2i0e_A          125 FYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGK  200 (353)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBST
T ss_pred             HHHHHHHHHHHHHHHC--CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCC
Confidence            4789999999999964  699999999999999999999999999986322221  234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|+.||.+.+.                ......+....  ...+...+..+.+|+.+||+.||.+
T Consensus       201 ~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~  262 (353)
T 2i0e_A          201 SVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGK  262 (353)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTS
T ss_pred             cccccchHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            99999999999999999999976431                11122222222  2345566788999999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      ||+     +.++++
T Consensus       263 R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          263 RLGCGPEGERDIKE  276 (353)
T ss_dssp             CTTCSTTHHHHHHT
T ss_pred             cCCCCCCCHHHHhc
Confidence            995     466664

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.6e-34  Score=226.40  Aligned_cols=155  Identities=25%  Similarity=0.348  Sum_probs=120.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.
T Consensus       117 ~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  193 (281)
T 3cc6_A          117 LYSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTT  193 (281)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCc
Confidence            5789999999999964  5999999999999999999999999999865433221 123345788999999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |+.||.......                 ....+........+..++..+.+|+.+||+.||.
T Consensus       194 ~~Di~slG~il~~llt~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  256 (281)
T 3cc6_A          194 ASDVWMFAVCMWEILSFGKQPFFWLENKD-----------------VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS  256 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhccHHHHHHHHHHHhCCCCCcccCChHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCch
Confidence            9999999999999998 999997543211                 1111222222233445667899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+.+.
T Consensus       257 ~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          257 DRPRFTELVCSLSDVY  272 (281)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-34  Score=226.05  Aligned_cols=157  Identities=27%  Similarity=0.424  Sum_probs=121.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC--cceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++.......  ........+|..|+|||.+.+..+
T Consensus       128 ~i~~qi~~~l~~LH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  205 (298)
T 3pls_A          128 SFGLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF  205 (298)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCC
Confidence            5789999999999964  599999999999999999999999999976533221  111234567889999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCc-CCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.++|||||||++|+|++|..| |...+.                 ......+........+...+..+.+|+.+||+.|
T Consensus       206 ~~~~Di~slG~il~~l~~g~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  268 (298)
T 3pls_A          206 TTKSDVWSFGVLLWELLTRGAPPYRHIDP-----------------FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEAD  268 (298)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             ChhhchhhHHHHHHHHhhCCCCCCccCCH-----------------HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCC
Confidence            9999999999999999995555 443221                 1122222222333344556678999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhcC
Q 027003          159 PKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~~  177 (229)
                      |.+|||+.++++.|+++..
T Consensus       269 p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          269 PAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             GGGSCCHHHHHHHHHHHHH
T ss_pred             hhhCcCHHHHHHHHHHHHH
Confidence            9999999999999988754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.7e-34  Score=240.60  Aligned_cols=152  Identities=24%  Similarity=0.429  Sum_probs=123.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++......     ....++..|+|||++.+..++.
T Consensus       293 ~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~  365 (450)
T 1k9a_A          293 KFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFST  365 (450)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCc
Confidence            5789999999999964  59999999999999999999999999998543221     1235788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||.+....                 .....+........+..++..+.+||.+||+.||.
T Consensus       366 ~sDvwslG~~l~el~t~g~~P~~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~  428 (450)
T 1k9a_A          366 KSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAA  428 (450)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTSCTT-----------------THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 99999765421                 11122223334455666788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+.+..
T Consensus       429 ~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          429 TRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHHH
Confidence            99999999999988753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.8e-34  Score=223.60  Aligned_cols=153  Identities=22%  Similarity=0.391  Sum_probs=122.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.+..|+||||||+|||++.++.++|+|||+......       ....||+.|+|||++.+..++.
T Consensus       115 ~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~  187 (271)
T 3kmu_A          115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDT  187 (271)
T ss_dssp             HHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGS
T ss_pred             HHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCC
Confidence            578999999999996544599999999999999999999998888654222       2346899999999998765544


Q ss_pred             ---cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           82 ---KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        82 ---~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                         ++|||||||++|+|++|+.||.+...                ................+..++..+.+++.+||+.|
T Consensus       188 ~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  251 (271)
T 3kmu_A          188 NRRSADMWSFAVLLWELVTREVPFADLSN----------------MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNED  251 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCSCTTTTSCH----------------HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCccccCh----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence               79999999999999999999976431                11222333344444555667788999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhcC
Q 027003          159 PKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~~  177 (229)
                      |.+|||+.++++.|+++..
T Consensus       252 p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          252 PAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             GGGSCCHHHHHHHHHHHCC
T ss_pred             hhhCcCHHHHHHHHHHhhc
Confidence            9999999999999998753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-33  Score=236.35  Aligned_cols=149  Identities=24%  Similarity=0.275  Sum_probs=117.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec---CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++   .++.+||+|||++........  ......||+.|+|||++.+..
T Consensus       114 ~i~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~  189 (444)
T 3soa_A          114 HCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDP  189 (444)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCC
Confidence            5789999999999964  599999999999998   467899999999986543322  133467999999999999889


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+.+..                .....+......  .......+..+.+|+.+||+
T Consensus       190 ~~~~~DIwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  253 (444)
T 3soa_A          190 YGKPVDLWACGVILYILLVGYPPFWDEDQH----------------RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLT  253 (444)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred             CCCccccHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcC
Confidence            999999999999999999999999764321                111122222111  12223457789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       254 ~dP~~Rpta~e~L~  267 (444)
T 3soa_A          254 INPSKRITAAEALK  267 (444)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CChhHCCCHHHHhc
Confidence            99999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-34  Score=227.04  Aligned_cols=156  Identities=27%  Similarity=0.425  Sum_probs=123.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||+++....... .......+|..|+|||++.+..++.
T Consensus       110 ~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  186 (269)
T 4hcu_A          110 GMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSS  186 (269)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCc
Confidence            5789999999999964  599999999999999999999999999986533211 1122345678899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||......                 .....+........+...+..+.+++.+||+.||.
T Consensus       187 ~~Di~slG~~l~~ll~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  249 (269)
T 4hcu_A          187 KSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE  249 (269)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             hhhhHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcc
Confidence            9999999999999999 99999764321                 11122222233334445577899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       250 ~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          250 DRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             cCcCHHHHHHHHHHHHH
Confidence            99999999999988754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-34  Score=233.51  Aligned_cols=156  Identities=22%  Similarity=0.284  Sum_probs=104.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc----------eeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH----------VSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aP   71 (229)
                      +++.||+.||.|||+.+.+|+||||||+|||++.++.+||+|||+++.........          ......||..|+||
T Consensus       140 ~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---------------------------
T ss_pred             HHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            57899999999999654449999999999999999999999999998754332211          11134689999999


Q ss_pred             ccc---ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHH
Q 027003           72 EYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA  148 (229)
Q Consensus        72 E~~---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (229)
                      |++   .+..++.++|||||||++|+|++|+.||......                    .+................+.
T Consensus       220 E~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~  279 (337)
T 3ll6_A          220 EIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--------------------RIVNGKYSIPPHDTQYTVFH  279 (337)
T ss_dssp             ----CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------------------------CCCCTTCCSSGGGH
T ss_pred             hhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--------------------HhhcCcccCCcccccchHHH
Confidence            998   5667889999999999999999999999754311                    11111111122222344578


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          149 TLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      +|+.+||+.||.+||++.++++.|+.+..
T Consensus       280 ~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          280 SLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            89999999999999999999999988764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.8e-34  Score=226.11  Aligned_cols=158  Identities=23%  Similarity=0.343  Sum_probs=117.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.
T Consensus       115 ~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  191 (294)
T 4eqm_A          115 NFTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDE  191 (294)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCc
Confidence            5789999999999964  599999999999999999999999999986543221 1233457999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC---CCCcHHHHHHHHHHHHHhccCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++|||||||++|+|++|+.||.+.....                ...+.+.....   ......++..+.+++.+||+.|
T Consensus       192 ~~Di~slG~~l~~ll~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  255 (294)
T 4eqm_A          192 CTDIYSIGIVLYEMLVGEPPFNGETAVS----------------IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKD  255 (294)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCSSCHHH----------------HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred             hHhHHHHHHHHHHHHhCCCCCCCCChHH----------------HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCC
Confidence            9999999999999999999998754210                00111111100   0112234678899999999999


Q ss_pred             CCCCC-CHHHHHHHHHhhcCC
Q 027003          159 PKLRP-RMSEVLAILERLEAP  178 (229)
Q Consensus       159 P~~Rp-t~~~v~~~l~~~~~~  178 (229)
                      |.+|| ++.++.+.|+.+...
T Consensus       256 p~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          256 KANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             GGGSCSSHHHHHHHHHTSSSS
T ss_pred             HhHccccHHHHHHHHHHHHhh
Confidence            99999 889999999876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-34  Score=240.20  Aligned_cols=156  Identities=29%  Similarity=0.454  Sum_probs=120.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.
T Consensus       284 ~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  360 (452)
T 1fmk_A          284 DMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTI  360 (452)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCc
Confidence            5789999999999964  599999999999999999999999999986543221 1122345678999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||.+...                 ......+........+..++..+.+|+.+||+.||+
T Consensus       361 ~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~  423 (452)
T 1fmk_A          361 KSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE  423 (452)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             cccHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999999 9999976431                 111222233333445566778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+.+..
T Consensus       424 ~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          424 ERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             GSCCHHHHHHHHHTTTS
T ss_pred             hCcCHHHHHHHHHHHhc
Confidence            99999999999987754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-34  Score=235.54  Aligned_cols=158  Identities=28%  Similarity=0.390  Sum_probs=114.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++........  .......+|..|+|||++.+..+
T Consensus       196 ~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  273 (373)
T 3c1x_A          196 GFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF  273 (373)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHC--CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCC
Confidence            5789999999999964  5999999999999999999999999999865332211  11233457889999999999999


Q ss_pred             cccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.++|||||||++|||++ |..||........                 ...+........+..++..+.+++.+||+.|
T Consensus       274 ~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~d  336 (373)
T 3c1x_A          274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----------------TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPK  336 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            999999999999999999 7778866442211                 1111112222334456678999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhcCC
Q 027003          159 PKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~~~  178 (229)
                      |.+||++.++++.|+++...
T Consensus       337 p~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          337 AEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             GGGSCCHHHHHHHHHHHHHT
T ss_pred             hhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999987643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-34  Score=243.68  Aligned_cols=155  Identities=22%  Similarity=0.390  Sum_probs=125.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.
T Consensus       322 ~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  398 (495)
T 1opk_A          322 YMATQISSAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSI  398 (495)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCc
Confidence            5789999999999964  59999999999999999999999999998754322 11222344678899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+.+..                 .....+........+..++..+.+||.+||+.||.
T Consensus       399 ~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  461 (495)
T 1opk_A          399 KSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS  461 (495)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChh
Confidence            9999999999999999 99999775421                 12233333444455666778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+.+.
T Consensus       462 ~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          462 DRPSFAEIHQAFETMF  477 (495)
T ss_dssp             GSCCHHHHHHHHHTSC
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-34  Score=234.61  Aligned_cols=146  Identities=27%  Similarity=0.386  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +|+||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       143 ~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  218 (373)
T 2r5t_A          143 FYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDR  218 (373)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCc
Confidence            3689999999999964  599999999999999999999999999986322221  234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|..||.+.+.                ......++....  ..+...+..+.+|+.+||+.||.+
T Consensus       219 ~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~  280 (373)
T 2r5t_A          219 TVDWWCLGAVLYEMLYGLPPFYSRNT----------------AEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTK  280 (373)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSBH----------------HHHHHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHh
Confidence            99999999999999999999976432                111222222222  234456778999999999999999


Q ss_pred             CCCHHHHH
Q 027003          162 RPRMSEVL  169 (229)
Q Consensus       162 Rpt~~~v~  169 (229)
                      ||++.+.+
T Consensus       281 R~~~~~~~  288 (373)
T 2r5t_A          281 RLGAKDDF  288 (373)
T ss_dssp             STTTTTTH
T ss_pred             CCCCCCCH
Confidence            99985433

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-33  Score=227.31  Aligned_cols=144  Identities=28%  Similarity=0.452  Sum_probs=117.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.+|.+||+|||+++.....     ....+||+.|+|||++.+..++.
T Consensus       110 ~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  182 (318)
T 1fot_A          110 FYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNK  182 (318)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCc
Confidence            468999999999995  46999999999999999999999999999865332     23467999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|..||.+.+.                .....+++...  ...+...+..+.+|+.+||+.||.+
T Consensus       183 ~~DiwslG~il~ell~g~~pf~~~~~----------------~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~  244 (318)
T 1fot_A          183 SIDWWSFGILIYEMLAGYTPFYDSNT----------------MKTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQ  244 (318)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHH
Confidence            99999999999999999999976431                11122222222  2344556778999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       245 R~~~~~~~~~~i~~  258 (318)
T 1fot_A          245 RLGNLQNGTEDVKN  258 (318)
T ss_dssp             CTTSSTTTTHHHHT
T ss_pred             cCCCcCCCHHHHhc
Confidence            99     8888885

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.3e-34  Score=233.02  Aligned_cols=147  Identities=31%  Similarity=0.476  Sum_probs=117.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       122 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  197 (345)
T 1xjd_A          122 FYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNH  197 (345)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCC
Confidence            4789999999999964  599999999999999999999999999986432221  134568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|..||.+.+..                .....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       198 ~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~  259 (345)
T 1xjd_A          198 SVDWWSFGVLLYEMLIGQSPFHGQDEE----------------ELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEK  259 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             hhhhHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhH
Confidence            999999999999999999999765421                111112211  12334456778999999999999999


Q ss_pred             CCCHH-HHHH
Q 027003          162 RPRMS-EVLA  170 (229)
Q Consensus       162 Rpt~~-~v~~  170 (229)
                      ||++. ++++
T Consensus       260 R~~~~~~i~~  269 (345)
T 1xjd_A          260 RLGVRGDIRQ  269 (345)
T ss_dssp             SBTTBSCGGG
T ss_pred             cCCChHHHHc
Confidence            99997 6653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-34  Score=237.92  Aligned_cols=152  Identities=14%  Similarity=0.073  Sum_probs=114.6

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc--CCCc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLT   80 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~   80 (229)
                      ++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++.....     .....+|..|+|||++.+  ..++
T Consensus       199 i~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~  271 (371)
T 3q60_A          199 LTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFT  271 (371)
T ss_dssp             HHHHHHHHHHHHHHT--TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECC
T ss_pred             HHHHHHHHHHHHHHC--CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcC
Confidence            468999999999964  5999999999999999999999999999865321     224567799999999987  6789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||++|+.||.+............         .................++..+.+|+.+||+.||+
T Consensus       272 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  342 (371)
T 3q60_A          272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR  342 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTT
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChh
Confidence            999999999999999999999987643211100000         00000001111122234577899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.++++
T Consensus       343 ~Rpt~~e~l~  352 (371)
T 3q60_A          343 RRLLPLEAME  352 (371)
T ss_dssp             TCCCHHHHTT
T ss_pred             hCCCHHHHhc
Confidence            9999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.4e-34  Score=226.52  Aligned_cols=156  Identities=26%  Similarity=0.364  Sum_probs=123.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++.......... ......++..|+|||++.+..++
T Consensus       121 ~i~~qi~~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  198 (291)
T 1xbb_A          121 ELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS  198 (291)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHHhC--CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC
Confidence            5789999999999964  59999999999999999999999999998754433221 12223467889999999988899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++ |+.||.+....                 .....+........+..++..+.+++.+||+.||
T Consensus       199 ~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  261 (291)
T 1xbb_A          199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV  261 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred             hhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence            99999999999999999 99999764321                 1122222223334455667889999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      .+||++.++++.|+.+-
T Consensus       262 ~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          262 ENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             TTSCCHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHH
Confidence            99999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-34  Score=232.61  Aligned_cols=173  Identities=25%  Similarity=0.330  Sum_probs=129.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++........ .......||..|+|||++.+..++
T Consensus       131 ~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  208 (327)
T 3lxl_A          131 LYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS  208 (327)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCC
Confidence            578999999999996  46999999999999999999999999999876443322 122334578889999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|..||............  ..............+........+..++..+.+|+.+||+.||.
T Consensus       209 ~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  286 (327)
T 3lxl_A          209 RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQ  286 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChh
Confidence            9999999999999999999998754321100000  00001111223334444445555667788899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +|||+.++++.|+.+...
T Consensus       287 ~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          287 DRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             GSCCHHHHHHHHHHC---
T ss_pred             hCcCHHHHHHHHHHHHhh
Confidence            999999999999987553

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.9e-33  Score=230.51  Aligned_cols=100  Identities=27%  Similarity=0.329  Sum_probs=88.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec--CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||.|||+++.+||||||||+|||++  .++.+||+|||+++.....     .....||..|+|||++.+..+
T Consensus       161 ~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~  235 (382)
T 2vx3_A          161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPY  235 (382)
T ss_dssp             HHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCC
Confidence            578999999999997667899999999999994  4778999999999875332     234578999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                      +.++|||||||++|||++|+.||.+.+
T Consensus       236 ~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          236 DLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-34  Score=229.34  Aligned_cols=144  Identities=24%  Similarity=0.315  Sum_probs=110.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||++........   .....||..|+|||++.+ .++.
T Consensus       161 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~  234 (311)
T 3p1a_A          161 GYLRDTLLALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGT  234 (311)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCST
T ss_pred             HHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCc
Confidence            5789999999999964  599999999999999999999999999886543222   334569999999999875 7899


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|..++.+...                   ...+.........+...+..+.+|+.+||+.||++
T Consensus       235 ~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  295 (311)
T 3p1a_A          235 AADVFSLGLTILEVACNMELPHGGEG-------------------WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL  295 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhh
Confidence            99999999999999999766644210                   00111111111112234678899999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |||+.++++
T Consensus       296 Rpt~~ell~  304 (311)
T 3p1a_A          296 RATAEALLA  304 (311)
T ss_dssp             SCCHHHHHT
T ss_pred             CcCHHHHHh
Confidence            999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-33  Score=225.76  Aligned_cols=165  Identities=20%  Similarity=0.275  Sum_probs=115.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+ ..++
T Consensus       123 ~~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  198 (311)
T 3niz_A          123 IYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYS  198 (311)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCC
Confidence            4789999999999964  699999999999999999999999999987543222  1334578999999999876 4689


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhc---chhhHHHHhhccc---CCC----CcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLS---DKRKLFRIMDTKL---GGQ----YPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~---~~~~~~~~~~~~~---~~~----~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|+.||.+........ +.... .+...   .............   ...    .....+..+.
T Consensus       199 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (311)
T 3niz_A          199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI  278 (311)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHH
T ss_pred             chHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHH
Confidence            99999999999999999999998755432111 11100 00000   0000000000000   000    0112356788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.|+++
T Consensus       279 ~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          279 DLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.1e-34  Score=225.64  Aligned_cols=155  Identities=21%  Similarity=0.357  Sum_probs=122.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||++.+..++.
T Consensus       124 ~i~~qi~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  200 (283)
T 3gen_A          124 EMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS  200 (283)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSH
T ss_pred             HHHHHHHHHHHHHHHC--CccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCCCc
Confidence            5789999999999964  599999999999999999999999999986533211 1122334678899999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |+.||......                 .....+........+...+..+.+|+.+||+.||.
T Consensus       201 ~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  263 (283)
T 3gen_A          201 KSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD  263 (283)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCccccChh-----------------HHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChh
Confidence            9999999999999998 99999765421                 11122222233334445567899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|.++.
T Consensus       264 ~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          264 ERPTFKILLSNILDVM  279 (283)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHh
Confidence            9999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-33  Score=223.31  Aligned_cols=171  Identities=16%  Similarity=0.203  Sum_probs=123.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee----cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc--
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--   75 (229)
                      .++.||+.||+|||+.  +|+||||||+|||+    +.++.+||+|||+++.......   .....||..|+|||++.  
T Consensus       116 ~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~  190 (319)
T 4euu_A          116 IVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERA  190 (319)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhc
Confidence            5789999999999964  59999999999999    7788899999999987544332   23457999999999986  


Q ss_pred             ------cCCCcccCceeehhHHHHHHHhCCCcCCCCccccch--hHHHhhhhhhc-chhhHHHH------h--hcccCCC
Q 027003           76 ------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLS-DKRKLFRI------M--DTKLGGQ  138 (229)
Q Consensus        76 ------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~------~--~~~~~~~  138 (229)
                            +..++.++|||||||++|||++|+.||.........  ........... ........      .  .......
T Consensus       191 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (319)
T 4euu_A          191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS  270 (319)
T ss_dssp             TSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCS
T ss_pred             cccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccc
Confidence                  567899999999999999999999999754322111  11110000000 00000000      0  0011123


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcC
Q 027003          139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       139 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      ........+.+|+.+||+.||++|||+.|+++......-
T Consensus       271 ~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            456788899999999999999999999999998876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.5e-34  Score=229.37  Aligned_cols=169  Identities=26%  Similarity=0.353  Sum_probs=128.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++......... .......||..|+|||++.+..++
T Consensus       130 ~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  207 (302)
T 4e5w_A          130 KYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY  207 (302)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHhhcC--CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC
Confidence            5789999999999964  5999999999999999999999999999876443321 223345688889999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhh--cchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL--SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|||||||++|+|++|..|+......    ......+..  .........+........+..++..+.+|+.+||+.|
T Consensus       208 ~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  283 (302)
T 4e5w_A          208 IASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ  283 (302)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             cchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            9999999999999999999887542210    111111111  1122233333344444556667788999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhc
Q 027003          159 PKLRPRMSEVLAILERLE  176 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~  176 (229)
                      |.+|||+.++++.|+++.
T Consensus       284 p~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          284 PSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             GGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHh
Confidence            999999999999998763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-33  Score=226.22  Aligned_cols=150  Identities=25%  Similarity=0.355  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ......||..|+|||++.+..++.
T Consensus       145 ~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  220 (321)
T 2c30_A          145 TVCEAVLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYAT  220 (321)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCc
Confidence            5789999999999964  699999999999999999999999999886543222  133467999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++|+.||.......                ....+..... ........+..+.+|+.+||+.||.
T Consensus       221 ~~Dv~slG~il~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  284 (321)
T 2c30_A          221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQ----------------AMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ  284 (321)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChh
Confidence            9999999999999999999997643210                0111111111 1122334567889999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|||+.++++.
T Consensus       285 ~Rps~~ell~h  295 (321)
T 2c30_A          285 ERATAQELLDH  295 (321)
T ss_dssp             TSCCHHHHHTS
T ss_pred             hCcCHHHHhcC
Confidence            99999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-33  Score=237.15  Aligned_cols=148  Identities=27%  Similarity=0.451  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+. .+||||||||+|||++.++.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       252 ~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  328 (446)
T 4ejn_A          252 FYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGR  328 (446)
T ss_dssp             HHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCT
T ss_pred             HHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCC
Confidence            4789999999999961 4699999999999999999999999999986432221  234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                .....+....  ...+...+..+.+||.+||+.||.+
T Consensus       329 ~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~  390 (446)
T 4ejn_A          329 AVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQ  390 (446)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred             ccchhhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHH
Confidence            999999999999999999999764321                1111112111  2344456778999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       391 R~~~~~~t~~ell~  404 (446)
T 4ejn_A          391 RLGGGSEDAKEIMQ  404 (446)
T ss_dssp             STTCSTTTHHHHHT
T ss_pred             hCCCCCCCHHHHHh
Confidence            99     9999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-33  Score=228.72  Aligned_cols=157  Identities=25%  Similarity=0.462  Sum_probs=117.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++......... ......+|..|+|||++.+..++
T Consensus       151 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  228 (333)
T 1mqb_A          151 GMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT  228 (333)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCC
Confidence            5789999999999964  59999999999999999999999999998654332111 12223467889999999988999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||++ |..||.....                 ......+........+..++..+.+|+.+||+.||
T Consensus       229 ~~~Di~slG~il~ellt~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  291 (333)
T 1mqb_A          229 SASDVWSFGIVMWEVMTYGERPYWELSN-----------------HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQER  291 (333)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSST
T ss_pred             chhhhHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCCh
Confidence            99999999999999999 9999976431                 11112222222333445567789999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcC
Q 027003          160 KLRPRMSEVLAILERLEA  177 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~  177 (229)
                      .+||++.++++.|+++..
T Consensus       292 ~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          292 ARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             TTSCCHHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHHh
Confidence            999999999999988754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-34  Score=225.00  Aligned_cols=157  Identities=25%  Similarity=0.344  Sum_probs=125.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++
T Consensus       114 ~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  191 (287)
T 1u59_A          114 ELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS  191 (287)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHC--CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCC
Confidence            5789999999999964  5999999999999999999999999999875433221 112234568899999999888899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++ |+.||......                 .....+........+..++..+.+|+.+||+.||
T Consensus       192 ~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p  254 (287)
T 1u59_A          192 SRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPPELYALMSDCWIYKW  254 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred             chhhHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCCh
Confidence            99999999999999998 99999764321                 1112222222334455677889999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcC
Q 027003          160 KLRPRMSEVLAILERLEA  177 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~  177 (229)
                      .+||++.++++.|+.+..
T Consensus       255 ~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          255 EDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             GGSCCHHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHHH
Confidence            999999999999988754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.2e-34  Score=225.46  Aligned_cols=158  Identities=25%  Similarity=0.397  Sum_probs=122.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++.......... ......+|..|+|||++.+..++
T Consensus       125 ~~~~~i~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  202 (291)
T 1u46_A          125 RYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS  202 (291)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCC
Confidence            5789999999999964  69999999999999999999999999998764433221 12334578889999999988899


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++ |+.||.+.+..                .....+.........+..++..+.+++.+||+.||
T Consensus       203 ~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  266 (291)
T 1u46_A          203 HASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP  266 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             chhhHHHHHHHHHHHHhCCCCCcccCCHH----------------HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCc
Confidence            99999999999999999 99999765321                11112222222333445567789999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcC
Q 027003          160 KLRPRMSEVLAILERLEA  177 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~  177 (229)
                      .+||++.++++.|+++..
T Consensus       267 ~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          267 EDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             GGSCCHHHHHHHHHHHC-
T ss_pred             ccCcCHHHHHHHHHHhCc
Confidence            999999999999988754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.4e-34  Score=225.72  Aligned_cols=157  Identities=27%  Similarity=0.399  Sum_probs=120.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++........  .......+|..|+|||++.+..+
T Consensus       132 ~i~~ql~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  209 (298)
T 3f66_A          132 GFGLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF  209 (298)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCC
Confidence            5789999999999964  5999999999999999999999999999865432211  11233467889999999999999


Q ss_pred             cccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.++|||||||++|+|++ |..||.......                 .............+..++..+.+++.+||+.|
T Consensus       210 ~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  272 (298)
T 3f66_A          210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----------------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPK  272 (298)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence            999999999999999999 566665543211                 11111122222334445678999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhcC
Q 027003          159 PKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       159 P~~Rpt~~~v~~~l~~~~~  177 (229)
                      |.+||++.++++.|+++..
T Consensus       273 p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          273 AEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             GGGSCCHHHHHHHHHHHHH
T ss_pred             hhhCcCHHHHHHHHHHHHH
Confidence            9999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-33  Score=230.44  Aligned_cols=148  Identities=26%  Similarity=0.350  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----cEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++    .+||+|||+++.......   ....+||+.|+|||++.+.
T Consensus       119 ~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~  193 (361)
T 2yab_A          119 SFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE  193 (361)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCC
Confidence            5789999999999964  599999999999998877    799999999987544322   2346799999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  155 (229)
                      .++.++|||||||++|+|++|..||.+.+..                .....+.......  ..+...+..+.+||.+||
T Consensus       194 ~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  257 (361)
T 2yab_A          194 PLGLEADMWSIGVITYILLSGASPFLGDTKQ----------------ETLANITAVSYDFDEEFFSQTSELAKDFIRKLL  257 (361)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHC
Confidence            9999999999999999999999999775321                1111111111110  011234667899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      ..||.+|||+.++++
T Consensus       258 ~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          258 VKETRKRLTIQEALR  272 (361)
T ss_dssp             CSSTTTSCCHHHHHT
T ss_pred             CCChhHCcCHHHHhc
Confidence            999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9e-34  Score=223.81  Aligned_cols=155  Identities=26%  Similarity=0.447  Sum_probs=123.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.
T Consensus       113 ~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  189 (279)
T 1qpc_A          113 DMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTI  189 (279)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHHC--CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCc
Confidence            5789999999999964  599999999999999999999999999987543321 1122345678899999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |+.||.+....                 .....+........+..++..+.+|+.+||+.||+
T Consensus       190 ~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  252 (279)
T 1qpc_A          190 KSDVWSFGILLTEIVTHGRIPYPGMTNP-----------------EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE  252 (279)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCcccCHH-----------------HHHHHHhcccCCCCcccccHHHHHHHHHHhccChh
Confidence            9999999999999999 99999764321                 11112222223334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|+.+.
T Consensus       253 ~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          253 DRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCCCHHHHHHHHHHHH
Confidence            9999999999998764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.6e-33  Score=229.54  Aligned_cols=144  Identities=22%  Similarity=0.319  Sum_probs=117.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +|+||||||+|||++.+|.+||+|||+++.....     ....+||+.|+|||++.+..++.
T Consensus       145 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  217 (350)
T 1rdq_E          145 FYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNK  217 (350)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCC
Confidence            4789999999999964  5999999999999999999999999999865332     23457999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|..||.+.+.                ......+....  ...+...+..+.+||.+||+.||.+
T Consensus       218 ~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~  279 (350)
T 1rdq_E          218 AVDWWALGVLIYEMAAGYPPFFADQP----------------IQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTK  279 (350)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTT
T ss_pred             cCCEecccHhHhHHhhCCCCCCCCCH----------------HHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            99999999999999999999976431                11112222222  2344556778999999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      ||+     +.++++
T Consensus       280 R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          280 RFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTSSTTTTHHHHT
T ss_pred             ccCCccCCHHHHHh
Confidence            998     788875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.9e-34  Score=248.16  Aligned_cols=156  Identities=26%  Similarity=0.369  Sum_probs=123.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-cceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .|+.||+.||+|||++  +||||||||+|||++.++.+||+|||+++....... ........+|..|+|||++.+..++
T Consensus       473 ~i~~qi~~~L~yLH~~--~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~  550 (635)
T 4fl3_A          473 ELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS  550 (635)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHC--CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCC
Confidence            5789999999999964  599999999999999999999999999986543322 1222334567899999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||++ |+.||.+...                 ......+........+..++..+.+||.+||+.||
T Consensus       551 ~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP  613 (635)
T 4fl3_A          551 SKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV  613 (635)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence            99999999999999998 9999977532                 12223333444445566778899999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      ++||++.++++.|+.+.
T Consensus       614 ~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          614 ENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             TTSCCHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHHHH
Confidence            99999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-34  Score=228.30  Aligned_cols=149  Identities=23%  Similarity=0.275  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC--CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.  ++.+||+|||+++.......   .....||+.|+|||++.+..+
T Consensus       106 ~i~~qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~  180 (321)
T 1tki_A          106 SYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVV  180 (321)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEE
T ss_pred             HHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCC
Confidence            5789999999999964  6999999999999987  78999999999987644322   344679999999999988888


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC--CcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|+|++|..||.+....                .....+........  .....+..+.+|+.+||+.
T Consensus       181 ~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (321)
T 1tki_A          181 STATDMWSLGTLVYVLLSGINPFLAETNQ----------------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK  244 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCcCCCHH----------------HHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999775421                11111221111111  0123467889999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027003          158 EPKLRPRMSEVLAI  171 (229)
Q Consensus       158 dP~~Rpt~~~v~~~  171 (229)
                      ||.+|||+.|+++.
T Consensus       245 dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          245 ERKSRMTASEALQH  258 (321)
T ss_dssp             SGGGSCCHHHHHHS
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999973

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-33  Score=223.29  Aligned_cols=151  Identities=25%  Similarity=0.441  Sum_probs=117.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.......     ....++..|+|||++.+..++.
T Consensus       121 ~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~  193 (278)
T 1byg_A          121 KFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFST  193 (278)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCc
Confidence            5789999999999964  59999999999999999999999999987543321     2235788999999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |+.||......                 .....+........+..++..+.+++.+||+.||.
T Consensus       194 ~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  256 (278)
T 1byg_A          194 KSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA  256 (278)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChh
Confidence            9999999999999998 99999764321                 11112222223344455678899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       257 ~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          257 MRPSFLQLREQLEHIK  272 (278)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCCCHHHHHHHHHHHH
Confidence            9999999999998875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-33  Score=224.41  Aligned_cols=155  Identities=23%  Similarity=0.396  Sum_probs=125.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++........ .......+|..|+|||++.+..++.
T Consensus       115 ~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  191 (288)
T 3kfa_A          115 YMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSI  191 (288)
T ss_dssp             HHHHHHHHHHHHHHHH--TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHC--CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCc
Confidence            5789999999999964  599999999999999999999999999987543322 2233455788999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+.+..                 .....+........+..++..+.+|+.+||+.||.
T Consensus       192 ~~Di~slG~il~~ll~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  254 (288)
T 3kfa_A          192 KSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS  254 (288)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChh
Confidence            9999999999999999 99999765421                 12223333334445556678899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+.+.
T Consensus       255 ~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          255 DRPSFAEIHQAFETMF  270 (288)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999987754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=245.78  Aligned_cols=156  Identities=24%  Similarity=0.346  Sum_probs=121.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||+|||+.  +||||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++
T Consensus       440 ~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~  517 (613)
T 2ozo_A          440 ELLHQVSMGMKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS  517 (613)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHC--CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCC
Confidence            5789999999999964  5999999999999999999999999999875432211 112223456899999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||++ |+.||.+....                 .....+........+..++..+.+||.+||+.||
T Consensus       518 ~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP  580 (613)
T 2ozo_A          518 SRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPPELYALMSDCWIYKW  580 (613)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSST
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCh
Confidence            99999999999999998 99999875421                 1222233333445566678899999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      ++||++.++++.|+.+.
T Consensus       581 ~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          581 EDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             TTSCCHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHHHH
Confidence            99999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-33  Score=229.98  Aligned_cols=147  Identities=29%  Similarity=0.406  Sum_probs=116.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc---cCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~   78 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....      .....||+.|+|||++.   ++.
T Consensus       158 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~  229 (348)
T 1u5q_A          158 AVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQ  229 (348)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCC
T ss_pred             HHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCC
Confidence            5789999999999964  599999999999999999999999999976532      22357999999999985   467


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|||++|+.||.+.+..                .....+.............+..+.+|+.+||+.|
T Consensus       230 ~~~~~DiwslG~il~ell~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  293 (348)
T 1u5q_A          230 YDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI  293 (348)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            889999999999999999999999764311                1111222222222223345677899999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 027003          159 PKLRPRMSEVLAIL  172 (229)
Q Consensus       159 P~~Rpt~~~v~~~l  172 (229)
                      |.+|||+.++++..
T Consensus       294 P~~Rps~~~ll~h~  307 (348)
T 1u5q_A          294 PQDRPTSEVLLKHR  307 (348)
T ss_dssp             GGGSCCHHHHTTCH
T ss_pred             hhhCcCHHHHhhCh
Confidence            99999999998643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-33  Score=245.67  Aligned_cols=147  Identities=29%  Similarity=0.466  Sum_probs=119.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +||||||||+||||+.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       446 ~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~  521 (674)
T 3pfq_A          446 FYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGK  521 (674)
T ss_dssp             HHHHHHHHHHHHHHHT--SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBST
T ss_pred             HHHHHHHHHHHHHHhC--CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCc
Confidence            4789999999999964  599999999999999999999999999986432221  234578999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+.                ......++...  ..++..++..+.+||.+||+.||.+
T Consensus       522 ~~DvwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~  583 (674)
T 3pfq_A          522 SVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGK  583 (674)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTT
T ss_pred             cceEechHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHH
Confidence            99999999999999999999987542                11222233222  2445567888999999999999999


Q ss_pred             CCCH-----HHHHH
Q 027003          162 RPRM-----SEVLA  170 (229)
Q Consensus       162 Rpt~-----~~v~~  170 (229)
                      |+++     .++++
T Consensus       584 R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          584 RLGCGPEGERDIKE  597 (674)
T ss_dssp             CTTCSTTHHHHHHS
T ss_pred             CCCCCCCcHHHHhc
Confidence            9997     66654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-33  Score=229.89  Aligned_cols=149  Identities=23%  Similarity=0.325  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++   .+||+|||++........   .....||+.|+|||++.+..
T Consensus       132 ~~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~  206 (362)
T 2bdw_A          132 HCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDP  206 (362)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCC
Confidence            5789999999999964  599999999999997654   599999999987543322   23467999999999999889


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+.+..                .....+......  ......++..+.+|+.+||+
T Consensus       207 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  270 (362)
T 2bdw_A          207 YSKPVDIWACGVILYILLVGYPPFWDEDQH----------------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT  270 (362)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSC
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcC
Confidence            999999999999999999999999764321                111111111111  11223457789999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||.+||++.++++.
T Consensus       271 ~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          271 VNPKKRITADQALKV  285 (362)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5e-34  Score=231.22  Aligned_cols=147  Identities=25%  Similarity=0.370  Sum_probs=116.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++........   ....+||+.|+|||++.+..+ +
T Consensus       112 ~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  186 (336)
T 3h4j_B          112 RFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAG  186 (336)
T ss_dssp             HHHHHHHHHHHHHHHH--TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGC
T ss_pred             HHHHHHHHHHHHHHHC--CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCC
Confidence            5789999999999964  599999999999999999999999999986543322   234579999999999988776 6


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||.+........                . + .......+...+..+.+|+.+||+.||.
T Consensus       187 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~-i-~~~~~~~p~~~s~~~~~li~~~L~~dP~  248 (336)
T 3h4j_B          187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------K-V-NSCVYVMPDFLSPGAQSLIRRMIVADPM  248 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------C-C-CSSCCCCCTTSCHHHHHHHHTTSCSSGG
T ss_pred             CccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------H-H-HcCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            89999999999999999999997654211100                0 0 0011223445667889999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|||+.|+++.
T Consensus       249 ~Rpt~~eil~h  259 (336)
T 3h4j_B          249 QRITIQEIRRD  259 (336)
T ss_dssp             GSCCHHHHTTC
T ss_pred             HCcCHHHHHhC
Confidence            99999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.9e-33  Score=226.78  Aligned_cols=148  Identities=28%  Similarity=0.313  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||++  +|+||||||+|||++.++.   +||+|||++........  .....+||+.|+|||++.+..
T Consensus       134 ~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~  209 (351)
T 3c0i_A          134 HYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREP  209 (351)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCC
Confidence            4789999999999964  5999999999999987654   99999999987544322  133457999999999999989


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC--CcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+....                 ....+........  .....+..+.+|+.+||+
T Consensus       210 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  272 (351)
T 3c0i_A          210 YGKPVDVWGCGVILFILLSGCLPFYGTKER-----------------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM  272 (351)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-----------------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred             CCchHhhHHHHHHHHHHHHCCCCCCCcHHH-----------------HHHHHHcCCCCCCccccccCCHHHHHHHHHHCC
Confidence            999999999999999999999999764211                 0111111111100  012346788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       273 ~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          273 LDPAERITVYEALN  286 (351)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4e-33  Score=229.52  Aligned_cols=149  Identities=26%  Similarity=0.391  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc---CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~   78 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.+|.+||+|||+++.......   ....+||+.|+|||++.+   ..
T Consensus       119 ~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~  193 (384)
T 4fr4_A          119 LFICELVMALDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAG  193 (384)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCC
T ss_pred             HHHHHHHHHHHHHHHC--CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCC
Confidence            4789999999999964  599999999999999999999999999987543322   345679999999999964   45


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|+|++|+.||...........              ...+. ......+..++..+.+||.+||+.|
T Consensus       194 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--------------~~~~~-~~~~~~p~~~s~~~~~li~~lL~~d  258 (384)
T 4fr4_A          194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI--------------VHTFE-TTVVTYPSAWSQEMVSLLKKLLEPN  258 (384)
T ss_dssp             BCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH--------------HHHHH-HCCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             CCccceeechHHHHHHHHhCCCCCCCCCCccHHHH--------------HHHHh-hcccCCCCcCCHHHHHHHHHHhcCC
Confidence            88999999999999999999999976442211111              11111 1122345556788999999999999


Q ss_pred             CCCCCC-HHHHHH
Q 027003          159 PKLRPR-MSEVLA  170 (229)
Q Consensus       159 P~~Rpt-~~~v~~  170 (229)
                      |.+||+ +.++++
T Consensus       259 P~~R~s~~~~l~~  271 (384)
T 4fr4_A          259 PDQRFSQLSDVQN  271 (384)
T ss_dssp             GGGSCCSHHHHHT
T ss_pred             HhHhcccHHHHHc
Confidence            999998 676664

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3e-33  Score=227.51  Aligned_cols=150  Identities=29%  Similarity=0.471  Sum_probs=114.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       114 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  189 (345)
T 3a8x_A          114 FYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGF  189 (345)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCCh
Confidence            4689999999999964  599999999999999999999999999986332221  234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHH-HHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|+|||||++|||++|+.||..........        ........ .+...  ....+...+..+.+|+.+||+.||.
T Consensus       190 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~  259 (345)
T 3a8x_A          190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPK  259 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTT
T ss_pred             HHhHHHHHHHHHHHHhCCCCcCCcccccccc--------cccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHh
Confidence            9999999999999999999997532211000        00111111 12222  2234556678899999999999999


Q ss_pred             CCCCH
Q 027003          161 LRPRM  165 (229)
Q Consensus       161 ~Rpt~  165 (229)
                      +||++
T Consensus       260 ~R~~~  264 (345)
T 3a8x_A          260 ERLGC  264 (345)
T ss_dssp             TSTTC
T ss_pred             HCCCC
Confidence            99996

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.2e-34  Score=229.47  Aligned_cols=172  Identities=28%  Similarity=0.410  Sum_probs=129.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++......... .......+|..|+|||++.+..++
T Consensus       138 ~i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  215 (318)
T 3lxp_A          138 LFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY  215 (318)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCC
Confidence            5789999999999964  5999999999999999999999999999876543322 123345678889999999998999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|..||......... ...+... ..........+........+..++..+.+|+.+||+.||.
T Consensus       216 ~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  293 (318)
T 3lxp_A          216 YASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQG-QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEAS  293 (318)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCH-HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             cHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhccccc-chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcc
Confidence            9999999999999999999999754221000 0000000 0011223334444445555667788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.++++.|+.+..
T Consensus       294 ~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          294 FRPTFENLIPILKTVHE  310 (318)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             cCcCHHHHHHHHHHHHH
Confidence            99999999999987753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=1.8e-33  Score=226.33  Aligned_cols=161  Identities=24%  Similarity=0.338  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+. .++
T Consensus       112 ~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  187 (317)
T 2pmi_A          112 YFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYS  187 (317)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCC
Confidence            467899999999996  4699999999999999999999999999986543221  12345789999999999764 589


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhc---c---------------hhhHHHHhhcccCCCCc
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLS---D---------------KRKLFRIMDTKLGGQYP  140 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~---~---------------~~~~~~~~~~~~~~~~~  140 (229)
                      .++|||||||++|+|++|+.||.+.+...... +..... +...   .               ...+...+....    .
T Consensus       188 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  263 (317)
T 2pmi_A          188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----K  263 (317)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----S
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc----c
Confidence            99999999999999999999998754321111 111000 0000   0               000001111111    1


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          141 QKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       141 ~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       264 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             SCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            123567899999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.98  E-value=1.7e-33  Score=223.68  Aligned_cols=165  Identities=24%  Similarity=0.264  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      .++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+.. ++
T Consensus       105 ~~~~ql~~~l~~lH~~--~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  180 (292)
T 3o0g_A          105 SFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcC
Confidence            5789999999999964  599999999999999999999999999986543222  233457899999999998766 79


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch--hHHHhh-hhhhcchhhHHHHhh---------cccCCCCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWA-KPYLSDKRKLFRIMD---------TKLGGQYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|..||.........  .+.... .+.............         ...........+..+.
T Consensus       181 ~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (292)
T 3o0g_A          181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR  260 (292)
T ss_dssp             THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred             chHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHH
Confidence            9999999999999999988886433221110  000000 000000000000000         0000112234567889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.|+++
T Consensus       261 ~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          261 DLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhccChhhCCCHHHHhc
Confidence            9999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.98  E-value=3.1e-33  Score=225.91  Aligned_cols=147  Identities=27%  Similarity=0.391  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++......  ......+||+.|+|||++.+..++.
T Consensus       125 ~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  200 (327)
T 3a62_A          125 FYLAEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNR  200 (327)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCT
T ss_pred             HHHHHHHHHHHHHHhC--CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCC
Confidence            4788999999999964  69999999999999999999999999987532221  1233467999999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.+..                .....+....  ...+...+..+.+|+.+||+.||.+
T Consensus       201 ~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~  262 (327)
T 3a62_A          201 AVDWWSLGALMYDMLTGAPPFTGENRK----------------KTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAAS  262 (327)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGG
T ss_pred             cccchhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhh
Confidence            999999999999999999999765321                1112222222  2334456778999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.++++
T Consensus       263 R~~~~~~~~~e~l~  276 (327)
T 3a62_A          263 RLGAGPGDAGEVQA  276 (327)
T ss_dssp             STTSSTTTHHHHHH
T ss_pred             ccCCCCCCHHHHHc
Confidence            99     6778776

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=2.4e-33  Score=233.78  Aligned_cols=167  Identities=26%  Similarity=0.332  Sum_probs=117.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||+|||+  .+|+||||||+|||++.+ +.+||+|||+++.......   ....+||..|+|||++.+. .+
T Consensus       160 ~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  234 (420)
T 1j1b_A          160 LYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDY  234 (420)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCC
Confidence            468999999999995  469999999999999965 5689999999986543322   2345789999999999765 68


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc-chhhHHHHhhcccC-CC------------CcHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLG-GQ------------YPQKAAH  145 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~------------~~~~~~~  145 (229)
                      +.++|||||||++|||++|+.||.+.+...  .+......... ....+.. +..... ..            ++...+.
T Consensus       235 ~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~  311 (420)
T 1j1b_A          235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPP  311 (420)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCH
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHh-hChhhhhhccCccCCCCHHHhcCCCCCH
Confidence            999999999999999999999998754211  11111110000 0001111 111000 00            1123457


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH--HHHhhc
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA--ILERLE  176 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~--~l~~~~  176 (229)
                      .+.+|+.+||+.||.+||++.|+++  .++.+.
T Consensus       312 ~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          312 EAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            8999999999999999999999986  344443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=4.8e-33  Score=227.34  Aligned_cols=98  Identities=33%  Similarity=0.451  Sum_probs=86.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-------------------------CCcEEEcccCCcccCCCCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------------EFNAKLSDFGLAKAGPTGDRT   56 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-------------------------~~~~kl~Dfg~~~~~~~~~~~   56 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.                         ++.+||+|||+++.....   
T Consensus       141 ~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---  215 (360)
T 3llt_A          141 LYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---  215 (360)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---
T ss_pred             HHHHHHHHHHHHHHHC--CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---
Confidence            4789999999999964  5999999999999975                         788999999999864332   


Q ss_pred             ceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCc
Q 027003           57 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK  106 (229)
Q Consensus        57 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~  106 (229)
                        .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus       216 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          216 --HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             --CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence              234578999999999999999999999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.98  E-value=3.8e-34  Score=235.45  Aligned_cols=139  Identities=15%  Similarity=0.169  Sum_probs=109.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      +|+.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++....     ......| ..|+|||++.+.    
T Consensus       210 ~i~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~  281 (377)
T 3byv_A          210 QLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATIS  281 (377)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTH
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccccccc
Confidence            4789999999999964  599999999999999999999999999986322     2334567 999999999887    


Q ss_pred             -------CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           78 -------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        78 -------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                             .++.++|||||||++|||++|+.||.+........                .+. .     ....++..+.+|
T Consensus       282 ~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~-~-----~~~~~~~~~~~l  339 (377)
T 3byv_A          282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE----------------WIF-R-----SCKNIPQPVRAL  339 (377)
T ss_dssp             HHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG----------------GGG-S-----SCCCCCHHHHHH
T ss_pred             ccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh----------------hhh-h-----hccCCCHHHHHH
Confidence                   79999999999999999999999997643211000                000 0     012235678899


Q ss_pred             HHHhccCCCCCCCCHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+||+.||.+||++.++++
T Consensus       340 i~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          340 LEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHcCCCchhCCCHHHHhh
Confidence            99999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.98  E-value=9e-34  Score=242.91  Aligned_cols=156  Identities=29%  Similarity=0.454  Sum_probs=124.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||++  +||||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.
T Consensus       367 ~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  443 (535)
T 2h8h_A          367 DMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI  443 (535)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCc
Confidence            5789999999999964  59999999999999999999999999998653321 11122334678899999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |+.||.+...                 ......+........+..++..+.+||.+||+.||+
T Consensus       444 ~sDvwSlGv~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~  506 (535)
T 2h8h_A          444 KSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE  506 (535)
T ss_dssp             HHHHHHHHHHHHHHTTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            9999999999999999 9999976431                 111222233333445556778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.+|++.|+.+..
T Consensus       507 ~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          507 ERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             GSCCHHHHHHHHHTSSC
T ss_pred             HCcCHHHHHHHHHHHhh
Confidence            99999999999987754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.98  E-value=6.1e-33  Score=227.82  Aligned_cols=165  Identities=24%  Similarity=0.319  Sum_probs=109.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++.
T Consensus       131 ~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  205 (371)
T 2xrw_A          131 YLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKE  205 (371)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCc
Confidence            4789999999999964  69999999999999999999999999998653321   123457899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-HHHh-hhh---hhcc-hhhHHHHhhcc---------------cCC---
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKP---YLSD-KRKLFRIMDTK---------------LGG---  137 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~-~~~---~~~~-~~~~~~~~~~~---------------~~~---  137 (229)
                      ++|||||||++|+|++|+.||.+.+...... +... ..+   +... ...........               ...   
T Consensus       206 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (371)
T 2xrw_A          206 NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS  285 (371)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSS
T ss_pred             hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccc
Confidence            9999999999999999999998754311100 0000 000   0000 00000000000               000   


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus       286 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          286 EHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0112346789999999999999999999999973

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.98  E-value=1.4e-33  Score=227.78  Aligned_cols=156  Identities=28%  Similarity=0.418  Sum_probs=122.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++......   ......++..|+|||++.+..++.
T Consensus       146 ~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  220 (327)
T 1fvr_A          146 HFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTT  220 (327)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCc
Confidence            5789999999999964  69999999999999999999999999987432211   122345688999999998888999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       221 ~~Di~slG~il~ellt~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  283 (327)
T 1fvr_A          221 NSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY  283 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred             hhcchHHHHHHHHHHcCCCCCCCCCcHH-----------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999998 99999765321                 11122222223334455677899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCC
Q 027003          161 LRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~~  179 (229)
                      +||++.++++.|.++....
T Consensus       284 ~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          284 ERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GSCCHHHHHHHHHHHHHSS
T ss_pred             hCcCHHHHHHHHHHHHHhh
Confidence            9999999999998876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.98  E-value=1.3e-33  Score=237.82  Aligned_cols=168  Identities=24%  Similarity=0.314  Sum_probs=108.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------------------   56 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------------------   56 (229)
                      .++.||+.||+|||+.  +||||||||+||||+.++.+||+|||+++........                         
T Consensus       160 ~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (458)
T 3rp9_A          160 TLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK  237 (458)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--------------------
T ss_pred             HHHHHHHHHHHHHHhC--CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccccccccc
Confidence            4789999999999964  5999999999999999999999999999865422110                         


Q ss_pred             ceeecccccccccccccc-ccCCCcccCceeehhHHHHHHHh-----------CCCcCCCCccccc--------------
Q 027003           57 HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLS-----------GRCAVDKTKVGIE--------------  110 (229)
Q Consensus        57 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt-----------g~~p~~~~~~~~~--------------  110 (229)
                      ......+||+.|+|||++ .+..++.++|||||||++|||++           |+.+|.+......              
T Consensus       238 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~  317 (458)
T 3rp9_A          238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHT  317 (458)
T ss_dssp             -------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------C
T ss_pred             ccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccc
Confidence            123446789999999976 45679999999999999999999           6666655431000              


Q ss_pred             ----hhH---HHhh-hhhhc-----chhhHHHHhhc---ccCC---CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          111 ----QSL---VDWA-KPYLS-----DKRKLFRIMDT---KLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       111 ----~~~---~~~~-~~~~~-----~~~~~~~~~~~---~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                          ..+   .... .+...     ........+..   ....   ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       318 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          318 RGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             HHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                000   0000 00000     00000000000   0000   0112346778999999999999999999999973

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=8.2e-34  Score=222.48  Aligned_cols=156  Identities=27%  Similarity=0.425  Sum_probs=122.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.
T Consensus       108 ~~~~~i~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  184 (267)
T 3t9t_A          108 GMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS  184 (267)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccc
Confidence            5789999999999964  59999999999999999999999999998653221 11122345678899999999889999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++||||||+++|+|++ |+.||......                 .....+........+...+..+.+++.+||+.||.
T Consensus       185 ~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~  247 (267)
T 3t9t_A          185 KSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE  247 (267)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             hhchhhhHHHHHHHhccCCCCCCCCCHH-----------------HHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChh
Confidence            9999999999999999 89999764311                 11111222222333445567889999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +||++.++++.|+++..
T Consensus       248 ~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          248 DRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHHh
Confidence            99999999999988754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.98  E-value=1.3e-33  Score=224.03  Aligned_cols=165  Identities=22%  Similarity=0.340  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+. .++
T Consensus       104 ~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  179 (288)
T 1ob3_A          104 SFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYS  179 (288)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCC
Confidence            5789999999999964  699999999999999999999999999876432211  12345689999999999764 589


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhh-hhhhcchhhHHHH--hhcccC-------CCCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKRKLFRI--MDTKLG-------GQYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~  149 (229)
                      .++|||||||++|+|++|+.||.+....... ...... .+...........  ......       .......+..+.+
T Consensus       180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (288)
T 1ob3_A          180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID  259 (288)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHH
Confidence            9999999999999999999999875421110 000000 0000000000000  000000       0011234667889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      |+.+||+.||.+|||+.++++
T Consensus       260 li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          260 LLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCcccCCCHHHHhc
Confidence            999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.98  E-value=1.6e-33  Score=227.47  Aligned_cols=148  Identities=26%  Similarity=0.350  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----cEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++    .+||+|||+++.......   .....||+.|+|||++.+.
T Consensus       118 ~i~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~  192 (326)
T 2y0a_A          118 EFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE  192 (326)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHC--CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCC
Confidence            5789999999999964  599999999999998887    799999999987543322   2345799999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  155 (229)
                      .++.++|||||||++|+|++|..||.+.....                ....+.......  ......+..+.+|+.+||
T Consensus       193 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  256 (326)
T 2y0a_A          193 PLGLEADMWSIGVITYILLSGASPFLGDTKQE----------------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLL  256 (326)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----------------HHHHHHhcCCCcCccccccCCHHHHHHHHHHc
Confidence            99999999999999999999999997643211                111111111100  011234567889999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.||.+|||+.++++
T Consensus       257 ~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          257 VKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhhCCCHHHHhc
Confidence            999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.98  E-value=1.8e-33  Score=229.28  Aligned_cols=164  Identities=18%  Similarity=0.199  Sum_probs=122.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC--cEEEcccCCcccCCCCCCc-----ceeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~   74 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++  .+||+|||+++........     .......||..|+|||++
T Consensus       163 ~i~~qi~~~L~~LH~~--~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  240 (352)
T 2jii_A          163 QVACRLLDALEFLHEN--EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH  240 (352)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence            5899999999999964  699999999999999998  8999999999765432111     112345799999999999


Q ss_pred             ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--c--CCCCcHHHHHHHHHH
Q 027003           75 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--L--GGQYPQKAAHTAATL  150 (229)
Q Consensus        75 ~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~l  150 (229)
                      .+..++.++|||||||++|+|++|+.||......... +.....          ......  .  ........+..+.+|
T Consensus       241 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~l  309 (352)
T 2jii_A          241 KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQKQ----------KFVDKPGPFVGPCGHWIRPSETLQKY  309 (352)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHHHH----------HHHHSCCCEECTTSCEECCCHHHHHH
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHHHH----------hccCChhhhhhhccccCCCcHHHHHH
Confidence            9989999999999999999999999999875321111 110000          000000  0  000112346789999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          151 ALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      +.+||+.||.+||++.++++.|+++...
T Consensus       310 i~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          310 LKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             HHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            9999999999999999999999887543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=2.7e-33  Score=231.19  Aligned_cols=161  Identities=23%  Similarity=0.298  Sum_probs=118.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC--------------------------------------------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--------------------------------------------   37 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~--------------------------------------------   37 (229)
                      .++.||+.||.|||++ .+|+||||||+|||++.++                                            
T Consensus       150 ~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (397)
T 1wak_A          150 KIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPK  228 (397)
T ss_dssp             HHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGG
T ss_pred             HHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccc
Confidence            5789999999999964 1699999999999998775                                            


Q ss_pred             -----cEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchh
Q 027003           38 -----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS  112 (229)
Q Consensus        38 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~  112 (229)
                           .+||+|||+++.....     ....+||..|+|||++.+..++.++|||||||++|+|++|+.||.+........
T Consensus       229 ~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  303 (397)
T 1wak_A          229 NAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR  303 (397)
T ss_dssp             GGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH
T ss_pred             cccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc
Confidence                 7999999999865332     234578999999999999999999999999999999999999998654322110


Q ss_pred             -------HHHhhhhhh--------------cch-----------hhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003          113 -------LVDWAKPYL--------------SDK-----------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus       113 -------~~~~~~~~~--------------~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                             +........              ...           ......+..  ....+...+..+.+|+.+||+.||.
T Consensus       304 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~  381 (397)
T 1wak_A          304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPE  381 (397)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGG
T ss_pred             hHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChh
Confidence                   000000000              000           000011111  1234567788999999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.|+++
T Consensus       382 ~Rpt~~e~l~  391 (397)
T 1wak_A          382 KRATAAECLR  391 (397)
T ss_dssp             GSCCHHHHHT
T ss_pred             hcCCHHHHhh
Confidence            9999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.98  E-value=3.1e-33  Score=226.68  Aligned_cols=165  Identities=23%  Similarity=0.352  Sum_probs=121.7

Q ss_pred             hhHHHHHHHHHHhhcC------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc--eeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||.|||..      ..+|+||||||+|||++.++.+||+|||++..........  ......||..|+|||+
T Consensus       143 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  222 (342)
T 1b6c_B          143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  222 (342)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhh
Confidence            5789999999999932      2469999999999999999999999999997654332211  1234579999999999


Q ss_pred             cccC------CCcccCceeehhHHHHHHHhC----------CCcCCCCccccchhHHHhhhhhhcchhhHHH-HhhcccC
Q 027003           74 VATG------RLTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLG  136 (229)
Q Consensus        74 ~~~~------~~~~~~Di~slG~il~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  136 (229)
                      +.+.      .++.++|||||||++|||++|          +.||........            ....+.. +......
T Consensus       223 ~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~  290 (342)
T 1b6c_B          223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP------------SVEEMRKVVCEQKLR  290 (342)
T ss_dssp             HTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSCCC
T ss_pred             hcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc------------cHHHHHHHHHHHHhC
Confidence            9765      334689999999999999999          667654322110            0111111 1222222


Q ss_pred             CCCc-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          137 GQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       137 ~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      ...+     ......+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       291 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            2332     25678899999999999999999999999999987543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.98  E-value=4.4e-33  Score=227.38  Aligned_cols=170  Identities=22%  Similarity=0.288  Sum_probs=119.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-L   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~   79 (229)
                      .++.|++.||.|||.+..+|+||||||+|||++. ++.+||+|||+++.......   .....||..|+|||++.+.. +
T Consensus       133 ~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  209 (360)
T 3e3p_A          133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHY  209 (360)
T ss_dssp             HHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCC
Confidence            4788999999999955567999999999999997 89999999999986543322   23457899999999987654 8


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc----------------cCCCCcHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----------------LGGQYPQKA  143 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~  143 (229)
                      +.++|||||||++|+|++|+.||.+.+.....  .................+...                .........
T Consensus       210 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (360)
T 3e3p_A          210 TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD  287 (360)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTT
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccc
Confidence            99999999999999999999999875432111  111000000000000000000                001111225


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH--HHhhc
Q 027003          144 AHTAATLALQCLNNEPKLRPRMSEVLAI--LERLE  176 (229)
Q Consensus       144 ~~~~~~li~~~l~~dP~~Rpt~~~v~~~--l~~~~  176 (229)
                      +..+.+|+.+||+.||.+|||+.|+++.  +..+.
T Consensus       288 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             cHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            6789999999999999999999999863  44443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=8.5e-34  Score=236.00  Aligned_cols=139  Identities=14%  Similarity=0.164  Sum_probs=109.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccc-------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-------   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------   74 (229)
                      .|+.||+.||+|||++  +||||||||+|||++.++.+||+|||+++.....     ....+| ..|+|||++       
T Consensus       215 ~i~~qi~~aL~~LH~~--~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~  286 (413)
T 3dzo_A          215 QLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPF  286 (413)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTT
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhcccccc
Confidence            4679999999999964  5999999999999999999999999998864322     334567 999999999       


Q ss_pred             ---ccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           75 ---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        75 ---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                         .+..++.++|||||||++|||++|+.||.........                ..++..      ...++..+.+|+
T Consensus       287 ~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~----------------~~~~~~------~~~~~~~~~~li  344 (413)
T 3dzo_A          287 GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----------------EWIFRS------CKNIPQPVRALL  344 (413)
T ss_dssp             GGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----------------GGGGSS------CCCCCHHHHHHH
T ss_pred             ccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH----------------HHHHhh------cccCCHHHHHHH
Confidence               5556888999999999999999999999765421100                000100      012346789999


Q ss_pred             HHhccCCCCCCCCHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+||+.||.+||++.++++
T Consensus       345 ~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          345 EGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHTCSSGGGSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            9999999999999888764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.98  E-value=4.5e-33  Score=219.29  Aligned_cols=152  Identities=26%  Similarity=0.365  Sum_probs=116.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      .++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++................||..|+|||++.+..+ +
T Consensus       109 ~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  186 (276)
T 2yex_A          109 RFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA  186 (276)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCC
Confidence            5789999999999964  599999999999999999999999999976533322222344678999999999987765 7


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||........ ...              ...............+..+.+|+.+||+.||.
T Consensus       187 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  251 (276)
T 2yex_A          187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS--------------DWKEKKTYLNPWKKIDSAPLALLHKILVENPS  251 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHH--------------HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHH--------------HhhhcccccCchhhcCHHHHHHHHHHCCCCch
Confidence            799999999999999999999977543211 111              11111111122234567888999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.++++
T Consensus       252 ~Rps~~~il~  261 (276)
T 2yex_A          252 ARITIPDIKK  261 (276)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCCCHHHHhc
Confidence            9999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.98  E-value=3.3e-33  Score=223.81  Aligned_cols=159  Identities=23%  Similarity=0.358  Sum_probs=112.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++........  ......|+..|+|||++.+..++.
T Consensus       140 ~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  215 (310)
T 2wqm_A          140 KYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNF  215 (310)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHHhhC--CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCc
Confidence            5789999999999964  599999999999999999999999999876533221  123456899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.+.......              ....+.............+..+.+|+.+||+.||.+
T Consensus       216 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  281 (310)
T 2wqm_A          216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------------LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK  281 (310)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTC---CCHHH--------------HHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCcccchhHHH--------------HHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhh
Confidence            999999999999999999999764321110              001111111111222345678999999999999999


Q ss_pred             CCCHHHHHHHHHhhcCC
Q 027003          162 RPRMSEVLAILERLEAP  178 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~~~  178 (229)
                      ||++.++++.|+++.+.
T Consensus       282 Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          282 RPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             SCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHh
Confidence            99999999999888643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=4.9e-33  Score=232.44  Aligned_cols=99  Identities=29%  Similarity=0.364  Sum_probs=87.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc--EEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +|+.||+.||+|||+.  +||||||||+|||++.++.  +||+|||+++.....     ....+||..|+|||++.+..+
T Consensus       204 ~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  276 (429)
T 3kvw_A          204 KFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARY  276 (429)
T ss_dssp             HHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCC
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCC
Confidence            5789999999999964  5999999999999999987  999999999764322     234578999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCcc
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKV  107 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~  107 (229)
                      +.++|||||||++|||++|..||.+.+.
T Consensus       277 ~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          277 GMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999999987653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.98  E-value=1.3e-33  Score=227.88  Aligned_cols=157  Identities=26%  Similarity=0.372  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.+   ..+||+|||++................||..|+|||++.+..
T Consensus       144 ~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  221 (327)
T 2yfx_A          144 HVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI  221 (327)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC
Confidence            5789999999999964  59999999999999844   469999999987543322222233456889999999999999


Q ss_pred             CcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|||||||++|+|++ |..||......                 .....+........+..++..+.+|+.+||+.
T Consensus       222 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  284 (327)
T 2yfx_A          222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----------------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQH  284 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999999999999998 99999764311                 11122222222333445667899999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcC
Q 027003          158 EPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      ||.+||++.++++.|+.+..
T Consensus       285 dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          285 QPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHHHHhc
Confidence            99999999999999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=7.9e-33  Score=226.84  Aligned_cols=163  Identities=25%  Similarity=0.338  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.....     ....++|..|+|||++.+ ..++
T Consensus       132 ~~~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~  204 (367)
T 1cm8_A          132 FLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYT  204 (367)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCC
T ss_pred             HHHHHHHHHHHHHHHC--CccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCC
Confidence            4789999999999964  5999999999999999999999999999875332     234578999999999987 6789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-hhh---c--chhhHHHHhhcc--c-C---CCCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYL---S--DKRKLFRIMDTK--L-G---GQYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~~---~--~~~~~~~~~~~~--~-~---~~~~~~~~~~~  147 (229)
                      .++|||||||++|||++|+.||.+.+..... .+..... +..   .  ........+...  . .   .......+..+
T Consensus       205 ~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (367)
T 1cm8_A          205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA  284 (367)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHH
T ss_pred             hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence            9999999999999999999999876432111 0111000 000   0  000001111100  0 0   01122446789


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+|+.+||+.||.+|||+.++++.
T Consensus       285 ~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          285 VNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHccCChhHCCCHHHHhcC
Confidence            999999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.98  E-value=6.7e-33  Score=218.87  Aligned_cols=146  Identities=29%  Similarity=0.451  Sum_probs=114.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++.++.++|+|||++.......    .....||..|+|||++.+..++.
T Consensus       113 ~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  186 (279)
T 3fdn_A          113 TYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDE  186 (279)
T ss_dssp             HHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCc
Confidence            578999999999995  569999999999999999999999999986543322    23457899999999999988999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++||||||+++|+|++|..||.......                ....+.  ......+...+..+.+|+.+||+.||.+
T Consensus       187 ~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~  248 (279)
T 3fdn_A          187 KVDLWSLGVLCYEFLVGKPPFEANTYQE----------------TYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQ  248 (279)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHH--HTCCCCCTTSCHHHHHHHHHHCCSSGGG
T ss_pred             cchhHhHHHHHHHHHHCCCCCCCCcHHH----------------HHHHHH--hCCCCCCCcCCHHHHHHHHHHhccChhh
Confidence            9999999999999999999997643210                111111  1122334456678899999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      ||++.++++.
T Consensus       249 Rps~~e~l~h  258 (279)
T 3fdn_A          249 RPMLREVLEH  258 (279)
T ss_dssp             SCCHHHHHHC
T ss_pred             CCCHHHHhhC
Confidence            9999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=7.8e-33  Score=224.68  Aligned_cols=151  Identities=26%  Similarity=0.275  Sum_probs=113.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC--cEEEcccCCcccCCCCC--Ccceeecccccccccccccccc-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVAT-   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-   76 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+ 
T Consensus       172 ~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  249 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQ--GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT  249 (345)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence            4789999999999964  599999999999998776  89999999997543221  1112334579999999999975 


Q ss_pred             -CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCC--cHHHHHHHHHHHHH
Q 027003           77 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQ  153 (229)
Q Consensus        77 -~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~  153 (229)
                       ..++.++|||||||++|+|++|+.||.+....                .....+.........  ....+..+.+|+.+
T Consensus       250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA----------------DTISQVLNKKLCFENPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH----------------HHHHHHHhcccccCCcccccCCHHHHHHHHH
Confidence             57889999999999999999999999765421                112222222222211  12356789999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||+.||.+||++.++++
T Consensus       314 ~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HSCSCTTTSCCHHHHHH
T ss_pred             HcCCChhHCCCHHHHhc
Confidence            99999999999999987

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.98  E-value=4.2e-33  Score=223.51  Aligned_cols=157  Identities=27%  Similarity=0.393  Sum_probs=110.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++........ .......||..|+|||++.+..++
T Consensus       120 ~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  197 (311)
T 3ork_A          120 EVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD  197 (311)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCC
Confidence            5789999999999964  5999999999999999999999999999865433211 123345789999999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|||||||++|+|++|+.||.+.....                ............  .....++..+.+|+.+||+.|
T Consensus       198 ~~~Di~slG~~l~~ll~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  261 (311)
T 3ork_A          198 ARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------------VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN  261 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSS
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCChHH----------------HHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcC
Confidence            99999999999999999999997654211                001111111000  001124667899999999999


Q ss_pred             CCCCCCHHHHH-HHHHhhc
Q 027003          159 PKLRPRMSEVL-AILERLE  176 (229)
Q Consensus       159 P~~Rpt~~~v~-~~l~~~~  176 (229)
                      |.+||+..+++ ..+.++.
T Consensus       262 P~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          262 PENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             GGGSCSSHHHHHHHHHHHH
T ss_pred             HhhChhhHHHHHHHHHHHh
Confidence            99999766554 5555543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.98  E-value=1.8e-33  Score=233.39  Aligned_cols=151  Identities=25%  Similarity=0.284  Sum_probs=117.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---   78 (229)
                      .++.||+.||+|||+.  +||||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++.+..   
T Consensus       172 ~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~  248 (410)
T 3v8s_A          172 FYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG  248 (410)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred             HHHHHHHHHHHHHHHC--CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCc
Confidence            4689999999999964  599999999999999999999999999987543321 1233568999999999997765   


Q ss_pred             -CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhc
Q 027003           79 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        79 -~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  155 (229)
                       ++.++|||||||++|||++|+.||.+.+..                ....+++...  ...+....++..+.+||.+||
T Consensus       249 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL  312 (410)
T 3v8s_A          249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL  312 (410)
T ss_dssp             EEETHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHS
T ss_pred             CCCCcceEecchHHHHHHHhCCCCCCCCChh----------------hHHHHHHhccccccCCCcccccHHHHHHHHHHc
Confidence             788999999999999999999999765421                1112222211  111222345778999999999


Q ss_pred             cCCCCC--CCCHHHHHHH
Q 027003          156 NNEPKL--RPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~--Rpt~~~v~~~  171 (229)
                      +.+|.+  |+++.|+++.
T Consensus       313 ~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          313 TDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             SCGGGCTTSSCHHHHHTS
T ss_pred             cChhhhCCCCCHHHHhcC
Confidence            999988  9999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.98  E-value=4.3e-33  Score=230.43  Aligned_cols=163  Identities=25%  Similarity=0.305  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++ .++.+||+|||+++.......   .....||..|+|||++.+. .+
T Consensus       145 ~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  219 (394)
T 4e7w_A          145 LYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNY  219 (394)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHHC--CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCC
Confidence            4688999999999964  599999999999998 789999999999987543322   2345789999999999765 58


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc-chhhHHHHhhcccCC------------CCcHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGG------------QYPQKAAHT  146 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------------~~~~~~~~~  146 (229)
                      +.++|||||||++|||++|+.||.+.+....  +......... ....+..........            ..+...+..
T Consensus       220 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (394)
T 4e7w_A          220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPD  297 (394)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHH
Confidence            9999999999999999999999987543211  1111000000 000000000000000            011234568


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+|+.+||+.||.+|||+.|+++.
T Consensus       298 ~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          298 AIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhCCChhhCCCHHHHhcC
Confidence            9999999999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=5.7e-33  Score=224.01  Aligned_cols=165  Identities=21%  Similarity=0.299  Sum_probs=110.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+ ..++
T Consensus       104 ~~~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  179 (324)
T 3mtl_A          104 LFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYS  179 (324)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHHC--CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCC
Confidence            4789999999999964  599999999999999999999999999976432221  1234578999999999876 5689


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhH-HHhhh-hhhc------chhhHHHHhhcccCCC----CcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAK-PYLS------DKRKLFRIMDTKLGGQ----YPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~-~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~  148 (229)
                      .++|||||||++|+|++|+.||.+.+....... ..... +...      ................    .....+..+.
T Consensus       180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (324)
T 3mtl_A          180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA  259 (324)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHH
Confidence            999999999999999999999987653211111 00000 0000      0000000000000000    0113456788


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.|+++
T Consensus       260 ~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          260 DLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCcCcccCCCHHHHhc
Confidence            9999999999999999999987

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.98  E-value=5.5e-33  Score=228.20  Aligned_cols=148  Identities=25%  Similarity=0.308  Sum_probs=116.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee--cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||+|||+.  +|+||||||+|||+  +.++.+||+|||+++.......   .....||+.|+|||++.+..+
T Consensus       191 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~  265 (373)
T 2x4f_A          191 LFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFV  265 (373)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBC
T ss_pred             HHHHHHHHHHHHHHHC--CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCC
Confidence            4688999999999964  59999999999999  5678899999999987544322   233569999999999998889


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|||++|..||.+.+..                ..+..+......  ......++..+.+|+.+||+.
T Consensus       266 ~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDA----------------ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             CcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999775421                111122221111  111234567899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+||++.++++
T Consensus       330 dp~~Rps~~e~l~  342 (373)
T 2x4f_A          330 EKSWRISASEALK  342 (373)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.98  E-value=1.8e-33  Score=235.10  Aligned_cols=150  Identities=21%  Similarity=0.287  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      .++.||+.||+|||+.  +||||||||+|||++.++.+||+|||+++....... ......+||+.|+|||++.     +
T Consensus       179 ~~~~qi~~aL~~LH~~--giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~  255 (437)
T 4aw2_A          179 FYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGK  255 (437)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHhC--CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCC
Confidence            4789999999999964  599999999999999999999999999976543322 2233468999999999997     4


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC---CCCcHHHHHHHHHHHHH
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQ  153 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  153 (229)
                      ..++.++|||||||++|||++|+.||.+.+..                ....+++.....   .......+..+.+||.+
T Consensus       256 ~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~  319 (437)
T 4aw2_A          256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETYGKIMNHKERFQFPTQVTDVSENAKDLIRR  319 (437)
T ss_dssp             CEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHT
T ss_pred             CCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh----------------HHHHhhhhccccccCCcccccCCHHHHHHHHH
Confidence            56899999999999999999999999875421                111122211111   11112357789999999


Q ss_pred             hccCCCCC--CCCHHHHHH
Q 027003          154 CLNNEPKL--RPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~--Rpt~~~v~~  170 (229)
                      ||..+|++  |+++.|+++
T Consensus       320 lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          320 LICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             TSSCGGGCTTTTTTHHHHT
T ss_pred             HhcccccccCCCCHHHHhC
Confidence            99988888  999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=6.8e-33  Score=225.47  Aligned_cols=166  Identities=24%  Similarity=0.263  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+. .++
T Consensus       116 ~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  191 (346)
T 1ua2_A          116 AYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYG  191 (346)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHHHHC--CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCC
Confidence            5789999999999964  599999999999999999999999999987543322  13345789999999999765 478


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHh-hhhhhcchhhHH---HHhhcccCCCCc-----HHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDKRKLF---RIMDTKLGGQYP-----QKAAHTAATL  150 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~l  150 (229)
                      .++|||||||++|+|++|..||.+....... .+... ..+.........   ...........+     ...+..+.+|
T Consensus       192 ~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  271 (346)
T 1ua2_A          192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL  271 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHH
T ss_pred             chhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHH
Confidence            9999999999999999999999775421110 00000 000000000000   000000000001     2345789999


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+||+.||.+|||+.|+++.
T Consensus       272 i~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          272 IQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHhccChhhCCCHHHHhcC
Confidence            999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.98  E-value=4.6e-33  Score=229.58  Aligned_cols=149  Identities=23%  Similarity=0.304  Sum_probs=117.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC--CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.  ++.+||+|||+++.......   .....||..|+|||++.+..+
T Consensus       153 ~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~  227 (387)
T 1kob_A          153 NYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPV  227 (387)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCC
Confidence            5789999999999964  5999999999999974  47799999999987543322   234579999999999999899


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cCCCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|+|++|..||.+.+..                .....+....  ........++..+.+||.+||+.
T Consensus       228 ~~~~DiwSlG~il~elltg~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  291 (387)
T 1kob_A          228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDL----------------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK  291 (387)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCS
T ss_pred             CCcccEeeHhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999875321                1111111111  11222334577899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027003          158 EPKLRPRMSEVLAI  171 (229)
Q Consensus       158 dP~~Rpt~~~v~~~  171 (229)
                      ||.+|||+.++++.
T Consensus       292 dP~~Rpt~~ell~h  305 (387)
T 1kob_A          292 EPRKRLTVHDALEH  305 (387)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhHCcCHHHHhhC
Confidence            99999999999863

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.98  E-value=2.8e-33  Score=225.81  Aligned_cols=148  Identities=24%  Similarity=0.368  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc----------ceeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------HVSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aP   71 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++........          .......||..|+||
T Consensus       168 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            5789999999999964  5999999999999999999999999999875443211          112345799999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      |++.+..++.++|||||||++|+|++|..++....                  ... ..................+.+|+
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------------------~~~-~~~~~~~~~~~~~~~~~~~~~li  306 (332)
T 3qd2_B          246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------------------RII-TDVRNLKFPLLFTQKYPQEHMMV  306 (332)
T ss_dssp             HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------------------HHH-HHHHTTCCCHHHHHHCHHHHHHH
T ss_pred             HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------------------HHH-HHhhccCCCcccccCChhHHHHH
Confidence            99999999999999999999999999876542210                  000 11111111111234556778999


Q ss_pred             HHhccCCCCCCCCHHHHHH
Q 027003          152 LQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+||+.||.+|||+.++++
T Consensus       307 ~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCcCCCHHHHhh
Confidence            9999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.98  E-value=1e-33  Score=224.51  Aligned_cols=153  Identities=27%  Similarity=0.376  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc--------EEEcccCCcccCCCCCCcceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   73 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.        +||+|||++.....      .....||..|+|||+
T Consensus       117 ~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~  188 (289)
T 4fvq_A          117 EVAKQLAAAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPEC  188 (289)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHH
T ss_pred             HHHHHHHHHHHHHhhC--CeECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHH
Confidence            5789999999999964  5999999999999988887        99999999875422      223458899999999


Q ss_pred             ccc-CCCcccCceeehhHHHHHHHhCC-CcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           74 VAT-GRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        74 ~~~-~~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      +.+ ..++.++|||||||++|+|++|. .||......                 ........  ....+...+..+.+|+
T Consensus       189 ~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~--~~~~~~~~~~~l~~li  249 (289)
T 4fvq_A          189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----------------RKLQFYED--RHQLPAPKAAELANLI  249 (289)
T ss_dssp             HHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHT--TCCCCCCSSCTTHHHH
T ss_pred             hCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----------------HHHHHhhc--cCCCCCCCCHHHHHHH
Confidence            987 67899999999999999999954 444432210                 00111111  1122222355688999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 027003          152 LQCLNNEPKLRPRMSEVLAILERLEAPKNS  181 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l~~~~~~~~~  181 (229)
                      .+||+.||.+|||+.++++.|+++..+...
T Consensus       250 ~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          250 NNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             HHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999988765444

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=9.7e-33  Score=232.91  Aligned_cols=146  Identities=29%  Similarity=0.448  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      +++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++........   ....+||+.|+|||++.+..+ +
T Consensus       120 ~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  194 (476)
T 2y94_A          120 RLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAG  194 (476)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCS
T ss_pred             HHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCC
Confidence            578999999999995  4699999999999999999999999999987543322   334579999999999988765 6


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|+.||.+....                ....++....  ...+...+..+.+|+.+||+.||.
T Consensus       195 ~~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~  256 (476)
T 2y94_A          195 PEVDIWSSGVILYALLCGTLPFDDDHVP----------------TLFKKICDGI--FYTPQYLNPSVISLLKHMLQVDPM  256 (476)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSSH----------------HHHHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred             CcceehhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcCC--cCCCccCCHHHHHHHHHHcCCCch
Confidence            8999999999999999999999865421                1111222211  123344567889999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.++++
T Consensus       257 ~Rpt~~eil~  266 (476)
T 2y94_A          257 KRATIKDIRE  266 (476)
T ss_dssp             TSCCHHHHHT
T ss_pred             hCcCHHHHHh
Confidence            9999999996

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.98  E-value=4.7e-33  Score=223.52  Aligned_cols=161  Identities=24%  Similarity=0.308  Sum_probs=120.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-------eeecccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-------VSTQVMGTHGYAAPEYV   74 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~   74 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++..........       ......||..|+|||++
T Consensus       138 ~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (317)
T 2buj_A          138 WLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF  215 (317)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHh
Confidence            5789999999999964  69999999999999999999999999987542211000       01124579999999999


Q ss_pred             ccCC---CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           75 ATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        75 ~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      .+..   ++.++|||||||++|+|++|+.||.......               ...................+..+.+|+
T Consensus       216 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li  280 (317)
T 2buj_A          216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------------DSVALAVQNQLSIPQSPRHSSALWQLL  280 (317)
T ss_dssp             SCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---------------SCHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             ccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---------------chhhHHhhccCCCCccccCCHHHHHHH
Confidence            7654   6889999999999999999999996421100               011111112222223344567899999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHhhcCCC
Q 027003          152 LQCLNNEPKLRPRMSEVLAILERLEAPK  179 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l~~~~~~~  179 (229)
                      .+||+.||.+||++.++++.|+.+..+.
T Consensus       281 ~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          281 NSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             HHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            9999999999999999999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.98  E-value=3.6e-33  Score=228.64  Aligned_cols=151  Identities=16%  Similarity=0.143  Sum_probs=117.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-----------CCcEEEcccCCcccCCCCCCcceeecccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA   70 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a   70 (229)
                      .|+.||+.||+|||+  .+||||||||+|||++.           ++.+||+|||+++..............+||..|+|
T Consensus       176 ~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  253 (365)
T 3e7e_A          176 SFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC  253 (365)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCC
T ss_pred             HHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCC
Confidence            578999999999995  46999999999999988           89999999999975433333333456789999999


Q ss_pred             ccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           71 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        71 PE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                      ||++.+..++.++|||||||++|||+||+.||.........                   ..... ...+  ....+.++
T Consensus       254 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------------~~~~~-~~~~--~~~~~~~~  311 (365)
T 3e7e_A          254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------------------PEGLF-RRLP--HLDMWNEF  311 (365)
T ss_dssp             HHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------------------ECSCC-TTCS--SHHHHHHH
T ss_pred             hHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------------------echhc-cccC--cHHHHHHH
Confidence            99999999999999999999999999999999654321100                   00000 1111  24567789


Q ss_pred             HHHhccCCCCCCC-CHHHHHHHHHhhc
Q 027003          151 ALQCLNNEPKLRP-RMSEVLAILERLE  176 (229)
Q Consensus       151 i~~~l~~dP~~Rp-t~~~v~~~l~~~~  176 (229)
                      +..||+.+|.+|+ ++.++.+.|+.+.
T Consensus       312 ~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          312 FHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             HHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            9999999999995 6777777776653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=8.2e-33  Score=219.52  Aligned_cols=148  Identities=24%  Similarity=0.423  Sum_probs=113.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||.|||+.+.+|+||||||+|||++ .++.+||+|||++.......    .....||..|+|||++. +.++
T Consensus       133 ~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~  207 (290)
T 1t4h_A          133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYD  207 (290)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCC
T ss_pred             HHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCC
Confidence            578999999999996544599999999999997 78999999999997643322    23457899999999886 4589


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|+|++|+.||.......                .....+... .....+...+..+.+|+.+||+.||
T Consensus       208 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  271 (290)
T 1t4h_A          208 ESVDVYAFGMCMLEMATSEYPYSECQNAA----------------QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK  271 (290)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSHH----------------HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSG
T ss_pred             CcchHHHHHHHHHHHHhCCCCCCCcCcHH----------------HHHHHHhccCCccccCCCCCHHHHHHHHHHccCCh
Confidence            99999999999999999999997643210                111111111 1111222334678999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      .+|||+.++++
T Consensus       272 ~~Rps~~ell~  282 (290)
T 1t4h_A          272 DERYSIKDLLN  282 (290)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhh
Confidence            99999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=5.3e-33  Score=225.25  Aligned_cols=141  Identities=22%  Similarity=0.299  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......   .....||..|+|||++.+..+ +
T Consensus       134 ~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  208 (335)
T 3dls_A          134 YIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRG  208 (335)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCS
T ss_pred             HHHHHHHHHHHHHHhC--CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCC
Confidence            5789999999999964  599999999999999999999999999987544322   234579999999999988876 7


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|+|++|..||......                      ...  ....+...+..+.+|+.+||+.||.
T Consensus       209 ~~~DiwslG~il~el~~g~~pf~~~~~~----------------------~~~--~~~~~~~~~~~l~~li~~~L~~dP~  264 (335)
T 3dls_A          209 PELEMWSLGVTLYTLVFEENPFCELEET----------------------VEA--AIHPPYLVSKELMSLVSGLLQPVPE  264 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------TTT--CCCCSSCCCHHHHHHHHHHTCSSGG
T ss_pred             CcccchhHHHHHHHHHhCCCchhhHHHH----------------------Hhh--ccCCCcccCHHHHHHHHHHccCChh
Confidence            8999999999999999999999753210                      000  0112223466789999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|||+.++++.
T Consensus       265 ~Rps~~ell~h  275 (335)
T 3dls_A          265 RRTTLEKLVTD  275 (335)
T ss_dssp             GSCCHHHHHHC
T ss_pred             hCcCHHHHhcC
Confidence            99999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=4.1e-33  Score=228.03  Aligned_cols=153  Identities=24%  Similarity=0.354  Sum_probs=106.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc--EEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||+|||++  +|+||||||+|||++.++.  +||+|||+++......   .....+||+.|+|||++.+..+
T Consensus       120 ~i~~ql~~~L~~LH~~--~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~  194 (361)
T 3uc3_A          120 FFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEY  194 (361)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSC
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCC
Confidence            5789999999999964  5999999999999987765  9999999987432221   1234579999999999988877


Q ss_pred             ccc-CceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           80 TTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        80 ~~~-~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      +.+ +|||||||++|+|++|+.||.+.......            ......+.............+..+.+|+.+||+.|
T Consensus       195 ~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  262 (361)
T 3uc3_A          195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY------------RKTIQRILSVKYSIPDDIRISPECCHLISRIFVAD  262 (361)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCSCC----CCCH------------HHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSC
T ss_pred             CCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH------------HHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCC
Confidence            655 89999999999999999999765421110            01111222222222222235678899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027003          159 PKLRPRMSEVLAI  171 (229)
Q Consensus       159 P~~Rpt~~~v~~~  171 (229)
                      |.+|||+.++++.
T Consensus       263 P~~Rps~~ell~h  275 (361)
T 3uc3_A          263 PATRISIPEIKTH  275 (361)
T ss_dssp             TTTSCCHHHHHTS
T ss_pred             hhHCcCHHHHHhC
Confidence            9999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=9.7e-33  Score=224.85  Aligned_cols=168  Identities=20%  Similarity=0.271  Sum_probs=115.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC--cceeeccccccccccccccccC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVATG-R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~   78 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.......  ........||..|+|||++.+. .
T Consensus       128 ~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  205 (351)
T 3mi9_A          128 RVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD  205 (351)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCS
T ss_pred             HHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCC
Confidence            5789999999999964  599999999999999999999999999986542211  1122345789999999998764 5


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHH-Hhhhhhhc----chh--hHHHHhhccc-CCC-CcHH-----HH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS----DKR--KLFRIMDTKL-GGQ-YPQK-----AA  144 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~----~~~--~~~~~~~~~~-~~~-~~~~-----~~  144 (229)
                      ++.++|||||||++|+|++|..||.+.......... ........    ...  .......... ... ....     .+
T Consensus       206 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (351)
T 3mi9_A          206 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD  285 (351)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCC
T ss_pred             CCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCC
Confidence            799999999999999999999999875432111111 00000000    000  0000000000 000 0001     14


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..+.+|+.+||+.||.+|||+.|+++.
T Consensus       286 ~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          286 PYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            568899999999999999999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=2.8e-32  Score=217.75  Aligned_cols=150  Identities=21%  Similarity=0.253  Sum_probs=117.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC--C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--L   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~   79 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++................||..|+|||++.+..  +
T Consensus       113 ~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  190 (305)
T 2wtk_C          113 GYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS  190 (305)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEE
T ss_pred             HHHHHHHHHHHHHHHC--CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCC
Confidence            5789999999999964  59999999999999999999999999998754333333334567899999999997654  3


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|+|++|+.||.+.....                ....+...  ....+..++..+.+|+.+||+.||
T Consensus       191 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp  252 (305)
T 2wtk_C          191 GFKVDIWSAGVTLYNITTGLYPFEGDNIYK----------------LFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEP  252 (305)
T ss_dssp             SHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSST
T ss_pred             cchhhHHHHHHHHHHHHhCCCCCCCchHHH----------------HHHHHhcC--CCCCCCccCHHHHHHHHHHccCCh
Confidence            679999999999999999999997643110                01111111  112334456788899999999999


Q ss_pred             CCCCCHHHHHHH
Q 027003          160 KLRPRMSEVLAI  171 (229)
Q Consensus       160 ~~Rpt~~~v~~~  171 (229)
                      .+||++.++++.
T Consensus       253 ~~Rps~~~ll~~  264 (305)
T 2wtk_C          253 AKRFSIRQIRQH  264 (305)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hhCCCHHHHhcC
Confidence            999999999974

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=5.4e-33  Score=226.37  Aligned_cols=149  Identities=23%  Similarity=0.344  Sum_probs=108.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.   ++.+||+|||+++......   ......||..|+|||++.+..
T Consensus       152 ~i~~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~  226 (349)
T 2w4o_A          152 DAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCA  226 (349)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCC
Confidence            5789999999999964  6999999999999975   8899999999998653321   123457899999999999989


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|||++|..||.......               .....+.....  ........+..+.+|+.+||+
T Consensus       227 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  291 (349)
T 2w4o_A          227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQ---------------FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIV  291 (349)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---------------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSC
T ss_pred             CCcccchHHHHHHHHHHHhCCCCCCCCcccH---------------HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHcc
Confidence            9999999999999999999999997643210               01111221111  112223456788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||++|||+.++++
T Consensus       292 ~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          292 LDPKKRLTTFQALQ  305 (349)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=6.1e-33  Score=222.63  Aligned_cols=152  Identities=25%  Similarity=0.391  Sum_probs=111.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      +++.|++.||.|||+.  +|+||||||+|||++. +.+||+|||+++...............||..|+|||++.+     
T Consensus       131 ~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  207 (313)
T 3cek_A          131 SYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR  207 (313)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC---
T ss_pred             HHHHHHHHHHHHHHHC--CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccc
Confidence            5789999999999964  5999999999999964 8999999999986544332222334578999999999875     


Q ss_pred             ------CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHH
Q 027003           77 ------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL  150 (229)
Q Consensus        77 ------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (229)
                            ..++.++|||||||++|+|++|+.||......               ................+...+..+.+|
T Consensus       208 ~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~l  272 (313)
T 3cek_A          208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISKLHAIIDPNHEIEFPDIPEKDLQDV  272 (313)
T ss_dssp             -------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------HHHHHHHHCTTSCCCCCCCSCHHHHHH
T ss_pred             ccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---------------HHHHHHHHhcccccCCcccchHHHHHH
Confidence                  46788999999999999999999999754311               111222333333333444446788999


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+||+.||.+||++.++++.
T Consensus       273 i~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          273 LKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHccCCcccCcCHHHHhcC
Confidence            999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=2.9e-33  Score=221.87  Aligned_cols=150  Identities=28%  Similarity=0.391  Sum_probs=107.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccc----ccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~   77 (229)
                      +++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++.......   .....||..|+|||++    .+.
T Consensus       113 ~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  188 (290)
T 3fme_A          113 KIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQK  188 (290)
T ss_dssp             HHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC-
T ss_pred             HHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCc
Confidence            5789999999999963 2699999999999999999999999999976533221   2334689999999996    456


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      .++.++|||||||++|+|++|+.||......               ....................+..+.+|+.+||+.
T Consensus       189 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  253 (290)
T 3fme_A          189 GYSVKSDIWSLGITMIELAILRFPYDSWGTP---------------FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK  253 (290)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---------------HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCS
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCccccCch---------------HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhc
Confidence            7889999999999999999999999753321               1112222222222223334567899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+|||+.++++
T Consensus       254 ~p~~Rpt~~e~l~  266 (290)
T 3fme_A          254 NSKERPTYPELMQ  266 (290)
T ss_dssp             SGGGSCCHHHHTT
T ss_pred             ChhhCcCHHHHHh
Confidence            9999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=3.5e-33  Score=220.65  Aligned_cols=150  Identities=27%  Similarity=0.411  Sum_probs=119.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++........   .....||..|+|||++.+..++.
T Consensus       126 ~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  200 (284)
T 2a19_B          126 ELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGK  200 (284)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCT
T ss_pred             HHHHHHHHHHHHHHhC--CeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcc
Confidence            5789999999999964  699999999999999999999999999987543322   23456899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||....                  .....+...    ..+...+..+.+|+.+||+.||.+
T Consensus       201 ~~Di~slG~il~~l~~~~~~~~~~~------------------~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~  258 (284)
T 2a19_B          201 EVDLYALGLILAELLHVCDTAFETS------------------KFFTDLRDG----IISDIFDKKEKTLLQKLLSKKPED  258 (284)
T ss_dssp             HHHHHHHHHHHHHHHSCCSSHHHHH------------------HHHHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhhHHHHHHHHHHHhcCCcchhHH------------------HHHHHhhcc----cccccCCHHHHHHHHHHccCChhh
Confidence            9999999999999999988764311                  000111111    122334567889999999999999


Q ss_pred             CCCHHHHHHHHHhhcCC
Q 027003          162 RPRMSEVLAILERLEAP  178 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~~~  178 (229)
                      ||++.++++.|..+...
T Consensus       259 Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          259 RPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             SCCHHHHHHHHHHHTC-
T ss_pred             CcCHHHHHHHHHHHhhC
Confidence            99999999999887654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=2e-33  Score=226.76  Aligned_cols=169  Identities=23%  Similarity=0.341  Sum_probs=125.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++......... .......++..|+|||++.+..++
T Consensus       149 ~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  226 (326)
T 2w1i_A          149 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS  226 (326)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCC
Confidence            578999999999996  46999999999999999999999999999876443321 112234577789999999988899


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc---chhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS---DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      .++|||||||++|+|++|..||......    ..........   ....+...+........+..++..+.+|+.+||+.
T Consensus       227 ~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  302 (326)
T 2w1i_A          227 VASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN  302 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             chhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCC
Confidence            9999999999999999999988643211    0000000000   01112233333333444566778899999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhc
Q 027003          158 EPKLRPRMSEVLAILERLE  176 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~~  176 (229)
                      ||.+||++.++++.|+++.
T Consensus       303 dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          303 NVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             SGGGSCCHHHHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHHHHH
Confidence            9999999999999998774

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=2e-32  Score=222.75  Aligned_cols=162  Identities=22%  Similarity=0.266  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee-------------------cCCCcEEEcccCCcccCCCCCCcceeecc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL-------------------DAEFNAKLSDFGLAKAGPTGDRTHVSTQV   62 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill-------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~   62 (229)
                      +++.||+.||.|||+  .+|+||||||+|||+                   +.++.+||+|||+++.....     ....
T Consensus       127 ~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~  199 (355)
T 2eu9_A          127 HMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTI  199 (355)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSS
T ss_pred             HHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCC
Confidence            578999999999995  469999999999999                   56788999999999864332     2345


Q ss_pred             ccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhH-HHhhhhhhc-------------------
Q 027003           63 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLS-------------------  122 (229)
Q Consensus        63 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~-------------------  122 (229)
                      .||..|+|||++.+..++.++|||||||++|||++|..||........... .....+...                   
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  279 (355)
T 2eu9_A          200 VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW  279 (355)
T ss_dssp             CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECC
T ss_pred             cCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccc
Confidence            789999999999999999999999999999999999999987543211110 000000000                   


Q ss_pred             -chhhHHHHhhcc-----cCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          123 -DKRKLFRIMDTK-----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       123 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                       ......+.....     .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          280 DENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             000000000000     001122345678999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=8.4e-33  Score=222.14  Aligned_cols=158  Identities=20%  Similarity=0.321  Sum_probs=113.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCC---Ccceeecccccccccccccccc--
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVAT--   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--   76 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++ ++.+||+|||+++......   .........||..|+|||++.+  
T Consensus       134 ~i~~qi~~al~~lH~~--~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  210 (319)
T 2y4i_B          134 QIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS  210 (319)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBS
T ss_pred             HHHHHHHHHHHHHHhC--CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhcc
Confidence            5789999999999964  599999999999998 6799999999987542211   1111233468999999999864  


Q ss_pred             -------CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHH
Q 027003           77 -------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT  149 (229)
Q Consensus        77 -------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (229)
                             ..++.++|||||||++|+|++|+.||.......                ....+............++..+.+
T Consensus       211 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~  274 (319)
T 2y4i_B          211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----------------IIWQMGTGMKPNLSQIGMGKEISD  274 (319)
T ss_dssp             CC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----------------HHHHHHTTCCCCCCCSSCCTTHHH
T ss_pred             ccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHhccCCCCCCCcCCCCHHHHH
Confidence                   347889999999999999999999997643210                111111111111112234567889


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          150 LALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      |+.+||+.||.+|||+.++++.|+++...
T Consensus       275 li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          275 ILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999887654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.8e-33  Score=231.62  Aligned_cols=149  Identities=22%  Similarity=0.279  Sum_probs=113.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------   75 (229)
                      .++.||+.||+|||+.  +||||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++.      
T Consensus       166 ~~~~qi~~aL~~LH~~--giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~  242 (412)
T 2vd5_A          166 FYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGP  242 (412)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred             HHHHHHHHHHHHHHHC--CeeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCc
Confidence            4688999999999964  599999999999999999999999999987543322 1223468999999999997      


Q ss_pred             -cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc--cC-CCCcHHHHHHHHHHH
Q 027003           76 -TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LG-GQYPQKAAHTAATLA  151 (229)
Q Consensus        76 -~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~li  151 (229)
                       +..++.++|+|||||++|||++|+.||.+.+..                ....+++...  .. ......++..+.+||
T Consensus       243 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~s~~~~dli  306 (412)
T 2vd5_A          243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA----------------ETYGKIVHYKEHLSLPLVDEGVPEEARDFI  306 (412)
T ss_dssp             TCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTHHHHCCCC----CCCHHHHHHH
T ss_pred             CCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcccCcCCCccccCCCHHHHHHH
Confidence             356899999999999999999999999775421                1111222111  11 111234577899999


Q ss_pred             HHhccCCCCCC---CCHHHHHH
Q 027003          152 LQCLNNEPKLR---PRMSEVLA  170 (229)
Q Consensus       152 ~~~l~~dP~~R---pt~~~v~~  170 (229)
                      .+||. +|.+|   +++.|+++
T Consensus       307 ~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          307 QRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHcC-ChhhcCCCCCHHHHhc
Confidence            99999 99998   58999876

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=2.8e-33  Score=227.43  Aligned_cols=153  Identities=28%  Similarity=0.390  Sum_probs=116.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC----CcEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.||+.||+|||+.  +|+||||||+|||+..+    +.+||+|||+++.......  .....+||+.|+|||++.+.
T Consensus       120 ~~~~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  195 (342)
T 2qr7_A          120 AVLFTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ  195 (342)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCC
Confidence            5789999999999964  59999999999998443    3599999999986543322  13346789999999999888


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  155 (229)
                      .++.++|||||||++|+|++|..||.+........+             ...+.....  ....+...+..+.+|+.+||
T Consensus       196 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  262 (342)
T 2qr7_A          196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-------------LARIGSGKFSLSGGYWNSVSDTAKDLVSKML  262 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH-------------HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHT
T ss_pred             CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH-------------HHHHccCCcccCccccccCCHHHHHHHHHHC
Confidence            899999999999999999999999976432111111             111111111  12233456788999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 027003          156 NNEPKLRPRMSEVLAI  171 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~~  171 (229)
                      +.||.+||++.++++.
T Consensus       263 ~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          263 HVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CSSTTTSCCHHHHTTS
T ss_pred             CCChhHCcCHHHHhcC
Confidence            9999999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=9.7e-33  Score=230.87  Aligned_cols=100  Identities=30%  Similarity=0.428  Sum_probs=79.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--------------------ceeec
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--------------------HVSTQ   61 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------------------~~~~~   61 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++........                    .....
T Consensus       133 ~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (432)
T 3n9x_A          133 TILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS  210 (432)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------
T ss_pred             HHHHHHHHHHHHHHHC--CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccC
Confidence            5789999999999965  5999999999999999999999999999875432211                    11345


Q ss_pred             ccccccccccccc-ccCCCcccCceeehhHHHHHHHhCCCcCC
Q 027003           62 VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVD  103 (229)
Q Consensus        62 ~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg~~p~~  103 (229)
                      .+||..|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       211 ~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            6899999999986 45668999999999999999998655543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=7.4e-33  Score=237.30  Aligned_cols=150  Identities=32%  Similarity=0.501  Sum_probs=119.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+|||++.+|.+||+|||+++.......   ....+||+.|+|||++.+..++.
T Consensus       290 ~i~~qIl~aL~yLH~~--gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~  364 (576)
T 2acx_A          290 FYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF  364 (576)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESS
T ss_pred             HHHHHHHHHHHHHHHC--CEeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCc
Confidence            4689999999999964  599999999999999999999999999987543322   23458999999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.......             ..+...+. .....++..++..+.+||.+||+.||.+
T Consensus       365 ~~DiwSLGvilyeLltG~~PF~~~~~~~~~-------------~~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~  430 (576)
T 2acx_A          365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAE  430 (576)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-------------HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             cchHHHHHHHHHHHHhCCCCCcccccchhH-------------HHHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHH
Confidence            999999999999999999999875432111             11111111 1223344556788999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      ||     ++.|+++
T Consensus       431 R~g~~~~sa~eil~  444 (576)
T 2acx_A          431 RLGCRGGSAREVKE  444 (576)
T ss_dssp             STTCSSSHHHHHHT
T ss_pred             cCCCCCCCHHHHHh
Confidence            99     6788875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6e-33  Score=226.59  Aligned_cols=153  Identities=31%  Similarity=0.396  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC--CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~   79 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++....... ......+||..|+|||++.+.  .+
T Consensus       163 ~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  239 (355)
T 1vzo_A          163 IYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGH  239 (355)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCC
Confidence            4688999999999964  599999999999999999999999999986533221 123346799999999999863  47


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|||++|+.||..........             .+.+.+. ......+..++..+.+|+.+||+.||
T Consensus       240 ~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP  305 (355)
T 1vzo_A          240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-------------EISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDP  305 (355)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-------------HHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCccCCccchHH-------------HHHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCH
Confidence            889999999999999999999997643221110             0111111 11223445567788999999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 027003          160 KLRP-----RMSEVLAI  171 (229)
Q Consensus       160 ~~Rp-----t~~~v~~~  171 (229)
                      .+||     ++.++++.
T Consensus       306 ~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          306 KKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             GGSTTSSTTTHHHHHTS
T ss_pred             HHhcCCCCCCHHHHHcC
Confidence            9999     88998864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=7.3e-33  Score=228.60  Aligned_cols=168  Identities=21%  Similarity=0.285  Sum_probs=112.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-----cceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||++........     .......+||..|+|||++.+
T Consensus       132 ~~~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (389)
T 3gni_B          132 YILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ  209 (389)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhc
Confidence            5789999999999964  599999999999999999999999998764322111     111223478999999999987


Q ss_pred             --CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhH-HHhhhhhhcc-----h-------------hhHHHHh----
Q 027003           77 --GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSD-----K-------------RKLFRIM----  131 (229)
Q Consensus        77 --~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~-----~-------------~~~~~~~----  131 (229)
                        ..++.++|||||||++|+|++|+.||.+......... .....+...+     .             .......    
T Consensus       210 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (389)
T 3gni_B          210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST  289 (389)
T ss_dssp             TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------------------------
T ss_pred             cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCc
Confidence              5789999999999999999999999977543211100 0000000000     0             0000000    


Q ss_pred             -----hcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          132 -----DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       132 -----~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                           ........+..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                 0000111234456789999999999999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=6.4e-33  Score=223.98  Aligned_cols=149  Identities=22%  Similarity=0.349  Sum_probs=114.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.   ++.+||+|||+++.......   .....||+.|+|||++.+..
T Consensus       135 ~i~~ql~~~L~~LH~~--givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~  209 (327)
T 3lm5_A          135 RLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDP  209 (327)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCC
Confidence            5789999999999964  5999999999999988   78999999999987543222   23457999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhh--cccCCCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|+.||.+.....                ....+..  ..........++..+.+|+.+||+
T Consensus       210 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  273 (327)
T 3lm5_A          210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQE----------------TYLNISQVNVDYSEETFSSVSQLATDFIQSLLV  273 (327)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCchH----------------HHHHHHhcccccCchhhcccCHHHHHHHHHHcC
Confidence            9999999999999999999999997754211                1111111  111222233466788999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||.+|||+.++++.
T Consensus       274 ~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          274 KNPEKRPTAEICLSH  288 (327)
T ss_dssp             SSGGGSCCHHHHTTC
T ss_pred             CChhhCcCHHHHhCC
Confidence            999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=1.4e-32  Score=225.41  Aligned_cols=161  Identities=17%  Similarity=0.281  Sum_probs=114.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec------CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD------AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~   75 (229)
                      +++.||+.||+|||++ .+|+||||||+|||++      ..+.+||+|||+++.....     .....||..|+|||++.
T Consensus       135 ~i~~qi~~aL~~lH~~-~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~  208 (373)
T 1q8y_A          135 QISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLL  208 (373)
T ss_dssp             HHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhc-CCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHh
Confidence            5789999999999964 1699999999999994      4457999999999865432     23357899999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccc----hhHHHh---hhhhhc----chh-------------------
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE----QSLVDW---AKPYLS----DKR-------------------  125 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~----~~~~~~---~~~~~~----~~~-------------------  125 (229)
                      +..++.++|||||||++|||++|+.||.+......    ..+...   ......    ...                   
T Consensus       209 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (373)
T 1q8y_A          209 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK  288 (373)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccccc
Confidence            99999999999999999999999999986542211    011100   000000    000                   


Q ss_pred             --hHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          126 --KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       126 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                        .......  .....+...+..+.+||.+||+.||.+|||+.++++
T Consensus       289 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          289 FWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             BCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             ccchhhhhh--hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence              0001111  112355678899999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=1.2e-32  Score=235.15  Aligned_cols=151  Identities=27%  Similarity=0.455  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||++  +|+||||||+|||++.+|.+||+|||+++........  ....+||+.|+|||++.+..++.
T Consensus       293 ~~~~qi~~aL~~LH~~--gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~  368 (543)
T 3c4z_A          293 FYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDF  368 (543)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHc--CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCCh
Confidence            4688999999999964  5999999999999999999999999999875433221  23458999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|+|||||++|||++|+.||.+.......            ......+...  ....+..++..+.+||.+||+.||.+
T Consensus       369 ~~DiwSlGvilyelltG~~PF~~~~~~~~~------------~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~  434 (543)
T 3c4z_A          369 SVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEK  434 (543)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCTTCCCCH------------HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             HHhcCcchHHHHHHHhCCCCCCCCccchhH------------HHHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhH
Confidence            999999999999999999999875421110            0111112221  12345566788999999999999999


Q ss_pred             CCCH-----HHHHH
Q 027003          162 RPRM-----SEVLA  170 (229)
Q Consensus       162 Rpt~-----~~v~~  170 (229)
                      ||++     .++++
T Consensus       435 R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          435 RLGFRDGSCDGLRT  448 (543)
T ss_dssp             SCCCBTTBSHHHHT
T ss_pred             CCCCcccCHHHHHc
Confidence            9975     55653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2e-32  Score=216.64  Aligned_cols=145  Identities=25%  Similarity=0.373  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.......    .....|+..|+|||++.+..++.
T Consensus       118 ~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  191 (284)
T 2vgo_A          118 TFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDE  191 (284)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCc
Confidence            578999999999995  469999999999999999999999999987643322    23456899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++||||||+++|+|++|..||......                .....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       192 ~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  253 (284)
T 2vgo_A          192 KVDLWCAGVLCYEFLVGMPPFDSPSHT----------------ETHRRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQ  253 (284)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             ccchhhHHHHHHHHHHCCCCCCCCCHh----------------HHHHHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhh
Confidence            999999999999999999999764311                011111111  12334456678899999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       254 Rps~~~ll~  262 (284)
T 2vgo_A          254 RLPLKGVME  262 (284)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHhh
Confidence            999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=7.3e-33  Score=223.54  Aligned_cols=156  Identities=24%  Similarity=0.357  Sum_probs=97.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++   .+||+|||+++.......  .....+||..|+|||++.+..
T Consensus       110 ~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~  185 (325)
T 3kn6_A          110 YIMRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNG  185 (325)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CC
T ss_pred             HHHHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCC
Confidence            5789999999999964  699999999999997765   799999999986543222  133457899999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC--CcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|+.||.+........         ........+........  ....++..+.+|+.+||+
T Consensus       186 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  256 (325)
T 3kn6_A          186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT---------SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT  256 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTC-------CC---------CHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHC
T ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCccccccc---------cHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCC
Confidence            9999999999999999999999997754211000         00111111111111111  112357789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       257 ~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          257 VDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCTTTCCCTTTSTT
T ss_pred             CChhHCCCHHHHhc
Confidence            99999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=1.8e-32  Score=221.61  Aligned_cols=162  Identities=22%  Similarity=0.279  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-------------------CCcEEEcccCCcccCCCCCCcceeecc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------EFNAKLSDFGLAKAGPTGDRTHVSTQV   62 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~   62 (229)
                      +++.||+.||+|||++  +|+||||||+|||++.                   ++.+||+|||+++.....     ....
T Consensus       122 ~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~  194 (339)
T 1z57_A          122 KMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTL  194 (339)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSS
T ss_pred             HHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccc
Confidence            5789999999999964  5999999999999987                   667999999999864332     2345


Q ss_pred             ccccccccccccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHH-Hhhhhhhc-------------------
Q 027003           63 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS-------------------  122 (229)
Q Consensus        63 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~-------------------  122 (229)
                      .||..|+|||++.+..++.++|||||||++|||++|..||...+........ ....+...                   
T Consensus       195 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  274 (339)
T 1z57_A          195 VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW  274 (339)
T ss_dssp             CSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECC
T ss_pred             cCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccc
Confidence            7899999999999989999999999999999999999999875432211111 00000000                   


Q ss_pred             -chhhHHHHhhcc-----cCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          123 -DKRKLFRIMDTK-----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       123 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                       ............     .........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          275 DEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence             000000000000     001223456788999999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2.3e-32  Score=219.07  Aligned_cols=157  Identities=22%  Similarity=0.258  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........ .......|+..|+|||++.+..++.
T Consensus       138 ~i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  214 (309)
T 2h34_A          138 AIVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATY  214 (309)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----C
T ss_pred             HHHHHHHHHHHHHHHC--cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCc
Confidence            5789999999999964  599999999999999999999999999876543221 1123456899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhccCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      ++|||||||++|+|++|+.||.+....                 .....+....  ....+..++..+.+|+.+||+.||
T Consensus       215 ~~Di~slG~il~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  277 (309)
T 2h34_A          215 RADIYALTCVLYECLTGSPPYQGDQLS-----------------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNP  277 (309)
T ss_dssp             CCHHHHHHHHHHHHHHSSCSSCSCHHH-----------------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSG
T ss_pred             hHhHHHHHHHHHHHHHCCCCCCCchHH-----------------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCH
Confidence            999999999999999999999764321                 0111111111  011233456678899999999999


Q ss_pred             CCCC-CHHHHHHHHHhhcCC
Q 027003          160 KLRP-RMSEVLAILERLEAP  178 (229)
Q Consensus       160 ~~Rp-t~~~v~~~l~~~~~~  178 (229)
                      ++|| ++.++++.|++....
T Consensus       278 ~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          278 EDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             GGSCSSHHHHHHHHHHTCC-
T ss_pred             HHHHHhHHHHHHHHHHHHHh
Confidence            9999 999999999876543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=9.6e-33  Score=229.08  Aligned_cols=168  Identities=22%  Similarity=0.253  Sum_probs=108.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee----cCCCcEEEcccCCcccCCCCCC-cceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      .|+.||+.||.|||+.  +|+||||||+|||+    +.++.+||+|||+++....... .......+||..|+|||++.+
T Consensus       132 ~i~~qi~~al~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (405)
T 3rgf_A          132 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  209 (405)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHhC--CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence            4789999999999964  59999999999999    6778999999999986543211 112334678999999999987


Q ss_pred             C-CCcccCceeehhHHHHHHHhCCCcCCCCccccc-------hhHHHhh----hhhhcch---------hhHHHHhhccc
Q 027003           77 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-------QSLVDWA----KPYLSDK---------RKLFRIMDTKL  135 (229)
Q Consensus        77 ~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-------~~~~~~~----~~~~~~~---------~~~~~~~~~~~  135 (229)
                      . .++.++|||||||++|+|++|+.||.+......       ..+....    .+.....         ...........
T Consensus       210 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  289 (405)
T 3rgf_A          210 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT  289 (405)
T ss_dssp             CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGG
T ss_pred             CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccC
Confidence            4 589999999999999999999999976543210       0000000    0000000         00000000000


Q ss_pred             CCCCc---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          136 GGQYP---------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       136 ~~~~~---------~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .....         ...+..+.+||.+||+.||.+|||+.|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          290 YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             GTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000         0114567899999999999999999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=1.8e-32  Score=216.83  Aligned_cols=149  Identities=23%  Similarity=0.308  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.   +||+|||++........   .....||..|+|||++.+..
T Consensus       109 ~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~  183 (284)
T 3kk8_A          109 HCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDP  183 (284)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCC
Confidence            5789999999999964  5999999999999976655   99999999976543322   23457899999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+.....                ....+.....  ........+..+.+|+.+||+
T Consensus       184 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  247 (284)
T 3kk8_A          184 YSKPVDIWACGVILYILLVGYPPFWDEDQHR----------------LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT  247 (284)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred             CCcccchHHHHHHHHHHHHCCCCCCCCchhH----------------HHHHHHhccccCCchhhcccCHHHHHHHHHHcc
Confidence            9999999999999999999999997643210                1111111111  111123456788999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||.+|||+.++++.
T Consensus       248 ~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          248 VNPKKRITADQALKV  262 (284)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             cChhhCCCHHHHhcC
Confidence            999999999999873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=8.9e-33  Score=241.55  Aligned_cols=155  Identities=26%  Similarity=0.373  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||++.+..++.
T Consensus       495 ~i~~qi~~aL~~LH~~--givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~  571 (656)
T 2j0j_A          495 LYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTS  571 (656)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCc
Confidence            5789999999999964  5999999999999999999999999999875443222 122345778999999999899999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+....                 .....+........+..++..+.+|+.+||+.||.
T Consensus       572 ~~DiwSlG~il~ellt~g~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~  634 (656)
T 2j0j_A          572 ASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS  634 (656)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhHHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChh
Confidence            9999999999999997 99999764321                 11111222223344556678899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +||++.++++.|+++.
T Consensus       635 ~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          635 RRPRFTELKAQLSTIL  650 (656)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999998763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=7.5e-33  Score=228.16  Aligned_cols=162  Identities=25%  Similarity=0.321  Sum_probs=115.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||.|||+  .+|+||||||+|||++ .++.+||+|||+++.......   .....||..|+|||++.+. .+
T Consensus       145 ~i~~qi~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  219 (383)
T 3eb0_A          145 IYIYQLFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEY  219 (383)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCC
Confidence            478999999999995  4699999999999997 688999999999986543322   2345789999999998775 48


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcchhhHHHHhh-------cccCC-----CCcHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMD-------TKLGG-----QYPQKAAHT  146 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~~  146 (229)
                      +.++|||||||++|||++|+.||.+....... .+.......  ....+.....       .....     ..+...+..
T Consensus       220 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (383)
T 3eb0_A          220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP--TKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL  297 (383)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC--CHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHH
T ss_pred             CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC--CHHHHHHhCcccccccCCccCcccHHhhCCCCCCHH
Confidence            99999999999999999999999875432111 111100000  0000000000       00000     012335667


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||+.||.+|||+.|+++
T Consensus       298 ~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          298 AIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhc
Confidence            899999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=1.3e-32  Score=225.30  Aligned_cols=167  Identities=26%  Similarity=0.341  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeecccccccccccccccc-CCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~   79 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++........ ......+||+.|+|||++.+ ..+
T Consensus       132 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  209 (364)
T 3qyz_A          132 YFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY  209 (364)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSC
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCC
Confidence            5789999999999964  5999999999999999999999999999865432211 11234579999999998754 458


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhcc-----hhhHHHHhhccc-CCCC-----cHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSD-----KRKLFRIMDTKL-GGQY-----PQKAAHT  146 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~-~~~~-----~~~~~~~  146 (229)
                      +.++|||||||++|+|++|+.||.+........ +..... +....     ............ ....     ....+..
T Consensus       210 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (364)
T 3qyz_A          210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK  289 (364)
T ss_dssp             STHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHH
T ss_pred             CcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHH
Confidence            999999999999999999999998765322111 111000 00000     000000000000 0011     1224567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||+.||.+|||+.++++
T Consensus       290 ~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          290 ALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhc
Confidence            899999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=9.4e-33  Score=226.35  Aligned_cols=163  Identities=24%  Similarity=0.318  Sum_probs=107.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.....     ....+||..|+|||++.+ ..++
T Consensus       136 ~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~  208 (367)
T 2fst_X          136 FLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYN  208 (367)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHC--CeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCC
Confidence            4789999999999964  5999999999999999999999999999864322     234578999999999977 6789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhh-hhhhc-----chhhHHHHhhcccC-CCCc-----HHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLS-----DKRKLFRIMDTKLG-GQYP-----QKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~-----~~~~~~~~~~~~~~-~~~~-----~~~~~~~  147 (229)
                      .++|||||||++|||++|+.||.+.+...... +.... .+...     ........+..... ....     ...+..+
T Consensus       209 ~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (367)
T 2fst_X          209 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA  288 (367)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHH
Confidence            99999999999999999999998765321111 11100 00000     00001111111000 0000     1235678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+|+.+||+.||.+|||+.++++.
T Consensus       289 ~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          289 VDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhCCCCcccCcCHHHHhcC
Confidence            999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=1.6e-32  Score=221.59  Aligned_cols=163  Identities=19%  Similarity=0.244  Sum_probs=115.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~   79 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++ .+||+|||+++.......   .....||..|+|||++.+ ..+
T Consensus       134 ~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~  208 (330)
T 3nsz_A          134 FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMY  208 (330)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcC
Confidence            4789999999999964  599999999999999777 899999999986543322   234578999999999977 568


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhh-------------cchhhHHHHhhc--------ccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL-------------SDKRKLFRIMDT--------KLGGQ  138 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~--------~~~~~  138 (229)
                      +.++|||||||++|+|++|+.||......... +........             ............        .....
T Consensus       209 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (330)
T 3nsz_A          209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE  287 (330)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTT
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcccc
Confidence            99999999999999999999999554322111 110000000             000000011100        01111


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       139 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       288 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          288 NQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22335778999999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=218.98  Aligned_cols=165  Identities=22%  Similarity=0.265  Sum_probs=110.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ......||..|+|||++.+ ..++
T Consensus       106 ~i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  181 (311)
T 4agu_A          106 SITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYG  181 (311)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCC
T ss_pred             HHHHHHHHHHHHHHHC--CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCC
Confidence            5789999999999964  599999999999999999999999999987543222  1234578999999999976 5679


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHH-hhhhhhcchhhHHHHh--hcccCCC-----C-----cHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLSDKRKLFRIM--DTKLGGQ-----Y-----PQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~-----~-----~~~~~~~~  147 (229)
                      .++|||||||++|+|++|..||.+........... ................  .......     .     ....+..+
T Consensus       182 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (311)
T 4agu_A          182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPA  261 (311)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHH
T ss_pred             cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHH
Confidence            99999999999999999999998754322111110 0000000000000000  0000000     0     02345678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+.+||+.||.+|||+.++++
T Consensus       262 ~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          262 LGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHccCChhhcCCHHHHhc
Confidence            89999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=2.6e-32  Score=223.62  Aligned_cols=148  Identities=28%  Similarity=0.442  Sum_probs=113.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----   77 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++........   .....||+.|+|||++.+.    
T Consensus       204 ~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  278 (365)
T 2y7j_A          204 SIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDET  278 (365)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTT
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhcccccccc
Confidence            5789999999999964  699999999999999999999999999987543322   2346799999999998643    


Q ss_pred             --CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHH
Q 027003           78 --RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQ  153 (229)
Q Consensus        78 --~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~  153 (229)
                        .++.++|||||||++|+|++|..||......                .....+.........+  ...+..+.+|+.+
T Consensus       279 ~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  342 (365)
T 2y7j_A          279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----------------LMLRMIMEGQYQFSSPEWDDRSSTVKDLISR  342 (365)
T ss_dssp             SCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHH
T ss_pred             CcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhCCCCCCCcccccCCHHHHHHHHH
Confidence              5788999999999999999999999764311                0111111111111100  1235678999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||+.||.+||++.++++
T Consensus       343 ~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          343 LLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HSCSSTTTSCCHHHHHH
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=3.2e-32  Score=219.29  Aligned_cols=146  Identities=27%  Similarity=0.365  Sum_probs=115.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----cEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++    .+||+|||++........   .....||..|+|||++.+.
T Consensus       119 ~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~  193 (321)
T 2a2a_A          119 SFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE  193 (321)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCC
Confidence            5789999999999964  599999999999999888    799999999987544322   2345689999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc----HHHHHHHHHHHHH
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQ  153 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  153 (229)
                      .++.++|||||||++|+|++|..||.+.....                ....+.....  ..+    ...+..+.+|+.+
T Consensus       194 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~  255 (321)
T 2a2a_A          194 PLGLEADMWSIGVITYILLSGASPFLGDTKQE----------------TLANITSVSY--DFDEEFFSHTSELAKDFIRK  255 (321)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHHHHHTTCC--CCCHHHHTTCCHHHHHHHHT
T ss_pred             CCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhccc--ccChhhhcccCHHHHHHHHH
Confidence            99999999999999999999999997643210                1111111111  111    2345678899999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||+.||.+|||+.++++
T Consensus       256 ~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          256 LLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TSCSSTTTSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.1e-32  Score=217.49  Aligned_cols=147  Identities=29%  Similarity=0.412  Sum_probs=95.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.........  .....||..|+|||++.+..++.
T Consensus       116 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  191 (278)
T 3cok_A          116 HFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGL  191 (278)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCc
Confidence            5789999999999964  6999999999999999999999999999865432211  23456899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||........                ...+...  ....+...+..+.+|+.+||+.||.+
T Consensus       192 ~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~  253 (278)
T 3cok_A          192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVVLA--DYEMPSFLSIEAKDLIHQLLRRNPAD  253 (278)
T ss_dssp             CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHhhc--ccCCccccCHHHHHHHHHHcccCHhh
Confidence            99999999999999999999976542110                0000001  11233445678899999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       254 Rps~~~~l~  262 (278)
T 3cok_A          254 RLSLSSVLD  262 (278)
T ss_dssp             SCCHHHHTT
T ss_pred             CCCHHHHhc
Confidence            999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.6e-32  Score=221.29  Aligned_cols=149  Identities=26%  Similarity=0.379  Sum_probs=108.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ......||..|+|||++.     +
T Consensus       133 ~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  208 (326)
T 2x7f_A          133 YICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPD  208 (326)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC------
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccC
Confidence            4789999999999964  599999999999999999999999999876533211  123457899999999987     4


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ..++.++|||||||++|+|++|..||......                .....+............++..+.+|+.+||.
T Consensus       209 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  272 (326)
T 2x7f_A          209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLV  272 (326)
T ss_dssp             --CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCC
T ss_pred             cCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----------------HHHHHhhcCccccCCccccCHHHHHHHHHHhc
Confidence            56889999999999999999999999764311                11111111111112223446788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+||++.++++
T Consensus       273 ~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          273 KNHSQRPATEQLMK  286 (326)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             cChhhCCCHHHHhh
Confidence            99999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=1.6e-32  Score=222.35  Aligned_cols=147  Identities=28%  Similarity=0.465  Sum_probs=117.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++........  .....||..|+|||++.+..++.
T Consensus       145 ~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~  220 (335)
T 2owb_A          145 YYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSF  220 (335)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCc
Confidence            5789999999999964  5999999999999999999999999999865432221  23457899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||.......                ....+....  ...+..++..+.+|+.+||+.||.+
T Consensus       221 ~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~  282 (335)
T 2owb_A          221 EVDVWSIGCIMYTLLVGKPPFETSCLKE----------------TYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTA  282 (335)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCcCCCCCCCHHH----------------HHHHHhcCC--CCCCccCCHHHHHHHHHHccCChhH
Confidence            9999999999999999999997643210                111111111  1233445677889999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      ||++.++++
T Consensus       283 Rps~~ell~  291 (335)
T 2owb_A          283 RPTINELLN  291 (335)
T ss_dssp             SCCGGGGGG
T ss_pred             CcCHHHHhc
Confidence            999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2e-32  Score=218.54  Aligned_cols=149  Identities=28%  Similarity=0.424  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++........  ......||..|+|||++.+..++.
T Consensus       123 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  198 (303)
T 3a7i_A          123 TILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDS  198 (303)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCc
Confidence            5789999999999964  599999999999999999999999999976533221  123457899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|+.||......                 .....+........+..++..+.+|+.+||+.||.+
T Consensus       199 ~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  261 (303)
T 3a7i_A          199 KADIWSLGITAIELARGEPPHSELHPM-----------------KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF  261 (303)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------HHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGG
T ss_pred             hhhhHHHHHHHHHHccCCCCCCCcCHH-----------------HHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhh
Confidence            999999999999999999999764311                 011111112222333445677899999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      |||+.++++.
T Consensus       262 Rps~~~ll~~  271 (303)
T 3a7i_A          262 RPTAKELLKH  271 (303)
T ss_dssp             SCCHHHHTTC
T ss_pred             CcCHHHHhhC
Confidence            9999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.3e-32  Score=227.67  Aligned_cols=172  Identities=16%  Similarity=0.200  Sum_probs=123.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee----cCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-   76 (229)
                      .++.||+.||+|||+.  +|+||||||+|||+    +.++.+||+|||+++.......   .....||..|+|||++.+ 
T Consensus       116 ~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~  190 (396)
T 4eut_A          116 IVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERA  190 (396)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhcc
Confidence            5789999999999964  59999999999999    7778899999999987543221   234579999999999865 


Q ss_pred             -------CCCcccCceeehhHHHHHHHhCCCcCCCCccccc--hhHHHhhhhhhc-chhhHHHHh--------hcccCCC
Q 027003           77 -------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE--QSLVDWAKPYLS-DKRKLFRIM--------DTKLGGQ  138 (229)
Q Consensus        77 -------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~  138 (229)
                             ..++.++|||||||++|||++|+.||........  ............ .........        .......
T Consensus       191 ~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (396)
T 4eut_A          191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS  270 (396)
T ss_dssp             CC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCS
T ss_pred             ccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccc
Confidence                   5678899999999999999999999975432211  111110000000 000000000        0001123


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhcCC
Q 027003          139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       139 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~~~  178 (229)
                      ........+.+++.+||+.||++||++.++++.++.+...
T Consensus       271 l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            4467888999999999999999999999999999887544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=5.1e-33  Score=219.39  Aligned_cols=152  Identities=26%  Similarity=0.321  Sum_probs=116.4

Q ss_pred             hhHHHHHHHHHHhhcCC---CCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~---~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.|++.||+|||+.+   .+|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+..
T Consensus       115 ~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~  192 (279)
T 2w5a_A          115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMS  192 (279)
T ss_dssp             HHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-
T ss_pred             HHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCC
Confidence            57899999999999643   1299999999999999999999999999976533221  123456899999999999889


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|+|++|..||......                 .....+........+..++..+.+++.+||+.|
T Consensus       193 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (279)
T 2w5a_A          193 YNEKSDIWSLGCLLYELCALMPPFTAFSQK-----------------ELAGKIREGKFRRIPYRYSDELNEIITRMLNLK  255 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCcccCHH-----------------HHHHHHhhcccccCCcccCHHHHHHHHHHcCCC
Confidence            999999999999999999999999765311                 111111122222344456778999999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 027003          159 PKLRPRMSEVLAIL  172 (229)
Q Consensus       159 P~~Rpt~~~v~~~l  172 (229)
                      |.+||++.++++.+
T Consensus       256 p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          256 DYHRPSVEEILENP  269 (279)
T ss_dssp             GGGSCCHHHHHTST
T ss_pred             cccCCCHHHHHhCh
Confidence            99999999999755

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=2.7e-32  Score=216.76  Aligned_cols=150  Identities=25%  Similarity=0.449  Sum_probs=115.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC--
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--   78 (229)
                      .++.|++.||.|||+.  +|+||||||+||+++. ++.+||+|||++........  ......||..|+|||++.+..  
T Consensus       126 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~  201 (295)
T 2clq_A          126 FYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRG  201 (295)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGG
T ss_pred             HHHHHHHHHHHHHHhC--CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCC
Confidence            3688999999999964  6999999999999987 89999999999986543221  123456899999999997653  


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|+|++|+.||........               ..............+...+..+.+|+.+||+.|
T Consensus       202 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  266 (295)
T 2clq_A          202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------------AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD  266 (295)
T ss_dssp             CSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---------------HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSS
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---------------HHHhhccccccccccccCCHHHHHHHHHHccCC
Confidence            78899999999999999999999965331100               011111112233445556778999999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+||++.++++
T Consensus       267 p~~Rps~~~ll~  278 (295)
T 2clq_A          267 PDKRACANDLLV  278 (295)
T ss_dssp             TTTSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=4.9e-32  Score=213.62  Aligned_cols=145  Identities=24%  Similarity=0.381  Sum_probs=113.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.|++.||+|||+.  +|+||||||+|||+   +.++.+||+|||++........   .....||..|+|||++.+ .
T Consensus       110 ~i~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~  183 (277)
T 3f3z_A          110 RIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-L  183 (277)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-C
T ss_pred             HHHHHHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhcc-c
Confidence            5789999999999964  59999999999999   7889999999999986543322   234568999999999865 4


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcH----HHHHHHHHHHHHh
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ----KAAHTAATLALQC  154 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~  154 (229)
                      ++.++|||||||++|+|++|+.||......                .....+.....  ..+.    ..+..+.+|+.+|
T Consensus       184 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~  245 (277)
T 3f3z_A          184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDS----------------EVMLKIREGTF--TFPEKDWLNVSPQAESLIRRL  245 (277)
T ss_dssp             BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHH
T ss_pred             CCchhhehhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhCCC--CCCchhhhcCCHHHHHHHHHH
Confidence            899999999999999999999999764321                11111111111  1121    3467889999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 027003          155 LNNEPKLRPRMSEVLA  170 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~  170 (229)
                      |+.||.+||++.++++
T Consensus       246 l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          246 LTKSPKQRITSLQALE  261 (277)
T ss_dssp             TCSSTTTSCCHHHHTT
T ss_pred             ccCChhhCcCHHHHhc
Confidence            9999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=1.2e-32  Score=222.54  Aligned_cols=165  Identities=21%  Similarity=0.215  Sum_probs=107.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-----CCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-----AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~   76 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++     .++.+||+|||+++.......  ......||..|+|||++.+
T Consensus       136 ~i~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~  211 (329)
T 3gbz_A          136 SFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLG  211 (329)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcC
Confidence            5789999999999964  599999999999994     455699999999976532221  1234568999999999987


Q ss_pred             C-CCcccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHh-hhhhhcchhhHHHH-----hhcccCCC-----CcHHH
Q 027003           77 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLSDKRKLFRI-----MDTKLGGQ-----YPQKA  143 (229)
Q Consensus        77 ~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~-----~~~~~~~~-----~~~~~  143 (229)
                      . .++.++|||||||++|+|++|..||.+........ .... ..+...........     ........     .....
T Consensus       212 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (329)
T 3gbz_A          212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALL  291 (329)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGS
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhccccc
Confidence            5 47999999999999999999999997754311110 0000 00000000000000     00000000     01124


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          144 AHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       144 ~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +..+.+|+.+||+.||.+|||+.|+++
T Consensus       292 ~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          292 DDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            567889999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=2.9e-32  Score=216.81  Aligned_cols=148  Identities=28%  Similarity=0.449  Sum_probs=117.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++.........  .....||..|+|||++.+..++.
T Consensus       119 ~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  194 (294)
T 2rku_A          119 YYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSF  194 (294)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCT
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCc
Confidence            5789999999999964  6999999999999999999999999999865432221  23456899999999999888999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++||||||+++|+|++|+.||.......                ....+...  ....+...+..+.+|+.+||+.||.+
T Consensus       195 ~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  256 (294)
T 2rku_A          195 EVDVWSIGCIMYTLLVGKPPFETSCLKE----------------TYLRIKKN--EYSIPKHINPVAASLIQKMLQTDPTA  256 (294)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhhc--cCCCccccCHHHHHHHHHHcccChhh
Confidence            9999999999999999999997653210                11111111  12234445678899999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      |||+.++++.
T Consensus       257 Rps~~~ll~~  266 (294)
T 2rku_A          257 RPTINELLND  266 (294)
T ss_dssp             SCCGGGGGGS
T ss_pred             CcCHHHHhhC
Confidence            9999999873

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=9.2e-32  Score=228.11  Aligned_cols=148  Identities=28%  Similarity=0.387  Sum_probs=114.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec---CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++   .++.+||+|||+++.......   ....+||+.|+|||++.+ .
T Consensus       125 ~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~  198 (486)
T 3mwu_A          125 RIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-T  198 (486)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-C
T ss_pred             HHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-C
Confidence            5789999999999964  599999999999995   456799999999986543322   234579999999999975 5


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+....                .....+.......  .....++..+.+||.+||+
T Consensus       199 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  262 (486)
T 3mwu_A          199 YDEKCDVWSAGVILYILLSGTPPFYGKNEY----------------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT  262 (486)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTC
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcC
Confidence            899999999999999999999999775421                1111222222211  1223457789999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||.+|||+.++++.
T Consensus       263 ~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          263 FHPSLRITATQCLEH  277 (486)
T ss_dssp             SSTTTSCCHHHHHHC
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=4.4e-32  Score=218.58  Aligned_cols=164  Identities=26%  Similarity=0.344  Sum_probs=116.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++.
T Consensus       124 ~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  198 (326)
T 1blx_A          124 DMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYAT  198 (326)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCc
Confidence            5789999999999964  69999999999999999999999999997643221   233457899999999999989999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhh-hhhhcchhh---H-HHHhhcc---cCCCCcHHHHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKRK---L-FRIMDTK---LGGQYPQKAAHTAATLAL  152 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~---~-~~~~~~~---~~~~~~~~~~~~~~~li~  152 (229)
                      ++|||||||++|+|++|+.||.+....... .+.... .+.......   . .......   .........+..+.+|+.
T Consensus       199 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  278 (326)
T 1blx_A          199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL  278 (326)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHH
Confidence            999999999999999999999875432110 010000 000000000   0 0000000   000112335677889999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+||++.++++
T Consensus       279 ~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          279 KCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCcccCCCHHHHhc
Confidence            999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=5.2e-32  Score=226.55  Aligned_cols=149  Identities=29%  Similarity=0.433  Sum_probs=110.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-------------CcEEEcccCCcccCCCCCCcc--eeecccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKLSDFGLAKAGPTGDRTH--VSTQVMGTH   66 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-------------~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~   66 (229)
                      +++.||+.||+|||+.  +|+||||||+|||++.+             +.+||+|||+++.........  ......||.
T Consensus       119 ~i~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~  196 (434)
T 2rio_A          119 SLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS  196 (434)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CC
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCC
Confidence            4899999999999964  59999999999999754             479999999998764432211  123457999


Q ss_pred             cccccccccc-------CCCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc----
Q 027003           67 GYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----  134 (229)
Q Consensus        67 ~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  134 (229)
                      .|+|||++.+       ..++.++|||||||++|||++ |..||.......                  ..++...    
T Consensus       197 ~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------------------~~i~~~~~~~~  258 (434)
T 2rio_A          197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------------------SNIIRGIFSLD  258 (434)
T ss_dssp             TTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------------------HHHHHTCCCCC
T ss_pred             CccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------------------HHHhcCCCCcc
Confidence            9999999976       568899999999999999999 999997543211                  0111111    


Q ss_pred             -cCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          135 -LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       135 -~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                       .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          259 EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             111224567889999999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=7.7e-32  Score=224.59  Aligned_cols=148  Identities=26%  Similarity=0.352  Sum_probs=106.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCcccCCCCCCcceeecccccccccccccccc--
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--   76 (229)
                      .++.|++.||+|||+.  +|+||||||+|||++.++   .+||+|||+++......   .....+||+.|+|||++.+  
T Consensus       243 ~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~  317 (419)
T 3i6u_A          243 LYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVG  317 (419)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC---
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCC
Confidence            4789999999999964  599999999999997544   59999999998754322   2345679999999999854  


Q ss_pred             -CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc---HHHHHHHHHHHH
Q 027003           77 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLAL  152 (229)
Q Consensus        77 -~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~  152 (229)
                       ..++.++|||||||++|+|++|..||........                ....+........+   ...+..+.+|+.
T Consensus       318 ~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~  381 (419)
T 3i6u_A          318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----------------LKDQITSGKYNFIPEVWAEVSEKALDLVK  381 (419)
T ss_dssp             -CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----------------HHHHHhcCCCCCCchhhcccCHHHHHHHH
Confidence             5678899999999999999999999976432111                11111111111111   124677899999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+||++.++++
T Consensus       382 ~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          382 KLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHSCSSTTTSCCHHHHHH
T ss_pred             HHccCChhHCcCHHHHhC
Confidence            999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=1.1e-32  Score=225.34  Aligned_cols=164  Identities=24%  Similarity=0.400  Sum_probs=116.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......    ......||..|+|||++.+..++.
T Consensus       135 ~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~  209 (360)
T 3eqc_A          135 KVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV  209 (360)
T ss_dssp             HHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSH
T ss_pred             HHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCc
Confidence            5789999999999963 25999999999999999999999999998643211    123457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHh--------------------------hhhhhcchhhHHHHhhccc
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--------------------------AKPYLSDKRKLFRIMDTKL  135 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~  135 (229)
                      ++|||||||++|+|++|+.||...+..........                          ..+..........+.....
T Consensus       210 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (360)
T 3eqc_A          210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP  289 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCC
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC
Confidence            99999999999999999999976543211110000                          0000000011111111222


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          136 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       136 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .......++..+.+|+.+||+.||.+|||+.++++
T Consensus       290 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            22222335678999999999999999999999996

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=5.8e-32  Score=221.99  Aligned_cols=163  Identities=22%  Similarity=0.328  Sum_probs=112.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.....     .....||..|+|||++.+ ..++
T Consensus       148 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~  220 (371)
T 4exu_A          148 YLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYN  220 (371)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCC
T ss_pred             HHHHHHHHHHHHHHHC--CCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCC
Confidence            5789999999999964  6999999999999999999999999999864322     234578999999999987 6789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-hh---hc--chhhHHHHhhcccCC---C---CcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PY---LS--DKRKLFRIMDTKLGG---Q---YPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~---~~--~~~~~~~~~~~~~~~---~---~~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||.+.+..... ....... +.   ..  ...............   .   .....+..+
T Consensus       221 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
T 4exu_A          221 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA  300 (371)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHH
T ss_pred             cHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHH
Confidence            9999999999999999999999875432111 0000000 00   00  000000111100000   0   012346788


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+|+.+||+.||.+|||+.++++.
T Consensus       301 ~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          301 ADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHCCCChhhcCCHHHHhcC
Confidence            999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=8.9e-32  Score=219.37  Aligned_cols=162  Identities=23%  Similarity=0.359  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.....     .....||..|+|||++.+ ..++
T Consensus       130 ~i~~qi~~al~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~  202 (353)
T 3coi_A          130 YLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYN  202 (353)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCC
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCC
Confidence            5789999999999964  5999999999999999999999999999864322     234578999999999877 5788


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-h---hhc--chhhHHHHhh---cccC---CCCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-P---YLS--DKRKLFRIMD---TKLG---GQYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~---~~~--~~~~~~~~~~---~~~~---~~~~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||.+.+..... ....... +   +..  ........+.   ....   .......+..+
T Consensus       203 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (353)
T 3coi_A          203 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA  282 (353)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHH
Confidence            9999999999999999999999875432110 0000000 0   000  0000001110   0000   11223457789


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+.+||+.||.+|||+.++++
T Consensus       283 ~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          283 ADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCCcccCCCHHHHhc
Confidence            99999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=4.4e-32  Score=215.02  Aligned_cols=147  Identities=29%  Similarity=0.397  Sum_probs=107.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||+|||+.  +|+||||||+|||+   +.++.+||+|||++........   .....||..|+|||++. +.
T Consensus       128 ~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~  201 (285)
T 3is5_A          128 ELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RD  201 (285)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TC
T ss_pred             HHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cC
Confidence            5789999999999964  59999999999999   4567899999999976543221   33457899999999985 56


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC-CCCcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|||||||++|+|++|+.||.+........                ........ .......+..+.+|+.+||+.
T Consensus       202 ~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  265 (285)
T 3is5_A          202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ----------------KATYKEPNYAVECRPLTPQAVDLLKQMLTK  265 (285)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHCCCCCCC--CCCCHHHHHHHHHHTCS
T ss_pred             CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh----------------hhccCCcccccccCcCCHHHHHHHHHHccC
Confidence            8899999999999999999999998754211110                00000000 000111356788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+|||+.|+++
T Consensus       266 dP~~Rps~~e~l~  278 (285)
T 3is5_A          266 DPERRPSAAQVLH  278 (285)
T ss_dssp             CTTTSCCHHHHHT
T ss_pred             ChhhCcCHHHHhc
Confidence            9999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=9.1e-32  Score=215.72  Aligned_cols=149  Identities=28%  Similarity=0.391  Sum_probs=117.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  +|+|+||||+||+++.++.+||+|||++........  ......||..|+|||++.+..++.
T Consensus       129 ~i~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  204 (314)
T 3com_A          129 TILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNC  204 (314)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred             HHHHHHHHHHHHHHhC--CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCc
Confidence            5789999999999964  599999999999999999999999999976533221  123456899999999999889999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++|+.||.......                ....+... ......+...+..+.+|+.+||+.||.
T Consensus       205 ~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  268 (314)
T 3com_A          205 VADIWSLGITAIEMAEGKPPYADIHPMR----------------AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE  268 (314)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTT
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCChHH----------------HHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChh
Confidence            9999999999999999999997643110                00111111 111122344567899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.++++
T Consensus       269 ~Rpt~~~ll~  278 (314)
T 3com_A          269 QRATATQLLQ  278 (314)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCcCHHHHHh
Confidence            9999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=2.7e-32  Score=219.66  Aligned_cols=139  Identities=25%  Similarity=0.401  Sum_probs=112.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-   79 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++ .++.+||+|||+++......    .....||..|+|||++.+..+ 
T Consensus       153 ~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~  226 (320)
T 3a99_A          153 SFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYH  226 (320)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBC
T ss_pred             HHHHHHHHHHHHHHHC--CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCC
Confidence            5789999999999964  599999999999999 78999999999998754322    234568999999999987765 


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|||++|+.||.....                      .....  ...+..++..+.+|+.+||+.||
T Consensus       227 ~~~~Di~slG~il~el~~g~~pf~~~~~----------------------~~~~~--~~~~~~~~~~~~~li~~~l~~dp  282 (320)
T 3a99_A          227 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIRGQ--VFFRQRVSSECQHLIRWCLALRP  282 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHHCC--CCCSSCCCHHHHHHHHHHTCSSG
T ss_pred             CccchHHhHHHHHHHHHHCCCCCCChhh----------------------hhccc--ccccccCCHHHHHHHHHHccCCh
Confidence            6789999999999999999999965320                      00010  11223345678899999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      .+|||+.++++
T Consensus       283 ~~Rps~~~ll~  293 (320)
T 3a99_A          283 SDRPTFEEIQN  293 (320)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCcCHHHHhc
Confidence            99999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=3e-32  Score=230.93  Aligned_cols=147  Identities=27%  Similarity=0.401  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||.|||++  +|+||||||+|||+   +.++.+||+|||+++.......   ....+||+.|+|||++.+ .
T Consensus       130 ~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~  203 (484)
T 3nyv_A          130 RIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-T  203 (484)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-C
T ss_pred             HHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-C
Confidence            5789999999999964  59999999999999   5678899999999986544322   234579999999999965 6


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC--CcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+.+..                .....+........  ....++..+.+|+.+||+
T Consensus       204 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  267 (484)
T 3nyv_A          204 YDEKCDVWSTGVILYILLSGCPPFNGANEY----------------DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLT  267 (484)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTC
T ss_pred             CCCcceeHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCC
Confidence            899999999999999999999999875421                11122222222211  223567789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       268 ~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          268 YVPSMRISARDALD  281 (484)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999996

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=8.7e-32  Score=215.06  Aligned_cols=147  Identities=24%  Similarity=0.389  Sum_probs=116.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeee---cCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.|++.||.|||+.  +|+||||||+||++   +.++.+||+|||++.......    .....||..|+|||++.+..
T Consensus       110 ~~~~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~  183 (304)
T 2jam_A          110 LVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKP  183 (304)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCS
T ss_pred             HHHHHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCC
Confidence            5789999999999964  69999999999999   778899999999987643221    23356899999999999989


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||......                .....+.....  ........+..+.+|+.+||+
T Consensus       184 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  247 (304)
T 2jam_A          184 YSKAVDCWSIGVITYILLCGYPPFYEETES----------------KLFEKIKEGYYEFESPFWDDISESAKDFICHLLE  247 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHC
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcC
Confidence            999999999999999999999999764321                01111111111  112234456789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+||++.++++
T Consensus       248 ~dp~~Rps~~~~l~  261 (304)
T 2jam_A          248 KDPNERYTCEKALS  261 (304)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=4.5e-32  Score=219.27  Aligned_cols=165  Identities=24%  Similarity=0.346  Sum_probs=111.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......  ......||..|+|||++.+. .++
T Consensus       128 ~~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~  203 (331)
T 4aaa_A          128 KYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYG  203 (331)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCC
T ss_pred             HHHHHHHHHHHHHHHC--CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcc
Confidence            5789999999999964  599999999999999999999999999976433221  12345689999999999775 688


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhhhcchhhHHHH-------hhcccCCCC-----cHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRI-------MDTKLGGQY-----PQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-----~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||.+........ ..................       .........     ...++..+
T Consensus       204 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  283 (331)
T 4aaa_A          204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV  283 (331)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHH
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHH
Confidence            99999999999999999999998754321111 100000000000000000       000000000     11346789


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+|+.+||+.||.+|||+.|+++
T Consensus       284 ~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          284 IDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHHHhccCcccCCCHHHHhc
Confidence            99999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=6.5e-32  Score=216.77  Aligned_cols=163  Identities=27%  Similarity=0.314  Sum_probs=110.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCcccCCCCCC-----cceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~   73 (229)
                      .++.||+.||+|||+.  +|+||||||+|||++.++.   +||+|||++........     .......+||..|+|||+
T Consensus       115 ~i~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  192 (316)
T 2ac3_A          115 VVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV  192 (316)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHH
Confidence            4789999999999964  6999999999999988776   99999999875432211     111223469999999999


Q ss_pred             ccc-----CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHH-HhhcccCCCCcH----HH
Q 027003           74 VAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQ----KA  143 (229)
Q Consensus        74 ~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~  143 (229)
                      +.+     ..++.++|||||||++|+|++|+.||.+............  ........+.. +.....  ..+.    ..
T Consensus       193 ~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~~~--~~~~~~~~~~  268 (316)
T 2ac3_A          193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE--ACPACQNMLFESIQEGKY--EFPDKDWAHI  268 (316)
T ss_dssp             HHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCHHHHHHHHHHHHHCCC--CCCHHHHTTS
T ss_pred             hhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc--cchhHHHHHHHHHhccCc--ccCchhcccC
Confidence            975     4578899999999999999999999987543211000000  00000011111 111111  1221    24


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          144 AHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       144 ~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +..+.+|+.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          269 SCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            667899999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=2.8e-32  Score=221.03  Aligned_cols=153  Identities=22%  Similarity=0.312  Sum_probs=95.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.   ++.+||+|||+++......    .....||+.|+|||++.+..
T Consensus       132 ~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~  205 (336)
T 3fhr_A          132 EIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEK  205 (336)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CH
T ss_pred             HHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCC
Confidence            5789999999999964  6999999999999976   4559999999998643321    23456899999999998888


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|+|++|..||..........          ....................++..+.+|+.+||+.|
T Consensus       206 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  275 (336)
T 3fhr_A          206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD  275 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCTTTSTTCCHHHHHHHHHHSCSS
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCC
Confidence            9999999999999999999999997644211100          000000000011111222345678899999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+|||+.++++
T Consensus       276 P~~Rpt~~ell~  287 (336)
T 3fhr_A          276 PTERLTITQFMN  287 (336)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhHCcCHHHHhc
Confidence            999999999997

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1e-31  Score=219.62  Aligned_cols=164  Identities=23%  Similarity=0.317  Sum_probs=108.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      +++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......   .....||..|+|||++.+ ..++
T Consensus       138 ~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  212 (362)
T 3pg1_A          138 YFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFT  212 (362)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCC
T ss_pred             HHHHHHHHHHHHHHHC--cCEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCC
Confidence            5789999999999964  599999999999999999999999999975433221   234578999999999877 6789


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhh-hhhc-----chhhHHHHhhcccCC---CC----cHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLS-----DKRKLFRIMDTKLGG---QY----PQKAAHT  146 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~-----~~~~~~~~~~~~~~~---~~----~~~~~~~  146 (229)
                      .++|||||||++|+|++|+.||.+....... .+..... +...     ...............   ..    ....+..
T Consensus       213 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
T 3pg1_A          213 KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPV  292 (362)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHH
T ss_pred             cHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHH
Confidence            9999999999999999999999875432111 1111000 0000     000011111111110   00    1123567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||+.||.+|||+.++++
T Consensus       293 ~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          293 ALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHc
Confidence            889999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=8.6e-32  Score=219.19  Aligned_cols=167  Identities=23%  Similarity=0.275  Sum_probs=114.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc--------eeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--------VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~   73 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.........        ......||..|+|||+
T Consensus       116 ~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          116 YFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHC--CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCee
Confidence            5789999999999964  69999999999999999999999999998654321110        1223578999999998


Q ss_pred             ccc-CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhH-HHhhh-hhh------cchhhHHHHhhcccCC-C-----
Q 027003           74 VAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAK-PYL------SDKRKLFRIMDTKLGG-Q-----  138 (229)
Q Consensus        74 ~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~-~~~------~~~~~~~~~~~~~~~~-~-----  138 (229)
                      +.+ ..++.++|||||||++|+|++|+.||.+.+....... ..... +..      ................ .     
T Consensus       194 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (353)
T 2b9h_A          194 MLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK  273 (353)
T ss_dssp             HHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred             eccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhh
Confidence            765 6789999999999999999999999987653211100 00000 000      0000011111110000 0     


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          139 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       139 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          274 MFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            01234677889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=223.40  Aligned_cols=150  Identities=27%  Similarity=0.391  Sum_probs=107.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-----CCcEEEcccCCcccCCCCCC-cceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~   75 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.     ...+||+|||+++....... ........||+.|+|||++.
T Consensus       122 ~i~~qi~~aL~~LH~~--~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          122 TLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTS
T ss_pred             HHHHHHHHHHHHHHHC--cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence            5789999999999964  5999999999999953     23588999999987543321 12234467999999999997


Q ss_pred             c---CCCcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-c-CCCCcHHHHHHHHH
Q 027003           76 T---GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L-GGQYPQKAAHTAAT  149 (229)
Q Consensus        76 ~---~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~  149 (229)
                      +   ..++.++|||||||++|||++ |..||.......                 ........ . ...........+.+
T Consensus       200 ~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~  262 (432)
T 3p23_A          200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----------------ANILLGACSLDCLHPEKHEDVIARE  262 (432)
T ss_dssp             CC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----------------HHHHTTCCCCTTSCTTCHHHHHHHH
T ss_pred             cccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----------------HHHHhccCCccccCccccccHHHHH
Confidence            3   567789999999999999999 999996532110                 00011100 0 01122345667889


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      |+.+||+.||.+|||+.++++
T Consensus       263 li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          263 LIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCHhhCCCHHHHHh
Confidence            999999999999999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=1.8e-31  Score=226.78  Aligned_cols=147  Identities=27%  Similarity=0.364  Sum_probs=114.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++..   +.+||+|||++........   ....+||+.|+|||++. ..
T Consensus       140 ~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~  213 (494)
T 3lij_A          140 VIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KK  213 (494)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TC
T ss_pred             HHHHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-cc
Confidence            5789999999999964  59999999999999764   5599999999987543321   33467999999999986 56


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+....                .....+.......  ......+..+.+|+.+||+
T Consensus       214 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  277 (494)
T 3lij_A          214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQ----------------EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQ  277 (494)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCC
Confidence            899999999999999999999999875421                1111122221111  1123456788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       278 ~dp~~R~s~~e~l~  291 (494)
T 3lij_A          278 FDSQRRISAQQALE  291 (494)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhhCccHHHHhc
Confidence            99999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=5.3e-32  Score=213.97  Aligned_cols=154  Identities=25%  Similarity=0.364  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----cEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.||+.||.|||+.  +|+||||||+||+++.++    .+||+|||++........   .....||..|+|||++.+.
T Consensus       112 ~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~  186 (283)
T 3bhy_A          112 QFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE  186 (283)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCC
Confidence            5789999999999964  699999999999998877    799999999986543322   2345689999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  155 (229)
                      .++.++||||||+++|+|++|..||.+.....                ....+.......  ......+..+.+|+.+||
T Consensus       187 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  250 (283)
T 3bhy_A          187 PLGLEADMWSIGVITYILLSGASPFLGETKQE----------------TLTNISAVNYDFDEEYFSNTSELAKDFIRRLL  250 (283)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTS
T ss_pred             CCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----------------HHHHhHhcccCCcchhcccCCHHHHHHHHHHc
Confidence            99999999999999999999999997653210                011111110000  011223567889999999


Q ss_pred             cCCCCCCCCHHHHHH--HHHhhc
Q 027003          156 NNEPKLRPRMSEVLA--ILERLE  176 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~--~l~~~~  176 (229)
                      +.||.+||++.++++  .++.+.
T Consensus       251 ~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          251 VKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cCCHhHCcCHHHHHhCHHHHHHH
Confidence            999999999999997  455443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1e-31  Score=212.42  Aligned_cols=141  Identities=16%  Similarity=0.271  Sum_probs=109.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-------------------CcEEEcccCCcccCCCCCCcceeecc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------FNAKLSDFGLAKAGPTGDRTHVSTQV   62 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~   62 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.+                   ..+||+|||++.......      ..
T Consensus       119 ~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~  190 (289)
T 1x8b_A          119 DLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VE  190 (289)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CC
T ss_pred             HHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------cc
Confidence            5789999999999964  59999999999999844                   479999999998754322      23


Q ss_pred             ccccccccccccccC-CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcH
Q 027003           63 MGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ  141 (229)
Q Consensus        63 ~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (229)
                      .||..|+|||++.+. .++.++|||||||++|+|++|..++....                   .... +........+.
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------------------~~~~-~~~~~~~~~~~  250 (289)
T 1x8b_A          191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-------------------QWHE-IRQGRLPRIPQ  250 (289)
T ss_dssp             CCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-------------------HHHH-HHTTCCCCCSS
T ss_pred             CCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-------------------HHHH-HHcCCCCCCCc
Confidence            589999999999776 56689999999999999999987764321                   0111 11122223444


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .++..+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          251 VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            56778999999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=1.8e-31  Score=210.22  Aligned_cols=147  Identities=29%  Similarity=0.463  Sum_probs=107.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      +++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++........   .....||..|+|||++.+..+ +
T Consensus       115 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  189 (276)
T 2h6d_A          115 RLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAG  189 (276)
T ss_dssp             HHHHHHHHHHHHHHHH--CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCH
T ss_pred             HHHHHHHHHHHHHHHC--CCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCC
Confidence            5789999999999964  599999999999999999999999999986543221   234568999999999987765 6


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++||||||+++|+|++|+.||......                 .....+... ....+...+..+.+++.+||+.||.
T Consensus       190 ~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~  251 (276)
T 2h6d_A          190 PEVDIWSCGVILYALLCGTLPFDDEHVP-----------------TLFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPL  251 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCcHH-----------------HHHHHhhcC-cccCchhcCHHHHHHHHHHccCChh
Confidence            8999999999999999999999764311                 011111111 1123344567789999999999999


Q ss_pred             CCCCHHHHHHH
Q 027003          161 LRPRMSEVLAI  171 (229)
Q Consensus       161 ~Rpt~~~v~~~  171 (229)
                      +|||+.++++.
T Consensus       252 ~Rps~~~~l~h  262 (276)
T 2h6d_A          252 KRATIKDIREH  262 (276)
T ss_dssp             GSCCHHHHHHS
T ss_pred             hCCCHHHHHhC
Confidence            99999999973

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=2.5e-32  Score=220.34  Aligned_cols=150  Identities=31%  Similarity=0.474  Sum_probs=96.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccc----ccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~   77 (229)
                      +++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......   .....||..|+|||++    .+.
T Consensus       129 ~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  204 (327)
T 3aln_A          129 KITLATVKALNHLKEN-LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQ  204 (327)
T ss_dssp             HHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------
T ss_pred             HHHHHHHHHHHHHhcc-CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcC
Confidence            5789999999999963 1699999999999999999999999999976533221   2234689999999998    456


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhh---cccCCCCcHHHHHHHHHHHHHh
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD---TKLGGQYPQKAAHTAATLALQC  154 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~  154 (229)
                      .++.++|||||||++|+|++|+.||.........               ...+..   ..........++..+.+|+.+|
T Consensus       205 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  269 (327)
T 3aln_A          205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------------LTQVVKGDPPQLSNSEEREFSPSFINFVNLC  269 (327)
T ss_dssp             -CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------------HHHHhcCCCCCCCCcccccCCHHHHHHHHHH
Confidence            7889999999999999999999999764311000               000000   0011111223567889999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 027003          155 LNNEPKLRPRMSEVLA  170 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~  170 (229)
                      |+.||.+||++.++++
T Consensus       270 l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          270 LTKDESKRPKYKELLK  285 (327)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             hhCChhhCcCHHHHHh
Confidence            9999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=2.7e-31  Score=215.88  Aligned_cols=163  Identities=20%  Similarity=0.284  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      +++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||++......    ......||..|+|||++.+. .++
T Consensus       155 ~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  229 (348)
T 2pml_X          155 CIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYN  229 (348)
T ss_dssp             HHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEE
T ss_pred             HHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCC
Confidence            578999999999996 156999999999999999999999999999865332    23446789999999999887 566


Q ss_pred             c-cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhh---hhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhcc
Q 027003           81 T-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK---PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        81 ~-~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  156 (229)
                      . ++|||||||++|+|++|..||........ .......   .........................+..+.+|+.+||+
T Consensus       230 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  308 (348)
T 2pml_X          230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR  308 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCC
T ss_pred             cchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHcc
Confidence            6 99999999999999999999987543110 0000000   00000000000000000000113456788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+||++.++++
T Consensus       309 ~dP~~Rps~~e~l~  322 (348)
T 2pml_X          309 KNPAERITSEDALK  322 (348)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=3.3e-31  Score=210.93  Aligned_cols=148  Identities=30%  Similarity=0.388  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc------
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------   75 (229)
                      .++.||+.||.|||+.  +|+||||||+||+++.++.+||+|||++........   .....|+..|+|||++.      
T Consensus       128 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  202 (298)
T 1phk_A          128 KIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDN  202 (298)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHHC--CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccc
Confidence            5789999999999964  599999999999999999999999999986543322   23456899999999985      


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHH
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQ  153 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  153 (229)
                      ...++.++|||||||++|+|++|..||......                .....+......  .......+..+.+|+.+
T Consensus       203 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  266 (298)
T 1phk_A          203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR  266 (298)
T ss_dssp             SCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHH
T ss_pred             cccCCcccccHhHHHHHHHHHHCCCCCcCccHH----------------HHHHHHhcCCcccCcccccccCHHHHHHHHH
Confidence            446788999999999999999999999764321                011111111111  12223567789999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||+.||.+|||+.++++
T Consensus       267 ~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          267 FLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HCCSSGGGSCCHHHHTT
T ss_pred             HccCCcccCCCHHHHHh
Confidence            99999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=214.77  Aligned_cols=150  Identities=27%  Similarity=0.421  Sum_probs=106.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      +++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++........   .....||..|+|||++.     +
T Consensus       128 ~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  203 (318)
T 2dyl_A          128 KMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTK  203 (318)
T ss_dssp             HHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC------
T ss_pred             HHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccc
Confidence            5789999999999962 2599999999999999999999999999976533221   23456899999999994     4


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|||||||++|+|++|+.||......               ......+..... .......++..+.+|+.+||
T Consensus       204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  268 (318)
T 2dyl_A          204 PDYDIRADVWSLGISLVELATGQFPYKNCKTD---------------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCL  268 (318)
T ss_dssp             --CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHT
T ss_pred             cCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHc
Confidence            56788999999999999999999999763211               011111111111 11111235677899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.||.+||++.++++
T Consensus       269 ~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          269 TKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CSCTTTSCCHHHHTT
T ss_pred             cCChhHCcCHHHHhh
Confidence            999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=3.3e-31  Score=225.66  Aligned_cols=147  Identities=26%  Similarity=0.348  Sum_probs=114.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC---cEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++   .+||+|||++........   ....+||+.|+|||++. +.
T Consensus       150 ~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~  223 (504)
T 3q5i_A          150 NIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KK  223 (504)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TC
T ss_pred             HHHHHHHHHHHHHHHC--CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cC
Confidence            5789999999999964  599999999999998776   699999999987543322   23457999999999986 56


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCC--cHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|++|..||.+.+..                .....+.........  ...++..+.+|+.+||+
T Consensus       224 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  287 (504)
T 3q5i_A          224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----------------DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLT  287 (504)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred             CCchHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcC
Confidence            899999999999999999999999875421                111111111111111  12346789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       288 ~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          288 YDYNKRCTAEEALN  301 (504)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhHCCCHHHHhc
Confidence            99999999999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=6.3e-32  Score=215.36  Aligned_cols=159  Identities=26%  Similarity=0.379  Sum_probs=110.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC---cceeecccccccccccccccc-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR---THVSTQVMGTHGYAAPEYVAT-G   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~   77 (229)
                      +++.||+.||.|||+.  +|+||||||+||+++.++.+||+|||++........   ........||..|+|||++.+ .
T Consensus       125 ~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  202 (303)
T 2vwi_A          125 TILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR  202 (303)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhC--CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc
Confidence            5789999999999964  699999999999999999999999999876543221   111234578999999999876 4


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      .++.++|||||||++|+|++|+.||..........  ............  ..    .........+..+.+|+.+||+.
T Consensus       203 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~li~~~l~~  274 (303)
T 2vwi_A          203 GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LTLQNDPPSLET--GV----QDKEMLKKYGKSFRKMISLCLQK  274 (303)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HHHTSSCCCTTC-----------CCCCCCCHHHHHHHHHHCCS
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--HHhccCCCcccc--cc----ccchhhhhhhHHHHHHHHHHccC
Confidence            68899999999999999999999997754221110  000000000000  00    00111223456788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+||++.++++
T Consensus       275 dp~~Rps~~~ll~  287 (303)
T 2vwi_A          275 DPEKRPTAAELLR  287 (303)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=4.5e-31  Score=212.59  Aligned_cols=148  Identities=25%  Similarity=0.322  Sum_probs=111.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCcccCCCCCCcceeeccccccccccccccc---
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---   75 (229)
                      .++.||+.||.|||++  +|+||||||+|||++.++.   +||+|||+++......   ......||..|+|||++.   
T Consensus       118 ~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~  192 (322)
T 2ycf_A          118 LYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVG  192 (322)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCC
Confidence            4789999999999964  5999999999999987664   9999999998753321   123456899999999974   


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCC---cHHHHHHHHHHHH
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLAL  152 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~  152 (229)
                      +..++.++|||||||++|+|++|..||.........                ...+........   ....+..+.+|+.
T Consensus       193 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (322)
T 2ycf_A          193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL----------------KDQITSGKYNFIPEVWAEVSEKALDLVK  256 (322)
T ss_dssp             TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH----------------HHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH----------------HHHHHhCccccCchhhhhcCHHHHHHHH
Confidence            456889999999999999999999999765422110                011111000001   1224567899999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+||++.++++
T Consensus       257 ~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          257 KLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHcccCHhhCCCHHHHhh
Confidence            999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.4e-31  Score=212.28  Aligned_cols=140  Identities=26%  Similarity=0.443  Sum_probs=113.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-   79 (229)
                      +++.||+.||.|||+.  +|+||||||+||+++ .++.+||+|||++.......    .....||..|+|||++.+..+ 
T Consensus       143 ~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~  216 (312)
T 2iwi_A          143 CFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYH  216 (312)
T ss_dssp             HHHHHHHHHHHHHHHH--TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBC
T ss_pred             HHHHHHHHHHHHHHHC--CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCC
Confidence            5789999999999964  599999999999999 88999999999998754332    234568999999999987766 


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|+|++|+.||.....                      +...  ....+...+..+.+|+.+||+.||
T Consensus       217 ~~~~Di~slG~il~~l~~g~~pf~~~~~----------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p  272 (312)
T 2iwi_A          217 ALPATVWSLGILLYDMVCGDIPFERDQE----------------------ILEA--ELHFPAHVSPDCCALIRRCLAPKP  272 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHHT--CCCCCTTSCHHHHHHHHHHTCSST
T ss_pred             CccchHHHHHHHHHHHHHCCCCCCChHH----------------------Hhhh--ccCCcccCCHHHHHHHHHHccCCh
Confidence            4589999999999999999999965310                      1111  112334456778999999999999


Q ss_pred             CCCCCHHHHHHH
Q 027003          160 KLRPRMSEVLAI  171 (229)
Q Consensus       160 ~~Rpt~~~v~~~  171 (229)
                      ++||++.++++.
T Consensus       273 ~~Rps~~e~l~~  284 (312)
T 2iwi_A          273 SSRPSLEEILLD  284 (312)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hhCcCHHHHhcC
Confidence            999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=3.2e-31  Score=212.70  Aligned_cols=166  Identities=20%  Similarity=0.306  Sum_probs=113.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCC-cceeecccccccccccccccc-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT-GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~   78 (229)
                      .++.|++.||+|||+.  +|+||||||+|||++ .++.+||+|||+++....... ........+|..|+|||++.+ ..
T Consensus       124 ~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  201 (320)
T 2i6l_A          124 LFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN  201 (320)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTC
T ss_pred             HHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCccc
Confidence            5789999999999964  599999999999997 567899999999986532211 111234467999999998865 67


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHH-------hhcccC-CC-----CcHHHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-------MDTKLG-GQ-----YPQKAAH  145 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~-----~~~~~~~  145 (229)
                      ++.++|||||||++|+|++|+.||.+..............+... .....+.       +..... ..     ....++.
T Consensus       202 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (320)
T 2i6l_A          202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH-EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR  280 (320)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC-HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCH
T ss_pred             CCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc-hhhhhhhhhcCcccccccccCCCCChhHhcchhhH
Confidence            88999999999999999999999987643211110000000000 0000000       000000 00     0123467


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          146 TAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       146 ~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+.+|+.+||+.||.+|||+.++++
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          281 EAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHcCCCccccCCHHHHhC
Confidence            8899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=1.2e-31  Score=213.81  Aligned_cols=149  Identities=26%  Similarity=0.388  Sum_probs=111.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      .++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++......  ........||..|+|||++.     +
T Consensus       121 ~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (302)
T 2j7t_A          121 VVCRQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKD  196 (302)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHHhcC--CcccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCC
Confidence            5789999999999964  6999999999999999999999999987532111  01122356899999999983     5


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc-CCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|||||||++|+|++|..||...+..                .....+..... ....+..++..+.+|+.+||
T Consensus       197 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  260 (302)
T 2j7t_A          197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIAL  260 (302)
T ss_dssp             TTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHS
T ss_pred             CCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----------------HHHHHHhccCCcccCCccccCHHHHHHHHHHc
Confidence            67889999999999999999999999764321                01111111111 11233455678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.||.+|||+.++++
T Consensus       261 ~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          261 DKNPETRPSAAQLLE  275 (302)
T ss_dssp             CSCTTTSCCHHHHTT
T ss_pred             ccChhhCCCHHHHhc
Confidence            999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=8.1e-31  Score=208.69  Aligned_cols=149  Identities=23%  Similarity=0.393  Sum_probs=106.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC------------cceeeccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------------THVSTQVMGTHGYA   69 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~   69 (229)
                      +++.|++.||+|||++  +|+||||||+|||++.++.+||+|||++........            ........||..|+
T Consensus       120 ~i~~qi~~~l~~LH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  197 (303)
T 1zy4_A          120 RLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV  197 (303)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTS
T ss_pred             HHHHHHHHHHHHHHhC--CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCccccc
Confidence            5789999999999964  599999999999999999999999999986532210            11123456899999


Q ss_pred             cccccccC-CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHh--hcccCCCCcHHHHHH
Q 027003           70 APEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM--DTKLGGQYPQKAAHT  146 (229)
Q Consensus        70 aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  146 (229)
                      |||++.+. .++.++|||||||++|+|++   ||.....               .......+.  ........+...+..
T Consensus       198 aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (303)
T 1zy4_A          198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---------------RVNILKKLRSVSIEFPPDFDDNKMKV  259 (303)
T ss_dssp             CHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---------------HHHHHHHHHSTTCCCCTTCCTTTSHH
T ss_pred             CcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---------------HHHHHHhccccccccCccccccchHH
Confidence            99999765 68899999999999999998   4432110               000011111  111222344455677


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          260 EKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCcccCcCHHHHhC
Confidence            899999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=1e-30  Score=207.25  Aligned_cols=147  Identities=29%  Similarity=0.429  Sum_probs=112.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC---CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||.|||+.  +|+||||||+||+++.+   +.+||+|||++........   .....||..|+|||++.+ .
T Consensus       125 ~i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~  198 (287)
T 2wei_A          125 RIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-T  198 (287)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-C
T ss_pred             HHHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-C
Confidence            5789999999999964  69999999999999764   4699999999986543322   223468999999999865 4


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc--HHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~  156 (229)
                      ++.++||||||+++|+|++|..||.+....                .....+.........+  ..++..+.+|+.+||+
T Consensus       199 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  262 (287)
T 2wei_A          199 YDEKCDVWSAGVILYILLSGTPPFYGKNEY----------------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT  262 (287)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred             CCCchhhHhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcc
Confidence            889999999999999999999999765321                0111111111111111  2456788999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 027003          157 NEPKLRPRMSEVLA  170 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~  170 (229)
                      .||.+|||+.++++
T Consensus       263 ~dp~~Rps~~ell~  276 (287)
T 2wei_A          263 FHPSLRITATQCLE  276 (287)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             cChhhCcCHHHHhc
Confidence            99999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=6.8e-29  Score=215.21  Aligned_cols=167  Identities=22%  Similarity=0.312  Sum_probs=116.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc---EEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.|++.||+|||+.  +|+||||||+|||++.++.   +||+|||++........   .....||..|+|||++.+..
T Consensus       125 ~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~  199 (676)
T 3qa8_A          125 TLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKK  199 (676)
T ss_dssp             HHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSC
T ss_pred             HHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCC
Confidence            5789999999999964  5999999999999987765   89999999987544322   23467999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhh---HHHHhh------c--ccCCCCcHHHHHHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK---LFRIMD------T--KLGGQYPQKAAHTA  147 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------~--~~~~~~~~~~~~~~  147 (229)
                      ++.++|||||||++|+|++|..||.+....     ..|..........   ......      .  ..........+..+
T Consensus       200 ~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L  274 (676)
T 3qa8_A          200 YTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL  274 (676)
T ss_dssp             CSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHH
T ss_pred             CCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHH
Confidence            999999999999999999999999764211     0110000000000   000000      0  01122345578899


Q ss_pred             HHHHHHhccCCCCCCCCHHH-----HHHHHHhhcCC
Q 027003          148 ATLALQCLNNEPKLRPRMSE-----VLAILERLEAP  178 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~-----v~~~l~~~~~~  178 (229)
                      .+|+.+||..||.+|||+.+     +++.++.+...
T Consensus       275 ~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             HHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             HHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            99999999999999999988     44556555443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=4.8e-29  Score=219.25  Aligned_cols=139  Identities=27%  Similarity=0.349  Sum_probs=108.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||++  +||||||||+|||++.+ .+||+|||+++.....      ....||+.|+|||++.+.. +.
T Consensus       186 ~~~~qi~~aL~~lH~~--giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~  255 (681)
T 2pzi_A          186 AYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TV  255 (681)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CH
T ss_pred             HHHHHHHHHHHHHHHC--CCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CC
Confidence            5789999999999964  59999999999999885 8999999999875432      3457999999999997654 88


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|+|++|..||.+.......                        ........+..+.+||.+||+.||.+
T Consensus       256 ~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~  311 (681)
T 2pzi_A          256 ATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------------EDDPVLKTYDSYGRLLRRAIDPDPRQ  311 (681)
T ss_dssp             HHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------------TTCHHHHHCHHHHHHHHHHTCSSGGG
T ss_pred             ceehhhhHHHHHHHHhCCCCCccccccccc------------------------ccccccccCHHHHHHHhhhccCChhh
Confidence            999999999999999999888653211000                        00011123467889999999999999


Q ss_pred             CCC-HHHHHHHHHh
Q 027003          162 RPR-MSEVLAILER  174 (229)
Q Consensus       162 Rpt-~~~v~~~l~~  174 (229)
                      ||+ +.++...|..
T Consensus       312 R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          312 RFTTAEEMSAQLTG  325 (681)
T ss_dssp             SCSSHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHH
Confidence            995 4555555544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=2.1e-28  Score=195.05  Aligned_cols=130  Identities=23%  Similarity=0.349  Sum_probs=95.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++.   ++.+||+|||++....                        +..
T Consensus       121 ~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~  174 (299)
T 3m2w_A          121 EIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEK  174 (299)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCG
T ss_pred             HHHHHHHHHHHHHHhC--CcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------ccc
Confidence            5789999999999964  5999999999999998   7889999999986421                        245


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCc----HHHHHHHHHHHHHh
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQC  154 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~  154 (229)
                      ++.++|||||||++|+|++|+.||.+........      ....      .+..  .....+    ..++..+.+|+.+|
T Consensus       175 ~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------~~~~------~~~~--~~~~~~~~~~~~~~~~~~~li~~~  240 (299)
T 3m2w_A          175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKT------RIRM--GQYEFPNPEWSEVSEEVKMLIRNL  240 (299)
T ss_dssp             GGGHHHHHHHHHHHHHHHHSSCSCCC-------C------CSCC------SSCT--TCCSSCHHHHTTSCHHHHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------HHHH------HHhh--ccccCCchhcccCCHHHHHHHHHH
Confidence            6789999999999999999999997643211000      0000      0000  000111    23467889999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 027003          155 LNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~  171 (229)
                      |+.||.+|||+.++++.
T Consensus       241 l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          241 LKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             TCSSTTTSCCHHHHHTS
T ss_pred             cccChhhCCCHHHHhcC
Confidence            99999999999999973

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=1.2e-27  Score=189.77  Aligned_cols=133  Identities=14%  Similarity=0.112  Sum_probs=97.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.|++.||+|||++  +|+||||||+|||++.+|.+||+++|.                      ++       .++.
T Consensus       133 ~i~~ql~~aL~~lH~~--givH~Dikp~NIll~~~g~~kl~~~~~----------------------~~-------~~~~  181 (286)
T 3uqc_A          133 RAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP-------DANP  181 (286)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEETTSCEEECSCCC----------------------CT-------TCCH
T ss_pred             HHHHHHHHHHHHHHHC--CCccCCCCcccEEEcCCCCEEEEeccc----------------------cC-------CCCc
Confidence            5789999999999964  599999999999999999999985543                      22       3678


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++|+.||.+.+..... .....    .........        .....++..+.+|+.+||+.||.
T Consensus       182 ~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~  249 (286)
T 3uqc_A          182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD----TAGQPIEPA--------DIDRDIPFQISAVAARSVQGDGG  249 (286)
T ss_dssp             HHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC----TTSCBCCHH--------HHCTTSCHHHHHHHHHHHCTTSS
T ss_pred             hhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH----hccCCCChh--------hcccCCCHHHHHHHHHHcccCCc
Confidence            999999999999999999999875432100 00000    000000000        01123456789999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCC
Q 027003          161 LRPRMSEVLAILERLEAP  178 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~~  178 (229)
                      +| |+.++++.|+++...
T Consensus       250 ~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          250 IR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CC-CHHHHHHHHHHHHC-
T ss_pred             cC-CHHHHHHHHHHHhcc
Confidence            99 999999999987653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=1.2e-27  Score=193.78  Aligned_cols=138  Identities=12%  Similarity=0.104  Sum_probs=103.8

Q ss_pred             hhHHHHHHHHHHhh-cCCCCceeecCCCCCeeecCCC--------------------cEEEcccCCcccCCCCCCcceee
Q 027003            2 KVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEF--------------------NAKLSDFGLAKAGPTGDRTHVST   60 (229)
Q Consensus         2 ~i~~~i~~~l~~LH-~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~   60 (229)
                      .++.||+.||+||| +.  +||||||||+|||++.++                    .+||+|||+++....       .
T Consensus       165 ~i~~qi~~aL~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred             HHHHHHHHHHHHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence            57899999999999 65  499999999999999887                    899999999986532       1


Q ss_pred             ccccccccccccccccCCCcccCceeehhHH-HHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-----c
Q 027003           61 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVV-LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-----K  134 (229)
Q Consensus        61 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  134 (229)
                      ..+||..|+|||++.+.. +.++||||||++ .+++++|..||....         |.      ......+...     .
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~------~~~~~~~~~~~~~~~~  299 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WL------HYLTDKMLKQMTFKTK  299 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HH------HHHHHHHHHTCCCSSC
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hh------hHHHHhhhhhhccCcc
Confidence            347999999999998766 889999998777 778889998884310         00      0000111111     0


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 027003          135 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL  169 (229)
Q Consensus       135 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~  169 (229)
                      .....+...+..+.+||.+||+.|     |+.|++
T Consensus       300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            111123467889999999999977     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.89  E-value=2.3e-25  Score=191.74  Aligned_cols=96  Identities=20%  Similarity=0.129  Sum_probs=64.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||++  |||||||||+||||+.+|.+||+|||+++.......  .....+||+.|+|||++.+ .+..
T Consensus       343 ~I~~QIl~AL~ylH~~--GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~  417 (569)
T 4azs_A          343 KILGSLLRSLAALEKQ--GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSW  417 (569)
T ss_dssp             HHHHHHHHHHHHHHHT--TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC-------
T ss_pred             HHHHHHHHHHHHHHHC--CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCC
Confidence            4789999999999964  599999999999999999999999999987544322  2345789999999999965 4677


Q ss_pred             cCceeehhHHHHHHHhCCCcC
Q 027003           82 KSDVYSFGVVLLELLSGRCAV  102 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~  102 (229)
                      ++|+|++|+++++++++..++
T Consensus       418 ~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          418 NGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -----------CCCCTTHHHH
T ss_pred             cccccccccchhhhccccchh
Confidence            899999999988877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.72  E-value=3.2e-19  Score=152.72  Aligned_cols=98  Identities=21%  Similarity=0.280  Sum_probs=80.2

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-----eeeccccccccccccccc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~   75 (229)
                      ++++.|++.||+|||++  +|+||||||+|||++.  .+||+|||+++.........     ......||+.|+|||++.
T Consensus       434 ~~i~~qi~~aL~~LH~~--gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          434 LDIAYKIGEIVGKLHKN--DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             THHHHHHHHHHHHHHHT--TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHC--cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence            36899999999999964  5999999999999998  99999999998764322111     123568999999999998


Q ss_pred             c--CCCcccCceeehhHHHHHHHhCCCcC
Q 027003           76 T--GRLTTKSDVYSFGVVLLELLSGRCAV  102 (229)
Q Consensus        76 ~--~~~~~~~Di~slG~il~elltg~~p~  102 (229)
                      +  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       510 ~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          510 RFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            7  56788899999998888887776555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.50  E-value=3.1e-15  Score=117.97  Aligned_cols=56  Identities=14%  Similarity=0.083  Sum_probs=48.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~   75 (229)
                      .++.|++.||.|||+.  +|+||||||+|||++ ++.+||+|||+++.               +..+.|||.+.
T Consensus       197 ~i~~qi~~~l~~lH~~--giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          197 EVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             HHHHHHHHHHHHHHHC--CCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            4789999999999964  599999999999999 99999999999863               33467888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.25  E-value=5.7e-12  Score=97.97  Aligned_cols=45  Identities=18%  Similarity=0.200  Sum_probs=40.7

Q ss_pred             hhHHHHHHHHHHhh-cCCCCceeecCCCCCeeecCCCcEEEcccCCcccC
Q 027003            2 KVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   50 (229)
Q Consensus         2 ~i~~~i~~~l~~LH-~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~   50 (229)
                      .++.|++.||.||| +.  +||||||||+|||++.  .++|+|||++...
T Consensus       174 ~i~~qi~~~l~~lH~~~--givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          174 GIFNDVVENVKRLYQEA--ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHHHHHHHHHHHTS--CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHC--CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            47899999999999 65  5999999999999998  8999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.85  E-value=9e-10  Score=89.89  Aligned_cols=46  Identities=20%  Similarity=0.166  Sum_probs=40.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----------cEEEcccCCccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------NAKLSDFGLAKA   49 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----------~~kl~Dfg~~~~   49 (229)
                      +++.||+.+|.|||.  .|||||||||.|||++.+|          .+.|+||+.+..
T Consensus       209 ~l~~qll~~l~~lH~--~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          209 SLYADLIALILRLAK--HGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            467899999999995  4699999999999998776          389999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.93  E-value=6e-06  Score=63.36  Aligned_cols=29  Identities=21%  Similarity=0.145  Sum_probs=25.5

Q ss_pred             ceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           21 VIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        21 ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ++|+|++|.|||++.++.+.|+||+.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            99999999999998776677999998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.81  E-value=8.9e-06  Score=62.72  Aligned_cols=30  Identities=20%  Similarity=0.177  Sum_probs=25.3

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCcc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAK   48 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~   48 (229)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            348999999999999876566799998765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.67  E-value=2.7e-05  Score=62.92  Aligned_cols=31  Identities=13%  Similarity=0.359  Sum_probs=26.6

Q ss_pred             CCceeecCCCCCeeecCCCc--EEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFN--AKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~~   49 (229)
                      ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            46999999999999987753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.61  E-value=1.5e-06  Score=68.84  Aligned_cols=78  Identities=21%  Similarity=0.271  Sum_probs=48.6

Q ss_pred             CCceeecCCCCCeeecC--CCcEEEcccCCcccCCCCCCcceeecccccccc---cccccccc--------------CCC
Q 027003           19 SQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY---AAPEYVAT--------------GRL   79 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~--------------~~~   79 (229)
                      ..++|+|+++.||+++.  .+.+.|+||+.+.........      .....+   ..++....              ...
T Consensus       191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~  264 (304)
T 3sg8_A          191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY  264 (304)
T ss_dssp             CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH
T ss_pred             ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH
Confidence            35899999999999988  456789999998753221000      000000   12221110              011


Q ss_pred             cccCceeehhHHHHHHHhCCCcC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAV  102 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~  102 (229)
                      ....+.|++|.++|.+.+|..+|
T Consensus       265 ~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          265 RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHcCCHHH
Confidence            22357899999999999998665

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.16  E-value=0.00025  Score=56.51  Aligned_cols=32  Identities=16%  Similarity=0.201  Sum_probs=28.2

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            35699999999999998888899999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.37  E-value=0.0023  Score=52.80  Aligned_cols=77  Identities=17%  Similarity=0.197  Sum_probs=45.4

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccc--ccccccccccccC---CCcccCceeehhHHH
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG--THGYAAPEYVATG---RLTTKSDVYSFGVVL   92 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Di~slG~il   92 (229)
                      ...++|+|+++.|||++.++ ++|+||+.+......-  .. .....  ...|++++.....   ......++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            35699999999999998876 9999999987532110  00 00111  1345666544211   112233445666677


Q ss_pred             HHHHhC
Q 027003           93 LELLSG   98 (229)
Q Consensus        93 ~elltg   98 (229)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            776654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.15  E-value=0.0093  Score=44.45  Aligned_cols=78  Identities=14%  Similarity=0.069  Sum_probs=45.0

Q ss_pred             hHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCccc
Q 027003            3 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK   82 (229)
Q Consensus         3 i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~   82 (229)
                      ++.|++.+|.-+-.... -..+=+.+..|++..+|.|.+.+ +.+.              .....+.+||... ...+.+
T Consensus        54 Lc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe~~~-~~~te~  116 (229)
T 2yle_A           54 VCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGKLGY-SQCMET  116 (229)
T ss_dssp             HHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C--------------------------CCSS-SSSCHH
T ss_pred             HHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc--------------ccccCCCChhhcc-ccchHH
Confidence            57788887766511000 11233456889999999988874 2111              0122456888763 344577


Q ss_pred             CceeehhHHHHHHHh
Q 027003           83 SDVYSFGVVLLELLS   97 (229)
Q Consensus        83 ~Di~slG~il~ellt   97 (229)
                      .-|||||+++|..+-
T Consensus       117 ~~IysLG~tLY~ALD  131 (229)
T 2yle_A          117 EVIESLGIIIYKALD  131 (229)
T ss_dssp             HHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhh
Confidence            789999999999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=95.99  E-value=0.0029  Score=48.63  Aligned_cols=30  Identities=23%  Similarity=0.228  Sum_probs=26.1

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            379999999999999877778999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=95.81  E-value=0.0023  Score=50.52  Aligned_cols=31  Identities=26%  Similarity=0.247  Sum_probs=26.4

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            4699999999999998876668999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.61  E-value=0.0093  Score=47.36  Aligned_cols=32  Identities=34%  Similarity=0.400  Sum_probs=27.6

Q ss_pred             CCCceeecCCCCCeeecCC----CcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~   49 (229)
                      ...++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3469999999999999874    6799999998875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.42  E-value=0.011  Score=46.63  Aligned_cols=29  Identities=24%  Similarity=0.274  Sum_probs=25.3

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999999 4 899999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=95.40  E-value=0.0063  Score=47.91  Aligned_cols=32  Identities=22%  Similarity=0.340  Sum_probs=26.3

Q ss_pred             CCCceeecCCCCCeeecC---CCc-EEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDA---EFN-AKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~---~~~-~kl~Dfg~~~~   49 (229)
                      ...++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            345899999999999987   455 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.32  E-value=0.0044  Score=49.70  Aligned_cols=31  Identities=13%  Similarity=0.252  Sum_probs=26.1

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644578999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=94.63  E-value=0.014  Score=47.12  Aligned_cols=30  Identities=20%  Similarity=0.256  Sum_probs=24.9

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+++.|||++.++ +.|+||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            4589999999999998655 89999988753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.39  E-value=0.012  Score=46.94  Aligned_cols=31  Identities=19%  Similarity=0.201  Sum_probs=27.4

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=94.39  E-value=0.015  Score=47.36  Aligned_cols=31  Identities=19%  Similarity=0.232  Sum_probs=26.2

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ...++|+|+.+.||+++.+ .++|+||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            3569999999999999876 489999988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.28  E-value=0.037  Score=43.20  Aligned_cols=30  Identities=17%  Similarity=0.068  Sum_probs=25.6

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            45899999999999 5667789999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.15  E-value=0.015  Score=48.09  Aligned_cols=31  Identities=29%  Similarity=0.285  Sum_probs=24.9

Q ss_pred             CCceeecCCCCCeeecCC----------------------------CcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAE----------------------------FNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~----------------------------~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.|||++.+                            +.+.|+||..+..
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            358999999999999875                            6789999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.09  E-value=0.023  Score=47.47  Aligned_cols=16  Identities=25%  Similarity=0.179  Sum_probs=14.5

Q ss_pred             CCceeecCCCCCeeec
Q 027003           19 SQVIYRDFKASNILLD   34 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~   34 (229)
                      ..++|+|+.+.|||++
T Consensus       290 ~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          290 IVLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEEECSCCCGGGEEEC
T ss_pred             eeEEecCCCCCcEEee
Confidence            3589999999999998

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=93.61  E-value=0.029  Score=45.63  Aligned_cols=31  Identities=29%  Similarity=0.275  Sum_probs=26.8

Q ss_pred             CCceeecCCCCCeeecCC----CcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            358999999999999876    7899999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.33  E-value=0.06  Score=44.01  Aligned_cols=29  Identities=28%  Similarity=0.324  Sum_probs=24.6

Q ss_pred             ceeecCCCCCeee------cCCCcEEEcccCCccc
Q 027003           21 VIYRDFKASNILL------DAEFNAKLSDFGLAKA   49 (229)
Q Consensus        21 ivHrDlkp~Nill------~~~~~~kl~Dfg~~~~   49 (229)
                      ++|+|+.+.|||+      +.+..++++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4456799999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=92.25  E-value=0.072  Score=42.05  Aligned_cols=27  Identities=4%  Similarity=0.020  Sum_probs=23.7

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcccC
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSDFG   45 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg   45 (229)
                      ...+||+|+.+.||+++.++ +.|.||.
T Consensus       206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          206 KPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            45699999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=91.75  E-value=0.09  Score=40.69  Aligned_cols=25  Identities=20%  Similarity=0.173  Sum_probs=20.6

Q ss_pred             CCCceeecCCCCCeeecCCCcEEEcc
Q 027003           18 ESQVIYRDFKASNILLDAEFNAKLSD   43 (229)
Q Consensus        18 ~~~ivHrDlkp~Nill~~~~~~kl~D   43 (229)
                      ...+||+|+.+.||+++.++. .+.|
T Consensus       187 ~p~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          187 PPARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             CCEEECSCCSGGGEEEETTEE-EECS
T ss_pred             CCeeeecCCCCCcEEEcCCCe-EEEe
Confidence            346999999999999999874 4656

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=90.92  E-value=0.089  Score=43.40  Aligned_cols=30  Identities=17%  Similarity=0.326  Sum_probs=26.2

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            35899999999999 7788899999998763

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.72  E-value=0.48  Score=35.22  Aligned_cols=42  Identities=10%  Similarity=0.147  Sum_probs=30.9

Q ss_pred             hhHHHHHHHHH-HhhcCCCCceeecCCCCCeeecCCCcEEEcccCCc
Q 027003            2 KVAIGAAKGLT-FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA   47 (229)
Q Consensus         2 ~i~~~i~~~l~-~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~   47 (229)
                      +++..|+.-.. +++    .-+|--|.|+||+++.++.+++.-.|+-
T Consensus        89 rll~nl~~L~~~~~~----~r~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A           89 RAAIHLVSKVKHHSA----RRLIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             HHHHHHHHHHSSCCS----SSEECCCCGGGEEECTTCCEEESCCEET
T ss_pred             HHHHHHHHHHHHhhh----CceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence            34455555444 333    3678889999999999999999987764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	229
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-33
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-31
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-30
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-28
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-28
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-28
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-27
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-25
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-25
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-22
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-22
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-22
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-21
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-21
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-21
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-21
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-19
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-19
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-18
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-18
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-16
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-15
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-15
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-14
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-43
 Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 19/184 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ +LH     +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164

Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+            +  D  
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQI 218

Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
              +        +                   L  +CL  +   RP   ++LA +E L  
Sbjct: 219 IFMVGRGYLSPDLSK------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

Query: 178 --PK 179
             PK
Sbjct: 273 SLPK 276

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (334), Expect = 2e-38
 Identities = 41/177 (23%), Positives = 74/177 (41%), Gaps = 22/177 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ +L   E + ++RD    N L+      K++DFGL++   + D      
Sbjct: 143 LCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  +  PE +   R TT+SDV+++GVVL E+ S                    +PY
Sbjct: 201 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-----------------QPY 243

Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
             ++ +  ++ + D  +    P+        L   C +  P  RP    +  IL+R+
Sbjct: 244 YGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 3e-36
 Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 21/175 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   AKG+ FL       ++RD  A N+L+      K+ DFGLA+   +     V  
Sbjct: 167 LCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +  G  T KSDV+S+G++L E+ S                     PY
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----------------NPY 267

Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
             +      ++++        P  A      +   C   + + RP    + + L 
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 5e-36
 Identities = 42/187 (22%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           + +  G A G+ +L       ++RD  A NIL+++    K+SDFGL++      + T+ +
Sbjct: 113 VGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           +       + APE ++  + T+ SDV+SFG+V+ E+++                      
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG----------------ERPY 214

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAP 178
           +     ++ + ++       P         L +QC   E   RP+ +++++IL++L  AP
Sbjct: 215 WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

Query: 179 KNSAKLS 185
            +   L+
Sbjct: 275 DSLKTLA 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-36
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 20/177 (11%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHV 58
           +   +  AKG+ FL     + ++RD  A N +LD +F  K++DFGLA+       D  H 
Sbjct: 133 IGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
            T       + A E + T + TTKSDV+SFGV+L EL++            + +  D   
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITV 245

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
             L  +R L            P+        + L+C + + ++RP  SE+++ +  +
Sbjct: 246 YLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 9e-36
 Identities = 37/176 (21%), Positives = 76/176 (43%), Gaps = 20/176 (11%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +   +  AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     ++ + + 
Sbjct: 114 LNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + A E +     T +SDV+S+GV + EL++                   +KPY
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG-----------------SKPY 214

Query: 121 LSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                 ++  I++       P         + ++C   +   RP+  E++    ++
Sbjct: 215 DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-35
 Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 20/194 (10%)

Query: 1   MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 54
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA    +  
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162

Query: 55  RT--HVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTK 106
            T        +GT  Y APE +             ++D+Y+ G+V  E+    C++    
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIH 221

Query: 107 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----AAHTAATLALQCLNNEPKL 161
              +    D      S +     + + KL    P +     A    A +  +C       
Sbjct: 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281

Query: 162 RPRMSEVLAILERL 175
           R     +   L +L
Sbjct: 282 RLTALRIKKTLSQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (310), Expect = 5e-35
 Identities = 37/175 (21%), Positives = 70/175 (40%), Gaps = 19/175 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   +  + +L   +   I+RD  A N L+      K++DFGL++    GD      
Sbjct: 118 LYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHA 174

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +A  + + KSDV++FGV+L E+ +   +                   
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------------- 220

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
             D  +++ +++     + P+        L   C    P  RP  +E+    E +
Sbjct: 221 --DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-35
 Identities = 47/196 (23%), Positives = 77/196 (39%), Gaps = 31/196 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A G+ ++       ++RD +A+NIL+      K++DFGLA+     +      
Sbjct: 116 VDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQ 172

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE    GR T KSDV+SFG++L EL +                    +  
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG------------------RVP 214

Query: 121 LSDK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
                 R++   ++       P +   +   L  QC   EP+ RP    + A LE     
Sbjct: 215 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--- 271

Query: 179 KNSAKLSQSEPHRQTG 194
                 + +EP  Q G
Sbjct: 272 -----FTSTEPQYQPG 282

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-34
 Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 17/175 (9%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  +   AKG+ FL       I+RD  A NILL      K+ DFGLA+         V  
Sbjct: 148 LSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +     T +SDV+S+G+ L EL S   +                 P 
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY---------------PG 250

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +    K ++++        P+ A      +   C + +P  RP   +++ ++E+ 
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 2e-34
 Identities = 42/187 (22%), Positives = 77/187 (41%), Gaps = 23/187 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +  G A G+ +L D     ++RD  A NIL+++    K+SDFGL++           T
Sbjct: 131 VGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188

Query: 61  QV---MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                     + APE +   + T+ SDV+S+G+V+ E++S                    
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----------------- 231

Query: 118 KPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
           +PY     + +   ++       P         L L C   +   RP+  +++  L+++ 
Sbjct: 232 RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291

Query: 177 APKNSAK 183
              NS K
Sbjct: 292 RNPNSLK 298

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 3e-34
 Identities = 35/176 (19%), Positives = 71/176 (40%), Gaps = 21/176 (11%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++     + + +L     Q ++RD  A N L++ +   K+SDFGL++     D    S 
Sbjct: 103 LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSV 159

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  ++ PE +   + ++KSD+++FGV++ E+ S                     PY
Sbjct: 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----------------MPY 202

Query: 121 LSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                 +    +   L    P  A+    T+   C + +   RP    +L+ +  +
Sbjct: 203 ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 4e-34
 Identities = 36/170 (21%), Positives = 61/170 (35%), Gaps = 21/170 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVS 59
                   KGL FLH     +I+RD K  NI +     + K+ D GLA       R   +
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFA 170

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
             V+GT  + APE     +     DVY+FG+ +LE+ +      + +   +         
Sbjct: 171 KAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------- 221

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                    R+        + + A      +   C+      R  + ++L
Sbjct: 222 -------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 6e-34
 Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 19/173 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + +A   A+G+ F+   E   I+RD +A+NIL+    + K++DFGLA+     +      
Sbjct: 112 LDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTARE 168

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +  G  T KSDV+SFG++L E+++                       
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------------- 214

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
                ++ + ++       P         L   C    P+ RP    + ++LE
Sbjct: 215 --TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 9e-34
 Identities = 49/192 (25%), Positives = 78/192 (40%), Gaps = 24/192 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L   + Q I+RD  A NIL+   + AK++DFGL++      +    T
Sbjct: 130 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + A E +     TT SDV+S+GV+L E++S                     PY
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----------------GGTPY 227

Query: 121 LSDKR-KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAP 178
                 +L+  +      + P         L  QC   +P  RP  +++L  L R LE  
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287

Query: 179 KNSAKLSQSEPH 190
           K     +  E  
Sbjct: 288 KTYVNTTLYEKF 299

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-33
 Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 19/175 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           + + +   +G+ +L   E+ VI+RD  A N L+      K+SDFG+ +     D+   ST
Sbjct: 104 LGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSST 160

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  +A+PE  +  R ++KSDV+SFGV++ E+ S      + +              
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------------- 206

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
                ++   + T      P+ A+     +   C    P+ RP  S +L  L  +
Sbjct: 207 --SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-33
 Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 17/175 (9%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  +   AKG+ FL     + I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 137 ICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +     T +SDV+SFGV+L E+ S   +                 P 
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---------------PG 239

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           +    +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-33
 Identities = 44/196 (22%), Positives = 82/196 (41%), Gaps = 31/196 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
            KV+I   KGLT+L + + ++++RD K SNIL+++    KL DFG++          ++ 
Sbjct: 107 GKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 161

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR----------------CAVDK 104
             +GT  Y +PE +     + +SD++S G+ L+E+  GR                C V+ 
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 105 TKVGIEQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQKAAHT----AATLALQC 154
                        +P  S          +F ++D  +    P+  +            +C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 155 LNNEPKLRPRMSEVLA 170
           L   P  R  + +++ 
Sbjct: 282 LIKNPAERADLKQLMV 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-33
 Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 28/171 (16%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
                  A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  RT +  
Sbjct: 109 ATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL-- 164

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
              GT  Y  PE +       K D++S GV+  E L G+                   P+
Sbjct: 165 --CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPF 204

Query: 121 LSDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            ++  +    RI   +    +P      A  L  + L + P  RP + EVL
Sbjct: 205 EANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 8e-33
 Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 26/174 (14%)

Query: 1   MKVAIGAAKGLTFLH---DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 57
           ++V       L   H   D    V++RD K +N+ LD + N KL DFGLA+       T 
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTS 169

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
            +   +GT  Y +PE +       KSD++S G +L EL +                    
Sbjct: 170 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------------------ 211

Query: 118 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            P+   S K    +I + K   + P + +     +  + LN +   RP + E+L
Sbjct: 212 PPFTAFSQKELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-32
 Identities = 42/170 (24%), Positives = 65/170 (38%), Gaps = 18/170 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
            +       G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  
Sbjct: 106 QRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163

Query: 61  QVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           ++ GT  Y APE +          DV+S G+VL  +L+G    D+      Q   DW + 
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 222

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
                                +K       L  + L   P  R  + ++ 
Sbjct: 223 KTYLN--------------PWKKIDSAPLALLHKILVENPSARITIPDIK 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 8e-32
 Identities = 37/177 (20%), Positives = 72/177 (40%), Gaps = 25/177 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +K ++   + + +L    +  ++RD  A N+L+  +  AK+SDFGL K     + +    
Sbjct: 106 LKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQD 158

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +   + +TKSDV+SFG++L E+ S                     PY
Sbjct: 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PY 201

Query: 121 LSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
                + +   ++       P         +   C + +  +RP   ++   LE ++
Sbjct: 202 PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 9e-32
 Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 21/175 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVS 59
           +++    + G+ +L +  S  ++RD  A N+LL  +  AK+SDFGL+KA     +     
Sbjct: 110 IELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           T       + APE +   + ++KSDV+SFGV++ E  S                    KP
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG-----------------QKP 210

Query: 120 YLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 173
           Y   K  ++  +++       P         L   C   + + RP  + V   L 
Sbjct: 211 YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-31
 Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 22/179 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-S 59
            + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  
Sbjct: 114 SRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
                   + APE + T   +  SD + FGV L E+ +                    +P
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG-----------------QEP 214

Query: 120 Y--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 176
           +  L+  + L +I         P+        + +QC  ++P+ RP    +   L   +
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-31
 Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 25/195 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 59
            ++    + G+ +L +     ++RD  A N+LL     AK+SDFGL+KA G         
Sbjct: 112 AELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
           +       + APE +   + +++SDV+S+GV + E LS                    KP
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG-----------------QKP 212

Query: 120 YLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           Y   K  ++   ++     + P +       L   C   + + RP    V    +R+ A 
Sbjct: 213 YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV---EQRMRAC 269

Query: 179 KNS-AKLSQSEPHRQ 192
             S A   +   H  
Sbjct: 270 YYSLASKVEGHHHHH 284

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-30
 Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 18/178 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +++A   A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      
Sbjct: 136 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           + +    + +PE +  G  TT SDV+SFGVVL E+ +                 +     
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQG 238

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
           LS+++ L  +M+  L    P         L   C    PK+RP   E+++ ++    P
Sbjct: 239 LSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 3e-30
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 20/178 (11%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   A+G+ +L     + I+RD  A N+L+  +   K++DFGLA+     D    +T
Sbjct: 138 VSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
                  + APE +     T +SDV+SFGV+L E+ +   +                 PY
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----------------PY 238

Query: 121 L-SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 177
                 +LF+++        P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 5e-30
 Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 30/178 (16%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             V       L +LH  ++++I+RD KA NIL   + + KL+DFG++       +     
Sbjct: 113 QVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--D 168

Query: 61  QVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 115
             +GT  + APE V            K+DV+S G+ L+E+                    
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE---------------- 212

Query: 116 WAKPY--LSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
              P+  L+  R L +I  ++      P + +        +CL      R   S++L 
Sbjct: 213 --PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-28
 Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 19/175 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
           +  A   +  L +L     + ++RD  A N+L+ +    KL DFGL++        + ++
Sbjct: 111 ILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKAS 167

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
           +      + APE +   R T+ SDV+ FGV + E+L                        
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV---------------KPFQG 212

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 175
           + +   + RI + +     P     T  +L  +C   +P  RPR +E+ A L  +
Sbjct: 213 VKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (268), Expect = 1e-28
 Identities = 44/174 (25%), Positives = 64/174 (36%), Gaps = 31/174 (17%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
             V  GA +GL +LH     +I+RD KA NILL      KL DFG A           + 
Sbjct: 118 AAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPAN 169

Query: 61  QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
             +GT  + APE +     G+   K DV+S G+  +EL   +                  
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------------------ 211

Query: 118 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            P   ++    L+ I   +         +         CL   P+ RP    +L
Sbjct: 212 PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 4e-28
 Identities = 36/180 (20%), Positives = 68/180 (37%), Gaps = 24/180 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
                     L +LH     +I+RD K  NILL+ + + +++DFG AK      +   + 
Sbjct: 111 RFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
             +GT  Y +PE +        SD+++ G ++ +L++G                    P+
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPF 210

Query: 121 LSDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 178
            +        +I+  +    +P+K    A  L  + L  +   R    E+         P
Sbjct: 211 RAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (259), Expect = 2e-27
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
            V     + L FLH   +QVI+RD K+ NILL  + + KL+DFG              + 
Sbjct: 120 AVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST 175

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 120
           ++GT  + APE V       K D++S G++ +E++ G                    PY 
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYL 217

Query: 121 -LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             +  R L+ I  +     Q P+K +        +CL+ + + R    E+L
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 3e-26
 Identities = 43/179 (24%), Positives = 68/179 (37%), Gaps = 16/179 (8%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
            +     +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T 
Sbjct: 120 DMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 174

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIEQ 111
           V+ T  Y APE +      T  D++S G +  E+   +     +           V    
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 112 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
              DW +   +  R+ F     +   ++          L L+CL   P  R      L+
Sbjct: 235 GEEDWPRDV-ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 98.3 bits (244), Expect = 3e-25
 Identities = 29/187 (15%), Positives = 53/187 (28%), Gaps = 28/187 (14%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAK-----AGP 51
             A      +  +H  E  ++YRD K  N L+    +       + DFG+ K        
Sbjct: 105 MAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162

Query: 52  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 111
                     + GT  Y +         + + D+ + G V +  L G             
Sbjct: 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL----------- 211

Query: 112 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEV 168
                     ++K+K  RI + K      +  A              N      P    +
Sbjct: 212 --PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

Query: 169 LAILERL 175
             +  ++
Sbjct: 270 QGLFSKV 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 99.0 bits (246), Expect = 3e-25
 Identities = 45/231 (19%), Positives = 75/231 (32%), Gaps = 31/231 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHV 58
           ++      KGL  +H+     ++ D K  NI+   + +   KL DFGL            
Sbjct: 127 VEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK- 183

Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
                GT  +AAPE      +   +D++S GV+   LLSG                    
Sbjct: 184 --VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------------------S 223

Query: 119 PY--LSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--IL 172
           P+   +D   L  +               +        + L  +P  R  + + L    L
Sbjct: 224 PFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283

Query: 173 ERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 223
               AP   +++  S   +    +  +     +   PL      S L  HR
Sbjct: 284 TPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 96.3 bits (239), Expect = 1e-24
 Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 33/180 (18%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
            K+     + +  LH     +++RD K  NILLD + N KL+DFG +     G++     
Sbjct: 113 RKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167

Query: 61  QVMGTHGYAAPEYVATGRL------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 114
           +V GT  Y APE +             + D++S GV++  LL+G                
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--------------- 212

Query: 115 DWAKPYLSDKRK--LFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
               P+   K+   L  IM  + + G       + T   L  + L  +P+ R    E LA
Sbjct: 213 ---PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.5 bits (237), Expect = 5e-24
 Identities = 46/235 (19%), Positives = 92/235 (39%), Gaps = 35/235 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHV 58
           +       + L FLH     + + D +  NI+     ++  K+ +FG A+    GD   +
Sbjct: 105 VSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162

Query: 59  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              +     Y APE      ++T +D++S G ++  LLSG                    
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------------------N 201

Query: 119 PYLSDKRK--LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---I 171
           P+L++  +  +  IM+ +     +  ++ +  A     + L  E K R   SE L    +
Sbjct: 202 PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

Query: 172 LERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 226
            +++E  + S K+ ++  HR+    T+ K  +    S   ++   +       S 
Sbjct: 262 KQKIE--RVSTKVIRTLKHRRYYH-TLIKKDLNMVVSAARISCGGAIRSQKGVSV 313

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 92.2 bits (228), Expect = 5e-23
 Identities = 35/183 (19%), Positives = 55/183 (30%), Gaps = 20/183 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKA-----GPT 52
           + +A      + ++H      I+RD K  N L           + DFGLAK         
Sbjct: 106 LLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163

Query: 53  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 112
                 +  + GT  YA+         + + D+ S G VL+    G       K      
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA----- 218

Query: 113 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 172
                + Y     K        L   YP + A         C +     +P  S +  + 
Sbjct: 219 -ATKRQKYERISEKKMSTPIEVLCKGYPSEFAT----YLNFCRSLRFDDKPDYSYLRQLF 273

Query: 173 ERL 175
             L
Sbjct: 274 RNL 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.1 bits (228), Expect = 8e-23
 Identities = 45/163 (27%), Positives = 64/163 (39%), Gaps = 22/163 (13%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
              A     GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD      
Sbjct: 106 TFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--N 161

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
              GT  Y APE +   +     D +SFGV+L E+L G+                   P+
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PF 203

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 163
                +            YP+     A  L ++    EP+ R 
Sbjct: 204 HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 246

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 91.7 bits (227), Expect = 1e-22
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 29/171 (16%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
             A      L +LH     +IYRD K  NILLD   + K++DFG AK  P    T     
Sbjct: 108 FYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC--- 162

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 120
             GT  Y APE V+T       D +SFG+++ E+L+G                    P+ 
Sbjct: 163 --GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------------------TPFY 202

Query: 121 -LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
             +  +   +I++ +L  ++P         L  + +  +   R    +   
Sbjct: 203 DSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT 251

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 91.0 bits (225), Expect = 1e-22
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 26/181 (14%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVS 59
           ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+    +G+    +
Sbjct: 114 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
             V+GT  Y +PE      +  +SDVYS G VL E+L+G                    P
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------------------PP 213

Query: 120 Y--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAILER 174
           +   S     ++ +  D        +  +     + L+ L   P+ R +  +E+ A L R
Sbjct: 214 FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

Query: 175 L 175
           +
Sbjct: 274 V 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 91.3 bits (226), Expect = 3e-22
 Identities = 44/171 (25%), Positives = 66/171 (38%), Gaps = 22/171 (12%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
              A     GL  +H     V+YRD K +NILLD   + ++SD GLA             
Sbjct: 110 RFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 164

Query: 61  QVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
             +GTHGY APE +  G    + +D +S G +L +LL G                 + + 
Sbjct: 165 -SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--------------FRQH 209

Query: 120 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
              DK ++ R+  T    + P   +    +L    L  +   R       A
Sbjct: 210 KTKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 3e-22
 Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 15/181 (8%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
               +   +GL +LH  +  +++RD K +N+LLD     KL+DFGLAK+  + +R +  T
Sbjct: 103 KAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--T 158

Query: 61  QVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKT----------KVGI 109
             + T  Y APE +   R+     D+++ G +L ELL     +             +   
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218

Query: 110 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
             +   W           F+             A      L        P  R   ++ L
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

Query: 170 A 170
            
Sbjct: 279 K 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 90.5 bits (224), Expect = 5e-22
 Identities = 42/226 (18%), Positives = 74/226 (32%), Gaps = 39/226 (17%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVS 59
                A +GL  +H  E  +++ D K  NI+ + +  +  K+ DFGLA      +     
Sbjct: 131 NYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-- 186

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 119
                T  +AAPE V    +   +D+++ GV+   LLSG                    P
Sbjct: 187 -VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------------------SP 227

Query: 120 Y--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA----- 170
           +    D   L  +   D +         +  A       L  EP+ R  + + L      
Sbjct: 228 FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

Query: 171 -----ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 211
                +  R+ + + +    + +      P            S L 
Sbjct: 288 GDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 333

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-21
 Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 14/181 (7%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
                   +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+ + 
Sbjct: 105 KSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-TH 161

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC----------AVDKTKVGIE 110
           +V+     A    +     +T  D++S G +  E+++ R                +    
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221

Query: 111 QSLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
              V W     + D +  F     +   +          +L  Q L+ +P  R      L
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

Query: 170 A 170
           A
Sbjct: 282 A 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.9 bits (217), Expect = 2e-21
 Identities = 39/176 (22%), Positives = 65/176 (36%), Gaps = 27/176 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRT 56
            +       G+ +LH    Q+ + D K  NI+L          K+ DFGLA     G+  
Sbjct: 116 TEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173

Query: 57  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 116
                + GT  + APE V    L  ++D++S GV+   LLSG                  
Sbjct: 174 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----------- 219

Query: 117 AKPYLSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
                + +  L  +   + +   +Y    +  A     + L  +PK R  + + L 
Sbjct: 220 -----TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 87.6 bits (216), Expect = 2e-21
 Identities = 33/181 (18%), Positives = 71/181 (39%), Gaps = 14/181 (7%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
               +    G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +   
Sbjct: 103 KSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-H 159

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIE 110
           +++     A    + + + +T  D++S G +  E+++G                 ++   
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

Query: 111 QSLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 169
            +  +W     L      F + +      + +    +   L  + L  +P  R    + L
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

Query: 170 A 170
            
Sbjct: 280 E 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.1 bits (215), Expect = 3e-21
 Identities = 41/188 (21%), Positives = 73/188 (38%), Gaps = 34/188 (18%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVS 59
                   + +   H     V++RD K  NIL+D      KL DFG         +  V 
Sbjct: 113 RSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVY 166

Query: 60  TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
           T   GT  Y+ PE++   R   +S  V+S G++L +++ G                    
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------------I 208

Query: 119 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLE 176
           P+  D+     I+  ++   + Q+ +     L   CL   P  RP   E+     ++ + 
Sbjct: 209 PFEHDE----EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

Query: 177 APKNSAKL 184
            P+ +A++
Sbjct: 263 LPQETAEI 270

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 5e-21
 Identities = 51/184 (27%), Positives = 76/184 (41%), Gaps = 17/184 (9%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVST 60
                  +GL ++H   + V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T
Sbjct: 113 YFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170

Query: 61  QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVGIEQSLVDWA 117
           + + T  Y APE +   +  TKS D++S G +L E+LS R           +   L    
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230

Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNNEPKLRPRMS 166
            P   D   +  +         P K           A   A  L  + L   P  R  + 
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

Query: 167 EVLA 170
           + LA
Sbjct: 291 QALA 294

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 4e-20
 Identities = 36/192 (18%), Positives = 69/192 (35%), Gaps = 21/192 (10%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTH 57
            ++     + + +LH     + +RD K  N+L  ++      KL+DFG AK   + +   
Sbjct: 114 SEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
                  T  Y APE +   +     D++S GV++  LL G                +  
Sbjct: 172 ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS----------NHG 218

Query: 118 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILER 174
                  +   R+   +       + +     L    L  EP  R  ++E +    I++ 
Sbjct: 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278

Query: 175 LEAPKNSAKLSQ 186
            + P+     S+
Sbjct: 279 TKVPQTPLHTSR 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.1 bits (204), Expect = 1e-19
 Identities = 40/182 (21%), Positives = 60/182 (32%), Gaps = 15/182 (8%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
                   KGL F H     V++RD K  N+L++     KL++FGLA+A     R + S 
Sbjct: 104 KSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SA 160

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--------- 111
           +V+                +T  D++S G +  EL +    +       +Q         
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

Query: 112 --SLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             +   W     L D +       T        K   T   L    L   P  R    E 
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

Query: 169 LA 170
           L 
Sbjct: 281 LQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 1e-19
 Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 19/186 (10%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-- 59
           +V      GL ++H   +++++RD KA+N+L+  +   KL+DFGLA+A      +  +  
Sbjct: 121 RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 60  TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR-------------CAVDKT 105
           T  + T  Y  PE +   R      D++  G ++ E+ +                     
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 106 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT-LALQCLNNEPKLRPR 164
                +   +     L +K +L +    K+  +         A  L  + L  +P  R  
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 165 MSEVLA 170
             + L 
Sbjct: 299 SDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (205), Expect = 2e-19
 Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 26/172 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
                     L +LH     V+YRD K  N++LD + + K++DFGL K G +   T    
Sbjct: 108 RFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--K 163

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
              GT  Y APE +         D +  GVV+ E++ GR                   P+
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------------------LPF 205

Query: 121 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
                +R    I+  ++  ++P+  +  A +L    L  +PK R       A
Sbjct: 206 YNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 7e-18
 Identities = 41/182 (22%), Positives = 65/182 (35%), Gaps = 16/182 (8%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVS 59
                   + L ++H     + +RD K  N+LLD +    KL DFG AK    G+     
Sbjct: 125 KLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-- 180

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-----CAVDKTKVGIEQSLV 114
           + +   +  A          T+  DV+S G VL ELL G+      +     V I + L 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 115 DWAKPYLSD------KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
              +  + +      + K  +I        +  +    A  L  + L   P  R    E 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

Query: 169 LA 170
            A
Sbjct: 301 CA 302

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 78.2 bits (192), Expect = 9e-18
 Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 30/177 (16%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTH 57
            ++       + +LH  +  +++RD K  N+L    D +    +SDFGL+K     D   
Sbjct: 110 SRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGS 164

Query: 58  VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 117
           V +   GT GY APE +A    +   D +S GV+   LL G                   
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------------------ 206

Query: 118 KPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
            P+   +D +   +I+  + +    Y    + +A       +  +P+ R    + L 
Sbjct: 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 74.8 bits (183), Expect = 2e-16
 Identities = 33/163 (20%), Positives = 57/163 (34%), Gaps = 25/163 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
              A        +LH     +IYRD K  N+L+D +   +++DFG AK       T    
Sbjct: 144 RFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 197

Query: 61  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 120
            + GT    APE + +       D ++ GV++ E+ +G                    P+
Sbjct: 198 -LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP------------------PF 238

Query: 121 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 163
            +D+             ++P   +     L    L  +   R 
Sbjct: 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.7 bits (180), Expect = 4e-16
 Identities = 35/182 (19%), Positives = 70/182 (38%), Gaps = 19/182 (10%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
            +     KGL ++H   + +I+RD K  N+ ++ +   K+ DFGLA+       + ++  
Sbjct: 125 FLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGY 178

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-------------CAVDKTKVG 108
           V+     A    +   R T   D++S G ++ E+++G+               +  T   
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 109 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 168
             + +         +  K    ++ K        A+  A  L  + L  + + R    E 
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

Query: 169 LA 170
           LA
Sbjct: 299 LA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 71.0 bits (173), Expect = 4e-15
 Identities = 31/191 (16%), Positives = 66/191 (34%), Gaps = 27/191 (14%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVST 60
                  K L + H     +++RD K  N+++D E    +L D+GLA+    G       
Sbjct: 133 FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---N 187

Query: 61  QVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------- 111
             + +  +  PE +   ++     D++S G +L  ++  +          +Q        
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247

Query: 112 ---SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---------AATLALQCLNNEP 159
               L D+   Y  +    F  +  +   +  ++  H+         A     + L  + 
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307

Query: 160 KLRPRMSEVLA 170
           + R    E + 
Sbjct: 308 QSRLTAREAME 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.9 bits (170), Expect = 7e-15
 Identities = 50/176 (28%), Positives = 68/176 (38%), Gaps = 27/176 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 60
                     L  LH     +IYRD K  NILLD+  +  L+DFGL+K     D T  + 
Sbjct: 132 QIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAY 188

Query: 61  QVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 118
              GT  Y AP+ V  G        D +S GV++ ELL+G                    
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------------------S 230

Query: 119 PY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 170
           P+    +K     I    L  +  YPQ+ +  A  L  + L  +PK R       A
Sbjct: 231 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 68.5 bits (166), Expect = 3e-14
 Identities = 29/201 (14%), Positives = 65/201 (32%), Gaps = 32/201 (15%)

Query: 1   MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVS 59
            +++     GL ++H     +I+ D K  N+L++       L    +A  G         
Sbjct: 128 KQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 60  TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD---- 115
           T  + T  Y +PE +        +D++S   ++ EL++G    +  +        D    
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 116 -----------------WAKPYLSDKRKLFRIMDTKL---------GGQYPQKAAHTAAT 149
                            + + + + +  L  I   K            ++ +  A   + 
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 150 LALQCLNNEPKLRPRMSEVLA 170
                L  +P+ R     ++ 
Sbjct: 307 FLSPMLQLDPRKRADAGGLVN 327

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 2e-13
 Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 29/193 (15%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 61
            +      G+  LH   + +I+RD K SNI++ ++   K+ DFGLA+   T       T 
Sbjct: 123 YLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177

Query: 62  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC----------------AVDKT 105
            + T  Y APE +         D++S G ++ E++  +                  +   
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 106 KVGIEQSLVDWAKPYLSDK--------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 157
                + L    + Y+ ++         KLF         ++ +  A  A  L  + L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 158 EPKLRPRMSEVLA 170
           +P  R  + + L 
Sbjct: 298 DPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 7e-13
 Identities = 36/176 (20%), Positives = 64/176 (36%), Gaps = 19/176 (10%)

Query: 8   AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 67
            +GL ++H   + +I+RD K SN+ ++ +   K+ DFGLA+         ++  V     
Sbjct: 131 LRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWY 184

Query: 68  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC-----AVDKTKVGIEQSLVDWAKPYLS 122
            A    +         D++S G ++ ELL+GR              I + +       L 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 123 DKRKLFRIMDTKLGGQYPQK--------AAHTAATLALQCLNNEPKLRPRMSEVLA 170
                      +   Q P+         A   A  L  + L  +   R   ++ LA
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 40.1 bits (93), Expect = 6e-05
 Identities = 7/47 (14%), Positives = 18/47 (38%), Gaps = 3/47 (6%)

Query: 2   KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 48
           +V     + +   +     +++ D    N+L+  E    + DF  + 
Sbjct: 107 EVLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	229
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.98
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.98
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.54
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.41
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	95.78
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	95.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.64
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	90.23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=272.68  Aligned_cols=158  Identities=28%  Similarity=0.483  Sum_probs=119.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC---C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~   78 (229)
                      +|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++...............||+.|+|||++.+.   .
T Consensus       108 ~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~  185 (276)
T d1uwha_         108 DIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP  185 (276)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCC
Confidence            579999999999996  46999999999999999999999999999876544333334567899999999999653   4


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC----CCCcHHHHHHHHHHHHHh
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG----GQYPQKAAHTAATLALQC  154 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~  154 (229)
                      ++.++|||||||++|||+||+.||.+.+...                .....+.....    ...+..++..+.+|+.+|
T Consensus       186 ~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----------------~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~c  249 (276)
T d1uwha_         186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRD----------------QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAEC  249 (276)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------------HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHH
T ss_pred             CCchhhhhhhHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcCCCCCcchhccccchHHHHHHHHHH
Confidence            7889999999999999999999997653211                11111111111    122344567899999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhcC
Q 027003          155 LNNEPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       155 l~~dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      |+.||++|||+.++++.|+.+..
T Consensus       250 l~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         250 LKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999988764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=277.88  Aligned_cols=154  Identities=26%  Similarity=0.389  Sum_probs=130.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.
T Consensus       168 ~i~~qi~~gl~yLH~~--~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  245 (325)
T d1rjba_         168 CFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI  245 (325)
T ss_dssp             HHHHHHHHHHHHHHHT--TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc
Confidence            4789999999999964  59999999999999999999999999998765544444445567899999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |+.||.+...                ...+.+++........+..++..+.+||.+||+.||+
T Consensus       246 ~~DiwS~Gvil~emlt~g~~Pf~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~  309 (325)
T d1rjba_         246 KSDVWSYGILLWEIFSLGVNPYPGIPV----------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR  309 (325)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCC----------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             ceeccchhHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence            9999999999999998 8999976542                2233444555555566677788999999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 027003          161 LRPRMSEVLAILE  173 (229)
Q Consensus       161 ~Rpt~~~v~~~l~  173 (229)
                      +|||+.||++.|.
T Consensus       310 ~RPt~~ei~~~L~  322 (325)
T d1rjba_         310 KRPSFPNLTSFLG  322 (325)
T ss_dssp             GSCCHHHHHHHHH
T ss_pred             HCcCHHHHHHHHh
Confidence            9999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=273.02  Aligned_cols=157  Identities=29%  Similarity=0.385  Sum_probs=122.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +||||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.
T Consensus       138 ~~~~qi~~gl~ylH~~--~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~  215 (299)
T d1ywna1         138 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI  215 (299)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc
Confidence            5789999999999964  59999999999999999999999999998655444333344567999999999999999999


Q ss_pred             cCceeehhHHHHHHHhC-CCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+|| ..||.+...                ...+...+........+..++..+.+|+.+||+.||+
T Consensus       216 ~sDiwS~Gvil~ellt~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  279 (299)
T d1ywna1         216 QSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  279 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCC----------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             ccceeehHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence            99999999999999986 567765432                1122233334444555666778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.|+++.|+++.
T Consensus       280 ~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         280 QRPTFSELVEHLGNLL  295 (299)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999998763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=265.55  Aligned_cols=152  Identities=26%  Similarity=0.364  Sum_probs=119.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~   80 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..+ +
T Consensus       107 ~i~~qi~~al~ylH~~--~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~  184 (271)
T d1nvra_         107 RFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA  184 (271)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCH
T ss_pred             HHHHHHHHHHHHHHHc--CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCC
Confidence            5789999999999964  599999999999999999999999999987644433333456789999999999988876 5


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||++|+.||.........               .................+..+.+|+.+||+.||+
T Consensus       185 ~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  249 (271)
T d1nvra_         185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS  249 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             CceeeeHhHHHHHHHHhCCCCCCCCChHHHH---------------HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChh
Confidence            7899999999999999999999765422111               1111111122222345577889999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.|+++
T Consensus       250 ~R~t~~eil~  259 (271)
T d1nvra_         250 ARITIPDIKK  259 (271)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhc
Confidence            9999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-41  Score=268.11  Aligned_cols=157  Identities=24%  Similarity=0.419  Sum_probs=117.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc---eeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---VSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      +++.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++.........   ......||+.|+|||++.++.
T Consensus       132 ~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  209 (299)
T d1jpaa_         132 GMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK  209 (299)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC
T ss_pred             HHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC
Confidence            588999999999996  459999999999999999999999999998654332211   122245789999999999999


Q ss_pred             CcccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccC
Q 027003           79 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        79 ~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      ++.++|||||||++|||+| |+.||.+...                 ..+...+........+..++..+.+|+.+||+.
T Consensus       210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~  272 (299)
T d1jpaa_         210 FTSASDVWSYGIVMWEVMSYGERPYWDMTN-----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK  272 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCcccccccchHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCC
Confidence            9999999999999999998 8999976431                 112222333444455666788899999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcC
Q 027003          158 EPKLRPRMSEVLAILERLEA  177 (229)
Q Consensus       158 dP~~Rpt~~~v~~~l~~~~~  177 (229)
                      ||++|||+.+|++.|+++..
T Consensus       273 ~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         273 DRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHHHHhc
Confidence            99999999999999988654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-41  Score=261.82  Aligned_cols=145  Identities=29%  Similarity=0.452  Sum_probs=119.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++......    .....||+.|+|||++.+..++.
T Consensus       110 ~i~~qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~  183 (263)
T d2j4za1         110 TYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDE  183 (263)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHC--CeeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCc
Confidence            5789999999999964  59999999999999999999999999998654322    33467999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                .....+...  ....+...+..+.+|+.+||+.||++
T Consensus       184 ~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~  245 (263)
T d2j4za1         184 KVDLWSLGVLCYEFLVGKPPFEANTYQ----------------ETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQ  245 (263)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhhhhhHhHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhH
Confidence            999999999999999999999764321                111112211  22345556788999999999999999


Q ss_pred             CCCHHHHHH
Q 027003          162 RPRMSEVLA  170 (229)
Q Consensus       162 Rpt~~~v~~  170 (229)
                      |||+.|+++
T Consensus       246 R~t~~eil~  254 (263)
T d2j4za1         246 RPMLREVLE  254 (263)
T ss_dssp             SCCHHHHHT
T ss_pred             CcCHHHHHc
Confidence            999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-41  Score=265.24  Aligned_cols=158  Identities=24%  Similarity=0.425  Sum_probs=119.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||+|||++  +|+||||||+||||+.++.+||+|||+++........ .......||..|+|||++.++.++
T Consensus       114 ~i~~~i~~gl~~lH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~  191 (283)
T d1mqba_         114 GMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT  191 (283)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHHhhhhcccc--ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC
Confidence            6899999999999964  5999999999999999999999999999875443222 122345689999999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||++|..||....                ....+.+.+........+..++..+.+|+.+||+.||+
T Consensus       192 ~~sDI~S~Gvil~el~t~~~~~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~  255 (283)
T d1mqba_         192 SASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA  255 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTC----------------CHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTT
T ss_pred             CcccccccHHHHHHHHhCCCCccccC----------------CHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHh
Confidence            99999999999999999665553321                11223333444455566667788899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.+|++.|+++..
T Consensus       256 ~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         256 RRPKFADIVSILDKLIR  272 (283)
T ss_dssp             TSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHhh
Confidence            99999999999988654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-41  Score=265.90  Aligned_cols=157  Identities=22%  Similarity=0.359  Sum_probs=127.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++....... .......|+..|+|||++.++.++.
T Consensus       119 ~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~  195 (287)
T d1opja_         119 YMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSI  195 (287)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSH
T ss_pred             HHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCc
Confidence            578999999999996  4699999999999999999999999999987544322 2233456899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|..||....                ....+.+.+........+..++..+.+|+.+||+.||++
T Consensus       196 k~DiwS~Gv~l~ell~~~~p~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  259 (287)
T d1opja_         196 KSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD  259 (287)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhhhhHHHHHHHHHhCCCCCCCcc----------------hHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhH
Confidence            9999999999999999766654322                122233444455555666777889999999999999999


Q ss_pred             CCCHHHHHHHHHhhcC
Q 027003          162 RPRMSEVLAILERLEA  177 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~~  177 (229)
                      |||+.++++.|+.+..
T Consensus       260 Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         260 RPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             SCCHHHHHHHHHHTTS
T ss_pred             CcCHHHHHHHHHHHHH
Confidence            9999999999987643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-41  Score=263.46  Aligned_cols=149  Identities=29%  Similarity=0.420  Sum_probs=121.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       120 ~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~  195 (293)
T d1yhwa1         120 AVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP  195 (293)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred             HHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCc
Confidence            578999999999996  4699999999999999999999999999987543322  234567999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhc-ccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|+|++|+.||.+.+..                ..+..+... ......+..++..+.+||.+||+.||+
T Consensus       196 ~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  259 (293)
T d1yhwa1         196 KVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE  259 (293)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTT
T ss_pred             hhceehHhHHHHHHhhCCCCCCCCCHH----------------HHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChh
Confidence            999999999999999999999764321                111122211 122344566788899999999999999


Q ss_pred             CCCCHHHHHH
Q 027003          161 LRPRMSEVLA  170 (229)
Q Consensus       161 ~Rpt~~~v~~  170 (229)
                      +|||+.|+++
T Consensus       260 ~R~s~~eil~  269 (293)
T d1yhwa1         260 KRGSAKELLQ  269 (293)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhc
Confidence            9999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=264.96  Aligned_cols=150  Identities=26%  Similarity=0.331  Sum_probs=110.5

Q ss_pred             hhHHHHHHHHHHhhcCC---CCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~---~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||.|||+.+   .+||||||||+|||++.++.+||+|||+++.......  .....+||+.|+|||++.+..
T Consensus       113 ~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~  190 (269)
T d2java1         113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMS  190 (269)
T ss_dssp             HHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCC
Confidence            57899999999999743   3599999999999999999999999999987543322  234568999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|||+||+.||.+.+..                .....+... .....+..++..+.+|+.+||+.|
T Consensus       191 ~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----------------~~~~~i~~~-~~~~~~~~~s~~l~~li~~~L~~d  253 (269)
T d2java1         191 YNEKSDIWSLGCLLYELCALMPPFTAFSQK----------------ELAGKIREG-KFRRIPYRYSDELNEIITRMLNLK  253 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             CChHHHHHhhCHHHHHHhhCCCCCCCCCHH----------------HHHHHHHcC-CCCCCCcccCHHHHHHHHHHcCCC
Confidence            999999999999999999999999764321                111122222 222345566788999999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+|||+.|+++
T Consensus       254 p~~Rps~~ell~  265 (269)
T d2java1         254 DYHRPSVEEILE  265 (269)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhHCcCHHHHHh
Confidence            999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-41  Score=262.41  Aligned_cols=155  Identities=26%  Similarity=0.415  Sum_probs=114.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.
T Consensus       105 ~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~  181 (263)
T d1sm2a_         105 GMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSS  181 (263)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCc
Confidence            589999999999996  45999999999999999999999999999875443322 233457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhC-CCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+|+ ..||.....                 ..+...+........+..++..+.+|+.+||+.||+
T Consensus       182 k~DVwS~Gvil~el~t~~~~~~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~  244 (263)
T d1sm2a_         182 KSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE  244 (263)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTCSCCH-----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             hhhhcchHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHh
Confidence            99999999999999995 555544321                 112222333334445556678899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||++++++.|+++.
T Consensus       245 ~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         245 DRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-41  Score=262.31  Aligned_cols=154  Identities=25%  Similarity=0.432  Sum_probs=123.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+++....... .......||+.|+|||++.++.++.
T Consensus       113 ~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~  189 (272)
T d1qpca_         113 DMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTI  189 (272)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCc
Confidence            689999999999996  4599999999999999999999999999987644322 2233457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcC-CCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+||..|+ ....                 .......+........+..++..+.+|+.+||+.||+
T Consensus       190 ~sDvwS~Gvvl~ellt~~~~~~~~~~-----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~  252 (272)
T d1qpca_         190 KSDVWSFGILLTEIVTHGRIPYPGMT-----------------NPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE  252 (272)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCC-----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhhhhhHHHHHHHHhCCCCCCCCCC-----------------HHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHh
Confidence            999999999999999965554 4322                 1112222333444455666778899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +|||+.+|++.|+.+
T Consensus       253 ~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         253 DRPTFDYLRSVLEDF  267 (272)
T ss_dssp             GSCCHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHhhhh
Confidence            999999999988764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-41  Score=262.26  Aligned_cols=155  Identities=26%  Similarity=0.377  Sum_probs=125.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +|+.||+.||+|||++  +||||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++
T Consensus       111 ~i~~qi~~gl~ylH~~--~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  188 (277)
T d1xbba_         111 ELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS  188 (277)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHhhHHhC--CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCC
Confidence            6899999999999964  5999999999999999999999999999876443322 223345789999999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||+| |+.||.+.+.                 ..+...+........+..++..+.+|+.+||+.||
T Consensus       189 ~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp  251 (277)
T d1xbba_         189 SKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV  251 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred             chhhhccchhhhhHHhhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCH
Confidence            99999999999999998 8999986431                 12223333344455666778899999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 027003          160 KLRPRMSEVLAILERL  175 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~  175 (229)
                      ++|||+.+|++.|+..
T Consensus       252 ~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         252 ENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TTSCCHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHhhCH
Confidence            9999999998877653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=268.41  Aligned_cols=156  Identities=23%  Similarity=0.376  Sum_probs=126.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++...............||..|+|||++.++.++.
T Consensus       115 ~i~~qi~~gl~yLH~~--~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~  192 (317)
T d1xkka_         115 NWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH  192 (317)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHc--CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCCh
Confidence            5789999999999964  59999999999999999999999999998765544433344457899999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |..||.+.+.                 ..+...+........+..++..+.+|+.+||+.||.
T Consensus       193 ~sDvwS~Gvil~el~t~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~  255 (317)
T d1xkka_         193 QSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDAD  255 (317)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTSCG-----------------GGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred             hhhhhhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChh
Confidence            9999999999999998 8999876542                 122333344444556667788899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.++++.|.++.
T Consensus       256 ~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         256 SRPKFRELIIEFSKMA  271 (317)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999988764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=259.40  Aligned_cols=148  Identities=24%  Similarity=0.435  Sum_probs=114.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec-CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.||+.||+|||+++.+||||||||+|||++ .++.+||+|||+++.....    .....+||+.|+|||++.+ .++
T Consensus       116 ~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~  190 (270)
T d1t4ha_         116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYD  190 (270)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCC
T ss_pred             HHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCC
Confidence            578999999999997655599999999999996 5789999999999864322    1345689999999999865 699


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||++|+.||.+....                ..+.+.+... .....+...+..+.+|+.+||+.||
T Consensus       191 ~~~DIwSlGvilyel~~g~~Pf~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp  254 (270)
T d1t4ha_         191 ESVDVYAFGMCMLEMATSEYPYSECQNA----------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK  254 (270)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSH----------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSG
T ss_pred             CcCchhhHHHHHHHHHHCCCCCCCcccH----------------HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCH
Confidence            9999999999999999999999754311                1111111111 1112223345678999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      ++|||+.|+++
T Consensus       255 ~~R~s~~ell~  265 (270)
T d1t4ha_         255 DERYSIKDLLN  265 (270)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hHCcCHHHHhC
Confidence            99999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=261.84  Aligned_cols=156  Identities=25%  Similarity=0.352  Sum_probs=127.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.++.++
T Consensus       113 ~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  190 (285)
T d1u59a_         113 ELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS  190 (285)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCC
Confidence            589999999999996  46999999999999999999999999999876543322 223345689999999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||+| |+.||.+....                 .+...+........+..++..+.+|+.+||+.||
T Consensus       191 ~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p  253 (285)
T d1u59a_         191 SRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPPELYALMSDCWIYKW  253 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred             ccchhhcchHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCH
Confidence            99999999999999998 99999764321                 1222233334445666778899999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      ++|||+.+|++.|+...
T Consensus       254 ~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         254 EDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             GGSCCHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHHHH
Confidence            99999999999887643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=262.78  Aligned_cols=150  Identities=23%  Similarity=0.359  Sum_probs=117.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||+.  +||||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.
T Consensus       112 ~~~~qi~~al~ylH~~--~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~  189 (288)
T d1uu3a_         112 FYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCH
T ss_pred             HHHHHHHHHHHhhccc--cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCc
Confidence            4789999999999964  59999999999999999999999999998765443333344568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                ....++....  ...+...+..+.+||.+||+.||.+
T Consensus       190 ~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~  251 (288)
T d1uu3a_         190 SSDLWALGCIIYQLVAGLPPFRAGNEY----------------LIFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATK  251 (288)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGG
T ss_pred             ccceehhhHHHHHHhhCCCCCCCcCHH----------------HHHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhH
Confidence            999999999999999999999865311                1112222222  2344556788999999999999999


Q ss_pred             CCCHHHHHHH
Q 027003          162 RPRMSEVLAI  171 (229)
Q Consensus       162 Rpt~~~v~~~  171 (229)
                      |||+.|++..
T Consensus       252 R~t~~e~~~~  261 (288)
T d1uu3a_         252 RLGCEEMEGY  261 (288)
T ss_dssp             STTSGGGTCH
T ss_pred             CcCHHHHcCC
Confidence            9999997643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=264.21  Aligned_cols=156  Identities=24%  Similarity=0.335  Sum_probs=124.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +|+.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++...........+...||+.|+|||++.+..++.
T Consensus       144 ~i~~qi~~gl~ylH~--~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~  221 (301)
T d1lufa_         144 CIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT  221 (301)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHhhhccc--CCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh
Confidence            579999999999996  459999999999999999999999999998654443333345567899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCC-CcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++|. .||.+.+.                .+ ....+........+..++..+.+|+.+||+.||+
T Consensus       222 ksDVwS~Gvvl~ell~~~~~p~~~~~~----------------~e-~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~  284 (301)
T d1lufa_         222 ESDVWAYGVVLWEIFSYGLQPYYGMAH----------------EE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPA  284 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hhhhccchhhHHHHHccCCCCCCCCCH----------------HH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChh
Confidence            999999999999999985 56765431                11 1122222333445566778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.||++.|+++.
T Consensus       285 ~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         285 DRPSFCSIHRILQRMC  300 (301)
T ss_dssp             GSCCHHHHHHHHHHTT
T ss_pred             HCcCHHHHHHHHHHhc
Confidence            9999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-40  Score=254.78  Aligned_cols=153  Identities=22%  Similarity=0.369  Sum_probs=125.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|+++||+|||+  ++|+||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.
T Consensus       104 ~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~  180 (258)
T d1k2pa_         104 EMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSS  180 (258)
T ss_dssp             HHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCc
Confidence            688999999999995  46999999999999999999999999999865443322 233467899999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |+.||.+....                 .+...+........+...+..+.+|+.+||+.||+
T Consensus       181 ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~  243 (258)
T d1k2pa_         181 KSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD  243 (258)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred             ceeecccchhhHhHHhcCCCCCCCCCHH-----------------HHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHh
Confidence            9999999999999998 89999775421                 12222233344455666778899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 027003          161 LRPRMSEVLAILER  174 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~  174 (229)
                      +|||+.++++.|..
T Consensus       244 ~RPt~~eil~~L~d  257 (258)
T d1k2pa_         244 ERPTFKILLSNILD  257 (258)
T ss_dssp             GSCCHHHHHHHHHC
T ss_pred             HCcCHHHHHHHhhC
Confidence            99999999998854

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=258.03  Aligned_cols=156  Identities=26%  Similarity=0.397  Sum_probs=126.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc-eeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      +++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++......... ......|+..|+|||++.+..++
T Consensus       115 ~~~~qi~~gl~ylH~~--~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  192 (273)
T d1u46a_         115 RYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS  192 (273)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHhhhC--CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCC
Confidence            6799999999999964  59999999999999999999999999999765443322 22345678899999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||+| |+.||.+.+.                ......+.......+.+..++..+.+|+.+||+.||
T Consensus       193 ~~~Di~S~Gvil~emlt~G~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp  256 (273)
T d1u46a_         193 HASDTWMFGVTLWEMFTYGQEPWIGLNG----------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP  256 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             cchhhhhhHHHHHHHHhCCCCCCCCcCH----------------HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCCh
Confidence            99999999999999998 8999976542                222333444444455566677889999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 027003          160 KLRPRMSEVLAILERL  175 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~  175 (229)
                      ++|||+.+|++.|++.
T Consensus       257 ~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         257 EDRPTFVALRDFLLEA  272 (273)
T ss_dssp             GGSCCHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHhc
Confidence            9999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-40  Score=260.51  Aligned_cols=145  Identities=30%  Similarity=0.428  Sum_probs=117.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc---CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~   78 (229)
                      .++.||+.||.|||++  +||||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.+   +.
T Consensus       119 ~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~  190 (309)
T d1u5ra_         119 AVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQ  190 (309)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCC
T ss_pred             HHHHHHHHHHHHHHhC--CEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCC
Confidence            5789999999999964  599999999999999999999999999986433      234579999999999864   35


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCC
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      ++.++|||||||++|||++|..||.+...                ...+.++.........+..++..+.+|+.+||+.|
T Consensus       191 y~~~~DiwSlGvilyel~~g~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d  254 (309)
T d1u5ra_         191 YDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI  254 (309)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSS
T ss_pred             cCchhhhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCC
Confidence            88999999999999999999999976431                11222333333323333456778999999999999


Q ss_pred             CCCCCCHHHHHH
Q 027003          159 PKLRPRMSEVLA  170 (229)
Q Consensus       159 P~~Rpt~~~v~~  170 (229)
                      |.+|||+.|+++
T Consensus       255 P~~Rpt~~ell~  266 (309)
T d1u5ra_         255 PQDRPTSEVLLK  266 (309)
T ss_dssp             GGGSCCHHHHTT
T ss_pred             hhHCcCHHHHHh
Confidence            999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-40  Score=259.73  Aligned_cols=157  Identities=27%  Similarity=0.427  Sum_probs=131.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.++.
T Consensus       139 ~~~~qi~~al~ylH~~--~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~  216 (299)
T d1fgka_         139 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  216 (299)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHhhhC--CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCc
Confidence            6899999999999964  59999999999999999999999999998765544444445567899999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++ |..||.+...                 ..+...+........+..++..+.+|+.+||+.||.
T Consensus       217 k~DiwS~Gvvl~ell~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~  279 (299)
T d1fgka_         217 QSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS  279 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGG
T ss_pred             hhhhHHhHHHHHHhccCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHh
Confidence            9999999999999998 7888876432                 122333444455566666778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.||++.|+++.+
T Consensus       280 ~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         280 QRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHhh
Confidence            99999999999988753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-40  Score=257.30  Aligned_cols=155  Identities=26%  Similarity=0.373  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||++  +||||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.
T Consensus       112 ~~~~qi~~gl~ylH~~--~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~  188 (273)
T d1mp8a_         112 LYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTS  188 (273)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSH
T ss_pred             HHHHHHHHHhhhhccc--CeeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCC
Confidence            5789999999999964  5999999999999999999999999999875433222 234456899999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |..||.+.+..                 .+...+........+..++..+.+||.+||+.||+
T Consensus       189 ~~DiwSlGvil~e~lt~g~~P~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~  251 (273)
T d1mp8a_         189 ASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS  251 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             ccccccchHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHh
Confidence            9999999999999998 89999775421                 11122223333455667788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhc
Q 027003          161 LRPRMSEVLAILERLE  176 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~  176 (229)
                      +|||+.+|++.|+++.
T Consensus       252 ~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         252 RRPRFTELKAQLSTIL  267 (273)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999998763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-40  Score=263.26  Aligned_cols=168  Identities=24%  Similarity=0.407  Sum_probs=118.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||.|||+. ++|+||||||+|||++.+|.+||+|||+|+.....    .....+||+.|+|||++.+..++.
T Consensus       108 ~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~  182 (322)
T d1s9ja_         108 KVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV  182 (322)
T ss_dssp             HHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCT
T ss_pred             HHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCc
Confidence            4789999999999963 35999999999999999999999999999864321    123568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhh--------------------------hhhhcchhhHHHHhhccc
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA--------------------------KPYLSDKRKLFRIMDTKL  135 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~  135 (229)
                      ++|||||||++|||++|+.||.+.+...........                          .+..........+.....
T Consensus       183 ~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (322)
T d1s9ja_         183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP  262 (322)
T ss_dssp             THHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCC
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCC
Confidence            999999999999999999999875532211100000                          000000000111111111


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHh
Q 027003          136 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILER  174 (229)
Q Consensus       136 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~--~l~~  174 (229)
                      ........+..+.+|+.+||+.||.+|||+.|+++  .+++
T Consensus       263 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            11111224567899999999999999999999987  3544

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=257.04  Aligned_cols=149  Identities=27%  Similarity=0.392  Sum_probs=117.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccc-----c
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----T   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~   76 (229)
                      .++.||+.||.|||++  +||||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.     +
T Consensus       114 ~i~~qi~~gL~ylH~~--~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~  189 (288)
T d2jfla1         114 VVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKD  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred             HHHHHHHHHHHHHHHC--CEEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCC
Confidence            5789999999999964  5999999999999999999999999998753221  11123467999999999984     4


Q ss_pred             CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcc-cCCCCcHHHHHHHHHHHHHhc
Q 027003           77 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCL  155 (229)
Q Consensus        77 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l  155 (229)
                      ..++.++|||||||++|||+||+.||.+.+..                ..+.++.... .....+...+..+.+||.+||
T Consensus       190 ~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L  253 (288)
T d2jfla1         190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPM----------------RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCL  253 (288)
T ss_dssp             SSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----------------GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHS
T ss_pred             CCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----------------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence            46789999999999999999999999775421                1122222221 122334566788999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.||.+|||+.|+++
T Consensus       254 ~~dp~~R~t~~ell~  268 (288)
T d2jfla1         254 EKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-39  Score=254.56  Aligned_cols=156  Identities=28%  Similarity=0.426  Sum_probs=119.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++....... .......||+.|+|||++.++.++.
T Consensus       117 ~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  193 (285)
T d1fmka3         117 DMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTI  193 (285)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCc
Confidence            689999999999995  4699999999999999999999999999986543322 2233457899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|..||.....                .......+......+.+..++..+.+|+.+||+.||++
T Consensus       194 ksDI~S~Giil~el~t~~~p~~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  257 (285)
T d1fmka3         194 KSDVWSFGILLTELTTKGRVPYPGMV----------------NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE  257 (285)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHhhhcchHHHHHHHhCCCCCCCCCC----------------HHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhH
Confidence            99999999999999996655543221                11122223334444566677888999999999999999


Q ss_pred             CCCHHHHHHHHHhhc
Q 027003          162 RPRMSEVLAILERLE  176 (229)
Q Consensus       162 Rpt~~~v~~~l~~~~  176 (229)
                      ||++.+|++.|+...
T Consensus       258 Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         258 RPTFEYLQAFLEDYF  272 (285)
T ss_dssp             SCCHHHHHHHHHTTT
T ss_pred             CcCHHHHHHHHhhhh
Confidence            999999999988754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=255.23  Aligned_cols=147  Identities=29%  Similarity=0.461  Sum_probs=119.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+|||++.+|.+||+|||+++.......  .....+||+.|+|||++.+..++.
T Consensus       109 ~~~~qil~al~ylH~~--~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~  184 (337)
T d1o6la_         109 FYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCT
T ss_pred             HHHHHHhhhhhhhhhc--CccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCCh
Confidence            3688999999999964  599999999999999999999999999986543222  234578999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                .....+....  ...+..++..+.+||.+||+.||.+
T Consensus       185 ~~DiwSlGvilyeml~G~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~  246 (337)
T d1o6la_         185 AVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQ  246 (337)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred             hhcccchhhHHHHHHHCCCCCCCcCHH----------------HHHHHHhcCC--CCCCccCCHHHHHHHHhhccCCchh
Confidence            999999999999999999999875421                1111222222  2445667788999999999999999


Q ss_pred             CCC-----HHHHHH
Q 027003          162 RPR-----MSEVLA  170 (229)
Q Consensus       162 Rpt-----~~~v~~  170 (229)
                      |++     +.++++
T Consensus       247 R~~~~~~~~~eil~  260 (337)
T d1o6la_         247 RLGGGPSDAKEVME  260 (337)
T ss_dssp             STTCSTTTHHHHHT
T ss_pred             hcccccccHHHHHc
Confidence            995     778775

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-39  Score=255.87  Aligned_cols=156  Identities=28%  Similarity=0.441  Sum_probs=130.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.
T Consensus       149 ~~~~qi~~gl~~LH~~--~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  226 (311)
T d1t46a_         149 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF  226 (311)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC--CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC
Confidence            5789999999999965  59999999999999999999999999999876555555555678999999999999999999


Q ss_pred             cCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+| |.++|.+...                ...+.+++........+...+..+.+||.+||+.||.
T Consensus       227 ~~DIwS~G~~l~ellt~g~p~~~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~  290 (311)
T d1t46a_         227 ESDVWSYGIFLWELFSLGSSPYPGMPV----------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL  290 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCS----------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             cccccchHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChh
Confidence            9999999999999999 5665655332                2233445555555566666788899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 027003          161 LRPRMSEVLAILERL  175 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~  175 (229)
                      +|||+.++++.|++.
T Consensus       291 ~RPs~~~il~~L~~~  305 (311)
T d1t46a_         291 KRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             GSCCHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHh
Confidence            999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-38  Score=253.15  Aligned_cols=144  Identities=28%  Similarity=0.452  Sum_probs=118.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.+|.+||+|||+++.....     ....+||+.|+|||++.+..++.
T Consensus       108 ~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~  180 (316)
T d1fota_         108 FYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNK  180 (316)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCT
T ss_pred             HHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCc
Confidence            468899999999995  46999999999999999999999999999875432     23468999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+.                .....++....  ...+...+..+.+++.+||+.||.+
T Consensus       181 ~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~  242 (316)
T d1fota_         181 SIDWWSFGILIYEMLAGYTPFYDSNT----------------MKTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQ  242 (316)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred             hhhccccchhHHHHHhCCCCCCCcCH----------------HHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHh
Confidence            99999999999999999999987532                11122222222  2345556778999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      |+     |+.++++
T Consensus       243 R~~~~r~t~~~il~  256 (316)
T d1fota_         243 RLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTSSTTTTHHHHT
T ss_pred             ccccchhhHHHHHc
Confidence            96     8899886

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.1e-39  Score=254.10  Aligned_cols=149  Identities=25%  Similarity=0.415  Sum_probs=107.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec---CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .++.||+.||+|||+  ++||||||||+|||+.   .++.+||+|||+++......   .....+||+.|+|||++.+..
T Consensus       111 ~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~  185 (307)
T d1a06a_         111 RLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKP  185 (307)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCC
Confidence            478999999999996  4699999999999994   57899999999998653322   234567999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|||++|+.||.+....                .....+.....  .......++..+.+|+.+||+
T Consensus       186 ~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  249 (307)
T d1a06a_         186 YSKAVDCWSIGVIAYILLCGYPPFYDENDA----------------KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME  249 (307)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred             CCcHHHhhhhhHHHHHHHhCCCCCCCCCHH----------------HHHHHHhccCCCCCCccccCCCHHHHHHHHHHcc
Confidence            999999999999999999999999764321                11122222222  122334567889999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||++|||+.|+++.
T Consensus       250 ~dP~~R~s~~eil~h  264 (307)
T d1a06a_         250 KDPEKRFTCEQALQH  264 (307)
T ss_dssp             SSGGGSCCHHHHHHS
T ss_pred             CCHhHCcCHHHHhcC
Confidence            999999999999873

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-38  Score=257.18  Aligned_cols=144  Identities=22%  Similarity=0.319  Sum_probs=118.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||++  +||||||||+|||++.+|.+||+|||+++.....     .....||+.|+|||++.+..++.
T Consensus       145 ~i~~qi~~aL~yLH~~--~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~  217 (350)
T d1rdqe_         145 FYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNK  217 (350)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHhC--CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCc
Confidence            5789999999999964  5999999999999999999999999999875432     23467999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||+||+.||.+.+.                .....++....  ...+..++..+.+||.+||+.||.+
T Consensus       218 ~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~k  279 (350)
T d1rdqe_         218 AVDWWALGVLIYEMAAGYPPFFADQP----------------IQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTK  279 (350)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTT
T ss_pred             cccccchhHHHHHHHhCCCCCCCcCH----------------HHHHHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHh
Confidence            99999999999999999999976431                11112222222  2334556788999999999999999


Q ss_pred             CC-----CHHHHHH
Q 027003          162 RP-----RMSEVLA  170 (229)
Q Consensus       162 Rp-----t~~~v~~  170 (229)
                      |+     |+.++++
T Consensus       280 R~~~~r~t~~ell~  293 (350)
T d1rdqe_         280 RFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTSSTTTTHHHHT
T ss_pred             ccccccccHHHHHc
Confidence            95     8999885

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=247.78  Aligned_cols=152  Identities=24%  Similarity=0.453  Sum_probs=120.0

Q ss_pred             ChhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCc
Q 027003            1 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         1 l~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      ++|+.||+.||.|||+  ++||||||||+|||++.++.+||+|||+++.....     .....+|..|+|||++.++.++
T Consensus       106 ~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t  178 (262)
T d1byga_         106 LKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFS  178 (262)
T ss_dssp             HHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCC
Confidence            3689999999999996  46999999999999999999999999999864332     2234678999999999999999


Q ss_pred             ccCceeehhHHHHHHHh-CCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           81 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        81 ~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      .++|||||||++|||+| |+.||...+.                 ..+...+......+.+..++..+.+|+.+||+.||
T Consensus       179 ~~sDIwSfG~il~el~t~~~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP  241 (262)
T d1byga_         179 TKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDA  241 (262)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             hHHHHHhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCH
Confidence            99999999999999998 7888766432                 11222233344455666677899999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 027003          160 KLRPRMSEVLAILERLE  176 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~  176 (229)
                      .+|||+.++++.|+++.
T Consensus       242 ~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         242 AMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             GGSCCHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHHHH
Confidence            99999999999998874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-38  Score=255.45  Aligned_cols=149  Identities=22%  Similarity=0.287  Sum_probs=118.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC--CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||+|||++  +||||||||+|||++.  ++.+||+|||+++.......   .....||+.|+|||++.+..+
T Consensus       128 ~i~~qi~~aL~ylH~~--~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~  202 (350)
T d1koaa2         128 EYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPV  202 (350)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCB
T ss_pred             HHHHHHHHHHHHHHhc--CCeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCC
Confidence            5789999999999964  5999999999999954  67899999999987644322   345679999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|+|++|+.||.+.+..                ..+..+.....  .......++..+.+||.+||+.
T Consensus       203 ~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  266 (350)
T d1koaa2         203 GYYTDMWSVGVLSYILLSGLSPFGGENDD----------------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA  266 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCS
T ss_pred             ChhHhhhhhhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccC
Confidence            99999999999999999999999765321                11122222221  1122234577899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027003          158 EPKLRPRMSEVLAI  171 (229)
Q Consensus       158 dP~~Rpt~~~v~~~  171 (229)
                      ||++|||+.|+++.
T Consensus       267 dP~~R~t~~eil~h  280 (350)
T d1koaa2         267 DPNTRMTIHQALEH  280 (350)
T ss_dssp             SGGGSCCHHHHHHS
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=252.52  Aligned_cols=157  Identities=24%  Similarity=0.379  Sum_probs=126.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.||.|||+  ++||||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.++.
T Consensus       137 ~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~  214 (308)
T d1p4oa_         137 QMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT  214 (308)
T ss_dssp             HHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCc
Confidence            578999999999996  469999999999999999999999999998654443333344557899999999999999999


Q ss_pred             cCceeehhHHHHHHHhC-CCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||+|| ..||.+.+.                . .....+........+..++..+.+|+.+||+.||+
T Consensus       215 ~~Dv~S~G~il~El~t~~~~p~~~~~~----------------~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~  277 (308)
T d1p4oa_         215 YSDVWSFGVVLWEIATLAEQPYQGLSN----------------E-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPK  277 (308)
T ss_dssp             HHHHHHHHHHHHHHHHTSCCTTTTSCH----------------H-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             ccccccHHHHHHHHHhCCCCCCCCCCH----------------H-HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChh
Confidence            99999999999999998 467765431                1 11222223333445566778899999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.+|++.|++...
T Consensus       278 ~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         278 MRPSFLEIISSIKEEME  294 (308)
T ss_dssp             GSCCHHHHHHHHGGGSC
T ss_pred             HCcCHHHHHHHHHHhcC
Confidence            99999999999987644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=252.41  Aligned_cols=159  Identities=27%  Similarity=0.384  Sum_probs=124.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      +++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++........  .......||..|+|||.+.+..+
T Consensus       134 ~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  211 (311)
T d1r0pa_         134 GFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF  211 (311)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCC
Confidence            689999999999995  45999999999999999999999999999865433221  12233568999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|||+||..||......                ......+........+..++..+.+|+.+||+.||
T Consensus       212 ~~ksDI~SfGivl~El~t~~~p~~~~~~~----------------~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP  275 (311)
T d1r0pa_         212 TTKSDVWSFGVLLWELMTRGAPPYPDVNT----------------FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKA  275 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSCC----------------------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             CChhHhhhhHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCH
Confidence            99999999999999999988887543211                01111122222334455667789999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCC
Q 027003          160 KLRPRMSEVLAILERLEAP  178 (229)
Q Consensus       160 ~~Rpt~~~v~~~l~~~~~~  178 (229)
                      ++||++.||++.|+++...
T Consensus       276 ~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         276 EMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             GGSCCHHHHHHHHHHHHHT
T ss_pred             hHCcCHHHHHHHHHHHHHh
Confidence            9999999999999988643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-38  Score=255.73  Aligned_cols=149  Identities=23%  Similarity=0.303  Sum_probs=120.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeec--CCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .|+.||+.||+|||+  ++||||||||+||||+  .++.+||+|||+++.......   .....||+.|+|||++.+..+
T Consensus       131 ~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~  205 (352)
T d1koba_         131 NYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPV  205 (352)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCC
Confidence            578999999999995  4699999999999997  578999999999987644322   345679999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|+|+||+.||.+.+.                ...+..+.....  .......++..+.+||.+||+.
T Consensus       206 ~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  269 (352)
T d1koba_         206 GFYTDMWAIGVLGYVLLSGLSPFAGEDD----------------LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK  269 (352)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCS
T ss_pred             CCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccC
Confidence            9999999999999999999999987542                111222222222  2233345678899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027003          158 EPKLRPRMSEVLAI  171 (229)
Q Consensus       158 dP~~Rpt~~~v~~~  171 (229)
                      ||.+|||+.|+++.
T Consensus       270 dp~~R~s~~eil~H  283 (352)
T d1koba_         270 EPRKRLTVHDALEH  283 (352)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999863

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5e-38  Score=254.98  Aligned_cols=148  Identities=28%  Similarity=0.415  Sum_probs=117.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-CCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~   80 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.+|.+||+|||+++......    ....+||+.|+|||++.+ ..++
T Consensus       111 ~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~  184 (364)
T d1omwa3         111 FYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYD  184 (364)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred             HHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCC
Confidence            478999999999996  469999999999999999999999999998754332    234579999999999965 4689


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      .++|||||||++|||+||+.||.+........+              .+. ........+..++..+.+||.+||+.||.
T Consensus       185 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--------------~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~  249 (364)
T d1omwa3         185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------------DRM-TLTMAVELPDSFSPELRSLLEGLLQRDVN  249 (364)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--------------HHH-SSSCCCCCCSSSCHHHHHHHHHHTCSSTT
T ss_pred             cccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHh-cccCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence            999999999999999999999987543221111              111 11122234455678899999999999999


Q ss_pred             CCCC-----HHHHHH
Q 027003          161 LRPR-----MSEVLA  170 (229)
Q Consensus       161 ~Rpt-----~~~v~~  170 (229)
                      +|||     +.|+++
T Consensus       250 ~R~t~~~~~a~eil~  264 (364)
T d1omwa3         250 RRLGCLGRGAQEVKE  264 (364)
T ss_dssp             TSTTTSSSTHHHHHT
T ss_pred             HhCCCcccCHHHHHc
Confidence            9999     678875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.7e-38  Score=246.64  Aligned_cols=157  Identities=27%  Similarity=0.400  Sum_probs=115.9

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCC-cceeeccccccccccccccccCCCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~   80 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.++..+|+|||++........ .......+||+.|+|||++.+..++
T Consensus       115 ~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~  192 (277)
T d1o6ya_         115 EVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD  192 (277)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCC
Confidence            578999999999996  4699999999999999999999999999875433221 1223456799999999999999999


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccC--CCCcHHHHHHHHHHHHHhccCC
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNE  158 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~d  158 (229)
                      .++|||||||++|||+||+.||.+.+..                ....+.+.....  ......++..+.+||.+||+.|
T Consensus       193 ~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  256 (277)
T d1o6ya_         193 ARSDVYSLGCVLYEVLTGEPPFTGDSPV----------------SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN  256 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSS
T ss_pred             cceecccchHHHHHHHhCCCCCCCcCHH----------------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCC
Confidence            9999999999999999999999765321                111111211111  1122345678999999999999


Q ss_pred             CCCCC-CHHHHHHHHHhhc
Q 027003          159 PKLRP-RMSEVLAILERLE  176 (229)
Q Consensus       159 P~~Rp-t~~~v~~~l~~~~  176 (229)
                      |.+|| |+.++++.|.++.
T Consensus       257 p~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         257 PENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGGSCSSHHHHHHHHHHHH
T ss_pred             HhHCHhHHHHHHHHHHHHh
Confidence            99999 8999999988775

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-38  Score=247.99  Aligned_cols=173  Identities=23%  Similarity=0.316  Sum_probs=122.4

Q ss_pred             hhHHHHHHHHHHhhcC------CCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcc--eeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~   73 (229)
                      +++.|++.||.|||+.      .++||||||||+||||+.++.+||+|||+++.........  .....+||+.|+|||+
T Consensus       104 ~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (303)
T d1vjya_         104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhh
Confidence            6889999999999963      3579999999999999999999999999998654432211  2334679999999999


Q ss_pred             cccCC------CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhH-HHHhhcccCCCCc-----H
Q 027003           74 VATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL-FRIMDTKLGGQYP-----Q  141 (229)
Q Consensus        74 ~~~~~------~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~  141 (229)
                      +.+..      ++.++|||||||++|||+||..||........... ... ......... ........+...+     .
T Consensus       184 ~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  261 (303)
T d1vjya_         184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSC  261 (303)
T ss_dssp             HTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGGC
T ss_pred             ccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hcc-cccchHHHHHHHHhccccCCCCCcccCCh
Confidence            87642      57789999999999999999988755332211100 000 000011111 1122222322222     2


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhc
Q 027003          142 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  176 (229)
Q Consensus       142 ~~~~~~~~li~~~l~~dP~~Rpt~~~v~~~l~~~~  176 (229)
                      .....+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus       262 ~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         262 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            45667999999999999999999999999998875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=246.13  Aligned_cols=165  Identities=25%  Similarity=0.268  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++........  ....+||+.|+|||++.+. .++
T Consensus       104 ~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~  179 (299)
T d1ua2a_         104 AYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYG  179 (299)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCC
Confidence            578999999999996  45999999999999999999999999999875443322  3346799999999998755 578


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch-hHHHhh-hhhhcchhhHHHHhhc---ccCCCCc-----HHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKRKLFRIMDT---KLGGQYP-----QKAAHTAATL  150 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~-----~~~~~~~~~l  150 (229)
                      .++|||||||++|||++|..||.+....... .+.... .+..............   ......+     ...+..+.+|
T Consensus       180 ~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  259 (299)
T d1ua2a_         180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL  259 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHH
T ss_pred             hhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHH
Confidence            9999999999999999999999775422110 000000 0000000000000000   0000011     1235678999


Q ss_pred             HHHhccCCCCCCCCHHHHHH
Q 027003          151 ALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       151 i~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +.+||+.||++|||+.|+++
T Consensus       260 l~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         260 IQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhC
Confidence            99999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-38  Score=250.24  Aligned_cols=164  Identities=26%  Similarity=0.333  Sum_probs=118.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.|++.||+|||++  +||||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.
T Consensus       120 ~~~~qi~~aL~yLH~~--~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~  194 (305)
T d1blxa_         120 DMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYAT  194 (305)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHhC--CEEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCCh
Confidence            4789999999999964  5999999999999999999999999998764322   2234568999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhh-hhhc----chhhHHHHhhccc---CCCCcHHHHHHHHHHHH
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLS----DKRKLFRIMDTKL---GGQYPQKAAHTAATLAL  152 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~  152 (229)
                      ++|||||||++|||++|+.||.+.+...... +..... +...    .............   ........+..+.+|+.
T Consensus       195 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  274 (305)
T d1blxa_         195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL  274 (305)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred             hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHH
Confidence            9999999999999999999998764321111 111000 0000    0000000000000   01112334667889999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 027003          153 QCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~  170 (229)
                      +||+.||.+|||+.|+++
T Consensus       275 ~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         275 KCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHCcCChhHCcCHHHHhc
Confidence            999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=248.99  Aligned_cols=153  Identities=23%  Similarity=0.284  Sum_probs=116.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~   78 (229)
                      .|+.||+.||+|||+.  +|+||||||+|||++.   ++.+||+|||+++.......   ....+||+.|+|||++.+..
T Consensus       115 ~i~~qi~~al~ylH~~--~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~  189 (335)
T d2ozaa1         115 EIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEK  189 (335)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGG
T ss_pred             HHHHHHHHHHHHHHHc--CCccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCC
Confidence            5789999999999964  5999999999999975   46799999999987544332   34567999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhcc
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLN  156 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~  156 (229)
                      ++.++|||||||++|+|+||+.||.+.+........            ...+.......  .....++..+.+||.+||+
T Consensus       190 y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  257 (335)
T d2ozaa1         190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK  257 (335)
T ss_dssp             GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSC
T ss_pred             CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------------HHHHhcCCCCCCCcccccCCHHHHHHHHHHcc
Confidence            999999999999999999999999765421110000            00000011111  1123567789999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027003          157 NEPKLRPRMSEVLAI  171 (229)
Q Consensus       157 ~dP~~Rpt~~~v~~~  171 (229)
                      .||++|||+.|+++.
T Consensus       258 ~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         258 TEPTQRMTITEFMNH  272 (335)
T ss_dssp             SSTTTSCCHHHHHHS
T ss_pred             CChhHCcCHHHHHcC
Confidence            999999999999873

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-38  Score=245.11  Aligned_cols=139  Identities=25%  Similarity=0.404  Sum_probs=112.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC-CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC-
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-   79 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.+ +.+||+|||+++......    .....||+.|+|||++.+..+ 
T Consensus       114 ~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~  187 (273)
T d1xwsa_         114 SFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYH  187 (273)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBC
T ss_pred             HHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCC
Confidence            478999999999996  469999999999999854 789999999998653322    335679999999999987765 


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||++|||++|+.||.+..                      ++....  ...+..++..+.+|+.+||+.||
T Consensus       188 ~~~~DiwSlGvilyell~g~~Pf~~~~----------------------~i~~~~--~~~~~~~s~~~~~li~~~L~~dp  243 (273)
T d1xwsa_         188 GRSAAVWSLGILLYDMVCGDIPFEHDE----------------------EIIRGQ--VFFRQRVSSECQHLIRWCLALRP  243 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCCSHH----------------------HHHHCC--CCCSSCCCHHHHHHHHHHTCSSG
T ss_pred             CcccccccceeeehhHhhCCCCCCCch----------------------HHhhcc--cCCCCCCCHHHHHHHHHHccCCH
Confidence            567999999999999999999997532                      011111  12233456788999999999999


Q ss_pred             CCCCCHHHHHH
Q 027003          160 KLRPRMSEVLA  170 (229)
Q Consensus       160 ~~Rpt~~~v~~  170 (229)
                      ++|||+.|+++
T Consensus       244 ~~R~s~~eil~  254 (273)
T d1xwsa_         244 SDRPTFEEIQN  254 (273)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hHCcCHHHHhc
Confidence            99999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=247.10  Aligned_cols=154  Identities=28%  Similarity=0.402  Sum_probs=123.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.||+.||.|||+.  +||||||||+|||++.++.+||+|||+++.......   .....||..|+|||.+.++.++.
T Consensus       131 ~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~  205 (309)
T d1fvra_         131 HFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTT  205 (309)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHhhhcC--CccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCc
Confidence            5789999999999964  599999999999999999999999999986433221   22346899999999999999999


Q ss_pred             cCceeehhHHHHHHHhCC-CcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCC
Q 027003           82 KSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  160 (229)
Q Consensus        82 ~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  160 (229)
                      ++|||||||++|||++|. .||.+.+.                 ..+...+........+..++..+.+||.+||+.||+
T Consensus       206 ~sDvwSfGvil~ell~~~~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~  268 (309)
T d1fvra_         206 NSDVWSYGVLLWEIVSLGGTPYCGMTC-----------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY  268 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred             cceeehhHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChh
Confidence            999999999999999975 56765431                 112222333344455666788999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcC
Q 027003          161 LRPRMSEVLAILERLEA  177 (229)
Q Consensus       161 ~Rpt~~~v~~~l~~~~~  177 (229)
                      +|||+.+|++.|+++..
T Consensus       269 ~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         269 ERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHHh
Confidence            99999999999988754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=248.45  Aligned_cols=147  Identities=31%  Similarity=0.476  Sum_probs=119.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..++.
T Consensus       107 ~~~~qi~~al~ylH~~--~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  182 (320)
T d1xjda_         107 FYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNH  182 (320)
T ss_dssp             HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHhC--CeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCc
Confidence            4789999999999964  599999999999999999999999999986543322  234567999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL  161 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  161 (229)
                      ++|||||||++|||++|+.||.+.+..                ....++...  ....+..++..+.+|+.+||+.||++
T Consensus       183 ~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~  244 (320)
T d1xjda_         183 SVDWWSFGVLLYEMLIGQSPFHGQDEE----------------ELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEK  244 (320)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             hhhhhhhhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcC--CCCCCccCCHHHHHHHHHhcccCCCC
Confidence            999999999999999999999875421                111112211  22445556788999999999999999


Q ss_pred             CCCHH-HHHH
Q 027003          162 RPRMS-EVLA  170 (229)
Q Consensus       162 Rpt~~-~v~~  170 (229)
                      ||++. ++++
T Consensus       245 R~s~~~~l~~  254 (320)
T d1xjda_         245 RLGVRGDIRQ  254 (320)
T ss_dssp             SBTTBSCGGG
T ss_pred             CcCHHHHHHh
Confidence            99985 6754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-37  Score=243.44  Aligned_cols=148  Identities=26%  Similarity=0.357  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC----cEEEcccCCcccCCCCCCcceeeccccccccccccccccC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG   77 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~   77 (229)
                      .++.||+.||+|||+.  +||||||||+|||++.++    .+||+|||+++.......   .....||+.|+|||++.+.
T Consensus       117 ~~~~qi~~al~yLH~~--~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~  191 (293)
T d1jksa_         117 EFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE  191 (293)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHhhhhc--ceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCC
Confidence            5789999999999964  599999999999998876    499999999987644332   3345789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCC--CCcHHHHHHHHHHHHHhc
Q 027003           78 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL  155 (229)
Q Consensus        78 ~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  155 (229)
                      .++.++|||||||++|||++|+.||.+.+..                .....+.......  ..+...+..+.+||.+||
T Consensus       192 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  255 (293)
T d1jksa_         192 PLGLEADMWSIGVITYILLSGASPFLGDTKQ----------------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLL  255 (293)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTS
T ss_pred             CCCCcccchhhhHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHc
Confidence            9999999999999999999999999875421                1111111111111  111234667899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 027003          156 NNEPKLRPRMSEVLA  170 (229)
Q Consensus       156 ~~dP~~Rpt~~~v~~  170 (229)
                      +.||++|||+.|+++
T Consensus       256 ~~dP~~R~s~~eil~  270 (293)
T d1jksa_         256 VKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-37  Score=244.05  Aligned_cols=161  Identities=20%  Similarity=0.190  Sum_probs=118.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC---CCcEEEcccCCcccCCCCCCc-----ceeeccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEY   73 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~   73 (229)
                      .++.|++.||+|||++  +||||||||+|||++.   +..+||+|||+++........     ......+||+.|+|||+
T Consensus       107 ~~~~qi~~~l~~lH~~--~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  184 (299)
T d1ckia_         107 LLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT  184 (299)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHH
T ss_pred             HHHHHHHHHHHHHHHC--CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHH
Confidence            5789999999999964  5999999999999854   457999999999876443221     12345679999999999


Q ss_pred             cccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHH-HhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHH
Q 027003           74 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  152 (229)
Q Consensus        74 ~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  152 (229)
                      +.+..++.++|||||||++|||+||+.||............ ......          ... ........++.++.+|+.
T Consensus       185 ~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~----------~~~-~~~~~~~~~p~~~~~li~  253 (299)
T d1ckia_         185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----------MST-PIEVLCKGYPSEFATYLN  253 (299)
T ss_dssp             HTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH----------HHS-CHHHHTTTSCHHHHHHHH
T ss_pred             HhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc----------CCC-ChhHhccCCCHHHHHHHH
Confidence            99999999999999999999999999999775432211111 000000          000 000011234567899999


Q ss_pred             HhccCCCCCCCCHHHHHHHHHhh
Q 027003          153 QCLNNEPKLRPRMSEVLAILERL  175 (229)
Q Consensus       153 ~~l~~dP~~Rpt~~~v~~~l~~~  175 (229)
                      +||+.||++||++.++.+.|+.+
T Consensus       254 ~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         254 FCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHHHHHH
Confidence            99999999999999998888765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-36  Score=238.12  Aligned_cols=148  Identities=30%  Similarity=0.408  Sum_probs=118.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeecccccccccccccccc-----
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----   76 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----   76 (229)
                      +++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++.......   .....||..|+|||.+.+     
T Consensus       114 ~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~  188 (277)
T d1phka_         114 KIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDN  188 (277)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhcccccc
Confidence            578999999999995  4699999999999999999999999999987644332   344679999999999864     


Q ss_pred             -CCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhccc--CCCCcHHHHHHHHHHHHH
Q 027003           77 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQ  153 (229)
Q Consensus        77 -~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  153 (229)
                       ..++.++||||+||++|+|++|+.||.+.+.                ......+.....  .......++..+.+|+.+
T Consensus       189 ~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  252 (277)
T d1phka_         189 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR  252 (277)
T ss_dssp             SCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHH
T ss_pred             CCCCCchheEcccchhhhhhccCCCCCCCCCH----------------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHH
Confidence             2467899999999999999999999987542                111222232222  222334678899999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 027003          154 CLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       154 ~l~~dP~~Rpt~~~v~~  170 (229)
                      ||+.||.+|||+.|+++
T Consensus       253 ~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         253 FLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HCCSSGGGSCCHHHHTT
T ss_pred             HccCChhHCcCHHHHHc
Confidence            99999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=238.83  Aligned_cols=166  Identities=25%  Similarity=0.288  Sum_probs=115.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      .++.||+.||.|||+  .+||||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.... ++
T Consensus       106 ~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~  181 (298)
T d1gz8a_         106 SYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS  181 (298)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCC
Confidence            578999999999996  4599999999999999999999999999986543222  233457999999999887765 47


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHH-hhhhhhcchhhHHHHhhc--c---cCCCC----cHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFRIMDT--K---LGGQY----PQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~--~---~~~~~----~~~~~~~~~~  149 (229)
                      .++|||||||++|+|++|+.||.+.+...... ... ...+..............  .   .....    ....+..+.+
T Consensus       182 ~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  261 (298)
T d1gz8a_         182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRS  261 (298)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHH
T ss_pred             ccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHH
Confidence            89999999999999999999998754211100 000 000000000000000000  0   00000    0123567899


Q ss_pred             HHHHhccCCCCCCCCHHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      |+.+||+.||.+|||+.|+++.
T Consensus       262 ll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         262 LLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHccCChhHCcCHHHHhCC
Confidence            9999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.6e-36  Score=236.98  Aligned_cols=163  Identities=14%  Similarity=0.145  Sum_probs=120.4

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecC-----CCcEEEcccCCcccCCCCCCc-----ceeeccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAP   71 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aP   71 (229)
                      .++.|++.||+|||+  .+||||||||+|||++.     ++.+||+|||+++........     ......+||+.|+||
T Consensus       105 ~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         105 MAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCH
Confidence            578999999999995  46999999999999964     578999999999875432211     123456799999999


Q ss_pred             cccccCCCcccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHH
Q 027003           72 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  151 (229)
Q Consensus        72 E~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  151 (229)
                      |++.+..++.++|||||||++|||+||..||.+..............          ..............++.++.+++
T Consensus       183 E~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~----------~~~~~~~~~~l~~~~p~~l~~ii  252 (293)
T d1csna_         183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------EKKQSTPLRELCAGFPEEFYKYM  252 (293)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----------HHHHHSCHHHHTTTSCHHHHHHH
T ss_pred             HHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH----------hccCCCChHHhcCCCCHHHHHHH
Confidence            99999999999999999999999999999998755432221111000          00000000001122346788999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHhhc
Q 027003          152 LQCLNNEPKLRPRMSEVLAILERLE  176 (229)
Q Consensus       152 ~~~l~~dP~~Rpt~~~v~~~l~~~~  176 (229)
                      ..|+..+|++||++..+.+.|+++.
T Consensus       253 ~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         253 HYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHhcCCcccCcCHHHHHHHHHHHH
Confidence            9999999999999999888877653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-36  Score=239.43  Aligned_cols=148  Identities=24%  Similarity=0.276  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCC--CcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~   79 (229)
                      .++.||+.||+|||++  +|+||||||+|||++.+  +.+||+|||+++......   ......+|+.|+|||.+.+..+
T Consensus       106 ~i~~qi~~al~yLH~~--~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~  180 (321)
T d1tkia_         106 SYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVV  180 (321)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEE
T ss_pred             HHHHHHHHHHHHHHHc--CCCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCC
Confidence            4789999999999964  59999999999999854  479999999998754332   2344678999999999999999


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCC--CcHHHHHHHHHHHHHhccC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNN  157 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~  157 (229)
                      +.++|||||||++|+|++|..||.+.+..                .....+........  ....++..+.+|+.+||+.
T Consensus       181 ~~~~DiWSlGvily~ll~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (321)
T d1tkia_         181 STATDMWSLGTLVYVLLSGINPFLAETNQ----------------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK  244 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred             CchhhcccHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccC
Confidence            99999999999999999999999875421                11122222221111  1113467789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 027003          158 EPKLRPRMSEVLA  170 (229)
Q Consensus       158 dP~~Rpt~~~v~~  170 (229)
                      ||.+|||+.|+++
T Consensus       245 dp~~R~s~~eil~  257 (321)
T d1tkia_         245 ERKSRMTASEALQ  257 (321)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHhc
Confidence            9999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-35  Score=235.81  Aligned_cols=168  Identities=21%  Similarity=0.289  Sum_probs=114.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc--ceeeccccccccccccccccC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-R   78 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~   78 (229)
                      .++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+++........  ......+||+.|+|||++.+. .
T Consensus       121 ~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~  198 (318)
T d3blha1         121 RVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD  198 (318)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCC
Confidence            478999999999996  46999999999999999999999999999765432211  122345799999999998765 6


Q ss_pred             CcccCceeehhHHHHHHHhCCCcCCCCccccchhHH-Hhhhhhhc------chhhHHHHhhcccCCCCc--H-----HHH
Q 027003           79 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS------DKRKLFRIMDTKLGGQYP--Q-----KAA  144 (229)
Q Consensus        79 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~--~-----~~~  144 (229)
                      ++.++|||||||++|||++|+.||.+.+........ ........      ..................  .     ...
T Consensus       199 ~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (318)
T d3blha1         199 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD  278 (318)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCC
T ss_pred             CCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCC
Confidence            889999999999999999999999875432111111 10000000      000000000000000110  0     124


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          145 HTAATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       145 ~~~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      ..+.+|+.+||+.||++|||+.|+++.
T Consensus       279 ~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         279 PYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            467789999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=238.76  Aligned_cols=169  Identities=26%  Similarity=0.328  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~   79 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.++ .+||+|||+++.......   ....+||..|+|||.+.+. .+
T Consensus       126 ~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  200 (350)
T d1q5ka_         126 LYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDY  200 (350)
T ss_dssp             HHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCC
Confidence            478999999999995  4699999999999999875 899999999987543322   3346799999999988754 68


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcc-hhhHHHHhhc----cc--------CCCCcHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-KRKLFRIMDT----KL--------GGQYPQKAAHT  146 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~--------~~~~~~~~~~~  146 (229)
                      +.++|||||||++|||++|+.||...+....  +.....-.... ...+......    ..        ........+..
T Consensus       201 ~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  278 (350)
T d1q5ka_         201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE  278 (350)
T ss_dssp             CTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHH
T ss_pred             CcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHH
Confidence            9999999999999999999999976543211  11100000000 0000000000    00        00112235667


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH--HHHhhcC
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLA--ILERLEA  177 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~--~l~~~~~  177 (229)
                      +.+|+.+||+.||.+|||+.|+++  .++++..
T Consensus       279 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         279 AIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            899999999999999999999996  3555543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-35  Score=233.86  Aligned_cols=165  Identities=21%  Similarity=0.324  Sum_probs=112.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||++........  ......+++.|+|||.+.+. .++
T Consensus       104 ~i~~qi~~~L~~LH~~--~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~  179 (286)
T d1ob3a_         104 SFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYS  179 (286)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHhccC--cEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCC
Confidence            5789999999999964  599999999999999999999999999976533222  13345689999999998765 468


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHH-hhhhhhcchhhHHHHhh--ccc-------CCCCcHHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFRIMD--TKL-------GGQYPQKAAHTAAT  149 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~  149 (229)
                      .++|||||||++|||++|+.||.+.+...... ... ...+.............  ...       ........+..+.+
T Consensus       180 ~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  259 (286)
T d1ob3a_         180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID  259 (286)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred             cceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHH
Confidence            99999999999999999999998754321100 000 00000000000000000  000       00112234678899


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 027003          150 LALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       150 li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      |+.+||+.||++|||+.|+++
T Consensus       260 li~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         260 LLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-35  Score=237.38  Aligned_cols=163  Identities=24%  Similarity=0.325  Sum_probs=116.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC-CCc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~   80 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++.....     .+..+||+.|+|||++.+. .++
T Consensus       125 ~~~~qi~~aL~~LH~~--~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~  197 (346)
T d1cm8a_         125 FLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYT  197 (346)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCC
T ss_pred             HHHHHHHHHHHHHHhC--CCcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCC
Confidence            5789999999999964  5999999999999999999999999999875432     2346799999999998764 568


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchh-HHHhhhhh----hc--chhhHHHHh--hcccCC----CCcHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPY----LS--DKRKLFRIM--DTKLGG----QYPQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~----~~--~~~~~~~~~--~~~~~~----~~~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||.+.+...... ........    ..  .........  ......    ......+..+
T Consensus       198 ~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  277 (346)
T d1cm8a_         198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA  277 (346)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHH
T ss_pred             ccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHH
Confidence            99999999999999999999998764321110 00000000    00  000000000  000100    1122346678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      .+||.+||+.||.+|||+.|+++.
T Consensus       278 ~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         278 VNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcC
Confidence            899999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-34  Score=231.57  Aligned_cols=168  Identities=25%  Similarity=0.287  Sum_probs=116.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCc-ceeecccccccccccccccc-CCC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~   79 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++........ ......+||+.|+|||++.. ..+
T Consensus       113 ~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  190 (345)
T d1pmea_         113 YFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY  190 (345)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSC
T ss_pred             HHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCC
Confidence            578999999999996  46999999999999999999999999999765332211 12334679999999999854 467


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhc-------chhhHHHHh-hcccCCCC-----cHHHHHH
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-------DKRKLFRIM-DTKLGGQY-----PQKAAHT  146 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~-----~~~~~~~  146 (229)
                      +.++||||+||++|+|++|+.||.+..................       ......... ........     ....+..
T Consensus       191 ~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  270 (345)
T d1pmea_         191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK  270 (345)
T ss_dssp             STHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHH
T ss_pred             CchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHH
Confidence            8899999999999999999999987543211111100000000       000000000 00011111     1123457


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 027003          147 AATLALQCLNNEPKLRPRMSEVLAI  171 (229)
Q Consensus       147 ~~~li~~~l~~dP~~Rpt~~~v~~~  171 (229)
                      +.+|+.+||+.||.+|||+.|+++.
T Consensus       271 ~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         271 ALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            8899999999999999999999863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=232.93  Aligned_cols=152  Identities=31%  Similarity=0.404  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccC--CC
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RL   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~   79 (229)
                      .++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++........ ......|++.|++||.+.+.  .+
T Consensus       133 ~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~  209 (322)
T d1vzoa_         133 IYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGH  209 (322)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---
T ss_pred             HHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCC
Confidence            468899999999996  45999999999999999999999999999865433222 23456799999999999765  46


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhHHHhhhhhhcchhhHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP  159 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  159 (229)
                      +.++|||||||+||+|++|+.||.+........             .+.+.. .......+...+..+.+|+.+||+.||
T Consensus       210 ~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-------------~i~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dP  275 (322)
T d1vzoa_         210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-------------EISRRI-LKSEPPYPQEMSALAKDLIQRLLMKDP  275 (322)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-------------HHHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHHhc-ccCCCCCcccCCHHHHHHHHHHcccCH
Confidence            779999999999999999999998754321111             011100 111223455678899999999999999


Q ss_pred             CCCCC-----HHHHHH
Q 027003          160 KLRPR-----MSEVLA  170 (229)
Q Consensus       160 ~~Rpt-----~~~v~~  170 (229)
                      .+|||     +.|+++
T Consensus       276 ~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         276 KKRLGCGPRDADEIKE  291 (322)
T ss_dssp             GGSTTSSTTTHHHHHT
T ss_pred             HHcCCCCcccHHHHHc
Confidence            99994     778775

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.4e-34  Score=229.04  Aligned_cols=164  Identities=17%  Similarity=0.241  Sum_probs=115.6

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCC-cEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-C
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-L   79 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~   79 (229)
                      .++.||+.||+|||++  +||||||||+|||++.++ .+||+|||+++.......   ....++|..|+|||.+.+.. +
T Consensus       133 ~i~~qil~aL~~LH~~--gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  207 (328)
T d3bqca1         133 FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMY  207 (328)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHhhc--ccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCC
Confidence            5789999999999964  599999999999998765 589999999987544322   33457899999999987754 7


Q ss_pred             cccCceeehhHHHHHHHhCCCcCCCCccccchhH--HHhhh-hhh--------cc-hhhHHHHh--------hcccCCCC
Q 027003           80 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL--VDWAK-PYL--------SD-KRKLFRIM--------DTKLGGQY  139 (229)
Q Consensus        80 ~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~--~~~~~-~~~--------~~-~~~~~~~~--------~~~~~~~~  139 (229)
                      +.++|||||||++|||++|+.||...........  ..... +..        .. ........        ........
T Consensus       208 ~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (328)
T d3bqca1         208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN  287 (328)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTT
T ss_pred             CcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccc
Confidence            8999999999999999999999976543221110  00000 000        00 00000000        00011112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          140 PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       140 ~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ....+.++.+||.+||+.||.+|||+.|+++
T Consensus       288 ~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         288 QHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2345678899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=9.8e-34  Score=223.40  Aligned_cols=165  Identities=24%  Similarity=0.261  Sum_probs=115.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      .++.|++.||+|||+  ++||||||||+|||++.++.+||+|||.++........  .....++..|+|||++.+.. ++
T Consensus       105 ~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~  180 (292)
T d1unla_         105 SFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCC
Confidence            478999999999995  46999999999999999999999999999876443322  33446788999999987765 68


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccch--hHHHhhh-hhhcchhhHHHHhh---------cccCCCCcHHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAK-PYLSDKRKLFRIMD---------TKLGGQYPQKAAHTAA  148 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~  148 (229)
                      .++|||||||++|||++|+.||.........  .+..... +.............         ...........+..+.
T Consensus       181 ~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  260 (292)
T d1unla_         181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR  260 (292)
T ss_dssp             THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred             chhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHH
Confidence            8999999999999999999997543321111  0111000 00000000000000         0011112234567889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHH
Q 027003          149 TLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       149 ~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      +|+.+||+.||.+|||+.|+++
T Consensus       261 dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         261 DLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.3e-33  Score=228.47  Aligned_cols=164  Identities=23%  Similarity=0.299  Sum_probs=111.2

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      .++.||+.||.|||+.  ||+||||||+|||++.++.+|++|||+++......   .....++|+.|+|||++.+..++.
T Consensus       123 ~~~~qil~gl~~LH~~--giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~  197 (355)
T d2b1pa1         123 YLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKE  197 (355)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHhhhc--ccccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCC
Confidence            4789999999999964  69999999999999999999999999988654332   234567999999999999999999


Q ss_pred             cCceeehhHHHHHHHhCCCcCCCCccccchh--HHHhhhh---hhc-chhhHHHHhhc---------------ccCC---
Q 027003           82 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKP---YLS-DKRKLFRIMDT---------------KLGG---  137 (229)
Q Consensus        82 ~~Di~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~---~~~-~~~~~~~~~~~---------------~~~~---  137 (229)
                      ++||||+||++|+|++|+.||.+.+......  ......+   ... ...........               ....   
T Consensus       198 ~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (355)
T d2b1pa1         198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS  277 (355)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred             CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccc
Confidence            9999999999999999999998654321110  0000000   000 00011111111               1101   


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          138 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       138 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       278 ~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         278 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            112345778999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-33  Score=226.00  Aligned_cols=162  Identities=25%  Similarity=0.317  Sum_probs=111.0

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCC-Cc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT   80 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~   80 (229)
                      .++.||+.||+|||+  ++|+||||||+|||++.++.+|++|||++......     .....||..|+|||++.+.. ++
T Consensus       125 ~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~  197 (348)
T d2gfsa1         125 FLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYN  197 (348)
T ss_dssp             HHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCC
Confidence            478999999999996  46999999999999999999999999998754221     33457899999999877654 58


Q ss_pred             ccCceeehhHHHHHHHhCCCcCCCCccccchhHH-Hhhh-hh---h--cchhhHHHHhhcccC-CCC-----cHHHHHHH
Q 027003           81 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAK-PY---L--SDKRKLFRIMDTKLG-GQY-----PQKAAHTA  147 (229)
Q Consensus        81 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~-~~---~--~~~~~~~~~~~~~~~-~~~-----~~~~~~~~  147 (229)
                      .++|||||||++|+|++|+.||.+.+........ .... +.   .  ............... ...     ....+..+
T Consensus       198 ~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  277 (348)
T d2gfsa1         198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA  277 (348)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHH
T ss_pred             cccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHH
Confidence            8999999999999999999999876532111111 0000 00   0  000000011110000 000     11245678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHH
Q 027003          148 ATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       148 ~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                      .+||.+||+.||.+|||+.|+++
T Consensus       278 ~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         278 VDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHCcCChhhCcCHHHHhc
Confidence            89999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=7.5e-33  Score=224.54  Aligned_cols=161  Identities=17%  Similarity=0.245  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCc------EEEcccCCcccCCCCCCcceeeccccccccccccccc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA   75 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~   75 (229)
                      .++.||+.||+|||+. .+|+||||||+|||++.++.      ++++|||.+......     ....+||+.|+|||++.
T Consensus       129 ~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~  202 (362)
T d1q8ya_         129 QISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLL  202 (362)
T ss_dssp             HHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhcc
Confidence            4789999999999962 56999999999999976653      899999999864332     23457999999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhCCCcCCCCccccch----hHHHhhhhhhcchh--------------------------
Q 027003           76 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----SLVDWAKPYLSDKR--------------------------  125 (229)
Q Consensus        76 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~--------------------------  125 (229)
                      +..++.++|||||||++++|++|+.||.........    .+............                          
T Consensus       203 ~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (362)
T d1q8ya_         203 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK  282 (362)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred             ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcccccc
Confidence            999999999999999999999999999765432111    11110000000000                          


Q ss_pred             --hHHHHhhcccCCCCcHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 027003          126 --KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  170 (229)
Q Consensus       126 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~v~~  170 (229)
                        ......  ..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       283 ~~~~~~~~--~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         283 FWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             BCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             CCchhhhc--ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000000  0122345677889999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.54  E-value=2.4e-16  Score=115.63  Aligned_cols=82  Identities=13%  Similarity=0.076  Sum_probs=55.1

Q ss_pred             hhHHHHHHHHHHhhcCCCCceeecCCCCCeeecCCCcEEEcccCCcccCCCCCCcceeeccccccccccccccccCCCcc
Q 027003            2 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT   81 (229)
Q Consensus         2 ~i~~~i~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~   81 (229)
                      +++.|++.+|.|||++  +|+||||||+|||++.+ .++|+|||++...............+..    -.+. ....|+.
T Consensus       107 ~i~~ql~~~l~~lH~~--giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~  178 (191)
T d1zara2         107 EVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRT  178 (191)
T ss_dssp             HHHHHHHHHHHHHHHT--TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCC
T ss_pred             HHHHHHHHHHHHHhhC--CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCC
Confidence            4789999999999964  59999999999999965 4899999999764322111000000000    0011 2356788


Q ss_pred             cCceeehhHH
Q 027003           82 KSDVYSFGVV   91 (229)
Q Consensus        82 ~~Di~slG~i   91 (229)
                      ++|+||+.--
T Consensus       179 ~~d~~s~~~~  188 (191)
T d1zara2         179 EKDINSAIDR  188 (191)
T ss_dssp             CCCHHHHHHH
T ss_pred             cccHHHHHHH
Confidence            9999996543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.41  E-value=0.00038  Score=53.20  Aligned_cols=30  Identities=27%  Similarity=0.258  Sum_probs=27.1

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCcc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAK   48 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~   48 (229)
                      .++||+|+.++||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            469999999999999988777899999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=95.78  E-value=0.0019  Score=47.54  Aligned_cols=30  Identities=20%  Similarity=0.194  Sum_probs=25.8

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            479999999999999877678999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=95.57  E-value=0.0019  Score=47.33  Aligned_cols=30  Identities=20%  Similarity=0.123  Sum_probs=25.7

Q ss_pred             CceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           20 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        20 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            379999999999999876678999987653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.64  E-value=0.011  Score=46.26  Aligned_cols=30  Identities=20%  Similarity=0.186  Sum_probs=26.0

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      ..++|+|+.+.|||++.++ ++|+||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            3599999999999998765 89999988865

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.55  E-value=0.013  Score=44.54  Aligned_cols=29  Identities=24%  Similarity=0.226  Sum_probs=23.8

Q ss_pred             CCceeecCCCCCeeecCCCcEEEcccCCccc
Q 027003           19 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   49 (229)
Q Consensus        19 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~   49 (229)
                      .++||+|+.+.|||++.+  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            468999999999999743  45899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=90.23  E-value=0.044  Score=42.71  Aligned_cols=15  Identities=33%  Similarity=0.454  Sum_probs=13.1

Q ss_pred             ceeecCCCCCeeecC
Q 027003           21 VIYRDFKASNILLDA   35 (229)
Q Consensus        21 ivHrDlkp~Nill~~   35 (229)
                      ++|+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            579999999999854